THIS INVENTION relates to compounds which are inhbitors across a broad range of cysteine proteases, to the use of these compounds, and to pharmaceutical compositions comprising them. Particular compounds of the invention are inhibitors of cathepsin K and related cysteine protesases of the CA clan. Furthermore, such compounds are useful for the in vivo therapeutic treatment of diseases in which participation of a cysteine protease is implicated.
Proteases form a substantial group of biological molecules which to date constitute approximately 2% of all the gene products identified following analysis of several completed genome sequencing programmes. Proteases have evolved to participate in an enormous range of biological processes, mediating their effect by cleavage of peptide amide bonds within the myriad of proteins found in nature. This hydrolytic action is performed by initially recognising, then binding to, particular three-dimensional electronic surfaces displayed by a protein, which aligns the bond for cleavage precisely within the protease catalytic site. Catalytic hydrolysis then commences through nucleophilic attack of the amide bond to be cleaved either via an amino acid side-chain of the protease itself, or through the action of a water molecule that is bound to and activated by the protease. Proteases in which the attacking nucleophile is the thiol side-chain of a Cys residue are known as cysteine proteases. The general classification of ‘cysteine protease’ contains many members found across a wide range of organisms from viruses, bacteria, protozoa, plants and fungi to mammals.
Cathepsin K and indeed many other crucial proteases belong to the papain-like CA C1 family. Cysteine proteases are classified into ‘clans’ based upon a similarity in the three-dimensional structure or a conserved arrangement of catalytic residues within the protease primary sequence. Additionally, ‘clans’ may be further classified into ‘families’ in which each protease shares a statistically significant relationship with other members when comparing the portions of amino acid sequence which constitute the parts responsible for the protease activity (see Barrett, A. J et al, in ‘Handbook of Proteolytic Enzymes’, Eds.
Barrett, A. J., Rawlings, N. D., and Woessner, J. F. Publ. Academic Press, 1998, for a thorough discussion).
To date, cysteine proteases have been classified into five clans, CA, CB, CC, CD and CE (Barrett, A. J. et al, 1998). A protease from the tropical papaya fruit ‘papain’ forms the foundation of clan CA, which currently contains over 80 distinct and complete entries in various sequence databases, with many more expected from the current genome sequencing efforts. Proteases of clan CA/family C1 have been implicated in a multitude of house-keeping roles and disease processes. e.g. human proteases such as cathepsin K (osteoporosis), cathepsin S (autoimmune disorders), cathepsin L (metastases), cathepsin B (metastases, arthritis), cathepsin F (antigen processing), cathepsin V (T-cell selection), dipeptidyl peptidase I (granulocyte serine protease activation) or parasitic proteases such as falcipain (malaria parasite Plasmodium falciparum) and cruzipain (Trypanosoma cruzi infection). Recently a bacterial protease, staphylopain (S. aureus infection) has also been tentatively assigned to clan CA. X-ray crystallographic structures are available for a range of the above mentioned proteases in complex with a range of inhibitors e.g. papain (PDB entries, 1pad, 1pe6, 1pip, 1pop, 4pad, 5pad, 6pad, 1ppp, 1the, 1csb, 1huc), cathepsin K (1au0, 1au2, 1au3, 1au4, 1atk, 1mem, 1bgo, 1ayw, 1ayu, 1 nl6, 1nlj), cathepsin L (1cs8, 1mhw), cathepsin S (1glo, 1ms6 and currently on-hold but published McGrath, M. E. et al, Protein Science, 7, 1294-1302, 1998), cathepsin V (1fh0), dipeptidyl peptidase I (1jqp, 1k3b), cathepsin B (1gmy), cathepsin F (currently on-hold, but published Somoza, J. R. et al, J. Mol. Biol., 322, 559-568, 2002), cruzain (a recombinant form of cruzipain see Eakin, A. E. et al, 268(9), 6115-6118, 1993) (1ewp, 1aim, 2aim, 1F29, 1F2A, 1F2B, 1F2C), staphylopain (1cv8). Each of the structures displays a similar overall active-site topology, as would be expected by their ‘clan’ and ‘family’ classification and such structural similarity exemplifies one aspect of the difficulties involved in discovering a selective inhibitor of cathepsin K suitable for human use. However, subtle differences in terms of the depth and intricate shape of the active site groove of each CA C1 protease are evident, which may be exploited for selective inhibitor design. Additionally, many of the current substrate-based inhibitor complexes of CA C1 family proteases show a series of conserved hydrogen bonds between the inhibitor and the protease backbone, which contribute significantly to inhibitor potency. Primarily a bidentate hydrogen-bond is observed between the protease Gly66 (C═O)/inhibitor N—H and the protease Gly66(NH)/inhibitor (C═O), where the inhibitor (C═O) and (NH) are provided by an amino acid residue NHCHRCO that constitutes the S2 sub-site binding element within the inhibitor (see Berger, A. and Schecter, I. Philos. Trans. R. Soc. Lond. [Biol.], 257, 249-264, 1970 for a description of protease binding site nomenclature). A further hydrogen-bond between the protease main-chain (C═O) of asparagine or aspartic acid (158 to 163, residue number varies between proteases) and an inhibitor (N—H) is often observed, where the inhibitor (N—H) is provided by the S1 sub-site binding element within the inhibitor. Thus, the motif X—NHCHRCO—NH—Y is widely observed amongst the prior art substrate-based inhibitors of CA C1 proteases.
Cathepsin K is thought to be significant in diseases involving excessive loss of bone or cartilage. Bone consists of a protein matrix incorporating hydroxyapatite crystals. About 90% of the structural protein of the matrix is type I collagen, with the remainder comprising various non-collagenous proteins such as osteocalcin, proteoglycans, osteopontin, osteonectin, thrombospondin, fibronectin and bone sialoprotein.
Skeletal bone is not a static structure but continually undergoes a cycle of bone resorption and replacement. Bone resorption is carried out by osteoclasts, which are multinuclear cells of haematopoietic lineage. Osteoclasts adhere to the bone surface and form a tight sealing zone. The membrane on the apical surface of the osteoclasts is folded so as to create a closed extracellular compartment between the osteoclast and the bone surface, which is acidified by proton pumps in the osteoclast membrane. Proteolytic enzymes are secreted into the compartment from the osteoclast. The high acidity in the compartment causes the hydroxyapatite at the surface of the bone to be dissolved and the proteolytic enzymes break down the protein matrix causing a resorption lacuna to be formed. Following bone resorption, osteoblasts produce a new protein matrix that is subsequently mineralised.
In disease states such as osteoporosis and Paget's disease, the bone resorption and replacement cycle is disrupted leading to a net loss of bone with each cycle. This leads to weakening of the bone and therefore to increased risk of bone fracture.
Cathepsin K is expressed at a high level in osteoclasts and is therefore thought to be essential for bone resorption. Therefore, selective inhibition of cathepsin K is likely to be effective in the treatment of diseases involving excessive bone loss. These include osteoporosis, gingival diseases such as gingivitis and periodontitis, Paget's disease, hypercalaemia of malignancy and metabolic bone disease.
In addition to osteoclasts, high levels of cathepsin K are also found in chondroclasts from the synovium of osteoarthritic patients. It therefore appears that cathepsin K inhibitors will be of use in the treatment of diseases involving matrix or cartilage degradation, in particular osteoarthritis and rheumatoid arthritis.
Elevated levels of cathepsin K are also found in metastatic neoplastic cells which suggests that cathepsin K inhibitors may also be useful for treating certain neoplastic diseases.
In the prior art, the development of cysteine protease inhibitors for human use has recently been an area of intense activity (e.g. see Bromme, D. and Kaleta, J., Curr. Pharm. Des., 8, 1639-1658, 2002; Kim, W. and Kang, K., Expert Opin. Ther. Patents, 12(3), 419-432, 2002; Leung-Toung, R. et al. Curr. Med. Chem., 9, 979-1002, 2002; Lecaille, F. et al., Chem. Rev., 102, 4459-4488, 2002; Hernandez, A. A. and Roush, W. R., Curr. Opin. Chem. Biol., 6, 459-465, 2002). Considering the CA C1 family members, particular emphasis has been placed upon the development of inhibitors of human cathepsins, primarily cathepsin K (osteoporosis), cathepsin S (autoimmune disorders), cathepsin L (metastases), cathepsin B (metastases, arthritis), cathepsin F (antigen processing), cathepsin V (T-cell selection) and dipeptidyl peptidase I (granulocyte serine protease activation), through the use of peptide and peptidomimetic nitriles (e.g. see WO-A-03041649, WO-A-03037892, WO-A-03029200, WO-A-02051983, WO-A-02020485, US-A-20020086996, WO-A-01096285, WO-A-0109910, WO-A-0051998, WO-A-0119816, WO-A-9924460, WO-A-0049008, WO-A-0048992, WO-A-0049007, WO-A-0130772, WO-A-0055125, WO-A-0055126, WO-A-0119808, WO-A-0149288, WO-A-0147886), linear and cyclic peptide and peptidomimetic ketones (e.g. see Veber, D. F. and Thompson, S. K., Curr. Opin. Drug Discovery Dev., 3(4), 362-369, 2000, WO-A-02092563, WO-A-02017924, WO-A-01095911, WO-A-0170232, WO-A-0178734, WO-A-0009653, WO-A-0069855, WO-A-0029408, WO-A-0134153 to WO-A-0134160, WO-A-0029408, WO-A-9964399, WO-A-9805336, WO-A-9850533), ketoheterocycles (e.g. see WO-A-02080920, WO-A-03042197, WO-A- WO-A-03024924, WO-A-0055144, WO-A-0055124), monobactams (e.g. see WO-A-0059881, WO-A-9948911, WO-A-0109169), α-ketoamides (e.g. see WO-A-03013518), cyanoamides (WO-A-01077073, WO-A-01068645), dihydro pyrimidines (e.g. see WO-A-02032879) and cyanoaminopyrimidines (e.g. see WO-A-03020278, WO-A-03020721). The prior art describes potent in vitro inhibitors, but also highlights the many difficulties in developing a human therapeutic. For example, WO-A-9850533 and WO-A-0029408 describe compounds that may be referred to as cyclic ketones and are inhibitors of cysteine proteases with a particular reference towards papain family proteases and as a most preferred embodiment, cathepsin K. WO-A-9850533 describes compounds subsequently detailed in the literature as potent inhibitors of cathepsin K with good oral bioavailability (Witherington, J., ‘Tetrahydrofurans as Selective Cathepsin K Inhibitors’, RSC meeting, Burlington House, London, 1999). The compounds of WO-A-9850533 were reported to bind to cathepsin K through the formation of a reversible covalent bond between the tetrahydrofuran carbonyl and the active site catalytic cysteine residue (Witherington, J., 1999). Additionally, the same cyclic ketone compounds are described in WO-A-9953039 as part of a wide-ranging description of inhibitors of cysteine proteases associated with parasitic diseases, with particular reference to the treatment of malaria by inhibition of falcipain. However, subsequent literature describes the cyclic ketone compounds of WO-A-9850533 to be unsuitable for further development or for full pharmacokinetic evaluation due to a physiochemical property of the inhibitors, the poor chiral stability of the α-aminoketone chiral centre (Marquis, R. W. et al, J. Med. Chem., 44(5), 725-736, 2001). WO-A-0069855 describes compounds that may also be referred to as cyclic ketones with particular reference towards inhibition of cathepsin S. The compounds of WO-A-0069855 are considered to be an advance on compounds of WO-A-9850533 due to the presence of the β-substituent on the cyclic ketone ring system that provides chiral stability to the α-carbon of the cyclic ketone ring system. However, the compounds of WO-A-0069855 and indeed those of WO-A-9850533 describe a requirement for the presence of the potential hydrogen-bonding motif X—NHCHRCO—NH—Y that is widely observed amongst the prior art substrate-based inhibitors of CA C1 proteases.
Our earlier patent application (WO-A-02057270) describes bicyclic compounds in which the chirality of the α-aminoketone is stabilised (for a review of energetic considerations within fused ring systems see Toromanoff, E. Tetrahedron Report No 96, 36, 2809-2931, 1980). These compounds do not contain the X—NHCHRCO—NH—Y motif and yet the compounds are highly potent inhibitors across a broad range of CA C1 cysteine proteases. In particular, certain of the compounds are potent and selective cruzipain inhibitors.
The present invention relates to variants of the compounds described in WO-A-02057270 which are also inhibitors of a wide range of CA C1 cysteine protease. In particular, some compounds of the present invention are potent and selective inhibitors of cathepsin K
Therefore, in the present invention, there is provided a compound of general formula (I)
wherein:
- Z=CR3R4, where R3 and R4 are independently chosen from C0-7-alkyl (when C=0, R3 or R4 is simply a hydrogen atom), C3-6-cycloalkyl, Ar—C0-4-alkyl (when C=0, R3 or R4 is simply an aromatic moiety Ar),
- P1=CR5R6, where R5 and R6 are independently chosen from C0-7-alkyl, C3-6-cycloalkyl, Ar—C0-7-alkyl, O—C0-7-alkyl, O—C3-6-cycloalkyl, O—Ar—C0-7-alkyl, S—C0-7-alkyl, S—C3-6-cycloalkyl, S—Ar—C0-7-alkyl, NH—C0-7-alkyl, NH—C3-6-cycloalkyl, NH—Ar—C0-7-alkyl, N(C0-7-alkyl)2, N(C3-6-cycloalkyl)2 or N(Ar—C0-7-alkyl)2;
- P2=O, CR7R8 or NR9, where R7 and R8 are independently chosen from C0-7-alkyl, C3-6-cycloalkyl, Ar—C0-7-alkyl and R9 is chosen from C0-7-alkyl, C3-6-cycloalkyl or Ar—C0-7-alkyl;
- Y=CR10R11—C(O) or CR10R11—C(S) or CR10R11—S(O) or CR10R11—SO2 where R10 and R11 are independently chosen from C0-7-alkyl, C3-6-cycloalkyl and Ar—C0-7-alkyl, or Y represents
- where L is a number from one to four and R12 and R13 are independently chosen from CR14R15 where R14 and R15 are independently chosen from C0-7-alkyl, C3-6-cycloalkyl, Ar—C0-7-alkyl or halogen; and for each R12 and R13 either R14 or R15 (but not both R14 and R15) may additionally be chosen from O—C0-7-alkyl, O—C3-6-cycloalkyl, O—Ar—C0-7-alkyl, S—C0-7-alkyl, S—C3-6-cycloalkyl, S—Ar—C0-7-alkyl, NH—C0-7-alkyl, NH—C3-6-cycloalkyl, NH—Ar—C0-7-alkyl, N—(C0-7-alkyl)2, N—(C3-6-cycloalkyl)2, and N—(Ar—C0-7-alkyl)2;
- (X)o=CR16R17, where R16 and R17 are independently chosen from C0-7-alkyl, C3-6-Cycloalkyl and Ar—C0-7-alkyl and o is a number from zero to three;
- (W)n=O, S, C(O), S(O) or S(O)2 or NR18, where R18 is chosen from C0-7-alkyl, C3-6-cycloalkyl and Ar—C0-7-alkyl and n is zero or one;
- (V)m=C(O), C(S), S(O), S(O)2, S(O)2NH, OC(O), NHC(O), NHS(O), NHS(O)2, OC(O)NH, C(O)NH or CR19R20, C═N—C(O)—OR19 or C═N—C(O)—NHR19, where R19 and R20 are independently chosen from C0-7 alkyl, C3-6-cycloalkyl, Ar—C0-7-alkyl and m is a number from zero to three, provided that when m is greater than one, (V)m contains a maximum of one carbonyl or sulphonyl group;
- U=a stable 5- to 7-membered monocyclic or a stable 8- to 11-membered bicyclic ring which is either saturated or unsaturated and which includes zero to four heteroatoms (as detailed below):
- wherein R21 is:
- C0-7-alkyl, C3-6-cycloalkyl, Ar—C0-7-alkyl, O—C0-7-alkyl, O—C3-6-cycloalkyl, —O—Ar—C0-7-alkyl, S—C0-7-alkyl, S—C3-6-cycloalkyl, S—Ar—C0-7-alkyl, SO2—C0-7-alkyl, SO2—C3-6-cycloalkyl, SO2—Ar—C0-7-alkyl, NH—C0-7-alkyl, NH—C3-6-cycloalkyl, NH—Ar—C0-7-alkyl, N(C0-7-alkyl)2, N(C3-6-cycloalkyl)2 or N(Ar—C0-7-alkyl)2; or, when part of a CHR21 or CR21 group, R21 may be halogen;
- A is chosen from:
- CH2, CHR21, O, S, SO2, NR22 or N-oxide (N→O), where R21 is as defined above; and R22 is chosen from C0-7-alkyl, C3-6-cycloalkyl and Ar—C0-7-alkyl;
- B, D and G are independently chosen from:
- CR21, where R21 is as defined above, or N or N-oxide (N→O);
- E is chosen from:
CH2, CHR21, O, S, SO2, NR2 or N-oxide (N→O), where R21 and R22 are defined as above;
- K is chosen from:
- CH2, CHR22, where R22 is defined as above;
- J, L, M, R, T, T2, T3 and T4 are independently chosen from:
- CR21 where R21 is as defined above, or N or N-oxide (N→O);
- T5 is chosen from:
- T6 is chosen from:
- NR22, SO2, OC(O), C(O), NR22C(O);
- q is a number from one to three, thereby defining a 5-, 6- or 7-membered ring;
- R1═R2C(O), R2OC(O), R2NQC(O), R2SO2, where R2 is chosen from C1-7-alkyl, C3-6-cycloalkyl or Ar—C0-7-alkyl (when C=0, R2 is simply an aromatic moiety Ar) and Q is C0-7-alkyl;
- provided that when Y is other than CR10R11—C(O) or when U is:
- R1 may also be C0-7-alkyl, C3-6-cycloalkyl or Ar—C7-alkyl.
The present invention includes all salts, hydrates, solvates, complexes and prodrugs of the compounds of this invention. The term “compound” is intended to include all such salts, hydrates, solvates, complexes and prodrugs, unless the context requires otherwise.
Appropriate pharmaceutically and veterinarily acceptable salts of the compounds of general formula (I) include salts of organic acids, especially carboxylic acids, including but not limited to acetate, trifluoroacetate, lactate, gluconate, citrate, tartrate, maleate, malate, pantothenate, adipate, alginate, aspartate, benzoate, butyrate, digluconate, cyclopentanate, glucoheptanate, glycerophosphate, oxalate, heptanoate, hexanoate, fumarate, nicotinate, palmoate, pectinate, 3-phenylpropionate, picrate, pivalate, proprionate, tartrate, lactobionate, pivolate, camphorate, undecanoate and succinate, organic sulphonic acids such as methanesulphonate, ethanesulphonate, 2-hydroxyethane sulphonate, camphorsulphonate, 2-naphthalenesulphonate, benzenesulphonate, p-chlorobenzenesulphonate and p-toluenesulphonate; and inorganic acids such as hydrochloride, hydrobromide, hydroiodide, sulphate, bisulphate, hemisulphate, thiocyanate, persulphate, phosphoric and sulphonic acids. Salts which are not pharmaceutically or veterinarily acceptable may still be valuable as intermediates.
Prodrugs are any covalently bonded compounds which release the active parent drug according to general formula (I) in vivo. A prodrug may for example constitute an acetal or hemiacetal derivative of the exocyclic ketone functionality present in the hexahydropyrrolo[3,2-b]pyrrol-3-one, hexahydropyrrolo[3,2-c]pyrazol-6-one or hexahydro-2-oxa-1,4-diazapentalen-6-one scaffold. If a chiral centre or another form of isomeric centre is present in a compound of the present invention, all forms of such isomer or isomers, including enantiomers and diastereoisomers, are intended to be covered herein. Compounds of the invention containing a chiral centre may be used as a racemic mixture, an enantiomerically enriched mixture, or the racemic mixture may be separated using well-known techniques and an individual enantiomer may be used alone.
‘Halogen’ as applied herein is meant to include F, Cl, Br, I;
‘Heteroatom’ as applied herein is meant to include O, S and N;
‘C0-7-alkyl’ as applied herein is meant to include stable straight and branched chain aliphatic carbon chains containing zero (i.e. simply hydrogen) to seven carbon atoms such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, pentyl, isopentyl, hexyl, heptyl and any simple isomers thereof. Additionally, where ‘C0-7-alkyl’ contains 2 or more contiguous carbon atoms, an alkene (—CH═CH—) may be present. Additionally, any C0-7-alkyl may optionally be substituted at any point by one, two or three halogen atoms (as defined above) for example to give a trifluoromethyl substituent. Furthermore, C0-7-alkyl may contain one or more heteroatoms (as defined above) for example to give ethers, thioethers, sulphones, sulphonamides, substituted amines, amidines, guanidines, carboxylic acids, carboxamides. If the heteroatom is located at a chain terminus then it is appropriately substituted with one or two hydrogen atoms. A heteroatom or halogen is only present when C0-7-alkyl contains a minimum of one carbon atom. For example, the group CH3—CH2—O—CH2—CH2— is defined within ‘C0-7-alkyl’ as a C4 alkyl that contains a centrally positioned heteroatom whereas the group CH3—CH2—CH2—CH2— is defined within ‘C0-7-alkyl’ as an unsubstituted C4 alkyl.
‘C3-6-cycloalkyl’ as applied herein is meant to include any variation of ‘C0-7-alkyl’ which additionally contains a carbocyclic ring such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl. The carbocyclic ring may optionally be substituted at any position with one or more halogens (as defined above) or heteroatoms (as defined above) for example to give a tetrahydrofuran, pyrrolidine, piperidine, piperazine or morpholine substituent.
‘Ar—C0-7-alkyl’ as applied herein is meant to include any variation of C0-7-alkyl which additionally contains an aromatic ring moiety ‘Ar’. The aromatic ring moiety Ar can be a stable 5 or 6-membered monocyclic or a stable 8 to 10 membered bicyclic ring which is unsaturated, as defined previously for U in general formula (I). The aromatic ring moiety Ar may be substituted by R21 (as defined above for U in general formula (I)). When C=0 in the substituent Ar—C0-7-alkyl, the substituent is simply the aromatic ring moiety Ar.
Other expressions containing terms such as alkyl and cycloalkyl are intended to be construed according to the definitions above. For example “C1-4 alkyl” is the same as C0-7-alkyl except that it contains from one to four carbon atoms.
If different structural isomers are present, and/or one or more chiral centres are present, all isomeric forms are intended to be covered. Enantiomers are characterised by the absolute configuration of their chiral centres and described by the R- and S-sequencing rules of Cahn, Ingold and Prelog. Such conventions are well known in the art (e.g. see ‘Advanced Organic Chemistry’, 3rd edition, ed. March, J., John Wiley and Sons, New York, 1985). It is also intended to include compounds of general formula (I) where any hydrogen atom has been replaced by a deuterium atom.
Compounds of general formula I are inhibitors of a wide range of CA C1 cysteinyl proteases for example cathepsin K, cathepsin S, cathepsin L, cathepsin F, cathepsin B, cruzipains, falcipains and leismania mexicana CPB protease.
For all the above mentioned CA C1 proteases, the preferred fundamental backbone shape of inhibitor molecules is broadly similar. Therefore, the preferred compounds of general formula (I) will have similar (V)m, (W)n, (X)o and R1 whether they act as cathepsin K cathepsin S, cathepsin L, cathepsin F, cathepsin B, cruzipains, falcipains or leismania mexicana CPB protease inhibitors. Within general formula (I), inhibitory potency and selectivity for each CA C1 protease is primarily determined by different preferences for the Y and U groups for each CA C1 protease.
Preferred compounds of general formula (I) include, but are not limited to those which, independently or in any combination:
Z is CH2;
P1 is CH2;
P2 is CH2, O or NH.
As mentioned above, cysteine protease inhibitors of general formula (I), comprise an R2 group chosen from C1-7-alkyl, C3-cycloalkyl and Ar—C0-7-alkyl.
When R2 comprises Ar—C0-7-alkyl, preferred R2 groups comprise Ar—C0-2-alkyl and examples include but are not limited to:
where J, L, M, R, T, T2, T3 and T4, B, D, G and E are as previously defined.
More preferred R2 comprises Ar—C0-1-alkyl and examples of such R2 groups include, but are not limited to:
where J, L, M, T2, T3, T4, B, D, G and E are as previously defined.
Still more active compounds of general formula (I) are those in which R2 comprises a monocyclic Ar—C0-1-alkyl and forms part of an R1 group such as:
wherein:
- J, L, M, B, D and G are as defined above (i.e. CR21, N or N→O) and wherein R21 is chosen from hydrogen, methyl, methoxy, ethyl, isopropyl, trifluoromethyl, trifluoromethoxy, F, Cl, SO2Me; and
E is as previously defined; and
Q is chosen from hydrogen or methyl.
In cysteine protease inhibitors of general formula (I) when R2 is C1-7-alkyl, preferred R2 groups comprise C3-7-alkyl which may include an —O— or —NH— as part of the chain and which is either unsubstituted or is substituted with one or more NH2, NHMe, NHC(O)CH3, NMeC(O)CH3, OH or OMe groups.
When R2 is C3-7-alkyl, more preferred groups include C3-6-alkyl, in particular those which are branched at the α-position or which include an NH2, NHMe, NHC(O)CH3, NMeC(O)CH3, OH or OMe substituent at the α-position.
In cysteine protease inhibitors of general formula (I) when R2 is C3-6-cycloalkyl, R2 may include a heteroatom in the ring system. Examples of R2 groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, pyrrolidine, piperidine, morpholine, tetrahydrofuran, cyclopentene, cyclopentadiene, cyclohexadiene and piperazine. Nitrogen-containing rings may be N-substituted with groups such as C1-4 alkyl, phenyl or benzyl.
It is yet more preferred that when R2 is a C3-6-cycloalkyl group, the ring system is either connected directly to the remainder of the R1 moiety or there is one intervening methylene group. The inventors have found that the activity of the molecule increases with the size of the cycloalkyl ring and therefore compounds in which R2 is a five- or six-membered cyclic ring are most favourable.
In compounds of general formula (I), particularly preferred R1 groups therefore include: benzoyl; pyridine-2-carbonyl; 1-oxy-pyridine-2-carbonyl; pyridine-3-carbonyl; 1-oxy-pyridine-3-carbonyl; pyridine-4-carbonyl; 1-oxy-pyridine-4-carbonyl; phenyl sulphonyl; pyridine-2-sulphonyl; 1-oxy-pyridine-2-sulphonyl; pyridine-3-sulphonyl; 1-oxy-pyridine-3-sulphonyl; pyridine-4-sulphonyl; 1-oxy-pyridine-4 sulphonyl; phenylacetyl; phenylcarbamoyl; isobutylcarbamoyl; phenyloxycarbonyl; isobutyloxycarbonyl; pyrrolidine-N-carbonyl; piperidine-N-carbonyl; morpholin-N-carbonyl; piperazine-N-carbonyl; 4-methyl-piperazie-N-carbonyl; (4-methyl-piperazin-1-yl)-acetoyl; piperazin-1-yl-acetoyl; furan-2-carbonyl; 5-chlorofuran-2-carbonyl; thiophene-2-carbonyl; 5-chlorothiophene-2-carbonyl; furan-3-carbonyl; thiophene-3-carbonyl; cyclopentoyl; cyclohexoyl; cyclopent-3-enoyl; cyclopentylmethylcarbonyl; cyclohexylmethylcarbonyl; pyrrolidine-2-carbonyl; N-acetyl-pyrrolidine-2-carbonyl; piperidine-2-carbonyl; N-acetyl-piperidine-2-carbonyl; tetrahydrofuran-2-carbonyl; 1-aminocyclobutanoyl; 1-aminocyclopentanoyl; 1-aminocyclohexanoyl; N-acetyl-1-aminocyclobutanoyl; N-acetyl-1-aminocyclopentanoyl; N-acetyl-1-aminocyclohexanoyl; 1-hydroxycyclobutanoyl; 1-hydroxycyclopentanoyl; 1-hydroxycyclohexanoyl; 1-methoxycyclobutanoyl; 1-methoxycyclopentanoyl; 1-methoxycyclohexanoyl; aminocyclopentylacetoyl; aminocyclohexylacetoyl; N-acetylaminocyclopentylacetoyl; N-acetylaminocyclohexylacetoyl; 2-acetylaminopropionoyl; 2-acetylaminoethanoyl; 2-acetyl-N-methylaminoethanoyl; N,N-dimethylaminoacetoyl; 2-aminobutanoyl; N-acetyl-2-aminobutanoyl; 2-amino-3-methylbutanoyl; N-acetyl-2-amino-3-methylbutanoyl, 2-amino-3,3-dimethylbutanoyl; N-acetyl-2-amino-3,3-dimethylbutanoyl; 2-amino-3-methylpentanoyl; N-acetyl-2-amino-3-methylpentanoyl; pentanoyl; 3-methylpentanoyl; 4-methylpentanoyl; 2-amino-4-methylpentanoyl; N-acetyl-2-amino-4-methylpentanoyl; 2-amino-4,4-dimethylpentanoyl; N-acetyl-2-amino-4,4-dimethylpentanoyl; 2-aminopentanoyl; N-acetyl-2-aminopentanoyl; 2-amino-5-methylhexanoyl; N-acetyl-2-amino-5-methylhexanoyl; 2-hydroxy-3-methylbutanoyl; 2-methoxy-3-methylbutanoyl; 2-hydroxy-3,3-dimethylbutanoyl; 2-methoxy-3,3-dimethylbutanoyl; 2-hydroxy-3-methylpentanoyl; 2-methoxy-3-methylpentanoyl; 2-hydroxy-4-methylpentanoyl; 2-methoxy-methylpentanoyl; 2-hydroxy-4,4-dimethylpentanoyl; 2-methoxy-4,4-dimethylpentanoyl; 2hydroxypentanoyl; 2-methoxypentanoyl; 2-hydroxy-5-methylhexanoyl; 2-methoxy-5-methylhexanoyl;
In cysteine protease inhibitors of general formula (I), it is preferred that in the group (X)o, each of R16 and R17 is selected from C0-7-alkyl or Ar—C0-7-alkyl, for example hydrogen, a straight or branched alkyl chain, a straight or branched heteroalkyl chain, an optionally substituted arylalkyl chain or an optionally substituted arylheteroalkyl chain.
More preferred (X)o groups comprise R16 chosen from hydrogen; R17 chosen from hydrogen or C1-4-alkyl, which may be substituted with OH, NR22R22, COOR22, or CONR22; or Ar—C1-4-alkyl, where the aryl group may be substituted with R21, wherein each R21 and R22 is independently as defined previously.
Yet more preferred (X)o groups are those in which R16 is from hydrogen and R17 is chosen from hydrogen or simple C1-4-alkyl groups such as methyl, ethyl, propyl, butyl.
In the most preferred (X)o groups, R16 and R17 are hydrogen and o is zero or one.
Preferred compounds of general formula (I) are those in which, in the group (W)n, W is chosen from O, S, SO2, S(O), C(O) or NR18, where R18 is chosen from C0-7-alkyl; and n is zero or one.
In more preferred (W)n groups, W comprises O, S, SO2, C(O) or NH where n is zero or one.
Still more active compounds are those in which W is C(O) or NH where n is zero or one.
It is most preferred that in the group (W)n, W is NH and n is zero or one.
In protease inhibitors of general formula (I), more active compounds are those in which, in the group (V)m, V is chosen from C(O), OC(O), NHC(O), C(O)NH, CHR20; C—N—C(O)—OR19 or C═N—C(O)—NHR19
- where R19 is chosen from C0-7-alkyl, C3-6-cycloalkyl, Ar—C0-7-alkyl and R20 is C0-4-alkyl, and
m is zero or one.
Examples of preferred V and W substituent combinations include, but are not limited to:
Preferred V, W and X substituent combinations include, but are not limited to:
As mentioned above, the substituents Y and U are important in determining the inhibitory potency and selectivity for various proteases and the preferred Y and U substituents vary depending on the target protease.
In compounds of general formula (I) that are inhibitors of cathepsin K, it is preferred that the Y substituent is CHR11CO where R11 is selected from C0-7-alkyl, Ar—C0-7-alkyl or C3-6-cycloalkyl. Examples of suitable R11 groups include, for example, hydrogen, a straight or branched alkyl chain, a straight or branched heteroalkyl chain, an optionally substituted arylalkyl chain or an optionally substituted arylheteroalkyl chain, cyclohexylmethyl or cyclopentylmethyl. Additionally, preferred compounds of general formula (I) are those in which Y comprises a group:
where R12 and R13 are each CR14R15 and each R14 and R15 is, independently, selected from C0-7-alkyl or Ar—C0-7-alkyl, for example hydrogen, a straight or branched alkyl chain, a straight or branched heteroalkyl chain, an optionally substituted arylalkyl chain or an optionally substituted arylheteroalkyl chain and L is a number from one to four.
Examples of preferred Y substituents in compounds of general formula (I) which are inhibitors of cathepsin K include, but are not limited to:
wherein E, R21, R22 and Ar are as defined previously, any of which may be substituted with one or more halogen, preferably fluoro, substituents.
In compounds that are inhibitors of cathepsin K, more preferred R11 groups include C1-4-alkyl, which may be substituted with cycloalkylmethyl or halogen, or R11 is chosen from cycloalkyl-1-carbonyl or R11 is chosen from Ar—C1-4-alkyl, where the aryl group may be substituted with R21; where R21 is defined above.
Increased inhibition of cathepsin K can be achieved in compounds in which the R11 groups are simple branched alkyl groups such as isobutyl or straight alkyl chains such as n-propyl, optionally substituted with one or more halogen (preferably fluoro) substitutents. Yet more preferred R11 groups comprise ArCH2—, where the aromatic ring is an optionally substituted monocyclic heterocycle and still more preferred R11 groups comprise cyclopropylmethyl and cyclohexyl-1-carbonyl. In compounds which are particularly active inhibitors of cathepsin K, Y substituents include, but are not limited to:
wherein R24 is chosen from hydrogen, methyl, methoxy, ethyl, isopropyl, F, Cl and wherein any of the alkyl groups may be substituted with one or more F or Cl.
In order to maximise the inhibition of cathepsin K, the compound of formula (I) may comprise R11 groups which are simple branched alkyl groups such as isobutyl or n-propyl or halogen substituted variants thereof such as 3,3,3-trifluoro-2-trifluoromethylpropyl.
In compounds of general formula (I) that are inhibitors of cathepsin K, it is preferred that the group U comprises an optionally substituted 5- or 6-membered saturated or unsaturated heterocycle or Ar group or an optionally substituted saturated or unsaturated 8 to 10-membered heterocycle or Ar group. Examples of such preferred U rings include, but are not limited to the following:
wherein R21, R22, A, B, D, E, G, J, L, M, R, T, T2, T4, T5 and T6 are as defined previously.
Stronger inhibition of cathepsin K can be achieved in compounds where the U groups comprise a bulky alkyl or aryl group at the para position of an aryl; a meta or para 5,6-biaryl Ar—Ar, where Ar is as previously defined; a 6,6 or 6,5 or 5,5-fused aromatic ring, where Ar is as previously defined, or a 4-substituted piperazine. Examples of more preferred U groups include but are not limited to:
wherein R21, R22, D, E, G, J, L, M, R, T, T2 and T4 are as defined previously.
In compounds that are inhibitors of cathepsin K, even more preferred U groups, comprise a 6-membered aromatic ring Ar containing a bulky alkyl or aryl group at the para position; a meta or para-biaryl Ar—Ar, where Ar is as previously defined; a 6,6 or 6,5 or 5,5-fused aromatic ring, where Ar is as previously defined; or a 4-substituted piperazine where R25 is chosen from hydrogen, C1-2-alkyl or Ar—C0-2-alkyl. Examples of even more preferred U groups include but are not limited to:
wherein R21, R25, D, E, G, J, L, M, R, T and T4 are as defined previously.
In order to maximise inhibition of cathepsin K, compounds of general formula (I) may be selected to have U groups chosen from the following:
wherein R21, R25, D, E, G, M, R and T are as defined previously.
In order to achieve the greatest inhibitory effect against cathepsin S, it is preferred that the Y substituent is chosen from the following;
wherein (X)o′ and Ar are as previously defined.
In order to achieve the greatest inhibitory effect against cathepsin S, it is preferred that the group U comprises an optionally substituted 5-membered unsaturated heterocycle or a 6,5- 5,5- or 5,6-fused aromatic ring, where Ar is as previously defined or a morpholine. Examples of such preferred U rings include, but are not limited to the following:
wherein R21, B, D, E, G, J, L, M, R and T6 are as defined previously.
In order to achieve the greatest inhibitory effect against cathepsin S whilst retaining selectivity against other CA C1 cysteinyl proteases, it is more preferred that the group U comprises an optionally substituted 5-membered unsaturated heterocycle or a 6,5- or 5,5-fused aromatic ring, where Ar is as previously defined. Examples of more preferred U rings include, but are not limited to the following:
wherein B, D, E, J, L, M, R and T6 are as defined previously.
In order to achieve the greatest inhibitory effect against cathepsin L, it is preferred that the Y substituent is chosen as an aromatic group as follows;
wherein T7 is chosen from CH, N or CR21 where R21 is as defined previously.
In particular, for cathepsin L inhibition it is more preferred that within the T7 substituent that the R21 substituent is chosen from single and multiple ring substitution combinations of Me, F, Cl, OH and OMe.
In order to achieve the greatest inhibitory effect against cathepsin L, it is preferred that the group U comprises an optionally substituted 5-membered unsaturated heterocycle or a 6,6- or 6,5- or 5,6-fused aromatic ring, where Ar is as previously defined or a meta-substituted Ar. Examples of such preferred U rings include, but are not limited to the following:
wherein R21, B, D, E, G. J, L, M, R, T, T2 and T3 are as defined previously.
In order to achieve the greatest inhibitory effect against cathepsin L whilst retaining selectivity against other CA C1 cysteinyl proteases, it is more preferred that the group U comprises a substituted 5-membered unsaturated heterocycle or a 6,6-fused aromatic ring, where Ar is as previously defined or a meta-substituted Ar. Examples of such preferred U rings include, but are not limited to the following:
wherein E is chosen from oxygen or N-ethyl, D is chosen from nitrogen or CCH3, B is chosen from nitrogen or CCH3, R21 is chosen from halogen, OMe, CF3, OCF3, CH2NH2 and J, L, M, R, T and T3 are as previously defined.
The inventors have observed that for the cruzipains and leismania mexicana CPB protease, that the U and Y substituent preferences are composed of a mixture of those described earlier for cathepsin K and cathepsin L. In essence, many of the preferred cathepsin K and cathepsin L inhibitors also show potency against the cruzipains and leismania mexicana CPB protease as highlighted in the EXAMPLES section. Such promiscurity can be used to provide potent and selective inhibitors of the cruzipains and leismania meicana CPB protease by combining a preferred U substituent as described for cathepsin K with a preferred Y substituent as described for cathepsin L or by combining a preferred U substituent as described for cathepsin L with a preferred Y substituent as described for cathepsin K Such preferred combinations provide potent inhibitors of the cruzipains and leismania mexicana CPB protease with selectivity against either or both cathepsin K and cathepsin L.
Particular compounds of the invention are selected from the compounds formed by joining one of the ‘U—(V)m’ fragments herein defined as the ‘Capping group (Cg1 to Cg103)’ of general formula (I) shown in Table 1, with one of the ‘(W)n—(X)o—Y’ fragments herein defined as the ‘P2 pocket group (Pg1 to Pg39)’ of general formula (I) shown in Table 2, with a 5,5-bicyclic scaffold containing one of the R1 fragments herein defined as the ‘Prime-side binding group (Ps1 to Ps243)’ of general formula (I) shown in Table 3.
TABLE 1
|
|
‘Capping group Cg’ Fragments
U—(V)m
|
|
Cg1
|
Cg2
|
Cg3
|
Cg4
|
Cg5
|
Cg6
|
Cg7
|
Cg8
|
Cg9
|
Cg10
|
Cg11
|
Cg12
|
Cg13
|
Cg14
|
Cg15
|
Cg16
|
Cg17
|
Cg18
|
Cg19
|
Cg20
|
Cg21
|
Cg22
|
Cg23
|
Cg24
|
Cg25
|
Cg26
|
Cg27
|
Cg28
|
Cg29
|
Cg30
|
Cg31
|
Cg32
|
Cg33
|
Cg34
|
Cg35
|
Cg36
|
Cg37
|
Cg38
|
Cg39
|
Cg40
|
Cg41
|
Cg42
|
Cg43
|
Cg44
|
Cg45
|
Cg46
|
Cg47
|
Cg48
|
Cg49
|
Cg50
|
Cg51
|
Cg52
|
Cg53
|
Cg54
|
Cg55
|
Cg56
|
Cg57
|
Cg58
|
Cg59
|
Cg60
|
Cg61
|
Cg62
|
Cg63
|
Cg64
|
Cg65
|
Cg66
|
Cg67
|
Cg68
|
Cg69
|
Cg70
|
Cg71
|
Cg72
|
Cg73
|
Cg74
|
Cg75
|
Cg76
|
Cg77
|
Cg78
|
Cg79
|
Cg80
|
Cg81
|
Cg82
|
Cg83
|
Cg84
|
Cg85
|
Cg86
|
Cg87
|
Cg88
|
Cg89
|
Cg90
|
Cg91
|
Cg92
|
Cg93
|
Cg94
|
Cg95
|
Cg96
|
Cg97
|
Cg98
|
Cg99
|
Cg100
|
Cg101
|
Cg102
|
Cg103
|
*signifies the point of attachment of ’Cg groups’ to ‘Pg groups’.
|
TABLE 2
|
|
|
‘P2 pocket group Pg’ Fragments
|
(W)n—(X)o—Y
|
|
|
Pg1
|
|
Pg2
|
|
Pg3
|
|
Pg4
|
|
Pg5
|
|
Pg6
|
|
Pg7
|
|
Pg8
|
|
Pg9
|
|
Pg10
|
|
Pg11
|
|
Pg12
|
|
Pg13
|
|
Pg14
|
|
Pg15
|
|
Pg16
|
|
Pg17
|
|
Pg18
|
|
Pg19
|
|
Pg20
|
|
Pg21
|
|
Pg22
|
|
Pg23
|
|
Pg24
|
|
Pg25
|
|
Pg26
|
|
Pg27
|
|
Pg28
|
|
Pg29
|
|
Pg30
|
|
Pg31
|
|
Pg32
|
|
Pg33
|
|
Pg34
|
|
Pg35
|
|
Pg36
|
|
Pg37
|
|
Pg38
|
|
Pg39
|
|
**signifies the point of attachment of ‘Pg groups’ to 5,5-bicyclic scaffold.
|
TABLE 3
|
|
|
‘Prime-side binding group Ps’ Fragments
|
R1
|
|
|
Ps1
|
|
Ps2
|
|
Ps3
|
|
Ps4
|
|
Ps5
|
|
Ps6
|
|
Ps7
|
|
Ps8
|
|
Ps9
|
|
Ps10
|
|
Ps11
|
|
Ps12
|
|
Ps13
|
|
Ps14
|
|
Ps15
|
|
Ps16
|
|
Ps17
|
|
Ps18
|
|
Ps19
|
|
Ps20
|
|
Ps21
|
|
Ps22
|
|
Ps23
|
|
Ps24
|
|
Ps25
|
|
Ps26
|
|
Ps27
|
|
Ps28
|
|
Ps29
|
|
Ps30
|
|
Ps31
|
|
Ps32
|
|
Ps33
|
|
Ps34
|
|
Ps35
|
|
Ps36
|
|
Ps37
|
|
Ps38
|
|
Ps39
|
|
Ps40
|
|
Ps41
|
|
Ps42
|
|
Ps43
|
|
Ps44
|
|
Ps45
|
|
Ps46
|
|
Ps47
|
|
Ps48
|
|
Ps49
|
|
Ps50
|
|
Ps51
|
|
Ps52
|
|
Ps53
|
|
Ps54
|
|
Ps55
|
|
Ps56
|
|
Ps57
|
|
Ps58
|
|
Ps59
|
|
Ps60
|
|
Ps61
|
|
Ps62
|
|
Ps63
|
|
Ps64
|
|
Ps65
|
|
Ps66
|
|
Ps67
|
|
Ps68
|
|
Ps69
|
|
Ps70
|
|
Ps71
|
|
Ps72
|
|
Ps73
|
|
Ps74
|
|
Ps75
|
|
Ps76
|
|
Ps77
|
|
Ps78
|
|
Ps79
|
|
Ps80
|
|
Ps81
|
|
Ps82
|
|
Ps83
|
|
Ps84
|
|
Ps85
|
|
Ps86
|
|
Ps87
|
|
Ps88
|
|
Ps89
|
|
Ps90
|
|
Ps91
|
|
Ps92
|
|
Ps93
|
|
Ps94
|
|
Ps95
|
|
Ps96
|
|
Ps97
|
|
Ps98
|
|
Ps99
|
|
Ps100
|
|
Ps101
|
|
Ps102
|
|
Ps103
|
|
Ps104
|
|
Ps105
|
|
Ps106
|
|
Ps107
|
|
Ps108
|
|
Ps109
|
|
Ps110
|
|
Ps111
|
|
Ps112
|
|
Ps113
|
|
Ps114
|
|
Ps115
|
|
Ps116
|
|
Ps117
|
|
Ps118
|
|
Ps119
|
|
Ps120
|
|
Ps121
|
|
Ps122
|
|
Ps123
|
|
Ps124
|
|
Ps125
|
|
Ps126
|
|
Ps127
|
|
Ps128
|
|
Ps129
|
|
Ps130
|
|
Ps131
|
|
Ps132
|
|
Ps133
|
|
Ps134
|
|
Ps135
|
|
Ps136
|
|
Ps137
|
|
Ps138
|
|
Ps139
|
|
Ps140
|
|
Ps141
|
|
Ps142
|
|
Ps143
|
|
Ps144
|
|
Ps145
|
|
Pd146
|
|
Ps147
|
|
Ps148
|
|
Ps149
|
|
Ps150
|
|
Ps151
|
|
Ps152
|
|
Ps153
|
|
Ps154
|
|
Ps155
|
|
Ps156
|
|
Ps157
|
|
Ps158
|
|
Ps159
|
|
Ps160
|
|
Ps161
|
|
Ps162
|
|
Ps163
|
|
Ps164
|
|
Ps165
|
|
Ps166
|
|
Ps167
|
|
Ps168
|
|
Ps169
|
|
Ps170
|
|
Ps171
|
|
Ps172
|
|
Ps173
|
|
Ps174
|
|
Ps175
|
|
Ps176
|
|
Ps177
|
|
Ps178
|
|
Ps179
|
|
Ps180
|
|
Ps181
|
|
Ps182
|
|
Ps183
|
|
Ps184
|
|
Ps185
|
|
Ps186
|
|
Ps187
|
|
Ps188
|
|
Ps189
|
|
Ps190
|
|
Ps191
|
|
Ps192
|
|
Ps193
|
|
Ps194
|
|
Ps195
|
|
Ps196
|
|
Ps197
|
|
Ps198
|
|
Ps199
|
|
Ps200
|
|
Ps201
|
|
Ps202
|
|
Ps203
|
|
Ps204
|
|
Ps205
|
|
Ps206
|
|
Ps207
|
|
Ps208
|
|
Ps209
|
|
Ps210
|
|
Ps211
|
|
Ps212
|
|
Ps213
|
|
Ps214
|
|
Ps215
|
|
Ps216
|
|
Ps217
|
|
Ps218
|
|
Ps219
|
|
Ps220
|
|
Ps221
|
|
Ps222
|
|
Ps223
|
|
Ps224
|
|
Ps225
|
|
Ps226
|
|
Ps227
|
|
Ps228
|
|
Ps229
|
|
Ps230
|
|
Ps231
|
|
Ps232
|
|
Ps233
|
|
Ps234
|
|
Ps235
|
|
Ps236
|
|
Ps237
|
|
Ps238
|
|
Ps239
|
|
Ps240
|
|
Ps241
|
|
Ps242
|
|
Ps243
|
|
***signifies the point of attachment of ‘Ps groups’ to 5,5-bicyclic scaffold.
|
Particularly preferred compounds of the invention are inhibitors of cathepsin K and include but are not limited to the compounds formed by the following Cg-Pg-Ps combinations;
|
|
Cg5-Pg1-Ps1Cg5-Pg1-Ps2Cg5-Pg1-Ps3Cg5-Pg1-Ps4
Cg5-Pg1-Ps5Cg5-Pg1-Ps6Cg5-Pg1-Ps7Cg5-Pg1-Ps8
Cg5-Pg1-Ps9Cg5-Pg1-Ps10Cg5-Pg1-Ps11Cg5-Pg1-Ps12
Cg5-Pg1-Ps13Cg5-Pg1-Ps14Cg5-Pg1-Ps15Cg5-Pg1-Ps16
Cg5-Pg1-Ps17Cg5-Pg1-Ps18Cg5-Pg1-Ps19Cg5-Pg1-Ps20
Cg5-Pg1-Ps21Cg5-Pg1-Ps22Cg5-Pg1-Ps23Cg5-Pg1-Ps24
Cg5-Pg1-Ps25Cg5-Pg1-Ps26Cg5-Pg1-Ps27Cg5-Pg1-Ps28
Cg5-Pg1-Ps29Cg5-Pg1-Ps30Cg5-Pg1-Ps31Cg5-Pg1-Ps32
Cg5-Pg1-Ps33Cg5-Pg1-Ps34Cg5-Pg1-Ps35Cg5-Pg1-Ps36
Cg5-Pg1-Ps37Cg5-Pg1-Ps38Cg5-Pg1-Ps39Cg5-Pg1-Ps40
Cg5-Pg1-Ps41Cg5-Pg1-Ps42Cg5-Pg1-Ps43Cg5-Pg1-Ps44
Cg5-Pg1-Ps45Cg5-Pg1-Ps46Cg5-Pg1-Ps47Cg5-Pg1-Ps48
Cg5-Pg1-Ps49Cg5-Pg1-Ps50Cg5-Pg1-Ps51Cg5-Pg1-Ps52
Cg5-Pg1-Ps53Cg5-Pg1-Ps54Cg5-Pg1-Ps55Cg5-Pg1-Ps56
Cg5-Pg1-Ps57Cg5-Pg1-Ps58Cg5-Pg1-Ps59Cg5-Pg1-Ps60
Cg5-Pg1-Ps61Cg5-Pg1-Ps62Cg5-Pg1-Ps63Cg5-Pg1-Ps64
Cg5-Pg1-Ps65Cg5-Pg1-Ps66Cg5-Pg1-Ps67Cg5-Pg1-Ps68
Cg5-Pg1-Ps69Cg5-Pg1-Ps70Cg5-Pg1-Ps71Cg5-Pg1-Ps72
Cg5-Pg1-Ps73Cg5-Pg1-Ps74Cg5-Pg1-Ps75Cg5-Pg1-Ps76
Cg5-Pg1-Ps77Cg5-Pg1-Ps78Cg5-Pg1-Ps79Cg5-Pg1-Ps80
Cg5-Pg1-Ps81Cg5-Pg1-Ps82Cg5-Pg1-Ps83Cg5-Pg1-Ps84
Cg5-Pg1-Ps85Cg5-Pg1-Ps86Cg5-Pg1-Ps87Cg5-Pg1-Ps88
Cg5-Pg1-Ps89Cg5-Pg1-Ps90Cg5-Pg1-Ps91Cg5-Pg1-Ps92
Cg5-Pg1-Ps93Cg5-Pg1-Ps94Cg5-Pg1-Ps95Cg5-Pg1-Ps96
Cg5-Pg1-Ps97Cg5-Pg1-Ps98Cg5-Pg1-Ps99Cg5-Pg1-Ps100
Cg5-Pg1-Ps101Cg5-Pg1-Ps102Cg5-Pg1-Ps103Cg5-Pg1-Ps104
Cg5-Pg1-Ps105Cg5-Pg1-Ps106Cg5-Pg1-Ps107Cg5-Pg1-Ps108
Cg5-Pg1-Ps109Cg5-Pg1-Ps110Cg5-Pg1-Ps111Cg5-Pg1-Ps112
Cg5-Pg1-Ps113Cg5-Pg1-Ps114Cg5-Pg1-Ps115Cg5-Pg1-Ps116
Cg5-Pg1-Ps117Cg5-Pg1-Ps118Cg5-Pg1-Ps119Cg5-Pg1-Ps120
Cg5-Pg1-Ps121Cg5-Pg1-Ps122Cg5-Pg1-Ps123Cg5-Pg1-Ps124
Cg5-Pg1-Ps125Cg5-Pg1-Ps126Cg5-Pg1-Ps127Cg5-Pg1-Ps128
Cg5-Pg1-Ps129Cg5-Pg1-Ps130Cg5-Pg1-Ps131Cg5-Pg1-Ps132
Cg5-Pg1-Ps133Cg5-Pg1-Ps134Cg5-Pg1-Ps135Cg5-Pg1-Ps136
Cg5-Pg1-Ps137Cg5-Pg1-Ps138Cg5-Pg1-Ps139Cg5-Pg1-Ps140
Cg5-Pg1-Ps141Cg5-Pg1-Ps142Cg5-Pg1-Ps143Cg5-Pg1-Ps144
Cg5-Pg1-Ps145Cg5-Pg1-Ps146Cg5-Pg1-Ps147Cg5-Pg1-Ps148
Cg5-Pg1-Ps149Cg5-Pg1-Ps150Cg5-Pg1-Ps151Cg5-Pg1-Ps152
Cg5-Pg1-Ps153Cg5-Pg1-Ps154Cg5-Pg1-Ps155Cg5-Pg1-Ps156
Cg5-Pg1-Ps157Cg5-Pg1-Ps158Cg5-Pg1-Ps159Cg5-Pg1-Ps160
Cg5-Pg1-Ps161Cg5-Pg1-Ps162Cg5-Pg1-Ps163Cg5-Pg1-Ps164
Cg5-Pg1-Ps165Cg5-Pg1-Ps166Cg5-Pg1-Ps167Cg5-Pg1-Ps168
Cg5-Pg1-Ps169Cg5-Pg1-Ps170Cg5-Pg1-Ps171Cg5-Pg1-Ps172
Cg5-Pg1-Ps173Cg5-Pg1-Ps174Cg5-Pg1-Ps175Cg5-Pg1-Ps176
Cg5-Pg1-Ps177Cg5-Pg1-Ps178Cg5-Pg1-Ps179Cg5-Pg1-Ps180
Cg5-Pg1-Ps181Cg5-Pg1-Ps182Cg5-Pg1-Ps183Cg5-Pg1-Ps184
Cg5-Pg1-Ps185Cg5-Pg1-Ps186Cg5-Pg1-Ps187Cg5-Pg1-Ps188
Cg5-Pg1-Ps189Cg5-Pg1-Ps190Cg5-Pg1-Ps191Cg5-Pg1-Ps192
Cg5-Pg1-Ps193Cg5-Pg1-Ps194Cg5-Pg1-Ps195Cg5-Pg1-Ps196
Cg5-Pg1-Ps197Cg5-Pg1-Ps198Cg5-Pg1-Ps199Cg5-Pg1-Ps200
Cg5-Pg1-Ps201Cg5-Pg1-Ps202Cg5-Pg1-Ps203Cg5-Pg1-Ps204
Cg5-Pg1-Ps205Cg5-Pg1-Ps206Cg5-Pg1-Ps207Cg5-Pg1-Ps208
Cg5-Pg1-Ps209Cg5-Pg1-Ps210Cg5-Pg1-Ps211Cg5-Pg1-Ps212
Cg5-Pg1-Ps213Cg5-Pg1-Ps214Cg5-Pg1-Ps215Cg5-Pg1-Ps216
Cg5-Pg1-Ps217Cg5-Pg1-Ps218Cg5-Pg1-Ps219Cg5-Pg1-Ps220
Cg5-Pg1-Ps221Cg5-Pg1-Ps222Cg5-Pg1-Ps223Cg5-Pg1-Ps224
Cg5-Pg1-Ps225Cg5-Pg1-Ps226Cg5-Pg1-Ps227Cg5-Pg1-Ps228
Cg5-Pg1-Ps229Cg5-Pg1-Ps230Cg5-Pg1-Ps231Cg5-Pg1-Ps232
Cg5-Pg1-Ps233Cg5-Pg1-Ps234Cg5-Pg1-Ps235Cg5-Pg1-Ps236
Cg5-Pg1-Ps237Cg5-Pg1-Ps238Cg5-Pg1-Ps239Cg5-Pg1-Ps240
Cg5-Pg1-Ps241Cg5-Pg1-Ps242Cg5-Pg1-Ps243
Cg6-Pg1-Ps1Cg6-Pg1-Ps2Cg6-Pg1-Ps3Cg6-Pg1-Ps4
Cg6-Pg1-Ps5Cg6-Pg1-Ps6Cg6-Pg1-Ps7Cg6-Pg1-Ps8
Cg6-Pg1-Ps9Cg6-Pg1-Ps10Cg6-Pg1-Ps11Cg6-Pg1-Ps12
Cg6-Pg1-Ps13Cg6-Pg1-Ps14Cg6-Pg1-Ps15Cg6-Pg1-Ps16
Cg6-Pg1-Ps17Cg6-Pg1-Ps18Cg6-Pg1-Ps19Cg6-Pg1-Ps20
Cg6-Pg1-Ps21Cg6-Pg1-Ps22Cg6-Pg1-Ps23Cg6-Pg1-Ps24
Cg6-Pg1-Ps25Cg6-Pg1-Ps26Cg6-Pg1-Ps27Cg6-Pg1-Ps28
Cg6-Pg1-Ps29Cg6-Pg1-Ps30Cg6-Pg1-Ps31Cg6-Pg1-Ps32
Cg6-Pg1-Ps33Cg6-Pg1-Ps34Cg6-Pg1-Ps35Cg6-Pg1-Ps36
Cg6-Pg1-Ps37Cg6-Pg1-Ps38Cg6-Pg1-Ps39Cg6-Pg1-Ps40
Cg6-Pg1-Ps41Cg6-Pg1-Ps42Cg6-Pg1-Ps43Cg6-Pg1-Ps44
Cg6-Pg1-Ps45Cg6-Pg1-Ps46Cg6-Pg1-Ps47Cg6-Pg1-Ps48
Cg6-Pg1-Ps49Cg6-Pg1-Ps50Cg6-Pg1-Ps51Cg6-Pg1-Ps52
Cg6-Pg1-Ps53Cg6-Pg1-Ps54Cg6-Pg1-Ps55Cg6-Pg1-Ps56
Cg6-Pg1-Ps57Cg6-Pg1-Ps58Cg6-Pg1-Ps59Cg6-Pg1-Ps60
Cg6-Pg1-Ps61Cg6-Pg1-Ps62Cg6-Pg1-Ps63Cg6-Pg1-Ps64
Cg6-Pg1-Ps65Cg6-Pg1-Ps66Cg6-Pg1-Ps67Cg6-Pg1-Ps68
Cg6-Pg1-Ps69Cg6-Pg1-Ps70Cg6-Pg1-Ps71Cg6-Pg1-Ps72
Cg6-Pg1-Ps73Cg6-Pg1-Ps74Cg6-Pg1-Ps75Cg6-Pg1-Ps76
Cg6-Pg1-Ps77Cg6-Pg1-Ps78Cg6-Pg1-Ps79Cg6-Pg1-Ps80
Cg6-Pg1-Ps81Cg6-Pg1-Ps82Cg6-Pg1-Ps83Cg6-Pg1-Ps84
Cg6-Pg1-Ps85Cg6-Pg1-Ps86Cg6-Pg1-Ps87Cg6-Pg1-Ps88
Cg6-Pg1-Ps89Cg6-Pg1-Ps90Cg6-Pg1-Ps91Cg6-Pg1-Ps92
Cg6-Pg1-Ps93Cg6-Pg1-Ps94Cg6-Pg1-Ps95Cg6-Pg1-Ps96
Cg6-Pg1-Ps97Cg6-Pg1-Ps98Cg6-Pg1-Ps99Cg6-Pg1-Ps100
Cg6-Pg1-Ps101Cg6-Pg1-Ps102Cg6-Pg1-Ps103Cg6-Pg1-Ps104
Cg6-Pg1-Ps105Cg6-Pg1-Ps106Cg6-Pg1-Ps107Cg6-Pg1-Ps108
Cg6-Pg1-Ps109Cg6-Pg1-Ps110Cg6-Pg1-Ps111Cg6-Pg1-Ps112
Cg6-Pg1-Ps113Cg6-Pg1-Ps114Cg6-Pg1-Ps115Cg6-Pg1-Ps116
Cg6-Pg1-Ps117Cg6-Pg1-Ps118Cg6-Pg1-Ps119Cg6-Pg1-Ps120
Cg6-Pg1-Ps121Cg6-Pg1-Ps122Cg6-Pg1-Ps123Cg6-Pg1-Ps124
Cg6-Pg1-Ps125Cg6-Pg1-Ps126Cg6-Pg1-Ps127Cg6-Pg1-Ps128
Cg6-Pg1-Ps129Cg6-Pg1-Ps130Cg6-Pg1-Ps131Cg6-Pg1-Ps132
Cg6-Pg1-Ps133Cg6-Pg1-Ps134Cg6-Pg1-Ps135Cg6-Pg1-Ps136
Cg6-Pg1-Ps137Cg6-Pg1-Ps138Cg6-Pg1-Ps139Cg6-Pg1-Ps140
Cg6-Pg1-Ps141Cg6-Pg1-Ps142Cg6-Pg1-Ps143Cg6-Pg1-Ps144
Cg6-Pg1-Ps145Cg6-Pg1-Ps146Cg6-Pg1-Ps147Cg6-Pg1-Ps148
Cg6-Pg1-Ps149Cg6-Pg1-Ps150Cg6-Pg1-Ps151Cg6-Pg1-Ps152
Cg6-Pg1-Ps153Cg6-Pg1-Ps154Cg6-Pg1-Ps155Cg6-Pg1-Ps156
Cg6-Pg1-Ps157Cg6-Pg1-Ps158Cg6-Pg1-Ps159Cg6-Pg1-Ps160
Cg6-Pg1-Ps161Cg6-Pg1-Ps162Cg6-Pg1-Ps163Cg6-Pg1-Ps164
Cg6-Pg1-Ps165Cg6-Pg1-Ps166Cg6-Pg1-Ps167Cg6-Pg1-Ps168
Cg6-Pg1-Ps169Cg6-Pg1-Ps170Cg6-Pg1-Ps171Cg6-Pg1-Ps172
Cg6-Pg1-Ps173Cg6-Pg1-Ps174Cg6-Pg1-Ps175Cg6-Pg1-Ps176
Cg6-Pg1-Ps177Cg6-Pg1-Ps178Cg6-Pg1-Ps179Cg6-Pg1-Ps180
Cg6-Pg1-Ps181Cg6-Pg1-Ps182Cg6-Pg1-Ps183Cg6-Pg1-Ps184
Cg6-Pg1-Ps185Cg6-Pg1-Ps186Cg6-Pg1-Ps187Cg6-Pg1-Ps188
Cg6-Pg1-Ps189Cg6-Pg1-Ps190Cg6-Pg1-Ps191Cg6-Pg1-Ps192
Cg6-Pg1-Ps193Cg6-Pg1-Ps194Cg6-Pg1-Ps195Cg6-Pg1-Ps196
Cg6-Pg1-Ps197Cg6-Pg1-Ps198Cg6-Pg1-Ps199Cg6-Pg1-Ps200
Cg6-Pg1-Ps201Cg6-Pg1-Ps202Cg6-Pg1-Ps203Cg6-Pg1-Ps204
Cg6-Pg1-Ps205Cg6-Pg1-Ps206Cg6-Pg1-Ps207Cg6-Pg1-Ps208
Cg6-Pg1-Ps209Cg6-Pg1-Ps210Cg6-Pg1-Ps211Cg6-Pg1-Ps212
Cg6-Pg1-Ps213Cg6-Pg1-Ps214Cg6-Pg1-Ps215Cg6-Pg1-Ps216
Cg6-Pg1-Ps217Cg6-Pg1-Ps218Cg6-Pg1-Ps219Cg6-Pg1-Ps220
Cg6-Pg1-Ps221Cg6-Pg1-Ps222Cg6-Pg1-Ps223Cg6-Pg1-Ps224
Cg6-Pg1-Ps225Cg6-Pg1-Ps226Cg6-Pg1-Ps227Cg6-Pg1-Ps228
Cg6-Pg1-Ps229Cg6-Pg1-Ps230Cg6-Pg1-Ps231Cg6-Pg1-Ps232
Cg6-Pg1-Ps233Cg6-Pg1-Ps234Cg6-Pg1-Ps235Cg6-Pg1-Ps236
Cg6-Pg1-Ps237Cg6-Pg1-Ps238Cg6-Pg1-Ps239Cg6-Pg1-Ps240
Cg6-Pg1-Ps241Cg6-Pg1-Ps242Cg6-Pg1-Ps243
Cg7-Pg1-Ps1Cg7-Pg1-Ps2Cg7-Pg1-Ps3Cg7-Pg1-Ps4
Cg7-Pg1-Ps5Cg7-Pg1-Ps6Cg7-Pg1-Ps7Cg7-Pg1-Ps8
Cg7-Pg1-Ps9Cg7-Pg1-Ps10Cg7-Pg1-Ps11Cg7-Pg1-Ps12
Cg7-Pg1-Ps13Cg7-Pg1-Ps14Cg7-Pg1-Ps15Cg7-Pg1-Ps16
Cg7-Pg1-Ps17Cg7-Pg1-Ps18Cg7-Pg1-Ps19Cg7-Pg1-Ps20
Cg7-Pg1-Ps21Cg7-Pg1-Ps22Cg7-Pg1-Ps23Cg7-Pg1-Ps24
Cg7-Pg1-Ps25Cg7-Pg1-Ps26Cg7-Pg1-Ps27Cg7-Pg1-Ps28
Cg7-Pg1-Ps29Cg7-Pg1-Ps30Cg7-Pg1-Ps31Cg7-Pg1-Ps32
Cg7-Pg1-Ps33Cg7-Pg1-Ps34Cg7-Pg1-Ps35Cg7-Pg1-Ps36
Cg7-Pg1-Ps37Cg7-Pg1-Ps38Cg7-Pg1-Ps39Cg7-Pg1-Ps40
Cg7-Pg1-Ps41Cg7-Pg1-Ps42Cg7-Pg1-Ps43Cg7-Pg1-Ps44
Cg7-Pg1-Ps45Cg7-Pg1-Ps46Cg7-Pg1-Ps47Cg7-Pg1-Ps48
Cg7-Pg1-Ps49Cg7-Pg1-Ps50Cg7-Pg1-Ps51Cg7-Pg1-Ps52
Cg7-Pg1-Ps53Cg7-Pg1-Ps54Cg7-Pg1-Ps55Cg7-Pg1-Ps56
Cg7-Pg1-Ps57Cg7-Pg1-Ps58Cg7-Pg1-Ps59Cg7-Pg1-Ps60
Cg7-Pg1-Ps61Cg7-Pg1-Ps62Cg7-Pg1-Ps63Cg7-Pg1-Ps64
Cg7-Pg1-Ps65Cg7-Pg1-Ps66Cg7-Pg1-Ps67Cg7-Pg1-Ps68
Cg7-Pg1-Ps69Cg7-Pg1-Ps70Cg7-Pg1-Ps71Cg7-Pg1-Ps72
Cg7-Pg1-Ps73Cg7-Pg1-Ps74Cg7-Pg1-Ps75Cg7-Pg1-Ps76
Cg7-Pg1-Ps77Cg7-Pg1-Ps78Cg7-Pg1-Ps79Cg7-Pg1-Ps80
Cg7-Pg1-Ps81Cg7-Pg1-Ps82Cg7-Pg1-Ps83Cg7-Pg1-Ps84
Cg7-Pg1-Ps85Cg7-Pg1-Ps86Cg7-Pg1-Ps87Cg7-Pg1-Ps88
Cg7-Pg1-Ps89Cg7-Pg1-Ps90Cg7-Pg1-Ps91Cg7-Pg1-Ps92
Cg7-Pg1-Ps93Cg7-Pg1-Ps94Cg7-Pg1-Ps95Cg7-Pg1-Ps96
Cg7-Pg1-Ps97Cg7-Pg1-Ps98Cg7-Pg1-Ps99Cg7-Pg1-Ps100
Cg7-Pg1-Ps101Cg7-Pg1-Ps102Cg7-Pg1-Ps103Cg7-Pg1-Ps104
Cg7-Pg1-Ps105Cg7-Pg1-Ps106Cg7-Pg1-Ps107Cg7-Pg1-Ps108
Cg7-Pg1-Ps109Cg7-Pg1-Ps110Cg7-Pg1-Ps111Cg7-Pg1-Ps112
Cg7-Pg1-Ps113Cg7-Pg1-Ps114Cg7-Pg1-Ps115Cg7-Pg1-Ps116
Cg7-Pg1-Ps117Cg7-Pg1-Ps118Cg7-Pg1-Ps119Cg7-Pg1-Ps120
Cg7-Pg1-Ps121Cg7-Pg1-Ps122Cg7-Pg1-Ps123Cg7-Pg1-Ps124
Cg7-Pg1-Ps125Cg7-Pg1-Ps126Cg7-Pg1-Ps127Cg7-Pg1-Ps128
Cg7-Pg1-Ps129Cg7-Pg1-Ps130Cg7-Pg1-Ps131Cg7-Pg1-Ps132
Cg7-Pg1-Ps133Cg7-Pg1-Ps134Cg7-Pg1-Ps135Cg7-Pg1-Ps136
Cg7-Pg1-Ps137Cg7-Pg1-Ps138Cg7-Pg1-Ps139Cg7-Pg1-Ps140
Cg7-Pg1-Ps141Cg7-Pg1-Ps142Cg7-Pg1-Ps143Cg7-Pg1-Ps144
Cg7-Pg1-Ps145Cg7-Pg1-Ps146Cg7-Pg1-Ps147Cg7-Pg1-Ps148
Cg7-Pg1-Ps149Cg7-Pg1-Ps150Cg7-Pg1-Ps151Cg7-Pg1-Ps152
Cg7-Pg1-Ps153Cg7-Pg1-Ps154Cg7-Pg1-Ps155Cg7-Pg1-Ps156
Cg7-Pg1-Ps157Cg7-Pg1-Ps158Cg7-Pg1-Ps159Cg7-Pg1-Ps160
Cg7-Pg1-Ps161Cg7-Pg1-Ps162Cg7-Pg1-Ps163Cg7-Pg1-Ps164
Cg7-Pg1-Ps165Cg7-Pg1-Ps166Cg7-Pg1-Ps167Cg7-Pg1-Ps168
Cg7-Pg1-Ps169Cg7-Pg1-Ps170Cg7-Pg1-Ps171Cg7-Pg1-Ps172
Cg7-Pg1-Ps173Cg7-Pg1-Ps174Cg7-Pg1-Ps175Cg7-Pg1-Ps176
Cg7-Pg1-Ps177Cg7-Pg1-Ps178Cg7-Pg1-Ps179Cg7-Pg1-Ps180
Cg7-Pg1-Ps181Cg7-Pg1-Ps182Cg7-Pg1-Ps183Cg7-Pg1-Ps184
Cg7-Pg1-Ps185Cg7-Pg1-Ps186Cg7-Pg1-Ps187Cg7-Pg1-Ps188
Cg7-Pg1-Ps189Cg7-Pg1-Ps190Cg7-Pg1-Ps191Cg7-Pg1-Ps192
Cg7-Pg1-Ps193Cg7-Pg1-Ps194Cg7-Pg1-Ps195Cg7-Pg1-Ps196
Cg7-Pg1-Ps197Cg7-Pg1-Ps198Cg7-Pg1-Ps199Cg7-Pg1-Ps200
Cg7-Pg1-Ps201Cg7-Pg1-Ps202Cg7-Pg1-Ps203Cg7-Pg1-Ps204
Cg7-Pg1-Ps205Cg7-Pg1-Ps206Cg7-Pg1-Ps207Cg7-Pg1-Ps208
Cg7-Pg1-Ps209Cg7-Pg1-Ps210Cg7-Pg1-Ps211Cg7-Pg1-Ps212
Cg7-Pg1-Ps213Cg7-Pg1-Ps214Cg7-Pg1-Ps215Cg7-Pg1-Ps216
Cg7-Pg1-Ps217Cg7-Pg1-Ps218Cg7-Pg1-Ps219Cg7-Pg1-Ps220
Cg7-Pg1-Ps221Cg7-Pg1-Ps222Cg7-Pg1-Ps223Cg7-Pg1-Ps224
Cg7-Pg1-Ps225Cg7-Pg1-Ps226Cg7-Pg1-Ps227Cg7-Pg1-Ps228
Cg7-Pg1-Ps229Cg7-Pg1-Ps230Cg7-Pg1-Ps231Cg7-Pg1-Ps232
Cg7-Pg1-Ps233Cg7-Pg1-Ps234Cg7-Pg1-Ps235Cg7-Pg1-Ps236
Cg7-Pg1-Ps237Cg7-Pg1-Ps238Cg7-Pg1-Ps239Cg7-Pg1-Ps240
Cg7-Pg1-Ps241Cg7-Pg1-Ps242Cg7-Pg1-Ps243
Cg18-Pg1-Ps1Cg18-Pg1-Ps2Cg18-Pg1-Ps3Cg18-Pg1-Ps4
Cg18-Pg1-Ps5Cg18-Pg1-Ps6Cg18-Pg1-Ps7Cg18-Pg1-Ps8
Cg18-Pg1-Ps9Cg18-Pg1-Ps10Cg18-Pg1-Ps11Cg18-Pg1-Ps12
Cg18-Pg1-Ps13Cg18-Pg1-Ps14Cg18-Pg1-Ps15Cg18-Pg1-Ps16
Cg18-Pg1-Ps17Cg18-Pg1-Ps18Cg18-Pg1-Ps19Cg18-Pg1-Ps20
Cg18-Pg1-Ps21Cg18-Pg1-Ps22Cg18-Pg1-Ps23Cg18-Pg1-Ps24
Cg18-Pg1-Ps25Cg18-Pg1-Ps26Cg18-Pg1-Ps27Cg18-Pg1-Ps28
Cg18-Pg1-Ps29Cg18-Pg1-Ps30Cg18-Pg1-Ps31Cg18-Pg1-Ps32
Cg18-Pg1-Ps33Cg18-Pg1-Ps34Cg18-Pg1-Ps35Cg18-Pg1-Ps36
Cg18-Pg1-Ps37Cg18-Pg1-Ps38Cg18-Pg1-Ps39Cg18-Pg1-Ps40
Cg18-Pg1-Ps41Cg18-Pg1-Ps42Cg18-Pg1-Ps43Cg18-Pg1-Ps44
Cg18-Pg1-Ps45Cg18-Pg1-Ps46Cg18-Pg1-Ps47Cg18-Pg1-Ps48
Cg18-Pg1-Ps49Cg18-Pg1-Ps50Cg18-Pg1-Ps51Cg18-Pg1-Ps52
Cg18-Pg1-Ps53Cg18-Pg1-Ps54Cg18-Pg1-Ps55Cg18-Pg1-Ps56
Cg18-Pg1-Ps57Cg18-Pg1-Ps58Cg18-Pg1-Ps59Cg18-Pg1-Ps60
Cg18-Pg1-Ps61Cg18-Pg1-Ps62Cg18-Pg1-Ps63Cg18-Pg1-Ps64
Cg18-Pg1-Ps65Cg18-Pg1-Ps66Cg18-Pg1-Ps67Cg18-Pg1-Ps68
Cg18-Pg1-Ps69Cg18-Pg1-Ps70Cg18-Pg1-Ps71Cg18-Pg1-Ps72
Cg18-Pg1-Ps73Cg18-Pg1-Ps74Cg18-Pg1-Ps75Cg18-Pg1-Ps76
Cg18-Pg1-Ps77Cg18-Pg1-Ps78Cg18-Pg1-Ps79Cg18-Pg1-Ps80
Cg18-Pg1-Ps81Cg18-Pg1-Ps82Cg18-Pg1-Ps83Cg18-Pg1-Ps84
Cg18-Pg1-Ps85Cg18-Pg1-Ps86Cg18-Pg1-Ps87Cg18-Pg1-Ps88
Cg18-Pg1-Ps89Cg18-Pg1-Ps90Cg18-Pg1-Ps91Cg18-Pg1-Ps92
Cg18-Pg1-Ps93Cg18-Pg1-Ps94Cg18-Pg1-Ps95Cg18-Pg1-Ps96
Cg18-Pg1-Ps97Cg18-Pg1-Ps98Cg18-Pg1-Ps99Cg18-Pg1-Ps100
Cg18-Pg1-Ps101Cg18-Pg1-Ps102Cg18-Pg1-Ps103Cg18-Pg1-Ps104
Cg18-Pg1-Ps105Cg18-Pg1-Ps106Cg18-Pg1-Ps107Cg18-Pg1-Ps108
Cg18-Pg1-Ps109Cg18-Pg1-Ps110Cg18-Pg1-Ps111Cg18-Pg1-Ps112
Cg18-Pg1-Ps113Cg18-Pg1-Ps114Cg18-Pg1-Ps115Cg18-Pg1-Ps116
Cg18-Pg1-Ps117Cg18-Pg1-Ps118Cg18-Pg1-Ps119Cg18-Pg1-Ps120
Cg18-Pg1-Ps121Cg18-Pg1-Ps122Cg18-Pg1-Ps123Cg18-Pg1-Ps124
Cg18-Pg1-Ps125Cg18-Pg1-Ps126Cg18-Pg1-Ps127Cg18-Pg1-Ps128
Cg18-Pg1-Ps129Cg18-Pg1-Ps130Cg18-Pg1-Ps131Cg18-Pg1-Ps132
Cg18-Pg1-Ps133Cg18-Pg1-Ps134Cg18-Pg1-Ps135Cg18-Pg1-Ps136
Cg18-Pg1-Ps137Cg18-Pg1-Ps138Cg18-Pg1-Ps139Cg18-Pg1-Ps140
Cg18-Pg1-Ps141Cg18-Pg1-Ps142Cg18-Pg1-Ps143Cg18-Pg1-Ps144
Cg18-Pg1-Ps145Cg18-Pg1-Ps146Cg18-Pg1-Ps147Cg18-Pg1-Ps148
Cg18-Pg1-Ps149Cg18-Pg1-Ps150Cg18-Pg1-Ps151Cg18-Pg1-Ps152
Cg18-Pg1-Ps153Cg18-Pg1-Ps154Cg18-Pg1-Ps155Cg18-Pg1-Ps156
Cg18-Pg1-Ps157Cg18-Pg1-Ps158Cg18-Pg1-Ps159Cg18-Pg1-Ps160
Cg18-Pg1-Ps161Cg18-Pg1-Ps162Cg18-Pg1-Ps163Cg18-Pg1-Ps164
Cg18-Pg1-Ps165Cg18-Pg1-Ps166Cg18-Pg1-Ps167Cg18-Pg1-Ps168
Cg18-Pg1-Ps169Cg18-Pg1-Ps170Cg18-Pg1-Ps171Cg18-Pg1-Ps172
Cg18-Pg1-Ps173Cg18-Pg1-Ps174Cg18-Pg1-Ps175Cg18-Pg1-Ps176
Cg18-Pg1-Ps177Cg18-Pg1-Ps178Cg18-Pg1-Ps179Cg18-Pg1-Ps180
Cg18-Pg1-Ps181Cg18-Pg1-Ps182Cg18-Pg1-Ps183Cg18-Pg1-Ps184
Cg18-Pg1-Ps185Cg18-Pg1-Ps186Cg18-Pg1-Ps187Cg18-Pg1-Ps188
Cg18-Pg1-Ps189Cg18-Pg1-Ps190Cg18-Pg1-Ps191Cg18-Pg1-Ps192
Cg18-Pg1-Ps193Cg18-Pg1-Ps194Cg18-Pg1-Ps195Cg18-Pg1-Ps196
Cg18-Pg1-Ps197Cg18-Pg1-Ps198Cg18-Pg1-Ps199Cg18-Pg1-Ps200
Cg18-Pg1-Ps201Cg18-Pg1-Ps202Cg18-Pg1-Ps203Cg18-Pg1-Ps204
Cg18-Pg1-Ps205Cg18-Pg1-Ps206Cg18-Pg1-Ps207Cg18-Pg1-Ps208
Cg18-Pg1-Ps209Cg18-Pg1-Ps210Cg18-Pg1-Ps211Cg18-Pg1-Ps212
Cg18-Pg1-Ps213Cg18-Pg1-Ps214Cg18-Pg1-Ps215Cg18-Pg1-Ps216
Cg18-Pg1-Ps217Cg18-Pg1-Ps218Cg18-Pg1-Ps219Cg18-Pg1-Ps220
Cg18-Pg1-Ps221Cg18-Pg1-Ps222Cg18-Pg1-Ps223Cg18-Pg1-Ps224
Cg18-Pg1-Ps225Cg18-Pg1-Ps226Cg18-Pg1-Ps227Cg18-Pg1-Ps228
Cg18-Pg1-Ps229Cg18-Pg1-Ps230Cg18-Pg1-Ps231Cg18-Pg1-Ps232
Cg18-Pg1-Ps233Cg18-Pg1-Ps234Cg18-Pg1-Ps235Cg18-Pg1-Ps236
Cg18-Pg1-Ps237Cg18-Pg1-Ps238Cg18-Pg1-Ps239Cg18-Pg1-Ps240
Cg18-Pg1-Ps241Cg18-Pg1-Ps242Cg18-Pg1-Ps243
Cg21-Pg1-Ps1Cg21-Pg1-Ps2Cg21-Pg1-Ps3Cg21-Pg1-Ps4
Cg21-Pg1-Ps5Cg21-Pg1-Ps6Cg21-Pg1-Ps7Cg21-Pg1-Ps8
Cg21-Pg1-Ps9Cg21-Pg1-Ps10Cg21-Pg1-Ps11Cg21-Pg1-Ps12
Cg21-Pg1-Ps13Cg21-Pg1-Ps14Cg21-Pg1-Ps15Cg21-Pg1-Ps16
Cg21-Pg1-Ps17Cg21-Pg1-Ps18Cg21-Pg1-Ps19Cg21-Pg1-Ps20
Cg21-Pg1-Ps21Cg21-Pg1-Ps22Cg21-Pg1-Ps23Cg21-Pg1-Ps24
Cg21-Pg1-Ps25Cg21-Pg1-Ps26Cg21-Pg1-Ps27Cg21-Pg1-Ps28
Cg21-Pg1-Ps29Cg21-Pg1-Ps30Cg21-Pg1-Ps31Cg21-Pg1-Ps32
Cg21-Pg1-Ps33Cg21-Pg1-Ps34Cg21-Pg1-Ps35Cg21-Pg1-Ps36
Cg21-Pg1-Ps37Cg21-Pg1-Ps38Cg21-Pg1-Ps39Cg21-Pg1-Ps40
Cg21-Pg1-Ps41Cg21-Pg1-Ps42Cg21-Pg1-Ps43Cg21-Pg1-Ps44
Cg21-Pg1-Ps45Cg21-Pg1-Ps46Cg21-Pg1-Ps47Cg21-Pg1-Ps48
Cg21-Pg1-Ps49Cg21-Pg1-Ps50Cg21-Pg1-Ps51Cg21-Pg1-Ps52
Cg21-Pg1-Ps53Cg21-Pg1-Ps54Cg21-Pg1-Ps55Cg21-Pg1-Ps56
Cg21-Pg1-Ps57Cg21-Pg1-Ps58Cg21-Pg1-Ps59Cg21-Pg1-Ps60
Cg21-Pg1-Ps61Cg21-Pg1-Ps62Cg21-Pg1-Ps63Cg21-Pg1-Ps64
Cg21-Pg1-Ps65Cg21-Pg1-Ps66Cg21-Pg1-Ps67Cg21-Pg1-Ps68
Cg21-Pg1-Ps69Cg21-Pg1-Ps70Cg21-Pg1-Ps71Cg21-Pg1-Ps72
Cg21-Pg1-Ps73Cg21-Pg1-Ps74Cg21-Pg1-Ps75Cg21-Pg1-Ps76
Cg21-Pg1-Ps77Cg21-Pg1-Ps78Cg21-Pg1-Ps79Cg21-Pg1-Ps80
Cg21-Pg1-Ps81Cg21-Pg1-Ps82Cg21-Pg1-Ps83Cg21-Pg1-Ps84
Cg21-Pg1-Ps85Cg21-Pg1-Ps86Cg21-Pg1-Ps87Cg21-Pg1-Ps88
Cg21-Pg1-Ps89Cg21-Pg1-Ps90Cg21-Pg1-Ps91Cg21-Pg1-Ps92
Cg21-Pg1-Ps93Cg21-Pg1-Ps94Cg21-Pg1-Ps95Cg21-Pg1-Ps96
Cg21-Pg1-Ps97Cg21-Pg1-Ps98Cg21-Pg1-Ps99Cg21-Pg1-Ps100
Cg21-Pg1-Ps101Cg21-Pg1-Ps102Cg21-Pg1-Ps103Cg21-Pg1-Ps104
Cg21-Pg1-Ps105Cg21-Pg1-Ps106Cg21-Pg1-Ps107Cg21-Pg1-Ps108
Cg21-Pg1-Ps109Cg21-Pg1-Ps110Cg21-Pg1-Ps111Cg21-Pg1-Ps112
Cg21-Pg1-Ps113Cg21-Pg1-Ps114Cg21-Pg1-Ps115Cg21-Pg1-Ps116
Cg21-Pg1-Ps117Cg21-Pg1-Ps118Cg21-Pg1-Ps119Cg21-Pg1-Ps120
Cg21-Pg1-Ps121Cg21-Pg1-Ps122Cg21-Pg1-Ps123Cg21-Pg1-Ps124
Cg21-Pg1-Ps125Cg21-Pg1-Ps126Cg21-Pg1-Ps127Cg21-Pg1-Ps128
Cg21-Pg1-Ps129Cg21-Pg1-Ps130Cg21-Pg1-Ps131Cg21-Pg1-Ps132
Cg21-Pg1-Ps133Cg21-Pg1-Ps134Cg21-Pg1-Ps135Cg21-Pg1-Ps136
Cg21-Pg1-Ps137Cg21-Pg1-Ps138Cg21-Pg1-Ps139Cg21-Pg1-Ps140
Cg21-Pg1-Ps141Cg21-Pg1-Ps142Cg21-Pg1-Ps143Cg21-Pg1-Ps144
Cg21-Pg1-Ps145Cg21-Pg1-Ps146Cg21-Pg1-Ps147Cg21-Pg1-Ps148
Cg21-Pg1-Ps149Cg21-Pg1-Ps150Cg21-Pg1-Ps151Cg21-Pg1-Ps152
Cg21-Pg1-Ps153Cg21-Pg1-Ps154Cg21-Pg1-Ps155Cg21-Pg1-Ps156
Cg21-Pg1-Ps157Cg21-Pg1-Ps158Cg21-Pg1-Ps159Cg21-Pg1-Ps160
Cg21-Pg1-Ps161Cg21-Pg1-Ps162Cg21-Pg1-Ps163Cg21-Pg1-Ps164
Cg21-Pg1-Ps165Cg21-Pg1-Ps166Cg21-Pg1-Ps167Cg21-Pg1-Ps168
Cg21-Pg1-Ps169Cg21-Pg1-Ps170Cg21-Pg1-Ps171Cg21-Pg1-Ps172
Cg21-Pg1-Ps173Cg21-Pg1-Ps174Cg21-Pg1-Ps175Cg21-Pg1-Ps176
Cg21-Pg1-Ps177Cg21-Pg1-Ps178Cg21-Pg1-Ps179Cg21-Pg1-Ps180
Cg21-Pg1-Ps181Cg21-Pg1-Ps182Cg21-Pg1-Ps183Cg21-Pg1-Ps184
Cg21-Pg1-Ps185Cg21-Pg1-Ps186Cg21-Pg1-Ps187Cg21-Pg1-Ps188
Cg21-Pg1-Ps189Cg21-Pg1-Ps190Cg21-Pg1-Ps191Cg21-Pg1-Ps192
Cg21-Pg1-Ps193Cg21-Pg1-Ps194Cg21-Pg1-Ps195Cg21-Pg1-Ps196
Cg21-Pg1-Ps197Cg21-Pg1-Ps198Cg21-Pg1-Ps199Cg21-Pg1-Ps200
Cg21-Pg1-Ps201Cg21-Pg1-Ps202Cg21-Pg1-Ps203Cg21-Pg1-Ps204
Cg21-Pg1-Ps205Cg21-Pg1-Ps206Cg21-Pg1-Ps207Cg21-Pg1-Ps208
Cg21-Pg1-Ps209Cg21-Pg1-Ps210Cg21-Pg1-Ps211Cg21-Pg1-Ps212
Cg21-Pg1-Ps213Cg21-Pg1-Ps214Cg21-Pg1-Ps215Cg21-Pg1-Ps216
Cg21-Pg1-Ps217Cg21-Pg1-Ps218Cg21-Pg1-Ps219Cg21-Pg1-Ps220
Cg21-Pg1-Ps221Cg21-Pg1-Ps222Cg21-Pg1-Ps223Cg21-Pg1-Ps224
Cg21-Pg1-Ps225Cg21-Pg1-Ps226Cg21-Pg1-Ps227Cg21-Pg1-Ps228
Cg21-Pg1-Ps229Cg21-Pg1-Ps230Cg21-Pg1-Ps231Cg21-Pg1-Ps232
Cg21-Pg1-Ps233Cg21-Pg1-Ps234Cg21-Pg1-Ps235Cg21-Pg1-Ps236
Cg21-Pg1-Ps237Cg21-Pg1-Ps238Cg21-Pg1-Ps239Cg21-Pg1-Ps240
Cg21-Pg1-Ps241Cg21-Pg1-Ps242Cg21-Pg1-Ps243
Cg22-Pg1-Ps1Cg22-Pg1-Ps2Cg22-Pg1-Ps3Cg22-Pg1-Ps4
Cg22-Pg1-Ps5Cg22-Pg1-Ps6Cg22-Pg1-Ps7Cg22-Pg1-Ps8
Cg22-Pg1-Ps9Cg22-Pg1-Ps10Cg22-Pg1-Ps11Cg22-Pg1-Ps12
Cg22-Pg1-Ps13Cg22-Pg1-Ps14Cg22-Pg1-Ps15Cg22-Pg1-Ps16
Cg22-Pg1-Ps17Cg22-Pg1-Ps18Cg22-Pg1-Ps19Cg22-Pg1-Ps20
Cg22-Pg1-Ps21Cg22-Pg1-Ps22Cg22-Pg1-Ps23Cg22-Pg1-Ps24
Cg22-Pg1-Ps25Cg22-Pg1-Ps26Cg22-Pg1-Ps27Cg22-Pg1-Ps28
Cg22-Pg1-Ps29Cg22-Pg1-Ps30Cg22-Pg1-Ps31Cg22-Pg1-Ps32
Cg22-Pg1-Ps33Cg22-Pg1-Ps34Cg22-Pg1-Ps35Cg22-Pg1-Ps36
Cg22-Pg1-Ps37Cg22-Pg1-Ps38Cg22-Pg1-Ps39Cg22-Pg1-Ps40
Cg22-Pg1-Ps41Cg22-Pg1-Ps42Cg22-Pg1-Ps43Cg22-Pg1-Ps44
Cg22-Pg1-Ps45Cg22-Pg1-Ps46Cg22-Pg1-Ps47Cg22-Pg1-Ps48
Cg22-Pg1-Ps49Cg22-Pg1-Ps50Cg22-Pg1-Ps51Cg22-Pg1-Ps52
Cg22-Pg1-Ps53Cg22-Pg1-Ps54Cg22-Pg1-Ps55Cg22-Pg1-Ps56
Cg22-Pg1-Ps57Cg22-Pg1-Ps58Cg22-Pg1-Ps59Cg22-Pg1-Ps60
Cg22-Pg1-Ps61Cg22-Pg1-Ps62Cg22-Pg1-Ps63Cg22-Pg1-Ps64
Cg22-Pg1-Ps65Cg22-Pg1-Ps66Cg22-Pg1-Ps67Cg22-Pg1-Ps68
Cg22-Pg1-Ps69Cg22-Pg1-Ps70Cg22-Pg1-Ps71Cg22-Pg1-Ps72
Cg22-Pg1-Ps73Cg22-Pg1-Ps74Cg22-Pg1-Ps75Cg22-Pg1-Ps76
Cg22-Pg1-Ps77Cg22-Pg1-Ps78Cg22-Pg1-Ps79Cg22-Pg1-Ps80
Cg22-Pg1-Ps81Cg22-Pg1-Ps82Cg22-Pg1-Ps83Cg22-Pg1-Ps84
Cg22-Pg1-Ps85Cg22-Pg1-Ps86Cg22-Pg1-Ps87Cg22-Pg1-Ps88
Cg22-Pg1-Ps89Cg22-Pg1-Ps90Cg22-Pg1-Ps91Cg22-Pg1-Ps92
Cg22-Pg1-Ps93Cg22-Pg1-Ps94Cg22-Pg1-Ps95Cg22-Pg1-Ps96
Cg22-Pg1-Ps97Cg22-Pg1-Ps98Cg22-Pg1-Ps99Cg22-Pg1-Ps100
Cg22-Pg1-Ps101Cg22-Pg1-Ps102Cg22-Pg1-Ps103Cg22-Pg1-Ps104
Cg22-Pg1-Ps105Cg22-Pg1-Ps106Cg22-Pg1-Ps107Cg22-Pg1-Ps108
Cg22-Pg1-Ps109Cg22-Pg1-Ps110Cg22-Pg1-Ps111Cg22-Pg1-Ps112
Cg22-Pg1-Ps113Cg22-Pg1-Ps114Cg22-Pg1-Ps115Cg22-Pg1-Ps116
Cg22-Pg1-Ps117Cg22-Pg1-Ps118Cg22-Pg1-Ps119Cg22-Pg1-Ps120
Cg22-Pg1-Ps121Cg22-Pg1-Ps122Cg22-Pg1-Ps123Cg22-Pg1-Ps124
Cg22-Pg1-Ps125Cg22-Pg1-Ps126Cg22-Pg1-Ps127Cg22-Pg1-Ps128
Cg22-Pg1-Ps129Cg22-Pg1-Ps130Cg22-Pg1-Ps131Cg22-Pg1-Ps132
Cg22-Pg1-Ps133Cg22-Pg1-Ps134Cg22-Pg1-Ps135Cg22-Pg1-Ps136
Cg22-Pg1-Ps137Cg22-Pg1-Ps138Cg22-Pg1-Ps139Cg22-Pg1-Ps140
Cg22-Pg1-Ps141Cg22-Pg1-Ps142Cg22-Pg1-Ps143Cg22-Pg1-Ps144
Cg22-Pg1-Ps145Cg22-Pg1-Ps146Cg22-Pg1-Ps147Cg22-Pg1-Ps148
Cg22-Pg1-Ps149Cg22-Pg1-Ps150Cg22-Pg1-Ps151Cg22-Pg1-Ps152
Cg22-Pg1-Ps153Cg22-Pg1-Ps154Cg22-Pg1-Ps155Cg22-Pg1-Ps156
Cg22-Pg1-Ps157Cg22-Pg1-Ps158Cg22-Pg1-Ps159Cg22-Pg1-Ps160
Cg22-Pg1-Ps161Cg22-Pg1-Ps162Cg22-Pg1-Ps163Cg22-Pg1-Ps164
Cg22-Pg1-Ps165Cg22-Pg1-Ps166Cg22-Pg1-Ps167Cg22-Pg1-Ps168
Cg22-Pg1-Ps169Cg22-Pg1-Ps170Cg22-Pg1-Ps171Cg22-Pg1-Ps172
Cg22-Pg1-Ps173Cg22-Pg1-Ps174Cg22-Pg1-Ps175Cg22-Pg1-Ps176
Cg22-Pg1-Ps177Cg22-Pg1-Ps178Cg22-Pg1-Ps179Cg22-Pg1-Ps180
Cg22-Pg1-Ps181Cg22-Pg1-Ps182Cg22-Pg1-Ps183Cg22-Pg1-Ps184
Cg22-Pg1-Ps185Cg22-Pg1-Ps186Cg22-Pg1-Ps187Cg22-Pg1-Ps188
Cg22-Pg1-Ps189Cg22-Pg1-Ps190Cg22-Pg1-Ps191Cg22-Pg1-Ps192
Cg22-Pg1-Ps193Cg22-Pg1-Ps194Cg22-Pg1-Ps195Cg22-Pg1-Ps196
Cg22-Pg1-Ps197Cg22-Pg1-Ps198Cg22-Pg1-Ps199Cg22-Pg1-Ps200
Cg22-Pg1-Ps201Cg22-Pg1-Ps202Cg22-Pg1-Ps203Cg22-Pg1-Ps204
Cg22-Pg1-Ps205Cg22-Pg1-Ps206Cg22-Pg1-Ps207Cg22-Pg1-Ps208
Cg22-Pg1-Ps209Cg22-Pg1-Ps210Cg22-Pg1-Ps211Cg22-Pg1-Ps212
Cg22-Pg1-Ps213Cg22-Pg1-Ps214Cg22-Pg1-Ps215Cg22-Pg1-Ps216
Cg22-Pg1-Ps217Cg22-Pg1-Ps218Cg22-Pg1-Ps219Cg22-Pg1-Ps220
Cg22-Pg1-Ps221Cg22-Pg1-Ps222Cg22-Pg1-Ps223Cg22-Pg1-Ps224
Cg22-Pg1-Ps225Cg22-Pg1-Ps226Cg22-Pg1-Ps227Cg22-Pg1-Ps228
Cg22-Pg1-Ps229Cg22-Pg1-Ps230Cg22-Pg1-Ps231Cg22-Pg1-Ps232
Cg22-Pg1-Ps233Cg22-Pg1-Ps234Cg22-Pg1-Ps235Cg22-Pg1-Ps236
Cg22-Pg1-Ps237Cg22-Pg1-Ps238Cg22-Pg1-Ps239Cg22-Pg1-Ps240
Cg22-Pg1-Ps241Cg22-Pg1-Ps242Cg22-Pg1-Ps243
Cg23-Pg1-Ps1Cg23-Pg1-Ps2Cg23-Pg1-Ps3Cg23-Pg1-Ps4
Cg23-Pg1-Ps5Cg23-Pg1-Ps6Cg23-Pg1-Ps7Cg23-Pg1-Ps8
Cg23-Pg1-Ps9Cg23-Pg1-Ps10Cg23-Pg1-Ps11Cg23-Pg1-Ps12
Cg23-Pg1-Ps13Cg23-Pg1-Ps14Cg23-Pg1-Ps15Cg23-Pg1-Ps16
Cg23-Pg1-Ps17Cg23-Pg1-Ps18Cg23-Pg1-Ps19Cg23-Pg1-Ps20
Cg23-Pg1-Ps21Cg23-Pg1-Ps22Cg23-Pg1-Ps23Cg23-Pg1-Ps24
Cg23-Pg1-Ps25Cg23-Pg1-Ps26Cg23-Pg1-Ps27Cg23-Pg1-Ps28
Cg23-Pg1-Ps29Cg23-Pg1-Ps30Cg23-Pg1-Ps31Cg23-Pg1-Ps32
Cg23-Pg1-Ps33Cg23-Pg1-Ps34Cg23-Pg1-Ps35Cg23-Pg1-Ps36
Cg23-Pg1-Ps37Cg23-Pg1-Ps38Cg23-Pg1-Ps39Cg23-Pg1-Ps40
Cg23-Pg1-Ps41Cg23-Pg1-Ps42Cg23-Pg1-Ps43Cg23-Pg1-Ps44
Cg23-Pg1-Ps45Cg23-Pg1-Ps46Cg23-Pg1-Ps47Cg23-Pg1-Ps48
Cg23-Pg1-Ps49Cg23-Pg1-Ps50Cg23-Pg1-Ps51Cg23-Pg1-Ps52
Cg23-Pg1-Ps53Cg23-Pg1-Ps54Cg23-Pg1-Ps55Cg23-Pg1-Ps56
Cg23-Pg1-Ps57Cg23-Pg1-Ps58Cg23-Pg1-Ps59Cg23-Pg1-Ps60
Cg23-Pg1-Ps61Cg23-Pg1-Ps62Cg23-Pg1-Ps63Cg23-Pg1-Ps64
Cg23-Pg1-Ps65Cg23-Pg1-Ps66Cg23-Pg1-Ps67Cg23-Pg1-Ps68
Cg23-Pg1-Ps69Cg23-Pg1-Ps70Cg23-Pg1-Ps71Cg23-Pg1-Ps72
Cg23-Pg1-Ps73Cg23-Pg1-Ps74Cg23-Pg1-Ps75Cg23-Pg1-Ps76
Cg23-Pg1-Ps77Cg23-Pg1-Ps78Cg23-Pg1-Ps79Cg23-Pg1-Ps80
Cg23-Pg1-Ps81Cg23-Pg1-Ps82Cg23-Pg1-Ps83Cg23-Pg1-Ps84
Cg23-Pg1-Ps85Cg23-Pg1-Ps86Cg23-Pg1-Ps87Cg23-Pg1-Ps88
Cg23-Pg1-Ps89Cg23-Pg1-Ps90Cg23-Pg1-Ps91Cg23-Pg1-Ps92
Cg23-Pg1-Ps93Cg23-Pg1-Ps94Cg23-Pg1-Ps95Cg23-Pg1-Ps96
Cg23-Pg1-Ps97Cg23-Pg1-Ps98Cg23-Pg1-Ps99Cg23-Pg1-Ps100
Cg23-Pg1-Ps101Cg23-Pg1-Ps102Cg23-Pg1-Ps103Cg23-Pg1-Ps104
Cg23-Pg1-Ps105Cg23-Pg1-Ps106Cg23-Pg1-Ps107Cg23-Pg1-Ps108
Cg23-Pg1-Ps109Cg23-Pg1-Ps110Cg23-Pg1-Ps111Cg23-Pg1-Ps112
Cg23-Pg1-Ps113Cg23-Pg1-Ps114Cg23-Pg1-Ps115Cg23-Pg1-Ps116
Cg23-Pg1-Ps117Cg23-Pg1-Ps118Cg23-Pg1-Ps119Cg23-Pg1-Ps120
Cg23-Pg1-Ps121Cg23-Pg1-Ps122Cg23-Pg1-Ps123Cg23-Pg1-Ps124
Cg23-Pg1-Ps125Cg23-Pg1-Ps126Cg23-Pg1-Ps127Cg23-Pg1-Ps128
Cg23-Pg1-Ps129Cg23-Pg1-Ps130Cg23-Pg1-Ps131Cg23-Pg1-Ps132
Cg23-Pg1-Ps133Cg23-Pg1-Ps134Cg23-Pg1-Ps135Cg23-Pg1-Ps136
Cg23-Pg1-Ps137Cg23-Pg1-Ps138Cg23-Pg1-Ps139Cg23-Pg1-Ps140
Cg23-Pg1-Ps141Cg23-Pg1-Ps142Cg23-Pg1-Ps143Cg23-Pg1-Ps144
Cg23-Pg1-Ps145Cg23-Pg1-Ps146Cg23-Pg1-Ps147Cg23-Pg1-Ps148
Cg23-Pg1-Ps149Cg23-Pg1-Ps150Cg23-Pg1-Ps151Cg23-Pg1-Ps152
Cg23-Pg1-Ps153Cg23-Pg1-Ps154Cg23-Pg1-Ps155Cg23-Pg1-Ps156
Cg23-Pg1-Ps157Cg23-Pg1-Ps158Cg23-Pg1-Ps159Cg23-Pg1-Ps160
Cg23-Pg1-Ps161Cg23-Pg1-Ps162Cg23-Pg1-Ps163Cg23-Pg1-Ps164
Cg23-Pg1-Ps165Cg23-Pg1-Ps166Cg23-Pg1-Ps167Cg23-Pg1-Ps168
Cg23-Pg1-Ps169Cg23-Pg1-Ps170Cg23-Pg1-Ps171Cg23-Pg1-Ps172
Cg23-Pg1-Ps173Cg23-Pg1-Ps174Cg23-Pg1-Ps175Cg23-Pg1-Ps176
Cg23-Pg1-Ps177Cg23-Pg1-Ps178Cg23-Pg1-Ps179Cg23-Pg1-Ps180
Cg23-Pg1-Ps181Cg23-Pg1-Ps182Cg23-Pg1-Ps183Cg23-Pg1-Ps184
Cg23-Pg1-Ps185Cg23-Pg1-Ps186Cg23-Pg1-Ps187Cg23-Pg1-Ps188
Cg23-Pg1-Ps189Cg23-Pg1-Ps190Cg23-Pg1-Ps191Cg23-Pg1-Ps192
Cg23-Pg1-Ps193Cg23-Pg1-Ps194Cg23-Pg1-Ps195Cg23-Pg1-Ps196
Cg23-Pg1-Ps197Cg23-Pg1-Ps198Cg23-Pg1-Ps199Cg23-Pg1-Ps200
Cg23-Pg1-Ps201Cg23-Pg1-Ps202Cg23-Pg1-Ps203Cg23-Pg1-Ps204
Cg23-Pg1-Ps205Cg23-Pg1-Ps206Cg23-Pg1-Ps207Cg23-Pg1-Ps208
Cg23-Pg1-Ps209Cg23-Pg1-Ps210Cg23-Pg1-Ps211Cg23-Pg1-Ps212
Cg23-Pg1-Ps213Cg23-Pg1-Ps214Cg23-Pg1-Ps215Cg23-Pg1-Ps216
Cg23-Pg1-Ps217Cg23-Pg1-Ps218Cg23-Pg1-Ps219Cg23-Pg1-Ps220
Cg23-Pg1-Ps221Cg23-Pg1-Ps222Cg23-Pg1-Ps223Cg23-Pg1-Ps224
Cg23-Pg1-Ps225Cg23-Pg1-Ps226Cg23-Pg1-Ps227Cg23-Pg1-Ps228
Cg23-Pg1-Ps229Cg23-Pg1-Ps230Cg23-Pg1-Ps231Cg23-Pg1-Ps232
Cg23-Pg1-Ps233Cg23-Pg1-Ps234Cg23-Pg1-Ps235Cg23-Pg1-Ps236
Cg23-Pg1-Ps237Cg23-Pg1-Ps238Cg23-Pg1-Ps239Cg23-Pg1-Ps240
Cg23-Pg1-Ps241Cg23-Pg1-Ps242Cg23-Pg1-Ps243
Cg24-Pg1-Ps1Cg24-Pg1-Ps2Cg24-Pg1-Ps3Cg24-Pg1-Ps4
Cg24-Pg1-Ps5Cg24-Pg1-Ps6Cg24-Pg1-Ps7Cg24-Pg1-Ps8
Cg24-Pg1-Ps9Cg24-Pg1-Ps10Cg24-Pg1-Ps11Cg24-Pg1-Ps12
Cg24-Pg1-Ps13Cg24-Pg1-Ps14Cg24-Pg1-Ps15Cg24-Pg1-Ps16
Cg24-Pg1-Ps17Cg24-Pg1-Ps18Cg24-Pg1-Ps19Cg24-Pg1-Ps20
Cg24-Pg1-Ps21Cg24-Pg1-Ps22Cg24-Pg1-Ps23Cg24-Pg1-Ps24
Cg24-Pg1-Ps25Cg24-Pg1-Ps26Cg24-Pg1-Ps27Cg24-Pg1-Ps28
Cg24-Pg1-Ps29Cg24-Pg1-Ps30Cg24-Pg1-Ps31Cg24-Pg1-Ps32
Cg24-Pg1-Ps33Cg24-Pg1-Ps34Cg24-Pg1-Ps35Cg24-Pg1-Ps36
Cg24-Pg1-Ps37Cg24-Pg1-Ps38Cg24-Pg1-Ps39Cg24-Pg1-Ps40
Cg24-Pg1-Ps41Cg24-Pg1-Ps42Cg24-Pg1-Ps43Cg24-Pg1-Ps44
Cg24-Pg1-Ps45Cg24-Pg1-Ps46Cg24-Pg1-Ps47Cg24-Pg1-Ps48
Cg24-Pg1-Ps49Cg24-Pg1-Ps50Cg24-Pg1-Ps51Cg24-Pg1-Ps52
Cg24-Pg1-Ps53Cg24-Pg1-Ps54Cg24-Pg1-Ps55Cg24-Pg1-Ps56
Cg24-Pg1-Ps57Cg24-Pg1-Ps58Cg24-Pg1-Ps59Cg24-Pg1-Ps60
Cg24-Pg1-Ps61Cg24-Pg1-Ps62Cg24-Pg1-Ps63Cg24-Pg1-Ps64
Cg24-Pg1-Ps65Cg24-Pg1-Ps66Cg24-Pg1-Ps67Cg24-Pg1-Ps68
Cg24-Pg1-Ps69Cg24-Pg1-Ps70Cg24-Pg1-Ps71Cg24-Pg1-Ps72
Cg24-Pg1-Ps73Cg24-Pg1-Ps74Cg24-Pg1-Ps75Cg24-Pg1-Ps76
Cg24-Pg1-Ps77Cg24-Pg1-Ps78Cg24-Pg1-Ps79Cg24-Pg1-Ps80
Cg24-Pg1-Ps81Cg24-Pg1-Ps82Cg24-Pg1-Ps83Cg24-Pg1-Ps84
Cg24-Pg1-Ps85Cg24-Pg1-Ps86Cg24-Pg1-Ps87Cg24-Pg1-Ps88
Cg24-Pg1-Ps89Cg24-Pg1-Ps90Cg24-Pg1-Ps91Cg24-Pg1-Ps92
Cg24-Pg1-Ps93Cg24-Pg1-Ps94Cg24-Pg1-Ps95Cg24-Pg1-Ps96
Cg24-Pg1-Ps97Cg24-Pg1-Ps98Cg24-Pg1-Ps99Cg24-Pg1-Ps100
Cg24-Pg1-Ps101Cg24-Pg1-Ps102Cg24-Pg1-Ps103Cg24-Pg1-Ps104
Cg24-Pg1-Ps105Cg24-Pg1-Ps106Cg24-Pg1-Ps107Cg24-Pg1-Ps108
Cg24-Pg1-Ps109Cg24-Pg1-Ps110Cg24-Pg1-Ps111Cg24-Pg1-Ps112
Cg24-Pg1-Ps113Cg24-Pg1-Ps114Cg24-Pg1-Ps115Cg24-Pg1-Ps116
Cg24-Pg1-Ps117Cg24-Pg1-Ps118Cg24-Pg1-Ps119Cg24-Pg1-Ps120
Cg24-Pg1-Ps121Cg24-Pg1-Ps122Cg24-Pg1-Ps123Cg24-Pg1-Ps124
Cg24-Pg1-Ps125Cg24-Pg1-Ps126Cg24-Pg1-Ps127Cg24-Pg1-Ps128
Cg24-Pg1-Ps129Cg24-Pg1-Ps130Cg24-Pg1-Ps131Cg24-Pg1-Ps132
Cg24-Pg1-Ps133Cg24-Pg1-Ps134Cg24-Pg1-Ps135Cg24-Pg1-Ps136
Cg24-Pg1-Ps137Cg24-Pg1-Ps138Cg24-Pg1-Ps139Cg24-Pg1-Ps140
Cg24-Pg1-Ps141Cg24-Pg1-Ps142Cg24-Pg1-Ps143Cg24-Pg1-Ps144
Cg24-Pg1-Ps145Cg24-Pg1-Ps146Cg24-Pg1-Ps147Cg24-Pg1-Ps148
Cg24-Pg1-Ps149Cg24-Pg1-Ps150Cg24-Pg1-Ps151Cg24-Pg1-Ps152
Cg24-Pg1-Ps153Cg24-Pg1-Ps154Cg24-Pg1-Ps155Cg24-Pg1-Ps156
Cg24-Pg1-Ps157Cg24-Pg1-Ps158Cg24-Pg1-Ps159Cg24-Pg1-Ps160
Cg24-Pg1-Ps161Cg24-Pg1-Ps162Cg24-Pg1-Ps163Cg24-Pg1-Ps164
Cg24-Pg1-Ps165Cg24-Pg1-Ps166Cg24-Pg1-Ps167Cg24-Pg1-Ps168
Cg24-Pg1-Ps169Cg24-Pg1-Ps170Cg24-Pg1-Ps171Cg24-Pg1-Ps172
Cg24-Pg1-Ps173Cg24-Pg1-Ps174Cg24-Pg1-Ps175Cg24-Pg1-Ps176
Cg24-Pg1-Ps177Cg24-Pg1-Ps178Cg24-Pg1-Ps179Cg24-Pg1-Ps180
Cg24-Pg1-Ps181Cg24-Pg1-Ps182Cg24-Pg1-Ps183Cg24-Pg1-Ps184
Cg24-Pg1-Ps185Cg24-Pg1-Ps186Cg24-Pg1-Ps187Cg24-Pg1-Ps188
Cg24-Pg1-Ps189Cg24-Pg1-Ps190Cg24-Pg1-Ps191Cg24-Pg1-Ps192
Cg24-Pg1-Ps193Cg24-Pg1-Ps194Cg24-Pg1-Ps195Cg24-Pg1-Ps196
Cg24-Pg1-Ps197Cg24-Pg1-Ps198Cg24-Pg1-Ps199Cg24-Pg1-Ps200
Cg24-Pg1-Ps201Cg24-Pg1-Ps202Cg24-Pg1-Ps203Cg24-Pg1-Ps204
Cg24-Pg1-Ps205Cg24-Pg1-Ps206Cg24-Pg1-Ps207Cg24-Pg1-Ps208
Cg24-Pg1-Ps209Cg24-Pg1-Ps210Cg24-Pg1-Ps211Cg24-Pg1-Ps212
Cg24-Pg1-Ps213Cg24-Pg1-Ps214Cg24-Pg1-Ps215Cg24-Pg1-Ps216
Cg24-Pg1-Ps217Cg24-Pg1-Ps218Cg24-Pg1-Ps219Cg24-Pg1-Ps220
Cg24-Pg1-Ps221Cg24-Pg1-Ps222Cg24-Pg1-Ps223Cg24-Pg1-Ps224
Cg24-Pg1-Ps225Cg24-Pg1-Ps226Cg24-Pg1-Ps227Cg24-Pg1-Ps228
Cg24-Pg1-Ps229Cg24-Pg1-Ps230Cg24-Pg1-Ps231Cg24-Pg1-Ps232
Cg24-Pg1-Ps233Cg24-Pg1-Ps234Cg24-Pg1-Ps235Cg24-Pg1-Ps236
Cg24-Pg1-Ps237Cg24-Pg1-Ps238Cg24-Pg1-Ps239Cg24-Pg1-Ps240
Cg24-Pg1-Ps241Cg24-Pg1-Ps242Cg24-Pg1-Ps243
Cg25-Pg1-Ps1Cg25-Pg1-Ps2Cg25-Pg1-Ps3Cg25-Pg1-Ps4
Cg25-Pg1-Ps5Cg25-Pg1-Ps6Cg25-Pg1-Ps7Cg25-Pg1-Ps8
Cg25-Pg1-Ps9Cg25-Pg1-Ps10Cg25-Pg1-Ps11Cg25-Pg1-Ps12
Cg25-Pg1-Ps13Cg25-Pg1-Ps14Cg25-Pg1-Ps15Cg25-Pg1-Ps16
Cg25-Pg1-Ps17Cg25-Pg1-Ps18Cg25-Pg1-Ps19Cg25-Pg1-Ps20
Cg25-Pg1-Ps21Cg25-Pg1-Ps22Cg25-Pg1-Ps23Cg25-Pg1-Ps24
Cg25-Pg1-Ps25Cg25-Pg1-Ps26Cg25-Pg1-Ps27Cg25-Pg1-Ps28
Cg25-Pg1-Ps29Cg25-Pg1-Ps30Cg25-Pg1-Ps31Cg25-Pg1-Ps32
Cg25-Pg1-Ps33Cg25-Pg1-Ps34Cg25-Pg1-Ps35Cg25-Pg1-Ps36
Cg25-Pg1-Ps37Cg25-Pg1-Ps38Cg25-Pg1-Ps39Cg25-Pg1-Ps40
Cg25-Pg1-Ps41Cg25-Pg1-Ps42Cg25-Pg1-Ps43Cg25-Pg1-Ps44
Cg25-Pg1-Ps45Cg25-Pg1-Ps46Cg25-Pg1-Ps47Cg25-Pg1-Ps48
Cg25-Pg1-Ps49Cg25-Pg1-Ps50Cg25-Pg1-Ps51Cg25-Pg1-Ps52
Cg25-Pg1-Ps53Cg25-Pg1-Ps54Cg25-Pg1-Ps55Cg25-Pg1-Ps56
Cg25-Pg1-Ps57Cg25-Pg1-Ps58Cg25-Pg1-Ps59Cg25-Pg1-Ps60
Cg25-Pg1-Ps61Cg25-Pg1-Ps62Cg25-Pg1-Ps63Cg25-Pg1-Ps64
Cg25-Pg1-Ps65Cg25-Pg1-Ps66Cg25-Pg1-Ps67Cg25-Pg1-Ps68
Cg25-Pg1-Ps69Cg25-Pg1-Ps70Cg25-Pg1-Ps71Cg25-Pg1-Ps72
Cg25-Pg1-Ps73Cg25-Pg1-Ps74Cg25-Pg1-Ps75Cg25-Pg1-Ps76
Cg25-Pg1-Ps77Cg25-Pg1-Ps78Cg25-Pg1-Ps79Cg25-Pg1-Ps80
Cg25-Pg1-Ps81Cg25-Pg1-Ps82Cg25-Pg1-Ps83Cg25-Pg1-Ps84
Cg25-Pg1-Ps85Cg25-Pg1-Ps86Cg25-Pg1-Ps87Cg25-Pg1-Ps88
Cg25-Pg1-Ps89Cg25-Pg1-Ps90Cg25-Pg1-Ps91Cg25-Pg1-Ps92
Cg25-Pg1-Ps93Cg25-Pg1-Ps94Cg25-Pg1-Ps95Cg25-Pg1-Ps96
Cg25-Pg1-Ps97Cg25-Pg1-Ps98Cg25-Pg1-Ps99Cg25-Pg1-Ps100
Cg25-Pg1-Ps101Cg25-Pg1-Ps102Cg25-Pg1-Ps103Cg25-Pg1-Ps104
Cg25-Pg1-Ps105Cg25-Pg1-Ps106Cg25-Pg1-Ps107Cg25-Pg1-Ps108
Cg25-Pg1-Ps109Cg25-Pg1-Ps110Cg25-Pg1-Ps111Cg25-Pg1-Ps112
Cg25-Pg1-Ps113Cg25-Pg1-Ps114Cg25-Pg1-Ps115Cg25-Pg1-Ps116
Cg25-Pg1-Ps117Cg25-Pg1-Ps118Cg25-Pg1-Ps119Cg25-Pg1-Ps120
Cg25-Pg1-Ps121Cg25-Pg1-Ps122Cg25-Pg1-Ps123Cg25-Pg1-Ps124
Cg25-Pg1-Ps125Cg25-Pg1-Ps126Cg25-Pg1-Ps127Cg25-Pg1-Ps128
Cg25-Pg1-Ps129Cg25-Pg1-Ps130Cg25-Pg1-Ps131Cg25-Pg1-Ps132
Cg25-Pg1-Ps133Cg25-Pg1-Ps134Cg25-Pg1-Ps135Cg25-Pg1-Ps136
Cg25-Pg1-Ps137Cg25-Pg1-Ps138Cg25-Pg1-Ps139Cg25-Pg1-Ps140
Cg25-Pg1-Ps141Cg25-Pg1-Ps142Cg25-Pg1-Ps143Cg25-Pg1-Ps144
Cg25-Pg1-Ps145Cg25-Pg1-Ps146Cg25-Pg1-Ps147Cg25-Pg1-Ps148
Cg25-Pg1-Ps149Cg25-Pg1-Ps150Cg25-Pg1-Ps151Cg25-Pg1-Ps152
Cg25-Pg1-Ps153Cg25-Pg1-Ps154Cg25-Pg1-Ps155Cg25-Pg1-Ps156
Cg25-Pg1-Ps157Cg25-Pg1-Ps158Cg25-Pg1-Ps159Cg25-Pg1-Ps160
Cg25-Pg1-Ps161Cg25-Pg1-Ps162Cg25-Pg1-Ps163Cg25-Pg1-Ps164
Cg25-Pg1-Ps165Cg25-Pg1-Ps166Cg25-Pg1-Ps167Cg25-Pg1-Ps168
Cg25-Pg1-Ps169Cg25-Pg1-Ps170Cg25-Pg1-Ps171Cg25-Pg1-Ps172
Cg25-Pg1-Ps173Cg25-Pg1-Ps174Cg25-Pg1-Ps175Cg25-Pg1-Ps176
Cg25-Pg1-Ps177Cg25-Pg1-Ps178Cg25-Pg1-Ps179Cg25-Pg1-Ps180
Cg25-Pg1-Ps181Cg25-Pg1-Ps182Cg25-Pg1-Ps183Cg25-Pg1-Ps184
Cg25-Pg1-Ps185Cg25-Pg1-Ps186Cg25-Pg1-Ps187Cg25-Pg1-Ps188
Cg25-Pg1-Ps189Cg25-Pg1-Ps190Cg25-Pg1-Ps191Cg25-Pg1-Ps192
Cg25-Pg1-Ps193Cg25-Pg1-Ps194Cg25-Pg1-Ps195Cg25-Pg1-Ps196
Cg25-Pg1-Ps197Cg25-Pg1-Ps198Cg25-Pg1-Ps199Cg25-Pg1-Ps200
Cg25-Pg1-Ps201Cg25-Pg1-Ps202Cg25-Pg1-Ps203Cg25-Pg1-Ps204
Cg25-Pg1-Ps205Cg25-Pg1-Ps206Cg25-Pg1-Ps207Cg25-Pg1-Ps208
Cg25-Pg1-Ps209Cg25-Pg1-Ps210Cg25-Pg1-Ps211Cg25-Pg1-Ps212
Cg25-Pg1-Ps213Cg25-Pg1-Ps214Cg25-Pg1-Ps215Cg25-Pg1-Ps216
Cg25-Pg1-Ps217Cg25-Pg1-Ps218Cg25-Pg1-Ps219Cg25-Pg1-Ps220
Cg25-Pg1-Ps221Cg25-Pg1-Ps222Cg25-Pg1-Ps223Cg25-Pg1-Ps224
Cg25-Pg1-Ps225Cg25-Pg1-Ps226Cg25-Pg1-Ps227Cg25-Pg1-Ps228
Cg25-Pg1-Ps229Cg25-Pg1-Ps230Cg25-Pg1-Ps231Cg25-Pg1-Ps232
Cg25-Pg1-Ps233Cg25-Pg1-Ps234Cg25-Pg1-Ps235Cg25-Pg1-Ps236
Cg25-Pg1-Ps237Cg25-Pg1-Ps238Cg25-Pg1-Ps239Cg25-Pg1-Ps240
Cg25-Pg1-Ps241Cg25-Pg1-Ps242Cg25-Pg1-Ps243
Cg26-Pg1-Ps1Cg26-Pg1-Ps2Cg26-Pg1-Ps3Cg26-Pg1-Ps4
Cg26-Pg1-Ps5Cg26-Pg1-Ps6Cg26-Pg1-Ps7Cg26-Pg1-Ps8
Cg26-Pg1-Ps9Cg26-Pg1-Ps10Cg26-Pg1-Ps11Cg26-Pg1-Ps12
Cg26-Pg1-Ps13Cg26-Pg1-Ps14Cg26-Pg1-Ps15Cg26-Pg1-Ps16
Cg26-Pg1-Ps17Cg26-Pg1-Ps18Cg26-Pg1-Ps19Cg26-Pg1-Ps20
Cg26-Pg1-Ps21Cg26-Pg1-Ps22Cg26-Pg1-Ps23Cg26-Pg1-Ps24
Cg26-Pg1-Ps25Cg26-Pg1-Ps26Cg26-Pg1-Ps27Cg26-Pg1-Ps28
Cg26-Pg1-Ps29Cg26-Pg1-Ps30Cg26-Pg1-Ps31Cg26-Pg1-Ps32
Cg26-Pg1-Ps33Cg26-Pg1-Ps34Cg26-Pg1-Ps35Cg26-Pg1-Ps36
Cg26-Pg1-Ps37Cg26-Pg1-Ps38Cg26-Pg1-Ps39Cg26-Pg1-Ps40
Cg26-Pg1-Ps41Cg26-Pg1-Ps42Cg26-Pg1-Ps43Cg26-Pg1-Ps44
Cg26-Pg1-Ps45Cg26-Pg1-Ps46Cg26-Pg1-Ps47Cg26-Pg1-Ps48
Cg26-Pg1-Ps49Cg26-Pg1-Ps50Cg26-Pg1-Ps51Cg26-Pg1-Ps52
Cg26-Pg1-Ps53Cg26-Pg1-Ps54Cg26-Pg1-Ps55Cg26-Pg1-Ps56
Cg26-Pg1-Ps57Cg26-Pg1-Ps58Cg26-Pg1-Ps59Cg26-Pg1-Ps60
Cg26-Pg1-Ps61Cg26-Pg1-Ps62Cg26-Pg1-Ps63Cg26-Pg1-Ps64
Cg26-Pg1-Ps65Cg26-Pg1-Ps66Cg26-Pg1-Ps67Cg26-Pg1-Ps68
Cg26-Pg1-Ps69Cg26-Pg1-Ps70Cg26-Pg1-Ps71Cg26-Pg1-Ps72
Cg26-Pg1-Ps73Cg26-Pg1-Ps74Cg26-Pg1-Ps75Cg26-Pg1-Ps76
Cg26-Pg1-Ps77Cg26-Pg1-Ps78Cg26-Pg1-Ps79Cg26-Pg1-Ps80
Cg26-Pg1-Ps81Cg26-Pg1-Ps82Cg26-Pg1-Ps83Cg26-Pg1-Ps84
Cg26-Pg1-Ps85Cg26-Pg1-Ps86Cg26-Pg1-Ps87Cg26-Pg1-Ps88
Cg26-Pg1-Ps89Cg26-Pg1-Ps90Cg26-Pg1-Ps91Cg26-Pg1-Ps92
Cg26-Pg1-Ps93Cg26-Pg1-Ps94Cg26-Pg1-Ps95Cg26-Pg1-Ps96
Cg26-Pg1-Ps97Cg26-Pg1-Ps98Cg26-Pg1-Ps99Cg26-Pg1-Ps100
Cg26-Pg1-Ps101Cg26-Pg1-Ps102Cg26-Pg1-Ps103Cg26-Pg1-Ps104
Cg26-Pg1-Ps105Cg26-Pg1-Ps106Cg26-Pg1-Ps107Cg26-Pg1-Ps108
Cg26-Pg1-Ps109Cg26-Pg1-Ps110Cg26-Pg1-Ps111Cg26-Pg1-Ps112
Cg26-Pg1-Ps113Cg26-Pg1-Ps114Cg26-Pg1-Ps115Cg26-Pg1-Ps116
Cg26-Pg1-Ps117Cg26-Pg1-Ps118Cg26-Pg1-Ps119Cg26-Pg1-Ps120
Cg26-Pg1-Ps121Cg26-Pg1-Ps122Cg26-Pg1-Ps123Cg26-Pg1-Ps124
Cg26-Pg1-Ps125Cg26-Pg1-Ps126Cg26-Pg1-Ps127Cg26-Pg1-Ps128
Cg26-Pg1-Ps129Cg26-Pg1-Ps130Cg26-Pg1-Ps131Cg26-Pg1-Ps132
Cg26-Pg1-Ps133Cg26-Pg1-Ps134Cg26-Pg1-Ps135Cg26-Pg1-Ps136
Cg26-Pg1-Ps137Cg26-Pg1-Ps138Cg26-Pg1-Ps139Cg26-Pg1-Ps140
Cg26-Pg1-Ps141Cg26-Pg1-Ps142Cg26-Pg1-Ps143Cg26-Pg1-Ps144
Cg26-Pg1-Ps145Cg26-Pg1-Ps146Cg26-Pg1-Ps147Cg26-Pg1-Ps148
Cg26-Pg1-Ps149Cg26-Pg1-Ps150Cg26-Pg1-Ps151Cg26-Pg1-Ps152
Cg26-Pg1-Ps153Cg26-Pg1-Ps154Cg26-Pg1-Ps155Cg26-Pg1-Ps156
Cg26-Pg1-Ps157Cg26-Pg1-Ps158Cg26-Pg1-Ps159Cg26-Pg1-Ps160
Cg26-Pg1-Ps161Cg26-Pg1-Ps162Cg26-Pg1-Ps163Cg26-Pg1-Ps164
Cg26-Pg1-Ps165Cg26-Pg1-Ps166Cg26-Pg1-Ps167Cg26-Pg1-Ps168
Cg26-Pg1-Ps169Cg26-Pg1-Ps170Cg26-Pg1-Ps171Cg26-Pg1-Ps172
Cg26-Pg1-Ps173Cg26-Pg1-Ps174Cg26-Pg1-Ps175Cg26-Pg1-Ps176
Cg26-Pg1-Ps177Cg26-Pg1-Ps178Cg26-Pg1-Ps179Cg26-Pg1-Ps180
Cg26-Pg1-Ps181Cg26-Pg1-Ps182Cg26-Pg1-Ps183Cg26-Pg1-Ps184
Cg26-Pg1-Ps185Cg26-Pg1-Ps186Cg26-Pg1-Ps187Cg26-Pg1-Ps188
Cg26-Pg1-Ps189Cg26-Pg1-Ps190Cg26-Pg1-Ps191Cg26-Pg1-Ps192
Cg26-Pg1-Ps193Cg26-Pg1-Ps194Cg26-Pg1-Ps195Cg26-Pg1-Ps196
Cg26-Pg1-Ps197Cg26-Pg1-Ps198Cg26-Pg1-Ps199Cg26-Pg1-Ps200
Cg26-Pg1-Ps201Cg26-Pg1-Ps202Cg26-Pg1-Ps203Cg26-Pg1-Ps204
Cg26-Pg1-Ps205Cg26-Pg1-Ps206Cg26-Pg1-Ps207Cg26-Pg1-Ps208
Cg26-Pg1-Ps209Cg26-Pg1-Ps210Cg26-Pg1-Ps211Cg26-Pg1-Ps212
Cg26-Pg1-Ps213Cg26-Pg1-Ps214Cg26-Pg1-Ps215Cg26-Pg1-Ps216
Cg26-Pg1-Ps217Cg26-Pg1-Ps218Cg26-Pg1-Ps219Cg26-Pg1-Ps220
Cg26-Pg1-Ps221Cg26-Pg1-Ps222Cg26-Pg1-Ps223Cg26-Pg1-Ps224
Cg26-Pg1-Ps225Cg26-Pg1-Ps226Cg26-Pg1-Ps227Cg26-Pg1-Ps228
Cg26-Pg1-Ps229Cg26-Pg1-Ps230Cg26-Pg1-Ps231Cg26-Pg1-Ps232
Cg26-Pg1-Ps233Cg26-Pg1-Ps234Cg26-Pg1-Ps235Cg26-Pg1-Ps236
Cg26-Pg1-Ps237Cg26-Pg1-Ps238Cg26-Pg1-Ps239Cg26-Pg1-Ps240
Cg26-Pg1-Ps241Cg26-Pg1-Ps242Cg26-Pg1-Ps243
Cg27-Pg1-Ps1Cg27-Pg1-Ps2Cg27-Pg1-Ps3Cg27-Pg1-Ps4
Cg27-Pg1-Ps5Cg27-Pg1-Ps6Cg27-Pg1-Ps7Cg27-Pg1-Ps8
Cg27-Pg1-Ps9Cg27-Pg1-Ps10Cg27-Pg1-Ps11Cg27-Pg1-Ps12
Cg27-Pg1-Ps13Cg27-Pg1-Ps14Cg27-Pg1-Ps15Cg27-Pg1-Ps16
Cg27-Pg1-Ps17Cg27-Pg1-Ps18Cg27-Pg1-Ps19Cg27-Pg1-Ps20
Cg27-Pg1-Ps21Cg27-Pg1-Ps22Cg27-Pg1-Ps23Cg27-Pg1-Ps24
Cg27-Pg1-Ps25Cg27-Pg1-Ps26Cg27-Pg1-Ps27Cg27-Pg1-Ps28
Cg27-Pg1-Ps29Cg27-Pg1-Ps30Cg27-Pg1-Ps31Cg27-Pg1-Ps32
Cg27-Pg1-Ps33Cg27-Pg1-Ps34Cg27-Pg1-Ps35Cg27-Pg1-Ps36
Cg27-Pg1-Ps37Cg27-Pg1-Ps38Cg27-Pg1-Ps39Cg27-Pg1-Ps40
Cg27-Pg1-Ps41Cg27-Pg1-Ps42Cg27-Pg1-Ps43Cg27-Pg1-Ps44
Cg27-Pg1-Ps45Cg27-Pg1-Ps46Cg27-Pg1-Ps47Cg27-Pg1-Ps48
Cg27-Pg1-Ps49Cg27-Pg1-Ps50Cg27-Pg1-Ps51Cg27-Pg1-Ps52
Cg27-Pg1-Ps53Cg27-Pg1-Ps54Cg27-Pg1-Ps55Cg27-Pg1-Ps56
Cg27-Pg1-Ps57Cg27-Pg1-Ps58Cg27-Pg1-Ps59Cg27-Pg1-Ps60
Cg27-Pg1-Ps61Cg27-Pg1-Ps62Cg27-Pg1-Ps63Cg27-Pg1-Ps64
Cg27-Pg1-Ps65Cg27-Pg1-Ps66Cg27-Pg1-Ps67Cg27-Pg1-Ps68
Cg27-Pg1-Ps69Cg27-Pg1-Ps70Cg27-Pg1-Ps71Cg27-Pg1-Ps72
Cg27-Pg1-Ps73Cg27-Pg1-Ps74Cg27-Pg1-Ps75Cg27-Pg1-Ps76
Cg27-Pg1-Ps77Cg27-Pg1-Ps78Cg27-Pg1-Ps79Cg27-Pg1-Ps80
Cg27-Pg1-Ps81Cg27-Pg1-Ps82Cg27-Pg1-Ps83Cg27-Pg1-Ps84
Cg27-Pg1-Ps85Cg27-Pg1-Ps86Cg27-Pg1-Ps87Cg27-Pg1-Ps88
Cg27-Pg1-Ps89Cg27-Pg1-Ps90Cg27-Pg1-Ps91Cg27-Pg1-Ps92
Cg27-Pg1-Ps93Cg27-Pg1-Ps94Cg27-Pg1-Ps95Cg27-Pg1-Ps96
Cg27-Pg1-Ps97Cg27-Pg1-Ps98Cg27-Pg1-Ps99Cg27-Pg1-Ps100
Cg27-Pg1-Ps101Cg27-Pg1-Ps102Cg27-Pg1-Ps103Cg27-Pg1-Ps104
Cg27-Pg1-Ps105Cg27-Pg1-Ps106Cg27-Pg1-Ps107Cg27-Pg1-Ps108
Cg27-Pg1-Ps109Cg27-Pg1-Ps110Cg27-Pg1-Ps111Cg27-Pg1-Ps112
Cg27-Pg1-Ps113Cg27-Pg1-Ps114Cg27-Pg1-Ps115Cg27-Pg1-Ps116
Cg27-Pg1-Ps117Cg27-Pg1-Ps118Cg27-Pg1-Ps119Cg27-Pg1-Ps120
Cg27-Pg1-Ps121Cg27-Pg1-Ps122Cg27-Pg1-Ps123Cg27-Pg1-Ps124
Cg27-Pg1-Ps125Cg27-Pg1-Ps126Cg27-Pg1-Ps127Cg27-Pg1-Ps128
Cg27-Pg1-Ps129Cg27-Pg1-Ps130Cg27-Pg1-Ps131Cg27-Pg1-Ps132
Cg27-Pg1-Ps133Cg27-Pg1-Ps134Cg27-Pg1-Ps135Cg27-Pg1-Ps136
Cg27-Pg1-Ps137Cg27-Pg1-Ps138Cg27-Pg1-Ps139Cg27-Pg1-Ps140
Cg27-Pg1-Ps141Cg27-Pg1-Ps142Cg27-Pg1-Ps143Cg27-Pg1-Ps144
Cg27-Pg1-Ps145Cg27-Pg1-Ps146Cg27-Pg1-Ps147Cg27-Pg1-Ps148
Cg27-Pg1-Ps149Cg27-Pg1-Ps150Cg27-Pg1-Ps151Cg27-Pg1-Ps152
Cg27-Pg1-Ps153Cg27-Pg1-Ps154Cg27-Pg1-Ps155Cg27-Pg1-Ps156
Cg27-Pg1-Ps157Cg27-Pg1-Ps158Cg27-Pg1-Ps159Cg27-Pg1-Ps160
Cg27-Pg1-Ps161Cg27-Pg1-Ps162Cg27-Pg1-Ps163Cg27-Pg1-Ps164
Cg27-Pg1-Ps165Cg27-Pg1-Ps166Cg27-Pg1-Ps167Cg27-Pg1-Ps168
Cg27-Pg1-Ps169Cg27-Pg1-Ps170Cg27-Pg1-Ps171Cg27-Pg1-Ps172
Cg27-Pg1-Ps173Cg27-Pg1-Ps174Cg27-Pg1-Ps175Cg27-Pg1-Ps176
Cg27-Pg1-Ps177Cg27-Pg1-Ps178Cg27-Pg1-Ps179Cg27-Pg1-Ps180
Cg27-Pg1-Ps181Cg27-Pg1-Ps182Cg27-Pg1-Ps183Cg27-Pg1-Ps184
Cg27-Pg1-Ps185Cg27-Pg1-Ps186Cg27-Pg1-Ps187Cg27-Pg1-Ps188
Cg27-Pg1-Ps189Cg27-Pg1-Ps190Cg27-Pg1-Ps191Cg27-Pg1-Ps192
Cg27-Pg1-Ps193Cg27-Pg1-Ps194Cg27-Pg1-Ps195Cg27-Pg1-Ps196
Cg27-Pg1-Ps197Cg27-Pg1-Ps198Cg27-Pg1-Ps199Cg27-Pg1-Ps200
Cg27-Pg1-Ps201Cg27-Pg1-Ps202Cg27-Pg1-Ps203Cg27-Pg1-Ps204
Cg27-Pg1-Ps205Cg27-Pg1-Ps206Cg27-Pg1-Ps207Cg27-Pg1-Ps208
Cg27-Pg1-Ps209Cg27-Pg1-Ps210Cg27-Pg1-Ps211Cg27-Pg1-Ps212
Cg27-Pg1-Ps213Cg27-Pg1-Ps214Cg27-Pg1-Ps215Cg27-Pg1-Ps216
Cg27-Pg1-Ps217Cg27-Pg1-Ps218Cg27-Pg1-Ps219Cg27-Pg1-Ps220
Cg27-Pg1-Ps221Cg27-Pg1-Ps222Cg27-Pg1-Ps223Cg27-Pg1-Ps224
Cg27-Pg1-Ps225Cg27-Pg1-Ps226Cg27-Pg1-Ps227Cg27-Pg1-Ps228
Cg27-Pg1-Ps229Cg27-Pg1-Ps230Cg27-Pg1-Ps231Cg27-Pg1-Ps232
Cg27-Pg1-Ps233Cg27-Pg1-Ps234Cg27-Pg1-Ps235Cg27-Pg1-Ps236
Cg27-Pg1-Ps237Cg27-Pg1-Ps238Cg27-Pg1-Ps239Cg27-Pg1-Ps240
Cg27-Pg1-Ps241Cg27-Pg1-Ps242Cg27-Pg1-Ps243
Cg28-Pg1-Ps1Cg28-Pg1-Ps2Cg28-Pg1-Ps3Cg28-Pg1-Ps4
Cg28-Pg1-Ps5Cg28-Pg1-Ps6Cg28-Pg1-Ps7Cg28-Pg1-Ps8
Cg28-Pg1-Ps9Cg28-Pg1-Ps10Cg28-Pg1-Ps11Cg28-Pg1-Ps12
Cg28-Pg1-Ps13Cg28-Pg1-Ps14Cg28-Pg1-Ps15Cg28-Pg1-Ps16
Cg28-Pg1-Ps17Cg28-Pg1-Ps18Cg28-Pg1-Ps19Cg28-Pg1-Ps20
Cg28-Pg1-Ps21Cg28-Pg1-Ps22Cg28-Pg1-Ps23Cg28-Pg1-Ps24
Cg28-Pg1-Ps25Cg28-Pg1-Ps26Cg28-Pg1-Ps27Cg28-Pg1-Ps28
Cg28-Pg1-Ps29Cg28-Pg1-Ps30Cg28-Pg1-Ps31Cg28-Pg1-Ps32
Cg28-Pg1-Ps33Cg28-Pg1-Ps34Cg28-Pg1-Ps35Cg28-Pg1-Ps36
Cg28-Pg1-Ps37Cg28-Pg1-Ps38Cg28-Pg1-Ps39Cg28-Pg1-Ps40
Cg28-Pg1-Ps41Cg28-Pg1-Ps42Cg28-Pg1-Ps43Cg28-Pg1-Ps44
Cg28-Pg1-Ps45Cg28-Pg1-Ps46Cg28-Pg1-Ps47Cg28-Pg1-Ps48
Cg28-Pg1-Ps49Cg28-Pg1-Ps50Cg28-Pg1-Ps51Cg28-Pg1-Ps52
Cg28-Pg1-Ps53Cg28-Pg1-Ps54Cg28-Pg1-Ps55Cg28-Pg1-Ps56
Cg28-Pg1-Ps57Cg28-Pg1-Ps58Cg28-Pg1-Ps59Cg28-Pg1-Ps60
Cg28-Pg1-Ps61Cg28-Pg1-Ps62Cg28-Pg1-Ps63Cg28-Pg1-Ps64
Cg28-Pg1-Ps65Cg28-Pg1-Ps66Cg28-Pg1-Ps67Cg28-Pg1-Ps68
Cg28-Pg1-Ps69Cg28-Pg1-Ps70Cg28-Pg1-Ps71Cg28-Pg1-Ps72
Cg28-Pg1-Ps73Cg28-Pg1-Ps74Cg28-Pg1-Ps75Cg28-Pg1-Ps76
Cg28-Pg1-Ps77Cg28-Pg1-Ps78Cg28-Pg1-Ps79Cg28-Pg1-Ps80
Cg28-Pg1-Ps81Cg28-Pg1-Ps82Cg28-Pg1-Ps83Cg28-Pg1-Ps84
Cg28-Pg1-Ps85Cg28-Pg1-Ps86Cg28-Pg1-Ps87Cg28-Pg1-Ps88
Cg28-Pg1-Ps89Cg28-Pg1-Ps90Cg28-Pg1-Ps91Cg28-Pg1-Ps92
Cg28-Pg1-Ps93Cg28-Pg1-Ps94Cg28-Pg1-Ps95Cg28-Pg1-Ps96
Cg28-Pg1-Ps97Cg28-Pg1-Ps98Cg28-Pg1-Ps99Cg28-Pg1-Ps100
Cg28-Pg1-Ps101Cg28-Pg1-Ps102Cg28-Pg1-Ps103Cg28-Pg1-Ps104
Cg28-Pg1-Ps105Cg28-Pg1-Ps106Cg28-Pg1-Ps107Cg28-Pg1-Ps108
Cg28-Pg1-Ps109Cg28-Pg1-Ps110Cg28-Pg1-Ps111Cg28-Pg1-Ps112
Cg28-Pg1-Ps113Cg28-Pg1-Ps114Cg28-Pg1-Ps115Cg28-Pg1-Ps116
Cg28-Pg1-Ps117Cg28-Pg1-Ps118Cg28-Pg1-Ps119Cg28-Pg1-Ps120
Cg28-Pg1-Ps121Cg28-Pg1-Ps122Cg28-Pg1-Ps123Cg28-Pg1-Ps124
Cg28-Pg1-Ps125Cg28-Pg1-Ps126Cg28-Pg1-Ps127Cg28-Pg1-Ps128
Cg28-Pg1-Ps129Cg28-Pg1-Ps130Cg28-Pg1-Ps131Cg28-Pg1-Ps132
Cg28-Pg1-Ps133Cg28-Pg1-Ps134Cg28-Pg1-Ps135Cg28-Pg1-Ps136
Cg28-Pg1-Ps137Cg28-Pg1-Ps138Cg28-Pg1-Ps139Cg28-Pg1-Ps140
Cg28-Pg1-Ps141Cg28-Pg1-Ps142Cg28-Pg1-Ps143Cg28-Pg1-Ps144
Cg28-Pg1-Ps145Cg28-Pg1-Ps146Cg28-Pg1-Ps147Cg28-Pg1-Ps148
Cg28-Pg1-Ps149Cg28-Pg1-Ps150Cg28-Pg1-Ps151Cg28-Pg1-Ps152
Cg28-Pg1-Ps153Cg28-Pg1-Ps154Cg28-Pg1-Ps155Cg28-Pg1-Ps156
Cg28-Pg1-Ps157Cg28-Pg1-Ps158Cg28-Pg1-Ps159Cg28-Pg1-Ps160
Cg28-Pg1-Ps161Cg28-Pg1-Ps162Cg28-Pg1-Ps163Cg28-Pg1-Ps164
Cg28-Pg1-Ps165Cg28-Pg1-Ps166Cg28-Pg1-Ps167Cg28-Pg1-Ps168
Cg28-Pg1-Ps169Cg28-Pg1-Ps170Cg28-Pg1-Ps171Cg28-Pg1-Ps172
Cg28-Pg1-Ps173Cg28-Pg1-Ps174Cg28-Pg1-Ps175Cg28-Pg1-Ps176
Cg28-Pg1-Ps177Cg28-Pg1-Ps178Cg28-Pg1-Ps179Cg28-Pg1-Ps180
Cg28-Pg1-Ps181Cg28-Pg1-Ps182Cg28-Pg1-Ps183Cg28-Pg1-Ps184
Cg28-Pg1-Ps185Cg28-Pg1-Ps186Cg28-Pg1-Ps187Cg28-Pg1-Ps188
Cg28-Pg1-Ps189Cg28-Pg1-Ps190Cg28-Pg1-Ps191Cg28-Pg1-Ps192
Cg28-Pg1-Ps193Cg28-Pg1-Ps194Cg28-Pg1-Ps195Cg28-Pg1-Ps196
Cg28-Pg1-Ps197Cg28-Pg1-Ps198Cg28-Pg1-Ps199Cg28-Pg1-Ps200
Cg28-Pg1-Ps201Cg28-Pg1-Ps202Cg28-Pg1-Ps203Cg28-Pg1-Ps204
Cg28-Pg1-Ps205Cg28-Pg1-Ps206Cg28-Pg1-Ps207Cg28-Pg1-Ps208
Cg28-Pg1-Ps209Cg28-Pg1-Ps210Cg28-Pg1-Ps211Cg28-Pg1-Ps212
Cg28-Pg1-Ps213Cg28-Pg1-Ps214Cg28-Pg1-Ps215Cg28-Pg1-Ps216
Cg28-Pg1-Ps217Cg28-Pg1-Ps218Cg28-Pg1-Ps219Cg28-Pg1-Ps220
Cg28-Pg1-Ps221Cg28-Pg1-Ps222Cg28-Pg1-Ps223Cg28-Pg1-Ps224
Cg28-Pg1-Ps225Cg28-Pg1-Ps226Cg28-Pg1-Ps227Cg28-Pg1-Ps228
Cg28-Pg1-Ps229Cg28-Pg1-Ps230Cg28-Pg1-Ps231Cg28-Pg1-Ps232
Cg28-Pg1-Ps233Cg28-Pg1-Ps234Cg28-Pg1-Ps235Cg28-Pg1-Ps236
Cg28-Pg1-Ps237Cg28-Pg1-Ps238Cg28-Pg1-Ps239Cg28-Pg1-Ps240
Cg28-Pg1-Ps241Cg28-Pg1-Ps242Cg28-Pg1-Ps243
Cg29-Pg1-Ps1Cg29-Pg1-Ps2Cg29-Pg1-Ps3Cg29-Pg1-Ps4
Cg29-Pg1-Ps5Cg29-Pg1-Ps6Cg29-Pg1-Ps7Cg29-Pg1-Ps8
Cg29-Pg1-Ps9Cg29-Pg1-Ps10Cg29-Pg1-Ps11Cg29-Pg1-Ps12
Cg29-Pg1-Ps13Cg29-Pg1-Ps14Cg29-Pg1-Ps15Cg29-Pg1-Ps16
Cg29-Pg1-Ps17Cg29-Pg1-Ps18Cg29-Pg1-Ps19Cg29-Pg1-Ps20
Cg29-Pg1-Ps21Cg29-Pg1-Ps22Cg29-Pg1-Ps23Cg29-Pg1-Ps24
Cg29-Pg1-Ps25Cg29-Pg1-Ps26Cg29-Pg1-Ps27Cg29-Pg1-Ps28
Cg29-Pg1-Ps29Cg29-Pg1-Ps30Cg29-Pg1-Ps31Cg29-Pg1-Ps32
Cg29-Pg1-Ps33Cg29-Pg1-Ps34Cg29-Pg1-Ps35Cg29-Pg1-Ps36
Cg29-Pg1-Ps37Cg29-Pg1-Ps38Cg29-Pg1-Ps39Cg29-Pg1-Ps40
Cg29-Pg1-Ps41Cg29-Pg1-Ps42Cg29-Pg1-Ps43Cg29-Pg1-Ps44
Cg29-Pg1-Ps45Cg29-Pg1-Ps46Cg29-Pg1-Ps47Cg29-Pg1-Ps48
Cg29-Pg1-Ps49Cg29-Pg1-Ps50Cg29-Pg1-Ps51Cg29-Pg1-Ps52
Cg29-Pg1-Ps53Cg29-Pg1-Ps54Cg29-Pg1-Ps55Cg29-Pg1-Ps56
Cg29-Pg1-Ps57Cg29-Pg1-Ps58Cg29-Pg1-Ps59Cg29-Pg1-Ps60
Cg29-Pg1-Ps61Cg29-Pg1-Ps62Cg29-Pg1-Ps63Cg29-Pg1-Ps64
Cg29-Pg1-Ps65Cg29-Pg1-Ps66Cg29-Pg1-Ps67Cg29-Pg1-Ps68
Cg29-Pg1-Ps69Cg29-Pg1-Ps70Cg29-Pg1-Ps71Cg29-Pg1-Ps72
Cg29-Pg1-Ps73Cg29-Pg1-Ps74Cg29-Pg1-Ps75Cg29-Pg1-Ps76
Cg29-Pg1-Ps77Cg29-Pg1-Ps78Cg29-Pg1-Ps79Cg29-Pg1-Ps80
Cg29-Pg1-Ps81Cg29-Pg1-Ps82Cg29-Pg1-Ps83Cg29-Pg1-Ps84
Cg29-Pg1-Ps85Cg29-Pg1-Ps86Cg29-Pg1-Ps87Cg29-Pg1-Ps88
Cg29-Pg1-Ps89Cg29-Pg1-Ps90Cg29-Pg1-Ps91Cg29-Pg1-Ps92
Cg29-Pg1-Ps93Cg29-Pg1-Ps94Cg29-Pg1-Ps95Cg29-Pg1-Ps96
Cg29-Pg1-Ps97Cg29-Pg1-Ps98Cg29-Pg1-Ps99Cg29-Pg1-Ps100
Cg29-Pg1-Ps101Cg29-Pg1-Ps102Cg29-Pg1-Ps103Cg29-Pg1-Ps104
Cg29-Pg1-Ps105Cg29-Pg1-Ps106Cg29-Pg1-Ps107Cg29-Pg1-Ps108
Cg29-Pg1-Ps109Cg29-Pg1-Ps110Cg29-Pg1-Ps111Cg29-Pg1-Ps112
Cg29-Pg1-Ps113Cg29-Pg1-Ps114Cg29-Pg1-Ps115Cg29-Pg1-Ps116
Cg29-Pg1-Ps117Cg29-Pg1-Ps118Cg29-Pg1-Ps119Cg29-Pg1-Ps120
Cg29-Pg1-Ps121Cg29-Pg1-Ps122Cg29-Pg1-Ps123Cg29-Pg1-Ps124
Cg29-Pg1-Ps125Cg29-Pg1-Ps126Cg29-Pg1-Ps127Cg29-Pg1-Ps128
Cg29-Pg1-Ps129Cg29-Pg1-Ps130Cg29-Pg1-Ps131Cg29-Pg1-Ps132
Cg29-Pg1-Ps133Cg29-Pg1-Ps134Cg29-Pg1-Ps135Cg29-Pg1-Ps136
Cg29-Pg1-Ps137Cg29-Pg1-Ps138Cg29-Pg1-Ps139Cg29-Pg1-Ps140
Cg29-Pg1-Ps141Cg29-Pg1-Ps142Cg29-Pg1-Ps143Cg29-Pg1-Ps144
Cg29-Pg1-Ps145Cg29-Pg1-Ps146Cg29-Pg1-Ps147Cg29-Pg1-Ps148
Cg29-Pg1-Ps149Cg29-Pg1-Ps150Cg29-Pg1-Ps151Cg29-Pg1-Ps152
Cg29-Pg1-Ps153Cg29-Pg1-Ps154Cg29-Pg1-Ps155Cg29-Pg1-Ps156
Cg29-Pg1-Ps157Cg29-Pg1-Ps158Cg29-Pg1-Ps159Cg29-Pg1-Ps160
Cg29-Pg1-Ps161Cg29-Pg1-Ps162Cg29-Pg1-Ps163Cg29-Pg1-Ps164
Cg29-Pg1-Ps165Cg29-Pg1-Ps166Cg29-Pg1-Ps167Cg29-Pg1-Ps168
Cg29-Pg1-Ps169Cg29-Pg1-Ps170Cg29-Pg1-Ps171Cg29-Pg1-Ps172
Cg29-Pg1-Ps173Cg29-Pg1-Ps174Cg29-Pg1-Ps175Cg29-Pg1-Ps176
Cg29-Pg1-Ps177Cg29-Pg1-Ps178Cg29-Pg1-Ps179Cg29-Pg1-Ps180
Cg29-Pg1-Ps181Cg29-Pg1-Ps182Cg29-Pg1-Ps183Cg29-Pg1-Ps184
Cg29-Pg1-Ps185Cg29-Pg1-Ps186Cg29-Pg1-Ps187Cg29-Pg1-Ps188
Cg29-Pg1-Ps189Cg29-Pg1-Ps190Cg29-Pg1-Ps191Cg29-Pg1-Ps192
Cg29-Pg1-Ps193Cg29-Pg1-Ps194Cg29-Pg1-Ps195Cg29-Pg1-Ps196
Cg29-Pg1-Ps197Cg29-Pg1-Ps198Cg29-Pg1-Ps199Cg29-Pg1-Ps200
Cg29-Pg1-Ps201Cg29-Pg1-Ps202Cg29-Pg1-Ps203Cg29-Pg1-Ps204
Cg29-Pg1-Ps205Cg29-Pg1-Ps206Cg29-Pg1-Ps207Cg29-Pg1-Ps208
Cg29-Pg1-Ps209Cg29-Pg1-Ps210Cg29-Pg1-Ps211Cg29-Pg1-Ps212
Cg29-Pg1-Ps213Cg29-Pg1-Ps214Cg29-Pg1-Ps215Cg29-Pg1-Ps216
Cg29-Pg1-Ps217Cg29-Pg1-Ps218Cg29-Pg1-Ps219Cg29-Pg1-Ps220
Cg29-Pg1-Ps221Cg29-Pg1-Ps222Cg29-Pg1-Ps223Cg29-Pg1-Ps224
Cg29-Pg1-Ps225Cg29-Pg1-Ps226Cg29-Pg1-Ps227Cg29-Pg1-Ps228
Cg29-Pg1-Ps229Cg29-Pg1-Ps230Cg29-Pg1-Ps231Cg29-Pg1-Ps232
Cg29-Pg1-Ps233Cg29-Pg1-Ps234Cg29-Pg1-Ps235Cg29-Pg1-Ps236
Cg29-Pg1-Ps237Cg29-Pg1-Ps238Cg29-Pg1-Ps239Cg29-Pg1-Ps240
Cg29-Pg1-Ps241Cg29-Pg1-Ps242Cg29-Pg1-Ps243
Cg30-Pg1-Ps1Cg30-Pg1-Ps2Cg30-Pg1-Ps3Cg30-Pg1-Ps4
Cg30-Pg1-Ps5Cg30-Pg1-Ps6Cg30-Pg1-Ps7Cg30-Pg1-Ps8
Cg30-Pg1-Ps9Cg30-Pg1-Ps10Cg30-Pg1-Ps11Cg30-Pg1-Ps12
Cg30-Pg1-Ps13Cg30-Pg1-Ps14Cg30-Pg1-Ps15Cg30-Pg1-Ps16
Cg30-Pg1-Ps17Cg30-Pg1-Ps18Cg30-Pg1-Ps19Cg30-Pg1-Ps20
Cg30-Pg1-Ps21Cg30-Pg1-Ps22Cg30-Pg1-Ps23Cg30-Pg1-Ps24
Cg30-Pg1-Ps25Cg30-Pg1-Ps26Cg30-Pg1-Ps27Cg30-Pg1-Ps28
Cg30-Pg1-Ps29Cg30-Pg1-Ps30Cg30-Pg1-Ps31Cg30-Pg1-Ps32
Cg30-Pg1-Ps33Cg30-Pg1-Ps34Cg30-Pg1-Ps35Cg30-Pg1-Ps36
Cg30-Pg1-Ps37Cg30-Pg1-Ps38Cg30-Pg1-Ps39Cg30-Pg1-Ps40
Cg30-Pg1-Ps41Cg30-Pg1-Ps42Cg30-Pg1-Ps43Cg30-Pg1-Ps44
Cg30-Pg1-Ps45Cg30-Pg1-Ps46Cg30-Pg1-Ps47Cg30-Pg1-Ps48
Cg30-Pg1-Ps49Cg30-Pg1-Ps50Cg30-Pg1-Ps51Cg30-Pg1-Ps52
Cg30-Pg1-Ps53Cg30-Pg1-Ps54Cg30-Pg1-Ps55Cg30-Pg1-Ps56
Cg30-Pg1-Ps57Cg30-Pg1-Ps58Cg30-Pg1-Ps59Cg30-Pg1-Ps60
Cg30-Pg1-Ps61Cg30-Pg1-Ps62Cg30-Pg1-Ps63Cg30-Pg1-Ps64
Cg30-Pg1-Ps65Cg30-Pg1-Ps66Cg30-Pg1-Ps67Cg30-Pg1-Ps68
Cg30-Pg1-Ps69Cg30-Pg1-Ps70Cg30-Pg1-Ps71Cg30-Pg1-Ps72
Cg30-Pg1-Ps73Cg30-Pg1-Ps74Cg30-Pg1-Ps75Cg30-Pg1-Ps76
Cg30-Pg1-Ps77Cg30-Pg1-Ps78Cg30-Pg1-Ps79Cg30-Pg1-Ps80
Cg30-Pg1-Ps81Cg30-Pg1-Ps82Cg30-Pg1-Ps83Cg30-Pg1-Ps84
Cg30-Pg1-Ps85Cg30-Pg1-Ps86Cg30-Pg1-Ps87Cg30-Pg1-Ps88
Cg30-Pg1-Ps89Cg30-Pg1-Ps90Cg30-Pg1-Ps91Cg30-Pg1-Ps92
Cg30-Pg1-Ps93Cg30-Pg1-Ps94Cg30-Pg1-Ps95Cg30-Pg1-Ps96
Cg30-Pg1-Ps97Cg30-Pg1-Ps98Cg30-Pg1-Ps99Cg30-Pg1-Ps100
Cg30-Pg1-Ps101Cg30-Pg1-Ps102Cg30-Pg1-Ps103Cg30-Pg1-Ps104
Cg30-Pg1-Ps105Cg30-Pg1-Ps106Cg30-Pg1-Ps107Cg30-Pg1-Ps108
Cg30-Pg1-Ps109Cg30-Pg1-Ps110Cg30-Pg1-Ps111Cg30-Pg1-Ps112
Cg30-Pg1-Ps113Cg30-Pg1-Ps114Cg30-Pg1-Ps115Cg30-Pg1-Ps116
Cg30-Pg1-Ps117Cg30-Pg1-Ps118Cg30-Pg1-Ps119Cg30-Pg1-Ps120
Cg30-Pg1-Ps121Cg30-Pg1-Ps122Cg30-Pg1-Ps123Cg30-Pg1-Ps124
Cg30-Pg1-Ps125Cg30-Pg1-Ps126Cg30-Pg1-Ps127Cg30-Pg1-Ps128
Cg30-Pg1-Ps129Cg30-Pg1-Ps130Cg30-Pg1-Ps131Cg30-Pg1-Ps132
Cg30-Pg1-Ps133Cg30-Pg1-Ps134Cg30-Pg1-Ps135Cg30-Pg1-Ps136
Cg30-Pg1-Ps137Cg30-Pg1-Ps138Cg30-Pg1-Ps139Cg30-Pg1-Ps140
Cg30-Pg1-Ps141Cg30-Pg1-Ps142Cg30-Pg1-Ps143Cg30-Pg1-Ps144
Cg30-Pg1-Ps145Cg30-Pg1-Ps146Cg30-Pg1-Ps147Cg30-Pg1-Ps148
Cg30-Pg1-Ps149Cg30-Pg1-Ps150Cg30-Pg1-Ps151Cg30-Pg1-Ps152
Cg30-Pg1-Ps153Cg30-Pg1-Ps154Cg30-Pg1-Ps155Cg30-Pg1-Ps156
Cg30-Pg1-Ps157Cg30-Pg1-Ps158Cg30-Pg1-Ps159Cg30-Pg1-Ps160
Cg30-Pg1-Ps161Cg30-Pg1-Ps162Cg30-Pg1-Ps163Cg30-Pg1-Ps164
Cg30-Pg1-Ps165Cg30-Pg1-Ps166Cg30-Pg1-Ps167Cg30-Pg1-Ps168
Cg30-Pg1-Ps169Cg30-Pg1-Ps170Cg30-Pg1-Ps171Cg30-Pg1-Ps172
Cg30-Pg1-Ps173Cg30-Pg1-Ps174Cg30-Pg1-Ps175Cg30-Pg1-Ps176
Cg30-Pg1-Ps177Cg30-Pg1-Ps178Cg30-Pg1-Ps179Cg30-Pg1-Ps180
Cg30-Pg1-Ps181Cg30-Pg1-Ps182Cg30-Pg1-Ps183Cg30-Pg1-Ps184
Cg30-Pg1-Ps185Cg30-Pg1-Ps186Cg30-Pg1-Ps187Cg30-Pg1-Ps188
Cg30-Pg1-Ps189Cg30-Pg1-Ps190Cg30-Pg1-Ps191Cg30-Pg1-Ps192
Cg30-Pg1-Ps193Cg30-Pg1-Ps194Cg30-Pg1-Ps195Cg30-Pg1-Ps196
Cg30-Pg1-Ps197Cg30-Pg1-Ps198Cg30-Pg1-Ps199Cg30-Pg1-Ps200
Cg30-Pg1-Ps201Cg30-Pg1-Ps202Cg30-Pg1-Ps203Cg30-Pg1-Ps204
Cg30-Pg1-Ps205Cg30-Pg1-Ps206Cg30-Pg1-Ps207Cg30-Pg1-Ps208
Cg30-Pg1-Ps209Cg30-Pg1-Ps210Cg30-Pg1-Ps211Cg30-Pg1-Ps212
Cg30-Pg1-Ps213Cg30-Pg1-Ps214Cg30-Pg1-Ps215Cg30-Pg1-Ps216
Cg30-Pg1-Ps217Cg30-Pg1-Ps218Cg30-Pg1-Ps219Cg30-Pg1-Ps220
Cg30-Pg1-Ps221Cg30-Pg1-Ps222Cg30-Pg1-Ps223Cg30-Pg1-Ps224
Cg30-Pg1-Ps225Cg30-Pg1-Ps226Cg30-Pg1-Ps227Cg30-Pg1-Ps228
Cg30-Pg1-Ps229Cg30-Pg1-Ps230Cg30-Pg1-Ps231Cg30-Pg1-Ps232
Cg30-Pg1-Ps233Cg30-Pg1-Ps234Cg30-Pg1-Ps235Cg30-Pg1-Ps236
Cg30-Pg1-Ps237Cg30-Pg1-Ps238Cg30-Pg1-Ps239Cg30-Pg1-Ps240
Cg30-Pg1-Ps241Cg30-Pg1-Ps242Cg30-Pg1-Ps243
Cg31-Pg1-Ps1Cg31-Pg1-Ps2Cg31-Pg1-Ps3Cg31-Pg1-Ps4
Cg31-Pg1-Ps5Cg31-Pg1-Ps6Cg31-Pg1-Ps7Cg31-Pg1-Ps8
Cg31-Pg1-Ps9Cg31-Pg1-Ps10Cg31-Pg1-Ps11Cg31-Pg1-Ps12
Cg31-Pg1-Ps13Cg31-Pg1-Ps14Cg31-Pg1-Ps15Cg31-Pg1-Ps16
Cg31-Pg1-Ps17Cg31-Pg1-Ps18Cg31-Pg1-Ps19Cg31-Pg1-Ps20
Cg31-Pg1-Ps21Cg31-Pg1-Ps22Cg31-Pg1-Ps23Cg31-Pg1-Ps24
Cg31-Pg1-Ps25Cg31-Pg1-Ps26Cg31-Pg1-Ps27Cg31-Pg1-Ps28
Cg31-Pg1-Ps29Cg31-Pg1-Ps30Cg31-Pg1-Ps31Cg31-Pg1-Ps32
Cg31-Pg1-Ps33Cg31-Pg1-Ps34Cg31-Pg1-Ps35Cg31-Pg1-Ps36
Cg31-Pg1-Ps37Cg31-Pg1-Ps38Cg31-Pg1-Ps39Cg31-Pg1-Ps40
Cg31-Pg1-Ps41Cg31-Pg1-Ps42Cg31-Pg1-Ps43Cg31-Pg1-Ps44
Cg31-Pg1-Ps45Cg31-Pg1-Ps46Cg31-Pg1-Ps47Cg31-Pg1-Ps48
Cg31-Pg1-Ps49Cg31-Pg1-Ps50Cg31-Pg1-Ps51Cg31-Pg1-Ps52
Cg31-Pg1-Ps53Cg31-Pg1-Ps54Cg31-Pg1-Ps55Cg31-Pg1-Ps56
Cg31-Pg1-Ps57Cg31-Pg1-Ps58Cg31-Pg1-Ps59Cg31-Pg1-Ps60
Cg31-Pg1-Ps61Cg31-Pg1-Ps62Cg31-Pg1-Ps63Cg31-Pg1-Ps64
Cg31-Pg1-Ps65Cg31-Pg1-Ps66Cg31-Pg1-Ps67Cg31-Pg1-Ps68
Cg31-Pg1-Ps69Cg31-Pg1-Ps70Cg31-Pg1-Ps71Cg31-Pg1-Ps72
Cg31-Pg1-Ps73Cg31-Pg1-Ps74Cg31-Pg1-Ps75Cg31-Pg1-Ps76
Cg31-Pg1-Ps77Cg31-Pg1-Ps78Cg31-Pg1-Ps79Cg31-Pg1-Ps80
Cg31-Pg1-Ps81Cg31-Pg1-Ps82Cg31-Pg1-Ps83Cg31-Pg1-Ps84
Cg31-Pg1-Ps85Cg31-Pg1-Ps86Cg31-Pg1-Ps87Cg31-Pg1-Ps88
Cg31-Pg1-Ps89Cg31-Pg1-Ps90Cg31-Pg1-Ps91Cg31-Pg1-Ps92
Cg31-Pg1-Ps93Cg31-Pg1-Ps94Cg31-Pg1-Ps95Cg31-Pg1-Ps96
Cg31-Pg1-Ps97Cg31-Pg1-Ps98Cg31-Pg1-Ps99Cg31-Pg1-Ps100
Cg31-Pg1-Ps101Cg31-Pg1-Ps102Cg31-Pg1-Ps103Cg31-Pg1-Ps104
Cg31-Pg1-Ps105Cg31-Pg1-Ps106Cg31-Pg1-Ps107Cg31-Pg1-Ps108
Cg31-Pg1-Ps109Cg31-Pg1-Ps110Cg31-Pg1-Ps111Cg31-Pg1-Ps112
Cg31-Pg1-Ps113Cg31-Pg1-Ps114Cg31-Pg1-Ps115Cg31-Pg1-Ps116
Cg31-Pg1-Ps117Cg31-Pg1-Ps118Cg31-Pg1-Ps119Cg31-Pg1-Ps120
Cg31-Pg1-Ps121Cg31-Pg1-Ps122Cg31-Pg1-Ps123Cg31-Pg1-Ps124
Cg31-Pg1-Ps125Cg31-Pg1-Ps126Cg31-Pg1-Ps127Cg31-Pg1-Ps128
Cg31-Pg1-Ps129Cg31-Pg1-Ps130Cg31-Pg1-Ps131Cg31-Pg1-Ps132
Cg31-Pg1-Ps133Cg31-Pg1-Ps134Cg31-Pg1-Ps135Cg31-Pg1-Ps136
Cg31-Pg1-Ps137Cg31-Pg1-Ps138Cg31-Pg1-Ps139Cg31-Pg1-Ps140
Cg31-Pg1-Ps141Cg31-Pg1-Ps142Cg31-Pg1-Ps143Cg31-Pg1-Ps144
Cg31-Pg1-Ps145Cg31-Pg1-Ps146Cg31-Pg1-Ps147Cg31-Pg1-Ps148
Cg31-Pg1-Ps149Cg31-Pg1-Ps150Cg31-Pg1-Ps151Cg31-Pg1-Ps152
Cg31-Pg1-Ps153Cg31-Pg1-Ps154Cg31-Pg1-Ps155Cg31-Pg1-Ps156
Cg31-Pg1-Ps157Cg31-Pg1-Ps158Cg31-Pg1-Ps159Cg31-Pg1-Ps160
Cg31-Pg1-Ps161Cg31-Pg1-Ps162Cg31-Pg1-Ps163Cg31-Pg1-Ps164
Cg31-Pg1-Ps165Cg31-Pg1-Ps166Cg31-Pg1-Ps167Cg31-Pg1-Ps168
Cg31-Pg1-Ps169Cg31-Pg1-Ps170Cg31-Pg1-Ps171Cg31-Pg1-Ps172
Cg31-Pg1-Ps173Cg31-Pg1-Ps174Cg31-Pg1-Ps175Cg31-Pg1-Ps176
Cg31-Pg1-Ps177Cg31-Pg1-Ps178Cg31-Pg1-Ps179Cg31-Pg1-Ps180
Cg31-Pg1-Ps181Cg31-Pg1-Ps182Cg31-Pg1-Ps183Cg31-Pg1-Ps184
Cg31-Pg1-Ps185Cg31-Pg1-Ps186Cg31-Pg1-Ps187Cg31-Pg1-Ps188
Cg31-Pg1-Ps189Cg31-Pg1-Ps190Cg31-Pg1-Ps191Cg31-Pg1-Ps192
Cg31-Pg1-Ps193Cg31-Pg1-Ps194Cg31-Pg1-Ps195Cg31-Pg1-Ps196
Cg31-Pg1-Ps197Cg31-Pg1-Ps198Cg31-Pg1-Ps199Cg31-Pg1-Ps200
Cg31-Pg1-Ps201Cg31-Pg1-Ps202Cg31-Pg1-Ps203Cg31-Pg1-Ps204
Cg31-Pg1-Ps205Cg31-Pg1-Ps206Cg31-Pg1-Ps207Cg31-Pg1-Ps208
Cg31-Pg1-Ps209Cg31-Pg1-Ps210Cg31-Pg1-Ps211Cg31-Pg1-Ps212
Cg31-Pg1-Ps213Cg31-Pg1-Ps214Cg31-Pg1-Ps215Cg31-Pg1-Ps216
Cg31-Pg1-Ps217Cg31-Pg1-Ps218Cg31-Pg1-Ps219Cg31-Pg1-Ps220
Cg31-Pg1-Ps221Cg31-Pg1-Ps222Cg31-Pg1-Ps223Cg31-Pg1-Ps224
Cg31-Pg1-Ps225Cg31-Pg1-Ps226Cg31-Pg1-Ps227Cg31-Pg1-Ps228
Cg31-Pg1-Ps229Cg31-Pg1-Ps230Cg31-Pg1-Ps231Cg31-Pg1-Ps232
Cg31-Pg1-Ps233Cg31-Pg1-Ps234Cg31-Pg1-Ps235Cg31-Pg1-Ps236
Cg31-Pg1-Ps237Cg31-Pg1-Ps238Cg31-Pg1-Ps239Cg31-Pg1-Ps240
Cg31-Pg1-Ps241Cg31-Pg1-Ps242Cg31-Pg1-Ps243
Cg32-Pg1-Ps1Cg32-Pg1-Ps2Cg32-Pg1-Ps3Cg32-Pg1-Ps4
Cg32-Pg1-Ps5Cg32-Pg1-Ps6Cg32-Pg1-Ps7Cg32-Pg1-Ps8
Cg32-Pg1-Ps9Cg32-Pg1-Ps10Cg32-Pg1-Ps11Cg32-Pg1-Ps12
Cg32-Pg1-Ps13Cg32-Pg1-Ps14Cg32-Pg1-Ps15Cg32-Pg1-Ps16
Cg32-Pg1-Ps17Cg32-Pg1-Ps18Cg32-Pg1-Ps19Cg32-Pg1-Ps20
Cg32-Pg1-Ps21Cg32-Pg1-Ps22Cg32-Pg1-Ps23Cg32-Pg1-Ps24
Cg32-Pg1-Ps25Cg32-Pg1-Ps26Cg32-Pg1-Ps27Cg32-Pg1-Ps28
Cg32-Pg1-Ps29Cg32-Pg1-Ps30Cg32-Pg1-Ps31Cg32-Pg1-Ps32
Cg32-Pg1-Ps33Cg32-Pg1-Ps34Cg32-Pg1-Ps35Cg32-Pg1-Ps36
Cg32-Pg1-Ps37Cg32-Pg1-Ps38Cg32-Pg1-Ps39Cg32-Pg1-Ps40
Cg32-Pg1-Ps41Cg32-Pg1-Ps42Cg32-Pg1-Ps43Cg32-Pg1-Ps44
Cg32-Pg1-Ps45Cg32-Pg1-Ps46Cg32-Pg1-Ps47Cg32-Pg1-Ps48
Cg32-Pg1-Ps49Cg32-Pg1-Ps50Cg32-Pg1-Ps51Cg32-Pg1-Ps52
Cg32-Pg1-Ps53Cg32-Pg1-Ps54Cg32-Pg1-Ps55Cg32-Pg1-Ps56
Cg32-Pg1-Ps57Cg32-Pg1-Ps58Cg32-Pg1-Ps59Cg32-Pg1-Ps60
Cg32-Pg1-Ps61Cg32-Pg1-Ps62Cg32-Pg1-Ps63Cg32-Pg1-Ps64
Cg32-Pg1-Ps65Cg32-Pg1-Ps66Cg32-Pg1-Ps67Cg32-Pg1-Ps68
Cg32-Pg1-Ps69Cg32-Pg1-Ps70Cg32-Pg1-Ps71Cg32-Pg1-Ps72
Cg32-Pg1-Ps73Cg32-Pg1-Ps74Cg32-Pg1-Ps75Cg32-Pg1-Ps76
Cg32-Pg1-Ps77Cg32-Pg1-Ps78Cg32-Pg1-Ps79Cg32-Pg1-Ps80
Cg32-Pg1-Ps81Cg32-Pg1-Ps82Cg32-Pg1-Ps83Cg32-Pg1-Ps84
Cg32-Pg1-Ps85Cg32-Pg1-Ps86Cg32-Pg1-Ps87Cg32-Pg1-Ps88
Cg32-Pg1-Ps89Cg32-Pg1-Ps90Cg32-Pg1-Ps91Cg32-Pg1-Ps92
Cg32-Pg1-Ps93Cg32-Pg1-Ps94Cg32-Pg1-Ps95Cg32-Pg1-Ps96
Cg32-Pg1-Ps97Cg32-Pg1-Ps98Cg32-Pg1-Ps99Cg32-Pg1-Ps100
Cg32-Pg1-Ps101Cg32-Pg1-Ps102Cg32-Pg1-Ps103Cg32-Pg1-Ps104
Cg32-Pg1-Ps105Cg32-Pg1-Ps106Cg32-Pg1-Ps107Cg32-Pg1-Ps108
Cg32-Pg1-Ps109Cg32-Pg1-Ps110Cg32-Pg1-Ps111Cg32-Pg1-Ps112
Cg32-Pg1-Ps113Cg32-Pg1-Ps114Cg32-Pg1-Ps115Cg32-Pg1-Ps116
Cg32-Pg1-Ps117Cg32-Pg1-Ps118Cg32-Pg1-Ps119Cg32-Pg1-Ps120
Cg32-Pg1-Ps121Cg32-Pg1-Ps122Cg32-Pg1-Ps123Cg32-Pg1-Ps124
Cg32-Pg1-Ps125Cg32-Pg1-Ps126Cg32-Pg1-Ps127Cg32-Pg1-Ps128
Cg32-Pg1-Ps129Cg32-Pg1-Ps130Cg32-Pg1-Ps131Cg32-Pg1-Ps132
Cg32-Pg1-Ps133Cg32-Pg1-Ps134Cg32-Pg1-Ps135Cg32-Pg1-Ps136
Cg32-Pg1-Ps137Cg32-Pg1-Ps138Cg32-Pg1-Ps139Cg32-Pg1-Ps140
Cg32-Pg1-Ps141Cg32-Pg1-Ps142Cg32-Pg1-Ps143Cg32-Pg1-Ps144
Cg32-Pg1-Ps145Cg32-Pg1-Ps146Cg32-Pg1-Ps147Cg32-Pg1-Ps148
Cg32-Pg1-Ps149Cg32-Pg1-Ps150Cg32-Pg1-Ps151Cg32-Pg1-Ps152
Cg32-Pg1-Ps153Cg32-Pg1-Ps154Cg32-Pg1-Ps155Cg32-Pg1-Ps156
Cg32-Pg1-Ps157Cg32-Pg1-Ps158Cg32-Pg1-Ps159Cg32-Pg1-Ps160
Cg32-Pg1-Ps161Cg32-Pg1-Ps162Cg32-Pg1-Ps163Cg32-Pg1-Ps164
Cg32-Pg1-Ps165Cg32-Pg1-Ps166Cg32-Pg1-Ps167Cg32-Pg1-Ps168
Cg32-Pg1-Ps169Cg32-Pg1-Ps170Cg32-Pg1-Ps171Cg32-Pg1-Ps172
Cg32-Pg1-Ps173Cg32-Pg1-Ps174Cg32-Pg1-Ps175Cg32-Pg1-Ps176
Cg32-Pg1-Ps177Cg32-Pg1-Ps178Cg32-Pg1-Ps179Cg32-Pg1-Ps180
Cg32-Pg1-Ps181Cg32-Pg1-Ps182Cg32-Pg1-Ps183Cg32-Pg1-Ps184
Cg32-Pg1-Ps185Cg32-Pg1-Ps186Cg32-Pg1-Ps187Cg32-Pg1-Ps188
Cg32-Pg1-Ps189Cg32-Pg1-Ps190Cg32-Pg1-Ps191Cg32-Pg1-Ps192
Cg32-Pg1-Ps193Cg32-Pg1-Ps194Cg32-Pg1-Ps195Cg32-Pg1-Ps196
Cg32-Pg1-Ps197Cg32-Pg1-Ps198Cg32-Pg1-Ps199Cg32-Pg1-Ps200
Cg32-Pg1-Ps201Cg32-Pg1-Ps202Cg32-Pg1-Ps203Cg32-Pg1-Ps204
Cg32-Pg1-Ps205Cg32-Pg1-Ps206Cg32-Pg1-Ps207Cg32-Pg1-Ps208
Cg32-Pg1-Ps209Cg32-Pg1-Ps210Cg32-Pg1-Ps211Cg32-Pg1-Ps212
Cg32-Pg1-Ps213Cg32-Pg1-Ps214Cg32-Pg1-Ps215Cg32-Pg1-Ps216
Cg32-Pg1-Ps217Cg32-Pg1-Ps218Cg32-Pg1-Ps219Cg32-Pg1-Ps220
Cg32-Pg1-Ps221Cg32-Pg1-Ps222Cg32-Pg1-Ps223Cg32-Pg1-Ps224
Cg32-Pg1-Ps225Cg32-Pg1-Ps226Cg32-Pg1-Ps227Cg32-Pg1-Ps228
Cg32-Pg1-Ps229Cg32-Pg1-Ps230Cg32-Pg1-Ps231Cg32-Pg1-Ps232
Cg32-Pg1-Ps233Cg32-Pg1-Ps234Cg32-Pg1-Ps235Cg32-Pg1-Ps236
Cg32-Pg1-Ps237Cg32-Pg1-Ps238Cg32-Pg1-Ps239Cg32-Pg1-Ps240
Cg32-Pg1-Ps241Cg32-Pg1-Ps242Cg32-Pg1-Ps243
Cg33-Pg1-Ps1Cg33-Pg1-Ps2Cg33-Pg1-Ps3Cg33-Pg1-Ps4
Cg33-Pg1-Ps5Cg33-Pg1-Ps6Cg33-Pg1-Ps7Cg33-Pg1-Ps8
Cg33-Pg1-Ps9Cg33-Pg1-Ps10Cg33-Pg1-Ps11Cg33-Pg1-Ps12
Cg33-Pg1-Ps13Cg33-Pg1-Ps14Cg33-Pg1-Ps15Cg33-Pg1-Ps16
Cg33-Pg1-Ps17Cg33-Pg1-Ps18Cg33-Pg1-Ps19Cg33-Pg1-Ps20
Cg33-Pg1-Ps21Cg33-Pg1-Ps22Cg33-Pg1-Ps23Cg33-Pg1-Ps24
Cg33-Pg1-Ps25Cg33-Pg1-Ps26Cg33-Pg1-Ps27Cg33-Pg1-Ps28
Cg33-Pg1-Ps29Cg33-Pg1-Ps30Cg33-Pg1-Ps31Cg33-Pg1-Ps32
Cg33-Pg1-Ps33Cg33-Pg1-Ps34Cg33-Pg1-Ps35Cg33-Pg1-Ps36
Cg33-Pg1-Ps37Cg33-Pg1-Ps38Cg33-Pg1-Ps39Cg33-Pg1-Ps40
Cg33-Pg1-Ps41Cg33-Pg1-Ps42Cg33-Pg1-Ps43Cg33-Pg1-Ps44
Cg33-Pg1-Ps45Cg33-Pg1-Ps46Cg33-Pg1-Ps47Cg33-Pg1-Ps48
Cg33-Pg1-Ps49Cg33-Pg1-Ps50Cg33-Pg1-Ps51Cg33-Pg1-Ps52
Cg33-Pg1-Ps53Cg33-Pg1-Ps54Cg33-Pg1-Ps55Cg33-Pg1-Ps56
Cg33-Pg1-Ps57Cg33-Pg1-Ps58Cg33-Pg1-Ps59Cg33-Pg1-Ps60
Cg33-Pg1-Ps61Cg33-Pg1-Ps62Cg33-Pg1-Ps63Cg33-Pg1-Ps64
Cg33-Pg1-Ps65Cg33-Pg1-Ps66Cg33-Pg1-Ps67Cg33-Pg1-Ps68
Cg33-Pg1-Ps69Cg33-Pg1-Ps70Cg33-Pg1-Ps71Cg33-Pg1-Ps72
Cg33-Pg1-Ps73Cg33-Pg1-Ps74Cg33-Pg1-Ps75Cg33-Pg1-Ps76
Cg33-Pg1-Ps77Cg33-Pg1-Ps78Cg33-Pg1-Ps79Cg33-Pg1-Ps80
Cg33-Pg1-Ps81Cg33-Pg1-Ps82Cg33-Pg1-Ps83Cg33-Pg1-Ps84
Cg33-Pg1-Ps85Cg33-Pg1-Ps86Cg33-Pg1-Ps87Cg33-Pg1-Ps88
Cg33-Pg1-Ps89Cg33-Pg1-Ps90Cg33-Pg1-Ps91Cg33-Pg1-Ps92
Cg33-Pg1-Ps93Cg33-Pg1-Ps94Cg33-Pg1-Ps95Cg33-Pg1-Ps96
Cg33-Pg1-Ps97Cg33-Pg1-Ps98Cg33-Pg1-Ps99Cg33-Pg1-Ps100
Cg33-Pg1-Ps101Cg33-Pg1-Ps102Cg33-Pg1-Ps103Cg33-Pg1-Ps104
Cg33-Pg1-Ps105Cg33-Pg1-Ps106Cg33-Pg1-Ps107Cg33-Pg1-Ps108
Cg33-Pg1-Ps109Cg33-Pg1-Ps110Cg33-Pg1-Ps111Cg33-Pg1-Ps112
Cg33-Pg1-Ps113Cg33-Pg1-Ps114Cg33-Pg1-Ps115Cg33-Pg1-Ps116
Cg33-Pg1-Ps117Cg33-Pg1-Ps118Cg33-Pg1-Ps119Cg33-Pg1-Ps120
Cg33-Pg1-Ps121Cg33-Pg1-Ps122Cg33-Pg1-Ps123Cg33-Pg1-Ps124
Cg33-Pg1-Ps125Cg33-Pg1-Ps126Cg33-Pg1-Ps127Cg33-Pg1-Ps128
Cg33-Pg1-Ps129Cg33-Pg1-Ps130Cg33-Pg1-Ps131Cg33-Pg1-Ps132
Cg33-Pg1-Ps133Cg33-Pg1-Ps134Cg33-Pg1-Ps135Cg33-Pg1-Ps136
Cg33-Pg1-Ps137Cg33-Pg1-Ps138Cg33-Pg1-Ps139Cg33-Pg1-Ps140
Cg33-Pg1-Ps141Cg33-Pg1-Ps142Cg33-Pg1-Ps143Cg33-Pg1-Ps144
Cg33-Pg1-Ps145Cg33-Pg1-Ps146Cg33-Pg1-Ps147Cg33-Pg1-Ps148
Cg33-Pg1-Ps149Cg33-Pg1-Ps150Cg33-Pg1-Ps151Cg33-Pg1-Ps152
Cg33-Pg1-Ps153Cg33-Pg1-Ps154Cg33-Pg1-Ps155Cg33-Pg1-Ps156
Cg33-Pg1-Ps157Cg33-Pg1-Ps158Cg33-Pg1-Ps159Cg33-Pg1-Ps160
Cg33-Pg1-Ps161Cg33-Pg1-Ps162Cg33-Pg1-Ps163Cg33-Pg1-Ps164
Cg33-Pg1-Ps165Cg33-Pg1-Ps166Cg33-Pg1-Ps167Cg33-Pg1-Ps168
Cg33-Pg1-Ps169Cg33-Pg1-Ps170Cg33-Pg1-Ps171Cg33-Pg1-Ps172
Cg33-Pg1-Ps173Cg33-Pg1-Ps174Cg33-Pg1-Ps175Cg33-Pg1-Ps176
Cg33-Pg1-Ps177Cg33-Pg1-Ps178Cg33-Pg1-Ps179Cg33-Pg1-Ps180
Cg33-Pg1-Ps181Cg33-Pg1-Ps182Cg33-Pg1-Ps183Cg33-Pg1-Ps184
Cg33-Pg1-Ps185Cg33-Pg1-Ps186Cg33-Pg1-Ps187Cg33-Pg1-Ps188
Cg33-Pg1-Ps189Cg33-Pg1-Ps190Cg33-Pg1-Ps191Cg33-Pg1-Ps192
Cg33-Pg1-Ps193Cg33-Pg1-Ps194Cg33-Pg1-Ps195Cg33-Pg1-Ps196
Cg33-Pg1-Ps197Cg33-Pg1-Ps198Cg33-Pg1-Ps199Cg33-Pg1-Ps200
Cg33-Pg1-Ps201Cg33-Pg1-Ps202Cg33-Pg1-Ps203Cg33-Pg1-Ps204
Cg33-Pg1-Ps205Cg33-Pg1-Ps206Cg33-Pg1-Ps207Cg33-Pg1-Ps208
Cg33-Pg1-Ps209Cg33-Pg1-Ps210Cg33-Pg1-Ps211Cg33-Pg1-Ps212
Cg33-Pg1-Ps213Cg33-Pg1-Ps214Cg33-Pg1-Ps215Cg33-Pg1-Ps216
Cg33-Pg1-Ps217Cg33-Pg1-Ps218Cg33-Pg1-Ps219Cg33-Pg1-Ps220
Cg33-Pg1-Ps221Cg33-Pg1-Ps222Cg33-Pg1-Ps223Cg33-Pg1-Ps224
Cg33-Pg1-Ps225Cg33-Pg1-Ps226Cg33-Pg1-Ps227Cg33-Pg1-Ps228
Cg33-Pg1-Ps229Cg33-Pg1-Ps230Cg33-Pg1-Ps231Cg33-Pg1-Ps232
Cg33-Pg1-Ps233Cg33-Pg1-Ps234Cg33-Pg1-Ps235Cg33-Pg1-Ps236
Cg33-Pg1-Ps237Cg33-Pg1-Ps238Cg33-Pg1-Ps239Cg33-Pg1-Ps240
Cg33-Pg1-Ps241Cg33-Pg1-Ps242Cg33-Pg1-Ps243
Cg34-Pg1-Ps1Cg34-Pg1-Ps2Cg34-Pg1-Ps3Cg34-Pg1-Ps4
Cg34-Pg1-Ps5Cg34-Pg1-Ps6Cg34-Pg1-Ps7Cg34-Pg1-Ps8
Cg34-Pg1-Ps9Cg34-Pg1-Ps10Cg34-Pg1-Ps11Cg34-Pg1-Ps12
Cg34-Pg1-Ps13Cg34-Pg1-Ps14Cg34-Pg1-Ps15Cg34-Pg1-Ps16
Cg34-Pg1-Ps17Cg34-Pg1-Ps18Cg34-Pg1-Ps19Cg34-Pg1-Ps20
Cg34-Pg1-Ps21Cg34-Pg1-Ps22Cg34-Pg1-Ps23Cg34-Pg1-Ps24
Cg34-Pg1-Ps25Cg34-Pg1-Ps26Cg34-Pg1-Ps27Cg34-Pg1-Ps28
Cg34-Pg1-Ps29Cg34-Pg1-Ps30Cg34-Pg1-Ps31Cg34-Pg1-Ps32
Cg34-Pg1-Ps33Cg34-Pg1-Ps34Cg34-Pg1-Ps35Cg34-Pg1-Ps36
Cg34-Pg1-Ps37Cg34-Pg1-Ps38Cg34-Pg1-Ps39Cg34-Pg1-Ps40
Cg34-Pg1-Ps41Cg34-Pg1-Ps42Cg34-Pg1-Ps43Cg34-Pg1-Ps44
Cg34-Pg1-Ps45Cg34-Pg1-Ps46Cg34-Pg1-Ps47Cg34-Pg1-Ps48
Cg34-Pg1-Ps49Cg34-Pg1-Ps50Cg34-Pg1-Ps51Cg34-Pg1-Ps52
Cg34-Pg1-Ps53Cg34-Pg1-Ps54Cg34-Pg1-Ps55Cg34-Pg1-Ps56
Cg34-Pg1-Ps57Cg34-Pg1-Ps58Cg34-Pg1-Ps59Cg34-Pg1-Ps60
Cg34-Pg1-Ps61Cg34-Pg1-Ps62Cg34-Pg1-Ps63Cg34-Pg1-Ps64
Cg34-Pg1-Ps65Cg34-Pg1-Ps66Cg34-Pg1-Ps67Cg34-Pg1-Ps68
Cg34-Pg1-Ps69Cg34-Pg1-Ps70Cg34-Pg1-Ps71Cg34-Pg1-Ps72
Cg34-Pg1-Ps73Cg34-Pg1-Ps74Cg34-Pg1-Ps75Cg34-Pg1-Ps76
Cg34-Pg1-Ps77Cg34-Pg1-Ps78Cg34-Pg1-Ps79Cg34-Pg1-Ps80
Cg34-Pg1-Ps81Cg34-Pg1-Ps82Cg34-Pg1-Ps83Cg34-Pg1-Ps84
Cg34-Pg1-Ps85Cg34-Pg1-Ps86Cg34-Pg1-Ps87Cg34-Pg1-Ps88
Cg34-Pg1-Ps89Cg34-Pg1-Ps90Cg34-Pg1-Ps91Cg34-Pg1-Ps92
Cg34-Pg1-Ps93Cg34-Pg1-Ps94Cg34-Pg1-Ps95Cg34-Pg1-Ps96
Cg34-Pg1-Ps97Cg34-Pg1-Ps98Cg34-Pg1-Ps99Cg34-Pg1-Ps100
Cg34-Pg1-Ps101Cg34-Pg1-Ps102Cg34-Pg1-Ps103Cg34-Pg1-Ps104
Cg34-Pg1-Ps105Cg34-Pg1-Ps106Cg34-Pg1-Ps107Cg34-Pg1-Ps108
Cg34-Pg1-Ps109Cg34-Pg1-Ps110Cg34-Pg1-Ps111Cg34-Pg1-Ps112
Cg34-Pg1-Ps113Cg34-Pg1-Ps114Cg34-Pg1-Ps115Cg34-Pg1-Ps116
Cg34-Pg1-Ps117Cg34-Pg1-Ps118Cg34-Pg1-Ps119Cg34-Pg1-Ps120
Cg34-Pg1-Ps121Cg34-Pg1-Ps122Cg34-Pg1-Ps123Cg34-Pg1-Ps124
Cg34-Pg1-Ps125Cg34-Pg1-Ps126Cg34-Pg1-Ps127Cg34-Pg1-Ps128
Cg34-Pg1-Ps129Cg34-Pg1-Ps130Cg34-Pg1-Ps131Cg34-Pg1-Ps132
Cg34-Pg1-Ps133Cg34-Pg1-Ps134Cg34-Pg1-Ps135Cg34-Pg1-Ps136
Cg34-Pg1-Ps137Cg34-Pg1-Ps138Cg34-Pg1-Ps139Cg34-Pg1-Ps140
Cg34-Pg1-Ps141Cg34-Pg1-Ps142Cg34-Pg1-Ps143Cg34-Pg1-Ps144
Cg34-Pg1-Ps145Cg34-Pg1-Ps146Cg34-Pg1-Ps147Cg34-Pg1-Ps148
Cg34-Pg1-Ps149Cg34-Pg1-Ps150Cg34-Pg1-Ps151Cg34-Pg1-Ps152
Cg34-Pg1-Ps153Cg34-Pg1-Ps154Cg34-Pg1-Ps155Cg34-Pg1-Ps156
Cg34-Pg1-Ps157Cg34-Pg1-Ps158Cg34-Pg1-Ps159Cg34-Pg1-Ps160
Cg34-Pg1-Ps161Cg34-Pg1-Ps162Cg34-Pg1-Ps163Cg34-Pg1-Ps164
Cg34-Pg1-Ps165Cg34-Pg1-Ps166Cg34-Pg1-Ps167Cg34-Pg1-Ps168
Cg34-Pg1-Ps169Cg34-Pg1-Ps170Cg34-Pg1-Ps171Cg34-Pg1-Ps172
Cg34-Pg1-Ps173Cg34-Pg1-Ps174Cg34-Pg1-Ps175Cg34-Pg1-Ps176
Cg34-Pg1-Ps177Cg34-Pg1-Ps178Cg34-Pg1-Ps179Cg34-Pg1-Ps180
Cg34-Pg1-Ps181Cg34-Pg1-Ps182Cg34-Pg1-Ps183Cg34-Pg1-Ps184
Cg34-Pg1-Ps185Cg34-Pg1-Ps186Cg34-Pg1-Ps187Cg34-Pg1-Ps188
Cg34-Pg1-Ps189Cg34-Pg1-Ps190Cg34-Pg1-Ps191Cg34-Pg1-Ps192
Cg34-Pg1-Ps193Cg34-Pg1-Ps194Cg34-Pg1-Ps195Cg34-Pg1-Ps196
Cg34-Pg1-Ps197Cg34-Pg1-Ps198Cg34-Pg1-Ps199Cg34-Pg1-Ps200
Cg34-Pg1-Ps201Cg34-Pg1-Ps202Cg34-Pg1-Ps203Cg34-Pg1-Ps204
Cg34-Pg1-Ps205Cg34-Pg1-Ps206Cg34-Pg1-Ps207Cg34-Pg1-Ps208
Cg34-Pg1-Ps209Cg34-Pg1-Ps210Cg34-Pg1-Ps211Cg34-Pg1-Ps212
Cg34-Pg1-Ps213Cg34-Pg1-Ps214Cg34-Pg1-Ps215Cg34-Pg1-Ps216
Cg34-Pg1-Ps217Cg34-Pg1-Ps218Cg34-Pg1-Ps219Cg34-Pg1-Ps220
Cg34-Pg1-Ps221Cg34-Pg1-Ps222Cg34-Pg1-Ps223Cg34-Pg1-Ps224
Cg34-Pg1-Ps225Cg34-Pg1-Ps226Cg34-Pg1-Ps227Cg34-Pg1-Ps228
Cg34-Pg1-Ps229Cg34-Pg1-Ps230Cg34-Pg1-Ps231Cg34-Pg1-Ps232
Cg34-Pg1-Ps233Cg34-Pg1-Ps234Cg34-Pg1-Ps235Cg34-Pg1-Ps236
Cg34-Pg1-Ps237Cg34-Pg1-Ps238Cg34-Pg1-Ps239Cg34-Pg1-Ps240
Cg34-Pg1-Ps241Cg34-Pg1-Ps242Cg34-Pg1-Ps243
Cg38-Pg1-Ps1Cg38-Pg1-Ps2Cg38-Pg1-Ps3Cg38-Pg1-Ps4
Cg38-Pg1-Ps5Cg38-Pg1-Ps6Cg38-Pg1-Ps7Cg38-Pg1-Ps8
Cg38-Pg1-Ps9Cg38-Pg1-Ps10Cg38-Pg1-Ps11Cg38-Pg1-Ps12
Cg38-Pg1-Ps13Cg38-Pg1-Ps14Cg38-Pg1-Ps15Cg38-Pg1-Ps16
Cg38-Pg1-Ps17Cg38-Pg1-Ps18Cg38-Pg1-Ps19Cg38-Pg1-Ps20
Cg38-Pg1-Ps21Cg38-Pg1-Ps22Cg38-Pg1-Ps23Cg38-Pg1-Ps24
Cg38-Pg1-Ps25Cg38-Pg1-Ps26Cg38-Pg1-Ps27Cg38-Pg1-Ps28
Cg38-Pg1-Ps29Cg38-Pg1-Ps30Cg38-Pg1-Ps31Cg38-Pg1-Ps32
Cg38-Pg1-Ps33Cg38-Pg1-Ps34Cg38-Pg1-Ps35Cg38-Pg1-Ps36
Cg38-Pg1-Ps37Cg38-Pg1-Ps38Cg38-Pg1-Ps39Cg38-Pg1-Ps40
Cg38-Pg1-Ps41Cg38-Pg1-Ps42Cg38-Pg1-Ps43Cg38-Pg1-Ps44
Cg38-Pg1-Ps45Cg38-Pg1-Ps46Cg38-Pg1-Ps47Cg38-Pg1-Ps48
Cg38-Pg1-Ps49Cg38-Pg1-Ps50Cg38-Pg1-Ps51Cg38-Pg1-Ps52
Cg38-Pg1-Ps53Cg38-Pg1-Ps54Cg38-Pg1-Ps55Cg38-Pg1-Ps56
Cg38-Pg1-Ps57Cg38-Pg1-Ps58Cg38-Pg1-Ps59Cg38-Pg1-Ps60
Cg38-Pg1-Ps61Cg38-Pg1-Ps62Cg38-Pg1-Ps63Cg38-Pg1-Ps64
Cg38-Pg1-Ps65Cg38-Pg1-Ps66Cg38-Pg1-Ps67Cg38-Pg1-Ps68
Cg38-Pg1-Ps69Cg38-Pg1-Ps70Cg38-Pg1-Ps71Cg38-Pg1-Ps72
Cg38-Pg1-Ps73Cg38-Pg1-Ps74Cg38-Pg1-Ps75Cg38-Pg1-Ps76
Cg38-Pg1-Ps77Cg38-Pg1-Ps78Cg38-Pg1-Ps79Cg38-Pg1-Ps80
Cg38-Pg1-Ps81Cg38-Pg1-Ps82Cg38-Pg1-Ps83Cg38-Pg1-Ps84
Cg38-Pg1-Ps85Cg38-Pg1-Ps86Cg38-Pg1-Ps87Cg38-Pg1-Ps88
Cg38-Pg1-Ps89Cg38-Pg1-Ps90Cg38-Pg1-Ps91Cg38-Pg1-Ps92
Cg38-Pg1-Ps93Cg38-Pg1-Ps94Cg38-Pg1-Ps95Cg38-Pg1-Ps96
Cg38-Pg1-Ps97Cg38-Pg1-Ps98Cg38-Pg1-Ps99Cg38-Pg1-Ps100
Cg38-Pg1-Ps101Cg38-Pg1-Ps102Cg38-Pg1-Ps103Cg38-Pg1-Ps104
Cg38-Pg1-Ps105Cg38-Pg1-Ps106Cg38-Pg1-Ps107Cg38-Pg1-Ps108
Cg38-Pg1-Ps109Cg38-Pg1-Ps110Cg38-Pg1-Ps111Cg38-Pg1-Ps112
Cg38-Pg1-Ps113Cg38-Pg1-Ps114Cg38-Pg1-Ps115Cg38-Pg1-Ps116
Cg38-Pg1-Ps117Cg38-Pg1-Ps118Cg38-Pg1-Ps119Cg38-Pg1-Ps120
Cg38-Pg1-Ps121Cg38-Pg1-Ps122Cg38-Pg1-Ps123Cg38-Pg1-Ps124
Cg38-Pg1-Ps125Cg38-Pg1-Ps126Cg38-Pg1-Ps127Cg38-Pg1-Ps128
Cg38-Pg1-Ps129Cg38-Pg1-Ps130Cg38-Pg1-Ps131Cg38-Pg1-Ps132
Cg38-Pg1-Ps133Cg38-Pg1-Ps134Cg38-Pg1-Ps135Cg38-Pg1-Ps136
Cg38-Pg1-Ps137Cg38-Pg1-Ps138Cg38-Pg1-Ps139Cg38-Pg1-Ps140
Cg38-Pg1-Ps141Cg38-Pg1-Ps142Cg38-Pg1-Ps143Cg38-Pg1-Ps144
Cg38-Pg1-Ps145Cg38-Pg1-Ps146Cg38-Pg1-Ps147Cg38-Pg1-Ps148
Cg38-Pg1-Ps149Cg38-Pg1-Ps150Cg38-Pg1-Ps151Cg38-Pg1-Ps152
Cg38-Pg1-Ps153Cg38-Pg1-Ps154Cg38-Pg1-Ps155Cg38-Pg1-Ps156
Cg38-Pg1-Ps157Cg38-Pg1-Ps158Cg38-Pg1-Ps159Cg38-Pg1-Ps160
Cg38-Pg1-Ps161Cg38-Pg1-Ps162Cg38-Pg1-Ps163Cg38-Pg1-Ps164
Cg38-Pg1-Ps165Cg38-Pg1-Ps166Cg38-Pg1-Ps167Cg38-Pg1-Ps168
Cg38-Pg1-Ps169Cg38-Pg1-Ps170Cg38-Pg1-Ps171Cg38-Pg1-Ps172
Cg38-Pg1-Ps173Cg38-Pg1-Ps174Cg38-Pg1-Ps175Cg38-Pg1-Ps176
Cg38-Pg1-Ps177Cg38-Pg1-Ps178Cg38-Pg1-Ps179Cg38-Pg1-Ps180
Cg38-Pg1-Ps181Cg38-Pg1-Ps182Cg38-Pg1-Ps183Cg38-Pg1-Ps184
Cg38-Pg1-Ps185Cg38-Pg1-Ps186Cg38-Pg1-Ps187Cg38-Pg1-Ps188
Cg38-Pg1-Ps189Cg38-Pg1-Ps190Cg38-Pg1-Ps191Cg38-Pg1-Ps192
Cg38-Pg1-Ps193Cg38-Pg1-Ps194Cg38-Pg1-Ps195Cg38-Pg1-Ps196
Cg38-Pg1-Ps197Cg38-Pg1-Ps198Cg38-Pg1-Ps199Cg38-Pg1-Ps200
Cg38-Pg1-Ps201Cg38-Pg1-Ps202Cg38-Pg1-Ps203Cg38-Pg1-Ps204
Cg38-Pg1-Ps205Cg38-Pg1-Ps206Cg38-Pg1-Ps207Cg38-Pg1-Ps208
Cg38-Pg1-Ps209Cg38-Pg1-Ps210Cg38-Pg1-Ps211Cg38-Pg1-Ps212
Cg38-Pg1-Ps213Cg38-Pg1-Ps214Cg38-Pg1-Ps215Cg38-Pg1-Ps216
Cg38-Pg1-Ps217Cg38-Pg1-Ps218Cg38-Pg1-Ps219Cg38-Pg1-Ps220
Cg38-Pg1-Ps221Cg38-Pg1-Ps222Cg38-Pg1-Ps223Cg38-Pg1-Ps224
Cg38-Pg1-Ps225Cg38-Pg1-Ps226Cg38-Pg1-Ps227Cg38-Pg1-Ps228
Cg38-Pg1-Ps229Cg38-Pg1-Ps230Cg38-Pg1-Ps231Cg38-Pg1-Ps232
Cg38-Pg1-Ps233Cg38-Pg1-Ps234Cg38-Pg1-Ps235Cg38-Pg1-Ps236
Cg38-Pg1-Ps237Cg38-Pg1-Ps238Cg38-Pg1-Ps239Cg38-Pg1-Ps240
Cg38-Pg1-Ps241Cg38-Pg1-Ps242Cg38-Pg1-Ps243
Cg39-Pg1-Ps1Cg39-Pg1-Ps2Cg39-Pg1-Ps3Cg39-Pg1-Ps4
Cg39-Pg1-Ps5Cg39-Pg1-Ps6Cg39-Pg1-Ps7Cg39-Pg1-Ps8
Cg39-Pg1-Ps9Cg39-Pg1-Ps10Cg39-Pg1-Ps11Cg39-Pg1-Ps12
Cg39-Pg1-Ps13Cg39-Pg1-Ps14Cg39-Pg1-Ps15Cg39-Pg1-Ps16
Cg39-Pg1-Ps17Cg39-Pg1-Ps18Cg39-Pg1-Ps19Cg39-Pg1-Ps20
Cg39-Pg1-Ps21Cg39-Pg1-Ps22Cg39-Pg1-Ps23Cg39-Pg1-Ps24
Cg39-Pg1-Ps25Cg39-Pg1-Ps26Cg39-Pg1-Ps27Cg39-Pg1-Ps28
Cg39-Pg1-Ps29Cg39-Pg1-Ps30Cg39-Pg1-Ps31Cg39-Pg1-Ps32
Cg39-Pg1-Ps33Cg39-Pg1-Ps34Cg39-Pg1-Ps35Cg39-Pg1-Ps36
Cg39-Pg1-Ps37Cg39-Pg1-Ps38Cg39-Pg1-Ps39Cg39-Pg1-Ps40
Cg39-Pg1-Ps41Cg39-Pg1-Ps42Cg39-Pg1-Ps43Cg39-Pg1-Ps44
Cg39-Pg1-Ps45Cg39-Pg1-Ps46Cg39-Pg1-Ps47Cg39-Pg1-Ps48
Cg39-Pg1-Ps49Cg39-Pg1-Ps50Cg39-Pg1-Ps51Cg39-Pg1-Ps52
Cg39-Pg1-Ps53Cg39-Pg1-Ps54Cg39-Pg1-Ps55Cg39-Pg1-Ps56
Cg39-Pg1-Ps57Cg39-Pg1-Ps58Cg39-Pg1-Ps59Cg39-Pg1-Ps60
Cg39-Pg1-Ps61Cg39-Pg1-Ps62Cg39-Pg1-Ps63Cg39-Pg1-Ps64
Cg39-Pg1-Ps65Cg39-Pg1-Ps66Cg39-Pg1-Ps67Cg39-Pg1-Ps68
Cg39-Pg1-Ps69Cg39-Pg1-Ps70Cg39-Pg1-Ps71Cg39-Pg1-Ps72
Cg39-Pg1-Ps73Cg39-Pg1-Ps74Cg39-Pg1-Ps75Cg39-Pg1-Ps76
Cg39-Pg1-Ps77Cg39-Pg1-Ps78Cg39-Pg1-Ps79Cg39-Pg1-Ps80
Cg39-Pg1-Ps81Cg39-Pg1-Ps82Cg39-Pg1-Ps83Cg39-Pg1-Ps84
Cg39-Pg1-Ps85Cg39-Pg1-Ps86Cg39-Pg1-Ps87Cg39-Pg1-Ps88
Cg39-Pg1-Ps89Cg39-Pg1-Ps90Cg39-Pg1-Ps91Cg39-Pg1-Ps92
Cg39-Pg1-Ps93Cg39-Pg1-Ps94Cg39-Pg1-Ps95Cg39-Pg1-Ps96
Cg39-Pg1-Ps97Cg39-Pg1-Ps98Cg39-Pg1-Ps99Cg39-Pg1-Ps100
Cg39-Pg1-Ps101Cg39-Pg1-Ps102Cg39-Pg1-Ps103Cg39-Pg1-Ps104
Cg39-Pg1-Ps105Cg39-Pg1-Ps106Cg39-Pg1-Ps107Cg39-Pg1-Ps108
Cg39-Pg1-Ps109Cg39-Pg1-Ps110Cg39-Pg1-Ps111Cg39-Pg1-Ps112
Cg39-Pg1-Ps113Cg39-Pg1-Ps114Cg39-Pg1-Ps115Cg39-Pg1-Ps116
Cg39-Pg1-Ps117Cg39-Pg1-Ps118Cg39-Pg1-Ps119Cg39-Pg1-Ps120
Cg39-Pg1-Ps121Cg39-Pg1-Ps122Cg39-Pg1-Ps123Cg39-Pg1-Ps124
Cg39-Pg1-Ps125Cg39-Pg1-Ps126Cg39-Pg1-Ps127Cg39-Pg1-Ps128
Cg39-Pg1-Ps129Cg39-Pg1-Ps130Cg39-Pg1-Ps131Cg39-Pg1-Ps132
Cg39-Pg1-Ps133Cg39-Pg1-Ps134Cg39-Pg1-Ps135Cg39-Pg1-Ps136
Cg39-Pg1-Ps137Cg39-Pg1-Ps138Cg39-Pg1-Ps139Cg39-Pg1-Ps140
Cg39-Pg1-Ps141Cg39-Pg1-Ps142Cg39-Pg1-Ps143Cg39-Pg1-Ps144
Cg39-Pg1-Ps145Cg39-Pg1-Ps146Cg39-Pg1-Ps147Cg39-Pg1-Ps148
Cg39-Pg1-Ps149Cg39-Pg1-Ps150Cg39-Pg1-Ps151Cg39-Pg1-Ps152
Cg39-Pg1-Ps153Cg39-Pg1-Ps154Cg39-Pg1-Ps155Cg39-Pg1-Ps156
Cg39-Pg1-Ps157Cg39-Pg1-Ps158Cg39-Pg1-Ps159Cg39-Pg1-Ps160
Cg39-Pg1-Ps161Cg39-Pg1-Ps162Cg39-Pg1-Ps163Cg39-Pg1-Ps164
Cg39-Pg1-Ps165Cg39-Pg1-Ps166Cg39-Pg1-Ps167Cg39-Pg1-Ps168
Cg39-Pg1-Ps169Cg39-Pg1-Ps170Cg39-Pg1-Ps171Cg39-Pg1-Ps172
Cg39-Pg1-Ps173Cg39-Pg1-Ps174Cg39-Pg1-Ps175Cg39-Pg1-Ps176
Cg39-Pg1-Ps177Cg39-Pg1-Ps178Cg39-Pg1-Ps179Cg39-Pg1-Ps180
Cg39-Pg1-Ps181Cg39-Pg1-Ps182Cg39-Pg1-Ps183Cg39-Pg1-Ps184
Cg39-Pg1-Ps185Cg39-Pg1-Ps186Cg39-Pg1-Ps187Cg39-Pg1-Ps188
Cg39-Pg1-Ps189Cg39-Pg1-Ps190Cg39-Pg1-Ps191Cg39-Pg1-Ps192
Cg39-Pg1-Ps193Cg39-Pg1-Ps194Cg39-Pg1-Ps195Cg39-Pg1-Ps196
Cg39-Pg1-Ps197Cg39-Pg1-Ps198Cg39-Pg1-Ps199Cg39-Pg1-Ps200
Cg39-Pg1-Ps201Cg39-Pg1-Ps202Cg39-Pg1-Ps203Cg39-Pg1-Ps204
Cg39-Pg1-Ps205Cg39-Pg1-Ps206Cg39-Pg1-Ps207Cg39-Pg1-Ps208
Cg39-Pg1-Ps209Cg39-Pg1-Ps210Cg39-Pg1-Ps211Cg39-Pg1-Ps212
Cg39-Pg1-Ps213Cg39-Pg1-Ps214Cg39-Pg1-Ps215Cg39-Pg1-Ps216
Cg39-Pg1-Ps217Cg39-Pg1-Ps218Cg39-Pg1-Ps219Cg39-Pg1-Ps220
Cg39-Pg1-Ps221Cg39-Pg1-Ps222Cg39-Pg1-Ps223Cg39-Pg1-Ps224
Cg39-Pg1-Ps225Cg39-Pg1-Ps226Cg39-Pg1-Ps227Cg39-Pg1-Ps228
Cg39-Pg1-Ps229Cg39-Pg1-Ps230Cg39-Pg1-Ps231Cg39-Pg1-Ps232
Cg39-Pg1-Ps233Cg39-Pg1-Ps234Cg39-Pg1-Ps235Cg39-Pg1-Ps236
Cg39-Pg1-Ps237Cg39-Pg1-Ps238Cg39-Pg1-Ps239Cg39-Pg1-Ps240
Cg39-Pg1-Ps241Cg39-Pg1-Ps242Cg39-Pg1-Ps243
Cg41-Pg1-Ps1Cg41-Pg1-Ps2Cg41-Pg1-Ps3Cg41-Pg1-Ps4
Cg41-Pg1-Ps5Cg41-Pg1-Ps6Cg41-Pg1-Ps7Cg41-Pg1-Ps8
Cg41-Pg1-Ps9Cg41-Pg1-Ps10Cg41-Pg1-Ps11Cg41-Pg1-Ps12
Cg41-Pg1-Ps13Cg41-Pg1-Ps14Cg41-Pg1-Ps15Cg41-Pg1-Ps16
Cg41-Pg1-Ps17Cg41-Pg1-Ps18Cg41-Pg1-Ps19Cg41-Pg1-Ps20
Cg41-Pg1-Ps21Cg41-Pg1-Ps22Cg41-Pg1-Ps23Cg41-Pg1-Ps24
Cg41-Pg1-Ps25Cg41-Pg1-Ps26Cg41-Pg1-Ps27Cg41-Pg1-Ps28
Cg41-Pg1-Ps29Cg41-Pg1-Ps30Cg41-Pg1-Ps31Cg41-Pg1-Ps32
Cg41-Pg1-Ps33Cg41-Pg1-Ps34Cg41-Pg1-Ps35Cg41-Pg1-Ps36
Cg41-Pg1-Ps37Cg41-Pg1-Ps38Cg41-Pg1-Ps39Cg41-Pg1-Ps40
Cg41-Pg1-Ps41Cg41-Pg1-Ps42Cg41-Pg1-Ps43Cg41-Pg1-Ps44
Cg41-Pg1-Ps45Cg41-Pg1-Ps46Cg41-Pg1-Ps47Cg41-Pg1-Ps48
Cg41-Pg1-Ps49Cg41-Pg1-Ps50Cg41-Pg1-Ps51Cg41-Pg1-Ps52
Cg41-Pg1-Ps53Cg41-Pg1-Ps54Cg41-Pg1-Ps55Cg41-Pg1-Ps56
Cg41-Pg1-Ps57Cg41-Pg1-Ps58Cg41-Pg1-Ps59Cg41-Pg1-Ps60
Cg41-Pg1-Ps61Cg41-Pg1-Ps62Cg41-Pg1-Ps63Cg41-Pg1-Ps64
Cg41-Pg1-Ps65Cg41-Pg1-Ps66Cg41-Pg1-Ps67Cg41-Pg1-Ps68
Cg41-Pg1-Ps69Cg41-Pg1-Ps70Cg41-Pg1-Ps71Cg41-Pg1-Ps72
Cg41-Pg1-Ps73Cg41-Pg1-Ps74Cg41-Pg1-Ps75Cg41-Pg1-Ps76
Cg41-Pg1-Ps77Cg41-Pg1-Ps78Cg41-Pg1-Ps79Cg41-Pg1-Ps80
Cg41-Pg1-Ps81Cg41-Pg1-Ps82Cg41-Pg1-Ps83Cg41-Pg1-Ps84
Cg41-Pg1-Ps85Cg41-Pg1-Ps86Cg41-Pg1-Ps87Cg41-Pg1-Ps88
Cg41-Pg1-Ps89Cg41-Pg1-Ps90Cg41-Pg1-Ps91Cg41-Pg1-Ps92
Cg41-Pg1-Ps93Cg41-Pg1-Ps94Cg41-Pg1-Ps95Cg41-Pg1-Ps96
Cg41-Pg1-Ps97Cg41-Pg1-Ps98Cg41-Pg1-Ps99Cg41-Pg1-Ps100
Cg41-Pg1-Ps101Cg41-Pg1-Ps102Cg41-Pg1-Ps103Cg41-Pg1-Ps104
Cg41-Pg1-Ps105Cg41-Pg1-Ps106Cg41-Pg1-Ps107Cg41-Pg1-Ps108
Cg41-Pg1-Ps109Cg41-Pg1-Ps110Cg41-Pg1-Ps111Cg41-Pg1-Ps112
Cg41-Pg1-Ps113Cg41-Pg1-Ps114Cg41-Pg1-Ps115Cg41-Pg1-Ps116
Cg41-Pg1-Ps117Cg41-Pg1-Ps118Cg41-Pg1-Ps119Cg41-Pg1-Ps120
Cg41-Pg1-Ps121Cg41-Pg1-Ps122Cg41-Pg1-Ps123Cg41-Pg1-Ps124
Cg41-Pg1-Ps125Cg41-Pg1-Ps126Cg41-Pg1-Ps127Cg41-Pg1-Ps128
Cg41-Pg1-Ps129Cg41-Pg1-Ps130Cg41-Pg1-Ps131Cg41-Pg1-Ps132
Cg41-Pg1-Ps133Cg41-Pg1-Ps134Cg41-Pg1-Ps135Cg41-Pg1-Ps136
Cg41-Pg1-Ps137Cg41-Pg1-Ps138Cg41-Pg1-Ps139Cg41-Pg1-Ps140
Cg41-Pg1-Ps141Cg41-Pg1-Ps142Cg41-Pg1-Ps143Cg41-Pg1-Ps144
Cg41-Pg1-Ps145Cg41-Pg1-Ps146Cg41-Pg1-Ps147Cg41-Pg1-Ps148
Cg41-Pg1-Ps149Cg41-Pg1-Ps150Cg41-Pg1-Ps151Cg41-Pg1-Ps152
Cg41-Pg1-Ps153Cg41-Pg1-Ps154Cg41-Pg1-Ps155Cg41-Pg1-Ps156
Cg41-Pg1-Ps157Cg41-Pg1-Ps158Cg41-Pg1-Ps159Cg41-Pg1-Ps160
Cg41-Pg1-Ps161Cg41-Pg1-Ps162Cg41-Pg1-Ps163Cg41-Pg1-Ps164
Cg41-Pg1-Ps165Cg41-Pg1-Ps166Cg41-Pg1-Ps167Cg41-Pg1-Ps168
Cg41-Pg1-Ps169Cg41-Pg1-Ps170Cg41-Pg1-Ps171Cg41-Pg1-Ps172
Cg41-Pg1-Ps173Cg41-Pg1-Ps174Cg41-Pg1-Ps175Cg41-Pg1-Ps176
Cg41-Pg1-Ps177Cg41-Pg1-Ps178Cg41-Pg1-Ps179Cg41-Pg1-Ps180
Cg41-Pg1-Ps181Cg41-Pg1-Ps182Cg41-Pg1-Ps183Cg41-Pg1-Ps184
Cg41-Pg1-Ps185Cg41-Pg1-Ps186Cg41-Pg1-Ps187Cg41-Pg1-Ps188
Cg41-Pg1-Ps189Cg41-Pg1-Ps190Cg41-Pg1-Ps191Cg41-Pg1-Ps192
Cg41-Pg1-Ps193Cg41-Pg1-Ps194Cg41-Pg1-Ps195Cg41-Pg1-Ps196
Cg41-Pg1-Ps197Cg41-Pg1-Ps198Cg41-Pg1-Ps199Cg41-Pg1-Ps200
Cg41-Pg1-Ps201Cg41-Pg1-Ps202Cg41-Pg1-Ps203Cg41-Pg1-Ps204
Cg41-Pg1-Ps205Cg41-Pg1-Ps206Cg41-Pg1-Ps207Cg41-Pg1-Ps208
Cg41-Pg1-Ps209Cg41-Pg1-Ps210Cg41-Pg1-Ps211Cg41-Pg1-Ps212
Cg41-Pg1-Ps213Cg41-Pg1-Ps214Cg41-Pg1-Ps215Cg41-Pg1-Ps216
Cg41-Pg1-Ps217Cg41-Pg1-Ps218Cg41-Pg1-Ps219Cg41-Pg1-Ps220
Cg41-Pg1-Ps221Cg41-Pg1-Ps222Cg41-Pg1-Ps223Cg41-Pg1-Ps224
Cg41-Pg1-Ps225Cg41-Pg1-Ps226Cg41-Pg1-Ps227Cg41-Pg1-Ps228
Cg41-Pg1-Ps229Cg41-Pg1-Ps230Cg41-Pg1-Ps231Cg41-Pg1-Ps232
Cg41-Pg1-Ps233Cg41-Pg1-Ps234Cg41-Pg1-Ps235Cg41-Pg1-Ps236
Cg41-Pg1-Ps237Cg41-Pg1-Ps238Cg41-Pg1-Ps239Cg41-Pg1-Ps240
Cg41-Pg1-Ps241Cg41-Pg1-Ps242Cg41-Pg1-Ps243
Cg42-Pg1-Ps1Cg42-Pg1-Ps2Cg42-Pg1-Ps3Cg42-Pg1-Ps4
Cg42-Pg1-Ps5Cg42-Pg1-Ps6Cg42-Pg1-Ps7Cg42-Pg1-Ps8
Cg42-Pg1-Ps9Cg42-Pg1-Ps10Cg42-Pg1-Ps11Cg42-Pg1-Ps12
Cg42-Pg1-Ps13Cg42-Pg1-Ps14Cg42-Pg1-Ps15Cg42-Pg1-Ps16
Cg42-Pg1-Ps17Cg42-Pg1-Ps18Cg42-Pg1-Ps19Cg42-Pg1-Ps20
Cg42-Pg1-Ps21Cg42-Pg1-Ps22Cg42-Pg1-Ps23Cg42-Pg1-Ps24
Cg42-Pg1-Ps25Cg42-Pg1-Ps26Cg42-Pg1-Ps27Cg42-Pg1-Ps28
Cg42-Pg1-Ps29Cg42-Pg1-Ps30Cg42-Pg1-Ps31Cg42-Pg1-Ps32
Cg42-Pg1-Ps33Cg42-Pg1-Ps34Cg42-Pg1-Ps35Cg42-Pg1-Ps36
Cg42-Pg1-Ps37Cg42-Pg1-Ps38Cg42-Pg1-Ps39Cg42-Pg1-Ps40
Cg42-Pg1-Ps41Cg42-Pg1-Ps42Cg42-Pg1-Ps43Cg42-Pg1-Ps44
Cg42-Pg1-Ps45Cg42-Pg1-Ps46Cg42-Pg1-Ps47Cg42-Pg1-Ps48
Cg42-Pg1-Ps49Cg42-Pg1-Ps50Cg42-Pg1-Ps51Cg42-Pg1-Ps52
Cg42-Pg1-Ps53Cg42-Pg1-Ps54Cg42-Pg1-Ps55Cg42-Pg1-Ps56
Cg42-Pg1-Ps57Cg42-Pg1-Ps58Cg42-Pg1-Ps59Cg42-Pg1-Ps60
Cg42-Pg1-Ps61Cg42-Pg1-Ps62Cg42-Pg1-Ps63Cg42-Pg1-Ps64
Cg42-Pg1-Ps65Cg42-Pg1-Ps66Cg42-Pg1-Ps67Cg42-Pg1-Ps68
Cg42-Pg1-Ps69Cg42-Pg1-Ps70Cg42-Pg1-Ps71Cg42-Pg1-Ps72
Cg42-Pg1-Ps73Cg42-Pg1-Ps74Cg42-Pg1-Ps75Cg42-Pg1-Ps76
Cg42-Pg1-Ps77Cg42-Pg1-Ps78Cg42-Pg1-Ps79Cg42-Pg1-Ps80
Cg42-Pg1-Ps81Cg42-Pg1-Ps82Cg42-Pg1-Ps83Cg42-Pg1-Ps84
Cg42-Pg1-Ps85Cg42-Pg1-Ps86Cg42-Pg1-Ps87Cg42-Pg1-Ps88
Cg42-Pg1-Ps89Cg42-Pg1-Ps90Cg42-Pg1-Ps91Cg42-Pg1-Ps92
Cg42-Pg1-Ps93Cg42-Pg1-Ps94Cg42-Pg1-Ps95Cg42-Pg1-Ps96
Cg42-Pg1-Ps97Cg42-Pg1-Ps98Cg42-Pg1-Ps99Cg42-Pg1-Ps100
Cg42-Pg1-Ps101Cg42-Pg1-Ps102Cg42-Pg1-Ps103Cg42-Pg1-Ps104
Cg42-Pg1-Ps105Cg42-Pg1-Ps106Cg42-Pg1-Ps107Cg42-Pg1-Ps108
Cg42-Pg1-Ps109Cg42-Pg1-Ps110Cg42-Pg1-Ps111Cg42-Pg1-Ps112
Cg42-Pg1-Ps113Cg42-Pg1-Ps114Cg42-Pg1-Ps115Cg42-Pg1-Ps116
Cg42-Pg1-Ps117Cg42-Pg1-Ps118Cg42-Pg1-Ps119Cg42-Pg1-Ps120
Cg42-Pg1-Ps121Cg42-Pg1-Ps122Cg42-Pg1-Ps123Cg42-Pg1-Ps124
Cg42-Pg1-Ps125Cg42-Pg1-Ps126Cg42-Pg1-Ps127Cg42-Pg1-Ps128
Cg42-Pg1-Ps129Cg42-Pg1-Ps130Cg42-Pg1-Ps131Cg42-Pg1-Ps132
Cg42-Pg1-Ps133Cg42-Pg1-Ps134Cg42-Pg1-Ps135Cg42-Pg1-Ps136
Cg42-Pg1-Ps137Cg42-Pg1-Ps138Cg42-Pg1-Ps139Cg42-Pg1-Ps140
Cg42-Pg1-Ps141Cg42-Pg1-Ps142Cg42-Pg1-Ps143Cg42-Pg1-Ps144
Cg42-Pg1-Ps145Cg42-Pg1-Ps146Cg42-Pg1-Ps147Cg42-Pg1-Ps148
Cg42-Pg1-Ps149Cg42-Pg1-Ps150Cg42-Pg1-Ps151Cg42-Pg1-Ps152
Cg42-Pg1-Ps153Cg42-Pg1-Ps154Cg42-Pg1-Ps155Cg42-Pg1-Ps156
Cg42-Pg1-Ps157Cg42-Pg1-Ps158Cg42-Pg1-Ps159Cg42-Pg1-Ps160
Cg42-Pg1-Ps161Cg42-Pg1-Ps162Cg42-Pg1-Ps163Cg42-Pg1-Ps164
Cg42-Pg1-Ps165Cg42-Pg1-Ps166Cg42-Pg1-Ps167Cg42-Pg1-Ps168
Cg42-Pg1-Ps169Cg42-Pg1-Ps170Cg42-Pg1-Ps171Cg42-Pg1-Ps172
Cg42-Pg1-Ps173Cg42-Pg1-Ps174Cg42-Pg1-Ps175Cg42-Pg1-Ps176
Cg42-Pg1-Ps177Cg42-Pg1-Ps178Cg42-Pg1-Ps179Cg42-Pg1-Ps180
Cg42-Pg1-Ps181Cg42-Pg1-Ps182Cg42-Pg1-Ps183Cg42-Pg1-Ps184
Cg42-Pg1-Ps185Cg42-Pg1-Ps186Cg42-Pg1-Ps187Cg42-Pg1-Ps188
Cg42-Pg1-Ps189Cg42-Pg1-Ps190Cg42-Pg1-Ps191Cg42-Pg1-Ps192
Cg42-Pg1-Ps193Cg42-Pg1-Ps194Cg42-Pg1-Ps195Cg42-Pg1-Ps196
Cg42-Pg1-Ps197Cg42-Pg1-Ps198Cg42-Pg1-Ps199Cg42-Pg1-Ps200
Cg42-Pg1-Ps201Cg42-Pg1-Ps202Cg42-Pg1-Ps203Cg42-Pg1-Ps204
Cg42-Pg1-Ps205Cg42-Pg1-Ps206Cg42-Pg1-Ps207Cg42-Pg1-Ps208
Cg42-Pg1-Ps209Cg42-Pg1-Ps210Cg42-Pg1-Ps211Cg42-Pg1-Ps212
Cg42-Pg1-Ps213Cg42-Pg1-Ps214Cg42-Pg1-Ps215Cg42-Pg1-Ps216
Cg42-Pg1-Ps217Cg42-Pg1-Ps218Cg42-Pg1-Ps219Cg42-Pg1-Ps220
Cg42-Pg1-Ps221Cg42-Pg1-Ps222Cg42-Pg1-Ps223Cg42-Pg1-Ps224
Cg42-Pg1-Ps225Cg42-Pg1-Ps226Cg42-Pg1-Ps227Cg42-Pg1-Ps228
Cg42-Pg1-Ps229Cg42-Pg1-Ps230Cg42-Pg1-Ps231Cg42-Pg1-Ps232
Cg42-Pg1-Ps233Cg42-Pg1-Ps234Cg42-Pg1-Ps235Cg42-Pg1-Ps236
Cg42-Pg1-Ps237Cg42-Pg1-Ps238Cg42-Pg1-Ps239Cg42-Pg1-Ps240
Cg42-Pg1-Ps241Cg42-Pg1-Ps242Cg42-Pg1-Ps243
Cg44-Pg1-Ps1Cg44-Pg1-Ps2Cg44-Pg1-Ps3Cg44-Pg1-Ps4
Cg44-Pg1-Ps5Cg44-Pg1-Ps6Cg44-Pg1-Ps7Cg44-Pg1-Ps8
Cg44-Pg1-Ps9Cg44-Pg1-Ps10Cg44-Pg1-Ps11Cg44-Pg1-Ps12
Cg44-Pg1-Ps13Cg44-Pg1-Ps14Cg44-Pg1-Ps15Cg44-Pg1-Ps16
Cg44-Pg1-Ps17Cg44-Pg1-Ps18Cg44-Pg1-Ps19Cg44-Pg1-Ps20
Cg44-Pg1-Ps21Cg44-Pg1-Ps22Cg44-Pg1-Ps23Cg44-Pg1-Ps24
Cg44-Pg1-Ps25Cg44-Pg1-Ps26Cg44-Pg1-Ps27Cg44-Pg1-Ps28
Cg44-Pg1-Ps29Cg44-Pg1-Ps30Cg44-Pg1-Ps31Cg44-Pg1-Ps32
Cg44-Pg1-Ps33Cg44-Pg1-Ps34Cg44-Pg1-Ps35Cg44-Pg1-Ps36
Cg44-Pg1-Ps37Cg44-Pg1-Ps38Cg44-Pg1-Ps39Cg44-Pg1-Ps40
Cg44-Pg1-Ps41Cg44-Pg1-Ps42Cg44-Pg1-Ps43Cg44-Pg1-Ps44
Cg44-Pg1-Ps45Cg44-Pg1-Ps46Cg44-Pg1-Ps47Cg44-Pg1-Ps48
Cg44-Pg1-Ps49Cg44-Pg1-Ps50Cg44-Pg1-Ps51Cg44-Pg1-Ps52
Cg44-Pg1-Ps53Cg44-Pg1-Ps54Cg44-Pg1-Ps55Cg44-Pg1-Ps56
Cg44-Pg1-Ps57Cg44-Pg1-Ps58Cg44-Pg1-Ps59Cg44-Pg1-Ps60
Cg44-Pg1-Ps61Cg44-Pg1-Ps62Cg44-Pg1-Ps63Cg44-Pg1-Ps64
Cg44-Pg1-Ps65Cg44-Pg1-Ps66Cg44-Pg1-Ps67Cg44-Pg1-Ps68
Cg44-Pg1-Ps69Cg44-Pg1-Ps70Cg44-Pg1-Ps71Cg44-Pg1-Ps72
Cg44-Pg1-Ps73Cg44-Pg1-Ps74Cg44-Pg1-Ps75Cg44-Pg1-Ps76
Cg44-Pg1-Ps77Cg44-Pg1-Ps78Cg44-Pg1-Ps79Cg44-Pg1-Ps80
Cg44-Pg1-Ps81Cg44-Pg1-Ps82Cg44-Pg1-Ps83Cg44-Pg1-Ps84
Cg44-Pg1-Ps85Cg44-Pg1-Ps86Cg44-Pg1-Ps87Cg44-Pg1-Ps88
Cg44-Pg1-Ps89Cg44-Pg1-Ps90Cg44-Pg1-Ps91Cg44-Pg1-Ps92
Cg44-Pg1-Ps93Cg44-Pg1-Ps94Cg44-Pg1-Ps95Cg44-Pg1-Ps96
Cg44-Pg1-Ps97Cg44-Pg1-Ps98Cg44-Pg1-Ps99Cg44-Pg1-Ps100
Cg44-Pg1-Ps101Cg44-Pg1-Ps102Cg44-Pg1-Ps103Cg44-Pg1-Ps104
Cg44-Pg1-Ps105Cg44-Pg1-Ps106Cg44-Pg1-Ps107Cg44-Pg1-Ps108
Cg44-Pg1-Ps109Cg44-Pg1-Ps110Cg44-Pg1-Ps111Cg44-Pg1-Ps112
Cg44-Pg1-Ps113Cg44-Pg1-Ps114Cg44-Pg1-Ps115Cg44-Pg1-Ps116
Cg44-Pg1-Ps117Cg44-Pg1-Ps118Cg44-Pg1-Ps119Cg44-Pg1-Ps120
Cg44-Pg1-Ps121Cg44-Pg1-Ps122Cg44-Pg1-Ps123Cg44-Pg1-Ps124
Cg44-Pg1-Ps125Cg44-Pg1-Ps126Cg44-Pg1-Ps127Cg44-Pg1-Ps128
Cg44-Pg1-Ps129Cg44-Pg1-Ps130Cg44-Pg1-Ps131Cg44-Pg1-Ps132
Cg44-Pg1-Ps133Cg44-Pg1-Ps134Cg44-Pg1-Ps135Cg44-Pg1-Ps136
Cg44-Pg1-Ps137Cg44-Pg1-Ps138Cg44-Pg1-Ps139Cg44-Pg1-Ps140
Cg44-Pg1-Ps141Cg44-Pg1-Ps142Cg44-Pg1-Ps143Cg44-Pg1-Ps144
Cg44-Pg1-Ps145Cg44-Pg1-Ps146Cg44-Pg1-Ps147Cg44-Pg1-Ps148
Cg44-Pg1-Ps149Cg44-Pg1-Ps150Cg44-Pg1-Ps151Cg44-Pg1-Ps152
Cg44-Pg1-Ps153Cg44-Pg1-Ps154Cg44-Pg1-Ps155Cg44-Pg1-Ps156
Cg44-Pg1-Ps157Cg44-Pg1-Ps158Cg44-Pg1-Ps159Cg44-Pg1-Ps160
Cg44-Pg1-Ps161Cg44-Pg1-Ps162Cg44-Pg1-Ps163Cg44-Pg1-Ps164
Cg44-Pg1-Ps165Cg44-Pg1-Ps166Cg44-Pg1-Ps167Cg44-Pg1-Ps168
Cg44-Pg1-Ps169Cg44-Pg1-Ps170Cg44-Pg1-Ps171Cg44-Pg1-Ps172
Cg44-Pg1-Ps173Cg44-Pg1-Ps174Cg44-Pg1-Ps175Cg44-Pg1-Ps176
Cg44-Pg1-Ps177Cg44-Pg1-Ps178Cg44-Pg1-Ps179Cg44-Pg1-Ps180
Cg44-Pg1-Ps181Cg44-Pg1-Ps182Cg44-Pg1-Ps183Cg44-Pg1-Ps184
Cg44-Pg1-Ps185Cg44-Pg1-Ps186Cg44-Pg1-Ps187Cg44-Pg1-Ps188
Cg44-Pg1-Ps189Cg44-Pg1-Ps190Cg44-Pg1-Ps191Cg44-Pg1-Ps192
Cg44-Pg1-Ps193Cg44-Pg1-Ps194Cg44-Pg1-Ps195Cg44-Pg1-Ps196
Cg44-Pg1-Ps197Cg44-Pg1-Ps198Cg44-Pg1-Ps199Cg44-Pg1-Ps200
Cg44-Pg1-Ps201Cg44-Pg1-Ps202Cg44-Pg1-Ps203Cg44-Pg1-Ps204
Cg44-Pg1-Ps205Cg44-Pg1-Ps206Cg44-Pg1-Ps207Cg44-Pg1-Ps208
Cg44-Pg1-Ps209Cg44-Pg1-Ps210Cg44-Pg1-Ps211Cg44-Pg1-Ps212
Cg44-Pg1-Ps213Cg44-Pg1-Ps214Cg44-Pg1-Ps215Cg44-Pg1-Ps216
Cg44-Pg1-Ps217Cg44-Pg1-Ps218Cg44-Pg1-Ps219Cg44-Pg1-Ps220
Cg44-Pg1-Ps221Cg44-Pg1-Ps222Cg44-Pg1-Ps223Cg44-Pg1-Ps224
Cg44-Pg1-Ps225Cg44-Pg1-Ps226Cg44-Pg1-Ps227Cg44-Pg1-Ps228
Cg44-Pg1-Ps229Cg44-Pg1-Ps230Cg44-Pg1-Ps231Cg44-Pg1-Ps232
Cg44-Pg1-Ps233Cg44-Pg1-Ps234Cg44-Pg1-Ps235Cg44-Pg1-Ps236
Cg44-Pg1-Ps237Cg44-Pg1-Ps238Cg44-Pg1-Ps239Cg44-Pg1-Ps240
Cg44-Pg1-Ps241Cg44-Pg1-Ps242Cg44-Pg1-Ps243
Cg45-Pg1-Ps1Cg45-Pg1-Ps2Cg45-Pg1-Ps3Cg45-Pg1-Ps4
Cg45-Pg1-Ps5Cg45-Pg1-Ps6Cg45-Pg1-Ps7Cg45-Pg1-Ps8
Cg45-Pg1-Ps9Cg45-Pg1-Ps10Cg45-Pg1-Ps11Cg45-Pg1-Ps12
Cg45-Pg1-Ps13Cg45-Pg1-Ps14Cg45-Pg1-Ps15Cg45-Pg1-Ps16
Cg45-Pg1-Ps17Cg45-Pg1-Ps18Cg45-Pg1-Ps19Cg45-Pg1-Ps20
Cg45-Pg1-Ps21Cg45-Pg1-Ps22Cg45-Pg1-Ps23Cg45-Pg1-Ps24
Cg45-Pg1-Ps25Cg45-Pg1-Ps26Cg45-Pg1-Ps27Cg45-Pg1-Ps28
Cg45-Pg1-Ps29Cg45-Pg1-Ps30Cg45-Pg1-Ps31Cg45-Pg1-Ps32
Cg45-Pg1-Ps33Cg45-Pg1-Ps34Cg45-Pg1-Ps35Cg45-Pg1-Ps36
Cg45-Pg1-Ps37Cg45-Pg1-Ps38Cg45-Pg1-Ps39Cg45-Pg1-Ps40
Cg45-Pg1-Ps41Cg45-Pg1-Ps42Cg45-Pg1-Ps43Cg45-Pg1-Ps44
Cg45-Pg1-Ps45Cg45-Pg1-Ps46Cg45-Pg1-Ps47Cg45-Pg1-Ps48
Cg45-Pg1-Ps49Cg45-Pg1-Ps50Cg45-Pg1-Ps51Cg45-Pg1-Ps52
Cg45-Pg1-Ps53Cg45-Pg1-Ps54Cg45-Pg1-Ps55Cg45-Pg1-Ps56
Cg45-Pg1-Ps57Cg45-Pg1-Ps58Cg45-Pg1-Ps59Cg45-Pg1-Ps60
Cg45-Pg1-Ps61Cg45-Pg1-Ps62Cg45-Pg1-Ps63Cg45-Pg1-Ps64
Cg45-Pg1-Ps65Cg45-Pg1-Ps66Cg45-Pg1-Ps67Cg45-Pg1-Ps68
Cg45-Pg1-Ps69Cg45-Pg1-Ps70Cg45-Pg1-Ps71Cg45-Pg1-Ps72
Cg45-Pg1-Ps73Cg45-Pg1-Ps74Cg45-Pg1-Ps75Cg45-Pg1-Ps76
Cg45-Pg1-Ps77Cg45-Pg1-Ps78Cg45-Pg1-Ps79Cg45-Pg1-Ps80
Cg45-Pg1-Ps81Cg45-Pg1-Ps82Cg45-Pg1-Ps83Cg45-Pg1-Ps84
Cg45-Pg1-Ps85Cg45-Pg1-Ps86Cg45-Pg1-Ps87Cg45-Pg1-Ps88
Cg45-Pg1-Ps89Cg45-Pg1-Ps90Cg45-Pg1-Ps91Cg45-Pg1-Ps92
Cg45-Pg1-Ps93Cg45-Pg1-Ps94Cg45-Pg1-Ps95Cg45-Pg1-Ps96
Cg45-Pg1-Ps97Cg45-Pg1-Ps98Cg45-Pg1-Ps99Cg45-Pg1-Ps100
Cg45-Pg1-Ps101Cg45-Pg1-Ps102Cg45-Pg1-Ps103Cg45-Pg1-Ps104
Cg45-Pg1-Ps105Cg45-Pg1-Ps106Cg45-Pg1-Ps107Cg45-Pg1-Ps108
Cg45-Pg1-Ps109Cg45-Pg1-Ps110Cg45-Pg1-Ps111Cg45-Pg1-Ps112
Cg45-Pg1-Ps113Cg45-Pg1-Ps114Cg45-Pg1-Ps115Cg45-Pg1-Ps116
Cg45-Pg1-Ps117Cg45-Pg1-Ps118Cg45-Pg1-Ps119Cg45-Pg1-Ps120
Cg45-Pg1-Ps121Cg45-Pg1-Ps122Cg45-Pg1-Ps123Cg45-Pg1-Ps124
Cg45-Pg1-Ps125Cg45-Pg1-Ps126Cg45-Pg1-Ps127Cg45-Pg1-Ps128
Cg45-Pg1-Ps129Cg45-Pg1-Ps130Cg45-Pg1-Ps131Cg45-Pg1-Ps132
Cg45-Pg1-Ps133Cg45-Pg1-Ps134Cg45-Pg1-Ps135Cg45-Pg1-Ps136
Cg45-Pg1-Ps137Cg45-Pg1-Ps138Cg45-Pg1-Ps139Cg45-Pg1-Ps140
Cg45-Pg1-Ps141Cg45-Pg1-Ps142Cg45-Pg1-Ps143Cg45-Pg1-Ps144
Cg45-Pg1-Ps145Cg45-Pg1-Ps146Cg45-Pg1-Ps147Cg45-Pg1-Ps148
Cg45-Pg1-Ps149Cg45-Pg1-Ps150Cg45-Pg1-Ps151Cg45-Pg1-Ps152
Cg45-Pg1-Ps153Cg45-Pg1-Ps154Cg45-Pg1-Ps155Cg45-Pg1-Ps156
Cg45-Pg1-Ps157Cg45-Pg1-Ps158Cg45-Pg1-Ps159Cg45-Pg1-Ps160
Cg45-Pg1-Ps161Cg45-Pg1-Ps162Cg45-Pg1-Ps163Cg45-Pg1-Ps164
Cg45-Pg1-Ps165Cg45-Pg1-Ps166Cg45-Pg1-Ps167Cg45-Pg1-Ps168
Cg45-Pg1-Ps169Cg45-Pg1-Ps170Cg45-Pg1-Ps171Cg45-Pg1-Ps172
Cg45-Pg1-Ps173Cg45-Pg1-Ps174Cg45-Pg1-Ps175Cg45-Pg1-Ps176
Cg45-Pg1-Ps177Cg45-Pg1-Ps178Cg45-Pg1-Ps179Cg45-Pg1-Ps180
Cg45-Pg1-Ps181Cg45-Pg1-Ps182Cg45-Pg1-Ps183Cg45-Pg1-Ps184
Cg45-Pg1-Ps185Cg45-Pg1-Ps186Cg45-Pg1-Ps187Cg45-Pg1-Ps188
Cg45-Pg1-Ps189Cg45-Pg1-Ps190Cg45-Pg1-Ps191Cg45-Pg1-Ps192
Cg45-Pg1-Ps193Cg45-Pg1-Ps194Cg45-Pg1-Ps195Cg45-Pg1-Ps196
Cg45-Pg1-Ps197Cg45-Pg1-Ps198Cg45-Pg1-Ps199Cg45-Pg1-Ps200
Cg45-Pg1-Ps201Cg45-Pg1-Ps202Cg45-Pg1-Ps203Cg45-Pg1-Ps204
Cg45-Pg1-Ps205Cg45-Pg1-Ps206Cg45-Pg1-Ps207Cg45-Pg1-Ps208
Cg45-Pg1-Ps209Cg45-Pg1-Ps210Cg45-Pg1-Ps211Cg45-Pg1-Ps212
Cg45-Pg1-Ps213Cg45-Pg1-Ps214Cg45-Pg1-Ps215Cg45-Pg1-Ps216
Cg45-Pg1-Ps217Cg45-Pg1-Ps218Cg45-Pg1-Ps219Cg45-Pg1-Ps220
Cg45-Pg1-Ps221Cg45-Pg1-Ps222Cg45-Pg1-Ps223Cg45-Pg1-Ps224
Cg45-Pg1-Ps225Cg45-Pg1-Ps226Cg45-Pg1-Ps227Cg45-Pg1-Ps228
Cg45-Pg1-Ps229Cg45-Pg1-Ps230Cg45-Pg1-Ps231Cg45-Pg1-Ps232
Cg45-Pg1-Ps233Cg45-Pg1-Ps234Cg45-Pg1-Ps235Cg45-Pg1-Ps236
Cg45-Pg1-Ps237Cg45-Pg1-Ps238Cg45-Pg1-Ps239Cg45-Pg1-Ps240
Cg45-Pg1-Ps241Cg45-Pg1-Ps242Cg45-Pg1-Ps243
Cg46-Pg1-Ps1Cg46-Pg1-Ps2Cg46-Pg1-Ps3Cg46-Pg1-Ps4
Cg46-Pg1-Ps5Cg46-Pg1-Ps6Cg46-Pg1-Ps7Cg46-Pg1-Ps8
Cg46-Pg1-Ps9Cg46-Pg1-Ps10Cg46-Pg1-Ps11Cg46-Pg1-Ps12
Cg46-Pg1-Ps13Cg46-Pg1-Ps14Cg46-Pg1-Ps15Cg46-Pg1-Ps16
Cg46-Pg1-Ps17Cg46-Pg1-Ps18Cg46-Pg1-Ps19Cg46-Pg1-Ps20
Cg46-Pg1-Ps21Cg46-Pg1-Ps22Cg46-Pg1-Ps23Cg46-Pg1-Ps24
Cg46-Pg1-Ps25Cg46-Pg1-Ps26Cg46-Pg1-Ps27Cg46-Pg1-Ps28
Cg46-Pg1-Ps29Cg46-Pg1-Ps30Cg46-Pg1-Ps31Cg46-Pg1-Ps32
Cg46-Pg1-Ps33Cg46-Pg1-Ps34Cg46-Pg1-Ps35Cg46-Pg1-Ps36
Cg46-Pg1-Ps37Cg46-Pg1-Ps38Cg46-Pg1-Ps39Cg46-Pg1-Ps40
Cg46-Pg1-Ps41Cg46-Pg1-Ps42Cg46-Pg1-Ps43Cg46-Pg1-Ps44
Cg46-Pg1-Ps45Cg46-Pg1-Ps46Cg46-Pg1-Ps47Cg46-Pg1-Ps48
Cg46-Pg1-Ps49Cg46-Pg1-Ps50Cg46-Pg1-Ps51Cg46-Pg1-Ps52
Cg46-Pg1-Ps53Cg46-Pg1-Ps54Cg46-Pg1-Ps55Cg46-Pg1-Ps56
Cg46-Pg1-Ps57Cg46-Pg1-Ps58Cg46-Pg1-Ps59Cg46-Pg1-Ps60
Cg46-Pg1-Ps61Cg46-Pg1-Ps62Cg46-Pg1-Ps63Cg46-Pg1-Ps64
Cg46-Pg1-Ps65Cg46-Pg1-Ps66Cg46-Pg1-Ps67Cg46-Pg1-Ps68
Cg46-Pg1-Ps69Cg46-Pg1-Ps70Cg46-Pg1-Ps71Cg46-Pg1-Ps72
Cg46-Pg1-Ps73Cg46-Pg1-Ps74Cg46-Pg1-Ps75Cg46-Pg1-Ps76
Cg46-Pg1-Ps77Cg46-Pg1-Ps78Cg46-Pg1-Ps79Cg46-Pg1-Ps80
Cg46-Pg1-Ps81Cg46-Pg1-Ps82Cg46-Pg1-Ps83Cg46-Pg1-Ps84
Cg46-Pg1-Ps85Cg46-Pg1-Ps86Cg46-Pg1-Ps87Cg46-Pg1-Ps88
Cg46-Pg1-Ps89Cg46-Pg1-Ps90Cg46-Pg1-Ps91Cg46-Pg1-Ps92
Cg46-Pg1-Ps93Cg46-Pg1-Ps94Cg46-Pg1-Ps95Cg46-Pg1-Ps96
Cg46-Pg1-Ps97Cg46-Pg1-Ps98Cg46-Pg1-Ps99Cg46-Pg1-Ps100
Cg46-Pg1-Ps101Cg46-Pg1-Ps102Cg46-Pg1-Ps103Cg46-Pg1-Ps104
Cg46-Pg1-Ps105Cg46-Pg1-Ps106Cg46-Pg1-Ps107Cg46-Pg1-Ps108
Cg46-Pg1-Ps109Cg46-Pg1-Ps110Cg46-Pg1-Ps111Cg46-Pg1-Ps112
Cg46-Pg1-Ps113Cg46-Pg1-Ps114Cg46-Pg1-Ps115Cg46-Pg1-Ps116
Cg46-Pg1-Ps117Cg46-Pg1-Ps118Cg46-Pg1-Ps119Cg46-Pg1-Ps120
Cg46-Pg1-Ps121Cg46-Pg1-Ps122Cg46-Pg1-Ps123Cg46-Pg1-Ps124
Cg46-Pg1-Ps125Cg46-Pg1-Ps126Cg46-Pg1-Ps127Cg46-Pg1-Ps128
Cg46-Pg1-Ps129Cg46-Pg1-Ps130Cg46-Pg1-Ps131Cg46-Pg1-Ps132
Cg46-Pg1-Ps133Cg46-Pg1-Ps134Cg46-Pg1-Ps135Cg46-Pg1-Ps136
Cg46-Pg1-Ps137Cg46-Pg1-Ps138Cg46-Pg1-Ps139Cg46-Pg1-Ps140
Cg46-Pg1-Ps141Cg46-Pg1-Ps142Cg46-Pg1-Ps143Cg46-Pg1-Ps144
Cg46-Pg1-Ps145Cg46-Pg1-Ps146Cg46-Pg1-Ps147Cg46-Pg1-Ps148
Cg46-Pg1-Ps149Cg46-Pg1-Ps150Cg46-Pg1-Ps151Cg46-Pg1-Ps152
Cg46-Pg1-Ps153Cg46-Pg1-Ps154Cg46-Pg1-Ps155Cg46-Pg1-Ps156
Cg46-Pg1-Ps157Cg46-Pg1-Ps158Cg46-Pg1-Ps159Cg46-Pg1-Ps160
Cg46-Pg1-Ps161Cg46-Pg1-Ps162Cg46-Pg1-Ps163Cg46-Pg1-Ps164
Cg46-Pg1-Ps165Cg46-Pg1-Ps166Cg46-Pg1-Ps167Cg46-Pg1-Ps168
Cg46-Pg1-Ps169Cg46-Pg1-Ps170Cg46-Pg1-Ps171Cg46-Pg1-Ps172
Cg46-Pg1-Ps173Cg46-Pg1-Ps174Cg46-Pg1-Ps175Cg46-Pg1-Ps176
Cg46-Pg1-Ps177Cg46-Pg1-Ps178Cg46-Pg1-Ps179Cg46-Pg1-Ps180
Cg46-Pg1-Ps181Cg46-Pg1-Ps182Cg46-Pg1-Ps183Cg46-Pg1-Ps184
Cg46-Pg1-Ps185Cg46-Pg1-Ps186Cg46-Pg1-Ps187Cg46-Pg1-Ps188
Cg46-Pg1-Ps189Cg46-Pg1-Ps190Cg46-Pg1-Ps191Cg46-Pg1-Ps192
Cg46-Pg1-Ps193Cg46-Pg1-Ps194Cg46-Pg1-Ps195Cg46-Pg1-Ps196
Cg46-Pg1-Ps197Cg46-Pg1-Ps198Cg46-Pg1-Ps199Cg46-Pg1-Ps200
Cg46-Pg1-Ps201Cg46-Pg1-Ps202Cg46-Pg1-Ps203Cg46-Pg1-Ps204
Cg46-Pg1-Ps205Cg46-Pg1-Ps206Cg46-Pg1-Ps207Cg46-Pg1-Ps208
Cg46-Pg1-Ps209Cg46-Pg1-Ps210Cg46-Pg1-Ps211Cg46-Pg1-Ps212
Cg46-Pg1-Ps213Cg46-Pg1-Ps214Cg46-Pg1-Ps215Cg46-Pg1-Ps216
Cg46-Pg1-Ps217Cg46-Pg1-Ps218Cg46-Pg1-Ps219Cg46-Pg1-Ps220
Cg46-Pg1-Ps221Cg46-Pg1-Ps222Cg46-Pg1-Ps223Cg46-Pg1-Ps224
Cg46-Pg1-Ps225Cg46-Pg1-Ps226Cg46-Pg1-Ps227Cg46-Pg1-Ps228
Cg46-Pg1-Ps229Cg46-Pg1-Ps230Cg46-Pg1-Ps231Cg46-Pg1-Ps232
Cg46-Pg1-Ps233Cg46-Pg1-Ps234Cg46-Pg1-Ps235Cg46-Pg1-Ps236
Cg46-Pg1-Ps237Cg46-Pg1-Ps238Cg46-Pg1-Ps239Cg46-Pg1-Ps240
Cg46-Pg1-Ps241Cg46-Pg1-Ps242Cg46-Pg1-Ps243
Cg47-Pg1-Ps1Cg47-Pg1-Ps2Cg47-Pg1-Ps3Cg47-Pg1-Ps4
Cg47-Pg1-Ps5Cg47-Pg1-Ps6Cg47-Pg1-Ps7Cg47-Pg1-Ps8
Cg47-Pg1-Ps9Cg47-Pg1-Ps10Cg47-Pg1-Ps11Cg47-Pg1-Ps12
Cg47-Pg1-Ps13Cg47-Pg1-Ps14Cg47-Pg1-Ps15Cg47-Pg1-Ps16
Cg47-Pg1-Ps17Cg47-Pg1-Ps18Cg47-Pg1-Ps19Cg47-Pg1-Ps20
Cg47-Pg1-Ps21Cg47-Pg1-Ps22Cg47-Pg1-Ps23Cg47-Pg1-Ps24
Cg47-Pg1-Ps25Cg47-Pg1-Ps26Cg47-Pg1-Ps27Cg47-Pg1-Ps28
Cg47-Pg1-Ps29Cg47-Pg1-Ps30Cg47-Pg1-Ps31Cg47-Pg1-Ps32
Cg47-Pg1-Ps33Cg47-Pg1-Ps34Cg47-Pg1-Ps35Cg47-Pg1-Ps36
Cg47-Pg1-Ps37Cg47-Pg1-Ps38Cg47-Pg1-Ps39Cg47-Pg1-Ps40
Cg47-Pg1-Ps41Cg47-Pg1-Ps42Cg47-Pg1-Ps43Cg47-Pg1-Ps44
Cg47-Pg1-Ps45Cg47-Pg1-Ps46Cg47-Pg1-Ps47Cg47-Pg1-Ps48
Cg47-Pg1-Ps49Cg47-Pg1-Ps50Cg47-Pg1-Ps51Cg47-Pg1-Ps52
Cg47-Pg1-Ps53Cg47-Pg1-Ps54Cg47-Pg1-Ps55Cg47-Pg1-Ps56
Cg47-Pg1-Ps57Cg47-Pg1-Ps58Cg47-Pg1-Ps59Cg47-Pg1-Ps60
Cg47-Pg1-Ps61Cg47-Pg1-Ps62Cg47-Pg1-Ps63Cg47-Pg1-Ps64
Cg47-Pg1-Ps65Cg47-Pg1-Ps66Cg47-Pg1-Ps67Cg47-Pg1-Ps68
Cg47-Pg1-Ps69Cg47-Pg1-Ps70Cg47-Pg1-Ps71Cg47-Pg1-Ps72
Cg47-Pg1-Ps73Cg47-Pg1-Ps74Cg47-Pg1-Ps75Cg47-Pg1-Ps76
Cg47-Pg1-Ps77Cg47-Pg1-Ps78Cg47-Pg1-Ps79Cg47-Pg1-Ps80
Cg47-Pg1-Ps81Cg47-Pg1-Ps82Cg47-Pg1-Ps83Cg47-Pg1-Ps84
Cg47-Pg1-Ps85Cg47-Pg1-Ps86Cg47-Pg1-Ps87Cg47-Pg1-Ps88
Cg47-Pg1-Ps89Cg47-Pg1-Ps90Cg47-Pg1-Ps91Cg47-Pg1-Ps92
Cg47-Pg1-Ps93Cg47-Pg1-Ps94Cg47-Pg1-Ps95Cg47-Pg1-Ps96
Cg47-Pg1-Ps97Cg47-Pg1-Ps98Cg47-Pg1-Ps99Cg47-Pg1-Ps100
Cg47-Pg1-Ps101Cg47-Pg1-Ps102Cg47-Pg1-Ps103Cg47-Pg1-Ps104
Cg47-Pg1-Ps105Cg47-Pg1-Ps106Cg47-Pg1-Ps107Cg47-Pg1-Ps108
Cg47-Pg1-Ps109Cg47-Pg1-Ps110Cg47-Pg1-Ps111Cg47-Pg1-Ps112
Cg47-Pg1-Ps113Cg47-Pg1-Ps114Cg47-Pg1-Ps115Cg47-Pg1-Ps116
Cg47-Pg1-Ps117Cg47-Pg1-Ps118Cg47-Pg1-Ps119Cg47-Pg1-Ps120
Cg47-Pg1-Ps121Cg47-Pg1-Ps122Cg47-Pg1-Ps123Cg47-Pg1-Ps124
Cg47-Pg1-Ps125Cg47-Pg1-Ps126Cg47-Pg1-Ps127Cg47-Pg1-Ps128
Cg47-Pg1-Ps129Cg47-Pg1-Ps130Cg47-Pg1-Ps131Cg47-Pg1-Ps132
Cg47-Pg1-Ps133Cg47-Pg1-Ps134Cg47-Pg1-Ps135Cg47-Pg1-Ps136
Cg47-Pg1-Ps137Cg47-Pg1-Ps138Cg47-Pg1-Ps139Cg47-Pg1-Ps140
Cg47-Pg1-Ps141Cg47-Pg1-Ps142Cg47-Pg1-Ps143Cg47-Pg1-Ps144
Cg47-Pg1-Ps145Cg47-Pg1-Ps146Cg47-Pg1-Ps147Cg47-Pg1-Ps148
Cg47-Pg1-Ps149Cg47-Pg1-Ps150Cg47-Pg1-Ps151Cg47-Pg1-Ps152
Cg47-Pg1-Ps153Cg47-Pg1-Ps154Cg47-Pg1-Ps155Cg47-Pg1-Ps156
Cg47-Pg1-Ps157Cg47-Pg1-Ps158Cg47-Pg1-Ps159Cg47-Pg1-Ps160
Cg47-Pg1-Ps161Cg47-Pg1-Ps162Cg47-Pg1-Ps163Cg47-Pg1-Ps164
Cg47-Pg1-Ps165Cg47-Pg1-Ps166Cg47-Pg1-Ps167Cg47-Pg1-Ps168
Cg47-Pg1-Ps169Cg47-Pg1-Ps170Cg47-Pg1-Ps171Cg47-Pg1-Ps172
Cg47-Pg1-Ps173Cg47-Pg1-Ps174Cg47-Pg1-Ps175Cg47-Pg1-Ps176
Cg47-Pg1-Ps177Cg47-Pg1-Ps178Cg47-Pg1-Ps179Cg47-Pg1-Ps180
Cg47-Pg1-Ps181Cg47-Pg1-Ps182Cg47-Pg1-Ps183Cg47-Pg1-Ps184
Cg47-Pg1-Ps185Cg47-Pg1-Ps186Cg47-Pg1-Ps187Cg47-Pg1-Ps188
Cg47-Pg1-Ps189Cg47-Pg1-Ps190Cg47-Pg1-Ps191Cg47-Pg1-Ps192
Cg47-Pg1-Ps193Cg47-Pg1-Ps194Cg47-Pg1-Ps195Cg47-Pg1-Ps196
Cg47-Pg1-Ps197Cg47-Pg1-Ps198Cg47-Pg1-Ps199Cg47-Pg1-Ps200
Cg47-Pg1-Ps201Cg47-Pg1-Ps202Cg47-Pg1-Ps203Cg47-Pg1-Ps204
Cg47-Pg1-Ps205Cg47-Pg1-Ps206Cg47-Pg1-Ps207Cg47-Pg1-Ps208
Cg47-Pg1-Ps209Cg47-Pg1-Ps210Cg47-Pg1-Ps211Cg47-Pg1-Ps212
Cg47-Pg1-Ps213Cg47-Pg1-Ps214Cg47-Pg1-Ps215Cg47-Pg1-Ps216
Cg47-Pg1-Ps217Cg47-Pg1-Ps218Cg47-Pg1-Ps219Cg47-Pg1-Ps220
Cg47-Pg1-Ps221Cg47-Pg1-Ps222Cg47-Pg1-Ps223Cg47-Pg1-Ps224
Cg47-Pg1-Ps225Cg47-Pg1-Ps226Cg47-Pg1-Ps227Cg47-Pg1-Ps228
Cg47-Pg1-Ps229Cg47-Pg1-Ps230Cg47-Pg1-Ps231Cg47-Pg1-Ps232
Cg47-Pg1-Ps233Cg47-Pg1-Ps234Cg47-Pg1-Ps235Cg47-Pg1-Ps236
Cg47-Pg1-Ps237Cg47-Pg1-Ps238Cg47-Pg1-Ps239Cg47-Pg1-Ps240
Cg47-Pg1-Ps241Cg47-Pg1-Ps242Cg47-Pg1-Ps243
Cg48-Pg1-Ps1Cg48-Pg1-Ps2Cg48-Pg1-Ps3Cg48-Pg1-Ps4
Cg48-Pg1-Ps5Cg48-Pg1-Ps6Cg48-Pg1-Ps7Cg48-Pg1-Ps8
Cg48-Pg1-Ps9Cg48-Pg1-Ps10Cg48-Pg1-Ps11Cg48-Pg1-Ps12
Cg48-Pg1-Ps13Cg48-Pg1-Ps14Cg48-Pg1-Ps15Cg48-Pg1-Ps16
Cg48-Pg1-Ps17Cg48-Pg1-Ps18Cg48-Pg1-Ps19Cg48-Pg1-Ps20
Cg48-Pg1-Ps21Cg48-Pg1-Ps22Cg48-Pg1-Ps23Cg48-Pg1-Ps24
Cg48-Pg1-Ps25Cg48-Pg1-Ps26Cg48-Pg1-Ps27Cg48-Pg1-Ps28
Cg48-Pg1-Ps29Cg48-Pg1-Ps30Cg48-Pg1-Ps31Cg48-Pg1-Ps32
Cg48-Pg1-Ps33Cg48-Pg1-Ps34Cg48-Pg1-Ps35Cg48-Pg1-Ps36
Cg48-Pg1-Ps37Cg48-Pg1-Ps38Cg48-Pg1-Ps39Cg48-Pg1-Ps40
Cg48-Pg1-Ps41Cg48-Pg1-Ps42Cg48-Pg1-Ps43Cg48-Pg1-Ps44
Cg48-Pg1-Ps45Cg48-Pg1-Ps46Cg48-Pg1-Ps47Cg48-Pg1-Ps48
Cg48-Pg1-Ps49Cg48-Pg1-Ps50Cg48-Pg1-Ps51Cg48-Pg1-Ps52
Cg48-Pg1-Ps53Cg48-Pg1-Ps54Cg48-Pg1-Ps55Cg48-Pg1-Ps56
Cg48-Pg1-Ps57Cg48-Pg1-Ps58Cg48-Pg1-Ps59Cg48-Pg1-Ps60
Cg48-Pg1-Ps61Cg48-Pg1-Ps62Cg48-Pg1-Ps63Cg48-Pg1-Ps64
Cg48-Pg1-Ps65Cg48-Pg1-Ps66Cg48-Pg1-Ps67Cg48-Pg1-Ps68
Cg48-Pg1-Ps69Cg48-Pg1-Ps70Cg48-Pg1-Ps71Cg48-Pg1-Ps72
Cg48-Pg1-Ps73Cg48-Pg1-Ps74Cg48-Pg1-Ps75Cg48-Pg1-Ps76
Cg48-Pg1-Ps77Cg48-Pg1-Ps78Cg48-Pg1-Ps79Cg48-Pg1-Ps80
Cg48-Pg1-Ps81Cg48-Pg1-Ps82Cg48-Pg1-Ps83Cg48-Pg1-Ps84
Cg48-Pg1-Ps85Cg48-Pg1-Ps86Cg48-Pg1-Ps87Cg48-Pg1-Ps88
Cg48-Pg1-Ps89Cg48-Pg1-Ps90Cg48-Pg1-Ps91Cg48-Pg1-Ps92
Cg48-Pg1-Ps93Cg48-Pg1-Ps94Cg48-Pg1-Ps95Cg48-Pg1-Ps96
Cg48-Pg1-Ps97Cg48-Pg1-Ps98Cg48-Pg1-Ps99Cg48-Pg1-Ps100
Cg48-Pg1-Ps101Cg48-Pg1-Ps102Cg48-Pg1-Ps103Cg48-Pg1-Ps104
Cg48-Pg1-Ps105Cg48-Pg1-Ps106Cg48-Pg1-Ps107Cg48-Pg1-Ps108
Cg48-Pg1-Ps109Cg48-Pg1-Ps110Cg48-Pg1-Ps111Cg48-Pg1-Ps112
Cg48-Pg1-Ps113Cg48-Pg1-Ps114Cg48-Pg1-Ps115Cg48-Pg1-Ps116
Cg48-Pg1-Ps117Cg48-Pg1-Ps118Cg48-Pg1-Ps119Cg48-Pg1-Ps120
Cg48-Pg1-Ps121Cg48-Pg1-Ps122Cg48-Pg1-Ps123Cg48-Pg1-Ps124
Cg48-Pg1-Ps125Cg48-Pg1-Ps126Cg48-Pg1-Ps127Cg48-Pg1-Ps128
Cg48-Pg1-Ps129Cg48-Pg1-Ps130Cg48-Pg1-Ps131Cg48-Pg1-Ps132
Cg48-Pg1-Ps133Cg48-Pg1-Ps134Cg48-Pg1-Ps135Cg48-Pg1-Ps136
Cg48-Pg1-Ps137Cg48-Pg1-Ps138Cg48-Pg1-Ps139Cg48-Pg1-Ps140
Cg48-Pg1-Ps141Cg48-Pg1-Ps142Cg48-Pg1-Ps143Cg48-Pg1-Ps144
Cg48-Pg1-Ps145Cg48-Pg1-Ps146Cg48-Pg1-Ps147Cg48-Pg1-Ps148
Cg48-Pg1-Ps149Cg48-Pg1-Ps150Cg48-Pg1-Ps151Cg48-Pg1-Ps152
Cg48-Pg1-Ps153Cg48-Pg1-Ps154Cg48-Pg1-Ps155Cg48-Pg1-Ps156
Cg48-Pg1-Ps157Cg48-Pg1-Ps158Cg48-Pg1-Ps159Cg48-Pg1-Ps160
Cg48-Pg1-Ps161Cg48-Pg1-Ps162Cg48-Pg1-Ps163Cg48-Pg1-Ps164
Cg48-Pg1-Ps165Cg48-Pg1-Ps166Cg48-Pg1-Ps167Cg48-Pg1-Ps168
Cg48-Pg1-Ps169Cg48-Pg1-Ps170Cg48-Pg1-Ps171Cg48-Pg1-Ps172
Cg48-Pg1-Ps173Cg48-Pg1-Ps174Cg48-Pg1-Ps175Cg48-Pg1-Ps176
Cg48-Pg1-Ps177Cg48-Pg1-Ps178Cg48-Pg1-Ps179Cg48-Pg1-Ps180
Cg48-Pg1-Ps181Cg48-Pg1-Ps182Cg48-Pg1-Ps183Cg48-Pg1-Ps184
Cg48-Pg1-Ps185Cg48-Pg1-Ps186Cg48-Pg1-Ps187Cg48-Pg1-Ps188
Cg48-Pg1-Ps189Cg48-Pg1-Ps190Cg48-Pg1-Ps191Cg48-Pg1-Ps192
Cg48-Pg1-Ps193Cg48-Pg1-Ps194Cg48-Pg1-Ps195Cg48-Pg1-Ps196
Cg48-Pg1-Ps197Cg48-Pg1-Ps198Cg48-Pg1-Ps199Cg48-Pg1-Ps200
Cg48-Pg1-Ps201Cg48-Pg1-Ps202Cg48-Pg1-Ps203Cg48-Pg1-Ps204
Cg48-Pg1-Ps205Cg48-Pg1-Ps206Cg48-Pg1-Ps207Cg48-Pg1-Ps208
Cg48-Pg1-Ps209Cg48-Pg1-Ps210Cg48-Pg1-Ps211Cg48-Pg1-Ps212
Cg48-Pg1-Ps213Cg48-Pg1-Ps214Cg48-Pg1-Ps215Cg48-Pg1-Ps216
Cg48-Pg1-Ps217Cg48-Pg1-Ps218Cg48-Pg1-Ps219Cg48-Pg1-Ps220
Cg48-Pg1-Ps221Cg48-Pg1-Ps222Cg48-Pg1-Ps223Cg48-Pg1-Ps224
Cg48-Pg1-Ps225Cg48-Pg1-Ps226Cg48-Pg1-Ps227Cg48-Pg1-Ps228
Cg48-Pg1-Ps229Cg48-Pg1-Ps230Cg48-Pg1-Ps231Cg48-Pg1-Ps232
Cg48-Pg1-Ps233Cg48-Pg1-Ps234Cg48-Pg1-Ps235Cg48-Pg1-Ps236
Cg48-Pg1-Ps237Cg48-Pg1-Ps238Cg48-Pg1-Ps239Cg48-Pg1-Ps240
Cg48-Pg1-Ps241Cg48-Pg1-Ps242Cg48-Pg1-Ps243
Cg49-Pg1-Ps1Cg49-Pg1-Ps2Cg49-Pg1-Ps3Cg49-Pg1-Ps4
Cg49-Pg1-Ps5Cg49-Pg1-Ps6Cg49-Pg1-Ps7Cg49-Pg1-Ps8
Cg49-Pg1-Ps9Cg49-Pg1-Ps10Cg49-Pg1-Ps11Cg49-Pg1-Ps12
Cg49-Pg1-Ps13Cg49-Pg1-Ps14Cg49-Pg1-Ps15Cg49-Pg1-Ps16
Cg49-Pg1-Ps17Cg49-Pg1-Ps18Cg49-Pg1-Ps19Cg49-Pg1-Ps20
Cg49-Pg1-Ps21Cg49-Pg1-Ps22Cg49-Pg1-Ps23Cg49-Pg1-Ps24
Cg49-Pg1-Ps25Cg49-Pg1-Ps26Cg49-Pg1-Ps27Cg49-Pg1-Ps28
Cg49-Pg1-Ps29Cg49-Pg1-Ps30Cg49-Pg1-Ps31Cg49-Pg1-Ps32
Cg49-Pg1-Ps33Cg49-Pg1-Ps34Cg49-Pg1-Ps35Cg49-Pg1-Ps36
Cg49-Pg1-Ps37Cg49-Pg1-Ps38Cg49-Pg1-Ps39Cg49-Pg1-Ps40
Cg49-Pg1-Ps41Cg49-Pg1-Ps42Cg49-Pg1-Ps43Cg49-Pg1-Ps44
Cg49-Pg1-Ps45Cg49-Pg1-Ps46Cg49-Pg1-Ps47Cg49-Pg1-Ps48
Cg49-Pg1-Ps49Cg49-Pg1-Ps50Cg49-Pg1-Ps51Cg49-Pg1-Ps52
Cg49-Pg1-Ps53Cg49-Pg1-Ps54Cg49-Pg1-Ps55Cg49-Pg1-Ps56
Cg49-Pg1-Ps57Cg49-Pg1-Ps58Cg49-Pg1-Ps59Cg49-Pg1-Ps60
Cg49-Pg1-Ps61Cg49-Pg1-Ps62Cg49-Pg1-Ps63Cg49-Pg1-Ps64
Cg49-Pg1-Ps65Cg49-Pg1-Ps66Cg49-Pg1-Ps67Cg49-Pg1-Ps68
Cg49-Pg1-Ps69Cg49-Pg1-Ps70Cg49-Pg1-Ps71Cg49-Pg1-Ps72
Cg49-Pg1-Ps73Cg49-Pg1-Ps74Cg49-Pg1-Ps75Cg49-Pg1-Ps76
Cg49-Pg1-Ps77Cg49-Pg1-Ps78Cg49-Pg1-Ps79Cg49-Pg1-Ps80
Cg49-Pg1-Ps81Cg49-Pg1-Ps82Cg49-Pg1-Ps83Cg49-Pg1-Ps84
Cg49-Pg1-Ps85Cg49-Pg1-Ps86Cg49-Pg1-Ps87Cg49-Pg1-Ps88
Cg49-Pg1-Ps89Cg49-Pg1-Ps90Cg49-Pg1-Ps91Cg49-Pg1-Ps92
Cg49-Pg1-Ps93Cg49-Pg1-Ps94Cg49-Pg1-Ps95Cg49-Pg1-Ps96
Cg49-Pg1-Ps97Cg49-Pg1-Ps98Cg49-Pg1-Ps99Cg49-Pg1-Ps100
Cg49-Pg1-Ps101Cg49-Pg1-Ps102Cg49-Pg1-Ps103Cg49-Pg1-Ps104
Cg49-Pg1-Ps105Cg49-Pg1-Ps106Cg49-Pg1-Ps107Cg49-Pg1-Ps108
Cg49-Pg1-Ps109Cg49-Pg1-Ps110Cg49-Pg1-Ps111Cg49-Pg1-Ps112
Cg49-Pg1-Ps113Cg49-Pg1-Ps114Cg49-Pg1-Ps115Cg49-Pg1-Ps116
Cg49-Pg1-Ps117Cg49-Pg1-Ps118Cg49-Pg1-Ps119Cg49-Pg1-Ps120
Cg49-Pg1-Ps121Cg49-Pg1-Ps122Cg49-Pg1-Ps123Cg49-Pg1-Ps124
Cg49-Pg1-Ps125Cg49-Pg1-Ps126Cg49-Pg1-Ps127Cg49-Pg1-Ps128
Cg49-Pg1-Ps129Cg49-Pg1-Ps130Cg49-Pg1-Ps131Cg49-Pg1-Ps132
Cg49-Pg1-Ps133Cg49-Pg1-Ps134Cg49-Pg1-Ps135Cg49-Pg1-Ps136
Cg49-Pg1-Ps137Cg49-Pg1-Ps138Cg49-Pg1-Ps139Cg49-Pg1-Ps140
Cg49-Pg1-Ps141Cg49-Pg1-Ps142Cg49-Pg1-Ps143Cg49-Pg1-Ps144
Cg49-Pg1-Ps145Cg49-Pg1-Ps146Cg49-Pg1-Ps147Cg49-Pg1-Ps148
Cg49-Pg1-Ps149Cg49-Pg1-Ps150Cg49-Pg1-Ps151Cg49-Pg1-Ps152
Cg49-Pg1-Ps153Cg49-Pg1-Ps154Cg49-Pg1-Ps155Cg49-Pg1-Ps156
Cg49-Pg1-Ps157Cg49-Pg1-Ps158Cg49-Pg1-Ps159Cg49-Pg1-Ps160
Cg49-Pg1-Ps161Cg49-Pg1-Ps162Cg49-Pg1-Ps163Cg49-Pg1-Ps164
Cg49-Pg1-Ps165Cg49-Pg1-Ps166Cg49-Pg1-Ps167Cg49-Pg1-Ps168
Cg49-Pg1-Ps169Cg49-Pg1-Ps170Cg49-Pg1-Ps171Cg49-Pg1-Ps172
Cg49-Pg1-Ps173Cg49-Pg1-Ps174Cg49-Pg1-Ps175Cg49-Pg1-Ps176
Cg49-Pg1-Ps177Cg49-Pg1-Ps178Cg49-Pg1-Ps179Cg49-Pg1-Ps180
Cg49-Pg1-Ps181Cg49-Pg1-Ps182Cg49-Pg1-Ps183Cg49-Pg1-Ps184
Cg49-Pg1-Ps185Cg49-Pg1-Ps186Cg49-Pg1-Ps187Cg49-Pg1-Ps188
Cg49-Pg1-Ps189Cg49-Pg1-Ps190Cg49-Pg1-Ps191Cg49-Pg1-Ps192
Cg49-Pg1-Ps193Cg49-Pg1-Ps194Cg49-Pg1-Ps195Cg49-Pg1-Ps196
Cg49-Pg1-Ps197Cg49-Pg1-Ps198Cg49-Pg1-Ps199Cg49-Pg1-Ps200
Cg49-Pg1-Ps201Cg49-Pg1-Ps202Cg49-Pg1-Ps203Cg49-Pg1-Ps204
Cg49-Pg1-Ps205Cg49-Pg1-Ps206Cg49-Pg1-Ps207Cg49-Pg1-Ps208
Cg49-Pg1-Ps209Cg49-Pg1-Ps210Cg49-Pg1-Ps211Cg49-Pg1-Ps212
Cg49-Pg1-Ps213Cg49-Pg1-Ps214Cg49-Pg1-Ps215Cg49-Pg1-Ps216
Cg49-Pg1-Ps217Cg49-Pg1-Ps218Cg49-Pg1-Ps219Cg49-Pg1-Ps220
Cg49-Pg1-Ps221Cg49-Pg1-Ps222Cg49-Pg1-Ps223Cg49-Pg1-Ps224
Cg49-Pg1-Ps225Cg49-Pg1-Ps226Cg49-Pg1-Ps227Cg49-Pg1-Ps228
Cg49-Pg1-Ps229Cg49-Pg1-Ps230Cg49-Pg1-Ps231Cg49-Pg1-Ps232
Cg49-Pg1-Ps233Cg49-Pg1-Ps234Cg49-Pg1-Ps235Cg49-Pg1-Ps236
Cg49-Pg1-Ps237Cg49-Pg1-Ps238Cg49-Pg1-Ps239Cg49-Pg1-Ps240
Cg49-Pg1-Ps241Cg49-Pg1-Ps242Cg49-Pg1-Ps243
Cg50-Pg1-Ps1Cg50-Pg1-Ps2Cg50-Pg1-Ps3Cg50-Pg1-Ps4
Cg50-Pg1-Ps5Cg50-Pg1-Ps6Cg50-Pg1-Ps7Cg50-Pg1-Ps8
Cg50-Pg1-Ps9Cg50-Pg1-Ps10Cg50-Pg1-Ps11Cg50-Pg1-Ps12
Cg50-Pg1-Ps13Cg50-Pg1-Ps14Cg50-Pg1-Ps15Cg50-Pg1-Ps16
Cg50-Pg1-Ps17Cg50-Pg1-Ps18Cg50-Pg1-Ps19Cg50-Pg1-Ps20
Cg50-Pg1-Ps21Cg50-Pg1-Ps22Cg50-Pg1-Ps23Cg50-Pg1-Ps24
Cg50-Pg1-Ps25Cg50-Pg1-Ps26Cg50-Pg1-Ps27Cg50-Pg1-Ps28
Cg50-Pg1-Ps29Cg50-Pg1-Ps30Cg50-Pg1-Ps31Cg50-Pg1-Ps32
Cg50-Pg1-Ps33Cg50-Pg1-Ps34Cg50-Pg1-Ps35Cg50-Pg1-Ps36
Cg50-Pg1-Ps37Cg50-Pg1-Ps38Cg50-Pg1-Ps39Cg50-Pg1-Ps40
Cg50-Pg1-Ps41Cg50-Pg1-Ps42Cg50-Pg1-Ps43Cg50-Pg1-Ps44
Cg50-Pg1-Ps45Cg50-Pg1-Ps46Cg50-Pg1-Ps47Cg50-Pg1-Ps48
Cg50-Pg1-Ps49Cg50-Pg1-Ps50Cg50-Pg1-Ps51Cg50-Pg1-Ps52
Cg50-Pg1-Ps53Cg50-Pg1-Ps54Cg50-Pg1-Ps55Cg50-Pg1-Ps56
Cg50-Pg1-Ps57Cg50-Pg1-Ps58Cg50-Pg1-Ps59Cg50-Pg1-Ps60
Cg50-Pg1-Ps61Cg50-Pg1-Ps62Cg50-Pg1-Ps63Cg50-Pg1-Ps64
Cg50-Pg1-Ps65Cg50-Pg1-Ps66Cg50-Pg1-Ps67Cg50-Pg1-Ps68
Cg50-Pg1-Ps69Cg50-Pg1-Ps70Cg50-Pg1-Ps71Cg50-Pg1-Ps72
Cg50-Pg1-Ps73Cg50-Pg1-Ps74Cg50-Pg1-Ps75Cg50-Pg1-Ps76
Cg50-Pg1-Ps77Cg50-Pg1-Ps78Cg50-Pg1-Ps79Cg50-Pg1-Ps80
Cg50-Pg1-Ps81Cg50-Pg1-Ps82Cg50-Pg1-Ps83Cg50-Pg1-Ps84
Cg50-Pg1-Ps85Cg50-Pg1-Ps86Cg50-Pg1-Ps87Cg50-Pg1-Ps88
Cg50-Pg1-Ps89Cg50-Pg1-Ps90Cg50-Pg1-Ps91Cg50-Pg1-Ps92
Cg50-Pg1-Ps93Cg50-Pg1-Ps94Cg50-Pg1-Ps95Cg50-Pg1-Ps96
Cg50-Pg1-Ps97Cg50-Pg1-Ps98Cg50-Pg1-Ps99Cg50-Pg1-Ps100
Cg50-Pg1-Ps101Cg50-Pg1-Ps102Cg50-Pg1-Ps103Cg50-Pg1-Ps104
Cg50-Pg1-Ps105Cg50-Pg1-Ps106Cg50-Pg1-Ps107Cg50-Pg1-Ps108
Cg50-Pg1-Ps109Cg50-Pg1-Ps110Cg50-Pg1-Ps111Cg50-Pg1-Ps112
Cg50-Pg1-Ps113Cg50-Pg1-Ps114Cg50-Pg1-Ps115Cg50-Pg1-Ps116
Cg50-Pg1-Ps117Cg50-Pg1-Ps118Cg50-Pg1-Ps119Cg50-Pg1-Ps120
Cg50-Pg1-Ps121Cg50-Pg1-Ps122Cg50-Pg1-Ps123Cg50-Pg1-Ps124
Cg50-Pg1-Ps125Cg50-Pg1-Ps126Cg50-Pg1-Ps127Cg50-Pg1-Ps128
Cg50-Pg1-Ps129Cg50-Pg1-Ps130Cg50-Pg1-Ps131Cg50-Pg1-Ps132
Cg50-Pg1-Ps133Cg50-Pg1-Ps134Cg50-Pg1-Ps135Cg50-Pg1-Ps136
Cg50-Pg1-Ps137Cg50-Pg1-Ps138Cg50-Pg1-Ps139Cg50-Pg1-Ps140
Cg50-Pg1-Ps141Cg50-Pg1-Ps142Cg50-Pg1-Ps143Cg50-Pg1-Ps144
Cg50-Pg1-Ps145Cg50-Pg1-Ps146Cg50-Pg1-Ps147Cg50-Pg1-Ps148
Cg50-Pg1-Ps149Cg50-Pg1-Ps150Cg50-Pg1-Ps151Cg50-Pg1-Ps152
Cg50-Pg1-Ps153Cg50-Pg1-Ps154Cg50-Pg1-Ps155Cg50-Pg1-Ps156
Cg50-Pg1-Ps157Cg50-Pg1-Ps158Cg50-Pg1-Ps159Cg50-Pg1-Ps160
Cg50-Pg1-Ps161Cg50-Pg1-Ps162Cg50-Pg1-Ps163Cg50-Pg1-Ps164
Cg50-Pg1-Ps165Cg50-Pg1-Ps166Cg50-Pg1-Ps167Cg50-Pg1-Ps168
Cg50-Pg1-Ps169Cg50-Pg1-Ps170Cg50-Pg1-Ps171Cg50-Pg1-Ps172
Cg50-Pg1-Ps173Cg50-Pg1-Ps174Cg50-Pg1-Ps175Cg50-Pg1-Ps176
Cg50-Pg1-Ps177Cg50-Pg1-Ps178Cg50-Pg1-Ps179Cg50-Pg1-Ps180
Cg50-Pg1-Ps181Cg50-Pg1-Ps182Cg50-Pg1-Ps183Cg50-Pg1-Ps184
Cg50-Pg1-Ps185Cg50-Pg1-Ps186Cg50-Pg1-Ps187Cg50-Pg1-Ps188
Cg50-Pg1-Ps189Cg50-Pg1-Ps190Cg50-Pg1-Ps191Cg50-Pg1-Ps192
Cg50-Pg1-Ps193Cg50-Pg1-Ps194Cg50-Pg1-Ps195Cg50-Pg1-Ps196
Cg50-Pg1-Ps197Cg50-Pg1-Ps198Cg50-Pg1-Ps199Cg50-Pg1-Ps200
Cg50-Pg1-Ps201Cg50-Pg1-Ps202Cg50-Pg1-Ps203Cg50-Pg1-Ps204
Cg50-Pg1-Ps205Cg50-Pg1-Ps206Cg50-Pg1-Ps207Cg50-Pg1-Ps208
Cg50-Pg1-Ps209Cg50-Pg1-Ps210Cg50-Pg1-Ps211Cg50-Pg1-Ps212
Cg50-Pg1-Ps213Cg50-Pg1-Ps214Cg50-Pg1-Ps215Cg50-Pg1-Ps216
Cg50-Pg1-Ps217Cg50-Pg1-Ps218Cg50-Pg1-Ps219Cg50-Pg1-Ps220
Cg50-Pg1-Ps221Cg50-Pg1-Ps222Cg50-Pg1-Ps223Cg50-Pg1-Ps224
Cg50-Pg1-Ps225Cg50-Pg1-Ps226Cg50-Pg1-Ps227Cg50-Pg1-Ps228
Cg50-Pg1-Ps229Cg50-Pg1-Ps230Cg50-Pg1-Ps231Cg50-Pg1-Ps232
Cg50-Pg1-Ps233Cg50-Pg1-Ps234Cg50-Pg1-Ps235Cg50-Pg1-Ps236
Cg50-Pg1-Ps237Cg50-Pg1-Ps238Cg50-Pg1-Ps239Cg50-Pg1-Ps240
Cg50-Pg1-Ps241Cg50-Pg1-Ps242Cg50-Pg1-Ps243
Cg51-Pg1-Ps1Cg51-Pg1-Ps2Cg51-Pg1-Ps3Cg51-Pg1-Ps4
Cg51-Pg1-Ps5Cg51-Pg1-Ps6Cg51-Pg1-Ps7Cg51-Pg1-Ps8
Cg51-Pg1-Ps9Cg51-Pg1-Ps10Cg51-Pg1-Ps11Cg51-Pg1-Ps12
Cg51-Pg1-Ps13Cg51-Pg1-Ps14Cg51-Pg1-Ps15Cg51-Pg1-Ps16
Cg51-Pg1-Ps17Cg51-Pg1-Ps18Cg51-Pg1-Ps19Cg51-Pg1-Ps20
Cg51-Pg1-Ps21Cg51-Pg1-Ps22Cg51-Pg1-Ps23Cg51-Pg1-Ps24
Cg51-Pg1-Ps25Cg51-Pg1-Ps26Cg51-Pg1-Ps27Cg51-Pg1-Ps28
Cg51-Pg1-Ps29Cg51-Pg1-Ps30Cg51-Pg1-Ps31Cg51-Pg1-Ps32
Cg51-Pg1-Ps33Cg51-Pg1-Ps34Cg51-Pg1-Ps35Cg51-Pg1-Ps36
Cg51-Pg1-Ps37Cg51-Pg1-Ps38Cg51-Pg1-Ps39Cg51-Pg1-Ps40
Cg51-Pg1-Ps41Cg51-Pg1-Ps42Cg51-Pg1-Ps43Cg51-Pg1-Ps44
Cg51-Pg1-Ps45Cg51-Pg1-Ps46Cg51-Pg1-Ps47Cg51-Pg1-Ps48
Cg51-Pg1-Ps49Cg51-Pg1-Ps50Cg51-Pg1-Ps51Cg51-Pg1-Ps52
Cg51-Pg1-Ps53Cg51-Pg1-Ps54Cg51-Pg1-Ps55Cg51-Pg1-Ps56
Cg51-Pg1-Ps57Cg51-Pg1-Ps58Cg51-Pg1-Ps59Cg51-Pg1-Ps60
Cg51-Pg1-Ps61Cg51-Pg1-Ps62Cg51-Pg1-Ps63Cg51-Pg1-Ps64
Cg51-Pg1-Ps65Cg51-Pg1-Ps66Cg51-Pg1-Ps67Cg51-Pg1-Ps68
Cg51-Pg1-Ps69Cg51-Pg1-Ps70Cg51-Pg1-Ps71Cg51-Pg1-Ps72
Cg51-Pg1-Ps73Cg51-Pg1-Ps74Cg51-Pg1-Ps75Cg51-Pg1-Ps76
Cg51-Pg1-Ps77Cg51-Pg1-Ps78Cg51-Pg1-Ps79Cg51-Pg1-Ps80
Cg51-Pg1-Ps81Cg51-Pg1-Ps82Cg51-Pg1-Ps83Cg51-Pg1-Ps84
Cg51-Pg1-Ps85Cg51-Pg1-Ps86Cg51-Pg1-Ps87Cg51-Pg1-Ps88
Cg51-Pg1-Ps89Cg51-Pg1-Ps90Cg51-Pg1-Ps91Cg51-Pg1-Ps92
Cg51-Pg1-Ps93Cg51-Pg1-Ps94Cg51-Pg1-Ps95Cg51-Pg1-Ps96
Cg51-Pg1-Ps97Cg51-Pg1-Ps98Cg51-Pg1-Ps99Cg51-Pg1-Ps100
Cg51-Pg1-Ps101Cg51-Pg1-Ps102Cg51-Pg1-Ps103Cg51-Pg1-Ps104
Cg51-Pg1-Ps105Cg51-Pg1-Ps106Cg51-Pg1-Ps107Cg51-Pg1-Ps108
Cg51-Pg1-Ps109Cg51-Pg1-Ps110Cg51-Pg1-Ps111Cg51-Pg1-Ps112
Cg51-Pg1-Ps113Cg51-Pg1-Ps114Cg51-Pg1-Ps115Cg51-Pg1-Ps116
Cg51-Pg1-Ps117Cg51-Pg1-Ps118Cg51-Pg1-Ps119Cg51-Pg1-Ps120
Cg51-Pg1-Ps121Cg51-Pg1-Ps122Cg51-Pg1-Ps123Cg51-Pg1-Ps124
Cg51-Pg1-Ps125Cg51-Pg1-Ps126Cg51-Pg1-Ps127Cg51-Pg1-Ps128
Cg51-Pg1-Ps129Cg51-Pg1-Ps130Cg51-Pg1-Ps131Cg51-Pg1-Ps132
Cg51-Pg1-Ps133Cg51-Pg1-Ps134Cg51-Pg1-Ps135Cg51-Pg1-Ps136
Cg51-Pg1-Ps137Cg51-Pg1-Ps138Cg51-Pg1-Ps139Cg51-Pg1-Ps140
Cg51-Pg1-Ps141Cg51-Pg1-Ps142Cg51-Pg1-Ps143Cg51-Pg1-Ps144
Cg51-Pg1-Ps145Cg51-Pg1-Ps146Cg51-Pg1-Ps147Cg51-Pg1-Ps148
Cg51-Pg1-Ps149Cg51-Pg1-Ps150Cg51-Pg1-Ps151Cg51-Pg1-Ps152
Cg51-Pg1-Ps153Cg51-Pg1-Ps154Cg51-Pg1-Ps155Cg51-Pg1-Ps156
Cg51-Pg1-Ps157Cg51-Pg1-Ps158Cg51-Pg1-Ps159Cg51-Pg1-Ps160
Cg51-Pg1-Ps161Cg51-Pg1-Ps162Cg51-Pg1-Ps163Cg51-Pg1-Ps164
Cg51-Pg1-Ps165Cg51-Pg1-Ps166Cg51-Pg1-Ps167Cg51-Pg1-Ps168
Cg51-Pg1-Ps169Cg51-Pg1-Ps170Cg51-Pg1-Ps171Cg51-Pg1-Ps172
Cg51-Pg1-Ps173Cg51-Pg1-Ps174Cg51-Pg1-Ps175Cg51-Pg1-Ps176
Cg51-Pg1-Ps177Cg51-Pg1-Ps178Cg51-Pg1-Ps179Cg51-Pg1-Ps180
Cg51-Pg1-Ps181Cg51-Pg1-Ps182Cg51-Pg1-Ps183Cg51-Pg1-Ps184
Cg51-Pg1-Ps185Cg51-Pg1-Ps186Cg51-Pg1-Ps187Cg51-Pg1-Ps188
Cg51-Pg1-Ps189Cg51-Pg1-Ps190Cg51-Pg1-Ps191Cg51-Pg1-Ps192
Cg51-Pg1-Ps193Cg51-Pg1-Ps194Cg51-Pg1-Ps195Cg51-Pg1-Ps196
Cg51-Pg1-Ps197Cg51-Pg1-Ps198Cg51-Pg1-Ps199Cg51-Pg1-Ps200
Cg51-Pg1-Ps201Cg51-Pg1-Ps202Cg51-Pg1-Ps203Cg51-Pg1-Ps204
Cg51-Pg1-Ps205Cg51-Pg1-Ps206Cg51-Pg1-Ps207Cg51-Pg1-Ps208
Cg51-Pg1-Ps209Cg51-Pg1-Ps210Cg51-Pg1-Ps211Cg51-Pg1-Ps212
Cg51-Pg1-Ps213Cg51-Pg1-Ps214Cg51-Pg1-Ps215Cg51-Pg1-Ps216
Cg51-Pg1-Ps217Cg51-Pg1-Ps218Cg51-Pg1-Ps219Cg51-Pg1-Ps220
Cg51-Pg1-Ps221Cg51-Pg1-Ps222Cg51-Pg1-Ps223Cg51-Pg1-Ps224
Cg51-Pg1-Ps225Cg51-Pg1-Ps226Cg51-Pg1-Ps227Cg51-Pg1-Ps228
Cg51-Pg1-Ps229Cg51-Pg1-Ps230Cg51-Pg1-Ps231Cg51-Pg1-Ps232
Cg51-Pg1-Ps233Cg51-Pg1-Ps234Cg51-Pg1-Ps235Cg51-Pg1-Ps236
Cg51-Pg1-Ps237Cg51-Pg1-Ps238Cg51-Pg1-Ps239Cg51-Pg1-Ps240
Cg51-Pg1-Ps241Cg51-Pg1-Ps242Cg51-Pg1-Ps243
Cg52-Pg1-Ps1Cg52-Pg1-Ps2Cg52-Pg1-Ps3Cg52-Pg1-Ps4
Cg52-Pg1-Ps5Cg52-Pg1-Ps6Cg52-Pg1-Ps7Cg52-Pg1-Ps8
Cg52-Pg1-Ps9Cg52-Pg1-Ps10Cg52-Pg1-Ps11Cg52-Pg1-Ps12
Cg52-Pg1-Ps13Cg52-Pg1-Ps14Cg52-Pg1-Ps15Cg52-Pg1-Ps16
Cg52-Pg1-Ps17Cg52-Pg1-Ps18Cg52-Pg1-Ps19Cg52-Pg1-Ps20
Cg52-Pg1-Ps21Cg52-Pg1-Ps22Cg52-Pg1-Ps23Cg52-Pg1-Ps24
Cg52-Pg1-Ps25Cg52-Pg1-Ps26Cg52-Pg1-Ps27Cg52-Pg1-Ps28
Cg52-Pg1-Ps29Cg52-Pg1-Ps30Cg52-Pg1-Ps31Cg52-Pg1-Ps32
Cg52-Pg1-Ps33Cg52-Pg1-Ps34Cg52-Pg1-Ps35Cg52-Pg1-Ps36
Cg52-Pg1-Ps37Cg52-Pg1-Ps38Cg52-Pg1-Ps39Cg52-Pg1-Ps40
Cg52-Pg1-Ps41Cg52-Pg1-Ps42Cg52-Pg1-Ps43Cg52-Pg1-Ps44
Cg52-Pg1-Ps45Cg52-Pg1-Ps46Cg52-Pg1-Ps47Cg52-Pg1-Ps48
Cg52-Pg1-Ps49Cg52-Pg1-Ps50Cg52-Pg1-Ps51Cg52-Pg1-Ps52
Cg52-Pg1-Ps53Cg52-Pg1-Ps54Cg52-Pg1-Ps55Cg52-Pg1-Ps56
Cg52-Pg1-Ps57Cg52-Pg1-Ps58Cg52-Pg1-Ps59Cg52-Pg1-Ps60
Cg52-Pg1-Ps61Cg52-Pg1-Ps62Cg52-Pg1-Ps63Cg52-Pg1-Ps64
Cg52-Pg1-Ps65Cg52-Pg1-Ps66Cg52-Pg1-Ps67Cg52-Pg1-Ps68
Cg52-Pg1-Ps69Cg52-Pg1-Ps70Cg52-Pg1-Ps71Cg52-Pg1-Ps72
Cg52-Pg1-Ps73Cg52-Pg1-Ps74Cg52-Pg1-Ps75Cg52-Pg1-Ps76
Cg52-Pg1-Ps77Cg52-Pg1-Ps78Cg52-Pg1-Ps79Cg52-Pg1-Ps80
Cg52-Pg1-Ps81Cg52-Pg1-Ps82Cg52-Pg1-Ps83Cg52-Pg1-Ps84
Cg52-Pg1-Ps85Cg52-Pg1-Ps86Cg52-Pg1-Ps87Cg52-Pg1-Ps88
Cg52-Pg1-Ps89Cg52-Pg1-Ps90Cg52-Pg1-Ps91Cg52-Pg1-Ps92
Cg52-Pg1-Ps93Cg52-Pg1-Ps94Cg52-Pg1-Ps95Cg52-Pg1-Ps96
Cg52-Pg1-Ps97Cg52-Pg1-Ps98Cg52-Pg1-Ps99Cg52-Pg1-Ps100
Cg52-Pg1-Ps101Cg52-Pg1-Ps102Cg52-Pg1-Ps103Cg52-Pg1-Ps104
Cg52-Pg1-Ps105Cg52-Pg1-Ps106Cg52-Pg1-Ps107Cg52-Pg1-Ps108
Cg52-Pg1-Ps109Cg52-Pg1-Ps110Cg52-Pg1-Ps111Cg52-Pg1-Ps112
Cg52-Pg1-Ps113Cg52-Pg1-Ps114Cg52-Pg1-Ps115Cg52-Pg1-Ps116
Cg52-Pg1-Ps117Cg52-Pg1-Ps118Cg52-Pg1-Ps119Cg52-Pg1-Ps120
Cg52-Pg1-Ps121Cg52-Pg1-Ps122Cg52-Pg1-Ps123Cg52-Pg1-Ps124
Cg52-Pg1-Ps125Cg52-Pg1-Ps126Cg52-Pg1-Ps127Cg52-Pg1-Ps128
Cg52-Pg1-Ps129Cg52-Pg1-Ps130Cg52-Pg1-Ps131Cg52-Pg1-Ps132
Cg52-Pg1-Ps133Cg52-Pg1-Ps134Cg52-Pg1-Ps135Cg52-Pg1-Ps136
Cg52-Pg1-Ps137Cg52-Pg1-Ps138Cg52-Pg1-Ps139Cg52-Pg1-Ps140
Cg52-Pg1-Ps141Cg52-Pg1-Ps142Cg52-Pg1-Ps143Cg52-Pg1-Ps144
Cg52-Pg1-Ps145Cg52-Pg1-Ps146Cg52-Pg1-Ps147Cg52-Pg1-Ps148
Cg52-Pg1-Ps149Cg52-Pg1-Ps150Cg52-Pg1-Ps151Cg52-Pg1-Ps152
Cg52-Pg1-Ps153Cg52-Pg1-Ps154Cg52-Pg1-Ps155Cg52-Pg1-Ps156
Cg52-Pg1-Ps157Cg52-Pg1-Ps158Cg52-Pg1-Ps159Cg52-Pg1-Ps160
Cg52-Pg1-Ps161Cg52-Pg1-Ps162Cg52-Pg1-Ps163Cg52-Pg1-Ps164
Cg52-Pg1-Ps165Cg52-Pg1-Ps166Cg52-Pg1-Ps167Cg52-Pg1-Ps168
Cg52-Pg1-Ps169Cg52-Pg1-Ps170Cg52-Pg1-Ps171Cg52-Pg1-Ps172
Cg52-Pg1-Ps173Cg52-Pg1-Ps174Cg52-Pg1-Ps175Cg52-Pg1-Ps176
Cg52-Pg1-Ps177Cg52-Pg1-Ps178Cg52-Pg1-Ps179Cg52-Pg1-Ps180
Cg52-Pg1-Ps181Cg52-Pg1-Ps182Cg52-Pg1-Ps183Cg52-Pg1-Ps184
Cg52-Pg1-Ps185Cg52-Pg1-Ps186Cg52-Pg1-Ps187Cg52-Pg1-Ps188
Cg52-Pg1-Ps189Cg52-Pg1-Ps190Cg52-Pg1-Ps191Cg52-Pg1-Ps192
Cg52-Pg1-Ps193Cg52-Pg1-Ps194Cg52-Pg1-Ps195Cg52-Pg1-Ps196
Cg52-Pg1-Ps197Cg52-Pg1-Ps198Cg52-Pg1-Ps199Cg52-Pg1-Ps200
Cg52-Pg1-Ps201Cg52-Pg1-Ps202Cg52-Pg1-Ps203Cg52-Pg1-Ps204
Cg52-Pg1-Ps205Cg52-Pg1-Ps206Cg52-Pg1-Ps207Cg52-Pg1-Ps208
Cg52-Pg1-Ps209Cg52-Pg1-Ps210Cg52-Pg1-Ps211Cg52-Pg1-Ps212
Cg52-Pg1-Ps213Cg52-Pg1-Ps214Cg52-Pg1-Ps215Cg52-Pg1-Ps216
Cg52-Pg1-Ps217Cg52-Pg1-Ps218Cg52-Pg1-Ps219Cg52-Pg1-Ps220
Cg52-Pg1-Ps221Cg52-Pg1-Ps222Cg52-Pg1-Ps223Cg52-Pg1-Ps224
Cg52-Pg1-Ps225Cg52-Pg1-Ps226Cg52-Pg1-Ps227Cg52-Pg1-Ps228
Cg52-Pg1-Ps229Cg52-Pg1-Ps230Cg52-Pg1-Ps231Cg52-Pg1-Ps232
Cg52-Pg1-Ps233Cg52-Pg1-Ps234Cg52-Pg1-Ps235Cg52-Pg1-Ps236
Cg52-Pg1-Ps237Cg52-Pg1-Ps238Cg52-Pg1-Ps239Cg52-Pg1-Ps240
Cg52-Pg1-Ps241Cg52-Pg1-Ps242Cg52-Pg1-Ps243
Cg53-Pg1-Ps1Cg53-Pg1-Ps2Cg53-Pg1-Ps3Cg53-Pg1-Ps4
Cg53-Pg1-Ps5Cg53-Pg1-Ps6Cg53-Pg1-Ps7Cg53-Pg1-Ps8
Cg53-Pg1-Ps9Cg53-Pg1-Ps10Cg53-Pg1-Ps11Cg53-Pg1-Ps12
Cg53-Pg1-Ps13Cg53-Pg1-Ps14Cg53-Pg1-Ps15Cg53-Pg1-Ps16
Cg53-Pg1-Ps17Cg53-Pg1-Ps18Cg53-Pg1-Ps19Cg53-Pg1-Ps20
Cg53-Pg1-Ps21Cg53-Pg1-Ps22Cg53-Pg1-Ps23Cg53-Pg1-Ps24
Cg53-Pg1-Ps25Cg53-Pg1-Ps26Cg53-Pg1-Ps27Cg53-Pg1-Ps28
Cg53-Pg1-Ps29Cg53-Pg1-Ps30Cg53-Pg1-Ps31Cg53-Pg1-Ps32
Cg53-Pg1-Ps33Cg53-Pg1-Ps34Cg53-Pg1-Ps35Cg53-Pg1-Ps36
Cg53-Pg1-Ps37Cg53-Pg1-Ps38Cg53-Pg1-Ps39Cg53-Pg1-Ps40
Cg53-Pg1-Ps41Cg53-Pg1-Ps42Cg53-Pg1-Ps43Cg53-Pg1-Ps44
Cg53-Pg1-Ps45Cg53-Pg1-Ps46Cg53-Pg1-Ps47Cg53-Pg1-Ps48
Cg53-Pg1-Ps49Cg53-Pg1-Ps50Cg53-Pg1-Ps51Cg53-Pg1-Ps52
Cg53-Pg1-Ps53Cg53-Pg1-Ps54Cg53-Pg1-Ps55Cg53-Pg1-Ps56
Cg53-Pg1-Ps57Cg53-Pg1-Ps58Cg53-Pg1-Ps59Cg53-Pg1-Ps60
Cg53-Pg1-Ps61Cg53-Pg1-Ps62Cg53-Pg1-Ps63Cg53-Pg1-Ps64
Cg53-Pg1-Ps65Cg53-Pg1-Ps66Cg53-Pg1-Ps67Cg53-Pg1-Ps68
Cg53-Pg1-Ps69Cg53-Pg1-Ps70Cg53-Pg1-Ps71Cg53-Pg1-Ps72
Cg53-Pg1-Ps73Cg53-Pg1-Ps74Cg53-Pg1-Ps75Cg53-Pg1-Ps76
Cg53-Pg1-Ps77Cg53-Pg1-Ps78Cg53-Pg1-Ps79Cg53-Pg1-Ps80
Cg53-Pg1-Ps81Cg53-Pg1-Ps82Cg53-Pg1-Ps83Cg53-Pg1-Ps84
Cg53-Pg1-Ps85Cg53-Pg1-Ps86Cg53-Pg1-Ps87Cg53-Pg1-Ps88
Cg53-Pg1-Ps89Cg53-Pg1-Ps90Cg53-Pg1-Ps91Cg53-Pg1-Ps92
Cg53-Pg1-Ps93Cg53-Pg1-Ps94Cg53-Pg1-Ps95Cg53-Pg1-Ps96
Cg53-Pg1-Ps97Cg53-Pg1-Ps98Cg53-Pg1-Ps99Cg53-Pg1-Ps100
Cg53-Pg1-Ps101Cg53-Pg1-Ps102Cg53-Pg1-Ps103Cg53-Pg1-Ps104
Cg53-Pg1-Ps105Cg53-Pg1-Ps106Cg53-Pg1-Ps107Cg53-Pg1-Ps108
Cg53-Pg1-Ps109Cg53-Pg1-Ps110Cg53-Pg1-Ps111Cg53-Pg1-Ps112
Cg53-Pg1-Ps113Cg53-Pg1-Ps114Cg53-Pg1-Ps115Cg53-Pg1-Ps116
Cg53-Pg1-Ps117Cg53-Pg1-Ps118Cg53-Pg1-Ps119Cg53-Pg1-Ps120
Cg53-Pg1-Ps121Cg53-Pg1-Ps122Cg53-Pg1-Ps123Cg53-Pg1-Ps124
Cg53-Pg1-Ps125Cg53-Pg1-Ps126Cg53-Pg1-Ps127Cg53-Pg1-Ps128
Cg53-Pg1-Ps129Cg53-Pg1-Ps130Cg53-Pg1-Ps131Cg53-Pg1-Ps132
Cg53-Pg1-Ps133Cg53-Pg1-Ps134Cg53-Pg1-Ps135Cg53-Pg1-Ps136
Cg53-Pg1-Ps137Cg53-Pg1-Ps138Cg53-Pg1-Ps139Cg53-Pg1-Ps140
Cg53-Pg1-Ps141Cg53-Pg1-Ps142Cg53-Pg1-Ps143Cg53-Pg1-Ps144
Cg53-Pg1-Ps145Cg53-Pg1-Ps146Cg53-Pg1-Ps147Cg53-Pg1-Ps148
Cg53-Pg1-Ps149Cg53-Pg1-Ps150Cg53-Pg1-Ps151Cg53-Pg1-Ps152
Cg53-Pg1-Ps153Cg53-Pg1-Ps154Cg53-Pg1-Ps155Cg53-Pg1-Ps156
Cg53-Pg1-Ps157Cg53-Pg1-Ps158Cg53-Pg1-Ps159Cg53-Pg1-Ps160
Cg53-Pg1-Ps161Cg53-Pg1-Ps162Cg53-Pg1-Ps163Cg53-Pg1-Ps164
Cg53-Pg1-Ps165Cg53-Pg1-Ps166Cg53-Pg1-Ps167Cg53-Pg1-Ps168
Cg53-Pg1-Ps169Cg53-Pg1-Ps170Cg53-Pg1-Ps171Cg53-Pg1-Ps172
Cg53-Pg1-Ps173Cg53-Pg1-Ps174Cg53-Pg1-Ps175Cg53-Pg1-Ps176
Cg53-Pg1-Ps177Cg53-Pg1-Ps178Cg53-Pg1-Ps179Cg53-Pg1-Ps180
Cg53-Pg1-Ps181Cg53-Pg1-Ps182Cg53-Pg1-Ps183Cg53-Pg1-Ps184
Cg53-Pg1-Ps185Cg53-Pg1-Ps186Cg53-Pg1-Ps187Cg53-Pg1-Ps188
Cg53-Pg1-Ps189Cg53-Pg1-Ps190Cg53-Pg1-Ps191Cg53-Pg1-Ps192
Cg53-Pg1-Ps193Cg53-Pg1-Ps194Cg53-Pg1-Ps195Cg53-Pg1-Ps196
Cg53-Pg1-Ps197Cg53-Pg1-Ps198Cg53-Pg1-Ps199Cg53-Pg1-Ps200
Cg53-Pg1-Ps201Cg53-Pg1-Ps202Cg53-Pg1-Ps203Cg53-Pg1-Ps204
Cg53-Pg1-Ps205Cg53-Pg1-Ps206Cg53-Pg1-Ps207Cg53-Pg1-Ps208
Cg53-Pg1-Ps209Cg53-Pg1-Ps210Cg53-Pg1-Ps211Cg53-Pg1-Ps212
Cg53-Pg1-Ps213Cg53-Pg1-Ps214Cg53-Pg1-Ps215Cg53-Pg1-Ps216
Cg53-Pg1-Ps217Cg53-Pg1-Ps218Cg53-Pg1-Ps219Cg53-Pg1-Ps220
Cg53-Pg1-Ps221Cg53-Pg1-Ps222Cg53-Pg1-Ps223Cg53-Pg1-Ps224
Cg53-Pg1-Ps225Cg53-Pg1-Ps226Cg53-Pg1-Ps227Cg53-Pg1-Ps228
Cg53-Pg1-Ps229Cg53-Pg1-Ps230Cg53-Pg1-Ps231Cg53-Pg1-Ps232
Cg53-Pg1-Ps233Cg53-Pg1-Ps234Cg53-Pg1-Ps235Cg53-Pg1-Ps236
Cg53-Pg1-Ps237Cg53-Pg1-Ps238Cg53-Pg1-Ps239Cg53-Pg1-Ps240
Cg53-Pg1-Ps241Cg53-Pg1-Ps242Cg53-Pg1-Ps243
Cg54-Pg1-Ps1Cg54-Pg1-Ps2Cg54-Pg1-Ps3Cg54-Pg1-Ps4
Cg54-Pg1-Ps5Cg54-Pg1-Ps6Cg54-Pg1-Ps7Cg54-Pg1-Ps8
Cg54-Pg1-Ps9Cg54-Pg1-Ps10Cg54-Pg1-Ps11Cg54-Pg1-Ps12
Cg54-Pg1-Ps13Cg54-Pg1-Ps14Cg54-Pg1-Ps15Cg54-Pg1-Ps16
Cg54-Pg1-Ps17Cg54-Pg1-Ps18Cg54-Pg1-Ps19Cg54-Pg1-Ps20
Cg54-Pg1-Ps21Cg54-Pg1-Ps22Cg54-Pg1-Ps23Cg54-Pg1-Ps24
Cg54-Pg1-Ps25Cg54-Pg1-Ps26Cg54-Pg1-Ps27Cg54-Pg1-Ps28
Cg54-Pg1-Ps29Cg54-Pg1-Ps30Cg54-Pg1-Ps31Cg54-Pg1-Ps32
Cg54-Pg1-Ps33Cg54-Pg1-Ps34Cg54-Pg1-Ps35Cg54-Pg1-Ps36
Cg54-Pg1-Ps37Cg54-Pg1-Ps38Cg54-Pg1-Ps39Cg54-Pg1-Ps40
Cg54-Pg1-Ps41Cg54-Pg1-Ps42Cg54-Pg1-Ps43Cg54-Pg1-Ps44
Cg54-Pg1-Ps45Cg54-Pg1-Ps46Cg54-Pg1-Ps47Cg54-Pg1-Ps48
Cg54-Pg1-Ps49Cg54-Pg1-Ps50Cg54-Pg1-Ps51Cg54-Pg1-Ps52
Cg54-Pg1-Ps53Cg54-Pg1-Ps54Cg54-Pg1-Ps55Cg54-Pg1-Ps56
Cg54-Pg1-Ps57Cg54-Pg1-Ps58Cg54-Pg1-Ps59Cg54-Pg1-Ps60
Cg54-Pg1-Ps61Cg54-Pg1-Ps62Cg54-Pg1-Ps63Cg54-Pg1-Ps64
Cg54-Pg1-Ps65Cg54-Pg1-Ps66Cg54-Pg1-Ps67Cg54-Pg1-Ps68
Cg54-Pg1-Ps69Cg54-Pg1-Ps70Cg54-Pg1-Ps71Cg54-Pg1-Ps72
Cg54-Pg1-Ps73Cg54-Pg1-Ps74Cg54-Pg1-Ps75Cg54-Pg1-Ps76
Cg54-Pg1-Ps77Cg54-Pg1-Ps78Cg54-Pg1-Ps79Cg54-Pg1-Ps80
Cg54-Pg1-Ps81Cg54-Pg1-Ps82Cg54-Pg1-Ps83Cg54-Pg1-Ps84
Cg54-Pg1-Ps85Cg54-Pg1-Ps86Cg54-Pg1-Ps87Cg54-Pg1-Ps88
Cg54-Pg1-Ps89Cg54-Pg1-Ps90Cg54-Pg1-Ps91Cg54-Pg1-Ps92
Cg54-Pg1-Ps93Cg54-Pg1-Ps94Cg54-Pg1-Ps95Cg54-Pg1-Ps96
Cg54-Pg1-Ps97Cg54-Pg1-Ps98Cg54-Pg1-Ps99Cg54-Pg1-Ps100
Cg54-Pg1-Ps101Cg54-Pg1-Ps102Cg54-Pg1-Ps103Cg54-Pg1-Ps104
Cg54-Pg1-Ps105Cg54-Pg1-Ps106Cg54-Pg1-Ps107Cg54-Pg1-Ps108
Cg54-Pg1-Ps109Cg54-Pg1-Ps110Cg54-Pg1-Ps111Cg54-Pg1-Ps112
Cg54-Pg1-Ps113Cg54-Pg1-Ps114Cg54-Pg1-Ps115Cg54-Pg1-Ps116
Cg54-Pg1-Ps117Cg54-Pg1-Ps118Cg54-Pg1-Ps119Cg54-Pg1-Ps120
Cg54-Pg1-Ps121Cg54-Pg1-Ps122Cg54-Pg1-Ps123Cg54-Pg1-Ps124
Cg54-Pg1-Ps125Cg54-Pg1-Ps126Cg54-Pg1-Ps127Cg54-Pg1-Ps128
Cg54-Pg1-Ps129Cg54-Pg1-Ps130Cg54-Pg1-Ps131Cg54-Pg1-Ps132
Cg54-Pg1-Ps133Cg54-Pg1-Ps134Cg54-Pg1-Ps135Cg54-Pg1-Ps136
Cg54-Pg1-Ps137Cg54-Pg1-Ps138Cg54-Pg1-Ps139Cg54-Pg1-Ps140
Cg54-Pg1-Ps141Cg54-Pg1-Ps142Cg54-Pg1-Ps143Cg54-Pg1-Ps144
Cg54-Pg1-Ps145Cg54-Pg1-Ps146Cg54-Pg1-Ps147Cg54-Pg1-Ps148
Cg54-Pg1-Ps149Cg54-Pg1-Ps150Cg54-Pg1-Ps151Cg54-Pg1-Ps152
Cg54-Pg1-Ps153Cg54-Pg1-Ps154Cg54-Pg1-Ps155Cg54-Pg1-Ps156
Cg54-Pg1-Ps157Cg54-Pg1-Ps158Cg54-Pg1-Ps159Cg54-Pg1-Ps160
Cg54-Pg1-Ps161Cg54-Pg1-Ps162Cg54-Pg1-Ps163Cg54-Pg1-Ps164
Cg54-Pg1-Ps165Cg54-Pg1-Ps166Cg54-Pg1-Ps167Cg54-Pg1-Ps168
Cg54-Pg1-Ps169Cg54-Pg1-Ps170Cg54-Pg1-Ps171Cg54-Pg1-Ps172
Cg54-Pg1-Ps173Cg54-Pg1-Ps174Cg54-Pg1-Ps175Cg54-Pg1-Ps176
Cg54-Pg1-Ps177Cg54-Pg1-Ps178Cg54-Pg1-Ps179Cg54-Pg1-Ps180
Cg54-Pg1-Ps181Cg54-Pg1-Ps182Cg54-Pg1-Ps183Cg54-Pg1-Ps184
Cg54-Pg1-Ps185Cg54-Pg1-Ps186Cg54-Pg1-Ps187Cg54-Pg1-Ps188
Cg54-Pg1-Ps189Cg54-Pg1-Ps190Cg54-Pg1-Ps191Cg54-Pg1-Ps192
Cg54-Pg1-Ps193Cg54-Pg1-Ps194Cg54-Pg1-Ps195Cg54-Pg1-Ps196
Cg54-Pg1-Ps197Cg54-Pg1-Ps198Cg54-Pg1-Ps199Cg54-Pg1-Ps200
Cg54-Pg1-Ps201Cg54-Pg1-Ps202Cg54-Pg1-Ps203Cg54-Pg1-Ps204
Cg54-Pg1-Ps205Cg54-Pg1-Ps206Cg54-Pg1-Ps207Cg54-Pg1-Ps208
Cg54-Pg1-Ps209Cg54-Pg1-Ps210Cg54-Pg1-Ps211Cg54-Pg1-Ps212
Cg54-Pg1-Ps213Cg54-Pg1-Ps214Cg54-Pg1-Ps215Cg54-Pg1-Ps216
Cg54-Pg1-Ps217Cg54-Pg1-Ps218Cg54-Pg1-Ps219Cg54-Pg1-Ps220
Cg54-Pg1-Ps221Cg54-Pg1-Ps222Cg54-Pg1-Ps223Cg54-Pg1-Ps224
Cg54-Pg1-Ps225Cg54-Pg1-Ps226Cg54-Pg1-Ps227Cg54-Pg1-Ps228
Cg54-Pg1-Ps229Cg54-Pg1-Ps230Cg54-Pg1-Ps231Cg54-Pg1-Ps232
Cg54-Pg1-Ps233Cg54-Pg1-Ps234Cg54-Pg1-Ps235Cg54-Pg1-Ps236
Cg54-Pg1-Ps237Cg54-Pg1-Ps238Cg54-Pg1-Ps239Cg54-Pg1-Ps240
Cg54-Pg1-Ps241Cg54-Pg1-Ps242Cg54-Pg1-Ps243
Cg57-Pg1-Ps1Cg57-Pg1-Ps2Cg57-Pg1-Ps3Cg57-Pg1-Ps4
Cg57-Pg1-Ps5Cg57-Pg1-Ps6Cg57-Pg1-Ps7Cg57-Pg1-Ps8
Cg57-Pg1-Ps9Cg57-Pg1-Ps10Cg57-Pg1-Ps11Cg57-Pg1-Ps12
Cg57-Pg1-Ps13Cg57-Pg1-Ps14Cg57-Pg1-Ps15Cg57-Pg1-Ps16
Cg57-Pg1-Ps17Cg57-Pg1-Ps18Cg57-Pg1-Ps19Cg57-Pg1-Ps20
Cg57-Pg1-Ps21Cg57-Pg1-Ps22Cg57-Pg1-Ps23Cg57-Pg1-Ps24
Cg57-Pg1-Ps25Cg57-Pg1-Ps26Cg57-Pg1-Ps27Cg57-Pg1-Ps28
Cg57-Pg1-Ps29Cg57-Pg1-Ps30Cg57-Pg1-Ps31Cg57-Pg1-Ps32
Cg57-Pg1-Ps33Cg57-Pg1-Ps34Cg57-Pg1-Ps35Cg57-Pg1-Ps36
Cg57-Pg1-Ps37Cg57-Pg1-Ps38Cg57-Pg1-Ps39Cg57-Pg1-Ps40
Cg57-Pg1-Ps41Cg57-Pg1-Ps42Cg57-Pg1-Ps43Cg57-Pg1-Ps44
Cg57-Pg1-Ps45Cg57-Pg1-Ps46Cg57-Pg1-Ps47Cg57-Pg1-Ps48
Cg57-Pg1-Ps49Cg57-Pg1-Ps50Cg57-Pg1-Ps51Cg57-Pg1-Ps52
Cg57-Pg1-Ps53Cg57-Pg1-Ps54Cg57-Pg1-Ps55Cg57-Pg1-Ps56
Cg57-Pg1-Ps57Cg57-Pg1-Ps58Cg57-Pg1-Ps59Cg57-Pg1-Ps60
Cg57-Pg1-Ps61Cg57-Pg1-Ps62Cg57-Pg1-Ps63Cg57-Pg1-Ps64
Cg57-Pg1-Ps65Cg57-Pg1-Ps66Cg57-Pg1-Ps67Cg57-Pg1-Ps68
Cg57-Pg1-Ps69Cg57-Pg1-Ps70Cg57-Pg1-Ps71Cg57-Pg1-Ps72
Cg57-Pg1-Ps73Cg57-Pg1-Ps74Cg57-Pg1-Ps75Cg57-Pg1-Ps76
Cg57-Pg1-Ps77Cg57-Pg1-Ps78Cg57-Pg1-Ps79Cg57-Pg1-Ps80
Cg57-Pg1-Ps81Cg57-Pg1-Ps82Cg57-Pg1-Ps83Cg57-Pg1-Ps84
Cg57-Pg1-Ps85Cg57-Pg1-Ps86Cg57-Pg1-Ps87Cg57-Pg1-Ps88
Cg57-Pg1-Ps89Cg57-Pg1-Ps90Cg57-Pg1-Ps91Cg57-Pg1-Ps92
Cg57-Pg1-Ps93Cg57-Pg1-Ps94Cg57-Pg1-Ps95Cg57-Pg1-Ps96
Cg57-Pg1-Ps97Cg57-Pg1-Ps98Cg57-Pg1-Ps99Cg57-Pg1-Ps100
Cg57-Pg1-Ps101Cg57-Pg1-Ps102Cg57-Pg1-Ps103Cg57-Pg1-Ps104
Cg57-Pg1-Ps105Cg57-Pg1-Ps106Cg57-Pg1-Ps107Cg57-Pg1-Ps108
Cg57-Pg1-Ps109Cg57-Pg1-Ps110Cg57-Pg1-Ps111Cg57-Pg1-Ps112
Cg57-Pg1-Ps113Cg57-Pg1-Ps114Cg57-Pg1-Ps115Cg57-Pg1-Ps116
Cg57-Pg1-Ps117Cg57-Pg1-Ps118Cg57-Pg1-Ps119Cg57-Pg1-Ps120
Cg57-Pg1-Ps121Cg57-Pg1-Ps122Cg57-Pg1-Ps123Cg57-Pg1-Ps124
Cg57-Pg1-Ps125Cg57-Pg1-Ps126Cg57-Pg1-Ps127Cg57-Pg1-Ps128
Cg57-Pg1-Ps129Cg57-Pg1-Ps130Cg57-Pg1-Ps131Cg57-Pg1-Ps132
Cg57-Pg1-Ps133Cg57-Pg1-Ps134Cg57-Pg1-Ps135Cg57-Pg1-Ps136
Cg57-Pg1-Ps137Cg57-Pg1-Ps138Cg57-Pg1-Ps139Cg57-Pg1-Ps140
Cg57-Pg1-Ps141Cg57-Pg1-Ps142Cg57-Pg1-Ps143Cg57-Pg1-Ps144
Cg57-Pg1-Ps145Cg57-Pg1-Ps146Cg57-Pg1-Ps147Cg57-Pg1-Ps148
Cg57-Pg1-Ps149Cg57-Pg1-Ps150Cg57-Pg1-Ps151Cg57-Pg1-Ps152
Cg57-Pg1-Ps153Cg57-Pg1-Ps154Cg57-Pg1-Ps155Cg57-Pg1-Ps156
Cg57-Pg1-Ps157Cg57-Pg1-Ps158Cg57-Pg1-Ps159Cg57-Pg1-Ps160
Cg57-Pg1-Ps161Cg57-Pg1-Ps162Cg57-Pg1-Ps163Cg57-Pg1-Ps164
Cg57-Pg1-Ps165Cg57-Pg1-Ps166Cg57-Pg1-Ps167Cg57-Pg1-Ps168
Cg57-Pg1-Ps169Cg57-Pg1-Ps170Cg57-Pg1-Ps171Cg57-Pg1-Ps172
Cg57-Pg1-Ps173Cg57-Pg1-Ps174Cg57-Pg1-Ps175Cg57-Pg1-Ps176
Cg57-Pg1-Ps177Cg57-Pg1-Ps178Cg57-Pg1-Ps179Cg57-Pg1-Ps180
Cg57-Pg1-Ps181Cg57-Pg1-Ps182Cg57-Pg1-Ps183Cg57-Pg1-Ps184
Cg57-Pg1-Ps185Cg57-Pg1-Ps186Cg57-Pg1-Ps187Cg57-Pg1-Ps188
Cg57-Pg1-Ps189Cg57-Pg1-Ps190Cg57-Pg1-Ps191Cg57-Pg1-Ps192
Cg57-Pg1-Ps193Cg57-Pg1-Ps194Cg57-Pg1-Ps195Cg57-Pg1-Ps196
Cg57-Pg1-Ps197Cg57-Pg1-Ps198Cg57-Pg1-Ps199Cg57-Pg1-Ps200
Cg57-Pg1-Ps201Cg57-Pg1-Ps202Cg57-Pg1-Ps203Cg57-Pg1-Ps204
Cg57-Pg1-Ps205Cg57-Pg1-Ps206Cg57-Pg1-Ps207Cg57-Pg1-Ps208
Cg57-Pg1-Ps209Cg57-Pg1-Ps210Cg57-Pg1-Ps211Cg57-Pg1-Ps212
Cg57-Pg1-Ps213Cg57-Pg1-Ps214Cg57-Pg1-Ps215Cg57-Pg1-Ps216
Cg57-Pg1-Ps217Cg57-Pg1-Ps218Cg57-Pg1-Ps219Cg57-Pg1-Ps220
Cg57-Pg1-Ps221Cg57-Pg1-Ps222Cg57-Pg1-Ps223Cg57-Pg1-Ps224
Cg57-Pg1-Ps225Cg57-Pg1-Ps226Cg57-Pg1-Ps227Cg57-Pg1-Ps228
Cg57-Pg1-Ps229Cg57-Pg1-Ps230Cg57-Pg1-Ps231Cg57-Pg1-Ps232
Cg57-Pg1-Ps233Cg57-Pg1-Ps234Cg57-Pg1-Ps235Cg57-Pg1-Ps236
Cg57-Pg1-Ps237Cg57-Pg1-Ps238Cg57-Pg1-Ps239Cg57-Pg1-Ps240
Cg57-Pg1-Ps241Cg57-Pg1-Ps242Cg57-Pg1-Ps243
Cg60-Pg1-Ps1Cg60-Pg1-Ps2Cg60-Pg1-Ps3Cg60-Pg1-Ps4
Cg60-Pg1-Ps5Cg60-Pg1-Ps6Cg60-Pg1-Ps7Cg60-Pg1-Ps8
Cg60-Pg1-Ps9Cg60-Pg1-Ps10Cg60-Pg1-Ps11Cg60-Pg1-Ps12
Cg60-Pg1-Ps13Cg60-Pg1-Ps14Cg60-Pg1-Ps15Cg60-Pg1-Ps16
Cg60-Pg1-Ps17Cg60-Pg1-Ps18Cg60-Pg1-Ps19Cg60-Pg1-Ps20
Cg60-Pg1-Ps21Cg60-Pg1-Ps22Cg60-Pg1-Ps23Cg60-Pg1-Ps24
Cg60-Pg1-Ps25Cg60-Pg1-Ps26Cg60-Pg1-Ps27Cg60-Pg1-Ps28
Cg60-Pg1-Ps29Cg60-Pg1-Ps30Cg60-Pg1-Ps31Cg60-Pg1-Ps32
Cg60-Pg1-Ps33Cg60-Pg1-Ps34Cg60-Pg1-Ps35Cg60-Pg1-Ps36
Cg60-Pg1-Ps37Cg60-Pg1-Ps38Cg60-Pg1-Ps39Cg60-Pg1-Ps40
Cg60-Pg1-Ps41Cg60-Pg1-Ps42Cg60-Pg1-Ps43Cg60-Pg1-Ps44
Cg60-Pg1-Ps45Cg60-Pg1-Ps46Cg60-Pg1-Ps47Cg60-Pg1-Ps48
Cg60-Pg1-Ps49Cg60-Pg1-Ps50Cg60-Pg1-Ps51Cg60-Pg1-Ps52
Cg60-Pg1-Ps53Cg60-Pg1-Ps54Cg60-Pg1-Ps55Cg60-Pg1-Ps56
Cg60-Pg1-Ps57Cg60-Pg1-Ps58Cg60-Pg1-Ps59Cg60-Pg1-Ps60
Cg60-Pg1-Ps61Cg60-Pg1-Ps62Cg60-Pg1-Ps63Cg60-Pg1-Ps64
Cg60-Pg1-Ps65Cg60-Pg1-Ps66Cg60-Pg1-Ps67Cg60-Pg1-Ps68
Cg60-Pg1-Ps69Cg60-Pg1-Ps70Cg60-Pg1-Ps71Cg60-Pg1-Ps72
Cg60-Pg1-Ps73Cg60-Pg1-Ps74Cg60-Pg1-Ps75Cg60-Pg1-Ps76
Cg60-Pg1-Ps77Cg60-Pg1-Ps78Cg60-Pg1-Ps79Cg60-Pg1-Ps80
Cg60-Pg1-Ps81Cg60-Pg1-Ps82Cg60-Pg1-Ps83Cg60-Pg1-Ps84
Cg60-Pg1-Ps85Cg60-Pg1-Ps86Cg60-Pg1-Ps87Cg60-Pg1-Ps88
Cg60-Pg1-Ps89Cg60-Pg1-Ps90Cg60-Pg1-Ps91Cg60-Pg1-Ps92
Cg60-Pg1-Ps93Cg60-Pg1-Ps94Cg60-Pg1-Ps95Cg60-Pg1-Ps96
Cg60-Pg1-Ps97Cg60-Pg1-Ps98Cg60-Pg1-Ps99Cg60-Pg1-Ps100
Cg60-Pg1-Ps101Cg60-Pg1-Ps102Cg60-Pg1-Ps103Cg60-Pg1-Ps104
Cg60-Pg1-Ps105Cg60-Pg1-Ps106Cg60-Pg1-Ps107Cg60-Pg1-Ps108
Cg60-Pg1-Ps109Cg60-Pg1-Ps110Cg60-Pg1-Ps111Cg60-Pg1-Ps112
Cg60-Pg1-Ps113Cg60-Pg1-Ps114Cg60-Pg1-Ps115Cg60-Pg1-Ps116
Cg60-Pg1-Ps117Cg60-Pg1-Ps118Cg60-Pg1-Ps119Cg60-Pg1-Ps120
Cg60-Pg1-Ps121Cg60-Pg1-Ps122Cg60-Pg1-Ps123Cg60-Pg1-Ps124
Cg60-Pg1-Ps125Cg60-Pg1-Ps126Cg60-Pg1-Ps127Cg60-Pg1-Ps128
Cg60-Pg1-Ps129Cg60-Pg1-Ps130Cg60-Pg1-Ps131Cg60-Pg1-Ps132
Cg60-Pg1-Ps133Cg60-Pg1-Ps134Cg60-Pg1-Ps135Cg60-Pg1-Ps136
Cg60-Pg1-Ps137Cg60-Pg1-Ps138Cg60-Pg1-Ps139Cg60-Pg1-Ps140
Cg60-Pg1-Ps141Cg60-Pg1-Ps142Cg60-Pg1-Ps143Cg60-Pg1-Ps144
Cg60-Pg1-Ps145Cg60-Pg1-Ps146Cg60-Pg1-Ps147Cg60-Pg1-Ps148
Cg60-Pg1-Ps149Cg60-Pg1-Ps150Cg60-Pg1-Ps151Cg60-Pg1-Ps152
Cg60-Pg1-Ps153Cg60-Pg1-Ps154Cg60-Pg1-Ps155Cg60-Pg1-Ps156
Cg60-Pg1-Ps157Cg60-Pg1-Ps158Cg60-Pg1-Ps159Cg60-Pg1-Ps160
Cg60-Pg1-Ps161Cg60-Pg1-Ps162Cg60-Pg1-Ps163Cg60-Pg1-Ps164
Cg60-Pg1-Ps165Cg60-Pg1-Ps166Cg60-Pg1-Ps167Cg60-Pg1-Ps168
Cg60-Pg1-Ps169Cg60-Pg1-Ps170Cg60-Pg1-Ps171Cg60-Pg1-Ps172
Cg60-Pg1-Ps173Cg60-Pg1-Ps174Cg60-Pg1-Ps175Cg60-Pg1-Ps176
Cg60-Pg1-Ps177Cg60-Pg1-Ps178Cg60-Pg1-Ps179Cg60-Pg1-Ps180
Cg60-Pg1-Ps181Cg60-Pg1-Ps182Cg60-Pg1-Ps183Cg60-Pg1-Ps184
Cg60-Pg1-Ps185Cg60-Pg1-Ps186Cg60-Pg1-Ps187Cg60-Pg1-Ps188
Cg60-Pg1-Ps189Cg60-Pg1-Ps190Cg60-Pg1-Ps191Cg60-Pg1-Ps192
Cg60-Pg1-Ps193Cg60-Pg1-Ps194Cg60-Pg1-Ps195Cg60-Pg1-Ps196
Cg60-Pg1-Ps197Cg60-Pg1-Ps198Cg60-Pg1-Ps199Cg60-Pg1-Ps200
Cg60-Pg1-Ps201Cg60-Pg1-Ps202Cg60-Pg1-Ps203Cg60-Pg1-Ps204
Cg60-Pg1-Ps205Cg60-Pg1-Ps206Cg60-Pg1-Ps207Cg60-Pg1-Ps208
Cg60-Pg1-Ps209Cg60-Pg1-Ps210Cg60-Pg1-Ps211Cg60-Pg1-Ps212
Cg60-Pg1-Ps213Cg60-Pg1-Ps214Cg60-Pg1-Ps215Cg60-Pg1-Ps216
Cg60-Pg1-Ps217Cg60-Pg1-Ps218Cg60-Pg1-Ps219Cg60-Pg1-Ps220
Cg60-Pg1-Ps221Cg60-Pg1-Ps222Cg60-Pg1-Ps223Cg60-Pg1-Ps224
Cg60-Pg1-Ps225Cg60-Pg1-Ps226Cg60-Pg1-Ps227Cg60-Pg1-Ps228
Cg60-Pg1-Ps229Cg60-Pg1-Ps230Cg60-Pg1-Ps231Cg60-Pg1-Ps232
Cg60-Pg1-Ps233Cg60-Pg1-Ps234Cg60-Pg1-Ps235Cg60-Pg1-Ps236
Cg60-Pg1-Ps237Cg60-Pg1-Ps238Cg60-Pg1-Ps239Cg60-Pg1-Ps240
Cg60-Pg1-Ps241Cg60-Pg1-Ps242Cg60-Pg1-Ps243
Cg61-Pg1-Ps1Cg61-Pg1-Ps2Cg61-Pg1-Ps3Cg61-Pg1-Ps4
Cg61-Pg1-Ps5Cg61-Pg1-Ps6Cg61-Pg1-Ps7Cg61-Pg1-Ps8
Cg61-Pg1-Ps9Cg61-Pg1-Ps10Cg61-Pg1-Ps11Cg61-Pg1-Ps12
Cg61-Pg1-Ps13Cg61-Pg1-Ps14Cg61-Pg1-Ps15Cg61-Pg1-Ps16
Cg61-Pg1-Ps17Cg61-Pg1-Ps18Cg61-Pg1-Ps19Cg61-Pg1-Ps20
Cg61-Pg1-Ps21Cg61-Pg1-Ps22Cg61-Pg1-Ps23Cg61-Pg1-Ps24
Cg61-Pg1-Ps25Cg61-Pg1-Ps26Cg61-Pg1-Ps27Cg61-Pg1-Ps28
Cg61-Pg1-Ps29Cg61-Pg1-Ps30Cg61-Pg1-Ps31Cg61-Pg1-Ps32
Cg61-Pg1-Ps33Cg61-Pg1-Ps34Cg61-Pg1-Ps35Cg61-Pg1-Ps36
Cg61-Pg1-Ps37Cg61-Pg1-Ps38Cg61-Pg1-Ps39Cg61-Pg1-Ps40
Cg61-Pg1-Ps41Cg61-Pg1-Ps42Cg61-Pg1-Ps43Cg61-Pg1-Ps44
Cg61-Pg1-Ps45Cg61-Pg1-Ps46Cg61-Pg1-Ps47Cg61-Pg1-Ps48
Cg61-Pg1-Ps49Cg61-Pg1-Ps50Cg61-Pg1-Ps51Cg61-Pg1-Ps52
Cg61-Pg1-Ps53Cg61-Pg1-Ps54Cg61-Pg1-Ps55Cg61-Pg1-Ps56
Cg61-Pg1-Ps57Cg61-Pg1-Ps58Cg61-Pg1-Ps59Cg61-Pg1-Ps60
Cg61-Pg1-Ps61Cg61-Pg1-Ps62Cg61-Pg1-Ps63Cg61-Pg1-Ps64
Cg61-Pg1-Ps65Cg61-Pg1-Ps66Cg61-Pg1-Ps67Cg61-Pg1-Ps68
Cg61-Pg1-Ps69Cg61-Pg1-Ps70Cg61-Pg1-Ps71Cg61-Pg1-Ps72
Cg61-Pg1-Ps73Cg61-Pg1-Ps74Cg61-Pg1-Ps75Cg61-Pg1-Ps76
Cg61-Pg1-Ps77Cg61-Pg1-Ps78Cg61-Pg1-Ps79Cg61-Pg1-Ps80
Cg61-Pg1-Ps81Cg61-Pg1-Ps82Cg61-Pg1-Ps83Cg61-Pg1-Ps84
Cg61-Pg1-Ps85Cg61-Pg1-Ps86Cg61-Pg1-Ps87Cg61-Pg1-Ps88
Cg61-Pg1-Ps89Cg61-Pg1-Ps90Cg61-Pg1-Ps91Cg61-Pg1-Ps92
Cg61-Pg1-Ps93Cg61-Pg1-Ps94Cg61-Pg1-Ps95Cg61-Pg1-Ps96
Cg61-Pg1-Ps97Cg61-Pg1-Ps98Cg61-Pg1-Ps99Cg61-Pg1-Ps100
Cg61-Pg1-Ps101Cg61-Pg1-Ps102Cg61-Pg1-Ps103Cg61-Pg1-Ps104
Cg61-Pg1-Ps105Cg61-Pg1-Ps106Cg61-Pg1-Ps107Cg61-Pg1-Ps108
Cg61-Pg1-Ps109Cg61-Pg1-Ps110Cg61-Pg1-Ps111Cg61-Pg1-Ps112
Cg61-Pg1-Ps113Cg61-Pg1-Ps114Cg61-Pg1-Ps115Cg61-Pg1-Ps116
Cg61-Pg1-Ps117Cg61-Pg1-Ps118Cg61-Pg1-Ps119Cg61-Pg1-Ps120
Cg61-Pg1-Ps121Cg61-Pg1-Ps122Cg61-Pg1-Ps123Cg61-Pg1-Ps124
Cg61-Pg1-Ps125Cg61-Pg1-Ps126Cg61-Pg1-Ps127Cg61-Pg1-Ps128
Cg61-Pg1-Ps129Cg61-Pg1-Ps130Cg61-Pg1-Ps131Cg61-Pg1-Ps132
Cg61-Pg1-Ps133Cg61-Pg1-Ps134Cg61-Pg1-Ps135Cg61-Pg1-Ps136
Cg61-Pg1-Ps137Cg61-Pg1-Ps138Cg61-Pg1-Ps139Cg61-Pg1-Ps140
Cg61-Pg1-Ps141Cg61-Pg1-Ps142Cg61-Pg1-Ps143Cg61-Pg1-Ps144
Cg61-Pg1-Ps145Cg61-Pg1-Ps146Cg61-Pg1-Ps147Cg61-Pg1-Ps148
Cg61-Pg1-Ps149Cg61-Pg1-Ps150Cg61-Pg1-Ps151Cg61-Pg1-Ps152
Cg61-Pg1-Ps153Cg61-Pg1-Ps154Cg61-Pg1-Ps155Cg61-Pg1-Ps156
Cg61-Pg1-Ps157Cg61-Pg1-Ps158Cg61-Pg1-Ps159Cg61-Pg1-Ps160
Cg61-Pg1-Ps161Cg61-Pg1-Ps162Cg61-Pg1-Ps163Cg61-Pg1-Ps164
Cg61-Pg1-Ps165Cg61-Pg1-Ps166Cg61-Pg1-Ps167Cg61-Pg1-Ps168
Cg61-Pg1-Ps169Cg61-Pg1-Ps170Cg61-Pg1-Ps171Cg61-Pg1-Ps172
Cg61-Pg1-Ps173Cg61-Pg1-Ps174Cg61-Pg1-Ps175Cg61-Pg1-Ps176
Cg61-Pg1-Ps177Cg61-Pg1-Ps178Cg61-Pg1-Ps179Cg61-Pg1-Ps180
Cg61-Pg1-Ps181Cg61-Pg1-Ps182Cg61-Pg1-Ps183Cg61-Pg1-Ps184
Cg61-Pg1-Ps185Cg61-Pg1-Ps186Cg61-Pg1-Ps187Cg61-Pg1-Ps188
Cg61-Pg1-Ps189Cg61-Pg1-Ps190Cg61-Pg1-Ps191Cg61-Pg1-Ps192
Cg61-Pg1-Ps193Cg61-Pg1-Ps194Cg61-Pg1-Ps195Cg61-Pg1-Ps196
Cg61-Pg1-Ps197Cg61-Pg1-Ps198Cg61-Pg1-Ps199Cg61-Pg1-Ps200
Cg61-Pg1-Ps201Cg61-Pg1-Ps202Cg61-Pg1-Ps203Cg61-Pg1-Ps204
Cg61-Pg1-Ps205Cg61-Pg1-Ps206Cg61-Pg1-Ps207Cg61-Pg1-Ps208
Cg61-Pg1-Ps209Cg61-Pg1-Ps210Cg61-Pg1-Ps211Cg61-Pg1-Ps212
Cg61-Pg1-Ps213Cg61-Pg1-Ps214Cg61-Pg1-Ps215Cg61-Pg1-Ps216
Cg61-Pg1-Ps217Cg61-Pg1-Ps218Cg61-Pg1-Ps219Cg61-Pg1-Ps220
Cg61-Pg1-Ps221Cg61-Pg1-Ps222Cg61-Pg1-Ps223Cg61-Pg1-Ps224
Cg61-Pg1-Ps225Cg61-Pg1-Ps226Cg61-Pg1-Ps227Cg61-Pg1-Ps228
Cg61-Pg1-Ps229Cg61-Pg1-Ps230Cg61-Pg1-Ps231Cg61-Pg1-Ps232
Cg61-Pg1-Ps233Cg61-Pg1-Ps234Cg61-Pg1-Ps235Cg61-Pg1-Ps236
Cg61-Pg1-Ps237Cg61-Pg1-Ps238Cg61-Pg1-Ps239Cg61-Pg1-Ps240
Cg61-Pg1-Ps241Cg61-Pg1-Ps242Cg61-Pg1-Ps243
Cg62-Pg1-Ps1Cg62-Pg1-Ps2Cg62-Pg1-Ps3Cg62-Pg1-Ps4
Cg62-Pg1-Ps5Cg62-Pg1-Ps6Cg62-Pg1-Ps7Cg62-Pg1-Ps8
Cg62-Pg1-Ps9Cg62-Pg1-Ps10Cg62-Pg1-Ps11Cg62-Pg1-Ps12
Cg62-Pg1-Ps13Cg62-Pg1-Ps14Cg62-Pg1-Ps15Cg62-Pg1-Ps16
Cg62-Pg1-Ps17Cg62-Pg1-Ps18Cg62-Pg1-Ps19Cg62-Pg1-Ps20
Cg62-Pg1-Ps21Cg62-Pg1-Ps22Cg62-Pg1-Ps23Cg62-Pg1-Ps24
Cg62-Pg1-Ps25Cg62-Pg1-Ps26Cg62-Pg1-Ps27Cg62-Pg1-Ps28
Cg62-Pg1-Ps29Cg62-Pg1-Ps30Cg62-Pg1-Ps31Cg62-Pg1-Ps32
Cg62-Pg1-Ps33Cg62-Pg1-Ps34Cg62-Pg1-Ps35Cg62-Pg1-Ps36
Cg62-Pg1-Ps37Cg62-Pg1-Ps38Cg62-Pg1-Ps39Cg62-Pg1-Ps40
Cg62-Pg1-Ps41Cg62-Pg1-Ps42Cg62-Pg1-Ps43Cg62-Pg1-Ps44
Cg62-Pg1-Ps45Cg62-Pg1-Ps46Cg62-Pg1-Ps47Cg62-Pg1-Ps48
Cg62-Pg1-Ps49Cg62-Pg1-Ps50Cg62-Pg1-Ps51Cg62-Pg1-Ps52
Cg62-Pg1-Ps53Cg62-Pg1-Ps54Cg62-Pg1-Ps55Cg62-Pg1-Ps56
Cg62-Pg1-Ps57Cg62-Pg1-Ps58Cg62-Pg1-Ps59Cg62-Pg1-Ps60
Cg62-Pg1-Ps61Cg62-Pg1-Ps62Cg62-Pg1-Ps63Cg62-Pg1-Ps64
Cg62-Pg1-Ps65Cg62-Pg1-Ps66Cg62-Pg1-Ps67Cg62-Pg1-Ps68
Cg62-Pg1-Ps69Cg62-Pg1-Ps70Cg62-Pg1-Ps71Cg62-Pg1-Ps72
Cg62-Pg1-Ps73Cg62-Pg1-Ps74Cg62-Pg1-Ps75Cg62-Pg1-Ps76
Cg62-Pg1-Ps77Cg62-Pg1-Ps78Cg62-Pg1-Ps79Cg62-Pg1-Ps80
Cg62-Pg1-Ps81Cg62-Pg1-Ps82Cg62-Pg1-Ps83Cg62-Pg1-Ps84
Cg62-Pg1-Ps85Cg62-Pg1-Ps86Cg62-Pg1-Ps87Cg62-Pg1-Ps88
Cg62-Pg1-Ps89Cg62-Pg1-Ps90Cg62-Pg1-Ps91Cg62-Pg1-Ps92
Cg62-Pg1-Ps93Cg62-Pg1-Ps94Cg62-Pg1-Ps95Cg62-Pg1-Ps96
Cg62-Pg1-Ps97Cg62-Pg1-Ps98Cg62-Pg1-Ps99Cg62-Pg1-Ps100
Cg62-Pg1-Ps101Cg62-Pg1-Ps102Cg62-Pg1-Ps103Cg62-Pg1-Ps104
Cg62-Pg1-Ps105Cg62-Pg1-Ps106Cg62-Pg1-Ps107Cg62-Pg1-Ps108
Cg62-Pg1-Ps109Cg62-Pg1-Ps110Cg62-Pg1-Ps111Cg62-Pg1-Ps112
Cg62-Pg1-Ps113Cg62-Pg1-Ps114Cg62-Pg1-Ps115Cg62-Pg1-Ps116
Cg62-Pg1-Ps117Cg62-Pg1-Ps118Cg62-Pg1-Ps119Cg62-Pg1-Ps120
Cg62-Pg1-Ps121Cg62-Pg1-Ps122Cg62-Pg1-Ps123Cg62-Pg1-Ps124
Cg62-Pg1-Ps125Cg62-Pg1-Ps126Cg62-Pg1-Ps127Cg62-Pg1-Ps128
Cg62-Pg1-Ps129Cg62-Pg1-Ps130Cg62-Pg1-Ps131Cg62-Pg1-Ps132
Cg62-Pg1-Ps133Cg62-Pg1-Ps134Cg62-Pg1-Ps135Cg62-Pg1-Ps136
Cg62-Pg1-Ps137Cg62-Pg1-Ps138Cg62-Pg1-Ps139Cg62-Pg1-Ps140
Cg62-Pg1-Ps141Cg62-Pg1-Ps142Cg62-Pg1-Ps143Cg62-Pg1-Ps144
Cg62-Pg1-Ps145Cg62-Pg1-Ps146Cg62-Pg1-Ps147Cg62-Pg1-Ps148
Cg62-Pg1-Ps149Cg62-Pg1-Ps150Cg62-Pg1-Ps151Cg62-Pg1-Ps152
Cg62-Pg1-Ps153Cg62-Pg1-Ps154Cg62-Pg1-Ps155Cg62-Pg1-Ps156
Cg62-Pg1-Ps157Cg62-Pg1-Ps158Cg62-Pg1-Ps159Cg62-Pg1-Ps160
Cg62-Pg1-Ps161Cg62-Pg1-Ps162Cg62-Pg1-Ps163Cg62-Pg1-Ps164
Cg62-Pg1-Ps165Cg62-Pg1-Ps166Cg62-Pg1-Ps167Cg62-Pg1-Ps168
Cg62-Pg1-Ps169Cg62-Pg1-Ps170Cg62-Pg1-Ps171Cg62-Pg1-Ps172
Cg62-Pg1-Ps173Cg62-Pg1-Ps174Cg62-Pg1-Ps175Cg62-Pg1-Ps176
Cg62-Pg1-Ps177Cg62-Pg1-Ps178Cg62-Pg1-Ps179Cg62-Pg1-Ps180
Cg62-Pg1-Ps181Cg62-Pg1-Ps182Cg62-Pg1-Ps183Cg62-Pg1-Ps184
Cg62-Pg1-Ps185Cg62-Pg1-Ps186Cg62-Pg1-Ps187Cg62-Pg1-Ps188
Cg62-Pg1-Ps189Cg62-Pg1-Ps190Cg62-Pg1-Ps191Cg62-Pg1-Ps192
Cg62-Pg1-Ps193Cg62-Pg1-Ps194Cg62-Pg1-Ps195Cg62-Pg1-Ps196
Cg62-Pg1-Ps197Cg62-Pg1-Ps198Cg62-Pg1-Ps199Cg62-Pg1-Ps200
Cg62-Pg1-Ps201Cg62-Pg1-Ps202Cg62-Pg1-Ps203Cg62-Pg1-Ps204
Cg62-Pg1-Ps205Cg62-Pg1-Ps206Cg62-Pg1-Ps207Cg62-Pg1-Ps208
Cg62-Pg1-Ps209Cg62-Pg1-Ps210Cg62-Pg1-Ps211Cg62-Pg1-Ps212
Cg62-Pg1-Ps213Cg62-Pg1-Ps214Cg62-Pg1-Ps215Cg62-Pg1-Ps216
Cg62-Pg1-Ps217Cg62-Pg1-Ps218Cg62-Pg1-Ps219Cg62-Pg1-Ps220
Cg62-Pg1-Ps221Cg62-Pg1-Ps222Cg62-Pg1-Ps223Cg62-Pg1-Ps224
Cg62-Pg1-Ps225Cg62-Pg1-Ps226Cg62-Pg1-Ps227Cg62-Pg1-Ps228
Cg62-Pg1-Ps229Cg62-Pg1-Ps230Cg62-Pg1-Ps231Cg62-Pg1-Ps232
Cg62-Pg1-Ps233Cg62-Pg1-Ps234Cg62-Pg1-Ps235Cg62-Pg1-Ps236
Cg62-Pg1-Ps237Cg62-Pg1-Ps238Cg62-Pg1-Ps239Cg62-Pg1-Ps240
Cg62-Pg1-Ps241Cg62-Pg1-Ps242Cg62-Pg1-Ps243
Cg63-Pg1-Ps1Cg63-Pg1-Ps2Cg63-Pg1-Ps3Cg63-Pg1-Ps4
Cg63-Pg1-Ps5Cg63-Pg1-Ps6Cg63-Pg1-Ps7Cg63-Pg1-Ps8
Cg63-Pg1-Ps9Cg63-Pg1-Ps10Cg63-Pg1-Ps11Cg63-Pg1-Ps12
Cg63-Pg1-Ps13Cg63-Pg1-Ps14Cg63-Pg1-Ps15Cg63-Pg1-Ps16
Cg63-Pg1-Ps17Cg63-Pg1-Ps18Cg63-Pg1-Ps19Cg63-Pg1-Ps20
Cg63-Pg1-Ps21Cg63-Pg1-Ps22Cg63-Pg1-Ps23Cg63-Pg1-Ps24
Cg63-Pg1-Ps25Cg63-Pg1-Ps26Cg63-Pg1-Ps27Cg63-Pg1-Ps28
Cg63-Pg1-Ps29Cg63-Pg1-Ps30Cg63-Pg1-Ps31Cg63-Pg1-Ps32
Cg63-Pg1-Ps33Cg63-Pg1-Ps34Cg63-Pg1-Ps35Cg63-Pg1-Ps36
Cg63-Pg1-Ps37Cg63-Pg1-Ps38Cg63-Pg1-Ps39Cg63-Pg1-Ps40
Cg63-Pg1-Ps41Cg63-Pg1-Ps42Cg63-Pg1-Ps43Cg63-Pg1-Ps44
Cg63-Pg1-Ps45Cg63-Pg1-Ps46Cg63-Pg1-Ps47Cg63-Pg1-Ps48
Cg63-Pg1-Ps49Cg63-Pg1-Ps50Cg63-Pg1-Ps51Cg63-Pg1-Ps52
Cg63-Pg1-Ps53Cg63-Pg1-Ps54Cg63-Pg1-Ps55Cg63-Pg1-Ps56
Cg63-Pg1-Ps57Cg63-Pg1-Ps58Cg63-Pg1-Ps59Cg63-Pg1-Ps60
Cg63-Pg1-Ps61Cg63-Pg1-Ps62Cg63-Pg1-Ps63Cg63-Pg1-Ps64
Cg63-Pg1-Ps65Cg63-Pg1-Ps66Cg63-Pg1-Ps67Cg63-Pg1-Ps68
Cg63-Pg1-Ps69Cg63-Pg1-Ps70Cg63-Pg1-Ps71Cg63-Pg1-Ps72
Cg63-Pg1-Ps73Cg63-Pg1-Ps74Cg63-Pg1-Ps75Cg63-Pg1-Ps76
Cg63-Pg1-Ps77Cg63-Pg1-Ps78Cg63-Pg1-Ps79Cg63-Pg1-Ps80
Cg63-Pg1-Ps81Cg63-Pg1-Ps82Cg63-Pg1-Ps83Cg63-Pg1-Ps84
Cg63-Pg1-Ps85Cg63-Pg1-Ps86Cg63-Pg1-Ps87Cg63-Pg1-Ps88
Cg63-Pg1-Ps89Cg63-Pg1-Ps90Cg63-Pg1-Ps91Cg63-Pg1-Ps92
Cg63-Pg1-Ps93Cg63-Pg1-Ps94Cg63-Pg1-Ps95Cg63-Pg1-Ps96
Cg63-Pg1-Ps97Cg63-Pg1-Ps98Cg63-Pg1-Ps99Cg63-Pg1-Ps100
Cg63-Pg1-Ps101Cg63-Pg1-Ps102Cg63-Pg1-Ps103Cg63-Pg1-Ps104
Cg63-Pg1-Ps105Cg63-Pg1-Ps106Cg63-Pg1-Ps107Cg63-Pg1-Ps108
Cg63-Pg1-Ps109Cg63-Pg1-Ps110Cg63-Pg1-Ps111Cg63-Pg1-Ps112
Cg63-Pg1-Ps113Cg63-Pg1-Ps114Cg63-Pg1-Ps115Cg63-Pg1-Ps116
Cg63-Pg1-Ps117Cg63-Pg1-Ps118Cg63-Pg1-Ps119Cg63-Pg1-Ps120
Cg63-Pg1-Ps121Cg63-Pg1-Ps122Cg63-Pg1-Ps123Cg63-Pg1-Ps124
Cg63-Pg1-Ps125Cg63-Pg1-Ps126Cg63-Pg1-Ps127Cg63-Pg1-Ps128
Cg63-Pg1-Ps129Cg63-Pg1-Ps130Cg63-Pg1-Ps131Cg63-Pg1-Ps132
Cg63-Pg1-Ps133Cg63-Pg1-Ps134Cg63-Pg1-Ps135Cg63-Pg1-Ps136
Cg63-Pg1-Ps137Cg63-Pg1-Ps138Cg63-Pg1-Ps139Cg63-Pg1-Ps140
Cg63-Pg1-Ps141Cg63-Pg1-Ps142Cg63-Pg1-Ps143Cg63-Pg1-Ps144
Cg63-Pg1-Ps145Cg63-Pg1-Ps146Cg63-Pg1-Ps147Cg63-Pg1-Ps148
Cg63-Pg1-Ps149Cg63-Pg1-Ps150Cg63-Pg1-Ps151Cg63-Pg1-Ps152
Cg63-Pg1-Ps153Cg63-Pg1-Ps154Cg63-Pg1-Ps155Cg63-Pg1-Ps156
Cg63-Pg1-Ps157Cg63-Pg1-Ps158Cg63-Pg1-Ps159Cg63-Pg1-Ps160
Cg63-Pg1-Ps161Cg63-Pg1-Ps162Cg63-Pg1-Ps163Cg63-Pg1-Ps164
Cg63-Pg1-Ps165Cg63-Pg1-Ps166Cg63-Pg1-Ps167Cg63-Pg1-Ps168
Cg63-Pg1-Ps169Cg63-Pg1-Ps170Cg63-Pg1-Ps171Cg63-Pg1-Ps172
Cg63-Pg1-Ps173Cg63-Pg1-Ps174Cg63-Pg1-Ps175Cg63-Pg1-Ps176
Cg63-Pg1-Ps177Cg63-Pg1-Ps178Cg63-Pg1-Ps179Cg63-Pg1-Ps180
Cg63-Pg1-Ps181Cg63-Pg1-Ps182Cg63-Pg1-Ps183Cg63-Pg1-Ps184
Cg63-Pg1-Ps185Cg63-Pg1-Ps186Cg63-Pg1-Ps187Cg63-Pg1-Ps188
Cg63-Pg1-Ps189Cg63-Pg1-Ps190Cg63-Pg1-Ps191Cg63-Pg1-Ps192
Cg63-Pg1-Ps193Cg63-Pg1-Ps194Cg63-Pg1-Ps195Cg63-Pg1-Ps196
Cg63-Pg1-Ps197Cg63-Pg1-Ps198Cg63-Pg1-Ps199Cg63-Pg1-Ps200
Cg63-Pg1-Ps201Cg63-Pg1-Ps202Cg63-Pg1-Ps203Cg63-Pg1-Ps204
Cg63-Pg1-Ps205Cg63-Pg1-Ps206Cg63-Pg1-Ps207Cg63-Pg1-Ps208
Cg63-Pg1-Ps209Cg63-Pg1-Ps210Cg63-Pg1-Ps211Cg63-Pg1-Ps212
Cg63-Pg1-Ps213Cg63-Pg1-Ps214Cg63-Pg1-Ps215Cg63-Pg1-Ps216
Cg63-Pg1-Ps217Cg63-Pg1-Ps218Cg63-Pg1-Ps219Cg63-Pg1-Ps220
Cg63-Pg1-Ps221Cg63-Pg1-Ps222Cg63-Pg1-Ps223Cg63-Pg1-Ps224
Cg63-Pg1-Ps225Cg63-Pg1-Ps226Cg63-Pg1-Ps227Cg63-Pg1-Ps228
Cg63-Pg1-Ps229Cg63-Pg1-Ps230Cg63-Pg1-Ps231Cg63-Pg1-Ps232
Cg63-Pg1-Ps233Cg63-Pg1-Ps234Cg63-Pg1-Ps235Cg63-Pg1-Ps236
Cg63-Pg1-Ps237Cg63-Pg1-Ps238Cg63-Pg1-Ps239Cg63-Pg1-Ps240
Cg63-Pg1-Ps241Cg63-Pg1-Ps242Cg63-Pg1-Ps243
Cg64-Pg1-Ps1Cg64-Pg1-Ps2Cg64-Pg1-Ps3Cg64-Pg1-Ps4
Cg64-Pg1-Ps5Cg64-Pg1-Ps6Cg64-Pg1-Ps7Cg64-Pg1-Ps8
Cg64-Pg1-Ps9Cg64-Pg1-Ps10Cg64-Pg1-Ps11Cg64-Pg1-Ps12
Cg64-Pg1-Ps13Cg64-Pg1-Ps14Cg64-Pg1-Ps15Cg64-Pg1-Ps16
Cg64-Pg1-Ps17Cg64-Pg1-Ps18Cg64-Pg1-Ps19Cg64-Pg1-Ps20
Cg64-Pg1-Ps21Cg64-Pg1-Ps22Cg64-Pg1-Ps23Cg64-Pg1-Ps24
Cg64-Pg1-Ps25Cg64-Pg1-Ps26Cg64-Pg1-Ps27Cg64-Pg1-Ps28
Cg64-Pg1-Ps29Cg64-Pg1-Ps30Cg64-Pg1-Ps31Cg64-Pg1-Ps32
Cg64-Pg1-Ps33Cg64-Pg1-Ps34Cg64-Pg1-Ps35Cg64-Pg1-Ps36
Cg64-Pg1-Ps37Cg64-Pg1-Ps38Cg64-Pg1-Ps39Cg64-Pg1-Ps40
Cg64-Pg1-Ps41Cg64-Pg1-Ps42Cg64-Pg1-Ps43Cg64-Pg1-Ps44
Cg64-Pg1-Ps45Cg64-Pg1-Ps46Cg64-Pg1-Ps47Cg64-Pg1-Ps48
Cg64-Pg1-Ps49Cg64-Pg1-Ps50Cg64-Pg1-Ps51Cg64-Pg1-Ps52
Cg64-Pg1-Ps53Cg64-Pg1-Ps54Cg64-Pg1-Ps55Cg64-Pg1-Ps56
Cg64-Pg1-Ps57Cg64-Pg1-Ps58Cg64-Pg1-Ps59Cg64-Pg1-Ps60
Cg64-Pg1-Ps61Cg64-Pg1-Ps62Cg64-Pg1-Ps63Cg64-Pg1-Ps64
Cg64-Pg1-Ps65Cg64-Pg1-Ps66Cg64-Pg1-Ps67Cg64-Pg1-Ps68
Cg64-Pg1-Ps69Cg64-Pg1-Ps70Cg64-Pg1-Ps71Cg64-Pg1-Ps72
Cg64-Pg1-Ps73Cg64-Pg1-Ps74Cg64-Pg1-Ps75Cg64-Pg1-Ps76
Cg64-Pg1-Ps77Cg64-Pg1-Ps78Cg64-Pg1-Ps79Cg64-Pg1-Ps80
Cg64-Pg1-Ps81Cg64-Pg1-Ps82Cg64-Pg1-Ps83Cg64-Pg1-Ps84
Cg64-Pg1-Ps85Cg64-Pg1-Ps86Cg64-Pg1-Ps87Cg64-Pg1-Ps88
Cg64-Pg1-Ps89Cg64-Pg1-Ps90Cg64-Pg1-Ps91Cg64-Pg1-Ps92
Cg64-Pg1-Ps93Cg64-Pg1-Ps94Cg64-Pg1-Ps95Cg64-Pg1-Ps96
Cg64-Pg1-Ps97Cg64-Pg1-Ps98Cg64-Pg1-Ps99Cg64-Pg1-Ps100
Cg64-Pg1-Ps101Cg64-Pg1-Ps102Cg64-Pg1-Ps103Cg64-Pg1-Ps104
Cg64-Pg1-Ps105Cg64-Pg1-Ps106Cg64-Pg1-Ps107Cg64-Pg1-Ps108
Cg64-Pg1-Ps109Cg64-Pg1-Ps110Cg64-Pg1-Ps111Cg64-Pg1-Ps112
Cg64-Pg1-Ps113Cg64-Pg1-Ps114Cg64-Pg1-Ps115Cg64-Pg1-Ps116
Cg64-Pg1-Ps117Cg64-Pg1-Ps118Cg64-Pg1-Ps119Cg64-Pg1-Ps120
Cg64-Pg1-Ps121Cg64-Pg1-Ps122Cg64-Pg1-Ps123Cg64-Pg1-Ps124
Cg64-Pg1-Ps125Cg64-Pg1-Ps126Cg64-Pg1-Ps127Cg64-Pg1-Ps128
Cg64-Pg1-Ps129Cg64-Pg1-Ps130Cg64-Pg1-Ps131Cg64-Pg1-Ps132
Cg64-Pg1-Ps133Cg64-Pg1-Ps134Cg64-Pg1-Ps135Cg64-Pg1-Ps136
Cg64-Pg1-Ps137Cg64-Pg1-Ps138Cg64-Pg1-Ps139Cg64-Pg1-Ps140
Cg64-Pg1-Ps141Cg64-Pg1-Ps142Cg64-Pg1-Ps143Cg64-Pg1-Ps144
Cg64-Pg1-Ps145Cg64-Pg1-Ps146Cg64-Pg1-Ps147Cg64-Pg1-Ps148
Cg64-Pg1-Ps149Cg64-Pg1-Ps150Cg64-Pg1-Ps151Cg64-Pg1-Ps152
Cg64-Pg1-Ps153Cg64-Pg1-Ps154Cg64-Pg1-Ps155Cg64-Pg1-Ps156
Cg64-Pg1-Ps157Cg64-Pg1-Ps158Cg64-Pg1-Ps159Cg64-Pg1-Ps160
Cg64-Pg1-Ps161Cg64-Pg1-Ps162Cg64-Pg1-Ps163Cg64-Pg1-Ps164
Cg64-Pg1-Ps165Cg64-Pg1-Ps166Cg64-Pg1-Ps167Cg64-Pg1-Ps168
Cg64-Pg1-Ps169Cg64-Pg1-Ps170Cg64-Pg1-Ps171Cg64-Pg1-Ps172
Cg64-Pg1-Ps173Cg64-Pg1-Ps174Cg64-Pg1-Ps175Cg64-Pg1-Ps176
Cg64-Pg1-Ps177Cg64-Pg1-Ps178Cg64-Pg1-Ps179Cg64-Pg1-Ps180
Cg64-Pg1-Ps181Cg64-Pg1-Ps182Cg64-Pg1-Ps183Cg64-Pg1-Ps184
Cg64-Pg1-Ps185Cg64-Pg1-Ps186Cg64-Pg1-Ps187Cg64-Pg1-Ps188
Cg64-Pg1-Ps189Cg64-Pg1-Ps190Cg64-Pg1-Ps191Cg64-Pg1-Ps192
Cg64-Pg1-Ps193Cg64-Pg1-Ps194Cg64-Pg1-Ps195Cg64-Pg1-Ps196
Cg64-Pg1-Ps197Cg64-Pg1-Ps198Cg64-Pg1-Ps199Cg64-Pg1-Ps200
Cg64-Pg1-Ps201Cg64-Pg1-Ps202Cg64-Pg1-Ps203Cg64-Pg1-Ps204
Cg64-Pg1-Ps205Cg64-Pg1-Ps206Cg64-Pg1-Ps207Cg64-Pg1-Ps208
Cg64-Pg1-Ps209Cg64-Pg1-Ps210Cg64-Pg1-Ps211Cg64-Pg1-Ps212
Cg64-Pg1-Ps213Cg64-Pg1-Ps214Cg64-Pg1-Ps215Cg64-Pg1-Ps216
Cg64-Pg1-Ps217Cg64-Pg1-Ps218Cg64-Pg1-Ps219Cg64-Pg1-Ps220
Cg64-Pg1-Ps221Cg64-Pg1-Ps222Cg64-Pg1-Ps223Cg64-Pg1-Ps224
Cg64-Pg1-Ps225Cg64-Pg1-Ps226Cg64-Pg1-Ps227Cg64-Pg1-Ps228
Cg64-Pg1-Ps229Cg64-Pg1-Ps230Cg64-Pg1-Ps231Cg64-Pg1-Ps232
Cg64-Pg1-Ps233Cg64-Pg1-Ps234Cg64-Pg1-Ps235Cg64-Pg1-Ps236
Cg64-Pg1-Ps237Cg64-Pg1-Ps238Cg64-Pg1-Ps239Cg64-Pg1-Ps240
Cg64-Pg1-Ps241Cg64-Pg1-Ps242Cg64-Pg1-Ps243
Cg65-Pg1-Ps1Cg65-Pg1-Ps2Cg65-Pg1-Ps3Cg65-Pg1-Ps4
Cg65-Pg1-Ps5Cg65-Pg1-Ps6Cg65-Pg1-Ps7Cg65-Pg1-Ps8
Cg65-Pg1-Ps9Cg65-Pg1-Ps10Cg65-Pg1-Ps11Cg65-Pg1-Ps12
Cg65-Pg1-Ps13Cg65-Pg1-Ps14Cg65-Pg1-Ps15Cg65-Pg1-Ps16
Cg65-Pg1-Ps17Cg65-Pg1-Ps18Cg65-Pg1-Ps19Cg65-Pg1-Ps20
Cg65-Pg1-Ps21Cg65-Pg1-Ps22Cg65-Pg1-Ps23Cg65-Pg1-Ps24
Cg65-Pg1-Ps25Cg65-Pg1-Ps26Cg65-Pg1-Ps27Cg65-Pg1-Ps28
Cg65-Pg1-Ps29Cg65-Pg1-Ps30Cg65-Pg1-Ps31Cg65-Pg1-Ps32
Cg65-Pg1-Ps33Cg65-Pg1-Ps34Cg65-Pg1-Ps35Cg65-Pg1-Ps36
Cg65-Pg1-Ps37Cg65-Pg1-Ps38Cg65-Pg1-Ps39Cg65-Pg1-Ps40
Cg65-Pg1-Ps41Cg65-Pg1-Ps42Cg65-Pg1-Ps43Cg65-Pg1-Ps44
Cg65-Pg1-Ps45Cg65-Pg1-Ps46Cg65-Pg1-Ps47Cg65-Pg1-Ps48
Cg65-Pg1-Ps49Cg65-Pg1-Ps50Cg65-Pg1-Ps51Cg65-Pg1-Ps52
Cg65-Pg1-Ps53Cg65-Pg1-Ps54Cg65-Pg1-Ps55Cg65-Pg1-Ps56
Cg65-Pg1-Ps57Cg65-Pg1-Ps58Cg65-Pg1-Ps59Cg65-Pg1-Ps60
Cg65-Pg1-Ps61Cg65-Pg1-Ps62Cg65-Pg1-Ps63Cg65-Pg1-Ps64
Cg65-Pg1-Ps65Cg65-Pg1-Ps66Cg65-Pg1-Ps67Cg65-Pg1-Ps68
Cg65-Pg1-Ps69Cg65-Pg1-Ps70Cg65-Pg1-Ps71Cg65-Pg1-Ps72
Cg65-Pg1-Ps73Cg65-Pg1-Ps74Cg65-Pg1-Ps75Cg65-Pg1-Ps76
Cg65-Pg1-Ps77Cg65-Pg1-Ps78Cg65-Pg1-Ps79Cg65-Pg1-Ps80
Cg65-Pg1-Ps81Cg65-Pg1-Ps82Cg65-Pg1-Ps83Cg65-Pg1-Ps84
Cg65-Pg1-Ps85Cg65-Pg1-Ps86Cg65-Pg1-Ps87Cg65-Pg1-Ps88
Cg65-Pg1-Ps89Cg65-Pg1-Ps90Cg65-Pg1-Ps91Cg65-Pg1-Ps92
Cg65-Pg1-Ps93Cg65-Pg1-Ps94Cg65-Pg1-Ps95Cg65-Pg1-Ps96
Cg65-Pg1-Ps97Cg65-Pg1-Ps98Cg65-Pg1-Ps99Cg65-Pg1-Ps100
Cg65-Pg1-Ps101Cg65-Pg1-Ps102Cg65-Pg1-Ps103Cg65-Pg1-Ps104
Cg65-Pg1-Ps105Cg65-Pg1-Ps106Cg65-Pg1-Ps107Cg65-Pg1-Ps108
Cg65-Pg1-Ps109Cg65-Pg1-Ps110Cg65-Pg1-Ps111Cg65-Pg1-Ps112
Cg65-Pg1-Ps113Cg65-Pg1-Ps114Cg65-Pg1-Ps115Cg65-Pg1-Ps116
Cg65-Pg1-Ps117Cg65-Pg1-Ps118Cg65-Pg1-Ps119Cg65-Pg1-Ps120
Cg65-Pg1-Ps121Cg65-Pg1-Ps122Cg65-Pg1-Ps123Cg65-Pg1-Ps124
Cg65-Pg1-Ps125Cg65-Pg1-Ps126Cg65-Pg1-Ps127Cg65-Pg1-Ps128
Cg65-Pg1-Ps129Cg65-Pg1-Ps130Cg65-Pg1-Ps131Cg65-Pg1-Ps132
Cg65-Pg1-Ps133Cg65-Pg1-Ps134Cg65-Pg1-Ps135Cg65-Pg1-Ps136
Cg65-Pg1-Ps137Cg65-Pg1-Ps138Cg65-Pg1-Ps139Cg65-Pg1-Ps140
Cg65-Pg1-Ps141Cg65-Pg1-Ps142Cg65-Pg1-Ps143Cg65-Pg1-Ps144
Cg65-Pg1-Ps145Cg65-Pg1-Ps146Cg65-Pg1-Ps147Cg65-Pg1-Ps148
Cg65-Pg1-Ps149Cg65-Pg1-Ps150Cg65-Pg1-Ps151Cg65-Pg1-Ps152
Cg65-Pg1-Ps153Cg65-Pg1-Ps154Cg65-Pg1-Ps155Cg65-Pg1-Ps156
Cg65-Pg1-Ps157Cg65-Pg1-Ps158Cg65-Pg1-Ps159Cg65-Pg1-Ps160
Cg65-Pg1-Ps161Cg65-Pg1-Ps162Cg65-Pg1-Ps163Cg65-Pg1-Ps164
Cg65-Pg1-Ps165Cg65-Pg1-Ps166Cg65-Pg1-Ps167Cg65-Pg1-Ps168
Cg65-Pg1-Ps169Cg65-Pg1-Ps170Cg65-Pg1-Ps171Cg65-Pg1-Ps172
Cg65-Pg1-Ps173Cg65-Pg1-Ps174Cg65-Pg1-Ps175Cg65-Pg1-Ps176
Cg65-Pg1-Ps177Cg65-Pg1-Ps178Cg65-Pg1-Ps179Cg65-Pg1-Ps180
Cg65-Pg1-Ps181Cg65-Pg1-Ps182Cg65-Pg1-Ps183Cg65-Pg1-Ps184
Cg65-Pg1-Ps185Cg65-Pg1-Ps186Cg65-Pg1-Ps187Cg65-Pg1-Ps188
Cg65-Pg1-Ps189Cg65-Pg1-Ps190Cg65-Pg1-Ps191Cg65-Pg1-Ps192
Cg65-Pg1-Ps193Cg65-Pg1-Ps194Cg65-Pg1-Ps195Cg65-Pg1-Ps196
Cg65-Pg1-Ps197Cg65-Pg1-Ps198Cg65-Pg1-Ps199Cg65-Pg1-Ps200
Cg65-Pg1-Ps201Cg65-Pg1-Ps202Cg65-Pg1-Ps203Cg65-Pg1-Ps204
Cg65-Pg1-Ps205Cg65-Pg1-Ps206Cg65-Pg1-Ps207Cg65-Pg1-Ps208
Cg65-Pg1-Ps209Cg65-Pg1-Ps210Cg65-Pg1-Ps211Cg65-Pg1-Ps212
Cg65-Pg1-Ps213Cg65-Pg1-Ps214Cg65-Pg1-Ps215Cg65-Pg1-Ps216
Cg65-Pg1-Ps217Cg65-Pg1-Ps218Cg65-Pg1-Ps219Cg65-Pg1-Ps220
Cg65-Pg1-Ps221Cg65-Pg1-Ps222Cg65-Pg1-Ps223Cg65-Pg1-Ps224
Cg65-Pg1-Ps225Cg65-Pg1-Ps226Cg65-Pg1-Ps227Cg65-Pg1-Ps228
Cg65-Pg1-Ps229Cg65-Pg1-Ps230Cg65-Pg1-Ps231Cg65-Pg1-Ps232
Cg65-Pg1-Ps233Cg65-Pg1-Ps234Cg65-Pg1-Ps235Cg65-Pg1-Ps236
Cg65-Pg1-Ps237Cg65-Pg1-Ps238Cg65-Pg1-Ps239Cg65-Pg1-Ps240
Cg65-Pg1-Ps241Cg65-Pg1-Ps242Cg65-Pg1-Ps243
Cg67-Pg1-Ps1Cg67-Pg1-Ps2Cg67-Pg1-Ps3Cg67-Pg1-Ps4
Cg67-Pg1-Ps5Cg67-Pg1-Ps6Cg67-Pg1-Ps7Cg67-Pg1-Ps8
Cg67-Pg1-Ps9Cg67-Pg1-Ps10Cg67-Pg1-Ps11Cg67-Pg1-Ps12
Cg67-Pg1-Ps13Cg67-Pg1-Ps14Cg67-Pg1-Ps15Cg67-Pg1-Ps16
Cg67-Pg1-Ps17Cg67-Pg1-Ps18Cg67-Pg1-Ps19Cg67-Pg1-Ps20
Cg67-Pg1-Ps21Cg67-Pg1-Ps22Cg67-Pg1-Ps23Cg67-Pg1-Ps24
Cg67-Pg1-Ps25Cg67-Pg1-Ps26Cg67-Pg1-Ps27Cg67-Pg1-Ps28
Cg67-Pg1-Ps29Cg67-Pg1-Ps30Cg67-Pg1-Ps31Cg67-Pg1-Ps32
Cg67-Pg1-Ps33Cg67-Pg1-Ps34Cg67-Pg1-Ps35Cg67-Pg1-Ps36
Cg67-Pg1-Ps37Cg67-Pg1-Ps38Cg67-Pg1-Ps39Cg67-Pg1-Ps40
Cg67-Pg1-Ps41Cg67-Pg1-Ps42Cg67-Pg1-Ps43Cg67-Pg1-Ps44
Cg67-Pg1-Ps45Cg67-Pg1-Ps46Cg67-Pg1-Ps47Cg67-Pg1-Ps48
Cg67-Pg1-Ps49Cg67-Pg1-Ps50Cg67-Pg1-Ps51Cg67-Pg1-Ps52
Cg67-Pg1-Ps53Cg67-Pg1-Ps54Cg67-Pg1-Ps55Cg67-Pg1-Ps56
Cg67-Pg1-Ps57Cg67-Pg1-Ps58Cg67-Pg1-Ps59Cg67-Pg1-Ps60
Cg67-Pg1-Ps61Cg67-Pg1-Ps62Cg67-Pg1-Ps63Cg67-Pg1-Ps64
Cg67-Pg1-Ps65Cg67-Pg1-Ps66Cg67-Pg1-Ps67Cg67-Pg1-Ps68
Cg67-Pg1-Ps69Cg67-Pg1-Ps70Cg67-Pg1-Ps71Cg67-Pg1-Ps72
Cg67-Pg1-Ps73Cg67-Pg1-Ps74Cg67-Pg1-Ps75Cg67-Pg1-Ps76
Cg67-Pg1-Ps77Cg67-Pg1-Ps78Cg67-Pg1-Ps79Cg67-Pg1-Ps80
Cg67-Pg1-Ps81Cg67-Pg1-Ps82Cg67-Pg1-Ps83Cg67-Pg1-Ps84
Cg67-Pg1-Ps85Cg67-Pg1-Ps86Cg67-Pg1-Ps87Cg67-Pg1-Ps88
Cg67-Pg1-Ps89Cg67-Pg1-Ps90Cg67-Pg1-Ps91Cg67-Pg1-Ps92
Cg67-Pg1-Ps93Cg67-Pg1-Ps94Cg67-Pg1-Ps95Cg67-Pg1-Ps96
Cg67-Pg1-Ps97Cg67-Pg1-Ps98Cg67-Pg1-Ps99Cg67-Pg1-Ps100
Cg67-Pg1-Ps101Cg67-Pg1-Ps102Cg67-Pg1-Ps103Cg67-Pg1-Ps104
Cg67-Pg1-Ps105Cg67-Pg1-Ps106Cg67-Pg1-Ps107Cg67-Pg1-Ps108
Cg67-Pg1-Ps109Cg67-Pg1-Ps110Cg67-Pg1-Ps111Cg67-Pg1-Ps112
Cg67-Pg1-Ps113Cg67-Pg1-Ps114Cg67-Pg1-Ps115Cg67-Pg1-Ps116
Cg67-Pg1-Ps117Cg67-Pg1-Ps118Cg67-Pg1-Ps119Cg67-Pg1-Ps120
Cg67-Pg1-Ps121Cg67-Pg1-Ps122Cg67-Pg1-Ps123Cg67-Pg1-Ps124
Cg67-Pg1-Ps125Cg67-Pg1-Ps126Cg67-Pg1-Ps127Cg67-Pg1-Ps128
Cg67-Pg1-Ps129Cg67-Pg1-Ps130Cg67-Pg1-Ps131Cg67-Pg1-Ps132
Cg67-Pg1-Ps133Cg67-Pg1-Ps134Cg67-Pg1-Ps135Cg67-Pg1-Ps136
Cg67-Pg1-Ps137Cg67-Pg1-Ps138Cg67-Pg1-Ps139Cg67-Pg1-Ps140
Cg67-Pg1-Ps141Cg67-Pg1-Ps142Cg67-Pg1-Ps143Cg67-Pg1-Ps144
Cg67-Pg1-Ps145Cg67-Pg1-Ps146Cg67-Pg1-Ps147Cg67-Pg1-Ps148
Cg67-Pg1-Ps149Cg67-Pg1-Ps150Cg67-Pg1-Ps151Cg67-Pg1-Ps152
Cg67-Pg1-Ps153Cg67-Pg1-Ps154Cg67-Pg1-Ps155Cg67-Pg1-Ps156
Cg67-Pg1-Ps157Cg67-Pg1-Ps158Cg67-Pg1-Ps159Cg67-Pg1-Ps160
Cg67-Pg1-Ps161Cg67-Pg1-Ps162Cg67-Pg1-Ps163Cg67-Pg1-Ps164
Cg67-Pg1-Ps165Cg67-Pg1-Ps166Cg67-Pg1-Ps167Cg67-Pg1-Ps168
Cg67-Pg1-Ps169Cg67-Pg1-Ps170Cg67-Pg1-Ps171Cg67-Pg1-Ps172
Cg67-Pg1-Ps173Cg67-Pg1-Ps174Cg67-Pg1-Ps175Cg67-Pg1-Ps176
Cg67-Pg1-Ps177Cg67-Pg1-Ps178Cg67-Pg1-Ps179Cg67-Pg1-Ps180
Cg67-Pg1-Ps181Cg67-Pg1-Ps182Cg67-Pg1-Ps183Cg67-Pg1-Ps184
Cg67-Pg1-Ps185Cg67-Pg1-Ps186Cg67-Pg1-Ps187Cg67-Pg1-Ps188
Cg67-Pg1-Ps189Cg67-Pg1-Ps190Cg67-Pg1-Ps191Cg67-Pg1-Ps192
Cg67-Pg1-Ps193Cg67-Pg1-Ps194Cg67-Pg1-Ps195Cg67-Pg1-Ps196
Cg67-Pg1-Ps197Cg67-Pg1-Ps198Cg67-Pg1-Ps199Cg67-Pg1-Ps200
Cg67-Pg1-Ps201Cg67-Pg1-Ps202Cg67-Pg1-Ps203Cg67-Pg1-Ps204
Cg67-Pg1-Ps205Cg67-Pg1-Ps206Cg67-Pg1-Ps207Cg67-Pg1-Ps208
Cg67-Pg1-Ps209Cg67-Pg1-Ps210Cg67-Pg1-Ps211Cg67-Pg1-Ps212
Cg67-Pg1-Ps213Cg67-Pg1-Ps214Cg67-Pg1-Ps215Cg67-Pg1-Ps216
Cg67-Pg1-Ps217Cg67-Pg1-Ps218Cg67-Pg1-Ps219Cg67-Pg1-Ps220
Cg67-Pg1-Ps221Cg67-Pg1-Ps222Cg67-Pg1-Ps223Cg67-Pg1-Ps224
Cg67-Pg1-Ps225Cg67-Pg1-Ps226Cg67-Pg1-Ps227Cg67-Pg1-Ps228
Cg67-Pg1-Ps229Cg67-Pg1-Ps230Cg67-Pg1-Ps231Cg67-Pg1-Ps232
Cg67-Pg1-Ps233Cg67-Pg1-Ps234Cg67-Pg1-Ps235Cg67-Pg1-Ps236
Cg67-Pg1-Ps237Cg67-Pg1-Ps238Cg67-Pg1-Ps239Cg67-Pg1-Ps240
Cg67-Pg1-Ps241Cg67-Pg1-Ps242Cg67-Pg1-Ps243
Cg68-Pg1-Ps1Cg68-Pg1-Ps2Cg68-Pg1-Ps3Cg68-Pg1-Ps4
Cg68-Pg1-Ps5Cg68-Pg1-Ps6Cg68-Pg1-Ps7Cg68-Pg1-Ps8
Cg68-Pg1-Ps9Cg68-Pg1-Ps10Cg68-Pg1-Ps11Cg68-Pg1-Ps12
Cg68-Pg1-Ps13Cg68-Pg1-Ps14Cg68-Pg1-Ps15Cg68-Pg1-Ps16
Cg68-Pg1-Ps17Cg68-Pg1-Ps18Cg68-Pg1-Ps19Cg68-Pg1-Ps20
Cg68-Pg1-Ps21Cg68-Pg1-Ps22Cg68-Pg1-Ps23Cg68-Pg1-Ps24
Cg68-Pg1-Ps25Cg68-Pg1-Ps26Cg68-Pg1-Ps27Cg68-Pg1-Ps28
Cg68-Pg1-Ps29Cg68-Pg1-Ps30Cg68-Pg1-Ps31Cg68-Pg1-Ps32
Cg68-Pg1-Ps33Cg68-Pg1-Ps34Cg68-Pg1-Ps35Cg68-Pg1-Ps36
Cg68-Pg1-Ps37Cg68-Pg1-Ps38Cg68-Pg1-Ps39Cg68-Pg1-Ps40
Cg68-Pg1-Ps41Cg68-Pg1-Ps42Cg68-Pg1-Ps43Cg68-Pg1-Ps44
Cg68-Pg1-Ps45Cg68-Pg1-Ps46Cg68-Pg1-Ps47Cg68-Pg1-Ps48
Cg68-Pg1-Ps49Cg68-Pg1-Ps50Cg68-Pg1-Ps51Cg68-Pg1-Ps52
Cg68-Pg1-Ps53Cg68-Pg1-Ps54Cg68-Pg1-Ps55Cg68-Pg1-Ps56
Cg68-Pg1-Ps57Cg68-Pg1-Ps58Cg68-Pg1-Ps59Cg68-Pg1-Ps60
Cg68-Pg1-Ps61Cg68-Pg1-Ps62Cg68-Pg1-Ps63Cg68-Pg1-Ps64
Cg68-Pg1-Ps65Cg68-Pg1-Ps66Cg68-Pg1-Ps67Cg68-Pg1-Ps68
Cg68-Pg1-Ps69Cg68-Pg1-Ps70Cg68-Pg1-Ps71Cg68-Pg1-Ps72
Cg68-Pg1-Ps73Cg68-Pg1-Ps74Cg68-Pg1-Ps75Cg68-Pg1-Ps76
Cg68-Pg1-Ps77Cg68-Pg1-Ps78Cg68-Pg1-Ps79Cg68-Pg1-Ps80
Cg68-Pg1-Ps81Cg68-Pg1-Ps82Cg68-Pg1-Ps83Cg68-Pg1-Ps84
Cg68-Pg1-Ps85Cg68-Pg1-Ps86Cg68-Pg1-Ps87Cg68-Pg1-Ps88
Cg68-Pg1-Ps89Cg68-Pg1-Ps90Cg68-Pg1-Ps91Cg68-Pg1-Ps92
Cg68-Pg1-Ps93Cg68-Pg1-Ps94Cg68-Pg1-Ps95Cg68-Pg1-Ps96
Cg68-Pg1-Ps97Cg68-Pg1-Ps98Cg68-Pg1-Ps99Cg68-Pg1-Ps100
Cg68-Pg1-Ps101Cg68-Pg1-Ps102Cg68-Pg1-Ps103Cg68-Pg1-Ps104
Cg68-Pg1-Ps105Cg68-Pg1-Ps106Cg68-Pg1-Ps107Cg68-Pg1-Ps108
Cg68-Pg1-Ps109Cg68-Pg1-Ps110Cg68-Pg1-Ps111Cg68-Pg1-Ps112
Cg68-Pg1-Ps113Cg68-Pg1-Ps114Cg68-Pg1-Ps115Cg68-Pg1-Ps116
Cg68-Pg1-Ps117Cg68-Pg1-Ps118Cg68-Pg1-Ps119Cg68-Pg1-Ps120
Cg68-Pg1-Ps121Cg68-Pg1-Ps122Cg68-Pg1-Ps123Cg68-Pg1-Ps124
Cg68-Pg1-Ps125Cg68-Pg1-Ps126Cg68-Pg1-Ps127Cg68-Pg1-Ps128
Cg68-Pg1-Ps129Cg68-Pg1-Ps130Cg68-Pg1-Ps131Cg68-Pg1-Ps132
Cg68-Pg1-Ps133Cg68-Pg1-Ps134Cg68-Pg1-Ps135Cg68-Pg1-Ps136
Cg68-Pg1-Ps137Cg68-Pg1-Ps138Cg68-Pg1-Ps139Cg68-Pg1-Ps140
Cg68-Pg1-Ps141Cg68-Pg1-Ps142Cg68-Pg1-Ps143Cg68-Pg1-Ps144
Cg68-Pg1-Ps145Cg68-Pg1-Ps146Cg68-Pg1-Ps147Cg68-Pg1-Ps148
Cg68-Pg1-Ps149Cg68-Pg1-Ps150Cg68-Pg1-Ps151Cg68-Pg1-Ps152
Cg68-Pg1-Ps153Cg68-Pg1-Ps154Cg68-Pg1-Ps155Cg68-Pg1-Ps156
Cg68-Pg1-Ps157Cg68-Pg1-Ps158Cg68-Pg1-Ps159Cg68-Pg1-Ps160
Cg68-Pg1-Ps161Cg68-Pg1-Ps162Cg68-Pg1-Ps163Cg68-Pg1-Ps164
Cg68-Pg1-Ps165Cg68-Pg1-Ps166Cg68-Pg1-Ps167Cg68-Pg1-Ps168
Cg68-Pg1-Ps169Cg68-Pg1-Ps170Cg68-Pg1-Ps171Cg68-Pg1-Ps172
Cg68-Pg1-Ps173Cg68-Pg1-Ps174Cg68-Pg1-Ps175Cg68-Pg1-Ps176
Cg68-Pg1-Ps177Cg68-Pg1-Ps178Cg68-Pg1-Ps179Cg68-Pg1-Ps180
Cg68-Pg1-Ps181Cg68-Pg1-Ps182Cg68-Pg1-Ps183Cg68-Pg1-Ps184
Cg68-Pg1-Ps185Cg68-Pg1-Ps186Cg68-Pg1-Ps187Cg68-Pg1-Ps188
Cg68-Pg1-Ps189Cg68-Pg1-Ps190Cg68-Pg1-Ps191Cg68-Pg1-Ps192
Cg68-Pg1-Ps193Cg68-Pg1-Ps194Cg68-Pg1-Ps195Cg68-Pg1-Ps196
Cg68-Pg1-Ps197Cg68-Pg1-Ps198Cg68-Pg1-Ps199Cg68-Pg1-Ps200
Cg68-Pg1-Ps201Cg68-Pg1-Ps202Cg68-Pg1-Ps203Cg68-Pg1-Ps204
Cg68-Pg1-Ps205Cg68-Pg1-Ps206Cg68-Pg1-Ps207Cg68-Pg1-Ps208
Cg68-Pg1-Ps209Cg68-Pg1-Ps210Cg68-Pg1-Ps211Cg68-Pg1-Ps212
Cg68-Pg1-Ps213Cg68-Pg1-Ps214Cg68-Pg1-Ps215Cg68-Pg1-Ps216
Cg68-Pg1-Ps217Cg68-Pg1-Ps218Cg68-Pg1-Ps219Cg68-Pg1-Ps220
Cg68-Pg1-Ps221Cg68-Pg1-Ps222Cg68-Pg1-Ps223Cg68-Pg1-Ps224
Cg68-Pg1-Ps225Cg68-Pg1-Ps226Cg68-Pg1-Ps227Cg68-Pg1-Ps228
Cg68-Pg1-Ps229Cg68-Pg1-Ps230Cg68-Pg1-Ps231Cg68-Pg1-Ps232
Cg68-Pg1-Ps233Cg68-Pg1-Ps234Cg68-Pg1-Ps235Cg68-Pg1-Ps236
Cg68-Pg1-Ps237Cg68-Pg1-Ps238Cg68-Pg1-Ps239Cg68-Pg1-Ps240
Cg68-Pg1-Ps241Cg68-Pg1-Ps242Cg68-Pg1-Ps243
Cg69-Pg1-Ps1Cg69-Pg1-Ps2Cg69-Pg1-Ps3Cg69-Pg1-Ps4
Cg69-Pg1-Ps5Cg69-Pg1-Ps6Cg69-Pg1-Ps7Cg69-Pg1-Ps8
Cg69-Pg1-Ps9Cg69-Pg1-Ps10Cg69-Pg1-Ps11Cg69-Pg1-Ps12
Cg69-Pg1-Ps13Cg69-Pg1-Ps14Cg69-Pg1-Ps15Cg69-Pg1-Ps16
Cg69-Pg1-Ps17Cg69-Pg1-Ps18Cg69-Pg1-Ps19Cg69-Pg1-Ps20
Cg69-Pg1-Ps21Cg69-Pg1-Ps22Cg69-Pg1-Ps23Cg69-Pg1-Ps24
Cg69-Pg1-Ps25Cg69-Pg1-Ps26Cg69-Pg1-Ps27Cg69-Pg1-Ps28
Cg69-Pg1-Ps29Cg69-Pg1-Ps30Cg69-Pg1-Ps31Cg69-Pg1-Ps32
Cg69-Pg1-Ps33Cg69-Pg1-Ps34Cg69-Pg1-Ps35Cg69-Pg1-Ps36
Cg69-Pg1-Ps37Cg69-Pg1-Ps38Cg69-Pg1-Ps39Cg69-Pg1-Ps40
Cg69-Pg1-Ps41Cg69-Pg1-Ps42Cg69-Pg1-Ps43Cg69-Pg1-Ps44
Cg69-Pg1-Ps45Cg69-Pg1-Ps46Cg69-Pg1-Ps47Cg69-Pg1-Ps48
Cg69-Pg1-Ps49Cg69-Pg1-Ps50Cg69-Pg1-Ps51Cg69-Pg1-Ps52
Cg69-Pg1-Ps53Cg69-Pg1-Ps54Cg69-Pg1-Ps55Cg69-Pg1-Ps56
Cg69-Pg1-Ps57Cg69-Pg1-Ps58Cg69-Pg1-Ps59Cg69-Pg1-Ps60
Cg69-Pg1-Ps61Cg69-Pg1-Ps62Cg69-Pg1-Ps63Cg69-Pg1-Ps64
Cg69-Pg1-Ps65Cg69-Pg1-Ps66Cg69-Pg1-Ps67Cg69-Pg1-Ps68
Cg69-Pg1-Ps69Cg69-Pg1-Ps70Cg69-Pg1-Ps71Cg69-Pg1-Ps72
Cg69-Pg1-Ps73Cg69-Pg1-Ps74Cg69-Pg1-Ps75Cg69-Pg1-Ps76
Cg69-Pg1-Ps77Cg69-Pg1-Ps78Cg69-Pg1-Ps79Cg69-Pg1-Ps80
Cg69-Pg1-Ps81Cg69-Pg1-Ps82Cg69-Pg1-Ps83Cg69-Pg1-Ps84
Cg69-Pg1-Ps85Cg69-Pg1-Ps86Cg69-Pg1-Ps87Cg69-Pg1-Ps88
Cg69-Pg1-Ps89Cg69-Pg1-Ps90Cg69-Pg1-Ps91Cg69-Pg1-Ps92
Cg69-Pg1-Ps93Cg69-Pg1-Ps94Cg69-Pg1-Ps95Cg69-Pg1-Ps96
Cg69-Pg1-Ps97Cg69-Pg1-Ps98Cg69-Pg1-Ps99Cg69-Pg1-Ps100
Cg69-Pg1-Ps101Cg69-Pg1-Ps102Cg69-Pg1-Ps103Cg69-Pg1-Ps104
Cg69-Pg1-Ps105Cg69-Pg1-Ps106Cg69-Pg1-Ps107Cg69-Pg1-Ps108
Cg69-Pg1-Ps109Cg69-Pg1-Ps110Cg69-Pg1-Ps111Cg69-Pg1-Ps112
Cg69-Pg1-Ps113Cg69-Pg1-Ps114Cg69-Pg1-Ps115Cg69-Pg1-Ps116
Cg69-Pg1-Ps117Cg69-Pg1-Ps118Cg69-Pg1-Ps119Cg69-Pg1-Ps120
Cg69-Pg1-Ps121Cg69-Pg1-Ps122Cg69-Pg1-Ps123Cg69-Pg1-Ps124
Cg69-Pg1-Ps125Cg69-Pg1-Ps126Cg69-Pg1-Ps127Cg69-Pg1-Ps128
Cg69-Pg1-Ps129Cg69-Pg1-Ps130Cg69-Pg1-Ps131Cg69-Pg1-Ps132
Cg69-Pg1-Ps133Cg69-Pg1-Ps134Cg69-Pg1-Ps135Cg69-Pg1-Ps136
Cg69-Pg1-Ps137Cg69-Pg1-Ps138Cg69-Pg1-Ps139Cg69-Pg1-Ps140
Cg69-Pg1-Ps141Cg69-Pg1-Ps142Cg69-Pg1-Ps143Cg69-Pg1-Ps144
Cg69-Pg1-Ps145Cg69-Pg1-Ps146Cg69-Pg1-Ps147Cg69-Pg1-Ps148
Cg69-Pg1-Ps149Cg69-Pg1-Ps150Cg69-Pg1-Ps151Cg69-Pg1-Ps152
Cg69-Pg1-Ps153Cg69-Pg1-Ps154Cg69-Pg1-Ps155Cg69-Pg1-Ps156
Cg69-Pg1-Ps157Cg69-Pg1-Ps158Cg69-Pg1-Ps159Cg69-Pg1-Ps160
Cg69-Pg1-Ps161Cg69-Pg1-Ps162Cg69-Pg1-Ps163Cg69-Pg1-Ps164
Cg69-Pg1-Ps165Cg69-Pg1-Ps166Cg69-Pg1-Ps167Cg69-Pg1-Ps168
Cg69-Pg1-Ps169Cg69-Pg1-Ps170Cg69-Pg1-Ps171Cg69-Pg1-Ps172
Cg69-Pg1-Ps173Cg69-Pg1-Ps174Cg69-Pg1-Ps175Cg69-Pg1-Ps176
Cg69-Pg1-Ps177Cg69-Pg1-Ps178Cg69-Pg1-Ps179Cg69-Pg1-Ps180
Cg69-Pg1-Ps181Cg69-Pg1-Ps182Cg69-Pg1-Ps183Cg69-Pg1-Ps184
Cg69-Pg1-Ps185Cg69-Pg1-Ps186Cg69-Pg1-Ps187Cg69-Pg1-Ps188
Cg69-Pg1-Ps189Cg69-Pg1-Ps190Cg69-Pg1-Ps191Cg69-Pg1-Ps192
Cg69-Pg1-Ps193Cg69-Pg1-Ps194Cg69-Pg1-Ps195Cg69-Pg1-Ps196
Cg69-Pg1-Ps197Cg69-Pg1-Ps198Cg69-Pg1-Ps199Cg69-Pg1-Ps200
Cg69-Pg1-Ps201Cg69-Pg1-Ps202Cg69-Pg1-Ps203Cg69-Pg1-Ps204
Cg69-Pg1-Ps205Cg69-Pg1-Ps206Cg69-Pg1-Ps207Cg69-Pg1-Ps208
Cg69-Pg1-Ps209Cg69-Pg1-Ps210Cg69-Pg1-Ps211Cg69-Pg1-Ps212
Cg69-Pg1-Ps213Cg69-Pg1-Ps214Cg69-Pg1-Ps215Cg69-Pg1-Ps216
Cg69-Pg1-Ps217Cg69-Pg1-Ps218Cg69-Pg1-Ps219Cg69-Pg1-Ps220
Cg69-Pg1-Ps221Cg69-Pg1-Ps222Cg69-Pg1-Ps223Cg69-Pg1-Ps224
Cg69-Pg1-Ps225Cg69-Pg1-Ps226Cg69-Pg1-Ps227Cg69-Pg1-Ps228
Cg69-Pg1-Ps229Cg69-Pg1-Ps230Cg69-Pg1-Ps231Cg69-Pg1-Ps232
Cg69-Pg1-Ps233Cg69-Pg1-Ps234Cg69-Pg1-Ps235Cg69-Pg1-Ps236
Cg69-Pg1-Ps237Cg69-Pg1-Ps238Cg69-Pg1-Ps239Cg69-Pg1-Ps240
Cg69-Pg1-Ps241Cg69-Pg1-Ps242Cg69-Pg1-Ps243
Cg70-Pg1-Ps1Cg70-Pg1-Ps2Cg70-Pg1-Ps3Cg70-Pg1-Ps4
Cg70-Pg1-Ps5Cg70-Pg1-Ps6Cg70-Pg1-Ps7Cg70-Pg1-Ps8
Cg70-Pg1-Ps9Cg70-Pg1-Ps10Cg70-Pg1-Ps11Cg70-Pg1-Ps12
Cg70-Pg1-Ps13Cg70-Pg1-Ps14Cg70-Pg1-Ps15Cg70-Pg1-Ps16
Cg70-Pg1-Ps17Cg70-Pg1-Ps18Cg70-Pg1-Ps19Cg70-Pg1-Ps20
Cg70-Pg1-Ps21Cg70-Pg1-Ps22Cg70-Pg1-Ps23Cg70-Pg1-Ps24
Cg70-Pg1-Ps25Cg70-Pg1-Ps26Cg70-Pg1-Ps27Cg70-Pg1-Ps28
Cg70-Pg1-Ps29Cg70-Pg1-Ps30Cg70-Pg1-Ps31Cg70-Pg1-Ps32
Cg70-Pg1-Ps33Cg70-Pg1-Ps34Cg70-Pg1-Ps35Cg70-Pg1-Ps36
Cg70-Pg1-Ps37Cg70-Pg1-Ps38Cg70-Pg1-Ps39Cg70-Pg1-Ps40
Cg70-Pg1-Ps41Cg70-Pg1-Ps42Cg70-Pg1-Ps43Cg70-Pg1-Ps44
Cg70-Pg1-Ps45Cg70-Pg1-Ps46Cg70-Pg1-Ps47Cg70-Pg1-Ps48
Cg70-Pg1-Ps49Cg70-Pg1-Ps50Cg70-Pg1-Ps51Cg70-Pg1-Ps52
Cg70-Pg1-Ps53Cg70-Pg1-Ps54Cg70-Pg1-Ps55Cg70-Pg1-Ps56
Cg70-Pg1-Ps57Cg70-Pg1-Ps58Cg70-Pg1-Ps59Cg70-Pg1-Ps60
Cg70-Pg1-Ps61Cg70-Pg1-Ps62Cg70-Pg1-Ps63Cg70-Pg1-Ps64
Cg70-Pg1-Ps65Cg70-Pg1-Ps66Cg70-Pg1-Ps67Cg70-Pg1-Ps68
Cg70-Pg1-Ps69Cg70-Pg1-Ps70Cg70-Pg1-Ps71Cg70-Pg1-Ps72
Cg70-Pg1-Ps73Cg70-Pg1-Ps74Cg70-Pg1-Ps75Cg70-Pg1-Ps76
Cg70-Pg1-Ps77Cg70-Pg1-Ps78Cg70-Pg1-Ps79Cg70-Pg1-Ps80
Cg70-Pg1-Ps81Cg70-Pg1-Ps82Cg70-Pg1-Ps83Cg70-Pg1-Ps84
Cg70-Pg1-Ps85Cg70-Pg1-Ps86Cg70-Pg1-Ps87Cg70-Pg1-Ps88
Cg70-Pg1-Ps89Cg70-Pg1-Ps90Cg70-Pg1-Ps91Cg70-Pg1-Ps92
Cg70-Pg1-Ps93Cg70-Pg1-Ps94Cg70-Pg1-Ps95Cg70-Pg1-Ps96
Cg70-Pg1-Ps97Cg70-Pg1-Ps98Cg70-Pg1-Ps99Cg70-Pg1-Ps100
Cg70-Pg1-Ps101Cg70-Pg1-Ps102Cg70-Pg1-Ps103Cg70-Pg1-Ps104
Cg70-Pg1-Ps105Cg70-Pg1-Ps106Cg70-Pg1-Ps107Cg70-Pg1-Ps108
Cg70-Pg1-Ps109Cg70-Pg1-Ps110Cg70-Pg1-Ps111Cg70-Pg1-Ps112
Cg70-Pg1-Ps113Cg70-Pg1-Ps114Cg70-Pg1-Ps115Cg70-Pg1-Ps116
Cg70-Pg1-Ps117Cg70-Pg1-Ps118Cg70-Pg1-Ps119Cg70-Pg1-Ps120
Cg70-Pg1-Ps121Cg70-Pg1-Ps122Cg70-Pg1-Ps123Cg70-Pg1-Ps124
Cg70-Pg1-Ps125Cg70-Pg1-Ps126Cg70-Pg1-Ps127Cg70-Pg1-Ps128
Cg70-Pg1-Ps129Cg70-Pg1-Ps130Cg70-Pg1-Ps131Cg70-Pg1-Ps132
Cg70-Pg1-Ps133Cg70-Pg1-Ps134Cg70-Pg1-Ps135Cg70-Pg1-Ps136
Cg70-Pg1-Ps137Cg70-Pg1-Ps138Cg70-Pg1-Ps139Cg70-Pg1-Ps140
Cg70-Pg1-Ps141Cg70-Pg1-Ps142Cg70-Pg1-Ps143Cg70-Pg1-Ps144
Cg70-Pg1-Ps145Cg70-Pg1-Ps146Cg70-Pg1-Ps147Cg70-Pg1-Ps148
Cg70-Pg1-Ps149Cg70-Pg1-Ps150Cg70-Pg1-Ps151Cg70-Pg1-Ps152
Cg70-Pg1-Ps153Cg70-Pg1-Ps154Cg70-Pg1-Ps155Cg70-Pg1-Ps156
Cg70-Pg1-Ps157Cg70-Pg1-Ps158Cg70-Pg1-Ps159Cg70-Pg1-Ps160
Cg70-Pg1-Ps161Cg70-Pg1-Ps162Cg70-Pg1-Ps163Cg70-Pg1-Ps164
Cg70-Pg1-Ps165Cg70-Pg1-Ps166Cg70-Pg1-Ps167Cg70-Pg1-Ps168
Cg70-Pg1-Ps169Cg70-Pg1-Ps170Cg70-Pg1-Ps171Cg70-Pg1-Ps172
Cg70-Pg1-Ps173Cg70-Pg1-Ps174Cg70-Pg1-Ps175Cg70-Pg1-Ps176
Cg70-Pg1-Ps177Cg70-Pg1-Ps178Cg70-Pg1-Ps179Cg70-Pg1-Ps180
Cg70-Pg1-Ps181Cg70-Pg1-Ps182Cg70-Pg1-Ps183Cg70-Pg1-Ps184
Cg70-Pg1-Ps185Cg70-Pg1-Ps186Cg70-Pg1-Ps187Cg70-Pg1-Ps188
Cg70-Pg1-Ps189Cg70-Pg1-Ps190Cg70-Pg1-Ps191Cg70-Pg1-Ps192
Cg70-Pg1-Ps193Cg70-Pg1-Ps194Cg70-Pg1-Ps195Cg70-Pg1-Ps196
Cg70-Pg1-Ps197Cg70-Pg1-Ps198Cg70-Pg1-Ps199Cg70-Pg1-Ps200
Cg70-Pg1-Ps201Cg70-Pg1-Ps202Cg70-Pg1-Ps203Cg70-Pg1-Ps204
Cg70-Pg1-Ps205Cg70-Pg1-Ps206Cg70-Pg1-Ps207Cg70-Pg1-Ps208
Cg70-Pg1-Ps209Cg70-Pg1-Ps210Cg70-Pg1-Ps211Cg70-Pg1-Ps212
Cg70-Pg1-Ps213Cg70-Pg1-Ps214Cg70-Pg1-Ps215Cg70-Pg1-Ps216
Cg70-Pg1-Ps217Cg70-Pg1-Ps218Cg70-Pg1-Ps219Cg70-Pg1-Ps220
Cg70-Pg1-Ps221Cg70-Pg1-Ps222Cg70-Pg1-Ps223Cg70-Pg1-Ps224
Cg70-Pg1-Ps225Cg70-Pg1-Ps226Cg70-Pg1-Ps227Cg70-Pg1-Ps228
Cg70-Pg1-Ps229Cg70-Pg1-Ps230Cg70-Pg1-Ps231Cg70-Pg1-Ps232
Cg70-Pg1-Ps233Cg70-Pg1-Ps234Cg70-Pg1-Ps235Cg70-Pg1-Ps236
Cg70-Pg1-Ps237Cg70-Pg1-Ps238Cg70-Pg1-Ps239Cg70-Pg1-Ps240
Cg70-Pg1-Ps241Cg70-Pg1-Ps242Cg70-Pg1-Ps243
Cg73-Pg1-Ps1Cg73-Pg1-Ps2Cg73-Pg1-Ps3Cg73-Pg1-Ps4
Cg73-Pg1-Ps5Cg73-Pg1-Ps6Cg73-Pg1-Ps7Cg73-Pg1-Ps8
Cg73-Pg1-Ps9Cg73-Pg1-Ps10Cg73-Pg1-Ps11Cg73-Pg1-Ps12
Cg73-Pg1-Ps13Cg73-Pg1-Ps14Cg73-Pg1-Ps15Cg73-Pg1-Ps16
Cg73-Pg1-Ps17Cg73-Pg1-Ps18Cg73-Pg1-Ps19Cg73-Pg1-Ps20
Cg73-Pg1-Ps21Cg73-Pg1-Ps22Cg73-Pg1-Ps23Cg73-Pg1-Ps24
Cg73-Pg1-Ps25Cg73-Pg1-Ps26Cg73-Pg1-Ps27Cg73-Pg1-Ps28
Cg73-Pg1-Ps29Cg73-Pg1-Ps30Cg73-Pg1-Ps31Cg73-Pg1-Ps32
Cg73-Pg1-Ps33Cg73-Pg1-Ps34Cg73-Pg1-Ps35Cg73-Pg1-Ps36
Cg73-Pg1-Ps37Cg73-Pg1-Ps38Cg73-Pg1-Ps39Cg73-Pg1-Ps40
Cg73-Pg1-Ps41Cg73-Pg1-Ps42Cg73-Pg1-Ps43Cg73-Pg1-Ps44
Cg73-Pg1-Ps45Cg73-Pg1-Ps46Cg73-Pg1-Ps47Cg73-Pg1-Ps48
Cg73-Pg1-Ps49Cg73-Pg1-Ps50Cg73-Pg1-Ps51Cg73-Pg1-Ps52
Cg73-Pg1-Ps53Cg73-Pg1-Ps54Cg73-Pg1-Ps55Cg73-Pg1-Ps56
Cg73-Pg1-Ps57Cg73-Pg1-Ps58Cg73-Pg1-Ps59Cg73-Pg1-Ps60
Cg73-Pg1-Ps61Cg73-Pg1-Ps62Cg73-Pg1-Ps63Cg73-Pg1-Ps64
Cg73-Pg1-Ps65Cg73-Pg1-Ps66Cg73-Pg1-Ps67Cg73-Pg1-Ps68
Cg73-Pg1-Ps69Cg73-Pg1-Ps70Cg73-Pg1-Ps71Cg73-Pg1-Ps72
Cg73-Pg1-Ps73Cg73-Pg1-Ps74Cg73-Pg1-Ps75Cg73-Pg1-Ps76
Cg73-Pg1-Ps77Cg73-Pg1-Ps78Cg73-Pg1-Ps79Cg73-Pg1-Ps80
Cg73-Pg1-Ps81Cg73-Pg1-Ps82Cg73-Pg1-Ps83Cg73-Pg1-Ps84
Cg73-Pg1-Ps85Cg73-Pg1-Ps86Cg73-Pg1-Ps87Cg73-Pg1-Ps88
Cg73-Pg1-Ps89Cg73-Pg1-Ps90Cg73-Pg1-Ps91Cg73-Pg1-Ps92
Cg73-Pg1-Ps93Cg73-Pg1-Ps94Cg73-Pg1-Ps95Cg73-Pg1-Ps96
Cg73-Pg1-Ps97Cg73-Pg1-Ps98Cg73-Pg1-Ps99Cg73-Pg1-Ps100
Cg73-Pg1-Ps101Cg73-Pg1-Ps102Cg73-Pg1-Ps103Cg73-Pg1-Ps104
Cg73-Pg1-Ps105Cg73-Pg1-Ps106Cg73-Pg1-Ps107Cg73-Pg1-Ps108
Cg73-Pg1-Ps109Cg73-Pg1-Ps110Cg73-Pg1-Ps111Cg73-Pg1-Ps112
Cg73-Pg1-Ps113Cg73-Pg1-Ps114Cg73-Pg1-Ps115Cg73-Pg1-Ps116
Cg73-Pg1-Ps117Cg73-Pg1-Ps118Cg73-Pg1-Ps119Cg73-Pg1-Ps120
Cg73-Pg1-Ps121Cg73-Pg1-Ps122Cg73-Pg1-Ps123Cg73-Pg1-Ps124
Cg73-Pg1-Ps125Cg73-Pg1-Ps126Cg73-Pg1-Ps127Cg73-Pg1-Ps128
Cg73-Pg1-Ps129Cg73-Pg1-Ps130Cg73-Pg1-Ps131Cg73-Pg1-Ps132
Cg73-Pg1-Ps133Cg73-Pg1-Ps134Cg73-Pg1-Ps135Cg73-Pg1-Ps136
Cg73-Pg1-Ps137Cg73-Pg1-Ps138Cg73-Pg1-Ps139Cg73-Pg1-Ps140
Cg73-Pg1-Ps141Cg73-Pg1-Ps142Cg73-Pg1-Ps143Cg73-Pg1-Ps144
Cg73-Pg1-Ps145Cg73-Pg1-Ps146Cg73-Pg1-Ps147Cg73-Pg1-Ps148
Cg73-Pg1-Ps149Cg73-Pg1-Ps150Cg73-Pg1-Ps151Cg73-Pg1-Ps152
Cg73-Pg1-Ps153Cg73-Pg1-Ps154Cg73-Pg1-Ps155Cg73-Pg1-Ps156
Cg73-Pg1-Ps157Cg73-Pg1-Ps158Cg73-Pg1-Ps159Cg73-Pg1-Ps160
Cg73-Pg1-Ps161Cg73-Pg1-Ps162Cg73-Pg1-Ps163Cg73-Pg1-Ps164
Cg73-Pg1-Ps165Cg73-Pg1-Ps166Cg73-Pg1-Ps167Cg73-Pg1-Ps168
Cg73-Pg1-Ps169Cg73-Pg1-Ps170Cg73-Pg1-Ps171Cg73-Pg1-Ps172
Cg73-Pg1-Ps173Cg73-Pg1-Ps174Cg73-Pg1-Ps175Cg73-Pg1-Ps176
Cg73-Pg1-Ps177Cg73-Pg1-Ps178Cg73-Pg1-Ps179Cg73-Pg1-Ps180
Cg73-Pg1-Ps181Cg73-Pg1-Ps182Cg73-Pg1-Ps183Cg73-Pg1-Ps184
Cg73-Pg1-Ps185Cg73-Pg1-Ps186Cg73-Pg1-Ps187Cg73-Pg1-Ps188
Cg73-Pg1-Ps189Cg73-Pg1-Ps190Cg73-Pg1-Ps191Cg73-Pg1-Ps192
Cg73-Pg1-Ps193Cg73-Pg1-Ps194Cg73-Pg1-Ps195Cg73-Pg1-Ps196
Cg73-Pg1-Ps197Cg73-Pg1-Ps198Cg73-Pg1-Ps199Cg73-Pg1-Ps200
Cg73-Pg1-Ps201Cg73-Pg1-Ps202Cg73-Pg1-Ps203Cg73-Pg1-Ps204
Cg73-Pg1-Ps205Cg73-Pg1-Ps206Cg73-Pg1-Ps207Cg73-Pg1-Ps208
Cg73-Pg1-Ps209Cg73-Pg1-Ps210Cg73-Pg1-Ps211Cg73-Pg1-Ps212
Cg73-Pg1-Ps213Cg73-Pg1-Ps214Cg73-Pg1-Ps215Cg73-Pg1-Ps216
Cg73-Pg1-Ps217Cg73-Pg1-Ps218Cg73-Pg1-Ps219Cg73-Pg1-Ps220
Cg73-Pg1-Ps221Cg73-Pg1-Ps222Cg73-Pg1-Ps223Cg73-Pg1-Ps224
Cg73-Pg1-Ps225Cg73-Pg1-Ps226Cg73-Pg1-Ps227Cg73-Pg1-Ps228
Cg73-Pg1-Ps229Cg73-Pg1-Ps230Cg73-Pg1-Ps231Cg73-Pg1-Ps232
Cg73-Pg1-Ps233Cg73-Pg1-Ps234Cg73-Pg1-Ps235Cg73-Pg1-Ps236
Cg73-Pg1-Ps237Cg73-Pg1-Ps238Cg73-Pg1-Ps239Cg73-Pg1-Ps240
Cg73-Pg1-Ps241Cg73-Pg1-Ps242Cg73-Pg1-Ps243
Cg74-Pg1-Ps1Cg74-Pg1-Ps2Cg74-Pg1-Ps3Cg74-Pg1-Ps4
Cg74-Pg1-Ps5Cg74-Pg1-Ps6Cg74-Pg1-Ps7Cg74-Pg1-Ps8
Cg74-Pg1-Ps9Cg74-Pg1-Ps10Cg74-Pg1-Ps11Cg74-Pg1-Ps12
Cg74-Pg1-Ps13Cg74-Pg1-Ps14Cg74-Pg1-Ps15Cg74-Pg1-Ps16
Cg74-Pg1-Ps17Cg74-Pg1-Ps18Cg74-Pg1-Ps19Cg74-Pg1-Ps20
Cg74-Pg1-Ps21Cg74-Pg1-Ps22Cg74-Pg1-Ps23Cg74-Pg1-Ps24
Cg74-Pg1-Ps25Cg74-Pg1-Ps26Cg74-Pg1-Ps27Cg74-Pg1-Ps28
Cg74-Pg1-Ps29Cg74-Pg1-Ps30Cg74-Pg1-Ps31Cg74-Pg1-Ps32
Cg74-Pg1-Ps33Cg74-Pg1-Ps34Cg74-Pg1-Ps35Cg74-Pg1-Ps36
Cg74-Pg1-Ps37Cg74-Pg1-Ps38Cg74-Pg1-Ps39Cg74-Pg1-Ps40
Cg74-Pg1-Ps41Cg74-Pg1-Ps42Cg74-Pg1-Ps43Cg74-Pg1-Ps44
Cg74-Pg1-Ps45Cg74-Pg1-Ps46Cg74-Pg1-Ps47Cg74-Pg1-Ps48
Cg74-Pg1-Ps49Cg74-Pg1-Ps50Cg74-Pg1-Ps51Cg74-Pg1-Ps52
Cg74-Pg1-Ps53Cg74-Pg1-Ps54Cg74-Pg1-Ps55Cg74-Pg1-Ps56
Cg74-Pg1-Ps57Cg74-Pg1-Ps58Cg74-Pg1-Ps59Cg74-Pg1-Ps60
Cg74-Pg1-Ps61Cg74-Pg1-Ps62Cg74-Pg1-Ps63Cg74-Pg1-Ps64
Cg74-Pg1-Ps65Cg74-Pg1-Ps66Cg74-Pg1-Ps67Cg74-Pg1-Ps68
Cg74-Pg1-Ps69Cg74-Pg1-Ps70Cg74-Pg1-Ps71Cg74-Pg1-Ps72
Cg74-Pg1-Ps73Cg74-Pg1-Ps74Cg74-Pg1-Ps75Cg74-Pg1-Ps76
Cg74-Pg1-Ps77Cg74-Pg1-Ps78Cg74-Pg1-Ps79Cg74-Pg1-Ps80
Cg74-Pg1-Ps81Cg74-Pg1-Ps82Cg74-Pg1-Ps83Cg74-Pg1-Ps84
Cg74-Pg1-Ps85Cg74-Pg1-Ps86Cg74-Pg1-Ps87Cg74-Pg1-Ps88
Cg74-Pg1-Ps89Cg74-Pg1-Ps90Cg74-Pg1-Ps91Cg74-Pg1-Ps92
Cg74-Pg1-Ps93Cg74-Pg1-Ps94Cg74-Pg1-Ps95Cg74-Pg1-Ps96
Cg74-Pg1-Ps97Cg74-Pg1-Ps98Cg74-Pg1-Ps99Cg74-Pg1-Ps100
Cg74-Pg1-Ps101Cg74-Pg1-Ps102Cg74-Pg1-Ps103Cg74-Pg1-Ps104
Cg74-Pg1-Ps105Cg74-Pg1-Ps106Cg74-Pg1-Ps107Cg74-Pg1-Ps108
Cg74-Pg1-Ps109Cg74-Pg1-Ps110Cg74-Pg1-Ps111Cg74-Pg1-Ps112
Cg74-Pg1-Ps113Cg74-Pg1-Ps114Cg74-Pg1-Ps115Cg74-Pg1-Ps116
Cg74-Pg1-Ps117Cg74-Pg1-Ps118Cg74-Pg1-Ps119Cg74-Pg1-Ps120
Cg74-Pg1-Ps121Cg74-Pg1-Ps122Cg74-Pg1-Ps123Cg74-Pg1-Ps124
Cg74-Pg1-Ps125Cg74-Pg1-Ps126Cg74-Pg1-Ps127Cg74-Pg1-Ps128
Cg74-Pg1-Ps129Cg74-Pg1-Ps130Cg74-Pg1-Ps131Cg74-Pg1-Ps132
Cg74-Pg1-Ps133Cg74-Pg1-Ps134Cg74-Pg1-Ps135Cg74-Pg1-Ps136
Cg74-Pg1-Ps137Cg74-Pg1-Ps138Cg74-Pg1-Ps139Cg74-Pg1-Ps140
Cg74-Pg1-Ps141Cg74-Pg1-Ps142Cg74-Pg1-Ps143Cg74-Pg1-Ps144
Cg74-Pg1-Ps145Cg74-Pg1-Ps146Cg74-Pg1-Ps147Cg74-Pg1-Ps148
Cg74-Pg1-Ps149Cg74-Pg1-Ps150Cg74-Pg1-Ps151Cg74-Pg1-Ps152
Cg74-Pg1-Ps153Cg74-Pg1-Ps154Cg74-Pg1-Ps155Cg74-Pg1-Ps156
Cg74-Pg1-Ps157Cg74-Pg1-Ps158Cg74-Pg1-Ps159Cg74-Pg1-Ps160
Cg74-Pg1-Ps161Cg74-Pg1-Ps162Cg74-Pg1-Ps163Cg74-Pg1-Ps164
Cg74-Pg1-Ps165Cg74-Pg1-Ps166Cg74-Pg1-Ps167Cg74-Pg1-Ps168
Cg74-Pg1-Ps169Cg74-Pg1-Ps170Cg74-Pg1-Ps171Cg74-Pg1-Ps172
Cg74-Pg1-Ps173Cg74-Pg1-Ps174Cg74-Pg1-Ps175Cg74-Pg1-Ps176
Cg74-Pg1-Ps177Cg74-Pg1-Ps178Cg74-Pg1-Ps179Cg74-Pg1-Ps180
Cg74-Pg1-Ps181Cg74-Pg1-Ps182Cg74-Pg1-Ps183Cg74-Pg1-Ps184
Cg74-Pg1-Ps185Cg74-Pg1-Ps186Cg74-Pg1-Ps187Cg74-Pg1-Ps188
Cg74-Pg1-Ps189Cg74-Pg1-Ps190Cg74-Pg1-Ps191Cg74-Pg1-Ps192
Cg74-Pg1-Ps193Cg74-Pg1-Ps194Cg74-Pg1-Ps195Cg74-Pg1-Ps196
Cg74-Pg1-Ps197Cg74-Pg1-Ps198Cg74-Pg1-Ps199Cg74-Pg1-Ps200
Cg74-Pg1-Ps201Cg74-Pg1-Ps202Cg74-Pg1-Ps203Cg74-Pg1-Ps204
Cg74-Pg1-Ps205Cg74-Pg1-Ps206Cg74-Pg1-Ps207Cg74-Pg1-Ps208
Cg74-Pg1-Ps209Cg74-Pg1-Ps210Cg74-Pg1-Ps211Cg74-Pg1-Ps212
Cg74-Pg1-Ps213Cg74-Pg1-Ps214Cg74-Pg1-Ps215Cg74-Pg1-Ps216
Cg74-Pg1-Ps217Cg74-Pg1-Ps218Cg74-Pg1-Ps219Cg74-Pg1-Ps220
Cg74-Pg1-Ps221Cg74-Pg1-Ps222Cg74-Pg1-Ps223Cg74-Pg1-Ps224
Cg74-Pg1-Ps225Cg74-Pg1-Ps226Cg74-Pg1-Ps227Cg74-Pg1-Ps228
Cg74-Pg1-Ps229Cg74-Pg1-Ps230Cg74-Pg1-Ps231Cg74-Pg1-Ps232
Cg74-Pg1-Ps233Cg74-Pg1-Ps234Cg74-Pg1-Ps235Cg74-Pg1-Ps236
Cg74-Pg1-Ps237Cg74-Pg1-Ps238Cg74-Pg1-Ps239Cg74-Pg1-Ps240
Cg74-Pg1-Ps241Cg74-Pg1-Ps242Cg74-Pg1-Ps243
Cg75-Pg1-Ps1Cg75-Pg1-Ps2Cg75-Pg1-Ps3Cg75-Pg1-Ps4
Cg75-Pg1-Ps5Cg75-Pg1-Ps6Cg75-Pg1-Ps7Cg75-Pg1-Ps8
Cg75-Pg1-Ps9Cg75-Pg1-Ps10Cg75-Pg1-Ps11Cg75-Pg1-Ps12
Cg75-Pg1-Ps13Cg75-Pg1-Ps14Cg75-Pg1-Ps15Cg75-Pg1-Ps16
Cg75-Pg1-Ps17Cg75-Pg1-Ps18Cg75-Pg1-Ps19Cg75-Pg1-Ps20
Cg75-Pg1-Ps21Cg75-Pg1-Ps22Cg75-Pg1-Ps23Cg75-Pg1-Ps24
Cg75-Pg1-Ps25Cg75-Pg1-Ps26Cg75-Pg1-Ps27Cg75-Pg1-Ps28
Cg75-Pg1-Ps29Cg75-Pg1-Ps30Cg75-Pg1-Ps31Cg75-Pg1-Ps32
Cg75-Pg1-Ps33Cg75-Pg1-Ps34Cg75-Pg1-Ps35Cg75-Pg1-Ps36
Cg75-Pg1-Ps37Cg75-Pg1-Ps38Cg75-Pg1-Ps39Cg75-Pg1-Ps40
Cg75-Pg1-Ps41Cg75-Pg1-Ps42Cg75-Pg1-Ps43Cg75-Pg1-Ps44
Cg75-Pg1-Ps45Cg75-Pg1-Ps46Cg75-Pg1-Ps47Cg75-Pg1-Ps48
Cg75-Pg1-Ps49Cg75-Pg1-Ps50Cg75-Pg1-Ps51Cg75-Pg1-Ps52
Cg75-Pg1-Ps53Cg75-Pg1-Ps54Cg75-Pg1-Ps55Cg75-Pg1-Ps56
Cg75-Pg1-Ps57Cg75-Pg1-Ps58Cg75-Pg1-Ps59Cg75-Pg1-Ps60
Cg75-Pg1-Ps61Cg75-Pg1-Ps62Cg75-Pg1-Ps63Cg75-Pg1-Ps64
Cg75-Pg1-Ps65Cg75-Pg1-Ps66Cg75-Pg1-Ps67Cg75-Pg1-Ps68
Cg75-Pg1-Ps69Cg75-Pg1-Ps70Cg75-Pg1-Ps71Cg75-Pg1-Ps72
Cg75-Pg1-Ps73Cg75-Pg1-Ps74Cg75-Pg1-Ps75Cg75-Pg1-Ps76
Cg75-Pg1-Ps77Cg75-Pg1-Ps78Cg75-Pg1-Ps79Cg75-Pg1-Ps80
Cg75-Pg1-Ps81Cg75-Pg1-Ps82Cg75-Pg1-Ps83Cg75-Pg1-Ps84
Cg75-Pg1-Ps85Cg75-Pg1-Ps86Cg75-Pg1-Ps87Cg75-Pg1-Ps88
Cg75-Pg1-Ps89Cg75-Pg1-Ps90Cg75-Pg1-Ps91Cg75-Pg1-Ps92
Cg75-Pg1-Ps93Cg75-Pg1-Ps94Cg75-Pg1-Ps95Cg75-Pg1-Ps96
Cg75-Pg1-Ps97Cg75-Pg1-Ps98Cg75-Pg1-Ps99Cg75-Pg1-Ps100
Cg75-Pg1-Ps101Cg75-Pg1-Ps102Cg75-Pg1-Ps103Cg75-Pg1-Ps104
Cg75-Pg1-Ps105Cg75-Pg1-Ps106Cg75-Pg1-Ps107Cg75-Pg1-Ps108
Cg75-Pg1-Ps109Cg75-Pg1-Ps110Cg75-Pg1-Ps111Cg75-Pg1-Ps112
Cg75-Pg1-Ps113Cg75-Pg1-Ps114Cg75-Pg1-Ps115Cg75-Pg1-Ps116
Cg75-Pg1-Ps117Cg75-Pg1-Ps118Cg75-Pg1-Ps119Cg75-Pg1-Ps120
Cg75-Pg1-Ps121Cg75-Pg1-Ps122Cg75-Pg1-Ps123Cg75-Pg1-Ps124
Cg75-Pg1-Ps125Cg75-Pg1-Ps126Cg75-Pg1-Ps127Cg75-Pg1-Ps128
Cg75-Pg1-Ps129Cg75-Pg1-Ps130Cg75-Pg1-Ps131Cg75-Pg1-Ps132
Cg75-Pg1-Ps133Cg75-Pg1-Ps134Cg75-Pg1-Ps135Cg75-Pg1-Ps136
Cg75-Pg1-Ps137Cg75-Pg1-Ps138Cg75-Pg1-Ps139Cg75-Pg1-Ps140
Cg75-Pg1-Ps141Cg75-Pg1-Ps142Cg75-Pg1-Ps143Cg75-Pg1-Ps144
Cg75-Pg1-Ps145Cg75-Pg1-Ps146Cg75-Pg1-Ps147Cg75-Pg1-Ps148
Cg75-Pg1-Ps149Cg75-Pg1-Ps150Cg75-Pg1-Ps151Cg75-Pg1-Ps152
Cg75-Pg1-Ps153Cg75-Pg1-Ps154Cg75-Pg1-Ps155Cg75-Pg1-Ps156
Cg75-Pg1-Ps157Cg75-Pg1-Ps158Cg75-Pg1-Ps159Cg75-Pg1-Ps160
Cg75-Pg1-Ps161Cg75-Pg1-Ps162Cg75-Pg1-Ps163Cg75-Pg1-Ps164
Cg75-Pg1-Ps165Cg75-Pg1-Ps166Cg75-Pg1-Ps167Cg75-Pg1-Ps168
Cg75-Pg1-Ps169Cg75-Pg1-Ps170Cg75-Pg1-Ps171Cg75-Pg1-Ps172
Cg75-Pg1-Ps173Cg75-Pg1-Ps174Cg75-Pg1-Ps175Cg75-Pg1-Ps176
Cg75-Pg1-Ps177Cg75-Pg1-Ps178Cg75-Pg1-Ps179Cg75-Pg1-Ps180
Cg75-Pg1-Ps181Cg75-Pg1-Ps182Cg75-Pg1-Ps183Cg75-Pg1-Ps184
Cg75-Pg1-Ps185Cg75-Pg1-Ps186Cg75-Pg1-Ps187Cg75-Pg1-Ps188
Cg75-Pg1-Ps189Cg75-Pg1-Ps190Cg75-Pg1-Ps191Cg75-Pg1-Ps192
Cg75-Pg1-Ps193Cg75-Pg1-Ps194Cg75-Pg1-Ps195Cg75-Pg1-Ps196
Cg75-Pg1-Ps197Cg75-Pg1-Ps198Cg75-Pg1-Ps199Cg75-Pg1-Ps200
Cg75-Pg1-Ps201Cg75-Pg1-Ps202Cg75-Pg1-Ps203Cg75-Pg1-Ps204
Cg75-Pg1-Ps205Cg75-Pg1-Ps206Cg75-Pg1-Ps207Cg75-Pg1-Ps208
Cg75-Pg1-Ps209Cg75-Pg1-Ps210Cg75-Pg1-Ps211Cg75-Pg1-Ps212
Cg75-Pg1-Ps213Cg75-Pg1-Ps214Cg75-Pg1-Ps215Cg75-Pg1-Ps216
Cg75-Pg1-Ps217Cg75-Pg1-Ps218Cg75-Pg1-Ps219Cg75-Pg1-Ps220
Cg75-Pg1-Ps221Cg75-Pg1-Ps222Cg75-Pg1-Ps223Cg75-Pg1-Ps224
Cg75-Pg1-Ps225Cg75-Pg1-Ps226Cg75-Pg1-Ps227Cg75-Pg1-Ps228
Cg75-Pg1-Ps229Cg75-Pg1-Ps230Cg75-Pg1-Ps231Cg75-Pg1-Ps232
Cg75-Pg1-Ps233Cg75-Pg1-Ps234Cg75-Pg1-Ps235Cg75-Pg1-Ps236
Cg75-Pg1-Ps237Cg75-Pg1-Ps238Cg75-Pg1-Ps239Cg75-Pg1-Ps240
Cg75-Pg1-Ps241Cg75-Pg1-Ps242Cg75-Pg1-Ps243
Cg76-Pg1-Ps1Cg76-Pg1-Ps2Cg76-Pg1-Ps3Cg76-Pg1-Ps4
Cg76-Pg1-Ps5Cg76-Pg1-Ps6Cg76-Pg1-Ps7Cg76-Pg1-Ps8
Cg76-Pg1-Ps9Cg76-Pg1-Ps10Cg76-Pg1-Ps11Cg76-Pg1-Ps12
Cg76-Pg1-Ps13Cg76-Pg1-Ps14Cg76-Pg1-Ps15Cg76-Pg1-Ps16
Cg76-Pg1-Ps17Cg76-Pg1-Ps18Cg76-Pg1-Ps19Cg76-Pg1-Ps20
Cg76-Pg1-Ps21Cg76-Pg1-Ps22Cg76-Pg1-Ps23Cg76-Pg1-Ps24
Cg76-Pg1-Ps25Cg76-Pg1-Ps26Cg76-Pg1-Ps27Cg76-Pg1-Ps28
Cg76-Pg1-Ps29Cg76-Pg1-Ps30Cg76-Pg1-Ps31Cg76-Pg1-Ps32
Cg76-Pg1-Ps33Cg76-Pg1-Ps34Cg76-Pg1-Ps35Cg76-Pg1-Ps36
Cg76-Pg1-Ps37Cg76-Pg1-Ps38Cg76-Pg1-Ps39Cg76-Pg1-Ps40
Cg76-Pg1-Ps41Cg76-Pg1-Ps42Cg76-Pg1-Ps43Cg76-Pg1-Ps44
Cg76-Pg1-Ps45Cg76-Pg1-Ps46Cg76-Pg1-Ps47Cg76-Pg1-Ps48
Cg76-Pg1-Ps49Cg76-Pg1-Ps50Cg76-Pg1-Ps51Cg76-Pg1-Ps52
Cg76-Pg1-Ps53Cg76-Pg1-Ps54Cg76-Pg1-Ps55Cg76-Pg1-Ps56
Cg76-Pg1-Ps57Cg76-Pg1-Ps58Cg76-Pg1-Ps59Cg76-Pg1-Ps60
Cg76-Pg1-Ps61Cg76-Pg1-Ps62Cg76-Pg1-Ps63Cg76-Pg1-Ps64
Cg76-Pg1-Ps65Cg76-Pg1-Ps66Cg76-Pg1-Ps67Cg76-Pg1-Ps68
Cg76-Pg1-Ps69Cg76-Pg1-Ps70Cg76-Pg1-Ps71Cg76-Pg1-Ps72
Cg76-Pg1-Ps73Cg76-Pg1-Ps74Cg76-Pg1-Ps75Cg76-Pg1-Ps76
Cg76-Pg1-Ps77Cg76-Pg1-Ps78Cg76-Pg1-Ps79Cg76-Pg1-Ps80
Cg76-Pg1-Ps81Cg76-Pg1-Ps82Cg76-Pg1-Ps83Cg76-Pg1-Ps84
Cg76-Pg1-Ps85Cg76-Pg1-Ps86Cg76-Pg1-Ps87Cg76-Pg1-Ps88
Cg76-Pg1-Ps89Cg76-Pg1-Ps90Cg76-Pg1-Ps91Cg76-Pg1-Ps92
Cg76-Pg1-Ps93Cg76-Pg1-Ps94Cg76-Pg1-Ps95Cg76-Pg1-Ps96
Cg76-Pg1-Ps97Cg76-Pg1-Ps98Cg76-Pg1-Ps99Cg76-Pg1-Ps100
Cg76-Pg1-Ps101Cg76-Pg1-Ps102Cg76-Pg1-Ps103Cg76-Pg1-Ps104
Cg76-Pg1-Ps105Cg76-Pg1-Ps106Cg76-Pg1-Ps107Cg76-Pg1-Ps108
Cg76-Pg1-Ps109Cg76-Pg1-Ps110Cg76-Pg1-Ps111Cg76-Pg1-Ps112
Cg76-Pg1-Ps113Cg76-Pg1-Ps114Cg76-Pg1-Ps115Cg76-Pg1-Ps116
Cg76-Pg1-Ps117Cg76-Pg1-Ps118Cg76-Pg1-Ps119Cg76-Pg1-Ps120
Cg76-Pg1-Ps121Cg76-Pg1-Ps122Cg76-Pg1-Ps123Cg76-Pg1-Ps124
Cg76-Pg1-Ps125Cg76-Pg1-Ps126Cg76-Pg1-Ps127Cg76-Pg1-Ps128
Cg76-Pg1-Ps129Cg76-Pg1-Ps130Cg76-Pg1-Ps131Cg76-Pg1-Ps132
Cg76-Pg1-Ps133Cg76-Pg1-Ps134Cg76-Pg1-Ps135Cg76-Pg1-Ps136
Cg76-Pg1-Ps137Cg76-Pg1-Ps138Cg76-Pg1-Ps139Cg76-Pg1-Ps140
Cg76-Pg1-Ps141Cg76-Pg1-Ps142Cg76-Pg1-Ps143Cg76-Pg1-Ps144
Cg76-Pg1-Ps145Cg76-Pg1-Ps146Cg76-Pg1-Ps147Cg76-Pg1-Ps148
Cg76-Pg1-Ps149Cg76-Pg1-Ps150Cg76-Pg1-Ps151Cg76-Pg1-Ps152
Cg76-Pg1-Ps153Cg76-Pg1-Ps154Cg76-Pg1-Ps155Cg76-Pg1-Ps156
Cg76-Pg1-Ps157Cg76-Pg1-Ps158Cg76-Pg1-Ps159Cg76-Pg1-Ps160
Cg76-Pg1-Ps161Cg76-Pg1-Ps162Cg76-Pg1-Ps163Cg76-Pg1-Ps164
Cg76-Pg1-Ps165Cg76-Pg1-Ps166Cg76-Pg1-Ps167Cg76-Pg1-Ps168
Cg76-Pg1-Ps169Cg76-Pg1-Ps170Cg76-Pg1-Ps171Cg76-Pg1-Ps172
Cg76-Pg1-Ps173Cg76-Pg1-Ps174Cg76-Pg1-Ps175Cg76-Pg1-Ps176
Cg76-Pg1-Ps177Cg76-Pg1-Ps178Cg76-Pg1-Ps179Cg76-Pg1-Ps180
Cg76-Pg1-Ps181Cg76-Pg1-Ps182Cg76-Pg1-Ps183Cg76-Pg1-Ps184
Cg76-Pg1-Ps185Cg76-Pg1-Ps186Cg76-Pg1-Ps187Cg76-Pg1-Ps188
Cg76-Pg1-Ps189Cg76-Pg1-Ps190Cg76-Pg1-Ps191Cg76-Pg1-Ps192
Cg76-Pg1-Ps193Cg76-Pg1-Ps194Cg76-Pg1-Ps195Cg76-Pg1-Ps196
Cg76-Pg1-Ps197Cg76-Pg1-Ps198Cg76-Pg1-Ps199Cg76-Pg1-Ps200
Cg76-Pg1-Ps201Cg76-Pg1-Ps202Cg76-Pg1-Ps203Cg76-Pg1-Ps204
Cg76-Pg1-Ps205Cg76-Pg1-Ps206Cg76-Pg1-Ps207Cg76-Pg1-Ps208
Cg76-Pg1-Ps209Cg76-Pg1-Ps210Cg76-Pg1-Ps211Cg76-Pg1-Ps212
Cg76-Pg1-Ps213Cg76-Pg1-Ps214Cg76-Pg1-Ps215Cg76-Pg1-Ps216
Cg76-Pg1-Ps217Cg76-Pg1-Ps218Cg76-Pg1-Ps219Cg76-Pg1-Ps220
Cg76-Pg1-Ps221Cg76-Pg1-Ps222Cg76-Pg1-Ps223Cg76-Pg1-Ps224
Cg76-Pg1-Ps225Cg76-Pg1-Ps226Cg76-Pg1-Ps227Cg76-Pg1-Ps228
Cg76-Pg1-Ps229Cg76-Pg1-Ps230Cg76-Pg1-Ps231Cg76-Pg1-Ps232
Cg76-Pg1-Ps233Cg76-Pg1-Ps234Cg76-Pg1-Ps235Cg76-Pg1-Ps236
Cg76-Pg1-Ps237Cg76-Pg1-Ps238Cg76-Pg1-Ps239Cg76-Pg1-Ps240
Cg76-Pg1-Ps241Cg76-Pg1-Ps242Cg76-Pg1-Ps243
Cg81-Pg1-Ps1Cg81-Pg1-Ps2Cg81-Pg1-Ps3Cg81-Pg1-Ps4
Cg81-Pg1-Ps5Cg81-Pg1-Ps6Cg81-Pg1-Ps7Cg81-Pg1-Ps8
Cg81-Pg1-Ps9Cg81-Pg1-Ps10Cg81-Pg1-Ps11Cg81-Pg1-Ps12
Cg81-Pg1-Ps13Cg81-Pg1-Ps14Cg81-Pg1-Ps15Cg81-Pg1-Ps16
Cg81-Pg1-Ps17Cg81-Pg1-Ps18Cg81-Pg1-Ps19Cg81-Pg1-Ps20
Cg81-Pg1-Ps21Cg81-Pg1-Ps22Cg81-Pg1-Ps23Cg81-Pg1-Ps24
Cg81-Pg1-Ps25Cg81-Pg1-Ps26Cg81-Pg1-Ps27Cg81-Pg1-Ps28
Cg81-Pg1-Ps29Cg81-Pg1-Ps30Cg81-Pg1-Ps31Cg81-Pg1-Ps32
Cg81-Pg1-Ps33Cg81-Pg1-Ps34Cg81-Pg1-Ps35Cg81-Pg1-Ps36
Cg81-Pg1-Ps37Cg81-Pg1-Ps38Cg81-Pg1-Ps39Cg81-Pg1-Ps40
Cg81-Pg1-Ps41Cg81-Pg1-Ps42Cg81-Pg1-Ps43Cg81-Pg1-Ps44
Cg81-Pg1-Ps45Cg81-Pg1-Ps46Cg81-Pg1-Ps47Cg81-Pg1-Ps48
Cg81-Pg1-Ps49Cg81-Pg1-Ps50Cg81-Pg1-Ps51Cg81-Pg1-Ps52
Cg81-Pg1-Ps53Cg81-Pg1-Ps54Cg81-Pg1-Ps55Cg81-Pg1-Ps56
Cg81-Pg1-Ps57Cg81-Pg1-Ps58Cg81-Pg1-Ps59Cg81-Pg1-Ps60
Cg81-Pg1-Ps61Cg81-Pg1-Ps62Cg81-Pg1-Ps63Cg81-Pg1-Ps64
Cg81-Pg1-Ps65Cg81-Pg1-Ps66Cg81-Pg1-Ps67Cg81-Pg1-Ps68
Cg81-Pg1-Ps69Cg81-Pg1-Ps70Cg81-Pg1-Ps71Cg81-Pg1-Ps72
Cg81-Pg1-Ps73Cg81-Pg1-Ps74Cg81-Pg1-Ps75Cg81-Pg1-Ps76
Cg81-Pg1-Ps77Cg81-Pg1-Ps78Cg81-Pg1-Ps79Cg81-Pg1-Ps80
Cg81-Pg1-Ps81Cg81-Pg1-Ps82Cg81-Pg1-Ps83Cg81-Pg1-Ps84
Cg81-Pg1-Ps85Cg81-Pg1-Ps86Cg81-Pg1-Ps87Cg81-Pg1-Ps88
Cg81-Pg1-Ps89Cg81-Pg1-Ps90Cg81-Pg1-Ps91Cg81-Pg1-Ps92
Cg81-Pg1-Ps93Cg81-Pg1-Ps94Cg81-Pg1-Ps95Cg81-Pg1-Ps96
Cg81-Pg1-Ps97Cg81-Pg1-Ps98Cg81-Pg1-Ps99Cg81-Pg1-Ps100
Cg81-Pg1-Ps101Cg81-Pg1-Ps102Cg81-Pg1-Ps103Cg81-Pg1-Ps104
Cg81-Pg1-Ps105Cg81-Pg1-Ps106Cg81-Pg1-Ps107Cg81-Pg1-Ps108
Cg81-Pg1-Ps109Cg81-Pg1-Ps110Cg81-Pg1-Ps111Cg81-Pg1-Ps112
Cg81-Pg1-Ps113Cg81-Pg1-Ps114Cg81-Pg1-Ps115Cg81-Pg1-Ps116
Cg81-Pg1-Ps117Cg81-Pg1-Ps118Cg81-Pg1-Ps119Cg81-Pg1-Ps120
Cg81-Pg1-Ps121Cg81-Pg1-Ps122Cg81-Pg1-Ps123Cg81-Pg1-Ps124
Cg81-Pg1-Ps125Cg81-Pg1-Ps126Cg81-Pg1-Ps127Cg81-Pg1-Ps128
Cg81-Pg1-Ps129Cg81-Pg1-Ps130Cg81-Pg1-Ps131Cg81-Pg1-Ps132
Cg81-Pg1-Ps133Cg81-Pg1-Ps134Cg81-Pg1-Ps135Cg81-Pg1-Ps136
Cg81-Pg1-Ps137Cg81-Pg1-Ps138Cg81-Pg1-Ps139Cg81-Pg1-Ps140
Cg81-Pg1-Ps141Cg81-Pg1-Ps142Cg81-Pg1-Ps143Cg81-Pg1-Ps144
Cg81-Pg1-Ps145Cg81-Pg1-Ps146Cg81-Pg1-Ps147Cg81-Pg1-Ps148
Cg81-Pg1-Ps149Cg81-Pg1-Ps150Cg81-Pg1-Ps151Cg81-Pg1-Ps152
Cg81-Pg1-Ps153Cg81-Pg1-Ps154Cg81-Pg1-Ps155Cg81-Pg1-Ps156
Cg81-Pg1-Ps157Cg81-Pg1-Ps158Cg81-Pg1-Ps159Cg81-Pg1-Ps160
Cg81-Pg1-Ps161Cg81-Pg1-Ps162Cg81-Pg1-Ps163Cg81-Pg1-Ps164
Cg81-Pg1-Ps165Cg81-Pg1-Ps166Cg81-Pg1-Ps167Cg81-Pg1-Ps168
Cg81-Pg1-Ps169Cg81-Pg1-Ps170Cg81-Pg1-Ps171Cg81-Pg1-Ps172
Cg81-Pg1-Ps173Cg81-Pg1-Ps174Cg81-Pg1-Ps175Cg81-Pg1-Ps176
Cg81-Pg1-Ps177Cg81-Pg1-Ps178Cg81-Pg1-Ps179Cg81-Pg1-Ps180
Cg81-Pg1-Ps181Cg81-Pg1-Ps182Cg81-Pg1-Ps183Cg81-Pg1-Ps184
Cg81-Pg1-Ps185Cg81-Pg1-Ps186Cg81-Pg1-Ps187Cg81-Pg1-Ps188
Cg81-Pg1-Ps189Cg81-Pg1-Ps190Cg81-Pg1-Ps191Cg81-Pg1-Ps192
Cg81-Pg1-Ps193Cg81-Pg1-Ps194Cg81-Pg1-Ps195Cg81-Pg1-Ps196
Cg81-Pg1-Ps197Cg81-Pg1-Ps198Cg81-Pg1-Ps199Cg81-Pg1-Ps200
Cg81-Pg1-Ps201Cg81-Pg1-Ps202Cg81-Pg1-Ps203Cg81-Pg1-Ps204
Cg81-Pg1-Ps205Cg81-Pg1-Ps206Cg81-Pg1-Ps207Cg81-Pg1-Ps208
Cg81-Pg1-Ps209Cg81-Pg1-Ps210Cg81-Pg1-Ps211Cg81-Pg1-Ps212
Cg81-Pg1-Ps213Cg81-Pg1-Ps214Cg81-Pg1-Ps215Cg81-Pg1-Ps216
Cg81-Pg1-Ps217Cg81-Pg1-Ps218Cg81-Pg1-Ps219Cg81-Pg1-Ps220
Cg81-Pg1-Ps221Cg81-Pg1-Ps222Cg81-Pg1-Ps223Cg81-Pg1-Ps224
Cg81-Pg1-Ps225Cg81-Pg1-Ps226Cg81-Pg1-Ps227Cg81-Pg1-Ps228
Cg81-Pg1-Ps229Cg81-Pg1-Ps230Cg81-Pg1-Ps231Cg81-Pg1-Ps232
Cg81-Pg1-Ps233Cg81-Pg1-Ps234Cg81-Pg1-Ps235Cg81-Pg1-Ps236
Cg81-Pg1-Ps237Cg81-Pg1-Ps238Cg81-Pg1-Ps239Cg81-Pg1-Ps240
Cg81-Pg1-Ps241Cg81-Pg1-Ps242Cg81-Pg1-Ps243
Cg82-Pg1-Ps1Cg82-Pg1-Ps2Cg82-Pg1-Ps3Cg82-Pg1-Ps4
Cg82-Pg1-Ps5Cg82-Pg1-Ps6Cg82-Pg1-Ps7Cg82-Pg1-Ps8
Cg82-Pg1-Ps9Cg82-Pg1-Ps10Cg82-Pg1-Ps11Cg82-Pg1-Ps12
Cg82-Pg1-Ps13Cg82-Pg1-Ps14Cg82-Pg1-Ps15Cg82-Pg1-Ps16
Cg82-Pg1-Ps17Cg82-Pg1-Ps18Cg82-Pg1-Ps19Cg82-Pg1-Ps20
Cg82-Pg1-Ps21Cg82-Pg1-Ps22Cg82-Pg1-Ps23Cg82-Pg1-Ps24
Cg82-Pg1-Ps25Cg82-Pg1-Ps26Cg82-Pg1-Ps27Cg82-Pg1-Ps28
Cg82-Pg1-Ps29Cg82-Pg1-Ps30Cg82-Pg1-Ps31Cg82-Pg1-Ps32
Cg82-Pg1-Ps33Cg82-Pg1-Ps34Cg82-Pg1-Ps35Cg82-Pg1-Ps36
Cg82-Pg1-Ps37Cg82-Pg1-Ps38Cg82-Pg1-Ps39Cg82-Pg1-Ps40
Cg82-Pg1-Ps41Cg82-Pg1-Ps42Cg82-Pg1-Ps43Cg82-Pg1-Ps44
Cg82-Pg1-Ps45Cg82-Pg1-Ps46Cg82-Pg1-Ps47Cg82-Pg1-Ps48
Cg82-Pg1-Ps49Cg82-Pg1-Ps50Cg82-Pg1-Ps51Cg82-Pg1-Ps52
Cg82-Pg1-Ps53Cg82-Pg1-Ps54Cg82-Pg1-Ps55Cg82-Pg1-Ps56
Cg82-Pg1-Ps57Cg82-Pg1-Ps58Cg82-Pg1-Ps59Cg82-Pg1-Ps60
Cg82-Pg1-Ps61Cg82-Pg1-Ps62Cg82-Pg1-Ps63Cg82-Pg1-Ps64
Cg82-Pg1-Ps65Cg82-Pg1-Ps66Cg82-Pg1-Ps67Cg82-Pg1-Ps68
Cg82-Pg1-Ps69Cg82-Pg1-Ps70Cg82-Pg1-Ps71Cg82-Pg1-Ps72
Cg82-Pg1-Ps73Cg82-Pg1-Ps74Cg82-Pg1-Ps75Cg82-Pg1-Ps76
Cg82-Pg1-Ps77Cg82-Pg1-Ps78Cg82-Pg1-Ps79Cg82-Pg1-Ps80
Cg82-Pg1-Ps81Cg82-Pg1-Ps82Cg82-Pg1-Ps83Cg82-Pg1-Ps84
Cg82-Pg1-Ps85Cg82-Pg1-Ps86Cg82-Pg1-Ps87Cg82-Pg1-Ps88
Cg82-Pg1-Ps89Cg82-Pg1-Ps90Cg82-Pg1-Ps91Cg82-Pg1-Ps92
Cg82-Pg1-Ps93Cg82-Pg1-Ps94Cg82-Pg1-Ps95Cg82-Pg1-Ps96
Cg82-Pg1-Ps97Cg82-Pg1-Ps98Cg82-Pg1-Ps99Cg82-Pg1-Ps100
Cg82-Pg1-Ps101Cg82-Pg1-Ps102Cg82-Pg1-Ps103Cg82-Pg1-Ps104
Cg82-Pg1-Ps105Cg82-Pg1-Ps106Cg82-Pg1-Ps107Cg82-Pg1-Ps108
Cg82-Pg1-Ps109Cg82-Pg1-Ps110Cg82-Pg1-Ps111Cg82-Pg1-Ps112
Cg82-Pg1-Ps113Cg82-Pg1-Ps114Cg82-Pg1-Ps115Cg82-Pg1-Ps116
Cg82-Pg1-Ps117Cg82-Pg1-Ps118Cg82-Pg1-Ps119Cg82-Pg1-Ps120
Cg82-Pg1-Ps121Cg82-Pg1-Ps122Cg82-Pg1-Ps123Cg82-Pg1-Ps124
Cg82-Pg1-Ps125Cg82-Pg1-Ps126Cg82-Pg1-Ps127Cg82-Pg1-Ps128
Cg82-Pg1-Ps129Cg82-Pg1-Ps130Cg82-Pg1-Ps131Cg82-Pg1-Ps132
Cg82-Pg1-Ps133Cg82-Pg1-Ps134Cg82-Pg1-Ps135Cg82-Pg1-Ps136
Cg82-Pg1-Ps137Cg82-Pg1-Ps138Cg82-Pg1-Ps139Cg82-Pg1-Ps140
Cg82-Pg1-Ps141Cg82-Pg1-Ps142Cg82-Pg1-Ps143Cg82-Pg1-Ps144
Cg82-Pg1-Ps145Cg82-Pg1-Ps146Cg82-Pg1-Ps147Cg82-Pg1-Ps148
Cg82-Pg1-Ps149Cg82-Pg1-Ps150Cg82-Pg1-Ps151Cg82-Pg1-Ps152
Cg82-Pg1-Ps153Cg82-Pg1-Ps154Cg82-Pg1-Ps155Cg82-Pg1-Ps156
Cg82-Pg1-Ps157Cg82-Pg1-Ps158Cg82-Pg1-Ps159Cg82-Pg1-Ps160
Cg82-Pg1-Ps161Cg82-Pg1-Ps162Cg82-Pg1-Ps163Cg82-Pg1-Ps164
Cg82-Pg1-Ps165Cg82-Pg1-Ps166Cg82-Pg1-Ps167Cg82-Pg1-Ps168
Cg82-Pg1-Ps169Cg82-Pg1-Ps170Cg82-Pg1-Ps171Cg82-Pg1-Ps172
Cg82-Pg1-Ps173Cg82-Pg1-Ps174Cg82-Pg1-Ps175Cg82-Pg1-Ps176
Cg82-Pg1-Ps177Cg82-Pg1-Ps178Cg82-Pg1-Ps179Cg82-Pg1-Ps180
Cg82-Pg1-Ps181Cg82-Pg1-Ps182Cg82-Pg1-Ps183Cg82-Pg1-Ps184
Cg82-Pg1-Ps185Cg82-Pg1-Ps186Cg82-Pg1-Ps187Cg82-Pg1-Ps188
Cg82-Pg1-Ps189Cg82-Pg1-Ps190Cg82-Pg1-Ps191Cg82-Pg1-Ps192
Cg82-Pg1-Ps193Cg82-Pg1-Ps194Cg82-Pg1-Ps195Cg82-Pg1-Ps196
Cg82-Pg1-Ps197Cg82-Pg1-Ps198Cg82-Pg1-Ps199Cg82-Pg1-Ps200
Cg82-Pg1-Ps201Cg82-Pg1-Ps202Cg82-Pg1-Ps203Cg82-Pg1-Ps204
Cg82-Pg1-Ps205Cg82-Pg1-Ps206Cg82-Pg1-Ps207Cg82-Pg1-Ps208
Cg82-Pg1-Ps209Cg82-Pg1-Ps210Cg82-Pg1-Ps211Cg82-Pg1-Ps212
Cg82-Pg1-Ps213Cg82-Pg1-Ps214Cg82-Pg1-Ps215Cg82-Pg1-Ps216
Cg82-Pg1-Ps217Cg82-Pg1-Ps218Cg82-Pg1-Ps219Cg82-Pg1-Ps220
Cg82-Pg1-Ps221Cg82-Pg1-Ps222Cg82-Pg1-Ps223Cg82-Pg1-Ps224
Cg82-Pg1-Ps225Cg82-Pg1-Ps226Cg82-Pg1-Ps227Cg82-Pg1-Ps228
Cg82-Pg1-Ps229Cg82-Pg1-Ps230Cg82-Pg1-Ps231Cg82-Pg1-Ps232
Cg82-Pg1-Ps233Cg82-Pg1-Ps234Cg82-Pg1-Ps235Cg82-Pg1-Ps236
Cg82-Pg1-Ps237Cg82-Pg1-Ps238Cg82-Pg1-Ps239Cg82-Pg1-Ps240
Cg82-Pg1-Ps241Cg82-Pg1-Ps242Cg82-Pg1-Ps243
Cg83-Pg1-Ps1Cg83-Pg1-Ps2Cg83-Pg1-Ps3Cg83-Pg1-Ps4
Cg83-Pg1-Ps5Cg83-Pg1-Ps6Cg83-Pg1-Ps7Cg83-Pg1-Ps8
Cg83-Pg1-Ps9Cg83-Pg1-Ps10Cg83-Pg1-Ps11Cg83-Pg1-Ps12
Cg83-Pg1-Ps13Cg83-Pg1-Ps14Cg83-Pg1-Ps15Cg83-Pg1-Ps16
Cg83-Pg1-Ps17Cg83-Pg1-Ps18Cg83-Pg1-Ps19Cg83-Pg1-Ps20
Cg83-Pg1-Ps21Cg83-Pg1-Ps22Cg83-Pg1-Ps23Cg83-Pg1-Ps24
Cg83-Pg1-Ps25Cg83-Pg1-Ps26Cg83-Pg1-Ps27Cg83-Pg1-Ps28
Cg83-Pg1-Ps29Cg83-Pg1-Ps30Cg83-Pg1-Ps31Cg83-Pg1-Ps32
Cg83-Pg1-Ps33Cg83-Pg1-Ps34Cg83-Pg1-Ps35Cg83-Pg1-Ps36
Cg83-Pg1-Ps37Cg83-Pg1-Ps38Cg83-Pg1-Ps39Cg83-Pg1-Ps40
Cg83-Pg1-Ps41Cg83-Pg1-Ps42Cg83-Pg1-Ps43Cg83-Pg1-Ps44
Cg83-Pg1-Ps45Cg83-Pg1-Ps46Cg83-Pg1-Ps47Cg83-Pg1-Ps48
Cg83-Pg1-Ps49Cg83-Pg1-Ps50Cg83-Pg1-Ps51Cg83-Pg1-Ps52
Cg83-Pg1-Ps53Cg83-Pg1-Ps54Cg83-Pg1-Ps55Cg83-Pg1-Ps56
Cg83-Pg1-Ps57Cg83-Pg1-Ps58Cg83-Pg1-Ps59Cg83-Pg1-Ps60
Cg83-Pg1-Ps61Cg83-Pg1-Ps62Cg83-Pg1-Ps63Cg83-Pg1-Ps64
Cg83-Pg1-Ps65Cg83-Pg1-Ps66Cg83-Pg1-Ps67Cg83-Pg1-Ps68
Cg83-Pg1-Ps69Cg83-Pg1-Ps70Cg83-Pg1-Ps71Cg83-Pg1-Ps72
Cg83-Pg1-Ps73Cg83-Pg1-Ps74Cg83-Pg1-Ps75Cg83-Pg1-Ps76
Cg83-Pg1-Ps77Cg83-Pg1-Ps78Cg83-Pg1-Ps79Cg83-Pg1-Ps80
Cg83-Pg1-Ps81Cg83-Pg1-Ps82Cg83-Pg1-Ps83Cg83-Pg1-Ps84
Cg83-Pg1-Ps85Cg83-Pg1-Ps86Cg83-Pg1-Ps87Cg83-Pg1-Ps88
Cg83-Pg1-Ps89Cg83-Pg1-Ps90Cg83-Pg1-Ps91Cg83-Pg1-Ps92
Cg83-Pg1-Ps93Cg83-Pg1-Ps94Cg83-Pg1-Ps95Cg83-Pg1-Ps96
Cg83-Pg1-Ps97Cg83-Pg1-Ps98Cg83-Pg1-Ps99Cg83-Pg1-Ps100
Cg83-Pg1-Ps101Cg83-Pg1-Ps102Cg83-Pg1-Ps103Cg83-Pg1-Ps104
Cg83-Pg1-Ps105Cg83-Pg1-Ps106Cg83-Pg1-Ps107Cg83-Pg1-Ps108
Cg83-Pg1-Ps109Cg83-Pg1-Ps110Cg83-Pg1-Ps111Cg83-Pg1-Ps112
Cg83-Pg1-Ps113Cg83-Pg1-Ps114Cg83-Pg1-Ps115Cg83-Pg1-Ps116
Cg83-Pg1-Ps117Cg83-Pg1-Ps118Cg83-Pg1-Ps119Cg83-Pg1-Ps120
Cg83-Pg1-Ps121Cg83-Pg1-Ps122Cg83-Pg1-Ps123Cg83-Pg1-Ps124
Cg83-Pg1-Ps125Cg83-Pg1-Ps126Cg83-Pg1-Ps127Cg83-Pg1-Ps128
Cg83-Pg1-Ps129Cg83-Pg1-Ps130Cg83-Pg1-Ps131Cg83-Pg1-Ps132
Cg83-Pg1-Ps133Cg83-Pg1-Ps134Cg83-Pg1-Ps135Cg83-Pg1-Ps136
Cg83-Pg1-Ps137Cg83-Pg1-Ps138Cg83-Pg1-Ps139Cg83-Pg1-Ps140
Cg83-Pg1-Ps141Cg83-Pg1-Ps142Cg83-Pg1-Ps143Cg83-Pg1-Ps144
Cg83-Pg1-Ps145Cg83-Pg1-Ps146Cg83-Pg1-Ps147Cg83-Pg1-Ps148
Cg83-Pg1-Ps149Cg83-Pg1-Ps150Cg83-Pg1-Ps151Cg83-Pg1-Ps152
Cg83-Pg1-Ps153Cg83-Pg1-Ps154Cg83-Pg1-Ps155Cg83-Pg1-Ps156
Cg83-Pg1-Ps157Cg83-Pg1-Ps158Cg83-Pg1-Ps159Cg83-Pg1-Ps160
Cg83-Pg1-Ps161Cg83-Pg1-Ps162Cg83-Pg1-Ps163Cg83-Pg1-Ps164
Cg83-Pg1-Ps165Cg83-Pg1-Ps166Cg83-Pg1-Ps167Cg83-Pg1-Ps168
Cg83-Pg1-Ps169Cg83-Pg1-Ps170Cg83-Pg1-Ps171Cg83-Pg1-Ps172
Cg83-Pg1-Ps173Cg83-Pg1-Ps174Cg83-Pg1-Ps175Cg83-Pg1-Ps176
Cg83-Pg1-Ps177Cg83-Pg1-Ps178Cg83-Pg1-Ps179Cg83-Pg1-Ps180
Cg83-Pg1-Ps181Cg83-Pg1-Ps182Cg83-Pg1-Ps183Cg83-Pg1-Ps184
Cg83-Pg1-Ps185Cg83-Pg1-Ps186Cg83-Pg1-Ps187Cg83-Pg1-Ps188
Cg83-Pg1-Ps189Cg83-Pg1-Ps190Cg83-Pg1-Ps191Cg83-Pg1-Ps192
Cg83-Pg1-Ps193Cg83-Pg1-Ps194Cg83-Pg1-Ps195Cg83-Pg1-Ps196
Cg83-Pg1-Ps197Cg83-Pg1-Ps198Cg83-Pg1-Ps199Cg83-Pg1-Ps200
Cg83-Pg1-Ps201Cg83-Pg1-Ps202Cg83-Pg1-Ps203Cg83-Pg1-Ps204
Cg83-Pg1-Ps205Cg83-Pg1-Ps206Cg83-Pg1-Ps207Cg83-Pg1-Ps208
Cg83-Pg1-Ps209Cg83-Pg1-Ps210Cg83-Pg1-Ps211Cg83-Pg1-Ps212
Cg83-Pg1-Ps213Cg83-Pg1-Ps214Cg83-Pg1-Ps215Cg83-Pg1-Ps216
Cg83-Pg1-Ps217Cg83-Pg1-Ps218Cg83-Pg1-Ps219Cg83-Pg1-Ps220
Cg83-Pg1-Ps221Cg83-Pg1-Ps222Cg83-Pg1-Ps223Cg83-Pg1-Ps224
Cg83-Pg1-Ps225Cg83-Pg1-Ps226Cg83-Pg1-Ps227Cg83-Pg1-Ps228
Cg83-Pg1-Ps229Cg83-Pg1-Ps230Cg83-Pg1-Ps231Cg83-Pg1-Ps232
Cg83-Pg1-Ps233Cg83-Pg1-Ps234Cg83-Pg1-Ps235Cg83-Pg1-Ps236
Cg83-Pg1-Ps237Cg83-Pg1-Ps238Cg83-Pg1-Ps239Cg83-Pg1-Ps240
Cg83-Pg1-Ps241Cg83-Pg1-Ps242Cg83-Pg1-Ps243
Cg84-Pg1-Ps1Cg84-Pg1-Ps2Cg84-Pg1-Ps3Cg84-Pg1-Ps4
Cg84-Pg1-Ps5Cg84-Pg1-Ps6Cg84-Pg1-Ps7Cg84-Pg1-Ps8
Cg84-Pg1-Ps9Cg84-Pg1-Ps10Cg84-Pg1-Ps11Cg84-Pg1-Ps12
Cg84-Pg1-Ps13Cg84-Pg1-Ps14Cg84-Pg1-Ps15Cg84-Pg1-Ps16
Cg84-Pg1-Ps17Cg84-Pg1-Ps18Cg84-Pg1-Ps19Cg84-Pg1-Ps20
Cg84-Pg1-Ps21Cg84-Pg1-Ps22Cg84-Pg1-Ps23Cg84-Pg1-Ps24
Cg84-Pg1-Ps25Cg84-Pg1-Ps26Cg84-Pg1-Ps27Cg84-Pg1-Ps28
Cg84-Pg1-Ps29Cg84-Pg1-Ps30Cg84-Pg1-Ps31Cg84-Pg1-Ps32
Cg84-Pg1-Ps33Cg84-Pg1-Ps34Cg84-Pg1-Ps35Cg84-Pg1-Ps36
Cg84-Pg1-Ps37Cg84-Pg1-Ps38Cg84-Pg1-Ps39Cg84-Pg1-Ps40
Cg84-Pg1-Ps41Cg84-Pg1-Ps42Cg84-Pg1-Ps43Cg84-Pg1-Ps44
Cg84-Pg1-Ps45Cg84-Pg1-Ps46Cg84-Pg1-Ps47Cg84-Pg1-Ps48
Cg84-Pg1-Ps49Cg84-Pg1-Ps50Cg84-Pg1-Ps51Cg84-Pg1-Ps52
Cg84-Pg1-Ps53Cg84-Pg1-Ps54Cg84-Pg1-Ps55Cg84-Pg1-Ps56
Cg84-Pg1-Ps57Cg84-Pg1-Ps58Cg84-Pg1-Ps59Cg84-Pg1-Ps60
Cg84-Pg1-Ps61Cg84-Pg1-Ps62Cg84-Pg1-Ps63Cg84-Pg1-Ps64
Cg84-Pg1-Ps65Cg84-Pg1-Ps66Cg84-Pg1-Ps67Cg84-Pg1-Ps68
Cg84-Pg1-Ps69Cg84-Pg1-Ps70Cg84-Pg1-Ps71Cg84-Pg1-Ps72
Cg84-Pg1-Ps73Cg84-Pg1-Ps74Cg84-Pg1-Ps75Cg84-Pg1-Ps76
Cg84-Pg1-Ps77Cg84-Pg1-Ps78Cg84-Pg1-Ps79Cg84-Pg1-Ps80
Cg84-Pg1-Ps81Cg84-Pg1-Ps82Cg84-Pg1-Ps83Cg84-Pg1-Ps84
Cg84-Pg1-Ps85Cg84-Pg1-Ps86Cg84-Pg1-Ps87Cg84-Pg1-Ps88
Cg84-Pg1-Ps89Cg84-Pg1-Ps90Cg84-Pg1-Ps91Cg84-Pg1-Ps92
Cg84-Pg1-Ps93Cg84-Pg1-Ps94Cg84-Pg1-Ps95Cg84-Pg1-Ps96
Cg84-Pg1-Ps97Cg84-Pg1-Ps98Cg84-Pg1-Ps99Cg84-Pg1-Ps100
Cg84-Pg1-Ps101Cg84-Pg1-Ps102Cg84-Pg1-Ps103Cg84-Pg1-Ps104
Cg84-Pg1-Ps105Cg84-Pg1-Ps106Cg84-Pg1-Ps107Cg84-Pg1-Ps108
Cg84-Pg1-Ps109Cg84-Pg1-Ps110Cg84-Pg1-Ps111Cg84-Pg1-Ps112
Cg84-Pg1-Ps113Cg84-Pg1-Ps114Cg84-Pg1-Ps115Cg84-Pg1-Ps116
Cg84-Pg1-Ps117Cg84-Pg1-Ps118Cg84-Pg1-Ps119Cg84-Pg1-Ps120
Cg84-Pg1-Ps121Cg84-Pg1-Ps122Cg84-Pg1-Ps123Cg84-Pg1-Ps124
Cg84-Pg1-Ps125Cg84-Pg1-Ps126Cg84-Pg1-Ps127Cg84-Pg1-Ps128
Cg84-Pg1-Ps129Cg84-Pg1-Ps130Cg84-Pg1-Ps131Cg84-Pg1-Ps132
Cg84-Pg1-Ps133Cg84-Pg1-Ps134Cg84-Pg1-Ps135Cg84-Pg1-Ps136
Cg84-Pg1-Ps137Cg84-Pg1-Ps138Cg84-Pg1-Ps139Cg84-Pg1-Ps140
Cg84-Pg1-Ps141Cg84-Pg1-Ps142Cg84-Pg1-Ps143Cg84-Pg1-Ps144
Cg84-Pg1-Ps145Cg84-Pg1-Ps146Cg84-Pg1-Ps147Cg84-Pg1-Ps148
Cg84-Pg1-Ps149Cg84-Pg1-Ps150Cg84-Pg1-Ps151Cg84-Pg1-Ps152
Cg84-Pg1-Ps153Cg84-Pg1-Ps154Cg84-Pg1-Ps155Cg84-Pg1-Ps156
Cg84-Pg1-Ps157Cg84-Pg1-Ps158Cg84-Pg1-Ps159Cg84-Pg1-Ps160
Cg84-Pg1-Ps161Cg84-Pg1-Ps162Cg84-Pg1-Ps163Cg84-Pg1-Ps164
Cg84-Pg1-Ps165Cg84-Pg1-Ps166Cg84-Pg1-Ps167Cg84-Pg1-Ps168
Cg84-Pg1-Ps169Cg84-Pg1-Ps170Cg84-Pg1-Ps171Cg84-Pg1-Ps172
Cg84-Pg1-Ps173Cg84-Pg1-Ps174Cg84-Pg1-Ps175Cg84-Pg1-Ps176
Cg84-Pg1-Ps177Cg84-Pg1-Ps178Cg84-Pg1-Ps179Cg84-Pg1-Ps180
Cg84-Pg1-Ps181Cg84-Pg1-Ps182Cg84-Pg1-Ps183Cg84-Pg1-Ps184
Cg84-Pg1-Ps185Cg84-Pg1-Ps186Cg84-Pg1-Ps187Cg84-Pg1-Ps188
Cg84-Pg1-Ps189Cg84-Pg1-Ps190Cg84-Pg1-Ps191Cg84-Pg1-Ps192
Cg84-Pg1-Ps193Cg84-Pg1-Ps194Cg84-Pg1-Ps195Cg84-Pg1-Ps196
Cg84-Pg1-Ps197Cg84-Pg1-Ps198Cg84-Pg1-Ps199Cg84-Pg1-Ps200
Cg84-Pg1-Ps201Cg84-Pg1-Ps202Cg84-Pg1-Ps203Cg84-Pg1-Ps204
Cg84-Pg1-Ps205Cg84-Pg1-Ps206Cg84-Pg1-Ps207Cg84-Pg1-Ps208
Cg84-Pg1-Ps209Cg84-Pg1-Ps210Cg84-Pg1-Ps211Cg84-Pg1-Ps212
Cg84-Pg1-Ps213Cg84-Pg1-Ps214Cg84-Pg1-Ps215Cg84-Pg1-Ps216
Cg84-Pg1-Ps217Cg84-Pg1-Ps218Cg84-Pg1-Ps219Cg84-Pg1-Ps220
Cg84-Pg1-Ps221Cg84-Pg1-Ps222Cg84-Pg1-Ps223Cg84-Pg1-Ps224
Cg84-Pg1-Ps225Cg84-Pg1-Ps226Cg84-Pg1-Ps227Cg84-Pg1-Ps228
Cg84-Pg1-Ps229Cg84-Pg1-Ps230Cg84-Pg1-Ps231Cg84-Pg1-Ps232
Cg84-Pg1-Ps233Cg84-Pg1-Ps234Cg84-Pg1-Ps235Cg84-Pg1-Ps236
Cg84-Pg1-Ps237Cg84-Pg1-Ps238Cg84-Pg1-Ps239Cg84-Pg1-Ps240
Cg84-Pg1-Ps241Cg84-Pg1-Ps242Cg84-Pg1-Ps243
Cg85-Pg1-Ps1Cg85-Pg1-Ps2Cg85-Pg1-Ps3Cg85-Pg1-Ps4
Cg85-Pg1-Ps5Cg85-Pg1-Ps6Cg85-Pg1-Ps7Cg85-Pg1-Ps8
Cg85-Pg1-Ps9Cg85-Pg1-Ps10Cg85-Pg1-Ps11Cg85-Pg1-Ps12
Cg85-Pg1-Ps13Cg85-Pg1-Ps14Cg85-Pg1-Ps15Cg85-Pg1-Ps16
Cg85-Pg1-Ps17Cg85-Pg1-Ps18Cg85-Pg1-Ps19Cg85-Pg1-Ps20
Cg85-Pg1-Ps21Cg85-Pg1-Ps22Cg85-Pg1-Ps23Cg85-Pg1-Ps24
Cg85-Pg1-Ps25Cg85-Pg1-Ps26Cg85-Pg1-Ps27Cg85-Pg1-Ps28
Cg85-Pg1-Ps29Cg85-Pg1-Ps30Cg85-Pg1-Ps31Cg85-Pg1-Ps32
Cg85-Pg1-Ps33Cg85-Pg1-Ps34Cg85-Pg1-Ps35Cg85-Pg1-Ps36
Cg85-Pg1-Ps37Cg85-Pg1-Ps38Cg85-Pg1-Ps39Cg85-Pg1-Ps40
Cg85-Pg1-Ps41Cg85-Pg1-Ps42Cg85-Pg1-Ps43Cg85-Pg1-Ps44
Cg85-Pg1-Ps45Cg85-Pg1-Ps46Cg85-Pg1-Ps47Cg85-Pg1-Ps48
Cg85-Pg1-Ps49Cg85-Pg1-Ps50Cg85-Pg1-Ps51Cg85-Pg1-Ps52
Cg85-Pg1-Ps53Cg85-Pg1-Ps54Cg85-Pg1-Ps55Cg85-Pg1-Ps56
Cg85-Pg1-Ps57Cg85-Pg1-Ps58Cg85-Pg1-Ps59Cg85-Pg1-Ps60
Cg85-Pg1-Ps61Cg85-Pg1-Ps62Cg85-Pg1-Ps63Cg85-Pg1-Ps64
Cg85-Pg1-Ps65Cg85-Pg1-Ps66Cg85-Pg1-Ps67Cg85-Pg1-Ps68
Cg85-Pg1-Ps69Cg85-Pg1-Ps70Cg85-Pg1-Ps71Cg85-Pg1-Ps72
Cg85-Pg1-Ps73Cg85-Pg1-Ps74Cg85-Pg1-Ps75Cg85-Pg1-Ps76
Cg85-Pg1-Ps77Cg85-Pg1-Ps78Cg85-Pg1-Ps79Cg85-Pg1-Ps80
Cg85-Pg1-Ps81Cg85-Pg1-Ps82Cg85-Pg1-Ps83Cg85-Pg1-Ps84
Cg85-Pg1-Ps85Cg85-Pg1-Ps86Cg85-Pg1-Ps87Cg85-Pg1-Ps88
Cg85-Pg1-Ps89Cg85-Pg1-Ps90Cg85-Pg1-Ps91Cg85-Pg1-Ps92
Cg85-Pg1-Ps93Cg85-Pg1-Ps94Cg85-Pg1-Ps95Cg85-Pg1-Ps96
Cg85-Pg1-Ps97Cg85-Pg1-Ps98Cg85-Pg1-Ps99Cg85-Pg1-Ps100
Cg85-Pg1-Ps101Cg85-Pg1-Ps102Cg85-Pg1-Ps103Cg85-Pg1-Ps104
Cg85-Pg1-Ps105Cg85-Pg1-Ps106Cg85-Pg1-Ps107Cg85-Pg1-Ps108
Cg85-Pg1-Ps109Cg85-Pg1-Ps110Cg85-Pg1-Ps111Cg85-Pg1-Ps112
Cg85-Pg1-Ps113Cg85-Pg1-Ps114Cg85-Pg1-Ps115Cg85-Pg1-Ps116
Cg85-Pg1-Ps117Cg85-Pg1-Ps118Cg85-Pg1-Ps119Cg85-Pg1-Ps120
Cg85-Pg1-Ps121Cg85-Pg1-Ps122Cg85-Pg1-Ps123Cg85-Pg1-Ps124
Cg85-Pg1-Ps125Cg85-Pg1-Ps126Cg85-Pg1-Ps127Cg85-Pg1-Ps128
Cg85-Pg1-Ps129Cg85-Pg1-Ps130Cg85-Pg1-Ps131Cg85-Pg1-Ps132
Cg85-Pg1-Ps133Cg85-Pg1-Ps134Cg85-Pg1-Ps135Cg85-Pg1-Ps136
Cg85-Pg1-Ps137Cg85-Pg1-Ps138Cg85-Pg1-Ps139Cg85-Pg1-Ps140
Cg85-Pg1-Ps141Cg85-Pg1-Ps142Cg85-Pg1-Ps143Cg85-Pg1-Ps144
Cg85-Pg1-Ps145Cg85-Pg1-Ps146Cg85-Pg1-Ps147Cg85-Pg1-Ps148
Cg85-Pg1-Ps149Cg85-Pg1-Ps150Cg85-Pg1-Ps151Cg85-Pg1-Ps152
Cg85-Pg1-Ps153Cg85-Pg1-Ps154Cg85-Pg1-Ps155Cg85-Pg1-Ps156
Cg85-Pg1-Ps157Cg85-Pg1-Ps158Cg85-Pg1-Ps159Cg85-Pg1-Ps160
Cg85-Pg1-Ps161Cg85-Pg1-Ps162Cg85-Pg1-Ps163Cg85-Pg1-Ps164
Cg85-Pg1-Ps165Cg85-Pg1-Ps166Cg85-Pg1-Ps167Cg85-Pg1-Ps168
Cg85-Pg1-Ps169Cg85-Pg1-Ps170Cg85-Pg1-Ps171Cg85-Pg1-Ps172
Cg85-Pg1-Ps173Cg85-Pg1-Ps174Cg85-Pg1-Ps175Cg85-Pg1-Ps176
Cg85-Pg1-Ps177Cg85-Pg1-Ps178Cg85-Pg1-Ps179Cg85-Pg1-Ps180
Cg85-Pg1-Ps181Cg85-Pg1-Ps182Cg85-Pg1-Ps183Cg85-Pg1-Ps184
Cg85-Pg1-Ps185Cg85-Pg1-Ps186Cg85-Pg1-Ps187Cg85-Pg1-Ps188
Cg85-Pg1-Ps189Cg85-Pg1-Ps190Cg85-Pg1-Ps191Cg85-Pg1-Ps192
Cg85-Pg1-Ps193Cg85-Pg1-Ps194Cg85-Pg1-Ps195Cg85-Pg1-Ps196
Cg85-Pg1-Ps197Cg85-Pg1-Ps198Cg85-Pg1-Ps199Cg85-Pg1-Ps200
Cg85-Pg1-Ps201Cg85-Pg1-Ps202Cg85-Pg1-Ps203Cg85-Pg1-Ps204
Cg85-Pg1-Ps205Cg85-Pg1-Ps206Cg85-Pg1-Ps207Cg85-Pg1-Ps208
Cg85-Pg1-Ps209Cg85-Pg1-Ps210Cg85-Pg1-Ps211Cg85-Pg1-Ps212
Cg85-Pg1-Ps213Cg85-Pg1-Ps214Cg85-Pg1-Ps215Cg85-Pg1-Ps216
Cg85-Pg1-Ps217Cg85-Pg1-Ps218Cg85-Pg1-Ps219Cg85-Pg1-Ps220
Cg85-Pg1-Ps221Cg85-Pg1-Ps222Cg85-Pg1-Ps223Cg85-Pg1-Ps224
Cg85-Pg1-Ps225Cg85-Pg1-Ps226Cg85-Pg1-Ps227Cg85-Pg1-Ps228
Cg85-Pg1-Ps229Cg85-Pg1-Ps230Cg85-Pg1-Ps231Cg85-Pg1-Ps232
Cg85-Pg1-Ps233Cg85-Pg1-Ps234Cg85-Pg1-Ps235Cg85-Pg1-Ps236
Cg85-Pg1-Ps237Cg85-Pg1-Ps238Cg85-Pg1-Ps239Cg85-Pg1-Ps240
Cg85-Pg1-Ps241Cg85-Pg1-Ps242Cg85-Pg1-Ps243
Cg86-Pg1-Ps1Cg86-Pg1-Ps2Cg86-Pg1-Ps3Cg86-Pg1-Ps4
Cg86-Pg1-Ps5Cg86-Pg1-Ps6Cg86-Pg1-Ps7Cg86-Pg1-Ps8
Cg86-Pg1-Ps9Cg86-Pg1-Ps10Cg86-Pg1-Ps11Cg86-Pg1-Ps12
Cg86-Pg1-Ps13Cg86-Pg1-Ps14Cg86-Pg1-Ps15Cg86-Pg1-Ps16
Cg86-Pg1-Ps17Cg86-Pg1-Ps18Cg86-Pg1-Ps19Cg86-Pg1-Ps20
Cg86-Pg1-Ps21Cg86-Pg1-Ps22Cg86-Pg1-Ps23Cg86-Pg1-Ps24
Cg86-Pg1-Ps25Cg86-Pg1-Ps26Cg86-Pg1-Ps27Cg86-Pg1-Ps28
Cg86-Pg1-Ps29Cg86-Pg1-Ps30Cg86-Pg1-Ps31Cg86-Pg1-Ps32
Cg86-Pg1-Ps33Cg86-Pg1-Ps34Cg86-Pg1-Ps35Cg86-Pg1-Ps36
Cg86-Pg1-Ps37Cg86-Pg1-Ps38Cg86-Pg1-Ps39Cg86-Pg1-Ps40
Cg86-Pg1-Ps41Cg86-Pg1-Ps42Cg86-Pg1-Ps43Cg86-Pg1-Ps44
Cg86-Pg1-Ps45Cg86-Pg1-Ps46Cg86-Pg1-Ps47Cg86-Pg1-Ps48
Cg86-Pg1-Ps49Cg86-Pg1-Ps50Cg86-Pg1-Ps51Cg86-Pg1-Ps52
Cg86-Pg1-Ps53Cg86-Pg1-Ps54Cg86-Pg1-Ps55Cg86-Pg1-Ps56
Cg86-Pg1-Ps57Cg86-Pg1-Ps58Cg86-Pg1-Ps59Cg86-Pg1-Ps60
Cg86-Pg1-Ps61Cg86-Pg1-Ps62Cg86-Pg1-Ps63Cg86-Pg1-Ps64
Cg86-Pg1-Ps65Cg86-Pg1-Ps66Cg86-Pg1-Ps67Cg86-Pg1-Ps68
Cg86-Pg1-Ps69Cg86-Pg1-Ps70Cg86-Pg1-Ps71Cg86-Pg1-Ps72
Cg86-Pg1-Ps73Cg86-Pg1-Ps74Cg86-Pg1-Ps75Cg86-Pg1-Ps76
Cg86-Pg1-Ps77Cg86-Pg1-Ps78Cg86-Pg1-Ps79Cg86-Pg1-Ps80
Cg86-Pg1-Ps81Cg86-Pg1-Ps82Cg86-Pg1-Ps83Cg86-Pg1-Ps84
Cg86-Pg1-Ps85Cg86-Pg1-Ps86Cg86-Pg1-Ps87Cg86-Pg1-Ps88
Cg86-Pg1-Ps89Cg86-Pg1-Ps90Cg86-Pg1-Ps91Cg86-Pg1-Ps92
Cg86-Pg1-Ps93Cg86-Pg1-Ps94Cg86-Pg1-Ps95Cg86-Pg1-Ps96
Cg86-Pg1-Ps97Cg86-Pg1-Ps98Cg86-Pg1-Ps99Cg86-Pg1-Ps100
Cg86-Pg1-Ps101Cg86-Pg1-Ps102Cg86-Pg1-Ps103Cg86-Pg1-Ps104
Cg86-Pg1-Ps105Cg86-Pg1-Ps106Cg86-Pg1-Ps107Cg86-Pg1-Ps108
Cg86-Pg1-Ps109Cg86-Pg1-Ps110Cg86-Pg1-Ps111Cg86-Pg1-Ps112
Cg86-Pg1-Ps113Cg86-Pg1-Ps114Cg86-Pg1-Ps115Cg86-Pg1-Ps116
Cg86-Pg1-Ps117Cg86-Pg1-Ps118Cg86-Pg1-Ps119Cg86-Pg1-Ps120
Cg86-Pg1-Ps121Cg86-Pg1-Ps122Cg86-Pg1-Ps123Cg86-Pg1-Ps124
Cg86-Pg1-Ps125Cg86-Pg1-Ps126Cg86-Pg1-Ps127Cg86-Pg1-Ps128
Cg86-Pg1-Ps129Cg86-Pg1-Ps130Cg86-Pg1-Ps131Cg86-Pg1-Ps132
Cg86-Pg1-Ps133Cg86-Pg1-Ps134Cg86-Pg1-Ps135Cg86-Pg1-Ps136
Cg86-Pg1-Ps137Cg86-Pg1-Ps138Cg86-Pg1-Ps139Cg86-Pg1-Ps140
Cg86-Pg1-Ps141Cg86-Pg1-Ps142Cg86-Pg1-Ps143Cg86-Pg1-Ps144
Cg86-Pg1-Ps145Cg86-Pg1-Ps146Cg86-Pg1-Ps147Cg86-Pg1-Ps148
Cg86-Pg1-Ps149Cg86-Pg1-Ps150Cg86-Pg1-Ps151Cg86-Pg1-Ps152
Cg86-Pg1-Ps153Cg86-Pg1-Ps154Cg86-Pg1-Ps155Cg86-Pg1-Ps156
Cg86-Pg1-Ps157Cg86-Pg1-Ps158Cg86-Pg1-Ps159Cg86-Pg1-Ps160
Cg86-Pg1-Ps161Cg86-Pg1-Ps162Cg86-Pg1-Ps163Cg86-Pg1-Ps164
Cg86-Pg1-Ps165Cg86-Pg1-Ps166Cg86-Pg1-Ps167Cg86-Pg1-Ps168
Cg86-Pg1-Ps169Cg86-Pg1-Ps170Cg86-Pg1-Ps171Cg86-Pg1-Ps172
Cg86-Pg1-Ps173Cg86-Pg1-Ps174Cg86-Pg1-Ps175Cg86-Pg1-Ps176
Cg86-Pg1-Ps177Cg86-Pg1-Ps178Cg86-Pg1-Ps179Cg86-Pg1-Ps180
Cg86-Pg1-Ps181Cg86-Pg1-Ps182Cg86-Pg1-Ps183Cg86-Pg1-Ps184
Cg86-Pg1-Ps185Cg86-Pg1-Ps186Cg86-Pg1-Ps187Cg86-Pg1-Ps188
Cg86-Pg1-Ps189Cg86-Pg1-Ps190Cg86-Pg1-Ps191Cg86-Pg1-Ps192
Cg86-Pg1-Ps193Cg86-Pg1-Ps194Cg86-Pg1-Ps195Cg86-Pg1-Ps196
Cg86-Pg1-Ps197Cg86-Pg1-Ps198Cg86-Pg1-Ps199Cg86-Pg1-Ps200
Cg86-Pg1-Ps201Cg86-Pg1-Ps202Cg86-Pg1-Ps203Cg86-Pg1-Ps204
Cg86-Pg1-Ps205Cg86-Pg1-Ps206Cg86-Pg1-Ps207Cg86-Pg1-Ps208
Cg86-Pg1-Ps209Cg86-Pg1-Ps210Cg86-Pg1-Ps211Cg86-Pg1-Ps212
Cg86-Pg1-Ps213Cg86-Pg1-Ps214Cg86-Pg1-Ps215Cg86-Pg1-Ps216
Cg86-Pg1-Ps217Cg86-Pg1-Ps218Cg86-Pg1-Ps219Cg86-Pg1-Ps220
Cg86-Pg1-Ps221Cg86-Pg1-Ps222Cg86-Pg1-Ps223Cg86-Pg1-Ps224
Cg86-Pg1-Ps225Cg86-Pg1-Ps226Cg86-Pg1-Ps227Cg86-Pg1-Ps228
Cg86-Pg1-Ps229Cg86-Pg1-Ps230Cg86-Pg1-Ps231Cg86-Pg1-Ps232
Cg86-Pg1-Ps233Cg86-Pg1-Ps234Cg86-Pg1-Ps235Cg86-Pg1-Ps236
Cg86-Pg1-Ps237Cg86-Pg1-Ps238Cg86-Pg1-Ps239Cg86-Pg1-Ps240
Cg86-Pg1-Ps241Cg86-Pg1-Ps242Cg86-Pg1-Ps243
Cg87-Pg1-Ps1Cg87-Pg1-Ps2Cg87-Pg1-Ps3Cg87-Pg1-Ps4
Cg87-Pg1-Ps5Cg87-Pg1-Ps6Cg87-Pg1-Ps7Cg87-Pg1-Ps8
Cg87-Pg1-Ps9Cg87-Pg1-Ps10Cg87-Pg1-Ps11Cg87-Pg1-Ps12
Cg87-Pg1-Ps13Cg87-Pg1-Ps14Cg87-Pg1-Ps15Cg87-Pg1-Ps16
Cg87-Pg1-Ps17Cg87-Pg1-Ps18Cg87-Pg1-Ps19Cg87-Pg1-Ps20
Cg87-Pg1-Ps21Cg87-Pg1-Ps22Cg87-Pg1-Ps23Cg87-Pg1-Ps24
Cg87-Pg1-Ps25Cg87-Pg1-Ps26Cg87-Pg1-Ps27Cg87-Pg1-Ps28
Cg87-Pg1-Ps29Cg87-Pg1-Ps30Cg87-Pg1-Ps31Cg87-Pg1-Ps32
Cg87-Pg1-Ps33Cg87-Pg1-Ps34Cg87-Pg1-Ps35Cg87-Pg1-Ps36
Cg87-Pg1-Ps37Cg87-Pg1-Ps38Cg87-Pg1-Ps39Cg87-Pg1-Ps40
Cg87-Pg1-Ps41Cg87-Pg1-Ps42Cg87-Pg1-Ps43Cg87-Pg1-Ps44
Cg87-Pg1-Ps45Cg87-Pg1-Ps46Cg87-Pg1-Ps47Cg87-Pg1-Ps48
Cg87-Pg1-Ps49Cg87-Pg1-Ps50Cg87-Pg1-Ps51Cg87-Pg1-Ps52
Cg87-Pg1-Ps53Cg87-Pg1-Ps54Cg87-Pg1-Ps55Cg87-Pg1-Ps56
Cg87-Pg1-Ps57Cg87-Pg1-Ps58Cg87-Pg1-Ps59Cg87-Pg1-Ps60
Cg87-Pg1-Ps61Cg87-Pg1-Ps62Cg87-Pg1-Ps63Cg87-Pg1-Ps64
Cg87-Pg1-Ps65Cg87-Pg1-Ps66Cg87-Pg1-Ps67Cg87-Pg1-Ps68
Cg87-Pg1-Ps69Cg87-Pg1-Ps70Cg87-Pg1-Ps71Cg87-Pg1-Ps72
Cg87-Pg1-Ps73Cg87-Pg1-Ps74Cg87-Pg1-Ps75Cg87-Pg1-Ps76
Cg87-Pg1-Ps77Cg87-Pg1-Ps78Cg87-Pg1-Ps79Cg87-Pg1-Ps80
Cg87-Pg1-Ps81Cg87-Pg1-Ps82Cg87-Pg1-Ps83Cg87-Pg1-Ps84
Cg87-Pg1-Ps85Cg87-Pg1-Ps86Cg87-Pg1-Ps87Cg87-Pg1-Ps88
Cg87-Pg1-Ps89Cg87-Pg1-Ps90Cg87-Pg1-Ps91Cg87-Pg1-Ps92
Cg87-Pg1-Ps93Cg87-Pg1-Ps94Cg87-Pg1-Ps95Cg87-Pg1-Ps96
Cg87-Pg1-Ps97Cg87-Pg1-Ps98Cg87-Pg1-Ps99Cg87-Pg1-Ps100
Cg87-Pg1-Ps101Cg87-Pg1-Ps102Cg87-Pg1-Ps103Cg87-Pg1-Ps104
Cg87-Pg1-Ps105Cg87-Pg1-Ps106Cg87-Pg1-Ps107Cg87-Pg1-Ps108
Cg87-Pg1-Ps109Cg87-Pg1-Ps110Cg87-Pg1-Ps111Cg87-Pg1-Ps112
Cg87-Pg1-Ps113Cg87-Pg1-Ps114Cg87-Pg1-Ps115Cg87-Pg1-Ps116
Cg87-Pg1-Ps117Cg87-Pg1-Ps118Cg87-Pg1-Ps119Cg87-Pg1-Ps120
Cg87-Pg1-Ps121Cg87-Pg1-Ps122Cg87-Pg1-Ps123Cg87-Pg1-Ps124
Cg87-Pg1-Ps125Cg87-Pg1-Ps126Cg87-Pg1-Ps127Cg87-Pg1-Ps128
Cg87-Pg1-Ps129Cg87-Pg1-Ps130Cg87-Pg1-Ps131Cg87-Pg1-Ps132
Cg87-Pg1-Ps133Cg87-Pg1-Ps134Cg87-Pg1-Ps135Cg87-Pg1-Ps136
Cg87-Pg1-Ps137Cg87-Pg1-Ps138Cg87-Pg1-Ps139Cg87-Pg1-Ps140
Cg87-Pg1-Ps141Cg87-Pg1-Ps142Cg87-Pg1-Ps143Cg87-Pg1-Ps144
Cg87-Pg1-Ps145Cg87-Pg1-Ps146Cg87-Pg1-Ps147Cg87-Pg1-Ps148
Cg87-Pg1-Ps149Cg87-Pg1-Ps150Cg87-Pg1-Ps151Cg87-Pg1-Ps152
Cg87-Pg1-Ps153Cg87-Pg1-Ps154Cg87-Pg1-Ps155Cg87-Pg1-Ps156
Cg87-Pg1-Ps157Cg87-Pg1-Ps158Cg87-Pg1-Ps159Cg87-Pg1-Ps160
Cg87-Pg1-Ps161Cg87-Pg1-Ps162Cg87-Pg1-Ps163Cg87-Pg1-Ps164
Cg87-Pg1-Ps165Cg87-Pg1-Ps166Cg87-Pg1-Ps167Cg87-Pg1-Ps168
Cg87-Pg1-Ps169Cg87-Pg1-Ps170Cg87-Pg1-Ps171Cg87-Pg1-Ps172
Cg87-Pg1-Ps173Cg87-Pg1-Ps174Cg87-Pg1-Ps175Cg87-Pg1-Ps176
Cg87-Pg1-Ps177Cg87-Pg1-Ps178Cg87-Pg1-Ps179Cg87-Pg1-Ps180
Cg87-Pg1-Ps181Cg87-Pg1-Ps182Cg87-Pg1-Ps183Cg87-Pg1-Ps184
Cg87-Pg1-Ps185Cg87-Pg1-Ps186Cg87-Pg1-Ps187Cg87-Pg1-Ps188
Cg87-Pg1-Ps189Cg87-Pg1-Ps190Cg87-Pg1-Ps191Cg87-Pg1-Ps192
Cg87-Pg1-Ps193Cg87-Pg1-Ps194Cg87-Pg1-Ps195Cg87-Pg1-Ps196
Cg87-Pg1-Ps197Cg87-Pg1-Ps198Cg87-Pg1-Ps199Cg87-Pg1-Ps200
Cg87-Pg1-Ps201Cg87-Pg1-Ps202Cg87-Pg1-Ps203Cg87-Pg1-Ps204
Cg87-Pg1-Ps205Cg87-Pg1-Ps206Cg87-Pg1-Ps207Cg87-Pg1-Ps208
Cg87-Pg1-Ps209Cg87-Pg1-Ps210Cg87-Pg1-Ps211Cg87-Pg1-Ps212
Cg87-Pg1-Ps213Cg87-Pg1-Ps214Cg87-Pg1-Ps215Cg87-Pg1-Ps216
Cg87-Pg1-Ps217Cg87-Pg1-Ps218Cg87-Pg1-Ps219Cg87-Pg1-Ps220
Cg87-Pg1-Ps221Cg87-Pg1-Ps222Cg87-Pg1-Ps223Cg87-Pg1-Ps224
Cg87-Pg1-Ps225Cg87-Pg1-Ps226Cg87-Pg1-Ps227Cg87-Pg1-Ps228
Cg87-Pg1-Ps229Cg87-Pg1-Ps230Cg87-Pg1-Ps231Cg87-Pg1-Ps232
Cg87-Pg1-Ps233Cg87-Pg1-Ps234Cg87-Pg1-Ps235Cg87-Pg1-Ps236
Cg87-Pg1-Ps237Cg87-Pg1-Ps238Cg87-Pg1-Ps239Cg87-Pg1-Ps240
Cg87-Pg1-Ps241Cg87-Pg1-Ps242Cg87-Pg1-Ps243
Cg88-Pg1-Ps1Cg88-Pg1-Ps2Cg88-Pg1-Ps3Cg88-Pg1-Ps4
Cg88-Pg1-Ps5Cg88-Pg1-Ps6Cg88-Pg1-Ps7Cg88-Pg1-Ps8
Cg88-Pg1-Ps9Cg88-Pg1-Ps10Cg88-Pg1-Ps11Cg88-Pg1-Ps12
Cg88-Pg1-Ps13Cg88-Pg1-Ps14Cg88-Pg1-Ps15Cg88-Pg1-Ps16
Cg88-Pg1-Ps17Cg88-Pg1-Ps18Cg88-Pg1-Ps19Cg88-Pg1-Ps20
Cg88-Pg1-Ps21Cg88-Pg1-Ps22Cg88-Pg1-Ps23Cg88-Pg1-Ps24
Cg88-Pg1-Ps25Cg88-Pg1-Ps26Cg88-Pg1-Ps27Cg88-Pg1-Ps28
Cg88-Pg1-Ps29Cg88-Pg1-Ps30Cg88-Pg1-Ps31Cg88-Pg1-Ps32
Cg88-Pg1-Ps33Cg88-Pg1-Ps34Cg88-Pg1-Ps35Cg88-Pg1-Ps36
Cg88-Pg1-Ps37Cg88-Pg1-Ps38Cg88-Pg1-Ps39Cg88-Pg1-Ps40
Cg88-Pg1-Ps41Cg88-Pg1-Ps42Cg88-Pg1-Ps43Cg88-Pg1-Ps44
Cg88-Pg1-Ps45Cg88-Pg1-Ps46Cg88-Pg1-Ps47Cg88-Pg1-Ps48
Cg88-Pg1-Ps49Cg88-Pg1-Ps50Cg88-Pg1-Ps51Cg88-Pg1-Ps52
Cg88-Pg1-Ps53Cg88-Pg1-Ps54Cg88-Pg1-Ps55Cg88-Pg1-Ps56
Cg88-Pg1-Ps57Cg88-Pg1-Ps58Cg88-Pg1-Ps59Cg88-Pg1-Ps60
Cg88-Pg1-Ps61Cg88-Pg1-Ps62Cg88-Pg1-Ps63Cg88-Pg1-Ps64
Cg88-Pg1-Ps65Cg88-Pg1-Ps66Cg88-Pg1-Ps67Cg88-Pg1-Ps68
Cg88-Pg1-Ps69Cg88-Pg1-Ps70Cg88-Pg1-Ps71Cg88-Pg1-Ps72
Cg88-Pg1-Ps73Cg88-Pg1-Ps74Cg88-Pg1-Ps75Cg88-Pg1-Ps76
Cg88-Pg1-Ps77Cg88-Pg1-Ps78Cg88-Pg1-Ps79Cg88-Pg1-Ps80
Cg88-Pg1-Ps81Cg88-Pg1-Ps82Cg88-Pg1-Ps83Cg88-Pg1-Ps84
Cg88-Pg1-Ps85Cg88-Pg1-Ps86Cg88-Pg1-Ps87Cg88-Pg1-Ps88
Cg88-Pg1-Ps89Cg88-Pg1-Ps90Cg88-Pg1-Ps91Cg88-Pg1-Ps92
Cg88-Pg1-Ps93Cg88-Pg1-Ps94Cg88-Pg1-Ps95Cg88-Pg1-Ps96
Cg88-Pg1-Ps97Cg88-Pg1-Ps98Cg88-Pg1-Ps99Cg88-Pg1-Ps100
Cg88-Pg1-Ps101Cg88-Pg1-Ps102Cg88-Pg1-Ps103Cg88-Pg1-Ps104
Cg88-Pg1-Ps105Cg88-Pg1-Ps106Cg88-Pg1-Ps107Cg88-Pg1-Ps108
Cg88-Pg1-Ps109Cg88-Pg1-Ps110Cg88-Pg1-Ps111Cg88-Pg1-Ps112
Cg88-Pg1-Ps113Cg88-Pg1-Ps114Cg88-Pg1-Ps115Cg88-Pg1-Ps116
Cg88-Pg1-Ps117Cg88-Pg1-Ps118Cg88-Pg1-Ps119Cg88-Pg1-Ps120
Cg88-Pg1-Ps121Cg88-Pg1-Ps122Cg88-Pg1-Ps123Cg88-Pg1-Ps124
Cg88-Pg1-Ps125Cg88-Pg1-Ps126Cg88-Pg1-Ps127Cg88-Pg1-Ps128
Cg88-Pg1-Ps129Cg88-Pg1-Ps130Cg88-Pg1-Ps131Cg88-Pg1-Ps132
Cg88-Pg1-Ps133Cg88-Pg1-Ps134Cg88-Pg1-Ps135Cg88-Pg1-Ps136
Cg88-Pg1-Ps137Cg88-Pg1-Ps138Cg88-Pg1-Ps139Cg88-Pg1-Ps140
Cg88-Pg1-Ps141Cg88-Pg1-Ps142Cg88-Pg1-Ps143Cg88-Pg1-Ps144
Cg88-Pg1-Ps145Cg88-Pg1-Ps146Cg88-Pg1-Ps147Cg88-Pg1-Ps148
Cg88-Pg1-Ps149Cg88-Pg1-Ps150Cg88-Pg1-Ps151Cg88-Pg1-Ps152
Cg88-Pg1-Ps153Cg88-Pg1-Ps154Cg88-Pg1-Ps155Cg88-Pg1-Ps156
Cg88-Pg1-Ps157Cg88-Pg1-Ps158Cg88-Pg1-Ps159Cg88-Pg1-Ps160
Cg88-Pg1-Ps161Cg88-Pg1-Ps162Cg88-Pg1-Ps163Cg88-Pg1-Ps164
Cg88-Pg1-Ps165Cg88-Pg1-Ps166Cg88-Pg1-Ps167Cg88-Pg1-Ps168
Cg88-Pg1-Ps169Cg88-Pg1-Ps170Cg88-Pg1-Ps171Cg88-Pg1-Ps172
Cg88-Pg1-Ps173Cg88-Pg1-Ps174Cg88-Pg1-Ps175Cg88-Pg1-Ps176
Cg88-Pg1-Ps177Cg88-Pg1-Ps178Cg88-Pg1-Ps179Cg88-Pg1-Ps180
Cg88-Pg1-Ps181Cg88-Pg1-Ps182Cg88-Pg1-Ps183Cg88-Pg1-Ps184
Cg88-Pg1-Ps185Cg88-Pg1-Ps186Cg88-Pg1-Ps187Cg88-Pg1-Ps188
Cg88-Pg1-Ps189Cg88-Pg1-Ps190Cg88-Pg1-Ps191Cg88-Pg1-Ps192
Cg88-Pg1-Ps193Cg88-Pg1-Ps194Cg88-Pg1-Ps195Cg88-Pg1-Ps196
Cg88-Pg1-Ps197Cg88-Pg1-Ps198Cg88-Pg1-Ps199Cg88-Pg1-Ps200
Cg88-Pg1-Ps201Cg88-Pg1-Ps202Cg88-Pg1-Ps203Cg88-Pg1-Ps204
Cg88-Pg1-Ps205Cg88-Pg1-Ps206Cg88-Pg1-Ps207Cg88-Pg1-Ps208
Cg88-Pg1-Ps209Cg88-Pg1-Ps210Cg88-Pg1-Ps211Cg88-Pg1-Ps212
Cg88-Pg1-Ps213Cg88-Pg1-Ps214Cg88-Pg1-Ps215Cg88-Pg1-Ps216
Cg88-Pg1-Ps217Cg88-Pg1-Ps218Cg88-Pg1-Ps219Cg88-Pg1-Ps220
Cg88-Pg1-Ps221Cg88-Pg1-Ps222Cg88-Pg1-Ps223Cg88-Pg1-Ps224
Cg88-Pg1-Ps225Cg88-Pg1-Ps226Cg88-Pg1-Ps227Cg88-Pg1-Ps228
Cg88-Pg1-Ps229Cg88-Pg1-Ps230Cg88-Pg1-Ps231Cg88-Pg1-Ps232
Cg88-Pg1-Ps233Cg88-Pg1-Ps234Cg88-Pg1-Ps235Cg88-Pg1-Ps236
Cg88-Pg1-Ps237Cg88-Pg1-Ps238Cg88-Pg1-Ps239Cg88-Pg1-Ps240
Cg88-Pg1-Ps241Cg88-Pg1-Ps242Cg88-Pg1-Ps243
|
Abbreviations and symbols commonly used in the peptide and chemical arts are used herein to describe compounds of the present invention, following the general guidelines presented by the IUPAC-IUB Joint Commission on Biochemical Nomenclature as described in Eur. J. Biochem., 158, 9-, 1984. Compounds of formula (I) and the intermediates and starting materials used in their preparation are named in accordance with the IUPAC rules of nomenclature in which the characteristic groups have decreasing priority for citation as the principle group. An example compound of formula (I), compound (1) in which Z is CH2, R1 is R2C(O), where R2 is 2-pyridyl, P1, P2 are methylene, Y is 4-methylpentoyl, (X)0 is zero, (W)n is NH, (V)m is C(O) and U is phenyl is thus named:—
- (3aR,6aS)—N-{(1S)-3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydropyrrolo [3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
A second example compound of formula (I), compound (2) in which Z is CH2, R1 is R2C(O), where R2 is 2-pyridyl, P1, is methylene, P2 is NH, Y is 4-methylpentoyl, (X)0 is zero, (W)n is NH, (V)m is C(O) and U is phenyl is thus named:—
- (3aR,6aS)—N-{(1S)-3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydropyrrolo [3,2-c]pyrazole-1-carbonyl]-butyl}-benzamide;
A third example compound of formula (I), compound (3) in which Z is CH2, R1 is R2C(O), where R2 is 2-pyridyl, P1, is methylene, P2 is O, Y is 4-methylpentoyl, (X)0 is zero, (W)n is NH, (V)m is C(O) and U is phenyl is thus named:—
- (3aS,6aS)—N-{(1S)-3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-2-oxa-1,4-diaza-pentalene-1-carbonyl]-butyl}-benzamide.
Compounds of the invention include, but are not limited to, the following examples where all 4 stereoisomeric combinations of the bicyclic ketone are included where P2 is CH2, i.e. (3aS,6aS), (3aR,6aS), (3aS,6aR), (3aR,6aR) and also included are the equivalent analogues where P2 is O and NH. More preferred compounds consist of the cis-bicyclic isomers which, when P2 is CH2, are designated as (3aR,6aS) and (3aS,6aR) and also more preferred are the equivalent cis-bicyclic analogues where P2 is O and NH.
- 4. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 5. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 6. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 7. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 8. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 9. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 10. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 11. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 12. {3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 13. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 14. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 15. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 16. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 17. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 18. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 19. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 20. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 21. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 22. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 23. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 24. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 25. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 26. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 27. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 28. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 29. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 30. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 31. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 32. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 33. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 34. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 35. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 36. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 37. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 38. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 39. Quinoline-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 40. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 41. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 42. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 43. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 44. 4-Dimethylamino-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 45. 7-Methoxy-benzofuran-2-caboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 46. {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 47. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 48. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 49. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 50. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 51. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 52. Quinoline-6-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 53. Furan-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 54. Thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 55. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 56. Furan-3-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 57. Thiophene-3-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 58. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 59. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 60. 4-Methyl-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 61. 4-Methoxy-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 62. 4-Isopropyl-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 63. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 64. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 65. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 66. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 67. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 68. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 69. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 70. 4-Difluoromethoxy-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 71. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 72. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 73. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 74. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 75. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 76. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 77. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 78. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 79. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 80. {3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 81. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 82. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 83. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 84. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 85. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 86. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 87. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 88. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 89. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 90. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 91. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 92. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 93. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 94. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 95. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 96. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 97. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 98. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 99. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 100. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 101. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 102. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 103. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 104. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 105. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 106. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 107. Quinoline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 108. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 109. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 110. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 111. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 112. 4-Dimethylamino-N-{-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 113. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 114. {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 115. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 116. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 117. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 118. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 119. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 120. Quinoline-6-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 121. Furan-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 122. Thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 123. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 124. Furan-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 125. Thiophene-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 126. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 127. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)benzamide;
- 128. 4-Methyl-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 129. 4-Methoxy-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 130. 4-Isopropyl-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 131. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 132. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 133. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 134. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 135. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 136. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 137. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 138. 4-Difluoromethoxy-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 139. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 140. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 141. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 142. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 143. Benzofuran-2-caboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 144. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 145. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 146. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 147. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 148. {3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 149. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 150. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 151. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 152. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 153. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 154. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 155. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 156. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 157. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 158. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 159. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 160. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 161. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 162. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 163. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-11 pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 164. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 165. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 166. 4-imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 167. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 168. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 169. 5-Phenyl-thiophene-2 carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 170. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 171. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 172. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 173. N-{3-Methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 174. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 175. Quinoline-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 176. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 177. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 178. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 179. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 180. 4-Dimethylamino-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 181. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 182. {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 183. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 184. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 185. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 186. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 187. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 188. Quinoline-6-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 189. Furan-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 190. Thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 191. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 192. Furan-3-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 193. Thiophene-3-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 194. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 195. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(methyl-piperazin-1-yl)-benzamide;
- 196. 4-Methyl-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 197. 4-Methoxy-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 198. 4-Isopropyl-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 199. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 200. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 201. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 202. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 203. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 204. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 205. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 206. 4-Difluoromethoxy-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 207. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 208. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 209. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 210. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 211. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 212. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 213. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 214. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 215. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 216. {3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 217. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 218. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 219. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 220. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 221. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-carbonyl]-butyl}-amide;
- 222. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 223. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 224. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 225. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 226. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 227. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 228. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 229. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 230. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 231. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 232. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 233. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 234. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 235. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 236. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 237. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 238. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 239. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 240. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 241. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 242. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 243. Quinoline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 244. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 245. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 246. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 247. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 248. 4-Dimethylamino-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 249. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 250. {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 251. 5-Methoxy-benzofuran-2-caboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 252. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 253. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 254. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 255. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 256. Quinoline-6-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 257. Furan-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 258. Thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 259. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 260. Furan-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 261. Thiophene-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 262. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 263. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 264. 4-Methyl-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 265. 4-Methoxy-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 266. 4-Isopropyl-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 267. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 268. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 269. N-f{-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 270. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 271. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 272. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 273. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 274. 4-Difluoromethoxy-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 275. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 276. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 277. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 278. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 279. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 280. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 281. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 282. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 283. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 284. {3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 285. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 286. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 287. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 288. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 289. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 290. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 291. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 292. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 293. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 294. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 295. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 296. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 297. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 298. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 299. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 300. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 301. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 302. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 303. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 304. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 305. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 306. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 307. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 308. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 309. N-{3-Methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 310. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 311. Quinoline-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 312. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 313. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 314. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 315. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 316. 4-Dimethylamino-N-{1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 317. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 318. {-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 319. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 320. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 321. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 322. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 323. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 324. Quinoline-6-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 325. Furan-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 326. Thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 327. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 328. Furan-3-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 329. Thiophene-3-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 330. N-{1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 331. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 332. 4-Methyl-N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 333. 4-Methoxy-N-{1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 334. 4-Isopropyl-N-{1-[6-oxo-1 (pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 335. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 336. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 337. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 338. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 339. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 340. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 341. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 342. 4-Difluoromethoxy-N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 343. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 344. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-1-(2-pyridine-3-yl-acetyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 345. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 346. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 347. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 348. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 349. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 350. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 351. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 352. {3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 353. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 354. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 355. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 356. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 357. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 358. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 359. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 360. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 361. N-{3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 362. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 363. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 364. N-{3-Methyl-1-[6-oxo-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 365. N-{3-Methyl-1-[6-oxo-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 366. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 367. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 368. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 369. N-{3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 370. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 371. N-{3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 372. N-{3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-oxazol-5-yl-benzamide;
- 373. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 374. N-{3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 375. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 376. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 377. N-{3-Methyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 378. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 379. Quinoline-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 380. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 381. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 382. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 383. 4-tert-Butyl-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 384. 4-Dimethylamino-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 385. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 386. {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 387. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 388. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 389. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 390. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 391. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 392. Quinoline-6-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 393. Furan-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 394. Thiophene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 395. N-{-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 396. Furan-3-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 397. Thiophene-3-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 398. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 399. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 400. 4-Methyl-N-{1-[6-oxo-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 401. 4-Methoxy-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 402. 4-Isopropyl-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 403. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 404. 4-imidazol-1-yl-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 405. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 406. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 407. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 408. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 409. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 410. 4-Difluoromethoxy-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 411. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 412. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 413. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 414. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 415. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 416. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 417. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 418. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 419. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 420. {3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 421. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 422. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 423. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 424. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 425. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 426. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 427. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 428. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 429. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide,
- 430. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 431. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 432. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 433. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 434. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 435. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 436. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 437. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 438. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 439. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 440. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 441. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 442. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 443. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 444. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 445. N-{3-Methyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 446. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 447. Quinoline-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 448. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 449. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 450. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 451. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 452. 4-Dimethylamino-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 453. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 454. {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 455. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 456. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 457. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 458. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 459. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 460. Quinoline-6-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 461. Furan-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 462. Thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 463. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 464. Furan-3-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 465. Thiophene-3-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 466. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 467. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 468. 4-Methyl-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 469. 4-Methoxy-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 470. 4-Isopropyl-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 471. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 472. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 473. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 474. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 475. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 476. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 477. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-carbonyl]-butyl}-amide;
- 478. 4-Difluoromethoxy-N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 479. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 480. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 481. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 482. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 483. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 484. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 485. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 486. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 487. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 488. {3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 489. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 490. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 491. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 492. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 493. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 494. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 495. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 496. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 497. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 498. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 499. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 500. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 501. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-methyl-piperazin-1-yl)-benzamide;
- 502. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 503. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 504. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 505. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 506. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 507. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 508. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 509. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 510. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 511. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 512. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 513. N-{3-Methyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 514. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 515. Quinoline-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 516. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 517. Benzofuran-2-carboxylic acid {1-[6-oxo-1-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 518. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 519. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 520. 4-Dimethylamino-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 521. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 522. {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 523. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 524. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 525. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 526. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 527. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 528. Quinoline-6-carboxylic acid {1-[6-oxo-4-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 529. Furan-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 530. Thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 531. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 532. Furan-3-carboxylic acid {1-[6-oxo-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 533. Thiophene-3-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 534. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 535. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 536. 4-Methyl-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 537. 4-Methoxy-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 538. 4-Isopropyl-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 539. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 540. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 541. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 542. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 543. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 544. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 545. 5-Pyridin-2-yl-thiophene-2 caboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 546. 4-Difluoromethoxy-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 547. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 548. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 549. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 550. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 551. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 552. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 553. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 554. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 555. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 556. {3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester,
- 557. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 558. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 559. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 560. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 561. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 562. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 563. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 564. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 565. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 566. Furan-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 567. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 568. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}phenoxy-benzamide;
- 569. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 570. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 571. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 572. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 573. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 574. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 575. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 576. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 577. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 578. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 579. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 580. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 581. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 582. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 583. Quinoline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 584. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 585. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 586. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 587. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 588. 4-Dimethylamino-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 589. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 590. {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 591. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 592. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 593. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 594. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 595. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 596. Quinoline-6-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 597. Furan-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 598. Thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 599. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 600. Furan-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 601. Thiophene-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 602. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 603. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 604. 4-Methyl-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 605. 4-Methoxy-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 606. 4-Isopropyl-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 607. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 608. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 609. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 610. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 611. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 612. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 613. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 614. 4-Difluoromethoxy-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 615. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 616. Naphthalene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 617. Quinoline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 618. Benzo[b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 619. Benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 620. Biphenyl-4-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 621. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 622. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 623. 7-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 624. {3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 625. 5-Methoxy-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 626. Thieno[3,2-b]thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 627. 3-Methyl-benzofuran-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 628. Quinoxaline-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 629. Benzo[1,3]dioxole-5-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 630. Quinoline-6-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 631. Furan-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 632. Thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 633. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 634. Furan-3-caboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 635. Thiophene-3-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 636. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 637. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl) benzamide;
- 638. 4-Methyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 639. 4-Methoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 640. 4-Isopropyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 641. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 642. 4-Imidazol-1-yl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 643. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 644. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 645. 5-Phenyl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 646. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 647. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 648. 4-Difluoromethoxy-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 649. N-{3-Methyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 650. Naphthalene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 651. Quinoline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 652. Benzo[b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 653. Benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 654. Biphenyl-4-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 655. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 656. 4-Dimethylamino-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 657. 7-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 658. {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-carbamic acid benzyl ester;
- 659. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 660. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 661. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 662. Quinoxaline-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 663. Benzo[1,3]dioxole-5-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 664. Quinoline-6-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 665. Furan-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 666. Thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 667. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethyl-benzamide;
- 668. Furan-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 669. Thiophene-3-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 670. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-phenoxy-benzamide;
- 671. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 672. 4-Methyl-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 673. 4-Methoxy-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 674. 4-Isopropyl-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 675. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-vinyl-benzamide;
- 676. 4-Imidazol-1-yl-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 677. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 678. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-oxazol-5-yl-benzamide;
- 679. 5-Phenyl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 680. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-trifluoromethoxy-benzamide;
- 681. 5-Pyridin-2-yl-thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 682. 4-Difluoromethoxy-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 683. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 684. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 685. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 686. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 687. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-sulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 688. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 689. N-{1-[6-oxo-4-(pyridine-2-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 690. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 691. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 692. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 693. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 694. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 695. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 696. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 697. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 698. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 699. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 700. N-{2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 701. N-{2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 702. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 703. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 704. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 705. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 706. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 707. N-{1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 708. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 709. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 710. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 711. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 712. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 713. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 714. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 715. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 716. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 717. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 718. N-{2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 719. N-{2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 720. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 721. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 722. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 723. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 724. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 725. N-{1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 726. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 727. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 728. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 729. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 730. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 731. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 732. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 733. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 734. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 735. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 736. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 737. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 738. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 739. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 740. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 741. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 742. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 743. N-{1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 744. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 745. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 746. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 747. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 748. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 749. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 750. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 751. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 752. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 753. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 754. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 755. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 756. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 757. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 758. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 759. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 760. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl})-phenoxy-benzamide;
- 761. N-{1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 762. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 763. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 764. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 765. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 766. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 767. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 768. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 769. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 770. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 771. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 772. N-{2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 773. N-{2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 774. 4-tert-Butyl-N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 775. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 776. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 777. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 778. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 779. N-{1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 780. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 781. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 782. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 783. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 784. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 785. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 786. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 787. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 788. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 789. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 790. N-{2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 791. N-{2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 792. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridin-Z-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 793. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 794. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 795. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 796. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 797. N-{1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 798. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 799. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 800. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 801. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 802. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 803. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 804. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 805. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 806. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 807. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 808. N-{2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 809. N-{2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 810. 4-tert-Butyl-N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 811. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 812. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 813. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 814. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 815. N-{1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 816. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 817. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 818. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 819. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 820. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 821. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 822. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 823. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 824. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 825. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 826. N-{2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 827. N-{2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 828. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 829. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 830. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 831. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 832. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 833. N-{1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 834. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 835. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 836. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 837. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 838. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 839. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 840. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 841. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 842. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 843. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 844. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 845. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 846. 4-tert-Butyl-N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-benzamide;
- 847. 5-Methoxy-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 848. Thieno[3,2-b]thiophene-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 849. 3-Methyl-benzofuran-2-carboxylic acid {1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-amide;
- 850. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-phenoxy-benzamide;
- 851. N-{1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-cyclohexyl}-4-thiophen-2-yl-benzamide;
- 852. 4-tert-Butyl-N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 853. 5-Methoxy-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 854. Thieno[3,2-b]thiophene-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 855. 3-Methyl-benzofuran-2-carboxylic acid {1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 856. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-phenoxy-benzamide;
- 857. N-{1-cyclopropylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-4-thiophen-2-yl-benzamide;
- 858. 4-tert-Butyl-N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide;
- 859. 5-Methoxy-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 860. Thieno[3,2-b]thiophene-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 861. 3-Methyl-benzofuran-2-carboxylic acid {2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-amide;
- 862. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-phenoxy-benzamide;
- 863. N-{2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-4-thiophen-2-yl-benzamide;
- 864. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-one;
- 865. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 866. 2-Isobutyl-1-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(1-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 867. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 868. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 869. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 870. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 871. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 872. 2-Isobutyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 873. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 874. 2-Isobutyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 875. 2-Isobutyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 876. 2-Isobutyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 877. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 878. 2-Isobutyl 4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 879. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 880. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 881. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 882. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 883. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 884. 4-(4-Benzyl-piperazin-1-yl)2-isobutyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 885. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 886. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 887. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 888. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 889. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 890. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 891. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 892. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 893. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 894. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 895. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 896. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 897. 2-Isobutyl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 898. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 899. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 900. 2-Isobutyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 901. 2-Isobutyl-1-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 902. 2-Isobutyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 903. 2-Isobutyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 904. 2-Isobutyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 905. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 906. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 907. 2-Isobutyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro pyrrolo[3,2-b]pyrrol-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 908. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 909. 2-Isobutyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 910. 2-Isobutyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 911. 2-Isobutyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 912. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 913. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 914. 2-Isobutyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 915. 2-Isobutyl-1-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 916. 2-Isobutyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 917. 2-Isobutyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 918. 2-Isobutyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 919. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 920. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 921. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 922. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 923. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 924. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 925. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 926. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 927. 2-Isobutyl-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 928. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-piperazin-1-yl-butane-1,4-dione;
- 929. 2-Isobutyl-4-(4-methyl-piperazin-1-yl)-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 930. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-4-(4-phenyl-piperazin-1-yl)-butane-1,4-dione;
- 931. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro pyrrolo[3,2-b]pyrrole-1-yl]-4-(3,4,4a,8a-tetrahydro-1H-isoquinolin-2-yl)-butane-1,4-dione;
- 932. 2-Isobutyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(1,3,3a,7a-tetrahydro-isoindol-2-yl)-butane-1,4-dione;
- 933. 4-(4-Benzyl-piperazin-1-yl)-2-isobutyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 934. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 935. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 936. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 937. 4-(2-Biphenyl-3-ylmethyl-pentanoyl)-1-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 938. 4-(2-Biphenyl-3-ylmethyl-pentanoyl)-1-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 939. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(2-pyridin-3-yl-acetyl) hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 940. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 941. 4-2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 942. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 943. 4-(2-Biphenyl-3-yl-4-methyl-pentanoyl)-1-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 944. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 945. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 946. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 947. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one,
- 948. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 949. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 950. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 951. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 952. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 953. 4-[4-Methyl-2-(3-pyridin-2-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 954. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 955. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 956. 4-[4-Methyl-2-3-pyridin-3-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 957. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 958. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 959. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 960. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 961. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 962. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 963. 4-[4-Methyl-2-(3-pyridin-3-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 964. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 965. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 966. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 967. 4-[4-Methyl-2-(3-pyridinyl-phenyl)-pentanoyl]-1-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 968. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 969. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 970. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 971. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 972. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one;
- 973. 4-[4-Methyl-2-(3-pyridin-4-yl-phenyl)-pentanoyl]-1-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one.
- Other compounds of the invention include, but are not limited to, the following examples where all 4 stereoisomeric combinations of the bicyclic ketone are included where P2 is CH2, i.e. (3aS,6aS), (3aR,6aS), (3aS,6aR), (3aR,6aR) and also included are the equivalent analogues where P2 is O and NH. More preferred compounds consist of the cis-bicyclic isomers which, when P2 is CH2, are designated as (3aR,6aS) and (3aS,6aR) and also more preferred are the equivalent cis-bicyclic analogues where P2 is O and NH.
- 974. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 975. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 976. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 977. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 978. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 979. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 980. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 981. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 982. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 983. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 984. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 985. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 986. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 987. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 988. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 989. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 990. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 991. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 992. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 993. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 994. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 995. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 996. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 997. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 998. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 999. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1000. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1001. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1002. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1003. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1004. Biphenyl-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1005. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1006. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1007. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1008. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1009. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1010. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1011. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1012. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1013. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1014. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1015. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1016. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1017. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1018. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1019. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1020. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1021. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1022. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1023. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1024. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1025. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 1026. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1027. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1028. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1029. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1030. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1031. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1032. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1033. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1034. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1035. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1036. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1037. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1038. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1039. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1040. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1041. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 1042. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1043. Benzo[b]thiophene-3-caboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 1044. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1045. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1046. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1047. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1048. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1049. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1050. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1051. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1052. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1053. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1054. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1055. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1056. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1057. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1058. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1059. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1060. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1061. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1062. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1063. 4-ten-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1064. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1065. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1066. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1067. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1068. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1069. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1070. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1071. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1072. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1073. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1074. Thiophene-3 carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1075. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1076. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1077. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1078. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1079. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1080. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1081. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1082. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1083. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1084. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1085. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1086. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1087. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1088. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1089. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1090. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1091. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1092. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1093. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1094. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1095. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1096. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1097. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1098. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1099. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1100. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1101. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1102. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1103. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1104. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1105. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1106. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1107. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 1108. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1109. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1110. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1111. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-(1-oxy-pyridin-2-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1112. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1113. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1114. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1115. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1116. Biphenyl-4-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1117. Biphenyl carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1118. Furan-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1119. Thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1120. Benzo[b]thiophene-3-carboxylic acid {3,3-dimethyl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1121. Furan-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1122. Thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1123. Benzo[b]thiophene-3-carboxylic acid {1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide;
- 1124. Naphthalene-1-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1125. Quinoline-8-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1126. 4-tert-Butyl-N-{1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1127. 4-tert-Butyl-N-{1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1128. 4-tert-Butyl-N-{1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1129. 4-tert-Butyl-N-{1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide;
- 1130. Biphenyl-4-carboxylic acid {1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1131. Biphenyl-4-carboxylic acid {1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1132. Biphenyl-carboxylic acid {1-(4-methoxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide,
- 1133. Biphenyl-4-carboxylic acid {1-(3-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide;
- 1134. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1135. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1136. 2-Cyclohexylmethyl morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1137. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1138. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1139. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1140. 2-Cyclohexylmethyl-4-morpholin-4-yl-4-yl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1141. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1142. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1143. 2-Cyclohexylmethyl-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1144. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1145. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1146. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1147. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1148. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1149. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(2-pyridin-3-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1150. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1151. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(pyridin-3-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1152. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridin-2-ylmethanesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione;
- 1153. 2-(2,2-Dimethyl-propyl)-4-morpholin-4-yl-1-[6-oxo-4-(1-oxy-pyridin-3-ylmethanesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-butane-1,4-dione.
Additional compounds of the invention include, but are not limited to, the following examples where all 4 stereoisomeric combinations of the bicyclic ketone are included where P2 is CH2, i.e. (3aS,6aS), (3aR,6aS), (3aS,6aR), (3aR,6aR) and also included are the equivalent analogues where P2 is O and NH. More preferred compounds consist of the cis-bicyclic isomers which, when P2 is CH2, are designated as (3aR,6aS) and (3aS,6aR) and also more preferred are the equivalent cis-bicyclic analogues where P2 is O and NH.
- 1154. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-tert-butylbenzamide;
- 1155. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1156. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1157. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1158. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1159. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinecarbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1160. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-tert-butyl-benzamide;
- 1161. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyridine-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1162. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-sulfonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1163. 4-tert-Butyl-N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1164. 4-[2-(4-tert-Butyl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1165. 4-[2-(4-tert-Butyl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1166. 4-[2-(4-tert-Butyl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester,
- 1167. 4-[2-(4-tert-Butyl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester,
- 1168. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1169. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1170. 4-tert-Butyl-N-{3-methyl-1-[4-(morpholin-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1171. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1172. 4-tert-Butyl-N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1173. 4-tert-Butyl-N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-benzamide;
- 1174. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1175. 4-tert-Butyl-N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1176. 4-tert-Butyl-N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1177. 4-tert-Butyl-N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1178. 4-tert-Butyl-N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1179. 4-tert-Butyl-N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1180. 4-tert-Butyl-N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1181. 4-tert-Butyl-N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 1182. 4-tert-Butyl-N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 1183. 4-tert-Butyl-N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1184. 4-tert-Butyl-N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1185. 4-tert-Butyl-N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1186. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1187. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1188. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1189. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1190. 4-tert-Butyl-N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1191. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1192. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1193. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1194. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1195. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1196. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1197. 4-tert-Butyl-N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1198. 4-tert-Butyl-N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1199. 4-tert-Butyl-N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1200. 4-tert-Butyl-N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1201. 4-tert-Butyl-N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1202. 4-tert-Butyl-N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1203. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1204. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1205. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1206. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1207. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1208. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1209. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-carbonyl}-3-methyl-butyl)-4-tert-butyl-benzamide;
- 1210. 4-tert-Butyl-N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1211. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1212. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1213. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1214. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1215. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1216. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1217. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1218. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1219. 4-tert-Butyl-N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1220. 4-tert-Butyl-N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1221. 4-tert-Butyl-N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1222. N-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1223. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1224. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1225. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1226. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1227. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1228. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1229. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1230. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1231. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide;
- 1232. 4-tert-Butyl-N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1233. 4-tert-Butyl-N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1234. 4-tert-Butyl-N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1235. 4-tert-Butyl-N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1236. 4-tert-Butyl-N-{1-[4-(2-hydroxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1237. 4-tert-Butyl-N-{1-[4-(2-methoxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1238. 4-tert-Butyl-N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1239. 4-tert-Butyl-N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1240. 4-tert-Butyl-N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1241. 4-tert-Butyl-N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1242. 4-tert-Butyl-N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1243. 4-tert-Butyl-N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1244. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylaminobenzamide;
- 1245. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1246. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1247. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1248. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1249. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinecarbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1250. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide;
- 1251. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyridinesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1252. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1253. 4-Dimethylamino-N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1254. 4-[2-(4-Dimethylamino-benzoylamino)methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1255. 4-[2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1256. 4-[2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester;
- 1257. 4-[2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester,
- 1258. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1259. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1260. 4-Dimethylamino-N-{3-methyl-1-[4-(morpholin-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1261. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1262. 4-Dimethylamino-N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1263. 4-Dimethylamino-N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-benzamide;
- 1264. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1265. 4-Dimethylamino-N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1266. 4-Dimethylamino-N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1267. 4-Dimethylamino-N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1268. 4-Dimethylamino-N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1269. 4-Dimethylamino-N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1270. 4-Dimethylamino-N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1271. 4-Dimethylamino-N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 1272. 4-Dimethylamino-N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 1273. 4-Dimethylamino-N-{1-[4-(2-cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1274. 4-Dimethylamino-N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1275. 4-Dimethylamino-N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1276. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1277. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1278. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1279. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1280. 4-Dimethylamino-N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1281. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1282. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1283. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1284. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1285. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1286. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1287. 4-Dimethylamino-N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1288. 4-Dimethylamino-N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1289. 4-Dimethylamino-N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1290. 4-Dimethylamino-N-{1-[4-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1291. 4-Dimethylamino-N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1292. 4-Dimethylamino-N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1293. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1294. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1295. N {1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1296. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1297. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1298. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1299. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-dimethylamino-benzamide;
- 1300. 4-Dimethylamino-N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1301. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1302. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1303. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1304. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1305. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1306. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1307. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1308. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1309. 4-Dimethylamino-N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1310. 4-Dimethylamino-N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1311. 4-Dimethylamino-N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1312. N-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1313. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethyl amino-benzamide;
- 1314. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1315. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1316. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1317. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1318. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1319. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1320. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1321. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide;
- 1322. 4-Dimethylamino-N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1323. 4-Dimethylamino-N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1324. 4-Dimethylamino-N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1325. 4-Dimethylamino-N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1326. 4-Dimethylamino-N-{1-[4-(2-hydroxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1327. 4-Dimethylamino-N-{1-[4-(2-methoxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1328. 4-Dimethylamino-N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1329. 4-Dimethylamino-N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1330. 4-Dimethylamino-N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1331. 4-Dimethylamino-N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1332. 4-Dimethylamino-N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1333. 4-Dimethylamino-N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1334. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-thiophen-2-yl-benzamide;
- 1335. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1336. N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1337. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1338. N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1339. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1340. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-thiophen-2-yl-benzamide;
- 1341. N-{3-methyl-1-[6-oxo-4-(pyridinesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1342. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinesulfonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1343. N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-thiophen-2-yl-benzamide;
- 1344. 4-[4-Methyl-2-(4-thiophen-2-yl-benzoylamino)-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1345. 4-[4-Methyl-2-(4-thiophen-2-yl-benzoylamino)-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1346. 4-[4-Methyl-2-(4-thiophen-2-yl-benzoylamino)-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester,
- 1347. 4-[4-Methyl-2-(4-thiophen-2-yl-benzoylamino)-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester,
- 1348. N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1349. N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1350. N-{3-methyl-1-[4-(morpholin-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1351. N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1352. N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1353. N-(3-methyl-1-{4-[2-(4-methyl-piperazine-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-4-thiophen-2-yl-benzamide;
- 1354. N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1355. N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1356. N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1357. N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1358. N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1359. N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1360. N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1361. N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-thiophen-2-yl-benzamide;
- 1362. N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-thiophen-2-yl-benzamide;
- 1363. N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1364. N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1365. N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1366. N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1367. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1368. N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1369. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1370. N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1371. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1372. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1373. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1374. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1375. N{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1376. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1377. N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1378. N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1379. N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1380. N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1381. N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1382. N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1383. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1384. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1385. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1386. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1387. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1388. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1389. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-thiophen-2-yl-benzamide;
- 1390. N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1391. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1392. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1393. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1394. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-6-thiophen-2-yl-benzamide;
- 1395. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1396. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1397. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1398. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1399. N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-thiophen-2-yl-benzamide;
- 1400. N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1401. N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-thiophen-2-yl-benzamide;
- 1402. N-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1403. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1404. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1405. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1406. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1407. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1408. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1409. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1410. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1411. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1412. N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1413. N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1414. N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide,
- 1415. N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1416. N-{1-[4-(2-hydroxy methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1417. N-{1-[4-(2-methoxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1418. N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1419. N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1420. N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1421. N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1422. N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1423. N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-thiophen-2-yl-benzamide;
- 1424. 5-Phenyl-thiophene-2-carboxylic acid-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide;
- 1425. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1426. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1427. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1428. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1429. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1430. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1431. 5-Phenyl-thiophene-2-carboxylic acid-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide;
- 1432. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1433. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1434. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1435. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1436. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1437. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1438. 5-Phenyl-thiophene-2-carboxylic acid-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-amide;
- 1439. 4-{4-Methyl-2-[(5-phenyl-thiophene-2-carbonyl)-amino]-pentanoyl}-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1440. 4-{4-Methyl-2-[(5-phenyl-thiophene-2-carbonyl)-amino]-pentanoyl}-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1441. 4-{4-Methyl-2-[(5-phenyl-thiophene-2-carbonyl)-amino]-pentanoyl}-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester;
- 1442. 4-{4-Methyl-2-[(5-phenyl-thiophene-2-carbonyl)-amino]-pentanoyl}-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester;
- 1443. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1444. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1445. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[4-(morpholin-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1446. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1447. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1448. 5-Phenyl-thiophene-2-carboxylic acid-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-amide;
- 1449. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1450. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1451. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1452. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1453. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1454. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1455. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1456. 5-Phenyl-thiophene-2-carboxylic acid-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl)-amide;
- 1457. 5-Phenyl-thiophene-2-carboxylic acid-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide;
- 1458. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1459. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1460. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1461. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1462. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1463. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxopiperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1464. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1465. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1466. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1467. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1468. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1469. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1470. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1471. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1472. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1473. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1474. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1475. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1476. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1477. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1478. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1479. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1480. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1481. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1482. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1483. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1484. 5-Phenyl-thiophene-2-carboxylic acid-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-amide;
- 1485. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1486. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl}-amide;
- 1487. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1488. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1489. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1490. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1491. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1492. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1493. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1494. 5-Phenyl-thiophene-2-carboxylic acid-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-amide;
- 1495. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1496. 5-Phenyl-thiophene-2-carboxylic acid-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide;
- 1497. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1498. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1499. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1500. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1501. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1502. 5-Phenyl-thiophene-2-carboxylic acid {1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1503. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1504. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1505. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1506. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1507. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1508. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1509. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1510. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1511. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-hydroxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1512. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1513. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1514. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1515. 5-Phenyl-thiophene-2-carboxylic acid {1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1516. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1517. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1518. 5-Phenyl-thiophene-2-carboxylic acid-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-amide;
- 1519. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-pyrrolidin-1-ylbenzamide;
- 1520. N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1521. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1522. N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1523. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1524. N-{3-methyl-1-[6-oxo-4-(pyridinecarbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1525. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinecarbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1526. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-pyrrolidin-1-yl-benzamide;
- 1527. N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1528. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1529. N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1530. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1531. N-{3-methyl-1-[6-oxo-4-(pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1532. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1533. N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-pyrrolidin-1-yl-benzamide;
- 1534. 4-[2-(4-pyrrolidin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1535. 4-[2-(4-pyrrolidin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1536. 4-[2-(4-pyrrolidin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester,
- 1537. 4-[2-(4-pyrrolidin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester;
- 1538. N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1539. N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1540. N-{3-methyl-1-[4-(morpholinecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1541. N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1542. N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1543. N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-4-pyrrolidin-1-yl-benzamide;
- 1544. N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1545. N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1546. N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1547. N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1548. N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1549. N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1550. N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1551. N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-pyrrolidin-1-yl-benzamide;
- 1552. N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-pyrrolidin-1-yl-benzamide;
- 1553. N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1554. N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1555. N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1556. 4-Pyrrolidin-1-yl-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1557. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1558. N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1559. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1560. N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1561. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1562. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1563. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1564. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1565. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1566. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1567. N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1568. N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1569. N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1570. N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1571. N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1572. N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1573. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1574. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1575. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1576. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1577. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1578. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1579. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl]-4-pyrrolidin-1-yl-benzamide;
- 1580. N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1581. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1582. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1583. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1584. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1585. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1586. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1587. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1588. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1589. N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-pyrrolidin-1-yl-benzamide;
- 1590. N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1591. N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1592. N-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1593. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1594. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1595. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1596. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1597. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1598. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1599. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1600. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1601. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1602. N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1603. N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1604. N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1605. N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1606. N-{1-[4-(2-hydroxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1607. N-{1-[4-(2-methoxymethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1608. N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1609. N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1610. N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1611. N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1612. N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1613. N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-pyrrolidin-1-yl-benzamide;
- 1614. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-morpholin-4-ylbenzamide;
- 1615. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-4-yl-benzamide;
- 1616. N-{3-methyl-1-[6-oxo-4-(4-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1617. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1618. N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1619. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1620. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-morpholin-4-yl-benzamide;
- 1621. N-{3-methyl-1-[6-oxo-4-(pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1622. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1623. N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-morpholin-4-yl-benzamide;
- 1624. 4-[2-(4-morpholin-4-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1625. 4-[2-(4-morpholin-4-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1626. 4-[2-(4-morpholin-4-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester;
- 1627. 4-[2-(4-morpholin-4-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester;
- 1628. N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1629. N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1630. N-{3-methyl-1-[4-(morpholin-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1631. N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1632. N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1633. N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-4-morpholin-4-yl-benzamide;
- 1634. N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1635. N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1636. N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1637. N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1638. N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1639. N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1640. N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1641. N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-morpholin-4-yl-benzamide;
- 1642. N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-morpholin-4-yl-benzamide;
- 1643. N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1644. N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1645. N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1646. 4-morpholin-4-yl-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1647. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1648. N-{3-methyl-1-[6-oxo-4-piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1649. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1650. N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1651. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1652. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1653. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1654. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1655. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1656. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1657. N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1658. N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1659. N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1660. N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1661. N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1662. N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1663. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1664. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1665. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1666. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1667. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1668. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1669. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-morpholin-4-yl-benzamide;
- 1670. N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1671. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1672. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1673. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1674. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1675. N-{1-[4-(2-amino-3,3-ethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1676. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1677. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1678. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1679. N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-morpholin-4-yl-benzamide;
- 1680. N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1681. N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-morpholin-4-yl-benzamide;
- 1682. N-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1683. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1684. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1685. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1686. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1687. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1688. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1689. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1690. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1691. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1692. N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1693. N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1694. N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1695. N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1696. N-{1-[4-(2-hydroxy methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1697. N-{1-[4-(2-methoxy methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1698. N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1699. N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1700. N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1701. N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1702. N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1703. N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-morpholin-4-yl-benzamide;
- 1704. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-piperazin-1-ylbenzamide;
- 1705. N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1706. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl})piperazin-1-yl-benzamide;
- 1707. N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1708. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1709. N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1710. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1711. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-piperazin-1-yl-benzamide;
- 1712. N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1713. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1714. N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1715. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1716. N-{3-methyl-1-[6-oxo-4-(pyridine sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1717. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1718. N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-piperazin-1-yl-benzamide;
- 1719. 4-[2-(4-piperazin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1720. 4-[2-(4-piperazin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1721. 4-[2-(4-piperazin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester,
- 1722. 4-[2-(4-piperazin-1-yl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester;
- 1723. N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1724. N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1725. N-{3-methyl-1-[4-morpholinecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1726. N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1727. N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1728. N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-4-piperazin-1-yl-benzamide;
- 1729. N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1730. N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1731. N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1732. N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1733. N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1734. N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1735. N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1736. N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-piperazin-1-yl-benzamide;
- 1737. N-[1-(4-Cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-piperazin-1-yl-benzamide;
- 1738. N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1739. N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1740. N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1741. 4-piperazin-1-yl-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1742. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1743. N-{3-methyl-1-[6-oxo piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1744. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1745. N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1746. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1747. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1748. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1749. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1750. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1751. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1752. N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1753. N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1754. N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1755. N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1756. N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1757. N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1758. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1759. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1760. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1761. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1762. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1763. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1764. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-piperazin-1-yl-benzamide;
- 1765. N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1766. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1767. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1768. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1769. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1770. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1771. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1772. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1773. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1774. N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-piperazin-1-yl-benzamide;
- 1775. N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1776. N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-piperazin-1-yl-benzamide;
- 1777. N-{1-[4-(2-Aminomethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1778. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1779. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1780. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1781. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1782. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1783. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1784. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1785. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1786. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1787. N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1788. N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1789. N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1790. N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1791. N-{1-[4-(2-hydroxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1792. N-{1-[4-(2-methoxymethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1793. N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1794. N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1795. N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1796. N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1797. N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1798. N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-piperazin-1-yl-benzamide;
- 1799. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-(4-methyl-piperazin-1-yl)benzamide;
- 1800. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1801. N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1802. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1803. N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1804. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1805. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1806. N-{3-methyl-1-[6-oxo-4-(pyridinesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1807. N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1808. N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1809. 4-[2-(4-(4-methyl-piperazin-1-yl)-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1810. 4-[2-(4-(4-methyl-piperazin-1-yl)benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1811. 4-[2-(4-(4-methyl-piperazin-1-yl)-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester,
- 1812. 4-[2-(4-(4-methyl-piperazin-1-yl)-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester,
- 1813. N-{3-methyl-1-[6-oxo-4-pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1814. N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl-}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1815. N-{3-methyl-1-[4-(morpholine-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1816. N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1817. N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1818. N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1819. N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1820. N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1821. N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1822. N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1823. N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1824. N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1825. N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1826. N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1827. N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1828. N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1829. N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1830. N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1831. 4-(4-methyl-piperazin-1-yl)-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1832. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1833. N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1834. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1835. N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1836. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1837. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1838. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1839. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1840. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1841. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1842. N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1843. N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1844. N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1845. N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1846. N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1847. N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1848. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1849. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1850. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1851. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1852. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1853. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1854. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1855. N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1856. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1857. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1858. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1859. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1860. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1861. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1862. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1863. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1864. N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1865. N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1866. N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1867. N-{1-[4-(2-Aminomethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1868. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1869. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1870. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1871. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1872. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1873. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1874. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1875. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1876. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1877. N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1878. N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazine-1-yl)-benzamide;
- 1879. N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazine-1-yl)-benzamide;
- 1880. N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1881. N-{1-[4-(2-hydroxy methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1882. N-{1-[4-(2-methoxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1883. N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1884. N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1885. N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1886. N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1887. N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1888. N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-(4-methyl-piperazin-1-yl)-benzamide;
- 1889. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-aminobenzamide;
- 1890. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1891. 4-Amino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1892. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1893. 4-Amino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1894. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1895. 4-Amino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1896. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-amino-benzamide;
- 1897. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1898. 4-Amino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1899. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1900. 4-Amino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1901. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1902. 4-Amino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridinesulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1903. 4-Amino-N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1904. 4-[2-(4-amino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 1905. 4-[2-(4-amino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 1906. 4-[2-(4-amino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester;
- 1907. 4-[2-(4-amino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester,
- 1908. 4-Amino-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1909. 4-Amino-N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1910. 4-Amino-N-{3-methyl-1-[4-(morpholin-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1911. 4-Amino-N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1912. 4-Amino-N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1913. 4-Amino-N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-benzamide;
- 1914. 4-Amino-N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1915. 4-Amino-N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1916. 4-Amino-N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1917. 4-Amino-N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1918. 4-Amino-N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1919. 4-Amino-N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1920. 4-Amino-N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1921. 4-Amino-N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 1922. 4-Amino-N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 1923. 4-Amino-N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1924. 4-Amino-N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1925. 4-Amino-N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1926. 4-Amino-N-{3-methyl-1-[6-oxo-4-pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1927. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1928. 4-Amino-N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1929. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1930. 4-Amino-N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1931. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-Amino-benzamide;
- 1932. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1933. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1934. N {1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1935. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1936. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1937. 4-Amino-N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl}-benzamide;
- 1938. 4-Amino-N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1939. 4-Amino-N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1940. 4-Amino-N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1941. 4-Amino-N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1942. 4-Amino-N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1943. N-{1-[4-(2-amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1944. N-{1-[4-(2-amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1945. N-{1-[4-(2-acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1946. N-{1-[4-(2-acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1947. N-{1-[4-(2-acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1948. N-{1-[4-(2-acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1949. N-(1-{4-[2-(acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-amino-benzamide;
- 1950. 4-Amino-N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1951. N-{1-[4-(2-amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1952. N-{1-[4-(2-acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1953. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1954. N-{1-[4-(2-acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1955. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1956. N-{1-[4-(2-acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1957. N-{1-[4-(2-amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1958. N-{1-[4-(2-acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1959. 4-Amino-N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1960. 4-Amino-N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1961. 4-Amino-N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1962. N-{1-[4-(2-amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1963. N-{1-[4-(2-acetylamino-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1964. N-{1-[4-(2-amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1965. N-{1-[4-(2-acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1966. N-{1-[4-(2-amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1967. N-{1-[4-(2-acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1968. N-{1-[4-(2-amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1969. N-{1-[4-(2-acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1970. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1971. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-amino-benzamide;
- 1972. 4-Amino-N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1973. 4-Amino-N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1974. 4-Amino-N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1975. 4-Amino-N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1976. 4-Amino-N-{1-[4-(2-hydroxymethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1977. 4-Amino-N-{1-[4-(2-methoxy-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1978. 4-Amino-N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1979. 4-Amino-N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1980. 4-Amino-N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1981. 4-Amino-N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1982. 4-Amino-N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1983. 4-Amino-N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 1984. N-[1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-diethylaminobenzamide;
- 1985. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1986. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1987. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1988. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1989. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl) hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1990. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1991. N-[1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-diethylamino-benzamide;
- 1992. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1993. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1994. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1995. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1996. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyridine sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1997. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-sulfonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 1998. 4-Diethylamino-N-[3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 1999. 4-[2-(4-diethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide;
- 2000. 4-[2-(4-diethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl-amide;
- 2001. 4-[2-(4-diethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenyl ester,
- 2002. 4-[2-(4-diethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid isobutyl ester,
- 2003. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2004. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2005. 4-Diethylamino-N-{3-methyl-1-[4-(morpholinecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2006. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(piperazine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2007. 4Diethylamino-N-{3-methyl-1-[4-(4-methyl-piperazine-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2008. 4-Diethylamino-N-(3-methyl-1-{4-[2-(4-methyl-piperazin-1-yl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-benzamide;
- 2009. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2010. 4-Diethylamino-N-{1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2011. 4-Diethylamino-N-{1-[4-(5-chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2012. 4-Diethylamino-N-{1-[4-(thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2013. 4-Diethylamino-N-{1-[4-(5-chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2014. 4-Diethylamino-N-{1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2015. 4-Diethylamino-N-{1-[4-(thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2016. 4-Diethylamino-N-[1-(4-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 2017. 4-Diethylamino-N-[1-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide;
- 2018. 4-Diethylamino-N-{1-[4-(cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2019. 4-Diethylamino-N-{1-[4-(2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2020. 4-Diethylamino-N-{1-[4-(2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2021. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2022. N-{1-[4-(1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2023. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2024. N-{1-[4-(1-Acetyl-piperidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2025. 4-Diethylamino-N-{3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2026. N-{1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2027. N-{1-[4-(1-Amino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2028. N-{1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2029. N-{1-[4-(1-Acetylamino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2030. N-{1-[4-(1-Acetylamino-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2031. N-{1-[4-(1-Acetylamino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2032. 4-Diethylamino-N-{1-[4-(1-hydroxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2033. 4-Diethylamino-N-{1-[4-(1-hydroxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2034. 4-Diethylamino-N-{1-[4-(1-hydroxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2035. 4-Diethylamino-N-{1-[4-(1-methoxy-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2036. 4-Diethylamino-N-{1-[4-(1-methoxy-cyclopentanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2037. 4-Diethylamino-N-{1-[4-(1-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2038. N-{1-[4-(2-Amino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2039. N-{1-[4-(2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2040. N-{1-[4-(2-Acetylamino-2-cyclopentyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2041. N-{1-[4-(2-Acetylamino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2042. N-{1-[4-(2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2043. N-{1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2044. N-(1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl]-4-diethylamino-benzamide;
- 2045. 4-Diethylamino-N-{1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2046. N-{1-[4-(2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2047. N-{1-[4-(2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2048. N-{1-[4-(2-amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2049. N-{1-[4-(2-Acetylamino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2050. N-{1-[4-(2-amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2051. N-{1-[4-(2-Acetylamino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2052. N-{1-[4-(2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2053. N-{1-[4-(2-Acetylamino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2054. 4-Diethylamino-N-[3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide;
- 2055. 4-Diethylamino-N-{3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2056. 4-Diethylamino-N-{3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide;
- 2057. N-{1-[4-(2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2058. N-{1-[4-(2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2059. N-{1-[4-(2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2060. N-{1-[4-(2-Acetylamino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2061. N-{1-[4-(2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2062. N-{1-[4-(2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2063. N-{1-[4-(2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2064. N-{1-[4-(2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2065. N-{1-[4-(2-hydroxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2066. N-{1-[4-(2-methoxy-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-diethylamino-benzamide;
- 2067. 4-Diethylamino-N-{1-[4-(2-hydroxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2068. 4-Diethylamino-N-{1-[4-(2-methoxy-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2069. 4-Diethylamino-N-{1-[4-(2-hydroxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2070. 4-Diethylamino-N-{1-[4-(2-methoxy-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide,
- 2071. 4-Diethylamino-N-{1-[4-(2-hydroxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2072. 4-Diethylamino-N-{1-[4-(2-methoxy-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2073. 4-Diethylamino-N-{1-[4-(2-hydroxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2074. 4-Diethylamino-N-{1-[4-(2-methoxy-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2075. 4-Diethylamino-N-{1-[4-(2-hydroxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2076. 4-Diethylamino-N-{1-[4-(2-methoxy-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2077. 4-Diethylamino-N-{1-[4-(2-hydroxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
- 2078. 4-Diethylamino-N-{1-[4-(2-methoxy-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide;
To those skilled in the practices of organic chemistry, compounds of general formula (I) may be readily synthesised by a number of chemical strategies, performed either in solution or on the solid phase (see Atherton, E. and Sheppard, R. C. In ‘Solid Phase Peptide Synthesis: A Practical Approach’, Oxford University Press, Oxford, U.K. 1989, for a general review of solid phase synthesis principles). The solid phase strategy is attractive in being able to generate many thousands of analogues, typically on a 5-100 mg scale, through established parallel synthesis methodologies (e.g. see (a) Bastos, M.; Maeji, N. J.; Abeles, R. H. Proc. Natl. Acad. Sci. USA, 92, 6738-6742, 1995).
Therefore, one strategy for the synthesis of compounds of general formula (I) comprises:—
- (a) Preparation of an appropriately functionalised and protected bicyclic ketone building block in solution.
- (b) Attachment of the building block (a) to the solid phase through a linker that is stable to the conditions of synthesis, but readily labile to cleavage at the end of a synthesis (see James, I. W., Tetrahedron, 55(Report No 489), 4855-4946, 1999, for examples of the ‘linker’ function as applied to solid phase synthesis).
- (c) Solid phase organic chemistry (see Brown, R. D. J. Chem. Soc., Perkin Trans.1, 19, 3293-3320, 1998), to construct the remainder of the molecule.
- (d) Compound cleavage from the solid phase into solution.
- (e) Cleavage work-up and compound analysis.
The first stage in a synthesis of compounds of general formula (I) is the preparation in solution of a functionalised and protected building block. Typical schemes towards the hexahydropyrrolo[3,2-b]pyrrol-3-one (6) are detailed in Schemes 1-3, a hexahydropyrrolo[3,2-c]pyrazol-6-one (21) in Scheme 4 and a hexahydro-2-oxa-1,4-diazapentalen-6-one (26) in Scheme 5. The synthetic descriptions detailed in Schemes 6-18 could equally be applied using each of the scaffolds of general formula (I).
‘Pg1’ and ‘Pg2’ denotes suitable amine protecting groups such as the 9-fluorenyl methoxycarbonyl (Fmoc, see Atherton, E. and Sheppard, R. C. In ‘Solid Phase Peptide Synthesis: A Practical Approach’, Oxford University Press, Oxford, U.K. 1989), tert-butoxycarbonyl (Boc), benzyloxycarbonyl (Cbz) or allyloxycarbonyl (Alloc) for example.
In the illustrated case, condensation with diazomethane provides Z=CH2 in general formula (I). Synthesis may commence from a suitably protected β-aminoproline (4) which are described in the literature e.g. Gomez-Vidal, J. A. and Silverman, R. B. Org. Lett., 3(16), 2481-2484, 2001.
Activation of the suitably protected β-aminoproline (4) via isobutyl chloroformate mixed anhydride, followed by condensation with diazomethane, yields the diazomethylketone intermediate (5). Treatment of diazomethylketone intermediate (5) with lithium chloride in aqueous acetic acid provides the protected hexahydropyrrolo[3,2-b]pyrrol-3-one (6). Alternatively, when Pg2 is Boc, treatment with HBr in acetic acid provides an intermediate bicycle with the secondary amine. HBr salt. This intermediate may be acylated with a variety of reagents e.g. activated carboxylic acids, sulphonyl chlorides, urethane chloroformates to provide many variations of (6) where the nitrogen substituent is a suitable protecting group ‘Pg2’ or R2C(O), R2SO2, etc. Alternatively, treatment of diazomethylketone intermediate (5) with rhodium (II) tetraacetate in dichloromethane provides the hexahydropyrrolo[3,2-b]pyrrol-3-one (6) (e.g. see Lall, M. S. et al, J. Org. Chem., 67, 1536-1547, 2002. and refs cited therein).
Introduction of simple ‘Z’ substituents may be achieved by condensation of activated (4) with alternatives to diazomethane such as diazoethane (Z=CHCH3, R3=H, R4=CH3), or I-phenyloxydiazoethane (Z=CHCH2OPh, R3=H, R4=CH2OPh).
An alternative route towards a suitably protected building block is detailed in Scheme 2. Using an Arndt-Eistert synthesis, a suitably protected 3,4-dehydroproline (7) may be homologated by methylene insertion between the α-carbon and carboxylic acid following standard literature methods (e.g. see Meier and Zeller, Angew. Chem. Intl. Ed. Engl., 14, 3243, 1975 for a review). Conversion of (7) into the α-diazomethylketone proceeds via isobutyl chloroformate mixed anhydride, followed by condensation with diazomethane. Wolff rearrangement, e.g. with silver oxide in methanol provides the protected homologated analogue (8), e.g. 2-Methoxycarbonylmethyl-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester.
Treatment of the methyl ester (8) with a reducing agent such as DIBAL-H (diisobutylaluminium hydride) provides the primary alcohol, which is readily converted to tosylate (9). Similarly the mesylate or triflate analogues of (9) may be prepared. Nucleophilic displacement of the activated alcohol with sodium azide provides intermediate (10) e.g. 2-(2-Azido-ethyl)-2,5-dihydro-pyrrole-1-carboxylic acid tert-butyl ester. Epoxidation of (10) with oxidising agents common to the art such as m-CPBA provides the epoxide (11) e.g. 2-(2-Azido-ethyl)-6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester. Reduction of the azide (11) to the amine intermediate may be effected under a range of conditions such as Pd—C/H2 or triphenylphosphine in THF and water. The amine intermediates undergo intramolecular epoxide ring opening to provide the bicyclic alcohol (12) e.g. 3-Hydroxy-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester. The free secondary amine (12) may be protected with a variety of suitable protecting groups such as Fmoc, Boc, Cbz, Alloc to provide orthogonal protection of the bicyclic scaffold. Protected alcohol (13) may be oxidised by reagents common to the art such as pyridine sulphur trioxide complex in DMSO and triethylamine or Dess-Martin periodane to provide ketone (6) e.g. 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester.
Alternative routes towards intermediate (9) (ex Scheme 2) are available such as that detailed in Scheme 3. Protected alkene (14) is readily available following literature procedures from the protected homoserine lactol ((a) Wright, D. L. et al, Org. Lett., 2(13), 1847-1850, 2000. (b) Boyle, P. H. et al, Tet. Asymm., 6, 2819, 1995. (c) Baldwin, J. E. and Flinn, A., Org. Lett., 2, 3605, 1987.). N-alkylation of (14) with a base such as sodium hydride and allyl bromide provides diene (15). Treatment of (15) with the olefin metathesis catalysts developed by Grubbs such as bis(tricyclohexylphosphine)benzylidine ruthenium (I) dichloride provides the protected primary alcohol intermediate of compound (9) detailed in Scheme 2.
The hexahydropyrrolo[3,2-c]pyrazol-6-one (21) scaffold may be prepared following a similar route to that described in Scheme 2 (see Scheme 4). Treatment of the protected 3,4-dehydroproline (7) with HCl in methanol provides the methyl ester. Reduction of the ester with a reducing agent such as DIBAL-H (diisobutylaluminium hydride) provides the primary alcohol, which is readily converted to tosylate (16). Similarly the mesylate or triflate analogues of (16) may be prepared. Nucleophilic displacement of the activated alcohol with a protected hydrazide e.g. Hydrazinecarboxylic acid allyl ester (Alloc-NHNH2) followed by Boc protection of the secondary hydrazide e.g. under standard Schotten-Baumenn conditions and removal of the alloc group e.g. (PPh3)-4Pdo/DCM/PhSiH3 provides (17). Epoxidation of (17) with oxidising agents common to the art such as m-CPBA provides the epoxide intermediate (18). Intermediate (18) readily undergoes intramolecular epoxide ring opening to provide the bicyclic alcohol (19). The free secondary hydrazide (19) may be protected with a variety of suitable protecting groups e.g. Fmoc, Cbz, Alloc to provide orthogonal protection of the bicyclic scaffold. Protected alcohol (20) may be oxidised by reagents common to the art such as pyridine sulphur trioxide complex in DMSO and triethylamine or Dess-Martin periodane to provide ketone (21).
The hexahydro-2-oxa-1,4-diazapentalen-6-one (26) scaffold may be prepared following a similar route to that described in Scheme 4. Tosylate (16) undergoes nucleophilic displacement with a protected oxyamine e.g. N-Boc hydroxylamine to provide intermediate (22). Epoxidation of (22) with oxidising agents common to the art such as m-CPBA provides the epoxide intermediate, which upon acidolytic removal of the Boc group provides intermediate amine.salt (23). Neutralisation of the amine.salt initiates intramolecular epoxide ring opening to provide the bicyclic alcohol (24). The free secondary amine (24) may be protected with a variety of suitable protecting groups e.g. Fmoc, Cbz, Alloc, Boc to provide orthogonal protection of the bicyclic scaffold. Protected alcohol (25) may be oxidised by reagents common to the art such as pyridine sulphur trioxide complex in DMSO and triethylamine or Dess-Martin periodane to provide ketone (26) e.g. 6-Oxo-tetrahydro-2-oxa-1,4-diaza-pentalene-1,4-dicarboxylic acid 4-benzyl ester 1-(9H-fluoren-9-ylmethyl) ester.
The protected building blocks detailed in Schemes 1, 2, 4 and 5 may be utilised in a solid phase synthesis of inhibitor molecules (steps (b) to (e)). Preferred protecting group combinations include ‘Pg1’=Fmoc/‘Pg2’=Boc, or ‘Pg1’=Fmoc/‘Pg2’=Alloc, or ‘Pg1’=Boc/‘Pg2’=Fmoc, or ‘Pg1’=Boc/‘Pg2’=Alloc, or ‘Pg1’=Alloc/‘Pg2’=Fmoc, or ‘Pg1’=Alloc/‘Pg2’=Boc. The solid phase syntheses exemplified in Schemes 6 and 7 by the use of hexahydropyrrolo[3,2-b]pyrrol-3-one (6) and octahydropyrrolo[3,2-b]pyrrol-3-ol (13) could equally apply to ketones (21) and (26) and alcohols (20) and (25). Step (b), the solid phase linkage of an aldehyde or ketone, has previously been described by a variety of methods (e.g. see (a) James, I. W., 1999, (b) Lee, A., Huang, L., Ellman, J. A., J. Am. Chem. Soc, 121(43), 9907-9914, 1999, (c) Murphy, A. M., et al, J. Am. Chem. Soc, 114, 3156-3157, 1992). A suitable method amenable to the reversible linkage of an alkyl ketone functionality such as (6) is through a combination of the previously described chemistries. The semicarbazide, 4[[hydrazinocarbonyl)amino]methyl]cyclohexane carboxylic acid. trifluoroacetate (Murphy, A. M., et al, J. Am. Chem. Soc, 114, 3156-3157, 1992), may be utilised as illustrated in Scheme 6, where ‘Pg1’=Fmoc and ‘Pg2’=Boc or Alloc, exemplified by linkage of the hexahydropyrrolo[3,2-b]pyrrol-3-one (6).
Construct (28) is prepared through reaction of the linker molecule (27) and the hexahydropyrrolo[3,2-b]pyrrol-3-one (6) by reflux in aqueous ethanol/sodium acetate. Standard solid phase techniques (e.g. see Atherton, E. and Sheppard, R. C. In ‘Solid Phase Peptide Synthesis: A Practical Approach’, Oxford University Press, Oxford, U.K. 1989) are used to anchor the construct to an amino-functionalised solid phase through the free carboxylic acid functionality of (27), providing the loaded construct (28). Loaded construct (28) may be reacted with a wide range of carboxylic acids or sulphonyl chlorides available commercially in the literature, to introduce the left-hand portion ‘U-V-W-X-Y’ in general formula (I), providing loaded construct (29). Orthogonal removal of ‘Pg2’ then liberates the secondary amine functionality of the right-hand ring, which may be acylated with a range of carboxylic acid and sulphonyl chlorides. Finally, compounds of general formula (I) are released from the solid phase by treatment with 95% aq trifluoroacetic acid.
An alternative solid phase synthesis of compounds of general formula (I) utilises the bicyclic alcohol intermediate (13), Scheme 7. The secondary alcohol may be attached to the solid phase through the acid labile dihydropyran linker (30) that is well known in the literature (e.g. see (a) Thompson, L. A. and Ellman, J. A., Tet. Lett., 35, 9333, 1994. (b) Kick, E. K and Ellman, J. A. J. Med. Chem., 38, 1427, 1995.). Preferred protecting group combinations include ‘Pg1’=Fmoc/‘Pg2’ Alloc, or ‘Pg1’=Alloc/‘Pg2’=Fmoc.
Loaded construct (31) may be reacted with a wide range of carboxylic acids or sulphonyl chlorides available commercially in the literature, to introduce the left-hand portion ‘U-V-W-X-Y’ in general formula (I), providing loaded construct (32). Orthogonal removal of ‘Pg2’ then liberates the secondary amine functionality of the right-hand ring, which may be acylated with a range of carboxylic acid and sulphonyl chlorides. Compounds of general formula (I) are released from the solid phase by treatment with 95% aq trifluoroacetic acid and the resultant alcohols may be oxidised with a range of solution based reagents e.g. Dess-Marin periodane in DCM or solid supported oxidants (e.g. see Ley, S. V. et al, J. Chem. Soc. Perkin Trans. 1., 3815-4195, 2000.) to provide the ketone products.
In the simplest example, the entire left hand portion of an inhibitor of general formula (I) comprises a capped amino acid (Scheme 8), providing for example analogues of general formula (I) where Z=‘CH2’, Y=CHR11C(O), (X)o=‘-’, (W)n=‘NH’, R18=‘H’, n=1, (V)m=‘CO’, m=1 and U=phenyl. Scheme 8 details chemistry utilising protected ketone construct (33) and the reactions could equally be applied to the protected alcohol construct (31).
Alternatively, carboxylic acids can be prepared in solution by traditional organic chemistry methods and coupled to constructs (28) and (31) on the solid phase (Schemes 9-13). For example (Scheme 9), treatment in solution of an amino acid, exemplified by (35) with sodium nitrite/H2SO4, provides the α-hydroxyacid, exemplified by (36) (Degerbeck, F. et al, J. Chem. Soc, Perkin Trans. 1, 11-14, 1993). Treatment of α-hydroxyacid, (36) with sodium hydride in a dimethylformamide/dichloromethane mixture followed by addition of benzyl bromide, provides (RS) 2-benzyloxymethyl-pentanoic acid (37). Coupling of (37) to the solid phase construct (33) followed by alloc deprotection, benzoylation then cleavage, provides (38), an example of general formula (I) where Z=‘CH2’, (X)o=‘-’, (W)n=‘O’, n=1, (V)m=‘CH2’, m=1, R19 and R20=H and U=phenyl. To those skilled in the practices of organic synthesis, a wide variety of aminoacids such as (35) may be converted to the corresponding α-hydroxyacid such as (36) following the general conditions detailed. Additionally, benzylbromide may be replaced by any reasonable Ar—CR19R20-halide, providing many variations of carboxylic acid (37) following the general conditions detailed. In certain instances, it may be advantageous to temporarily protect the carboxylic acid as the methyl ester (for example compound (43), Scheme 11) prior to reaction with the alkylhalide. The ester intermediate is then simply hydrolysed to acid (37). Analogues of (38), exploring a wide range of (V)m and U in general formula (I) may be prepared through the general conditions detailed in Scheme 9.
Since the final synthetic step involves a trifluoroacetic acid (TFA) mediated cleavage of the solid phase bound compound, analogues where the substituted ether is labile to TFA may be prepared in solution by an alternative route (see Scheme 16).
Alternatively, coupling of construct (33) (following removal of Fmoc) with the α-hydroxyacid (36), provides a versatile solid phase bound intermediate ‘Y’ substituent in general formula (I) that may be reacted with many reagents. For example, the α-hydroxyl can be reacted under Mitsunobu conditions (Hughes, D. L. Org. React. (N.Y), 42, 335-656, 1992) to give ethers (i.e. X=‘-’, W=‘O’, in general formula (I)) (see Grabowska, U. et al, J. Comb. Chem., 2(5), 475-490, 2000, for an example of Mitsunobu reaction on the solid phase). Alternatively, the α-hydroxyl can be reacted with a carbamoyl chloride to give a carbamate (i.e. X=‘-’, W=‘O’, V=‘NHC(O)’, in general formula (I)).
Alternatively, (Scheme 10), treatment in solution of an amino acid, exemplified by (35) with sodium nitrite/H2SO4/potassium bromide provides the α-bromoacid, exemplified by (39) (Souers, A. J. et al, Synthesis, 4, 583-585, 1999) with retention of configuration. Treatment of α-bromoacid (39) with an alkylthiol exemplified by 4-tert-butylphenylmethanethiol (40) in dimethylformamide/triethylamine, provides 2R-(4-tert-butylbenzylsulfanyl)-4-methylpropionic acid (41), with inversion of configuration. Coupling of (41) to the solid phase construct (33) followed by alloc deprotection, benzoylation, then cleavage provides (42), an example of general formula (I) where Z=‘CH2’, (X)o=‘-’, (W)n=‘S’, n=1, (V)m=‘CH2’, m=1, R19 and R20=H and U=4-tert-butylphenyl. To those skilled in the practices of organic synthesis, a wide variety of aminoacids such as (35) may be converted to the corresponding α-bromoacid such as (39) following the general conditions detailed. Additionally, starting with the R-isomer of (35) gives the R-bromoacid analogue of (39) and S-thioether analogue of (41). Additionally, (4-tert-butylphehyl)methanethiol (40) may be replaced by any reasonable Ar—CR19R20—SH, providing many variations of carboxylic acid (41) following the general conditions detailed. Thus analogues of (42) exploring a wide range of (V)m and U in general formula (I) may be prepared through the general conditions detailed in Scheme 10.
Alternatively, coupling of construct (33) (following removal of Fmoc) with an α-bromoacid e.g. (39), provides a versatile intermediate ‘Y’ substituent in general formula (I) that may be reacted with many reagents. For example, the α-bromide can be displaced with nucleophiles e.g. alcohols, thiols, carbanions etc, to give ethers (i.e. X=‘-’, W=‘O’, in general formula (I)), thioethers (i.e. X=‘-’, W=‘S’, in general formula (I)). The thioethers may optionally be oxidised to the sulphone (see Scheme 14, i.e. X=‘-’, W=‘SO2’, in general formula (I)) (see Grabowska, U. et al, J. Comb. Chem., 2(5), 475-490, 2000, for an example of bromide displacement and thioether oxidation on the solid phase).
Alternatively, (Scheme 11), treatment of an α-hydroxyacid, exemplified by (36) with trimethylsilylchloride and methanol provides the methyl ester (43). Activation of the free hydroxyl to the chloroformate with phosgene in dichloromethane followed by addition of morpholine, then hydrolysis, provides morpholin-4-carboxylic acid 1-carboxy-3-methyl-butyl ester (44). Coupling of (44) to the solid phase construct (33) followed by alloc deprotection, benzoylation then cleavage provides (45), an example of general formula (I) where Z=‘CH2’, (X)o=‘-’, (W)n=‘O’, n=1, (V)m=‘CO’ and U=morpholino. To those skilled in the practices of organic synthesis, a wide variety of α-hydroxyacid esters such as (36) could be converted to the activated chloroformate following the general conditions detailed. Additionally, morpholine may be replaced by any reasonable amine, providing many variations of carboxylic acid (44) following the general conditions detailed. Thus analogues of (45) exploring a wide range of (V)m and U in general formula (I) may be prepared through the general conditions detailed in Scheme 11.
Alternatively, (Scheme 12), a wide range of alkylsuccinate esters exemplified by 2R-isobutyl-succinic acid 1-methyl ester (46) are commercially available or readily prepared by known methods (see (a) Azam et al, J. Chem. Soc. Perkin Trans. 1, 621-, 1996; (b) Evans et al, J. Chem. Soc. Perkin Trans. 1, 103, 2127, 1981; (c) Oikawa et al, Tet. Lett, 37, 6169, 1996). Carboxyl activation of alkylsuccinate ester (46) followed by addition of morpholine in dimethylformamide and subsequent ester hydroylsis, provides 4-Methyl-2R-(2-morpholin-4-yl-2-oxo-ethyl)-pentanoic acid (47). Coupling of (47) to the solid phase construct (33) followed by alloc deprotection, benzoylation then cleavage provides (48), an example of general formula (I) where Z=‘CH2’, (X)o=‘CH2’, (W)n=‘CO’, n=1, (V)m=‘-’ and U=morpholino. To those skilled in the practices of organic synthesis, a wide variety of alkylsuccinate esters such as (46) may be prepared and converted to the corresponding substituted alkylsuccinate acid such as (47) following the general conditions detailed. Additionally, morpholine may be replaced by any reasonable amine, providing many variations of carboxylic acid (47) following the general conditions detailed. Thus analogues of (48) exploring a wide range of (X)o, (V)m and U in general formula (I) may be prepared through the general conditions detailed in Scheme 12.
Alternatively, (Scheme 13), a wide range of biarylalkylacetic acids, exemplified by 2RS-biphenyl-3-yl-4-methylpentanoic acid (50) are readily available by known methods (see (a) DesJarlais, R. L. et al, J. Am. Chem. Soc, 120, 9114-9115, 1998; (b) Oballa, R. M. et al, WO 0149288). Coupling of biarylalkylacetic acid (50) to the solid phase construct (33) followed by alloc deprotection, benzoylation then cleavage provides (51), an example of general formula (I) where Z=‘CH2’, (X)o=‘-’, (W)n=‘-’, (V)m=‘-’ and U=m-biphenyl. To those skilled in the practices of organic synthesis, a wide variety of biarylalkylacetic acids such as (50) may be prepared by alkylation of the α-anion of the free acid analogue of (49), which in turn is prepared by Suzuki coupling of phenylboronic acid and 3-bromophenylacetic acid methyl ester. Phenylboronic acid may be replaced by a wide range of arylboronic acids in the Suzuki coupling, providing many variations of carboxylic acid (50) following the general conditions detailed. Thus analogues of (51) exploring a wide range of group ‘U’ in general formula (I) may be prepared through the general conditions detailed in Scheme 13.
Many other possibilities for solid phase organic chemistry (e.g. see Brown, R. D. J. Chem. Soc., Perkin Trans. 1, 19, 3293-3320, 1998, for a review of recent SPOC publications) can be used to derivatise constructs (28) and (31) towards compounds of general formula (I). For example, the left-hand portion ‘U-V-W-X-Y’ in general formula (I) can be partially constructed in solution, coupled to constructs (28) and (31) and further modified on the solid phase. For example (Scheme 14), a simple extension of Scheme 10 is through the oxidation of the intermediate solid phase bound species, with m-chloroperbenzoic acid in dichloromethane prior to cleavage, to give the sulphone analogue. Commencing from 2R-(4-tert-butylbenzylsulfanyl)-4-methylpropionic acid (41), sulphone (52) is prepared, an example of general formula (I) where Z=‘CH2’, (X)o=‘-’, (W)n=‘SO2’, n=1, (V)m=‘CH2’, m=1, R19 and R20=H and U=4-tert-butylphenyl. As described in Scheme 10, many variations of carboxylic acid (41) may be prepared following the general conditions detailed. Thus analogues of (52) exploring a wide range of (V)m and U in general formula (I) may be prepared through the general conditions detailed in Schemes 10 and 14.
Compounds of general formula (I) are finally released from the solid phase by treatment with trifluoroacetic acid/water, followed by evaporation, lyophylis and standard analytical characterisation.
A second strategy for the synthesis of compounds of general formula (I) comprises:—
- (a) Preparation of an appropriately functionalised and protected hexahydropyrrolo[3,2-b]pyrrol-3-one, hexahydropyrrolo[3,2-c]pyrazol-6-one or hexahydro-2-oxa-1,4-diazapentalen-6-one building block in solution.
- Preferred protecting groups for solution phase chemistry are the 9-fluorenylmethoxycarbonyl, Nα-tert-butoxycarbonyl, Nα-benzyloxy carbonyl and Nα-allyloxycarbonyl group.
- (b) Standard organic chemistry methods for the conversion of building block (a) towards compounds of general formula (I).
In the simplest example, the entire left hand portion of an inhibitor of general formula (I) can be prepared in solution by traditional organic chemistry methods and coupled to building block (a) (see Scheme 15 exemplified by the use of 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid allyl ester (54)).
The general strategy detailed in Scheme 15 is particularly useful when the compound of general formula (I) contains a substituent that is labile to trifluoroacetic acid, this being the final reagent used in each of the solid phase Schemes 6-14. For example (Scheme 16), treatment in solution of α-hydroxyacid (36) with sodium hydride in a dimethylformamide/dichloromethane mixture followed by addition of 4-tert-butylbenzyl bromide, provides 2RS-(4-tert-butylbenzyloxy)-4-methylpentanoic acid (58). Coupling of (58) to hydrochloride salt (54), followed by alloc deprotection then benzoylation provides (59), an example of general formula (I) where Z=‘CH2’, (X)o=‘-’, (W)n=‘O’, n=1, (V)m=‘CH2’, m=1, R19 and R20=H and U=4-tert-butylphenyl. To those skilled in the practices of organic synthesis, 4-tert-butylbenzyl bromide may be replaced by any reasonable Ar—CR19R20-halide, providing many variations of carboxylic acid (58) under the conditions shown. Thus analogues of (59) exploring a wide range of (V)m and U in general formula (I) may be prepared through the conditions detailed in Scheme 16.
A third strategy for the synthesis of compounds of general formula (I) where the addition of U-V-W-X-Y to the protected building block involves multistep organic reactions comprises:—
- (a) Preparation of an appropriately functionalised and protected hexahydropyrrolo[3,2-b]pyrrol-3-one, hexahydropyrrolo[3,2-c]pyrazol-6-one or hexahydro-2-oxa-1,4-diazapentalen-6-one building block in solution.
- Preferred protecting groups for solution phase chemistry are the 9-fluorenylmethoxycarbonyl, Nα-tert-butoxycarbonyl, Nα-benzyloxy carbonyl and Nα-allyloxycarbonyl group.
- (b) Protection of the ketone functionality of the hexahydropyrrolo[3,2-b]pyrrol-3-one, hexahydropyrrolo[3,2-c]pyrazol-6-one or hexahydro-2-oxa-1,4-diaza pentalen-6-one building block e.g. as a dimethylacetal. Alternatively, the reduced ketone (achiral secondary alcohols (13), (20) and (25)) intermediates may be used and re-oxidised as the final synthetic step.
- (c) Standard organic chemistry methods for the conversion of building block (b) towards compounds of general formula (I).
Intermediates may be prepared in solution, followed by coupling to building block (b) and further derivitisation towards compounds of general formula (I) (see Scheme 17 exemplified by preparation and use of the 3-Hydroxy-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid allyl ester (61)).
Alternatively, depending upon the types of chemistry used to construct the left hand side U-V-W-X-Y of compounds of general formula (I), the ketone may require protection e.g. as the dimethyl acetal. Such a method is detailed and exemplified in Scheme 18 by the preparation and use of 3,3-Dimethoxy-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid allyl ester (66).
The invention extends to novel intermediates as described above, and to processes for preparing compounds of general formula (I) from each of their immediate precursors. In turn, processes for preparing intermediates from their immediate precursors also form part of the invention.
Compounds of general formula (I) are useful both as laboratory tools and as therapeutic agents. In the laboratory certain compounds of the invention are useful in establishing whether a known or newly discovered cysteine protease contributes a critical or at least significant biochemical function during the establishment or progression of a disease state, a process commonly referred to as ‘target validation’.
According to a second aspect of the invention, there is provided a method of validating a known or putative cysteine protease inhibitor as a therapeutic target, the method comprising:
(a) assessing the in vitro binding of a compound as described above to an isolated known or putative cysteine protease, providing a measure of potency, and optionally, one or more of the steps of:
(b) assessing the binding of the compound to closely related homologous proteases of the target and general house-keeping proteases (e.g. trypsin) to provides a measure of selectivity,
(c) monitoring a cell-based functional marker of a particular cysteine protease activity, in the presence of the compound; and
(d) monitoring an animal model-based functional marker of a particular cysteine protease activity in the presence of the compound.
The invention therefore provides a method of validating a known or putative cysteine protease inhibitor as a therapeutic target. Differing approaches and levels of complexity are appropriate to the effective inhibition and ‘validation’ of a particular target. In the first instance, the method comprises assessing the in vitro binding of a compound of general formula (I) to an isolated known or putative cysteine protease, providing a measure of ‘potency’. An additional assessment of the binding of a compound of general formula (I) to closely related homologous proteases of the target and general house-keeping proteases (e.g. trypsin) provides a measure of ‘selectivity’. A second level of complexity may be assessed by monitoring a cell-based functional marker of a particular cysteine protease activity, in the presence of a compound of general formula (I). For example, a ‘human osteoclast resorption assay’ has been utilised as a cell-based secondary in vitro testing system for monitoring the activity of cathepsin K and the biochemical effect of protease inhibitors (e.g. see WO-A-9850533). An ‘MHC-II processing—T-cell activation assay’ has been utilised as a cell-based secondary in vitro testing system for monitoring the activity of cathepsin S and the biochemical effect of protease inhibitors (Shi, G-P., et al, Immunity, 10, 197-206, 1999). When investigating viral or bacterial infections such a marker could simply be a functional assessment of viral (e.g. count of mRNA copies) or bacterial loading and assessing the biochemical effect of protease inhibitors. A third level of complexity may be assessed by monitoring an animal model-based functional marker of a particular cysteine protease activity, in the presence of a compound of general formula (I). For example, murine models of Leishmania infection, P. vinckei infection, malaria (inhibition of falcipain) and T. cruzi infection (cruzipain), indicate that inhibition of cysteine proteases that play a key role in pathogen propagation is effective in arresting disease symptoms, ‘validating’ said targets.
The invention therefore extends to the use of a compound of general formula (I) in the validation of a known or putative cysteine protease inhibitor as a therapeutic target.
Compounds of general formula (I) are useful for the in vivo treatment or prevention of diseases in which participation of a cysteine protease is implicated.
According to a third aspect of the invention, there is provided a compound of general formula (I) for use in medicine, especially for preventing or treating diseases in which the disease pathology may be modified by inhibiting a cysteine protease.
According to a fourth aspect of the invention, there is provided the use of a compound of general formula (I) in the preparation of a medicament for preventing or treating diseases in which the disease pathology may be modified by inhibiting a cysteine protease.
Certain cysteine proteases function in the normal physiological process of protein degradation in animals, including humans, e.g. in the degradation of connective tissue. However, elevated levels of these enzymes in the body can result in pathological conditions leading to disease. Thus, cysteine proteases have been implicated in various disease states, including but not limited to, infections by Pneumocystis carinii, Trypsanoma cruzi, Trypsanoma brucei brucei and Crithidia fusiculata; as well as in osteoporosis, autoimmunity, schistosomiasis, malaria, tumour metastasis, metachromatic leukodystrophy, muscular dystrophy, amytrophy, and the like. See WO-A-9404172 and EP-A-0603873 and references cited in both of them. Additionally, a secreted bacterial cysteine protease from S. Aureus called staphylopain has been implicated as a bacterial virulence factor (Potempa, J., et al. J. Biol. Chem, 262(6), 2664-2667, 1998).
The invention is useful in the prevention and/or treatment of each of the disease states mentioned or implied above. The present invention also is useful in a methods of treatment or prevention of diseases caused by pathological levels of cysteine proteases, particularly cysteine proteases of the papain superfamily, which methods comprise administering to an animal, particularly a mammal, most particularly a human, in need thereof a compound of the present invention. The present invention particularly provides methods for treating diseases in which cysteine proteases are implicated, including infections by Pneumocystis carinii, Trypsanoma cruzi, Trypsanoma brucei, Leishmania mexicana, Clostridium histolyticum, Staphylococcus aureus, foot-and-mouth disease virus and Crithidia fusiculata; as well as in osteoporosis, autoimmuunity, schistosomiasis, malaria, tumour metastasis, metachromatic leukodystrophy, muscular dystrophy and amytrophy.
Inhibitors of cathepsin K, particularly cathepsin K-specific compounds, are useful for the treatment of osteoporosis, Paget's disease, gingival diseases such as gingivitis and periodontitis, hypercalaemia of malignancy, metabolic bone disease, diseases involving matrix or cartilage degradation, in particular osteoarthritis and rheumatoid arthritis and neoplastic diseases.
In accordance with this invention, an effective amount of a compound of general formula (I) may be administered to inhibit the protease implicated with a particular condition or disease. Of course, this dosage amount will further be modified according to the type of administration of the compound. For example, to achieve an “effective amount” for acute therapy, parenteral administration of a compound of general formula (I) is preferred. An intravenous infusion of the compound in 5% dextrose in water or normal saline, or a similar formulation with suitable excipients, is most effective, although an intramuscular bolus injection is also useful. Typically, the parenteral dose will be about 0.01 to about 100 mg/kg; preferably between 0.1 and 20 mg/kg, in a manner to maintain the concentration of drug in the plasma at a concentration effective to inhibit a cysteine protease.
The compounds may be administered one to four times daily at a level to achieve a total daily dose of about 0.4 to about 400 mg/kg/day. The precise amount of an inventive compound which is therapeutically effective, and the route by which such compound is best administered, is readily determined by one of ordinary skill in the art by comparing the blood level of the agent to the concentration required to have a therapeutic effect. Prodrugs of compounds of the present invention may be prepared by any suitable method. For those compounds in which the prodrug moiety is a ketone functionality, specifically ketals and/or hemiacetals, the conversion may be effected in accordance with conventional methods.
The compounds of this invention may also be administered orally to the patient, in a manner such that the concentration of drug is sufficient to inhibit bone resorption or to achieve any other therapeutic indication as disclosed herein. Typically, a pharmaceutical composition containing the compound is administered at an oral dose of between about 0.1 to about 50 mg/kg in a manner consistent with the condition of the patient. Preferably the oral dose would be about 0.5 to about 20 mg/kg.
No unacceptable toxicological effects are expected when compounds of the present invention are administered in accordance with the present invention. The compounds of this invention, which may have good bioavailability, may be tested in one of several biological assays to determine the concentration of a compound which is required to have a given pharmacological effect.
According to a fifth aspect of the invention, there is provided a pharmaceutical or veterinary composition comprising one or more compounds of general formula (I) and a pharmaceutically or veterinarily acceptable carrier. Other active materials may also be present, as may be considered appropriate or advisable for the disease or condition being treated or prevented.
The carrier, or, if more than one be present, each of the carriers, must be acceptable in the sense of being compatible with the other ingredients of the formulation and not deleterious to the recipient.
The formulations include those suitable for rectal, nasal, topical (including buccal and sublingual), vaginal or parenteral (including subcutaneous, intramuscular, intravenous and intradermal) administration, but preferably the formulation is an orally administered formulation. The formulations may conveniently be presented in unit dosage form, e.g. tablets and sustained release capsules, and may be prepared by any methods well known in the art of pharmacy.
Such methods include the step of bringing into association the above defined active agent with the carrier. In general, the formulations are prepared by uniformly and intimately bringing into association the active agent with liquid carriers or finely divided solid carriers or both, and then if necessary shaping the product. The invention extends to methods for preparing a pharmaceutical composition comprising bringing a compound of general formula (I) in conjunction or association with a pharmaceutically or veterinarily acceptable carrier or vehicle.
Formulations for oral administration in the present invention may be presented as: discrete units such as capsules, cachets or tablets each containing a predetermined amount of the active agent; as a powder or granules; as a solution or a suspension of the active agent in an aqueous liquid or a non-aqueous liquid; or as an oil-in-water liquid emulsion or a water in oil liquid emulsion; or as a bolus etc.
For compositions for oral administration (e.g. tablets and capsules), the term “acceptable carrier” includes vehicles such as common excipients e.g. binding agents, for example syrup, acacia, gelatin, sorbitol, tragacanth, polyvinylpyrrolidone (Povidone), methylcellulose, ethylcellulose, sodium carboxymethylcellulose, hydroxypropylmethylcellulose, sucrose and starch; fillers and carriers, for example corn starch, gelatin, lactose, sucrose, microcrystalline cellulose, kaolin, mannitol, dicalcium phosphate, sodium chloride and alginic acid; and lubricants such as magnesium stearate, sodium stearate and other metallic stearates, glycerol stearate stearic acid, silicone fluid, talc waxes, oils and colloidal silica. Flavouring agents such as peppermint, oil of wintergreen, cherry flavouring and the like can also be used. It may be desirable to add a colouring agent to make the dosage form readily identifiable. Tablets may also be coated by methods well known in the art.
A tablet may be made by compression or moulding, optionally with one or more accessory ingredients. Compressed tablets may be prepared by compressing in a suitable machine the active agent in a free flowing form such as a powder or granules, optionally mixed with a binder, lubricant, inert diluent, preservative, surface-active or dispersing agent. Moulded tablets may be made by moulding in a suitable machine a mixture of the powdered compound moistened with an inert liquid diluent. The tablets may be optionally be coated or scored and may be formulated so as to provide slow or controlled release of the active agent.
Other formulations suitable for oral administration include lozenges comprising the active agent in a flavoured base, usually sucrose and acacia or tragacanth; pastilles comprising the active agent in an inert base such as gelatin and glycerin, or sucrose and acacia; and mouthwashes comprising the active agent in a suitable liquid carrier.
Parenteral formulations will generally be sterile.
According to a sixth aspect of the invention, there is provided a process for the preparation of a pharmaceutical or veterinary composition as described above, the process comprising bringing the active compound(s) into association with the carrier, for example by admixture.
Preferred features for each aspect of the invention are as for each other aspect mutatis mutandis.
EXPERIMENTAL PROCEDURES
Solution Phase Chemistry—General Methods
All solvents were purchased from ROMIL Ltd (Waterbeach, Cambridge, UK) at SpS or Hi-Dry grade unless otherwise stated. General peptide synthesis reagents were obtained from Chem-Impex Intl. Inc. (Wood Dale Ill. 60191. USA). Thin layer chromatography (TLC) was performed on pre-coated plates (Merck aluminium sheets silica 60 F254, part no. 5554). Visualisation of compounds was achieved under ultraviolet light (254 nm) or by using an appropriate staining reagent. Flash column purification was performed on silica gel 60 (Merck 9385) or Isolute Flash silica cartridge. All analytical HPLC were obtained on Phenomenex Jupiter C4, 5μ, 300 A, 250×4.6 mm, using mixtures of solvent A=0.1% aq trifluoroacetic acid (TFA) and solvent B=90% acetonitrile/10% solvent A on automated Agilent systems with 215 and 1 or 254 nm UV detection. Unless otherwise stated a gradient of 10-90% B in A over 25 minutes at 1.5 mL/min was performed for full analytical HPLC analysis. HPLC-MS analysis was performed on an Agilent 1100 series LC/MSD, using-automated Agilent HPLC systems, with a gradient of 10-90% B in A over 10 minutes on Phenomenex Columbus C8, 5μ, 300 A, 50×2.0 mm at 0.4 mL/min. Nuclear magnetic resonance (NMR) were obtained on a Bruker DPX400 (400 MHz 1H frequency, QXI probe) or Bruker DPX500 (500 MHz 1H frequency) in the solvents and temperature indicated (298 K unless otherwise stated). Chemical shifts are expressed in parts per million (δ) and are referenced to residual signals of the solvent. Coupling constants (J) are expressed in Hz. High resolution mass spectrometry was performed on a Micromass QTOF 1.
Solid Phase Chemistry—General Methods
Example inhibitors were prepared through a combination of solution and solid phase Fmoc-based chemistries (see ‘Solid Phase Peptide Synthesis’, Atherton, E. and Sheppard, R. C., IRL Press Ltd, Oxford, UK, 1989, for a general description). An appropriately protected and functionalised building block was prepared in solution (e.g. general compound (6), Scheme 6), then reversibly attached to the solid phase through an appropriate linker followed by rounds of coupling/deprotection/chemical modification (Scheme 6). Example inhibitors were then released (cleaved) from the solid phase, analysed, purified and assayed for inhibition verses a range of proteases.
Generally, multipins (polyamide 1.3→10 μmole loadings, see www.mimotopes.com) were used for the solid phase synthesis, although any suitable solid phase surface could be chosen. In general, the 1.3 μmole gears were used to provide small scale crude examples for preliminary screening, whilst the 10 μmole crowns were used for scale-up synthesis and purification of preferred examples. Standard coupling and Fmoc deprotection methods were employed (see Grabowska, U. et al, J. Comb. Chem. 2(5), 475-490, 2000. for a thorough description of solid phase multipin methodologies).
Preparation of Initial Assembly
Building Block-linker constructs (e.g. (27), typically 10 mg to 100 mg) were carboxyl activated with 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluoro phosphate (HBTU, 1 mole equivalent), 1-hydroxybenzotriazole.hydrate (HOBT, 1 mole equivalent) and N-methylmorpholine (NMM, 2 mole equivalents) in dimethylformamide (DMF, typically 1 to 10 mL) for 5 minutes. Amino functionalised DA/MDA crowns or HEMA gears (10 μmole per crown/1.2 μmole per gear, 0.33 mole equivalent of total surface amino functionalisation compared to activated construct) were added, followed by additional DMF to cover the solid phase surface. The loading reaction was left overnight. Following overnight loading, crowns/gears were taken through standard cycles washing, Fmoc deprotection and loading quantification (see Grabowska, U. et al) to provide loaded Building Block-linker constructs (e.g. (28)).
Coupling Cycles
The coupling of standard Fmoc-aminoacids (10 or 20 mole equivalent) were performed via carboxyl activated with 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluoro phosphate (HBTU, 10 or 20 mole equivalent), 1-hydroxybenzotriazole.hydrate (HOBT, 10 or 20 mole equivalent) and N-methylmorpholine (NMM, 20 or 40 mole equivalents) in dimethylformamide, with pre-activation for 5 minutes. Activated species were dispensed to the appropriate wells of a polypropylene 96-well plate (Beckman, 1 mL wells, 500 μL solution per well for crowns or 250 μL solution per well for gears) in a pattern required for synthesis. Loaded free amino Building Block-linker constructs (e.g. (28)) were added and the coupling reaction left overnight. Following overnight coupling, crowns/gears were taken through standard cycles washing and Fmoc deprotection (see Grabowska, U. et al). Identical activation and coupling conditions were used for the coupling of a range of carboxylic acids (R—COOH). Alternatively, chloroformates e.g. morpholine-4-carbonylchloride (10 mole equivalent), were coupled in DMF with the addition of NMM (10 mole equivalents).
Acidolytic Cleavage Cycle
A mixture of 95% TFA/5% water was pre-dispensed into two polystyrene 96-well plates (Beckman, 1 mL wells, 600 μL solution per well for crowns or 300 μL solution per well for gears) in a pattern corresponding to that of the synthesis. The completed multipin assembly was added to the first plate (mother plate), the block covered in tin foil and cleaved for 2 hours. The cleaved multipin assembly was then removed from the first plate and added to the second plate (washing plate) for 15 minutes. The spent multipin assembly was then discarded and the mother 1 washing plates evaporated on an HT4 GeneVac plate evaporator.
Analysis and Purification of Cleaved Examples
- (a) Ex 1.2 μmole Gears. 100 μL dimethylsulphoxide (DMSO) was added to each post cleaved and dried washing plate well, thoroughly mixed, transferred to the corresponding post cleaved and dried mother plate well and again thoroughly mixed. 10 μL of this DMSO solution was diluted to 100 μL with a 90% acetonitrile/10% 0.1% aq TFA mixture. 20 μL aliquots were analysed by HPLC-MS and full analytical HPLC. In each case the crude example molecules gave the expected [M+H]+ ion and an HPLC peak at >80% (by 215 nm UV analysis). This provided an approximately 10 mM DMSO stock solution of good quality crude examples for preliminary protease inhibitory screening.
- (b) Ex 10 μmole Crowns. 500 μL of a 90% acetonitrile/10% 0.1% aq TFA mixture was added to each washing plate well, thoroughly mixed, transferred to the corresponding mother plate well and again thoroughly mixed. 5 μL of this solution was diluted to 100 μL with a 90% acetonitrile/10% 0.1% aq TFA mixture. 20 μL aliquots were analysed by HPLC-MS and full analytical HPLC. In each case the crude example molecules gave the expected [M+H]+ ion and an HPLC peak at >80% (by 215 nm WV analysis). The polystyrene blocks containing crude examples were then lyophilised.
- (c) Individual examples (ex (b)) were re-dissolved in a 1:1 mixture of 0.1% aq TFA/acetonitrile (1 mL) and purified by semi-preparative HPLC (Phenomenex Jupiter C4, 5μ, 300 A, 250×10 mm, a 25-90% B in A gradient over 25 mins, 4.0 mL/min, 215 nm UV detection). Fractions were lyophilised into pre-tarred glass sample vials to provide purified examples (typically 2 to 4 mg, 40 to 80% yield).
- (d) Purified examples were dissolved in an appropriate volume of DMSO to provide a 10 mM stock solution, for accurate protease inhibitory screening.
EXAMPLES 1-248 were prepared using the general solid phase descriptions above and are inhibitors of cathepsin K with Ki ranging from 1-5000 nM;
EXAMPLE 1
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-tert-butylbenzamide
Following the general details from Scheme 1, the required bicycle building block (3aS,6aR) 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (6) was prepared in 8 steps as follows;
- (1) Preparation of (2S,3S) 3-hydroxypyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester.
- Trans-3-hydroxy-L-proline (10.0 g, 76.3 mmole) was added to a vigorously stirred, ice-cooled solution of sodium carbonate (16.90 g, 160.2 mmole) in water (100 mL). 1,4-Dioxan (75 mL) was added providing an opaque but mobile mixture. 9-Fluorenylmethyl chloroformate (20.31 g, 80 mmole) in 1,4-dioxan (75 mL) was added over 1 hr, then the ice-cooling removed and the mixture stirred at RT for an additional 2 hr. Additional water (300 mL) was added, the reaction mixture washed with chloroform (2×250 mL) and the combined organic layers discarded. The aqueous phase was acidified with 1N HCl to ˜pH 2, providing a thick opaque mixture. The acidified aqueous mixture was extracted with chloroform (2×500 mL) and the now clear aqueous phase discarded. The opaque combined chloroform layers were dried (Na2SO4), filtered and reduced in vacuo to provide batch 1 (5.70 g). The residual precipitate (a mixture of product and drying agent) was triturated with hot methanol (2×250 mL) and the combined methanol solutions reduced in vacuo to provide batch 2 (10.25 g). Batch 1 and 2 were individually analysed by TLC (single UV spot, Rf=0.15, 20% MeOH in CHCl3), and HPLC-MS (single main UV peak with Rt=7.069 mins, 354.2 [M+H]+, 376.2 [M+Na]+) and found to be identical, giving a combined yield of 15.95 g (45.2 mmole, 59.2%). Analysis by 1H and 13C NMR showed the presence of cis and trans geometrical isomers around the 3° amide bond.
δH (DMSO-d6 at 298 K); 1.80-2.02 (2Hγ, m), 3.49-3.62 (2Hδ, m), 4.12-4.38 (Hα, Hβ, Fmoc H-9 and CH2, m), 5.55/5.62 (OH), 7.30-7.31 (2H aromatic, Fmoc H-2 and H-7), 7.35-7.37 (2H aromatic, Fmoc H-3 and H-6), 7.43-7.45 (2H aromatic, Fmoc H-1 and H-8), 7.63-7.65 (2H aromatic, Fmoc H-4 and H-5), 12.8-13.0 (COOH); δC (DMSO d6 at 298 K); 31.70/32.70 (d, Cγ), 44.68/45.32 (d, Cδ), 46.94/46.97 (u, Fmoc C-9), 67.04/67.33 (d, Fmoc CH2), 68.24/68.51 (u, Cα), 73.12/74.23 (u, Cβ), 120.49/120.52 (u, Fmoc C-4 and C-5), 125.49/125.58 (u, Fmoc C-1 and C-8), 127.50 (u, Fmoc C-2 and C-7), 128.04 (u, Fmoc C-3 and C-6), 140.99/141.09 (q, Fmoc C-4′ and C-5′), 144.02/144.16 (q, Fmoc C-1′ and C-8′), 154.33/154.54 (q, OCON), 172.10/172.39 (COOH).
- (2) Preparation of (2S,3R) 3-hydroxypyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-(9H-fluoren-9-ylmethyl) ester.
- (2S,3S) (3-hydroxy)pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester (10.9 g, 30.8 mmole) was dissolved in toluene (75 mL) in a Dean-Stark apparatus. Allyl alcohol (20 mL) was added followed by p-toluenesulphonic acid.hydrate (6.05 g, 31.4 mmole). The mixture was refluxed for 1 hr, cooled and CHCl3 (300 mL) added. The organic layer was washed with NaHCO3 (300 mL), 0.1N HCl (300 mL) and brine (300 mL), then dried (Na2SO4). Filtration and reduction in vacuo gave a pale yellow foam (13.5 g). The crude foam was purified over silica gel (150 g) eluting with a gradient of heptane:ethyl acetate 3:1→1:1. Desired fractions were combined and reduced in vacuo to a colourless gum yield 10.34 g (26.3 mmole, 85.4%). TLC (single UV spot, Rf=0.30, heptane:ethyl acetate 1:1), analytical HPLC Rt=18.849 mins, HPLC-MS (single main UV peak with Rt=8.354 mins, 394.2 [M+H]+, 416.2 [M+Na]+).
Analysis by 1H and 13C NMR showed the presence of cis and trans geometrical isomers around the 3° amide bond.
δH (CDCl3 at 298 K); 2.00-2.21 (2Hγ, m), 2.70/2.85 (OH, b), 3.72-3.81 (2Hδ, m), 4.12-4.67 (Hα, Hβ, Fmoc H-9 and CH2, 2×COOCH2CH═CH2, m), 5.20-5.40 (2×COOCH2CH═CH2, m), 5.82-5.99 (1×COOCH2CH═CH2, m), 7.28-7.33 (2H aromatic, Fmoc H-2 and H-7), 7.34-7.41 (2H aromatic, Fmoc H-3 and H-6), 7.53-7.66 (2H aromatic, Fmoc H-1 and H-8), 7.77-7.81 (2H aromatic, Fmoc H-4 and H-5); δC (CDCl3 at 298 K); 32.28/33.04 (d, Cγ), 44.98/45.32 (d, Cδ), 47.56/47.63 (u, Fmoc C-9), 66.44 (d, COOCH2CH═CH2), 68.01/68.11 (d, Fmoc CH2), 68.32/68.72 (u, Cα), 74.49/75.67 (u, Cβ), 119.20/119.48 (d, COOCH2CH═CH2), 120.34/120.37 (u, Fmoc C-4 and C-5), 125.36/125.60 (u, Fmoc C-1 and C-8), 127.47 (u, Fmoc C-2 and C-7), 128.06/128.12 (u, Fmoc C-3 and C-6), 131.79/131.94 (u, COOCH2CH═CH2), 141.65/141.71 (q, Fmoc C-4′ and C-5′), 144.12/144.34 (q, Fmoc C-1′ and C-8′), 155.13/155.59 (q, OCON), 170.53/170.55 (COOCH2CH═CH2).
- (3) Preparation of (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-(9H-fluoren-9-ylmethyl) ester.
- Diethyl azodicarboxylate (1.24 ml, 7.9 mmol) was added dropwise over 20 minutes to a stirred solution of triphenylphosphine (2.07 g, 7.9 mmol) in tetrahydrofuran (30 ml) at 0° C. The mixture was stirred for 5 minutes at 0° C. then a solution of (2S,3S)-3-hydroxypyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-(9H-fluoren-9-ylmethyl) ester (2.59 g, 6.6 mmol) and hydrazoic acid (14.3 ml of 0.7M solution in toluene) in tetrahydrofuran (30 ml) was added dropwise over 35 minutes. The mixture was stirred for 5 minutes at 0° C. then at ambient temperature for 14 hours. The solvent was removed in vacuo and the residue purified by flash chromatography over silica gel eluting with a gradient of heptane:ethyl acetate 5:1→3:1. Appropriate fractions were combined and the solvents removed in vacuo to obtain (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid allyl ester 1-(9H-fluoren-9-ylmethyl) ester as a colourless oil (1.45 g, 53%). TLC (single UV spot, Rf=0.30, heptane:ethyl acetate 3:1), analytical HPLC main UV peak with Rt=19.896 mins and HPLC-MS 419.2 [M+H]+, 441.2 [M+Na]+.
δH (CDCl3 at 298 K); 2.08-2.25 (2H, H-4, m), 3.52-3.59 (1H, H-5, m), 3.68-3.76 (1H, H-5, m), 4.15 (0.5H, Fmoc-CH2, t, J=6.6 Hz), 4.24 (0.5H, Fmoc-CH2, t, J=7.1 Hz), 4.33-4.38 (2H, H-3 and Fmoc-CH, m), 4.44-4.48 (1.5H, 0.5H-2 and Fmoc-CH, m), 4.51-4.66 (1.5H, 0.5H-2 and CH2CH═CH2, m), 4.67-4.70 (1H, CH2CH═CH2, m), 5.21-5.40 (2H, CH2CH═CH2, m), 5.84-5.98 (1H, CH2CH═CH2, m), 7.26-7.32 (2H, aromatic, Fmoc H-2 and H-7), 7.37-7.40 (2H, aromatic, Fmoc H-3 and H-6), 7.51-7.60 (2H, aromatic, Fmoc H-1 and H-8), 7.74-7.77 (2H, aromatic, Fmoc H-4 and H-5); δC (CDCl3 at 298 K); 29.14/30.13 (d, C-5), 44.40/44.72 (d, C-5), 47.12/47.21 (u, Fmoc-CH), 61.02/61.87 (u, C-3), 61.63/62.07 (u, C-2), 66.17 (d, Fmoc-CH2), 67.65 (d, CH2CH═CH2), 118.86/119.11 (d, CH2CH═CH2), 119.94/124.83/124.95/125.05/127.03/127.69 (u, aromatic, Fmoc-CH), 131.384/131.50 (u, CH2CH═CH2), 141.29 (q, aromatic Fmoc quaternary carbon b), 143.49/143.65/143.92 (q, aromatic Fmoc quaternary carbon a), 154.07/154.49 (q, Fmoc-CO), 168.62/168.70 (q, allyl-CO).
- (4) Preparation of (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester.
- Dichloromethane (30 ml) then phenyltrihydrosilane (0.81 ml, 6.6 mmol) were added consecutively to a stirred mixture of tetrakistriphenylphosphine palladium(0) (76 mg, 0.066 mmol) and (2S,3R)-3-azidopyrrolidine-1,2-dicarboxylic acid allyl ester 1-(9H-fluoren-9-ylmethyl) ester (1.38 g, 3.3 mmol) under argon. The mixture was stirred for 30 minutes then diluted with chloroform (200 ml) and washed with 0.01M hydrochloric acid (200 ml). The aqueous layer was extracted with chloroform (100 ml), then the combined chloroform layers were dried (Na2SO4) and the solvent removed in vacuo. The brown residue was purified by flash chromatography over silica gel eluting with a gradient of heptane:ethyl acetate 3.5:1→0:1 followed by methanol:dichloromethane 1:4. Appropriate fractions were combined and the solvents removed in vacuo to leave (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester as a brown foam (890 mg, 71%). TLC (main UV spot, Rf=0.20, methanol:chloroform 1:9), analytical HPLC main UV peak with Rt=16.528 mins and HPLC-MS 379.2 [M+H]+, 401.1 [M+Na]+, 779.3 [2M+Na]+.
- (5) Preparation of (2S,3R) 3-aminopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester.
- Acetic acid was added to a suspension of (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester (3.25 g, 8.6 mmol), palladium on carbon (10%, 320 mg) and ethanol (80 ml) under an atmosphere of argon. The mixture was then stirred under an atmosphere of hydrogen for 3.5 hours then the hydrogen was replaced with argon and the suspension stored at 0° C. for 14 hours. A further portion of palladium on carbon (10%, 150 mg) was added then the mixture stirred at ambient temperature for 3 hours under an atmosphere of hydrogen. The catalyst was removed by filtration in vacuo through a pad of celite which was washed with acetic acid:water (1:1, 150 ml). The filtrate was concentrated in vacuo then toluene (50 ml) was added to the residue and solvents removed in vacuo. A further portion of toluene was added (50 ml) and the solvent removed in vacuo to leave an oily residue which was triturated with diethyl ether (125 ml) to obtain (2S,3R) 3-aminopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester acetate as a pale brown solid (1.05 g, 30%). Analytical HPLC single UV peak with Rt=12.541 mins and HPLC-MS 353.2 [M+H]+, 705.3 [2M+Na]+.
- (6) Preparation of (2S,3R) 3-tert-Butoxycarbonylamino-pyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester
- A solution of di-tert-butyl dicarbonate (210 mg, 0.96 mmol) in 1,4-dioxan (10 ml) was added to a stirred suspension of (2S,3R)-3-aminopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester (360 mg, 0.87 mmol) and sodium carbonate (195 mg, 1.84 mmol) in water (10 ml) and 1,4-dioxan (10 ml) over 1 hour at 0° C. The reaction mixture was stirred for 16 hours at ambient temperature then the majority of solvents were removed in vacuo. The residue was dissolved in dichloromethane (200 ml) and water (100 ml) then acidified to pH˜2.5 using 1M hydrochloric acid. The dichloromethane layer was separated then the aqueous layer extracted with dichloromethane. The combined dichloromethane layers were dried (Na2SO4) and the solvent removed in vacuo. The orange-brown residue was purified by flash chromatography over silica gel eluting with a gradient of dichloromethane:methanol 19:1→9:1. Appropriate fractions were combined and the solvents removed in vacuo to leave (2S,3R) 3-tert-butoxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester as a light brown solid (235 mg, 60%). TLC (single UV spot, Rf=0.25, methanol:chloroform 1:9), analytical HPLC single UV peak with Rt=17.476 mins and HPLC-MS 397.2 [M−Bu+2H]+, 475.2 [M+Na]+, 927.4 [2M+Na]+.
δH (CDCl3 at 298 K); 1.35 (2H, brs Me3C), 1.48 (1H, brs Me3C), 1.75-2.20 (2H, m, H-4), 2.75-3.85 (4H, m, H-5, H-3, Fmoc-CH), 3.85-4.60 (4H, m, Fmoc-CH2, H-2 and NH), 6.20-6.75 (0.5H, brs, NH), 7.05-7.90 (8H, aromatic); δC (d6-DMSO at 298 K); 1.39 and 1.46 (9H total, each s, Me3C), 1.70-1.85 (1H, m, H-4), 1.70-1.85 (1H, m, H-4), 3.24-3.35 (1H, m, H-5), 3.44-3.54 (1H, m, H-5), 4.02-4.30 (5H, m, H-2, H-3, Fmoc-CH2 and Fmoc-CH), 6.80 and 7.0 (1H total, each brs, NH), 7.30-7.98 (8H, aromatic)
- (7) Preparation of (2S,3R) 3-tert-Butoxycarbonylamino-2-(2-diazo-acetyl)-pyrrolidine-1-carboxylic acid 9H-fluoren-9-ylmethyl ester.
- A solution of iso-butyl chloroformate (68 μl, 0.52 mmol) in dichloromethane (2 ml) and a solution of 4-methylmorpholine (105 μl, 0.95 mmol) in dichloromethane (2 ml) were simultaneously added in portions to a stirred suspension of (2S,3R)-3-tert-butoxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester (215 mg, 0.48 mmol) in dichloromethane (5 ml) at −15° C. over 20 minutes under an atmosphere of nitrogen. The solution was stirred for 2 hours then additional solutions of iso-butyl chloroformate (15 μl, 0.115 mmol) in dichloromethane (0.5 ml) and 4-methylmorpholine (26 μl, 0.237 mmol) in dichloromethane (0.5 ml) were simultaneously added in one portion. The mixture was stirred for 30 minutes at −15° C. then ethereal diazomethane [˜15 mmol generated from diazald (4.7 g mmol) addition in diethyl ether (75 ml) to sodium hydroxide (5.25 g) in water (7.5 ml)/ethanol (15 ml) at 65° C.] was cautiously added and the resulting yellow solution stirred at room temperature for 16 hrs. Acetic acid (˜1 ml) was cautiously added (until effervescence had ceased), then the mixture was diluted with diethyl ether (100 ml). The ethereal layer was washed with water (3×100 ml), dried (Na2SO4) and the solvents removed in vacuo to leave an oily residue (250 mg) which was purified by flash chromatography over silica gel eluting with a gradient of heptane:ethyl acetate 2:1→1:1. Appropriate fractions were combined and the solvents removed in vacuo to leave (2S,3R) 3-tert-butoxycarbonylamino-2-(2-diazoacetyl)pyrrolidine-1-carboxylic acid 9H-fluoren-9-ylmethyl ester as a pale yellow solid (91 mg, 40%). TLC (single UV spot, Rf=0.4, heptane:ethyl acetate 1:1), analytical HPLC main UV peak with Rt=18.363 mins and HPLC-MS 449.2 [M−N2+H]+, 499.2 [M+Na]+, 975.5 [2M+Na]+.
- (8) Cyclisation to (3aS,6aR) 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (6)
- A solution of (2S,3R) 3-tert-butoxycarbonylamino-2-(2-diazoacetyl) pyrrolidine-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (100 mg, 0.21 mmol) in chloroform (2.5 ml) was added dropwise over 28 minutes to a stirred suspension of rhodium (II) acetate dimer (10 mg) in toluene (2.5 ml) at 75° C. under an atmosphere of argon. The mixture was stirred for an additional 30 minutes at this temperature then the solvents removed in vacuo to leave an oily residue which was purified by flash chromatography over silica gel eluting with a gradient of hexane:ethyl acetate 3:1→1:1. Appropriate fractions were combined and the solvents removed in vacuo to leave (3aS,6aR) 3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester as a white solid (28 mg, 30%). TLC (two UV spots, major and minor Rf=0.30 and 0.35 respectively, hexane:ethyl acetate 7:3), analytical HPLC broad group of UV peaks with Rt=20.043-21.472 mins and HPLC-MS 449.2 [M+H]+, 471.2 [M+Na]+, 919.4 [2M+Na]+.
δH (CDCl3 at 298 K); (Spectrum poorly resolved) 1.46 (9H, s, Me3C), 1.85-2.35 (2H, m, H-6), 3.2-5.0 (9H, m, 2×H-2, H-3a, 2×H-5, H-6a, Fmoc-CH2, Fmoc-CH), 7.2-7.85 (8H, aromatic).
Alternatively, following the general details from Scheme 2, the required bicycle building block (3aS,6aR) 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (6) was prepared following Schemes 19 and 20;
Preparation of (S)-2-(2-diazoacetyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (72)
2,5-Dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester (71) (1.066 g, 5 mmol) was dissolved with stirring in anhydrous dichloromethane (40 ml). The reaction was flushed with nitrogen and cooled to −15° C. iso-Butylchloroformate (0.713 ml, 5.5 mmol) in anhydrous dichloromethane (5 ml) and 4-methylmorpholine (1.099 ml, 10 mmol) in anhydrous dichloromethane (5 ml) were added simultaneously in 1 ml aliquots over 50 minutes. The mixture was stirred for 2.5 hours at −15° C. then ethereal diazomethane [˜15 mmol generated from addition of diazald (4.7 g) in diethyl ether (75 ml) onto sodium hydroxide (5.25 g) in water (7.5 ml)/ethanol (15 ml) at 60° C.] was added to the activated amino acid solution. The mixture was allowed to warm to ambient temperature and stirred for 2.5 hours. A few drops of acetic acid were cautiously added to the mixture, followed by dichloromethane (40 ml). The ethereal layers were washed with aqueous saturated sodium hydrogen carbonate solution (2×40 ml), dried (Na2SO4) and the solvents removed in vacuo to leave a yellow residue (1.4 g). Flash chromatography of the residue over silica (35 g) eluting with ethyl acetate:heptane 3:7 gave (S)-2-(2-diazoacetyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (72) (1.024 g, 86%). TLC (Single spot, Rf=0.47, EtOAc:heptane 1:1), analytical HPLC Rt=11.537 min; HPLC-MS 497.2 [2M+Na]+; dH (500 MHz, CDCl3) 1.41-1.51 (9H, m, C(CH3)3), 4.11-4.35 (2H, m, BocNCH2), 4.86-5.05 (1H, m, BocNCH), 5.25-5.50 (1H, m, CHN2), 5.70-5.80 (1H, m, olefinic CH) and 5.88-6.03 (1H, m, olefinic CH); dC (125 MHz, CDCl3) 28.3 and 28.4 (C(CH3)3), 51.8 and 52.3 (CHN2), 53.65 and 54.0 (BocNCH2), 71.5 and 72.3 (BocNCH), 80.6 and 80.9 (OC(CH3)3), 126.1 and 126.3 (olefinic CH), 128.35 and 128.5 (olefinic CH), 153.7 and 154.15 (NCO2), 192.7 and 193.4 (COCHN2).
Preparation of (R)-2-methoxycarbonylmethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (73)
(S)-2-(2-Diazoacetyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (72) (912 mg, 3.85 mmol) was dissolved in tetrahydrofuran (14 ml) and methanol (1.6 ml) then cooled to 0° C. A solution of silver trifluoroacetate (94 mg) in 4-methylmorpholine (1.06 ml) was added, and the mixture allowed to warm to ambient temperature over 6 hours in the dark. Methanol (40 ml) was added, followed by 10% aqueous citric acid solution (100 ml). The majority of the organic solvents were removed in vacuo then the aqueous phase extracted with ethyl acetate (3×40 ml). The combined organic layers were washed with brine (40 ml), dried (Na2SO4) and evaporated in vacuo to afford a residue (1.35 g). Flash chromatography of the residue over silica (200 g) eluting with ethyl acetate:hexane 3:17 afforded (R)-2-methoxycarbonylmethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (73) as a colourless oil (670 mg, 72%). TLC (Single spot, Rf=0.27, EtOAc:hexane 1:4), analytical HPLC Rt=15.033 min; HPLC-MS 505.3 [2M+Na]+; dH (500 MHz, CDCl3) 1.44-1.53 (9H, m, C(CH3)3), 2.37-2.55 (1H, m, CH2CO2Me), 2.90-4.00 (1H, ma, CH2CO2Me), 3.63-3.70 (3H, m, OCH3), 3.97-4.26 (2H, m, BocNCH2), 4.70-4.90 (1H, m, BocNCH), 5.74-5.89 (2H, m, 2× olefinic CH); dC (125 MHz, CDCl3) 28.2, 28.3 and 28.5 (C(CH3)3), 39.4 and 38.4 (CH2CO2Me), 51.5 and 51.6 (OCH3), 53.3 and 53.5 (BocNCH2), 60.7 and 60.9 (BocNCH), 79.6 and 80.0 (OC(CH3)3), 126.0 and 126.1 (olefinic CH), 129.3 and 129.5 (olefinic CH), 153.9 (NCO2), 171.5 and 171.7 (CO2Me).
Preparation of (R)-2-(2-hydroxyethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (74)
Diisobutylaluminium hydride (1M solution in tetrahydrofuran, 13.6 ml, 13.6 mmol) was added dropwise over 20 minutes to a stirred solution of (R)-2-methoxycarbonylmethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (73) (630 mg, 2.61 mmol) in tetrahydrofuran (20 ml) at −78° C. under a nitrogen atmosphere. The mixture was stirred for 2 hours at −78° C. then at ambient temperature for 18 hours. Methanol (11.94 ml) was slowly added to the mixture, followed by ethyl acetate (40 ml) and magnesium sulfate. The resultant slurry was vigorously stirred for 2 hours, then filtered and the solid residue washed with excess ethyl acetate. The filtrate was evaporated in vacuo to afford a residue (1.4 g). Flash chromatography of the residue over silica gel (150 g) eluting with ethyl acetate:hexane 7:13 gave (R)-2-(2-hydroxyethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (74) (430 mg, 77%). TLC (Single spot, Rf=0.37, EtOAc:hexane 1:1), analytical HPLC Rt=12.161 min; HPLC-MS 236.1 [M+Na]+, 449.3 [2M+Na]+; [a]D22 −112° (c=1, CHCl3); dH (500 MHz, CDCl3) 1.42-1.55 (10H, br. s, C(CH3)3 and NCHCH2), 1.84-1.95 (1H, m, NCHCH2), 3.60-3.72 (2H, m, CH2OH), 3.93-4.28 (2H, m, BocNCH2), 4.53-4.78 (1H, m, BocNCH), 5.67-5.84 (2H, m, 2× olefinic CH); dC (125 MHz, CDCl3) 28.4 (C(CH3)3), 37.4 and 38.7 (CH2CH2OH), 53.45 and 53.6 (NCH2), 59.2 and 59.6 (OCH2), 61.2 and 61.9 (BocNCH), 79.9 and 80.1 (OC(CH3)3), 124.4 and 125.3 (olefinic CH), 130.3 and 131.1 (olefinic CH), 154.4 and 156.0 (NCO2).
Alternative preparation of (R)-2-(2-hydroxyethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (74)
Methanol (0.27 ml, 6.7 mmol) was added dropwise to a stirred suspension of lithium borohydride (146 mg, 6.6 mmol) in tetrahydrofuran (3.5 ml) under an atmosphere of argon over 4 minutes, followed by a solution of (R)-2-methoxycarbonylmethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (73) (0.8 g, 3.3 mmol) in tetrahydrofuran (8 ml) over 15 minutes. The mixture was stirred for 1 hour then poured into water (25 ml). The product was extracted into dichloromethane (3×20 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 25:75 to give (R)-2-(2-hydroxyethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (74) as a colourless oil (0.48 g, 67%), [a]D22 −127° (c=1, CHCl3).
Preparation of (R)-2-(2-methanesulfonylethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (75)
Triethylamine (2.35 ml, 16.9 mmol) was added dropwise to a stirred solution of (R)-2-(2-hydroxyethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (74) (2.33 g, 10.9 mmol) in dichloromethane (20 ml) at 0° C. over 2 minutes followed by methanesulfonyl chloride (1.27 ml, 16.4 mmol) over 4 minutes. The mixture was stirred for 1 hour at 0° C. then washed with water (170 ml) and brine (170 ml), dried (Na2SO4) and the solvents removed in vacuo to leave a residue (3.42 g), which was used without further purification (see below). HPLC-MS 236.0 [M+2H−Bu]+, 314.1 [M+Na]+, 605.1 [2M+Na]+.
Preparation of (R)-2-(2-azidoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (76)
Sodium azide (3.55 g, 54.7 mmol) was added to a stirred solution of (R)-2-(2-methanesulfonylethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (75) (prepared as above) in dimethylformamide (45 ml) under an atmosphere of argon. The mixture was stirred at 60° C. for 1.5 hours then the majority of solvents were removed by distillation in vacuo and the residue partitioned between water (200 ml) and ethyl acetate (200 ml). The ethyl acetate layer was washed with brine (150 ml), dried (Na2SO4), and the solvents removed in vacuo to leave a residue (2.49 g) which was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 10:90 to give (R)-2-(2-azidoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (76) as a colourless oil (2.05 g, 79%). TLC (Single spot, Rf=0.45, EtOAc:hexane 3:7), analytical HPLC Rt=15.910 min; HPLC-MS 139.1 [M+2H−Boc]+, 183.1 [M+2H−Bu]+, 499.2 [2M+Na]+; dH (500 MHz, CDCl3) 1.40-1.50 (9H, m, C(CH3)3), 1.90-2.10 (2H, m, NCHCH2), 3.17-3.33 (2H, m, CH2N3), 3.96-4.27 (2H, m, BocNCH2), 4.53-4.68 (1H, m, BocNCH), 5.66-5.86 (2H, m, 2× olefinic CH); dC (125 MHz, CDCl3) 28.3 and 28.5 (C(CH3)3), 32.5 and 33.0 (CH2CH2N3), 47.5 and 47.9 (CH2N3), 53.6 and 53.8 (BocNCH2), 62.0 and 62.3 (BocNCH), 79.55 and 79.9 (OC(CH3)3), 125.6 and 126.1 (olefinic CH), 128.9 and 129.4 (olefinic CH), 154.2 and 154.3 (NCO2), followed by (R)-2-(2-hydroxyethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (74) (22 mg, 9%).
Preparation of (R)-2-(2-benzyloxycarbonylaminoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (77)
Water (2.1 ml, 118 mmol) was added to a stirred solution of (R)-2-(2-azidoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (76) (2.8 g, 11.8 mmol) and triphenylphosphine (4.6 g, 17.5 mmol) in tetrahydrofuran (350 ml) under an atmosphere of argon. The solution was heated at 45° C. for 7.5 hours then at ambient temperature for 14 hours. An aliquot (18.5 ml, ˜0.63 mmol) was removed, concentrated in vacuo then azeotroped with toluene (3×10 ml) and used for the preparation of (2R)-2-[2-((2S)-2-benzyloxycarbonylamino-4-methylpentanoylamino) ethyl]-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (140) (see Scheme 28). An additional 5.0 ml aliquot was removed for analysis, then the remainder of the solution was concentrated in vacuo to obtain an oily residue. The residue was dissolved in 1,4-dioxane (35 ml) with stirring, ice-cooled and a solution of sodium carbonate (2.45 g, 23.1 mmol) in water (35 ml) was added. Benzyl chloroformate (2.18 g, 1.824 ml, 12.8 mmol) in 1,4-dioxane (10 ml) was then added dropwise over 30 minutes and the mixture stirred for an additional 30 minutes before adding water (250 ml). The aqueous phase was extracted with dichloromethane (2×250 ml) and the combined organic layers were dried (Na2SO4), filtered and reduced in vacuo to leave a clear mobile oil (10.2 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (R)-2-(2-benzyloxycarbonylaminoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (77) (3.58 g, 94%) as a mobile colourless oil. TLC (Rf=0.32, EtOAc:heptane 1:1), analytical HPLC single main peak, Rt=17.39 min., HPLC-MS 247.1 [M+2H−Boc]+, 291.1 [M+2H−Bu]+, 347.1 [M+H]+, 369.1 [M+Na]+, 715.2 [2M+Na]+; Elemental analysis C19H26N2O4 req. (fnd.) % C 65.87 (65.79), % H 7.56 (7.53), % N 8.09 (7.97); HRMS C19H26N2O4Na req. 369.1790, fnd. 369.1803 (3.37 ppm); δH (500 z, CDCl3) 1.45 (9H, br. s, C(CH3)3), 1.60-1.95 (2H, m, BocNCHCH2), 3.00-3.44 (2H, m, CH2NH), 3.90-4.29 (2H, m, BocNCH2), 4.45-4.81 (1H, m, BocNCH), 5.01-5.16 (2H, m, OCH2Ph), 5.50-5.83 (2H, m, 2× olefinic CH) and 7.25-7.38 (6H, m, C6H5 and NH); δC (125 MHz, CDCl3) 28.4 (C(CH3)3), 34.4, 34.6 (CH2CH2NH), 37.2, 37.6 (CH2NH), 53.6, 53.7 (BocNCH2), 61.7, 62.1 (BocNCH), 66.4, 66.6 (OCH2Ph), 79.6, 79.9 (OC(CH3)3), 125.2, 125.9, 127.0, 127.6, 127.9, 128.0, 128.4, 129.5, 130.2 (5× aromatic CH and 2× olefinic CH), 154.3, 155.0, 156.2, 156.5 (NHCO2 and NCO2).
Preparation of (2R)-2-(2-benzyloxycarbonylaminoethyl)-6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid tert-butyl ester (78)
(R)-2-(2-Benzyloxycarbonylaminoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (77) (3.57 g, 10.3 mmol) was dissolved in anhydrous dichloromethane (60 ml) with stirring and meta-chloroperoxybenzoic acid (27.3 g, 65% reagent, 103 mmol) added. The mixture was stirred at ambient temperature under argon for 16 hours. Dichloromethane (400 ml) was added and the organic phase washed with 10% aqueous w/v solution of sodium hydroxide (2×400 ml), then dried (Na2SO4), filtered and reduced in vacuo to leave a clear oil (˜5 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (2R)-2-(2-benzyloxycarbonyl aminoethyl)-6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid-tert-butyl ester (78) (3.57 g, 95.3%) as a mobile colourless oil. TLC (Rf=0.36 (minor) and 0.40 (major) (mixture of anti and syn epoxides), EtOAc:heptane 2:1), analytical HPLC single main peak, Rt=17.74 min., HPLC-MS 263.1 [M+2H−Boc]+, 307.1 [M+2H−Bu]+, 363.1 [M+H]+, 385.1 [M+Na]+, 747.2 [2M+Na]+; Elemental analysis C19H26N2O5 req. (fnd.) % C 62.97 (62.93), % H 7.23 (7.22), % N 7.73 (7.61); HRMS C19H26N2O5Na req. 385.1739, fnd. 385.1725 (−3.82 ppm); dH (500 MHz, CDCl3) 1.32-1.62 (10H, m, C(CH3)3 and CH2CH2NH), 1.67-2.00 (1H, m, CH2CH2NH), 2.90-4.21 (7H, m, CH2NH, BocNCHCH, BocNCH2CH), 4.70-5.17 (2H, m, OCH2Ph), 5.78-6.05 (1H, m, NH) and 7.27-7.37 (5H, aromatics); dC (125 MHz, CDCl3) 28.1, 28.3, 28.35 and 28.4 (C(CH3)3), 30.8 and 31.2 (CH2CH2NH), 37.4 and 37.7 (CH2NH), 46.15 and 46.6 (BocNCH2), 53.9, 54.2, 54.9 and 55.8 (2× epoxide CH), 58.1 and 58.2 (BocNCH), 66.5 and 66.7 (OCH2Ph), 80.3 and 80.7 (OC(CH3)3), 128.0, 128.1, 128.2, 128.4, 128.5 (5× aromatic CH), 136.7 (OCH2C), 155.1, 155.9, 156.3 and 156.6 (NHCO2 and NCO2).
Preparation of (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (79)
(2R)-2-(2-Benzyloxycarbonylaminoethyl)-6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (78) (3.57 g, 9.86 mmol) was dissolved in ethanol (60 ml), cooled to 0° C. and 10% palladium on charcoal (0.40 g) added. The mixture was stirred, then evacuated and flushed with hydrogen. The mixture was allowed to warm to ambient temperature and after 2.5 hours filtered through celite. The filter cake was washed with ethanol (3×60 ml) and the combined organic filtrates reduced in vacuo to provide crude (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (79) (˜2.4 g). HPLC-MS 173.1 [M+2H−Bu]+, 229.1 [M+H]+.
Preparation of (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 4-benzyl ester 1-tert-butyl ester (80)
Crude (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (79) (−2.4 g) was dissolved in 1,4-dioxane (30 ml) with stirring, ice-cooled and a solution of sodium carbonate (2.19 g, 20.7 mmol) in water (25 ml) was added. Benzyl chloroformate (1.63 ml, 11.4 mmol) in 1,4-dioxane (15 ml) was then added dropwise over 30 minutes and the mixture stirred for a further 30 minutes. The mixture was then reduced in vacuo by approximately ⅔ volume to leave a mobile pulp. Water (200 ml) was added and the aqueous phase extracted with dichloromethane (2×100 ml). The combined organic layers were dried (Na2SO4), filtered and reduced in vacuo to leave a clear mobile oil (3.96 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 4-benzyl ester 1-tert-butyl ester (80) (2.16 g, 60.5%) as an opaque gum. TLC (Rf=0.15, EtOAc:heptane 1:1), analytical HPLC single main peak, Rt=17.15 min., HPLC-MS 263.1 [M+2H−Boc]+, 307.1 [M+2H−Bu]+, 363.1 [M+H]+, 385.1 [M+Na]+, 747.2 [2M+Na]+; Elemental analysis C19H26N2O5 req. (fnd.) % C 62.97 (62.82), % H 7.23 (7.39), % N 7.73 (7.57); HRMS C19H26N2O5Na req. 385.1739, fnd. 385.1725 (2.15 ppm); δH (400 MHz, CD3CN, T=75° C.) 1.46 (9H, x, C(CH3)3), 1.90-2.00 (1H, m obscured by NMR solvent peaks, BocNCHCH2), 2.14 (1H, dd, J=6.15, 13.15 Hz, BocNCHCH2), 3.07-3.20 (2H, m, OH+CbzNCH2), 3.24 (1H, dd, J=3.8, 12.2 Hz, BocNCH2), 3.51 (1H, d, J=12.2 Hz, BocNCH2), 3.68 (1H, ddd, J=1.7, 8.6, 10.9 Hz, CbzNCH2), 4.10 (1H, br. d, J=5.8 Hz, CbzNCH), 4.27 (1H, br. s, CHOH), 4.40-4.46 (1H, m, BocNCR), 5.12 (1H, d, J=12.7 Hz, OCH2Ph), 5.16 (1H, d, J=12.7 Hz, OCH2Ph) and 7.42-7.29 (5H, aromatics); δC (120 MHz, CDCl3) 28.5 (C(CH3)3), 29.7, 30.4, 31.2, 31.9, 32.0 (BocNCHCH2), 45.5, 45.7 (CbzNCH2), 53.1, 53.4, 53.5 (BocNCH2), 60.1, 61.2 (BocNCH), 67.2, 67.6, 68.2, 68.4, 69.0 (OCH2Ph+Cbz−NCH), 72.7, 73.3, 73.4 (CHOH), 79.9, 80.1 (OC(CH3)3), 127.9, 128.0, 128.2, 128.3, 128.5, 128.6, 136.3, 136.4 (aromatics), 154.1, 154.2, 155.2 (2×NCO2).
Preparation of (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (81)
(3S,3aS,6aR)-3-Hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 4-benzyl ester 1-tert-butyl ester (80) (0.54 g, 1.5 mmol) was dissolved in ethanol (10 ml), cooled to 0° C. and 10% palladium on charcoal (0.055 g) added. The mixture was stirred, then evacuated and flushed with hydrogen. The mixture was warmed to ambient temperature and after 2.5 hours filtered through celite. The filter cake was washed with ethanol (3×10 ml) and the combined filtrates reduced in vacuo to provide the crude amine (˜0.36 g). HPLC-MS 173.1 [M+2H−Bu]+, 229.1 [M+H]+. The crude amine was dissolved in 1,4-dioxane (15 ml) with stirring, ice-cooled and a solution of sodium carbonate (0.33 g, 3.15 mmol) in water (15 ml) was added. 9-Fluorenylmethyl chloroformate (0.463 g, 1.79 mmol) in 1,4-dioxane (10 ml) was added dropwise over 30 minutes and the mixture stirred for a further 30 minutes. Water (200 ml) was then added and the aqueous phase extracted with ethyl acetate (2×100 ml). The combined organic layers were dried (Na2SO4), filtered and reduced in vacuo to leave a clear mobile oil (1.02 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (3S,3aS,6aR)-3-hydroxy hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (81) (0.64 g, 95%) as a fine white crystalline solid. TLC (Rf=0.33, EtOAc:heptane 2:1), analytical HPLC single main peak, Rt=19.98 min., HPLC-MS 395.1 [M+2H−Bu]+, 451.1 [M+H]+, 473.1 [M+Na]+, 923.2 [2M+Na]+; Elemental analysis C26H30N2O5 req. (fnd.) % C 69.31 (69.11), % H 6.71 (7.06), % N 6.22 (5.84); HRMS C26H30N2O5Na req. 473.2052, fnd. 473.2053 (0.06 ppm); OH (400 MHz, CD3CN, T=75° C.) 1.46 (9H, s, C(CH3)3), 1.75-1.90 (1H, m, BocNCHCH2), 2.05-2.13 (1H, m, BocNCHCH2), 3.02 (1H, m, FmocNCH2), 3.08-3.20 (1H, m, BocNCH2), 3.46 (1H, m, BocNCH2), 3.46-3.60 (1H, m, FmocNCH2), 3.90-4.15 (2H, m, FmocNCH and CHOH), 4.28 (1H, t, J=6.1 Hz, FmocCH), 4.34-4.40 (1H, m, BocNCH), 4.49 (2H, d, J=6.1 Hz, FmocCH2), 7.31-7.45 (4H, m, Fmoc aromatics), 7.65 (2H, d, J=7.3 Hz, Fmoc aromatics), 7.83 (2H, d, J=7.5 Hz, Fmoc aromatics); δC (100 MHz, CDCl3) 28.45 (C(CH3)3), 30.2, 31.2, 32.0 (BocNCHCH2), 44.8, 45.3, 45.6 (FmocNCH2), 47.3, 47.4 (FmocCH), 52.8, 53.1, 53.4, 53.5 (BocNCH2), 60.1, 60.8 (BocNCH), 65.9, 66.2, 67.3 (FmocCH2), 67.85, 68.4, 68.9 (FmocNCH), 72.5, 72.9, 73.3, 73.6 (CHOH), 79.95 (OC(CH3)3), 119.8, 120.0, 124.6, 124.9, 125.0, 127.0, 127.4, 127.8 (Fmoc CH aromatics), 141.3, 141.5, 143.7, 143.8, 144.1 (Fmoc quaternary aromatics), 154.0, 154.3, 155.0, 155.2 (2×NCO2).
Alternative preparation of (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (81)
meta-Chloroperoxybenzoic acid (864 mg, 57-86%) was added to a solution of (R)-2-(2-azidoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (76) (175 mg, 0.735 mmol) in anhydrous dichloromethane (4 ml). The mixture was stirred at ambient temperature for 7 hours then saturated aqueous sodium hydrogen carbonate solution (40 ml) and dichloromethane (60 ml) were added. The phases were mixed and separated and the organic phase washed with 10% aqueous sodium hydroxide solution (40 ml), dried Na2SO4) and evaporated in vacuo to afford a residue (185 mg). The residue was dissolved in ethanol (6.8 ml) and cooled to 0° C. 10% Palladium on carbon (84 mg) was added to the mixture and the atmosphere purged with hydrogen gas. The mixture was stirred overnight under a hydrogen atmosphere at ambient temperature, filtered over celite and the filter cake washed with excess ethyl acetate. The filtrate was concentrated in vacuo, and the residue suspended in a solution of sodium carbonate (193 mg, 1.82 mmol) in water (4 ml). 1,4-Dioxane (2 ml) was added and the mixture cooled to 0° C., then a solution of 9-fluorenylmethyl chloroformate (198 mg, 0.77 mmol) in 1,4-dioxane (2 ml) added in small portions over 40 minutes. The mixture was then allowed to warm to ambient temperature over 40 minutes. Water (40 ml) was added and the product extracted into dichloromethane (3×40 ml). The combined organic layers were dried Na2SO4) and evaporated in vacuo to afford a residue (335 mg). Flash chromatography of the residue over silica gel (35 g) eluting with ethyl acetate:heptane mixtures 1:4 followed by 1:1 gave (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (81) (90 mg, 27%). TLC (Single spot, Rf=0.24, EtOAc:heptane 1:1), analytical HPLC Rt=16.348 min; HPLC-MS 451.2 [M+H]+, 473.2 [M+Na]+, 923.4 [2M+Na]+; dH (500 MHz, CDCl3) 1.36-1.49 (9H, s, C(CH3)3), 1.65-2.25 (3H, m, BocNCHCH2 and OH), 2.85-3.68 (5H, m, FmocNCH2, BocNCH2 and FmocNCH), 4.05-4.80 (5H, m, OCH2CH, OCH2, CHOH and BocNCH), 7.26-7.45 (4H, m, Fmoc aromatic CH), 7.53-7.64 (2H, m, Fmoc aromatic CH) and 7.73-7.80 (2H, m, Fmoc aromatic CH);
Preparation of (3aS,6aR)-3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (6)
(3S,3aS,6aR)-3-Hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (81) (0.495 g, 1.10 mmol) was dissolved in anhydrous dichloromethane (18 ml) with stirring under argon. Dess-Martin periodinane (0.962 g, 2.27 mmol) was added and the mixture stirred for 4 hours. The mixture was concentrated in vacuo and the residue purified by flash chromatography over silica, eluting with ethyl acetate:heptane mixtures to give (3aS,6aR)-3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (6) (0.480 g, 97%) as a white crystalline solid. TLC (Rf=0.38, EtOAc:heptane 1:1), analytical HPLC single broad main peak, Rt=20.27-21.79 min., HPLC-MS 393.1 [M+2H−Bu)+, 449.1 [M+H]+, 471.1 [M+Na]+, 919.2 [2M+Na]+; Elemental analysis C26H28N2O5.0.25EtOAc req. (fnd.) % C 68.96 (68.88), % H 6.43 (6.61), % N 5.95 (5.95); HRMS C26H28N2O5Na req. 471.1896, fnd. 471.1903 (1.44 ppm); δC (125 MHz, CDCl3) 28.36 (C(CH3)3), 30.50, 30.93, 31.20 (BocNCHCH2), 45.68 (FmocNCH2), 47.20 (FmocCH), 51.71, 52.22 (BocNCH2), 57.58, 58.64 (BocNCH), 63.03, 63.57 (FmocNCH), 67.70, 68.06 (FmocCH2), 81.10 (OC(CH3)3), 119.94, 124.99, 125.15, 125.29, 127.05, 127.55, 127.71, 127.85 (Fmoc CH aromatics), 143.69, 143.92, 144.23 (Fmoc quaternary aromatics), 153.99, 154.74, 155.04 (2×NCO2), 206.33, 206.59 (C═O).
Following the general details from Scheme 6, the required bicycle building block (3aS,6aR) 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (6) was converted to building block-linker construct (27) as follows:
- A solution of sodium acetate trihydrate (42 mg, 0.311 mmol) in water (0.5 ml) was added to a solution of (3aS,6aR) 3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (18.6 mg, 0.0415 mmol) and 4-[[(hydrazinocarbonyl)amino]methyl)cyclohexane carboxylic acid. trifluoroacetate (Murphy, A. M., et al, J. Am. Chem. Soc, 114, 3156-3157, 1992) (68 mg, 0.208 mmol) in ethanol (2.0 ml). Remaining traces of sodium acetate were rinsed into the mixture using a further aliquot of ethanol (1.5 ml) then the reaction heated at 75° C. in a sealed tube for 1 hour. The mixture was stood at ambient temperature for 14 hours then heated at 75° C. for 2.5 hours. The product was extracted into chloroform (60 ml) then washed with hydrochloric acid (0.1M, 2×30 ml), saturated aqueous sodium chloride solution (30 ml) then dried (Na2SO4) and the solvent removed in vacuo to leave the product as a pale yellow oil (22.9 mg, 86%). Analytical HPLC has main UV peaks with Rt=19.706 and 21.287 mins and HPLC-MS (main UV peaks each with 646.3 [M+H]+).
Following the general details from Scheme 6, the required building block-linker construct (27) was attached to the solid phase providing loaded building block-linker construct (28) as follows:
Building block-linker construct (27) (35.5 μmoles mmoles), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluroniumhexafluoro phosphate (HBTU, 13.5 mg, 35.5 μmoles mmoles), 1-hydroxybenzotriazole.hydrate and (HOBT, 5.5 mg, 35.5 μmoles mmoles) were dissolved in dimethylformamide (1.5 mL) and N-methylmorpholine (NMM, 7.8 μL, 71 μmoles mmoles) added. After pre-activation for 5 minutes, free amine gears (10×1.3 μmole) were added and left overnight. The spent coupling solution was then added to free amine gears (6×1.3 μmole) and left overnight. Standard washing and analyses indicated quantitative loading.
Following the general details from Scheme 6, the required loaded building block-linker construct (28) was elaborated on the solid phase as follows:
Loaded construct (28) was elaborated to EXAMPLE 1 (3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-tert-butylbenzamide by standard Fmoc deprotection and sequential rounds of coupling and washing with the appropriate reagents as follows:—
- (i) Fmoc-Leu-OH (2×20 eq, overnight and 4 hr), HBTU, HOBT, NMM activation in DMF
- (ii) Standard Fmoc deprotection
- (iii) 4-tert-butylbenzoic acid (1×10 eq, overnight), HBTU, HOBT, NMM activation in DMF
- (iv) Treatment with 35% TFA in dichloromethane for 30 mins, followed by washing with 2×DMF, 1×2% NMM in DMF, 4×DMF, 4×acetonitrile.
- (v) Benzoic anhydride (20 eq) and NMM (5 eq) in DMF for 20 hr.
The crude example was cleaved and analysed (see general techniques). HPLC Rt=18.879-19.62 mins (>90%), HPLC-MS 504.3 [M+H]+, 1029.5 [2M+Na]+.
The solid phase experimental detailed for EXAMPLE 1 may be followed to couple with a vast range of aminoacids, carboxylic acids, sulphonyl chlorides etc to provide a vast range of analogues of general formula I.
In certain combinations of groupings, the order of solid phase events is amended. For example, when preparing EXAMPLE 194, the U substituent contains an amine group that requires protection via the Boc group, thus the following order of events is utilised:—
- (vi) Fmoc-Leu-OH (2×20 eq, overnight and 4 hr), HBTU, HOBT, NMM activation in DMF
- (vii) Treatment with 35% TFA in dichloromethane for 30 mins, followed by washing with 2×DMF, 1×2% NMM in DMF, 4×DMF, 4×acetonitrile.
- (viii) Benzoic anhydride (20 eq) and NMM (5 eq) in DMF for 20 hr.
- (ix) Standard Fmoc deprotection
- (x) 4-(4-Carboxyphenyl)-piperazine-1-carboxylic acid tert-butyl ester sodium salt (1×10 eq, overnight), HBTU, HOBT, NMM activation in DMF.
- (xi) Standard cleavage
As a further variation, when preparing EXAMPLE 151, the following order of events is utilised
- (xii) Fmoc-Leu-OH (2×20 eq, overnight and 4 hr), HBTU, HOBT, NMM activation in DMF
- (xiii) Standard Fmoc deprotection
- (xiv) 4-Dimethylaminobenzoic acid (1×10 eq, overnight), HBTU, HOBT, NMM activation in DMF
- (xv) Washing with 1×DMF, 1×20% piperidine in DMF, 4×DMF, 4×acetonitrile.
- (xvi) Treatment with 35% TFA in dichloromethane for 30 mins, followed by washing with 2×DMF, 1×2% NMM in DMF, 4×DMF, 4×acetonitrile.
- (xvii) Fmoc-Leu-OH (20 eq, overnight), HBTU, HOBT, NMM activation in DMF.
- (xviii) Standard Fmoc deprotection
- (xix) Acetic anhydride (50 eq) and NMM (25 eq) in DMF for 1 hr.
- (xx) Washing with 1×DMF, 1×20% piperidine in DMF, 4×DMF, 4×acetonitrile.
- (xxi) Standard cleavage
As a further variation, when preparing EXAMPLE 80, the following order of events is utilised:—
- (xxii) Fmoc-Leu-OH (2×20 eq, overnight and 4 hr), HBTU, HOBT, NMM activation in DMF
- (xxiii) Treatment with 35% TFA in dichloromethane for 30 mins, followed by washing with 2×DMF, 1×2% NMM in DMF, 4×DMF, 4×acetonitrile.
- (xxiv) Pyridine-2-carboxylic acid (20 eq) and NMM (5 eq) in DMF for 20 hr.
- (xxv) Washing with 2×DMF, 1×2% NMM in DMF, 4×DMF, 4×acetonitrile.
- (xxvi) Oxidation with m-chloroperbenzoic acid (5 eq) in DCM for 8 hrs.
- (xxvii) Washing with 4×DMF, 4×acetonitrile.
- (xxviii) Standard Fmoc deprotection
- (xxix) 4-Dimethylaminobenzoic acid (1×10 eq, overnight), HBTU, HOBT, NMM activation in DMF.
- (xxx) Washing with 1×DMF, 1×20% piperidine in DMF, 4×DMF, 4×acetonitrile.
- (xxxi) Standard cleavage
The following examples (2-248) were prepared as detailed for EXAMPLE 1, coupling with the required reagents to provide the full length molecule (see i→v, or vi→xi, or xii→xxi above, or xxii→xxxi above). For step (v), (viii) and (xix) where the anhydride is not readily available, an R2COOH (20 eq)/HBTU (20 eq)/HOBT (20 eq)/NMM (40 eq) mixture in DMF with overnight coupling may be used or an RNHCOCl (20 eq)/NMM (10 eq) mixture in DMF with overnight coupling may be used or an RNCO (20 eq) mixture in DMF with overnight coupling may be used. Following final coupling where the R2 or U groups contain a protonatable nitrogen (e.g. pyridyl or 4-dimethylaminobenzoyl), the solid phase intermediate is treated with 20% piperidine in DMF for 10 mins followed by standard washing protocols prior to cleavage.
EXAMPLE 2
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-thiophen-2-yl-benzamide
HPLC Rt=18.0-19.2 mins (>90%), HPLC-MS 530.2 [M+H]+, 1081.4 [2M+Na]+.
EXAMPLE 3
(3aR,6aS)-4-tert-Butyl-N-[(1S)-3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide
HPLC Rt=19.1-20.2 mins (>90%), HPLC-MS 518.3 [M+H]+, 1057.6 [2M+Na]+.
EXAMPLE 4
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=17.2-18.1 mins (>90%), HPLC-MS 505.3 [M+H]+, 1031.5 [2M+Na]+.
EXAMPLE 5
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=15.2-16.4 mins (>90%), HPLC-MS 505.3 [M+H]+, 1031.5 [2M+Na]+.
EXAMPLE 6
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=15.3-16.4 mins (>90%), HPLC-MS 505.3 [M+H]+, 523.3 [M+H+H2O]+.
EXAMPLE 7
(3aR,6aS)-Benzo[b]thiophene-2-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=16.8-17.9 mins (>90%), HPLC-MS 504.2 [M+H]+.
EXAMPLE 8
(3aR,6aS)-Quinoline-2-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=17.0-17.8 mins (>90%), HPLC-MS 499.1 [M+H]+.
EXAMPLE 9
(3aR,6aS)-Benzofuran-2-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=16.2-17.7 mins (>90%), HPLC-MS 488.1 [M+H]+, 997.2 [2M+Na]+.
EXAMPLE 10
(3aR,6aS)-3-Methyl-benzofuran-2-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=17.8-18,9 mins (>85%), HPLC-MS 502.1 [M+H]+, 520.1 [M+H+H2O]+.
EXAMPLE 11
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-tert-butyl-benzamide
HPLC Rt=17.4-18.2 mins (>90%), HPLC-MS 490.2 [M+H]+.
EXAMPLE 12
(3aR,6aS)-Quinoxaline-2-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=15.6-16.7 mins (>90%), HPLC-MS 500.2 [M+H]+.
EXAMPLE 13
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-3-phenoxy-benzamide
HPLC Rt=18.5-19.7 mins (>80%), HPLC-MS 540.1 [M+H]+.
EXAMPLE 14
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=12.16 mins (>90%), HPLC-MS 491.2 [M+H]+, 509.2 [M+H+H2O]+.
EXAMPLE 15
(3aR,6aS)-Benzo[b]thiophene-2-carboxylic acid {(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide
HPLC Rt=13.93 mins (>95%), HPLC-MS 505.2 [M+H]+.
EXAMPLE 16
(3aR,6aS)-Benzofuran-2-carboxylic acid {(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide
HPLC Rt=13.42 mins (>85%), HPLC-MS 489.2 [M+H]+, 999.4 [2M+Na]+.
EXAMPLE 17
(3aR,6aS)-3-Methyl-benzofuran-2-carboxylic acid {(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide
HPLC Rt=14.58 mins (>90%), HPLC-MS 503.2 [M+H]+.
EXAMPLE 18
(3aR,6aS)-Quinoline-2-carboxylic acid {(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide
HPLC Rt=14.00 mins (>90%), HPLC-MS 500.2 [M+H]+.
EXAMPLE 19
(3aR,6aS)-Quinoxaline-2-carboxylic acid {(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-amide
HPLC Rt=12.77 mins (>90%), HPLC-MS 501.2 [M+H]+.
EXAMPLE 20
(3aR,6aS)-N-{(1S)-3-Methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-3-phenoxy-benzamide
HPLC Rt=16.06 mins (>85%), HPLC-MS 541.2 [M+H]+.
EXAMPLE 21
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=8.70 mins (>95%), HPLC-MS 255.6 [M+2H+H2O]2+, 492.2 [M+H]+, 510.2 [M+H+H2O]+.
EXAMPLE 22
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b ] pyrrol-1-yl)-2-oxo-1-thiophen-2-ylmethyl-ethyl]-4-tert-butyl-benzamide
HPLC Rt=18.0-19.0 mins (>80%), HPLC-MS 544.2 [M+H]+.
EXAMPLE 23
(3aR,6aS)-4-tert-Butyl-N-{(1S)-2-oxo-2-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-thiophen-2-ylmethyl-ethyl}-benzamide
HPLC Rt=15.626 mins (>85%), HPLC-MS 545.2 [M+H]+.
EXAMPLE 24
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(3-phenoxy-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=22.0-23.2 mins (>75%), HPLC-MS 596.1 [M+H]+.
EXAMPLE 25
(3aR,6aS)-N-{(1S)-1-[4-(3-Bromo-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide
HPLC Rt=20.3-21.5 mins (>80%), HPLC-MS 582.1/584.1 [M+H]+.
EXAMPLE 26
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(4-[1,2,4] triazol-1-yl-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=17.4-8.7 mins (>80%), HPLC-MS 571.1 [M+H]+.
EXAMPLE 27
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(2-phenyl-thiazole-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=21.4-22.7 mins (>80%), HPLC-MS 587.1 [M+H]+.
EXAMPLE 28
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(5-phenyl-thiophene-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=22.0-23.0 mins (>70%), HPLC-MS 586.1 [M+H]+.
EXAMPLE 29
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-[4-(2,3-dihydro benzo[1,4]dioxine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=20.1-21.3 mins (>80%), HPLC-MS 562.1 [M+H]+.
EXAMPLE 30
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-[4-(2,3-dihydro-benzo[1,4]dioxine-6-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=18.3-19.1 mins (>85%), HPLC-MS 562.1 [M+H]+.
EXAMPLE 31
(3aR,6aS)-N-{(1S)-1-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide
HPLC Rt=20.5-21.8 mins (>80%), HPLC-MS 560.2 [M+H]+.
EXAMPLE 32
(3aR,6aS)-N-{(1S)-1-[4-(Benzothiazole-6-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide
HPLC Rt=17.9-18.9 mins (>75%), HPLC-MS 561.2 [M+H]+.
EXAMPLE 33
(3aR,6aS)-tert-Butyl-N-{(1)-3-methyl-1-[4-(naphthalene-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl-]-butyl}-benzamide
HPLC Rt=20.5-21.7 mins (>80%), HPLC-MS 554.1 [M+H]+.
EXAMPLE 34
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[4-(naphthalene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=20.7-21.8 mins (>75%), HPLC-MS 554.2 [M+H]+.
EXAMPLE 35
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[6-oxo-4-(5-thiophen-2-yl-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=18.9-19.8 mins (>70%), HPLC-MS 587.1 [M+H]+.
EXAMPLE 36
(3aR,6aS)-N-{(1S)-1-[4-(2-Benzyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide
HPLC Rt=21.8-22.9 mins (>80%), HPLC-MS 594.1 [M+H]+.
EXAMPLE 37
(3aS,6aR)-((1S)-1-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-carbamic acid benzyl ester
HPLC Rt=17.15 mins (>85%), HPLC-MS 634.3 M+H]+.
EXAMPLE 38
(3aS,6aR)-(2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-2-oxo-ethyl)-carbamic acid benzyl ester
HPLC Rt=13.79 mins (>85%), HPLC-MS 578.3 [M+H]+.
EXAMPLE 39
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-phenoxy-benzamide
HPLC Rt=17.5-18.2 mins (>75%), HPLC-MS 540.2 [M+H]+.
EXAMPLE 40
(3aR,6aS)-N-{(1S)-1-[4-(2-Methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-phenoxy-benzamide
HPLC Rt=16.9-17.9 mins (>75%), HPLC-MS 618.2 [M+H]+, 636.2 [M+H+H2O]+.
EXAMPLE 41
(3aR,6aS)-N-{(1S)-1-[4-(3-Methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-phenoxy-benzamide
HPLC Rt=16.6-17.7 mins (>70%), HPLC-MS 618.2 [M+H]+.
EXAMPLE 42
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=13.10 mins (>90%), HPLC-MS 569.3 [M+H]+, 1159.4 [2M+Na]+.
EXAMPLE 43
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=11.59 mins (>95%), HPLC-MS 569.2 [M+H]+, 587.2 [M+H+H2O]+.
EXAMPLE 44
(3aR,6aS)-5-Phenyl-thiophene-2-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=17.2-18.1 mins (>75%), HPLC-MS 530.2 [M+H]+.
EXAMPLE 45
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(2-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.47 mins (>95%), HPLC-MS 536.2 [M+H]+, 554.2 [M+H+H2O]+.
EXAMPLE 46
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(3-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=13.17 mins (>90%), HPLC-MS 536.2 [M+H]+, 554.2 [M+H+H2O]+.
EXAMPLE 47
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(4-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=13.19 mins (>95%), HPLC-MS 536.2 [M+H]+, 554.2 [M+H+H2O]+.
EXAMPLE 48
(3aR,6aS)-N-{(1S)-1-[4-(Adamantane-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=16.4-17.1 mins (>50%), HPLC-MS 549.3 [M+H]+.
EXAMPLE 49
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(4-hydroxy-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=11.05 mins (>90%), HPLC-MS 507.2 [M+H]+, 525.2 [M+H+H2O]+.
EXAMPLE 50
(3aR,6aS)-N-{(1S)-1-[4-(4-Amino-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.33 mins (>85%), HPLC-MS 506.2 [M+H]+, 524.2 [M+H+H2O]+.
EXAMPLE 51
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(5-methanesulfonyl-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=12.10 mins (>95%), HPLC-MS 575.1 [M+H]+, 593.1 [M+H+H2O]+.
EXAMPLE 52
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(quinoline-6-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=9.99 mins (>85%), HPLC-MS 542.2 [M+H]+, 560.2 [M+H+H2O]+.
EXAMPLE 53
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(2-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=13.08 mins (>90%), HPLC-MS 505.2 [M+H]+, 523.2 [M+H+H2O]+.
EXAMPLE 54
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(3-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=13.12 mins (>85%), HPLC-MS 505.2 [M+H]+, 523.2 [M+H+H2O]+.
EXAMPLE 55
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(4-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=13.65 mins (>90%), HPLC-MS 505.2 [M+H]+, 523.2 [M+H+H2O]+.
EXAMPLE 56
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(4-phenoxy-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=16.38 mins (>80%), HPLC-MS 583.2 [M+H]+.
EXAMPLE 57
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(4-fluoro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=12.83 mins (>90%), HPLC-MS 509.1 [M+H]+, 527.1 [M+H+H2O]+.
EXAMPLE 58
(3aR,6aS)-N-{(1S)-1-[4-(3-Methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-nitro-benzamide
HPLC Rt=13.37 mins (>95%), HPLC-MS 571.1 [M+H]+.
EXAMPLE 59
(3aR,6aS)-3-Dimethylamino-N-{(1S)-1-[4-(3-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=10.29 mins (>85%), HPLC-MS 569.1 [M+H]+, 587.2 [M+H+H2O]+.
EXAMPLE 60
(3aR,6aS)-4-Diethylamino-N-{(1S)-1-[4-(3-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=11.13 mins (>90%), HPLC-MS 597.2 [M+H]+, 615.2 [M+H+H2O]+.
EXAMPLE 61
(3aR,6aS)-4-Amino-N-{(1S)-1-[4-(3-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=9.69 mins (>80%), HPLC-MS 541.1 [M+H]+.
EXAMPLE 62
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-fluoro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=9.18 mins (>95%), HPLC-MS 509.2 [M+H]+, 527.2 [M+H+H2O]+.
EXAMPLE 63
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3-fluoro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=10.59 mins (>90%), HPLC-MS 509.2 [M+H]+, 527.2 [M+H+H2O]+.
EXAMPLE 64
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-methoxy-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=11.20 mins (>95%), HPLC-MS 521.2 [M+H]+.
EXAMPLE 65
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3-methoxy-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=12.5 mins (>90%), HPLC-MS 521.2 [M+H]+.
EXAMPLE 66
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(4-methoxy-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=13.33 mins (>95%), HPLC-MS 521.1 [M+H]+.
EXAMPLE 67
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(2-trifluoromethyl-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=10.98 mins (>95%), HPLC-MS 559.2 [M+H]+, 577.2 [M+H+H2O]+.
EXAMPLE 68
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(3-trifluoromethyl-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.11 mins (>95%), HPLC-MS 559.2 [M+H]+, 577.2 [M+H+H2O]+.
EXAMPLE 69
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(4 trifluoromethyl-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=9.76 mins (>95%), HPLC-MS 559.2 [M+H]+, 577.2 [M+H+H2O]+.
EXAMPLE 70
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(3-trifluoromethoxy-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=10.42 mins (>95%), HPLC-MS 575.2 [M+H]+, 593.2 [M+H+H2O]+.
EXAMPLE 71
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-(4-trifluoromethoxy-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=10.48 mins (>95%), HPLC-MS 575.2 [M+H]+, 593.2 [M+H+H2O]+.
EXAMPLE 72
(3aR,6aS)-N-{(1S)-1-[4-(2-Chloro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.99 mins (>95%), HPLC-MS 525.2/527.2 [M+H]+, 543.2/545.2 [M+H+H2O]+.
EXAMPLE 73
(3aR,6aS)-N-{(1S)-1-[4-(3-Chloro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.08 mins (>95%), HPLC-MS 525.2/527.2 [M+H]+, 543.2/545.2 [M+H+H2O]+.
EXAMPLE 74
(3aR,6aS)-N-{(1S)-1-[4-(4-Chloro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.03 mins (>95%), HPLC-MS 525.2/527.2 [M+H]+, 543.2/545.2 [M+H+H2O]+.
EXAMPLE 75
(3aR,6aS)-N-{(1S)-1-[4-(4-tert-Butyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.51 mins (>95%), HPLC-MS 547.3 [M+H]+.
EXAMPLE 76
(3aS,6aR)-4-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-benzoic acid methyl ester
HPLC Rt=9.76 mins (>95%), HPLC-MS 549.2 [M+H]+, 567.2 [M+H+H2O]+.
EXAMPLE 77
(3aR,6aS)-N-{(1S)-1-[4-(Benzo[1,3]dioxole-5-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.3 mins (>90%), HPLC-MS 535.2 [M+H]+.
EXAMPLE 78
(3aR,6aS)-4-Dimethylamino-N-[(1S)-1-(4-diphenylacetyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=14.0-15.1 mins (>85%), HPLC-MS 581.2 [M+H]+.
EXAMPLE 79
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=6.17 mins (>95%), HPLC-MS 492.2 [M+H]+.
EXAMPLE 80
(3aR,6aS)-4-Dimethylamino-N-{1S)-3-methyl-1-[6-oxo-4-(1-oxy-pyridine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=5.82 mins (>75%), HPLC-MS 508.2 [M+H]+.
Oxidation of the intermediate was performed as detailed in the general soild phase methods prior to compound release from the solid phase.
EXAMPLE 81
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(1-oxy-pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=4.7 mins (>95%), HPLC-MS 508.2 [M+H]+, 526.2 [M+H+H2O]+.
Oxidation of the intermediate was performed as detailed in the general soild phase methods prior to compound release from the solid phase.
EXAMPLE 82
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(pyridinecarbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=4.5 mins (>95%), HPLC-MS 492.2 [M+H]+, 510.2 [M+H+H2O]+.
EXAMPLE 83
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(1-oxy-pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=4.9 mins (>95%), HPLC-MS 508.2 [M+H]+, 526.2 [M+H+H2O]+.
Oxidation of the intermediate was performed as detailed in the general soild phase methods prior to compound release from the solid phase.
EXAMPLE 84
(3aR,6aS)-1-(4-Trifluoromethyl-pyrimidin-2-yl)-piperidine-4-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=16.49 mins (>95%), HPLC-MS 601.2 [M+H]+.
EXAMPLE 85
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-morpholin-4-yl-benzamide
HPLC Rt=9.37 mins (>95%), HPLC-MS 533.2 [M+H]+.
EXAMPLE 86
(3aR,6aS)-Quinoline-6-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=11.73 mins (>95%), HPLC-MS 499.2 [M+H]+.
EXAMPLE 87
(3aR,6aS)-1,2,3,4-Tetrahydro-quinoline-6-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=9.06 mins (>95%), HPLC-MS 503.2 [M+H]+, 521.2 [M+H+H2O]+.
EXAMPLE 88
(3aR,6aS)-1H-Indole-6-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=10. 13 mins (>85%), HPLC-MS 487.1 [M+H]+.
EXAMPLE 89
(3aR,6aS)-1H-Indole-5-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=9.58 mins (>85%), HPLC-MS 487.2 [M+H]+.
EXAMPLE 90
(3aR,6aS)-Benzothiazole-6-carboxylic acid [(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=14.15 mins (>95%), HPLC-MS 505.1 [M+H]+.
EXAMPLE 91
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-pyrazol-1-yl-benzamide
HPLC Rt=10.25 mins (>95%), HPLC-MS 514.2 [M+H]+.
EXAMPLE 92
(3aR,6aS)-3-Aminomethyl-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=7.42 mins (>95%), HPLC-MS 477.2 [M+H]+, 495.2 [M+H+H2O]+, 975.3 [2M+Na]+.
EXAMPLE 93
(3aR,6aS)-4-Aminomethyl-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=6.86 mins (>95%), HPLC-MS 477.2 (M+H)+, 495.2 [M+H+H2O]+, 975.3 [2M+Na]+.
EXAMPLE 94
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(6-morpholin-4-yl-pyridine-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=4.4 mins (>90%), HPLC-MS 577.2 [M+H]+.
EXAMPLE 95
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(thiophene-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=7.7 mins (>90%), HPLC-MS 497.1 [M+H]+.
EXAMPLE 96
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=7.3 mins (>90%), HPLC-MS 481.2 [M+H]+, 499.2 [M+H+H2O]+, 983.3 [2M+Na]+.
EXAMPLE 97
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(furan-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=7.30 mins (>90%), HPLC-MS 481.2 [M+H]+, 499.2 [M+H+H2O]+, 983.3 [2M+Na]+.
EXAMPLE 98
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(1H-indole-5-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=9.0 mins (>80%), HPLC-MS 530.2 [M+H]+.
EXAMPLE 99
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(1H-indole-6-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=7.8 mins (>80%), HPLC-MS 530.2 [M+H]+.
EXAMPLE 100
(3aR,6aS)-N-{(1S)-1-[4-(Benzo[b]thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.85 mins (>95%), HPLC-MS 547.2 [M+H]+.
EXAMPLE 101
(3aR,6aS)-N-{(1S)-1-[4-(Benzofuran-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.9 mins (>95%), HPLC-MS 531.2 [M+H]+.
EXAMPLE 102
(3aR,6aS)-N-{(1S)-1-[4-(Benzo[1,2,5]oxadiazole-5-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=7.06 mins (>90%), HPLC-MS 533.2 [M+H]+, 551.2 [M+H+H2O]+.
EXAMPLE 103
(3aR,6aS)-N-{(1S)-1-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.8 mins (>95%), HPLC-MS 547.2 [M+H]+.
EXAMPLE 104
(3aR,6aS)-N-[(1S)-1-(4-Cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=12.9-13.9 mins (>90%), HPLC-MS 497.2 [M+H]+, 515.2 [M+H+H2O]+.
EXAMPLE 105
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=13.08 mins (>90%), HPLC-MS 485.2 [M+H]+, 503.2 [M+H+H2O]+, 991.4 [2M+Na]+,
EXAMPLE 106
(3aS,6aR)-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl}-4-oxo-butyric acid
HPLC Rt=4.35 mins (>90%), HPLC-MS 487.2 [M+H]+.
EXAMPLE 107
(3aS,6aR)-5-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-5-oxo-pentanoic acid
HPLC Rt=4.99 mins (>90%), HPLC-MS 501.2 [M+H]+.
EXAMPLE 108
(3aR,6aS)-N-{(1S)-1-[4-(3-Amino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=3.9 mins (>90%), HPLC-MS 458.2 [M+H]+, 915.4 [2M+H]+.
EXAMPLE 109
(3aS,6aR)-((1R)-1-{4[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-carbamic acid benzyl ester
HPLC Rt=13.0-14.2 mins (>90%), HPLC-MS 634.3 [M+H]+.
EXAMPLE 110
(3aR,6aS)-N-[(1S)-1-(4-Acetyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=4.58 mins (>90%), HPLC-MS 429.2 [M+H]+, 451.2 [M+Na]+.
EXAMPLE 111
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3,5-dimethyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=15.53 mins (>90%), HPLC-MS 519.3 [M+H]+.
EXAMPLE 112
(3aR,6aS)-N-{(1S)-1-[4-(3,5-Dimethoxy-benzoyl)-6-oxo-hexahydro pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=14.43 mins (>90%), HPLC-MS 551.2 [M+H]+.
EXAMPLE 113
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3-fluoromethyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=15.04 mins (>95%), HPLC-MS 523.2 [M+H]+, 541.2 [M+H+H2O]+.
EXAMPLE 114
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3,4-dimethyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=15.70 mins (>90%), HPLC-MS 519.3 [M+H]+.
EXAMPLE 115
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(4-fluoro-3-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=15.00 mins (>90%), HPLC-MS 523.2 [M+H]+, 541.2 [M+H+H2O]+.
EXAMPLE 116
(3aR,6aS)-N-{(1S)-1-[4-(3,4-Difluoro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=14.47 mins (>90%), HPLC-MS 527.2 [M+H]+, 545.2 [M+H+H2O]+.
EXAMPLE 117
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-(N-oxy-dimethylamino)-benzamide
HPLC Rt=11.64 mins (>95%), HPLC-MS 507.2 [M+H]+, 525.2 [M+H+H2O]+.
Oxidation of the intermediate was performed as detailed in the general soild phase methods prior to compound release from the solid phase.
EXAMPLE 118
(3aR,6aS)-3-Aminomethyl-N-[(1S)-3-methyl-1-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide
HPLC Rt=12.06 mins (>90%), HPLC-MS 491.2 [M+H]+, 509.2 [M+H+H2O]+, 981.4 [2M+H]+.
EXAMPLE 119
(3aR,6aS)-N-[(1S)-1-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-tert-butyl-benzamide
HPLC Rt=21.0-22.4 mins (>75%), HPLC-MS 540.1 [M+H]+.
EXAMPLES 119-123 were prepared following the general methods detailed for EXAMPLE 1, but using an alternative building block (3aR,6aS)-4-benzenesulfonyl-6-oxo-hexahydropyrrolo [3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (84) prepared following Scheme 21.
Preparation of (3aR,6S,6aS)-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester hydrochloride (82)
A solution of HCl in 1,4-dioxane (4.0M, 2.0 ml, 8 mmol) was added to (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-tert-butyl ester 4-(9H-fluoren-9-ylmethyl) ester (81) (65 mg, 0.14 mmol). The mixture was stirred in a sealed system for 50 minutes then the solvents were removed in vacuo to leave a residue which was azeotroped with diethyl ether (3×10 ml) to obtain (3aR,6S,6aS)-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester hydrochloride (82) as a white solid which was used without further purification (see below). HPLC-MS 351.1 [M+H]+, 373.1 [M+Na]+, 723.2 [2M+Na]+; HRMS C21H23N2O3Na req. 351.1708, fnd. 351.1712 (0.95 ppm).
Preparation of (3aR,6S,6aS)-4-benzenesulfonyl-4-hydroxyhexahydropyrrolo [3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (83)
Dichloromethane (1.5 ml), benzenesulfonyl chloride (20 μl, 0.16 mmol) then triethylamine (44 μl, 0.32 mmol) were added consecutively whilst stirring to (3aR,6S,6aS)-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester hydrochloride (82) (prepared as above, 0.14 mmol) under an atmosphere of argon. The mixture was stirred for 1 hour then the product extracted into ethyl acetate (40 ml), washed with aqueous saturated sodium hydrogen carbonate (40 ml), pH 3 hydrochloric acid (40 ml) and brine (40 ml) then dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 30:70 to give (3aR,6S,6aS)-4-benzenesulfonyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (83) as a white solid (60 mg, 86%). TLC (Single spot, Rf=0.40, EtOAc:heptane 1:1), analytical HPLC single main peak Rt=20.112 min; HPLC-MS 491.0 [M+H]+, 513.0 [M+Na]+; Elemental analysis C27H26N2O5S req. (fnd.) % C 66.10 (66.02), % H 5.34 (5.36), % N 5.71 (5.61); HRMS C27H26N2O5SNa req. 513.1460, fnd. 513.1489 (5.56 ppm).
Preparation of (3aR,6aS)-4-benzenesulfonyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (84)
Dess-Martin periodinane (95 mg, 0.22 mmol) was added in portions to a stirred solution of (3aR,6S,6aS)-4-benzenesulfonyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-yl methyl ester (83) (55 mg, 0.11 mmol) in dichloromethane (1.5 ml) under an atmosphere of argon over 2 minutes. The mixture was stirred for 3.25 hours then the solvents removed in vacuo to obtain a residue which was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 25:75 to give (3aR,6aS)-4-benzenesulfonyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (84) as a white solid (44 mg, 82%). TLC (Single spot, Rf=0.55, EtOAc:heptane 65:35), analytical HPLC broad peak Rt=20.0-21.5 min; HPLC-MS single broad main UV peak, 489.0 [M+H]+, 511.0 [M+Na]+, 529.0 [M+H2O+Na]+, 999.0 [2M+Na]+; C27H24N2O5S.0.4CDCl3 req. (fnd.) % C 61.36 (61.09), % H 4.51 (4.76), % N 5.22 (4.79); HRMS C21H24N2O5SNa req. 511.1304, fnd. 511.1615 (2.16 ppm); dH (500 MHz, CDCl3) mixture of rotamers 2.10-2.28 (2H, m, PhSO2NCHCH2), 3.40-3.60 (2H, m, FmocNCH2), 3.62-3.84 (2H, m, PhSO2NCH2), 4.16-4.46 (4H, m, FmocNCH, Fmoc-CH and Fmoc-CH2), 4.48-4.61 (1H, m, PhSO2NCR), 7.32-7.90 (13H, m, aromatic); dC (125 MHz, CDCl3) 31.72, 31.86 (PhSO2NCHCH2), 45.41 (FmocNCH2), 47.15 (Fmoc-CH), 52.62 (PhSO2NCH2), 60.17 (PhSO2NCH), 63.30, 63.52 (FmocNCH), 67.79, 68.12 (Fmoc-CH2), 119.97, 120.09, 124.94, 127.07, 127.53, 127.74, 127.91, 129.65, 133.75 (aromatic CH), 141.29, 143.40, 143.58, 143.81, 144.12 (quaternary aromatic), 154.93 (NC═O), 203.85, 204.07 (C═O).
Following the general details from Scheme 6, the required bicycle building block (3aR,6aS)-4-benzenesulfonyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (84) was converted to building block-linker construct (27) (where Pg2 is phenylsulphonyl) as follows:
- A solution of sodium acetate trihydrate (30 mg, 0.221 mmol) in water (0.3 ml) was added to a solution of (3aR,6aS)-1-benzenesulfonyl-6-oxo-hexahydropyrrolo [3,2-b]pyrrole-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (84) (36 mg, 0.074 mmol) and 4-[[(hydrazinocarbonyl)amino]methyl]cyclohexane carboxylic acid. trifluoroacetate (Murphy, A. M., et al, J. Am. Chem. Soc, 114, 3156-3157, 1992) (49 mg, 0.148 mmol) in ethanol (2.1 ml). The reaction heated at 75° C. in a sealed tube for 4.5 hour. The product was extracted into chloroform (50 ml) then washed with hydrochloric acid (0.1M, 2×25 ml), saturated aqueous sodium chloride solution (30 ml) then dried (Na2SO4) and the solvent removed in vacuo to leave the product as a white solid (46 mg, 91%). Analytical HPLC has main UV peaks with Rt=19.624 and 21.252 mins and HPLC-MS (main UV peaks each with 686.3 [M+H]+).
Following the general details from Scheme 6, the required building block-linker construct (27) was attached to the solid phase providing loaded building block-linker construct (28) following standard loading protocols and indicated quantitative loading.
EXAMPLES 120 to 123 were prepared as detailed for EXAMPLE 119, substituting the appropriate carboxylic acids as required;
EXAMPLE 120
(3aR,6aS)-N-[(1S)-1-(4-Benzenesulfonyl-6-oxo-hexahydropyrrolo [3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-thiophen-2-yl-benzamide
HPLC Rt=20.3-21.7 mins (>75%), HPLC-MS 566.1 [M+H]+.
EXAMPLE 121
(3aR,6aS)-Benzofuran-2-carboxylic acid [(1S)-1-(4-benzene sulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-amide
HPLC Rt=18.3-19.9 mins (>95%), HPLC-MS 524.1 [M+H]+, 546.2 [M+Na]+.
EXAMPLE 122
(3aR,6aS)-N-[(1S)-1-(4-Benzenesulfonyl-6-oxo-hexahydropyrrolo [3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-morpholin-4-yl-benzamide
HPLC Rt=16.4-17.8 mins (>90%), HPLC-MS 569.1 [M+H]+, 587.1 [M+H+H2O]+.
EXAMPLE 123
(3aR,6aS)-3-Aminomethyl-N-[(1S)-1-(4-benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=13.0-14.1 mins (>90%), HPLC-MS 513.1 [M+H]+, 531.1 [M+H+H2O]+.
The following examples were prepared as detailed for EXAMPLE 1, substituting the appropriate carboxylic acids as required;
EXAMPLE 124
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(3,3,3-trifluoro-propionyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=10.46 mins (>95%), HPLC-MS 497.2 [M+H]+, 515.2 [M+H+H2O]+.
EXAMPLE 125
(3aR,6aS)-N-{(1S)-1-[4-(2,2-Difluoro-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.31 mins (>60%), HPLC-MS 465.1 [M+H]+, 483.1 [M+H+H2O]+.
EXAMPLE 126
(3aR,6aS)-4-Dimethylamino-N-[(1S)-3-methyl-1-(6-oxo-4-propionyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide
HPLC Rt=9.90 mins (>95%), HPLC-MS 443.2 [M+H]+, 461.2 [M+H+H2O]+, 907.3 [2M+Na]+.
EXAMPLE 127
(3aR,6aS)-N-[(1S)-1-(4-Butyryl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=10.95 mins (>90%), HPLC-MS 457.2 [M+H]+, 475.2 [M+H+H2O]+, 935.3 [2M+Na]+.
EXAMPLE 128
(3aR,6aS)-4-Dimethylamino-N-[(1S)-3-methyl-1-(6-oxo-4-pentanoyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-benzamide
HPLC Rt=12.0-13.1 mins (>90%), HPLC-MS 471.2 [M+H]+, 489.2 (M+H+ H2O]+, 963.3 [2M+Na]+.
EXAMPLE 129
(3aR,6aS)-4-Dimethylamino-N-[(1S)-1-(4-isobutyryl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=10.55 mins (>90%), HPLC-MS 457.2 [M+H]+, 475.2 [M+H+H2O]+, 935.4 [2M+Na]+.
EXAMPLE 130
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=11.81 mins (>90%), HPLC-MS 471.2 [M+H]+, 489.2 [M+H+H2O]+, 963.4 [2M+Na]+.
EXAMPLE 131
(3aR,6aS)-N-[(1S)-1-(4-Cyclopropanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=110.10 mins (>90%), HPLC-MS 455.2 [M+H]+, 473.2 [M+H+H2O]+, 931.3 [2M+Na]+.
EXAMPLE 132
(3aR,6aS)-N-{(1S)-1-[4-(2-Cyclopropyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.13 mins (>90%), HPLC-MS 469.2 [M+H]+, 487.2 [M+H+H2O]+, 959.3 [2M+Na]+.
EXAMPLE 133
(3aR,6aS)-N-[(1S)-1-(4-Cyclobutanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=11.41 mins (>90%), HPLC-MS 469.2 [M+H]+, 487.2 [M+H+H2O]+, 959.4 [2M+Na]+.
EXAMPLE 134
(3aR,6aS)-N-[(1S)-1-(4-Cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=12.2-13.1 mins (>90%), HPLC-MS 483.2 [M+H]+, 501.2 [M+H+H2O]+, 987.4 [2M+Na]+.
EXAMPLE 135
(3aR,6aS)-N-[(1S)-1-(4-Cycloheptanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=14.0-14.9 mins (>85%), HPLC-MS 511.2 [M+H]+, 529.3 [M+H+H2O]+.
EXAMPLE 136
(3aR,6aS)-4-Dimethylamino-N-[(1S)-1-(4-heptanoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=14.3-15.2 mins (>80%), HPLC-MS 499.2 [M+H]+, 517.2 [M+H+H2O]+.
EXAMPLE 137
(3aR,6aS)-N-{(1S)-1-[4-(2-Cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=14.27 mins (>80%), HPLC-MS 511.2 [M+H]+, 529.3 [M+H+H2O]+.
EXAMPLE 138
(3aR,6aS)-N-{(1S)-1-[4-(Cyclohex-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.2-13.3 mins (>80%), HPLC-MS 495.2 [M+H]+, 513.2 [M+H+H2O]+.
EXAMPLE 139
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(3-methoxy-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=11.1-12.8 mins (>90%), HPLC-MS 527.2 [M+H]+, 545.3 [M+H+H2O]+.
EXAMPLE 140
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(piperidine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=7.8-9.3 mins (>75%), HPLC-MS 498.2 [M+H]+, 516.2 [M+H+H2O]+, 995.5 [2M+H]+.
EXAMPLE 141
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.9-13.8 mins (>75%), HPLC-MS 485.2 [M+H]+, 503.3 [M+H+H2O]+, 991.5 [2M+Na]+.
EXAMPLE 142
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(morpholin-4-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=9.82 mins (>85%), HPLC-MS 500.2 [M+H]+.
EXAMPLE 143
(3aR,6aS)-N-{(1S)-1-[4-(3-Benzenesulfonyl-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.27 mins (>90%), HPLC-MS 583.2 [M+H]+.
EXAMPLE 144
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-methanesulfonyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=8.00 mins (>50%), HPLC-MS 507.1 [M+H]+.
EXAMPLE 145
(3aS,6aR)-((1S)-2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-1-methyl-2-oxo-ethyl)-carbamic acid benzyl ester
HPLC Rt=12.4-14.0 trims (>85%), HPLC-MS 592.2 [M+H]+.
EXAMPLE 146
(3aS,6aR)-((1R)-2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl}-1-methyl-2-oxo-ethyl)-carbamic acid benzyl ester
HPLC Rt=12.5-13.9 mins (>75%), HPLC-MS 592.2 [M+H]+.
EXAMPLE 147
(3aS,6aR)-((1S)-2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-1-hydroxymethyl-2-oxo-ethyl)-carbamic acid benzyl ester
HPLC Rt=11.8-13.3 mins (>80%), HPLC-MS 608.3 [M+H]+.
EXAMPLE 148
(3aS,6aR)-((1S)-1-Carbamoylmethyl-2-{4-[(2S)-2-(4-dimethyl aminobenzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl}-2-oxo-ethyl)-carbamic acid benzyl ester
HPLC Rt=11.4-13.2 mins (>75%), HPLC-MS 635.2 [M+H]+.
EXAMPLE 149
(3aS,6aR)-(3S)-3-Benzyloxycarbonylamino-4-{4-[(2S)-2-(4-dimethylamino-benzoylamino)methyl-pentanoyl)-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-4-oxo-butyric acid
HPLC Rt=12.1-13.5 mins (>85%), HPLC-MS 636.2 [M+H]+, 654.3 [M+H+H2O]+.
EXAMPLE 150
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.00 mins (>90%), HPLC-MS 500.2 [M+H]+, 999.5 [2M+H]+.
EXAMPLE 151
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.5-13.0 mins (>90%), HPLC-MS 542.2 [M+H]+.
EXAMPLE 152
(3aR,6aS)-N-{(1S)-1-[4-((2R)-2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.9-10.8 mins (>90%), HPLC-MS 500.2 [M+H]+, 999.5 [2M+H]+.
EXAMPLE 153
(3aR,6aS)-N-{(1S)-1-[4-((2R)-2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=10.4-12.2 mins (>85%), HPLC-MS 542.3 [M+H]+.
EXAMPLE 154
(3aS,6aR)-(2S)-2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-pyrrolidine-1-carboxylic acid benzyl ester
HPLC Rt=1]3.2-14.3 mins (>90%), HPLC-MS 618.2 [M+H]+.
EXAMPLE 155
(3aS,6aR)-(2R)-2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-pyrrolidine-1-carboxylic acid benzyl ester
HPLC Rt=13.2-14.2 mins (>90%), HPLC-MS 618.2 [M+H]+.
EXAMPLE 156
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-((2S)-pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=8.82 mins (>85%), HPLC-MS 484.2 [M+H]+, 967.4 [2M+H]+.
EXAMPLE 157
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-((2R)-pyrrolidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=7.3-9.1 mins (>85%), HPLC-MS 484.2 [M+H]+, 502.2 [M+H+H2O]+, 985.4 [2M+H+H2O]+.
EXAMPLE 158
(3aS,6aR)-((S)-1-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-2-methyl-propyl)-carbamic acid benzyl ester
HPLC Rt=15.18 mins (>85%), HPLC-MS 620.3 [M+H]+.
EXAMPLE 159
(3aS,6aR)-((1S)-1-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-propyl)-carbamic acid benzyl ester
HPLC Rt=14.22 mins (>85%), HPLC-MS 606.2 [M+H]+.
EXAMPLE 160
(3aS,6aR)-((1S)-1-Benzyl-2-{-[(2S)-2-(4-dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-2-oxo-ethyl)-carbamic acid benzyl ester
HPLC Rt=16.23 mins (>80%), HPLC-MS 668.2 [M+H]+.
EXAMPLE 161
(3 aS,6aR)-((1S,2S)-1-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-2-methyl-butyl)-carbamic acid benzyl ester
HPLC Rt=16.17 mins (>90%), HPLC-MS 634.3 [M+H]+.
EXAMPLE 162
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.01 mins (>90%), HPLC-MS 458.2 [M+H]+, 937.4 [2M+Na]+.
EXAMPLE 163
(3aR,6aS)-N-{(1S)-1-[4-((2R)-2-Amino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=6.9-8.3 mins (>90%), HPLC-MS 458.2 [M+H]+, 937.4 [2M+Na]+.
EXAMPLE 164
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(thiophene-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=11.0-12.0 mins (>90%), HPLC-MS 497.2 [M+H]+, 515.2 [M+H+H2O]+.
EXAMPLE 165
(3aR,6aS)-N-{(1S)-[4-(3-Acetylamino-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=10.94 mins (>80%), HPLC-MS 554.2 [M+H]+, 572.2 [M+H+H2O]+.
EXAMPLE 166
(3aR,6aS)-N-{(1S)-1-[4-(5-Chloro-thiophene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=13.83 mins (>95%), HPLC-MS 531.1/533.1 [M+H]+, 549.1/551.1 [M+H+H2O]+.
EXAMPLE 167
(3aS,6aR)-4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide
HPLC Rt=11.4-12.1 mins (>95%), HPLC-MS 506.2 [M+H]+.
EXAMPLE 168
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(2-trifluoromethoxy-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=14.42 mins (>85%), HPLC-MS 575.2 [M+H]+, 593.2 [M+H+H2O]+.
EXAMPLE 169
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-hydroxy-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=7.77 mins (>50%), HPLC-MS 507.2 [M+H]+.
EXAMPLE 170
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]methyl-benzamide
HPLC Rt=14.35 mins (>90%), HPLC-MS 462.2 [M+H]+, 945.3 [2M+Na]+.
EXAMPLE 171
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-ethyl-benzamide
HPLC Rt=15.40 mins (>90%), HPLC-MS 476.2 [M+H]+, 973.4 [2M+Na]+.
EXAMPLE 172
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-isopropyl-benzamide
HPLC Rt=16.41 mins (>85%), HPLC-MS 490.2 [M+H]+.
EXAMPLE 173
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-trifluoromethoxy-benzamide
HPLC Rt=16.44 mins (>90%), HPLC-MS 532.1 [M+H]+.
EXAMPLE 174
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=13.30 mins (>90%), HPLC-MS 448.2 [M+H]+, 470.1 [M+Na]+, 917.2 [2M+Na]+.
EXAMPLE 175
(3aS,6aR)-4-[(2S)-2-(3-Aminomethyl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide
HPLC Rt=10.69 mins (>95%), HPLC-MS 492.2 [M+H]+, 983.4 [2M+H]+.
EXAMPLE 176
(3aR,6aS)-3-Aminomethyl-N-{(1S)-3-methyl-1-[6-oxo-4-((2R)-2-phenyl-propionyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.2-13.8 mins (>90%), HPLC-MS 505.2 [M+H]+, 523.2 [M+H+H2O]+.
EXAMPLE 177
(3aR,6aS)-3-Aminomethyl-N-{(1S)-3-methyl-1-[6-oxo-4-((2S)-2-phenyl-propionyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=11.9-13.5 mins (>85%), HPLC-MS 505.2 [M+H]+.
EXAMPLE 178
(3aR,6aS)-3-Aminomethyl-N-((1S)-1-{4-[2-(2-fluoro-phenyl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-benzamide
HPLC Rt=11.65 mins (>90%), HPLC-MS 509.2 [M+H]+.
EXAMPLE 179
(3aR,6aS)-3-Aminomethyl-N-((1S)-1-{4-[2-(3-fluoro-phenyl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-benzamide
HPLC Rt=11.70 mins (>95%), HPLC-MS 509.2 [M+H]+.
EXAMPLE 180
(3aR,6aS)-3-Aminomethyl-N-((1S)-1-{4-[2-(4-fluoro-phenyl)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-benzamide
HPLC Rt=11.74 mins (>95%), HPLC-MS 509.2 [M+H]+.
EXAMPLE 181
(3aR,6aS)-3-Aminomethyl-N-{(1S)-1-[4-((2R)-2-amino-2-phenyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=8.93 mins (>50%), HPLC-MS 506.2 [M+H]+, 524.2 [M+H+H2O]+.
EXAMPLE 182
(3aR,6aS)-3-Aminomethyl-N-{(1S)-1-[4-((2S)-2-amino-2-phenyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl}-benzamide
HPLC Rt=7.2-9.3 mins (>60%), HPLC-MS 506.2 [M+H]+, 524.2 [M+H+H2O]+.
EXAMPLE 183
(3aS,6aR)-(2-{4-[(2S)-2-(4-Dimethylamino-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl}-2-oxo-ethyl)-carbamic acid methyl ester
HPLC Rt=7.96 mins (>95%), HPLC-MS 502.2 [M+H]+.
EXAMPLE 184
(3aR,6aS)-4-Dimethylamino-N-((1S)-3-methyl-1-{6-oxo-4-[2-(toluene-sulfonylamino)-acetyl]-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-butyl)-benzamide
HPLC Rt=13.40 mins (>90%), HPLC-MS 598.2 [M+H]+.
EXAMPLE 185
(3aR,6aS)-3-Aminomethyl-N-{(1S)-1-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=9.4-10.4 mins (>85%), HPLC-MS 555.2 [M+H]+, 573.2 [M+H+H2O]+.
EXAMPLE 186
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-cyclopropylmethyl-2-oxo-ethyl]-4-dimethylamino-benzamide
HPLC Rt=11.0-13.0 mins (>85%), HPLC-MS [489.2 M+H]+, 507.2 [M+H+H2O]+.
EXAMPLE 187
(3aR,6aS)-Thiophene-3-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclopropylmethyl-2-oxo-ethyl]-amide
HPLC Rt=12.10 mins (>80%), HPLC-MS 452.1 [M+H]+, 925.2 [2M+Na]+.
EXAMPLE 188
(3aR,6aS)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-4-(3,4-dihydro-1H-isoquinolin-2-yl)-2-isobutyl-butane-1,4-dione
HPLC Rt=15.1-16.5 mins (>80%), HPLC-MS 502.1 [M+H]+, 520.2 [M+H+H2O]+.
EXAMPLE 189
(3aS,6aR)-1-Benzoyl-4-(2-biphenyl-3-yl-4-methyl-pentanoyl)-hexahydro-pyrrolo[3,2-b]pyrrol-3-one
HPLC Rt=18.1-20.1 mins (>80%), HPLC-MS 481.2 [M+H]+, 499.2 [M+H+H2O]+, 983.3 [2M+Na]+.
EXAMPLE 190
(3aS,6aR)-4-(2S-2-(4-tert-Butyl-benzoylamino)-4-methyl-pentanoyl]-3-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carboxylic acid phenylamide
HPLC Rt=16.9-18.4 mins (>85%), HPLC-MS 519.2 [M+H]+.
EXAMPLE 191
(3aR,6aS)-4-tert-Butyl-N-{(1S)-3-methyl-1-[4-(4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=16.3-17.5 mins (>85%), HPLC-MS 498.2 [M+H]+.
EXAMPLE 192
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide
HPLC Rt=16.19 mins (>90%), HPLC-MS 513.3 [M+H]+.
EXAMPLE 193
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-pyrrolidin-1-yl-benzamide
HPLC Rt=17.45 mins (>85%), HPLC-MS 517.1 [M+H]+, 535.2 [M+H+H2O]+.
EXAMPLE 194
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-piperazin-1-yl-benzamide
HPLC Rt=11.50 mins (>95%), HPLC-MS 532.1 [M+H]+, 550.2 [M+H+H2O]+.
EXAMPLE 195
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-N-methyl-benzamide
HPLC Rt=18.29 mins (>50%), HPLC-MS 505.1 [M+H]+.
EXAMPLE 196
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-butyl]-4-dimethylamino-benzamide
HPLC Rt=11.09 mins (>80%), HPLC-MS 477.1 [M+H]+, 495.1 (M+H+H2O]+.
EXAMPLE 197
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.06 mins (>90%), HPLC-MS 500.1 [M+H]+, 518.2 (M+H+H2O]+.
EXAMPLE 198
(3aR,6aS)-N-{(1S)-1-[4-(2-Amino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=7.93 mins (>90%), HPLC-MS 444.1 [M+H]+.
EXAMPLE 199
(3aR,6aS)-N-{(1S)-1-[4-(2-Acetylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.1 mins (>90%), HPLC-MS 486.1 [M+H]+.
EXAMPLE 200
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(2-methylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=7.89 mins (>90%), HPLC-MS 458.2 [M+H]+.
EXAMPLE 201
(3aR,6aS)-N-((1S)-1-{4-[2-(Acetyl-methyl-amino)-acetyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-dimethylamino-benzamide
HPLC Rt=8.89 mins (>90%), HPLC-MS 500.2 [M+H]+.
EXAMPLE 202
(3aR,6aS)-N-{(1S)-1-[4-(3-Acetylamino-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.57 mins (>90%), HPLC-MS 500.1 [M+H]+.
EXAMPLE 203
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.29 mins (>90%), HPLC-MS 472.2 [M+H]+.
EXAMPLE 204
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Acetylamino-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=10.45 mins (>90%), HPLC-MS 514.2 [M+H]+.
EXAMPLE 205
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-3-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.92 mins (>90%), HPLC-MS 486.2 [M+H]+.
EXAMPLE 206
(3aR,6aS)-N-{(1S)-1-[((2S)-2-Amino-3-hydroxy-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=7.56 mins (>90%), HPLC-MS 474.1 [M+H]+.
EXAMPLE 207
(3aR,6aS)-N-{(1S)-1-[4-((2S,3R)-2-Amino-3-hydroxy-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.00 mins (>80%), HPLC-MS 488.1 [M+H]+.
EXAMPLE 208
(3aR,6aS)-N-{(1S)-1-[4-((2S,3S)-2-Amino-3-hydroxy-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.13 mins (>85%), HPLC-MS 488.1 [M+H]+.
EXAMPLE 209
(3aR,6aS)-N-{(1S)-1-[4-((2S,3S)-2-Amino-3-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=10.97 mins (>90%), HPLC-MS 500.2 [M+H]+.
EXAMPLE 210
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=10.32 mins (>90%), HPLC-MS 486.2 [M+H]+.
EXAMPLE 211
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-3,3-dimethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.14 mins (>90%), HPLC-MS 500.2 [M+H]+.
EXAMPLE 212
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-4,4-dimethyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.01 mins (>90%), HPLC-MS 514.2 [M+H]+.
EXAMPLE 213
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.83 mins (>95%), HPLC-MS 514.2 [M+H]+.
EXAMPLE 214
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Acetylamino-5-methyl-hexanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=14.18 mins (>95%), HPLC-MS 556.2 [M+H]+.
EXAMPLE 215
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-3-cyclohexyl-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=13.54 mins (>95%), HPLC-MS 540.2 [M+H]+.
EXAMPLE 216
(3aR,6aS)-N-{(1S)-1-[4-((2S)-1-Acetyl-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.88 mins (>95%), HPLC-MS 526.2 [M+H]+.
EXAMPLE 217
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-((2S)-piperidine-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=9.12 mins (>90%), HPLC-MS 498.2 [M+H]+, 995.3 [2M+H]+.
EXAMPLE 218
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-((2S,4R)-4-hydroxy-pyrrolidine-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=8.00 mins (>90%), HPLC-MS 500.2 [M+H]+, 999.3 [2M+H]+.
EXAMPLE 219
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-3-benzyloxy-propionyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.6-12.7 mins (>85%), HPLC-MS 564.2 [M+H]+.
EXAMPLE 220
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-((2S)-4-methyl-2-methylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.12 mins (>90%), HPLC-MS 514.2 [M+H]+.
EXAMPLE 221
(3aR,6aS)-N-((1S)-1-{4-[(2S)-2-(Acetyl-methyl-amino)-4-methyl-pentanoyl]-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl}-3-methyl-butyl)-4-dimethylamino-benzamide
HPLC Rt=13.37 mins (>50%), HPLC-MS 556.2 [M+H]+.
EXAMPLE 222
(3aR,6aS)-N-{(1S)-1-[4-(1-Amino-cyclopropanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.16 mins (>50%), HPLC-MS 470.2 [M+H]+.
EXAMPLE 223
(3aR,6aS)-N-{(1S)-1-[4-(1-Amino-cyclobutanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.4-8.9 mins (>75%), HPLC-MS 484.2 [M+H]+.
EXAMPLE 224
(3aR,6aS)-N-{(1S)-1-[4-(1-Amino-cyclopentanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=8.5-8.9 mins (>40%), HPLC-MS 498.2 [M+H]+.
EXAMPLE 225
(3aR,6aS)-N-{(1S)-1-[4-(1-Amino-cyclohexanecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=9.1-9.5 mins (>25%), HPLC-MS 529.9 [M+H+H2O]+.
EXAMPLE 226
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-2-cyclohexyl-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=12.17 mins (>90%), HPLC-MS 526.2 [M+H]+.
EXAMPLE 227
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-dimethylamino-acetyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=7.7-8.1 mins (>90%), HPLC-MS 472.2 [M+H]+, 490.2 [M+H+H2O]+.
EXAMPLE 228
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-tert-butyl-benzamide
HPLC Rt=15.47 mins (>95%), HPLC-MS 513.2 [M+H]+.
EXAMPLE 229
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(2-methyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=11.4-11.5 mins (>80%), HPLC-MS 471.2 [M+H]+, 493.2 [M+Na]+.
EXAMPLE 230
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[4-(2-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.4-13.3 mins (>80%), HPLC-MS 485.2 [M+H]+.
EXAMPLE 231
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-(2-ethyl-butyryl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=12.34 mins (>80%), HPLC-MS 485.2 [M+H]+, 991.3 [2M+Na]+.
EXAMPLE 232
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(2-propyl-pentanoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=14.75 mins (>90%), HPLC-MS 513.2 [M+H]+.
EXAMPLE 233
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-[4-((2S)2-hydroxy-4 methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-benzamide
HPLC Rt=12.04 mins (>95%), HPLC-MS 501.2 [M+H]+, 519.2 [M+H+H2O]+.
EXAMPLE 234
(3aR,6aS)-4-Dimethylamino-N-[(1S)-1-(4-hexanoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-benzamide
HPLC Rt=13.24 mins (>95%), HPLC-MS 485.2 [M+H]+, 503.2 [M+H+H2O]+.
EXAMPLE 235
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(pyrrolidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=11.06 mins (>95%), HPLC-MS 484.1 [M+H]+, 989.3 [2M+Na]+.
EXAMPLE 236
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(piperidine-1-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=12.21 mins (>95%), HPLC-MS 498.2 [M+H]+, 516.3 [M+H+H2O]+.
EXAMPLE 237
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(pyrrolidine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=8.13 mins (>95%), HPLC-MS 484.1 [M+H]+, 502.2 [M+H+H2O]+.
EXAMPLE 238
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(tetrahydro-furan-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=9.89 mins (>95%), HPLC-MS 485.1 [M+H]+, 503.1 [M+H+H2O]+.
EXAMPLE 239
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(tetrahydro-furan-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=10.40 mins (>90%), HPLC-MS 485.1 [M+H]+, 503.1 [M+H+H2O]+.
EXAMPLE 240
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(2-piperidinyl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=8.8-9.6 mins (>90%), HPLC-MS 512.2 [M+H]+, 530.2 [M+H+H2O]+.
EXAMPLE 241
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(2-piperazin-1-yl-acetyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=7.3-8.2 mins (>85%), HPLC-MS 513.1 [M+H]+, 531.2 [M+H+H2O]+.
EXAMPLE 242
(3aR,6aS)-4-Dimethylamino-N-{(1S)-3-methyl-1-[6-oxo-4-(piperidine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-butyl}-benzamide
HPLC Rt=8.2-8.9 mins (>90%), HPLC-MS 498.2 [M+H]+, 516.2 [M+H+H2O]+, 995.3 [2M+H]+,
EXAMPLE 243
(3aR,6aS)-N-{(1S)-1-[4-(Cyclopent-3-enecarbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.39 mins (>95%), HPLC-MS 481.2 [M+H]+, 983.3 [2M+Na]+.
EXAMPLE 244
(3aR,6aS)-N-{(1S)-1-[4-(5-Chloro-furan-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=13.17 mins (90%), HPLC-MS 515.1 [M+H]+, 537.1 [M+Na]+.
EXAMPLE 245
(3aR,6aS)-N-{(1S)-1-[4-((2S)-2-Acetylamino-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-4-dimethylamino-benzamide
HPLC Rt=11.18 mins (>90%), HPLC-MS 528.2 [M+H]+.
EXAMPLE 246
(3aR,6aS)-3-Aminomethyl-N-{(1S)-1-[4-((2S)-2-amino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl}-benzamide
HPLC Rt=8.87 mins (>95%), HPLC-MS 486.2 [M+H]+, 971.4 [2M+H]+.
EXAMPLE 247
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-3-piperazin-1-yl-benzamide
HPLC Rt=10.92 mins (>85%), HPLC-MS 532.1 [M+H]+, 550.2 [M+H+H2O]+.
EXAMPLE 248
(3aS,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-2-oxa-1,4-diaza-pentalene-1-carbonyl)-3-methyl-butyl]-4-dimethylamino-benzamide
HPLC Rt=13.18 mins (>95%), HPLC-MS 493.1 [M+H]+, 511.1 [M+H+H2O]+.
EXAMPLE 248 was prepared following the general methods detailed for EXAMPLE 1, but using an alternative building block (3aS,6aS)-6-oxo-tetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (91) prepared following general Scheme 5 and Scheme 22. Following solid phase synthesis, the crude product was purified by semi-preparative HPLC and lyophilised to give EXAMPLE 248.
Preparation of (S)-2,5-dihydropyrrole-1,2-dicarboxylic Acid 1-tert-butyl ester 2-methyl ester (85)
Ethereal diazomethane [˜23 mmol generated from addition of diazald (7.1 g,) in diethyl ether (115 ml) onto sodium hydroxide (8.0 g) in water (14 ml)/ethanol (28 ml) at 65° C.] was added in portions to a stirred solution of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester (71) (ex Bachem, 4.98 g, 23.4 mmol) in dichloromethane (100 ml) at 0° C. over 5 minutes. The solution was stirred for 1 hour at 0° C. then glacial acetic acid (0.5 ml) was added dropwise. The product was extracted into dichloromethane (50 ml) then washed with saturated aqueous sodium hydrogen carbonate solution (100 ml), water (100 ml) and brine (100 ml). The organic layer was dried (Na2SO4) and the solvents removed in vacuo to obtain (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester (85) (4.66 g, 88%), which was used without further purification. TLC (Single spot, Rf=0.25, EtOAc:heptane 1:4), HPLC-MS 172.1 [M+2H−Bu]+, 250.1 [M+Na]+, 477.2 [2M+Na]+; C11H17NO4.0.4H2O req. (fnd.) % C 56.38 (56.47), % H 7.66 (7.25), % N 5.97 (5.88).
Preparation of (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (86)
Methanol (1.66 ml, 41 mmol) was added dropwise to a stirred suspension of lithium borohydride (0.90 g, 41 mmol) in tetrahydrofuran (20 ml) over 2 minutes under an atmosphere of argon, followed by a solution of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester (85) (4.65 g, 20.5 mmol) in tetrahydrofuran (50 ml) over 15 minutes. The mixture was stirred for 70 minutes then poured into water (125 ml). The product was extracted into dichloromethane (3×100 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 15:85 to 25:75 to give (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (86) as a colourless oil (3.75 g, 92%), [a]D22 −136° (c=1, CHCl3). TLC (Single spot, Rf=0.30, EtOAc:heptane 2:3), HPLC-MS 222.1 [M+Na]+, 421.1 [2M+Na]+; C10H17NO3.0.3H2O req. (fnd.) % C 58.72 (58.82), % H 8.67 (8.35), % N 6.85 (6.88); dH (500 MHz, CDCl3) mixture of rotamers (major:minor=4:1) 1.47 and 1.49 (9H total, each s, (CH3)3C), 3.55 (0.8H, ddd, J=11.1, 7.7, 1.1 Hz, CH2OH major), 3.61-3.66 (0.2H, m, CH2OH minor), 3.77 (1H, m, CH2OH), 3.95-4.09 (1H, m, H-5), 4.14-4.19 (0.8H, m, H-5 major), 4.24-4.30 (0.2H, m, H-5 minor), 4.58 (0.2H, br. s, H-2 minor), 4.64 (1H, m, OH), 4.69-4.75 (0.8H, m, H-2 major), 5.57-5.63 and 5.78-5.82 (each 0.8H, m, H-3 and H-4 major), 5.65-5.70 and 5.89-5.94 (each 0.2H, m, H-3 and H-4 minor).
Alternative preparation of (S)-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (86)
A solution of diisobutylaluminium hydride (1.0M in tetrahydrofuran, 18.7 ml, 18.7 mmol) was added dropwise to a stirred solution of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester (85) (ex Bachem, 1.06 g, 4.67 mmol) in tetrahydrofuran (15 ml) at −70° C. over 45 minutes under an atmosphere of argon. The mixture was stirred for 15 minutes at −70° C. then at ambient temperature for 3.25 hours before cooling to 0° C. and adding ethyl acetate (10 ml) dropwise followed by saturated aqueous sodium potassium tartrate solution (60 ml), ethyl acetate (65 ml) and brine (60 ml). The organic layer was separated then the aqueous layer extracted with ethyl acetate (60 ml). The organic layers were combined then washed with brine (50 ml), dried (MgSO4), and solvents removed in vacuo to leave a residue which was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 15:85 to 25:75 to give (S)-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (86) as a colourless oil (0.34 g, 36%), [a]D22 −120.5° (c=1, CHCl3). TLC (Single spot, Rf=0.30, EtOAc:heptane 2:3), analytical HPLC Rt=9.375 min; HPLC-MS 222.1 [M+Na]+, 421.2 [2M+Na]+.
Preparation of (S)—(N′-benzyloxycarbonylaminooxymethyl)-2,5-dihydro pyrrole-1-carboxylic acid tert-butyl ester (87)
i) Pyridine (7.6 ml, 94.2 mmol) was added to a solution of (S)-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (86) (3.75 g, 18.8 mmol) in dichloromethane whilst stirring at 0° C. followed by methanesulfonyl chloride (1.53 ml, 19.8 mmol) in portions over 10 minutes. The mixture was stirred for 1 hour at 0° C. then at ambient temperature for 14 hours. The product was extracted into dichloromethane (250 ml), washed with ice-chilled hydrochloric acid (1M, 2×125 ml) and aqueous saturated sodium hydrogen carbonate solution (125 ml), dried (Na2SO4), and solvents removed in vacuo to leave (S)-methanesulfonyloxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester as an oily residue (5.2 g, 100%) which was used without further purification. TLC (Single spot, Rf=0.20, EtOAc:heptane 3:7), analytical HPLC Rt=12.785 min; HPLC-MS 222.0 [M+2H−Bu]+, 577.1 [2M+Na]+; dH (500 MHz, CDCl3) mixture of rotamers (major:minor=4:3) 1.45 and 1.49 (9H total, each s, (CH3)3C), 2.96 (3H, s, SO2CH3), 4.02-4.03 (0.43H, m, H-5 minor), 4.04-4.07 (0.57H, m, H-5 major), 4.12-4.57 (3H, m, H-5, CH2OS), 4.67 (0.43H, br. s, H-2), 4.74 (0.57H, br. s, H-2), 5.73-5.98 (2H, m, H-3 and H-4); dC (125 MHz, CDCl3) 28.41 (C(CH3)3), 36.99, 37.46 (SCH3), 53.80, 53.95 (C-5), 62.90, 63.02 (C-2), 69.14, 69.34 (CH2OS), 80.12, 80.62 (C(CH3)3), 126.08, 126.16 and 128.27, 128.36 (C-3 and C-4), 153.73, 154.13 (q, NC═O).
ii) Sodium hydride (60% dispersion in oil, 3.0 g, 75.1 mmol) was added to a stirred solution of benzyl N-hydroxycarbamate (13.2 g, 78.8 mmol) in tetrahydrofuran (200 ml) at 0° C. in portions over 30 minutes under an atmosphere of argon. The mixture was stirred for 5 minutes at 0° C. then a solution of (S)-methanesulfonyloxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (5.2 g, 18.6 mmol, prepared as above) in tetrahydrofuran (175 ml) was added dropwise over 15 minutes. The resulting cloudy suspension was stirred for 1 hour at ambient temperature then at 65° C. for 4 hours, followed by 14 hours at ambient temperature then 7 hours at 65° C. The product was extracted into dichloromethane (250 ml) then cautiously washed with water (250 ml). The aqueous layer was extracted with dichloromethane (250 ml) then the combined organic layers washed with water (3×150 ml) and brine (250 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified twice by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 25:75 to 30:70 then 0:100 to 25:75 to give (S)—(N′-benzyloxy carbonylaminooxymethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (87) as a colourless oil (1.67 g, 26%) together with recovered (S)-methanesulfonyloxymethyl-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (2.44 g, 47%). Data for (S)—(N′-benzyloxycarbonylaminooxymethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (87). TLC (Single spot, Rf=0.35, EtOAc:heptane 2:3), analytical HPLC Rt=17.141 min; HPLC-MS 349.1 [M+H]+, 371.1 [M+Na]+, 719.2 [2M+Na]+; Elemental analysis C18H24N2O5 req. (fnd.) % C 62.05 (62.18), % H 6.94 (7.05), % N 8.04 (7.90); HRMS C18H24N2O5Na req. 371.1583, fnd. 371.1590 (1.83 ppm); dH (500 MHz, CDCl3) mixture of rotamers (major:minor=2:1) 1.46 (9H, s, (CH3)3C), 3.67 (0.67H, dd, J=11.45 and 7.6 Hz, CH2ONH major), 3.89 (0.33H, dd, J=10.2 and 6.2 Hz, CH2ONH minor), 3.99 (0.67H, dd, J=11.45 and 3.7 Hz, CH2ONH major), 3.95-4.10 (1H, m, H-5), 4.08-4.13 (0.33H, m, CH2ONH minor), 4.21 (0.67H, dd, J=15.7 and 1.8 Hz, H-5 major), 4.20-4.26 (0.33H, m, H-5, minor), 4.63 (0.33H, br. s, H-2 minor), 4.85-4.90 (0.67H, m, H-2 m, major), 5.13-5.18 (2H, m, OCH2Ph), 5.68-5.73 and 5.82-5.87 (2H, m, H-3 and H-4), 7.30-7.37 (5H, aromatics), 7.52 (0.33H, br. s, NH, minor), 8.69 (0.67H, br. s, NH, major); dC (125 MHz, CDCl3) 28.40 (C(CH3)3), 53.57, 53.78 (C-5), 62.18, 62.76 (C-2), 67.13, 67.55 (OCH2Ph), 77.27, 77.86 (CH2ONH), 80.07 (C(CH3)3), 126.62, 126.72, 127.47, 127.85, 128.12, 128.24, 128.50, 128.54, 128.58 (C-3, C-4, aromatic CH), 135.48, 135.87, 136.18 (aromatic quaternary), 154.04, 155.24 (CH2NC═O), 156.94, 157.39 (ONC═O).
Preparation of (2R)-(N′-benzyloxycarbonylaminooxymethyl)-oxa-3-aza bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (88)
meta-Chloroperoxybenzoic acid (57-86%, 1.9 g, ˜7.7 mmol) was added in portions under an atmosphere of argon over 15 minutes to a stirred solution of (S)—(N′-benzyloxycarbonylaminooxymethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (87) (600 mg, 1.72 mmol) in dichloromethane (12 ml). The mixture was stirred for 14 hours then the product was extracted into dichloromethane (50 ml), washed with aqueous saturated sodium hydrogen carbonate solution (2×30 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane 0:100 to 30:70 to give (2R)-(N′-benzyloxycarbonylaminooxymethyl)-6-oxa-3azabicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (88) as a colourless oil (390 mg, 62%). TLC (Single spot, Rf=0.35, EtOAc:heptane 2:3), analytical HPLC Rt=15.733 min; HPLC-MS 265.1 [M+2H−Boc]+, 309.0 [M+2H−Bu]+, 387.1 [M+Na]+, 751.2 [2M+Na]+; C18H24N2O6.0.4H2O req. (fnd.) % C 58.21 (58.24), % H 6.73 (6.62), % N 7.54 (7.57); HRMS C18H24N2O6Na req. 387.1532, fnd. 387.1534 (0.42 ppm).
Preparation of (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (89)
Potassium carbonate (1.06 g, 7.7 mmol) was added to a stirred solution of (2R)-(N′-benzyloxycarbonylaminooxymethyl)-6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (88) (280 mg, 0.77 mmol) in acetonitrile (4 ml) under an atmosphere of argon. The suspension was stirred for 5 hours then the product was extracted into dichloromethane (30 ml) and washed with water (10 ml). The aqueous layer was extracted with dichloromethane (10 ml) then the combined organic layers washed with water (10 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 30:70 to give (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (89) as a colourless oil (141 mg, 50%) together with recovered (1S,2R,5R)-2-(N′-benzyloxycarbonylaminooxymethyl)-6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (88) as a colourless oil (71 mg, 25%). Data for (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (89). TLC (Single spot, Rf=0.20, EtOAc:heptane 2:3), analytical HPLC Rt=14.994 min; HPLC-MS 265.1 [M+2H−Boc]+, 309.1 [M+2H−Bu]+, 751.2 [2M+Na]+; HRMS C18H24N2O6Na req. 387.1532, fnd. 387.1529 (−0.87 ppm); dH (500 MHz, CDCl3) mixture of rotamers, tentative proton assignment, 1.45 (9H, s, C(CH3)3), 2.28 (1H, d, J=3.9 Hz, OH), 3.45-4.81 (7H, m, BocNCHCH2, BocNCH, BocNCH2, CHOH, CbzNCH), 5.12-5.26 (2H, m, OCH2Ph), 7.32-7.42 (5H, aromatics). Data for (1S,2R,5R)-2-(N′-benzyloxycarbonylaminooxymethyl)-6-oxa-3-azabicyclo[3.1.0]hexane-3 caboxylic acid tert-butyl ester (88). TLC (Single spot, Rf=0.35, EtOAc:heptane 40:60), HPLC-MS 265.1 [M+2H−Boc]+, 309.1 [M+2H−Bu]+, 387.1 [M+Na]+, 751.2 [2M+Na]+; dH (500 MHz, CDCl3) mixture of rotamers, tentative proton assignment, 1.41 (9H, s, C(CH3)3), 3.39-3.72 (3H, m, H-2 and H-5), 3.90-4.41 (4H, m, H-3, H-4 and CH2ON), 5.12-5.20 (2H, m, OCH2Ph), 7.31-7.39 (5H, aromatics), 7.60 and 8.0 (0.8H total, each br. s, NH).
Preparation of (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (90)
Ethanol (2.5 ml) was cautiously added to a stirred mixture of (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (89) (43 mg, 0.118 mmol) and 10% palladium on charcoal (5 mg) under an atmosphere of argon at 0° C. The argon was replaced by hydrogen then the suspension was stirred at ambient temperature for 45 minutes then the hydrogen was replaced by argon before filtering the mixture through celite in vacuo. The filter cake was washed with ethanol (25 ml) then solvents removed in vacuo from the filtrate to leave (3aS,6S,6aS)-6-hydroxyhexahydro-2-oxa-1,4-diazapentalene-4-carboxylic acid tert-butyl ester as an oily residue (28 mg), which was used without further purification. HPLC-MS 175.1 [M+2H−Bu]+, 483.2 [2M+Na]+. A solution of sodium carbonate (31 mg, 0.295 mmol) in water (1.75 ml) was added whilst stirring to a solution of (3aS,6S,6aS)-6-hydroxyhexahydro-2-oxa-1,4-diazapentalene-4-carboxylic acid tert-butyl ester (28 mg) in 1,4-dioxane (1.0 ml). The mixture was cooled to 0° C. then a solution of Fmoc-Cl (34 mg, 0.132 mmol) in 1,4-dioxane (0.75 ml) was added dropwise over 40 minutes. The mixture was stirred at 0° C. for 2.25 hours then at ambient temperature for 30 minutes. Water (20 ml) was added then the product extracted into dichloromethane (3×15 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 30:70 to give (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (90) as a white solid (40 mg, 75%). TLC (Single spot, Rf=0.20, EtOAc:heptane 3:7), analytical HPLC Rt=18.217 min; HPLC-MS 475.1 [+Na]+, 927.2 [2M+Na]+; C25H28N2O6.0.5EtOAc req. (fnd.) % C 65.35 (64.85), % H 6.50 (6.21), % N 5.64 (5.66).
Preparation of (3aS,6aS)-6-oxo-tetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (91)
Dess-Martin periodinane (73 mg, 0.170 mmol) was added to a stirred solution of (3aS,6S,6aS)-6-hydroxytetrahydro-2-oxa-1,4-diazapentalene-1,4-dicaboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (90) (39 mg, 0.086 mmol) in dichloromethane (1.25 ml). The mixture was stirred for 2.5 hours, stored at −80° C. for 14 hours, and then purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 5:95 to 15:85 to give (3aS,6aS)-6-oxo-tetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (91) as a white solid (31 mg, 80%). TLC (Single spot, Rf=0.30, EtOAc:heptane 2:3), analytical HPLC broad peak Rt=19.57-22.15 min; HPLC-MS single broad main UV peak, 473.1 [M+Na]+, 491.1 [M+H2O+Na]+, 923.1 [2M+Na]+, 959.1 [2M+2H2O+Na]+; HRMS C25H26N2O6Na req. 473.1689, fnd. 473.1690 (0.24 ppm); dH (500 MHz, CDCl3) mixture of rotamers major:minor 1.5:1, 1.48 (5.4H, s, C(CH3)3 major), 1.50 (3.6H, s, C(CH3)3 minor), 3.49-3.58 (1H, m, BocNCHCH2), 3.78-3.92 (2H, m, BocNCH2), 4.13 (0.4H, d, J=9.5 Hz, BocNCHCH2 [minor]), 4.20-4.29 (1.6H, m, Fmoc-CH and BocNCHCH2 [major]), 4.46-4.52 (1H, m, Fmoc-CH2), 4.60-4.74 (2.4H, m, Fmoc-CH2, FmocNCH, BocNCH [minor]), 4.83 (0.6H, dd, J=7.5 and 4.3 Hz, BocNCH [major]), 7.29-7.78 (8H, aromatic); dC (125 MHz, CDCl3) 28.38, 28.31 (C(CH3)3), 46.96, 47.05 (Fmoc-CH), 52.40, 52.93 (BocNCH2), 61.95 (BocNCH), 64.48, 65.31 (FmocNCH), 68.59, 68.76 (Fmoc-CH2), 77.17, 77.31 (BocNCHCH2), 81.61 (C(CH3)3), 120.02, 125.11, 125.35, 127.21, 127.28, 127.98 (Fmoc aromatic CH), 141.29, 141.33, 143.04, 143.12 (Fmoc quaternary), 153.09, 154.00 (Boc C═O), 157.64 (Fmoc C═O), 204.85, 205.44 (C═O).
Broadly following the general details from Scheme 6, the required bicycle building block (3aS,6aS)-6-oxo-tetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (91) was converted to the corresponding equivalent of building block-linker construct (27) (where Pg2 is tert-butoxycarbonyl) as follows:
- A solution of sodium acetate trihydrate (24 mg, 0.173 mmol) in water (0.25 ml) was added to a solution of (3aS,6aS)-6-oxo-tetrahydro-2-oxa-1,4-diazapentalene-1,4-dicarboxylic acid 4-tert-butyl ester 1-(9H-fluoren-9-ylmethyl) ester (91) (26 mg, 0.058 mmol) and 4-[[(hydrazinocarbonyl)amino]methyl]cyclohexane carboxylic acid. trifluoroacetate (Murphy, A. M., et al, J. Am. Chem. Soc, 114, 3156-3157, 1992) (38 mg, 0.116 mmol) in ethanol (1.75 ml). The reaction heated at 75° C. in a sealed tube for 1.5 hour. The product was extracted into chloroform (50 ml) then washed with hydrochloric acid (0.1M, 2×25 ml), saturated aqueous sodium chloride solution (30 ml) then dried (Na2SO4) and the solvent removed in vacuo to leave the product as a white solid (37 mg, ˜100%). Analytical HPLC has main UV peaks with Rt=20.223 and 21.596 mins and HPLC-MS (main UV peaks each with 648.2 [M+H]+).
Following the general details from Scheme 6, the corresponding building block-linker construct was attached to the solid phase providing loaded building block-linker construct following standard loading protocols and indicated quantitative loading.
EXAMPLES 249a to 249c were prepared entirely by solution phase synthesis methods (broadly defined by the general strategy detailed in Scheme 4) following Schemes 23 to 25 and have utility as inhibitors of cathepsin K with Ki<1000 nM.
Preparation of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester (92)
Carbonic acid benzyl ester 2,5-dioxopyrrolidin-1-yl ester (8.45 g, 33.9 mmol) then triethylamine (10.8 ml, 77 mmol) were added dropwise to a stirred solution of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester hydrochloride (5.0 g, 30.6 mmol) and THF:water (1:1, 306 ml) at 0° C. The mixture was stirred at ambient temperature for 12 hours then half of the solvent was removed in vacuo. The product was extracted into tert-butyl methyl ether (3×100 ml) then the combined organic layers were washed with 5% hydrochloric acid (100 ml), 5% aqueous sodium hydrogen carbonate solution (100 ml) and brine (100 ml), dried (MgSO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with heptane:tert-butyl methyl ether 2:1 to give (S)-2,5-dihydro pyrrole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester (92) as a pale yellow oil (7.9 g, 99%). TLC (Rf=0.30, heptane:tert-butyl methyl ether 1:1), analytical HPLC single peak with Rt=13.935 min, HPLC-MS 262.0 [M+H]+, 284.0 [M+Na]+, 545.1 [2M+Na]+. δH (500 MHz, CDCl3) approximately 1:1 mixture of rotamers, 3.57 and 3.64 (3H, each s, OCH3), 4.22-4.36 (2H, m, H-5), 5.03-5.14 (3H, m, OCH2Ph and H-2), 5.69-5.78 and 5.92-5.99 (2H, each m, H-3 and H-4), 7.29-7.39 (5H, aromatics); δC (125 MHz, CDCl3) δ2.25 and 52.42 (OCH3), 53.36 and 53.85 (C-5), 66.25 and 66.56 (C-2), 67.09 and 67.16 (PhCH2O), 124.66, 127.80, 127.91, 127.98, 128.03, 128.40, 128.46, 129.09 and 129.18 (C-3, C-4 and aromatic CH), 136.43 and 136.51 (aromatic quaternary), 153.91 and 154.36 (NC═O), 170.38 and 170.62 (CHC═O).
Preparation of (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (93)
Diisobutylaluminium hydride (1.5M in toluene, 2.62 ml, 3.93 mmol) was added dropwise over 20 minutes to a stirred solution of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester (92) (0.41 g, 1.57 mmol) in THF (15 ml), at −78° C. under an atmosphere of argon. The mixture was stirred for 2 hours at −78° C. then at ambient temperature for 18 hours. Saturated aqueous potassium sodium tartrate solution (40 ml) was added slowly to the mixture, followed by ethyl acetate (40 ml) and magnesium sulphate ˜5 g. The resultant slurry was vigorously stirred for 2 hours, then filtered and the filter cake washed with ethyl acetate. The filtrate was concentrated in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane 1:4 to give (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (93) as a pale yellow oil (130 mg, 36%). TLC (Rf=0.30, heptane:ethyl acetate 1:1), analytical HPLC single peak with Rt=11.033 min, HPLC-MS 234.1 [M+H]+, 256.0 [M+Na]+, 489.1 [2M+Na]+. dH (500 MHz, CDCl3) approximately 4:1 mixture of rotamers, 3.58-3.66 (1H, m, CH2OH), 3.77-3.85 (1H, m, CH2OH), 4.14-4.32 (3H, m, CH2OH and H-5), 4.63-4.68 (0.2H, br. s, H-2 minor), 4.76-4.81 (0.8H, m, H-2 major), 5.14-5.21 (2H, m, OCH2Ph), 5.63-5.66 and 5.81-5.85 (1.6H, m, H-3 and H-4 major), 5.69-5.73 and 5.90-5.96 (0.4H, m, H-3 and H-4 minor), 7.29-7.39 (5H, aromatics); dC (125 MHz, CDCl3) δ3.98 (major) and 54.59 (minor) (C-5), 64.27 (minor) and 66.65 (major) (CH2OH), 66.11 (minor) and 68.08 (major) (C-2), 67.41 (PhCH2O), 126.67, 126.70, 126.96, 127.19, 127.40, 127.62, 127.95, 128.17, 128.54 and 128.60 (C-3, C-4 and aromatic CH), 136.30 (aromatic quaternary), 156.68 (NC═O).
Alternative preparation of (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (93)
Methanol (2.43 ml) followed by a solution of (S)-2,5-dihydropyrrole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester (92) (7.90 g, 30.2 mmol) in THF (125 ml) were added dropwise to a stirred suspension of lithium borohydride (1.32 g, 60.5 mmol) in THF (45 ml). The mixture was stirred for 1 hour then water (10 ml) cautiously added dropwise. The product was extracted into tert-butyl methyl ether (3×100 ml) then the combined organic layers dried (MgSO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with heptane:ethyl acetate 4:1 to give (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (93) as a pale yellow oil (6.38 g, 90%). TLC (Rf=0.30, heptane:ethyl acetate 1:1), analytical HPLC single peak with Rt=11.036 min, HPLC-MS 234.1 [M+H]+, 256.0 [M+Na]+, 489.1 [2M+Na]+.
Preparation of (S)-2-methanesulfonyloxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (94)
Triethylamine (337 μl, 2.4 mmol) was added dropwise to a stirred solution of (S)-2-hydroxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (93) (0.35 g, 1.50 mmol) and methanesulfonyl chloride (174 μl, 2.25 mmol) in dichloromethane (10 ml) at 0° C. The mixture was stirred for 30 minutes then washed with water (10 ml) and brine (10 ml), dried (Na2SO4), and the solvents removed in vacuo to give (S)-2-methanesulfonyloxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (94) as a pale yellow oil (443 mg, 95%) which was used without further purification. TLC (Rf=0.30, heptane:ethyl acetate 1:1), analytical HPLC single peak with Rt=14.115 min, HPLC-MS 312.0 [M+H]+, 334.0 [M+Na]+, 645.1 [2M+Na]+;
Preparation of (S)-2-azidomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (95)
Sodium azide (8.89 g, 137 mmol) was added to a stirred solution of (S)-2-methanesulfonyloxymethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (94) (8.52 g, 27.4 mmol) in DMF (150 ml). The reaction mixture was stirred at 110° C. for 1 hour. The solvent was removed in vacuo then the product extracted into ethyl acetate (300 ml), washed with water (300 ml), brine (200 ml), dried (MgSO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with heptane:ethyl acetate 9:1 to give (S)-2-azidomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (95) as a pale yellow oil (5.05 g, 72%). TLC (Rf=0.65, heptane:ethyl acetate 1:1), analytical HPLC single peak with Rt=17.855 min, HPLC-MS 259.0 [M+H]+, 281.0 [M+Na]+, 539.1 [2M+Na]+.
Preparation of (S)-2-aminomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (96)
Triphenylphosphine (3.20 g, 12.2 mmol) was added to a stirred solution of (S)-2-azidomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (95) (2.10 g, 8.13 mmol) in THF (170 ml) containing water (2 ml). The mixture was stirred at 50° C. for 2.5 hours then at ambient temperature 16 hours. The were solvents removed in vacuo then the residue was purified by flash chromatography over silica eluting with dichloromethane:methanol 99:1 to 95:5 mixtures to give (S)-2-aminomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (96) as a pale yellow oil (2.15 g) which was contaminated with triphenylphosphine oxide. The pale yellow oil was dissolved in tert-butyl methyl ether (15 ml) then cooled to 0° C. before adding HCl in 1,4-dioxane (4M, 5 ml) followed by iced-water (20 ml). The aqueous layer was extracted with tert-butyl methyl ether (3×20 ml), then the pH adjusted to ˜12 using 1M aqueous sodium hydroxide solution. The product was then extracted into dichloromethane (3×50 ml) and the combined dichloromethane layers were dried (MgSO4), and the solvents removed in vacuo to give (S)-2-aminomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (96) as a pale yellow oil (1.40 g, 74%). TLC (Rf=0.20, methanol:dichloromethane 1:9), HPLC-MS 233.1 [M+H]+, 255.1 [M+Na]+, 487.1 [2M+Na]+. dH (500 MHz, D6-DMSO) 1.30-2.10 (1H, br. s, CH2NH2), 3.00-3.70 (1H, br. s, CH2NH2), 2.64-2.75 (1H, m, CH2NH2), 2.79-2.88 (1H, m, CH2NH2), 4.00-4.21 (2H, m, H-5), 4.42-4.47 (1H, m, H-2), 5.05-5.16 (2H, m, PhCH2O), 5.84-6.01 (2H, m, H-4 and H-5), 7.31-7.40 (5H, aromatics); dC (125 MHz, D6-DMSO) 43.91 and 44.85 (CH2NH2), 53.86 and 54.47 (C-5), 65.81 and 65.99 (PhCH2O), 66.41 and 67.17 (C-2), 126.30, 126.36, 127.55, 127.58, 127.84, 127.86, 128.48, 128.51, 128.83 and 129.06 (C-3, C-4 and aromatic CH), 137.13 and 137.17 (aromatic quaternary), 153.82 and 153.97 (NC═O).
Preparation of (S)-2-(N′-allyloxycarbonylhydrazinomethyl)-2,5-dihydro pyrrole-1-carboxylic acid benzyl ester (97)
i) Preparation of 3-phenyloxaziridine-2-carboxylic Acid Allyl Ester
Ice-chilled sodium hydroxide (2M, 50 ml, 100 mmol) was added to a vigorously stirred solution of benzaldehyde (5.3 g, 50 mmol) in diethyl ether (50 ml) at ambient temperature, then ice-chilled solutions of hydroxylamine-O-sulfuric acid (6.0 g, 53 mmol) in water (50 ml) and sodium hydroxide (2M, 25 ml, 50 mmol) were added simultaneously over 20 minutes. Allyl chloroformate (5.31 ml, 50 mmol) was added dropwise over 5 minutes then the mixture was stirred at 0° C. for 10 minutes before separating the ethereal layer. The aqueous phase was extracted with diethyl ether (2×25 ml), then the combined organic layers stirred at 0° C. for 10 minutes with a solution of hydroxylamine-O-sulfuric acid (2.5 g, 21 mmol) in water (25 ml). The phases were separated, then the aqueous phase extracted with diethyl ether (2×25 ml). The combined ethereal layers were dried (MgSO4), and the solvents removed in vacuo. The brown oily residue was purified by flash chromatography over silica eluting with heptane:ethyl acetate 9:1 to give 3-phenyloxaziridine-2-carboxylic acid allyl ester as a pale yellow oil (1.44 g, 14%). TLC (Rf=0.7, heptane:ethyl acetate 1:1), HPLC-MS 206.0 [M+H]+, 228.1 [M+Na]+, 433.0 [2M+Na]+.
ii) 3-Phenyloxaziridine-2-carboxylic acid allyl ester (prepared as above, 1.16 g, 5.63 mmol) was added to a stirred solution of (S)-2-aminomethyl-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (96) (0.35 g, 1.50 mmol) in dichloromethane (10 ml). The mixture was stirred for 16 hours then the solvents were removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 1:4 to give (S)-2-(N′-allyloxycarbonylhydrazinomethyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (97) as a pale yellow oil (0.18 g, 36%). TLC (Rf=0.45, heptane:ethyl acetate 1:1), analytical HPLC Rt=14.789 min, HPLC-MS 332.1 [M+H]+, 354.1 [M+Na]+, 685.2 [2M+Na]+. dH (500 MHz, CDCl3) mixture of rotamers, tentative assignment of spectrum 2.73-3.40 (2H, m, CH2NHNH), 4.08-4.80 (5H, m, H-2, H-5 and CH2CH═CH2), 4.95-5.35 (4H, m, PhCH2O and CH2CH═CH2), 5.57-5.98 (3H, m, H-4, H-5 and CH2CH═CH2), 7.25-7.55 (5H, aromatics); dC (125 Mz, CDCl3) δ3.61, 53.65, 54.02 and 54.07 (C-5 and CH2NHNH), 65.24 (C-2), 65.87, 66.21, 66.43, 66.82 and 67.13 (CH2CH═CH2 and PhCH2O), 117.48, 117.83, 118.20 and 118.49 (CH2CH═CH2), 127.00, 127.13, 127.70, 127.79, 127.93, 128.02, 128.13, 128.33, 128.52 and 128.54 (C-3, C-4 and aromatic CH), 132.11, 132.17, 132.21, 132.46, 132.54 and 132.68 (CH2CH═CH2), 136.65 (aromatic quaternary), 154.52, 154.82, 155.85 and 156.21 (NNHC═O), 158.69 (CH2NC═O).
Preparation of (S)-2-(N-tert-butoxycarbonyl-N′-allyloxycarbonylhydrazino methyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (98)
Three portions of Boc anhydride (each 1.20 g, 5.55 mmol) were added at one hour intervals to a stirred solution of (S)-2-(N′-allyloxycarbonylhydrazinomethyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (97) (184 mg, 0.56 mmol) in triethylamine:methanol (1:9, 10 ml). The mixture was stirred at 60° C. for 3 hours then the solvents were removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 1:4 to give (S)-2-(N-tert-butoxycarbonyl-N′-allyloxycarbonylhydrazinomethyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (98) as a pale yellow oil (190 mg, 79%). TLC (Rf=0.5, heptane:ethyl acetate 1:1), analytical HPLC Rt=19.828 min, HPLC-MS 432.2 [M+H]+, 454.1 [M+Na]+, 885.2 [2M+Na]+. dH (500 MHz, CDCl3) mixture of rotamers approximately 4:1, 1.38-1.45 (9H, br. s, C(CH3)3), 3.45-3.74 (2H, m, CH2NNH), 4.02-4.16 (1H, m, H-5), 4.24-4.38 (1H, m, H-5), 4.54-4.68 (2H, m, CH2CH═CH2), 4.72 (minor), 4.84 (major) (1H total, each br. s, H-2), 5.03-5.20 (2H, m, PhCH2O), 5.18-5.34 (2H, m, CH2CH═CH2), 5.76 (1H, br. s, H-3), 5.79-5.85 (1H, m, H-4), 5.84-5.95 (1H, m, CH2CH═CH2), 7.28-7.40 (5H, aromatics); dC (125 MHz, CDCl3) 28.07 (C(CH3)3), 53.32 (CH2NNH), 53.86 (C-5), 62.45 and 62.86 (C-2), 66.21 and 67.02 (CH2CH═CH2 and PhCH2O), 81.03 and 81.43 (C(CH3)3), 117.97 and 118.26 (CH2CH═CH2), 126.63, 128.00, 128.47 and 128.68 (C-3, C-4 and aromatic CH), 132.22 and 132.42 (CH2CH═CH2), 136.48 (aromatic quaternary), 154.96 and 155.57 (NHNHC═O and CH2NC═O).
Preparation of (S)-2-(N-tert-butoxycarbonylhydrazinomethyl)-2,5-dihydro pyrrole-1-carboxylic acid benzyl ester (99)
Tetrakis(triphenylphosphine)palladium(0) (10.2 mg, 0.0088 mmol) was added to a stirred solution of (S)-2-(N-tert-butoxycarbonyl-N′-allyloxycarbonylhydrazine methyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (98) (190 mg, 0.44 mmol) in dichloromethane (10 ml) under an atmosphere of argon. Phenylsilane (0.109 ml, 0.88 mmol) was then added dropwise over two minutes. The solution was stirred for 1 hour then the solvents were removed in vacuo. The oily residue was purified by flash chromatography over silica eluting with heptane:tert-butyl methyl ether 9:1 to 0:1 mixtures to give (S)-2-(N-tert-butoxycarbonylhydrazinomethyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (99) as a pale yellow oil (148 mg, 97%). TLC (Rf=0.35, heptane:ethyl acetate 1:1), analytical HPLC Rt=15.669 min, HPLC-MS 248.1 [M+2H−Boc]+, 292.1 [M+2H−Bu]+, 370.1 [M+Na]+, 717.3 [2M+Na]+. dH (500 MHz, CDCl3) 1.41-1.45 (9H, br. s, C(CH3)3), 1.45-1.70 (2H, br. s, NH2), 3.53-3.95 (2H, m, CH2NNH2), 4.03-4.12 (1H, m, H-5), 4.25-4.36 (1H, r, H-5), 4.74-4.91 (1H, m, H-2), 5.04-5.26 (2H, m, PhCH2O), 5.73-5.87 (2H, m, H-4 and H-5), 7.28-7.41 (5H, aromatics); dC (125 MHz, CDCl3) 28.26 (C(CH3)3), 53.23 (C-5), 53.70 (CH2NNH2), 63.24 (C-2), 66.73 and 67.18 (PhCH2O), 80.25 and 80.53 (C(CH3)3), 126.01, 127.82, 127.91, 128.08, 128.22, 128.42 and 128.49 (C-3 C-4, and aromatic CH), 136.69 (aromatic quaternary).
Preparation of (2S)-2-[N′-((2S)-2-allyloxycarbonylamino-4-methylpentanoyl)-N-tert-butoxycarbonylhydrazinomethyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (100)
(i) Preparation of Alloc-L-Leucine Fluoride (Alloc-Leu-F)
Alloc-L-Leucine (0.90 g, 4.2 mmol) was dissolved in dichloromethane (50 ml) with stirring under nitrogen. (Diethylamino)sulfur trifluoride (DAST, 790 μl, 6.0 mmol) was added and the mixture stirred for 1.75 hours. The mixture was added to iced-water (200 ml) and product extracted into dichloromethane (50 ml), dried (MgSO4), and reduced in vacuo to a mobile tan oil (0.70 g, 77%). An analytical sample, pre-treated with 10% pyridine in methanol gave HPLC-MS 230.1 [M+H]+, 481.1 [2M+Na]+ (methyl ester).
(ii) Alloc-Leu-F (prepared as above, 47 mg, 0.21 mmol) was dissolved in dimethylformamide (1.5 ml) then added to (S)-2-(N-tert-butoxycarbonyl-1-hydrazinomethyl)-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (99) (71 mg, 0.20 mmol) under an atmosphere of nitrogen. The solution was stirred for 19 hours then the solvents were removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 3:7 to give (2S)-2-[N′-((2S)-2-allyloxycarbonylamino-4-methylpentanoyl)-N-tert-butoxycarbonylhydrazinomethyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (100) as a sticky white solid (69 mg, 63%). TLC (Single spot, Rf=0.75, EtOAc:heptane 2:1), analytical HPLC broad double peak Rt=21.214 and 21.483 min; HPLC-MS 445.2 [M+2H−Boc]+, 489.2 [M+2H−Bu]+, 545.2 [M+H]+.
Preparation of (2S)-2-[N′-((2S)-2-amino-4-methylpentanoyl)-N-tert-butoxy carbonylhydrazinomethyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (101)
Dichloromethane (1.5 ml) followed by phenylsilane (32 μl, 0.26 mmol) were consecutively added with stirring under an atmosphere of nitrogen to a mixture of tetrakistriphenylphosphine palladium(0) (3.0 mg, 0.003 mmol) and (2S)-[N′-((2S)-2-allyloxycarbonylamino-4-methylpentanoyl)-N-tert-butoxycarbonyl hydrazinomethyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (100) (70 mg, 0.129 mmol). The solution was stirred for 80 minutes then purified by flash chromatography over silica eluting with methanol:dichloromethane mixtures 0:100 to 5:95 to give (2S)-2-[N′-((2S)-2-amino-4-methylpentanoyl)-N-tert-butoxycarbonylhydrazinomethyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (101) as a colourless oil (57 mg, 96%). TLC (Single spot, Rf=0.65, MeOH:dichloromethane 1:9), analytical HPLC Rt=16.345 min; HPLC-MS 461.2 [M+H]+, 483.2 [M+Na]+, 921.4 [2M+H]+.
Preparation of (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butylbenzoyl amino)-4-methylpentanoyl]-hydrazinoylmethyl}-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (102)
4-Methylmorpholine (26.6 μl, 0.244 mmol) was added to a solution of HBTU (46 mg, 0.122 mmol), 1-hydroxybenzotriazole monohydrate (18.6 mg, 0.122 mmol) and 4-(tert-butyl)benzoic acid (22 mg, 0.122 mmol) in dimethylformamide (1.5 ml). The solution was stood for 5 minutes then added to (2S)-2-[N′-((2S)-2-amino-4-methylpentanoyl)-N-tert-butoxycarbonylhydrazinomethyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (101) (56 mg, 0.122 mmol). The mixture was stirred for 1 hour then the solvents were removed in vacuo (water bath temperature<33° C.). The residue was dissolved in dichloromethane (15 ml) then washed with pH 3 hydrochloric acid (5 ml), saturated aqueous sodium hydrogen carbonate solution (5 ml) and brine (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The yellow residue (108 mg) was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 3:7 to give (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-hydrazinoylmethyl}-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (102) as a sticky white solid (63 mg, 84%). TLC (Rf=0.55, EtOAc:heptane 1:1), analytical HPLC Rt=24.205 min; HPLC-MS 521.2 [M+2H−Boc]+, 621.3 [M+H]+.
Preparation of (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butylbenzoyl amino)-4-methylpentanoyl]-hydrazinomethyl}-6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid benzyl ester (103)
A solution of meta-chloroperoxybenzoic acid (57-86%, 196 mg, ˜0.81 mmol) in dichloromethane (1.2 ml) was added to (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl)-hydrazinoylmethyl}-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (102) (50 mg, 0.081 mmol) under an atmosphere of nitrogen. The solution was stirred for 20 hours then dichloromethane (15 ml) was added and the mixture washed with 5% aqueous sodium hydroxide solution (10 ml), then 10% aqueous sodium hydroxide solution (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 40:60 to give (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-hydrazino methyl}-6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid benzyl ester (103) as a white solid (39 mg, 75%). TLC (Rf=0.30, EtOAc:heptane 2:3), analytical HPLC Rt=23.156 min; HPLC-MS 537.2 [M+2H−Boc]+, 637.2 [M+H]+.
Preparation of (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2,4-dicarboxylic acid 4-benzyl ester 2-tert-butyl ester (104)
A solution of (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butyl benzoylamino)-4-methylpentanoyl]-hydrazinomethyl}-6-oxa-3-aza-bicyclo[3.1.0] hexane-3-carboxylic acid benzyl ester (103) (38.5 mg, 0.061 mmol) in acetonitrile (4.0 ml) was added to potassium carbonate (210 mg, 1.51 mmol). The suspension was placed under an atmosphere of nitrogen then heated at 60° C. whilst stirring for 4.75 hours before being allowed to cool to ambient temperature. The suspension was filtered then the filtrate concentrated in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 50:50 to give (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butylbenzoylamino)methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2,4-dicarboxylic acid 4-benzyl ester 2-tert-butyl ester (104) as a white solid (16.2 mg, 42%). TLC (Rf=0.30, EtOAc:heptane 1:1), analytical HPLC Rt=21.762 min; HPLC-MS 537.2 [M+2H−Boc]+, 581.1 [M+2H−Bu]+, 637.2 [M+H]+.
Preparation of (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (106)
Under an atmosphere of nitrogen a solution of (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2,4-dicarboxylic acid 4-benzyl ester 2-tert-butyl ester (104) (16.0 mg, 0.025 mmol) in ethanol (1.5 ml) was added to 10% palladium on charcoal (10 mg) whilst stirring. The nitrogen was replaced by hydrogen then stirring continued for 30 minutes. The hydrogen was replaced by nitrogen then the mixture filtered through celite. The filter cake was washed with ethanol (40 ml) then the filtrate concentrated in vacuo. The residue was used without further purification. Analytical HPLC Rt=18.568 min; HPLC-MS 403.2 [M+2H−Boc]+, 503.2 [M+H]+ for (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c] pyrazole-2-carboxylic acid tert-butyl ester (105).
Benzoic anhydride (6.0 mg, 0.026 mmol), dimethylformamide (0.3 ml) then 4-methylmorpholine (5.8 μl, 0.053 mmol) were added consecutively to (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexa hydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (105) (−0.025 mmol, prepared as above). The solution was stirred for 65 minutes then the majority of solvents were removed in vacuo. The residue was dissolved in ethyl acetate (10 ml), then washed with saturated aqueous sodium hydrogen carbonate solution (5 ml), pH 3 hydrochloric acid (5 ml) and brine (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue (15.5 mg) was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 5:95 to 50:50 to give (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino) methylpentanoyl]-6-hydroxyhexa hydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (106) as a white solid (10.3 mg, 68%). TLC (Rf=0.25, EtOAc:heptane 1:1), analytical HPLC Rt=22.101 min; HPLC-MS 278.1, 507.2 [M+2H−Boc]+, 607.2 [M+H]+.
Preparation of (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (107)
A solution of Dess-Martin periodinane (54 mg, 0.128 mmol) in dichloromethane (1.25 ml) was added to (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (106) (15.5 mg, 0.026 mmol) under an atmosphere of nitrogen. The mixture was stirred for 4.5 hours then purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 2:3 to give (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)4 methylpentanoyl]-6-oxo-hexahydro pyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (107) as a white solid (12.8 mg, 81%). TLC (Rf=0.65, EtOAc:heptane 3:2), analytical HPLC broad peak Rt=21.02-23.60 min; HPLC-MS single broad main UV peak 274.1, 505.2 [M+2H−Boc]+, 549.1 [M+2H−Bu]+, 605.2 [M+H]+, 623.2 [M+H2O+H]+, 627.2 [M+Na]+, 645.2 [M+H2O+Na]+.
Preparation of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-c] pyrazole-1-carbonyl)-3-methylbutyl]-4-tert-butylbenzamide
EXAMPLE 249a
Trifluoroacetic acid (0.15 ml) was added to (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-oxo-hexahydropyrrolo[3,2-c] pyrazole-2-carboxylic acid tert-butyl ester (107) (10.3 mg, 0.017 mmol) under an atmosphere of nitrogen. The solution was stirred for 45 minutes then cautiously added to saturated aqueous sodium hydrogen carbonate solution (10 ml). The product was extracted into dichloromethane (10 ml) then washed with water (10 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue (10 mg) was combined with a second batch of material (0.8 mg, prepared in a similar way to above from 1.14 mg of (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butyl benzoylamino)-4-methylpentanoyl]-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (107), then purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 20:80 to 65:35 to give (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-1-carbonyl)-3-methylbutyl]-4-tert-butylbenzamide (EXAMPLE 249a) as an off-white solid (3.49 mg, 37%), together with recovered (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (107) (1.83 mg, 16%). Data for (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-1 carbonyl)-3-methyl butyl]tert-butylbenzamide (EXAMPLE 249a), TLC (Rf=0.26, EtOAc:heptane 3:1), analytical HPLC broad peak Rt=18.10-19.70 min; HPLC-MS single broad main UV peak 274.1, 505.1 [M+H]+, 523.2 [M+H2O+H]+.
An alternative preparation of (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (106) is detailed in Scheme 24.
Preparation of (S)-1-benzoyl-2,5-dihydro-1H-pyrrole-2-carboxylic acid 1-methyl ester (108)
Benzoic anhydride (4.15 g, 18.3 mmol) followed by 4-methylmorpholine (2.82 ml, 25.7 mmol) were consecutively added to a stirred solution of (S)-2,5-dihydro-1H-pyrrole-2-carboxylic acid methyl ester hydrochloride (2.0 g, 12.2 mmol) in DMF (50 ml). The mixture was stirred for 1.5 hours then the solvents were removed in vacuo. The product was extracted into tert-butyl methyl ether (300 ml) then washed with 5% hydrochloric acid (100 ml), 5% aqueous sodium hydrogen carbonate solution (100 ml), and brine (100 ml), dried (MgSO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane 1:4 to give (S)-1-benzoyl-2,5-dihydro-1H-pyrrole-2-carboxylic acid 1-methyl ester (108) as a colourless oil (2.05 g, 73%). TLC (Rf=0.25, EtOAc:heptane 1:1); HPLC-MS 232.1, [M+H]+, 254.0 [M+Na]+, 485.1 [2M+Na]+; OH (500 MHz, CDCl3) 3.78 (3H, s, OCH3), 4.15-4.22 (1H, m, H-5), 4.41-4.47 (1H, m, H-5), 5.45-5.49 (1H, m, H-2), 5.83-5.95 (2H, m, H-3 and H-4), 7.36-7.58 (5H, aromatics); Sc (125 MHz, CDCl3) δ2.50 (OCH3), 55.90 (C-5), 66.39 (C-2), 124.89, 127.01, 128.39, 128.41, 128.60 and 130.24 (C-3, C-4 and aromatic CH), 135.86 (aromatic quaternary), 169.73 and 170.16 (CHC═O and NC═OPh).
Preparation of (S)-(2-hydroxymethyl-2,5-dihydropyrrole-1-yl)phenyl methanone (109)
Methanol (0.71 ml) followed by a solution of (S)-1-benzoyl-2,5-dihydro-1H-pyrrole-2-carboxylic acid 1-methyl ester (108 (2.05 g, 8.9 mmol) in THF (37 ml) were added dropwise to a stirred suspension of lithium borohydride (390 mg, 17.7 mmol) in THF (13 ml). The mixture was stirred for 1 hour then water (5 ml) was carefully added. The product was extracted into tert-butyl methyl ether (3×50 ml), then the combined-organic layers dried (MgSO4), and the solvents removed in vacuo to give (S)-(2-hydroxymethyl-2,5-dihydropyrrole-1-yl)phenylmethanone (109) as a pale yellow oil (1.68 g, 93%) which was used without further purification. TLC (Rf=0.1, EtOAc:heptane 1:1), HPLC-MS 204.1 [M+H]; dH (500 MHz, CDCl3) 1.65-1.95 (1H, br. s, CH2OH), 3.72 (1H, dd J=11.4 and 7.1 Hz, CH2OH), 3.90 (1H, dd J=11.6 and 2.1 Hz, CH2OH), 4.11-4.16 (1H, m, H-5), 4.27-4.38 (1H, m, H-5), 5.17-5.21 (1H, m, H-2), 5.74-5.82 (2H, m, H-3 and H-4), 7.38-7.53 (5H, aromatics); dC (125 MHz, CDCl3) δ6.76 (C-5), 66.44 (CH2OH), 68.68 (C-2), 126.25, 126.67, 126.93, 126.95, 128.50 and 130.20 (C-3, C-4 and aromatic CH), 136.21 (aromatic quaternary), 172.12 (NC═OPh).
Preparation of (S)-methanesulfonic acid 1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl ester (110)
Triethylamine (1.86 ml, 13.2 mmol) was added dropwise to a stirred solution of (S)-(2-hydroxymethyl-2,5-dihydropyrrole-1-yl)phenylmethanone (109) (1.68 g, 8.3 mmol) and methanesulfonyl chloride (0.96 ml, 12.4 mmol) in dichloromethane (30 ml) at 0° C. The mixture was stirred for 30 minutes at ambient temperature then washed with water (100 ml), and brine (100 ml), dried (Na2SO4), and the solvents removed in vacuo to give (S)-methanesulfonic acid 1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl ester (110) as a pale yellow oil (1.88 g, 81%) which was used without further purification. HPLC-MS 282.0 [M+H]+, 585.1 [2M+Na]+.
Preparation of (S)-(2-azidomethyl-2,5-dihydropyrrol-1-yl)phenylmethanone (111)
Sodium azide (2.17 g, 33.4 mmol) was added to a stirred solution of (S)-methanesulfonic acid 1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl ester (110) (1.88 g, 6.68 mmol) in DMF (50 ml). The reaction mixture was stirred at 110° C. for 1 hour. The solvent was removed in vacuo then the product was extracted into ethyl acetate (100 ml), washed with water (100 ml) and brine (100 ml), dried (MgSO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with heptane:ethyl acetate 9:1 to give (S)-(2-azidomethyl-2,5-dihydropyrrol-1-yl)phenylmethanone (111) as a pale yellow oil (0.96 g, 63%). TLC (Rf=0.40, heptane:ethyl acetate 1:1), analytical HPLC Rt=13.943 min, HPLC-MS 229.1 [M+H]+, 251.1 [M+Na]+, 479.1 [2M+Na]+.
Preparation of (S)-(2-aminomethyl-2,5-dihydro-pyrrol-1-yl)phenyl methanone (112)
Triphenylphosphine (1.65 g, 6.30 mmol) was added to a stirred solution of (S)-(2-azidomethyl-2,5-dihydropyrrol-1-yl)phenylmethanone (111) (0.96 g, 4.2 mmol) in THF (87 ml) containing water (1 ml). The mixture was stirred at 50° C. for 24 hours then the solvents were removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane 1:9 then ethyl acetate:methanol 4:1 mixtures to give (S)-(2-aminomethyl-2,5-dihydro-pyrrol-1-yl)phenylmethanone (112) as a pale yellow oil (0.77 g, 91%). TLC (Rf=0.1, chloroform:methanol 9:1), analytical HPLC with UV peaks at Rt=6.705 and 7.943 min; HPLC-MS 203.1 [M+H]+, 427.1 [2M+Na]+. dH (500 MHz, D6-DMSO) 1.30-2.10 (2H, br. s, CH2NH2), 2.84 (2H, m, CH2NH2), 3.87 (1H, dd, J=14.9 and 1.0 Hz, H-5), 4.26-4.35 (1H, m, H-5), 4.84 (1H, m, H-2), 5.83-6.03 (2H, m, H-4 and H-5), 7.39-7.58 (5H, aromatics); dC (125 MHz, D6-DMSO) 44.25 (CH2NH2), 56.96 (C-5), 67.20 (C-2), 126.50, 126.62, 126.83, 127.51, 128.63, 128.84, 128.96, 129.52, 129.81 and 130.22 (C-3, C-4 and aromatic CH), 137.48 (aromatic quaternary), 169.44 (NC═O).
Preparation of (S)-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazine Carboxylic acid allyl ester (113)
3-Phenyloxaziridine-2-carboxylic acid allyl ester (prepared as above, 1.95 g, 9.5 mmol) was added to a stirred solution of (S)-(2-aminomethyl-2,5-dihydro-pyrrol-1-yl)phenylmethanone (112) (0.64 g, 3.17 mmol) in dichloromethane (10 ml). The mixture was stirred for 16 hours then the solvents were removed in vacuo. The oily residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 1:4 to give (S)-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazinecarboxylic acid allyl ester (113) as a pale yellow oil (0.26 g, 27%). TLC (Rf=0.45, heptane:ethyl acetate 1:1), HPLC-MS 302.1 [M+H]+, 324.1 [M+Na]+, 625.1 [2M+Na]+.
Preparation of (S)-N′-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)-N′-tert-butoxycarbonyl-hydrazinecarboxylic acid allyl ester (114)
Three portions of Boc anhydride (each 1.84 g, 8.1 mmol) were added at one hour intervals to a stirred solution of (S)-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazinecarboxylic acid allyl ester (113) (0.26 g, 0.85 mmol) in triethylamine:methanol (1:9, 10 ml). The mixture was stirred at 60° C. for 3 hours then the solvents were removed in vacuo. The oily residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:1 to 1:4 to give (S)-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)-N′-tert-butoxycarbonyl-hydrazinecarboxylic acid allyl ester (114) as a pale yellow oil (96 mg, 280%). TLC (Rf=0.25, heptane:ethyl acetate 1:1), analytical HPLC Rt=6.025 min; HPLC-MS 402.1 [M+H]+, 825.1 [2M+Na]+.
Preparation of (S)-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazine carboxylic acid tert-butyl ester (115)
Tetrakis(triphenylphosphine)palladium(0) (7.5 mg, 0.0065 mmol) was added to a stirred solution of (S)-N′-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)-N′-tert-butoxycarbonyl-hydrazinecarboxylic acid allyl ester (114) (131 mg, 0.326 mmol) in dichloromethane (5 ml) under an atmosphere of argon. Phenylsilane (81 μl, 0.65 mmol) was then added dropwise over two minutes. The solution was stirred for 1 hour then the solvents were removed in vacuo. The oily residue was purified by flash chromatography over silica eluting with heptane:tert-butyl methyl ether 9:1 to 0:1 mixtures to give (S)-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazine carboxylic acid tert-butyl ester (115) as a brown oil (77 mg, 74%). TLC (Rf=0.35, heptane:ethyl acetate 1:1), analytical HPLC Rt=12.738 min; HPLC-MS 218.1 [M+2H−Boc]+, 262.1 [M+2H−Bu]+, 318.1 [M+H]+, 635.3 [2M+H]+, 657.2 [2M+Na]+.
Preparation of N′-((2S)-2-allyloxycarbonylamino-4-methylpentanoyl)-N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazinecarboxylic acid tert-butyl ester (116)
Alloc-Leu-F (prepared as above, 55 mg, 0.26 mmol) was added to a stirred solution of (S)-2-N-(1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazine carboxylic acid tert-butyl ester (115) (77 mg, 0.24 mmol) in dimethylformamide (1.5 ml) under an atmosphere of nitrogen. The solution was stirred for 4.5 hours then the solvents were removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 2:3 to give N′-((2S)-2-allyloxycarbonylamino-4-methylpentanoyl)-N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazinecarboxylic acid tert-butyl ester (116) as a viscous oil (83 mg, 67%). TLC (Single spot, Rf=0.45, EtOAc:heptane 1:1), analytical HPLC Rt=19.157 min; HPLC-MS 415.1 [M+2H−Boc]+, 459.1 [M+2H−Bu]+, 515.2 [M+H]+.
Preparation of N′-((2S)-2-amino-4-methylpentanoyl)-N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazinecarboxylic acid tert-butyl ester (117)
Dichloromethane (1.5 ml) followed by phenylsilane (39 μl, 0.32 mmol) were consecutively added with stirring under an atmosphere of nitrogen to a mixture of tetrakistriphenylphosphine palladium(0) (3.7 mg, 0.003 mmol) and N′-((2S)-2-allyloxycarbonylamino-4-methylpentanoyl)-N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)hydrazinecarboxylic acid tert-butyl ester (116) (82 mg, 0.16 mmol). The solution was stirred for 1.75 hours then purified by flash chromatography over silica eluting with methanol:dichloromethane mixtures 1:99 to 5:95 to give N′-((2S)-2-amino-4-methylpentanoyl)-N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl) hydrazinecarboxylic acid tert-butyl ester (117) as a colourless oil (57 mg, 83%). TLC (Single spot, Rf=0.45, MeOH dichloromethane 6:94), analytical HPLC Rt=14.217 min; HPLC-MS 431.1 [M+H]+, 861.3 [2M+H]+, 883.3 [2M+Na]+.
Preparation of N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]hydrazinecarboxylic acid tert-butyl ester (118)
4-Methylmorpholine (28.5 μl, 0.26 mmol) was added to a solution of HBTU (49 mg, 0.13 mmol), 1-hydroxybenzotriazole monohydrate (20 mg, 0.13 mmol) and 4-(tert-butyl)benzoic acid (23 mg, 0.13 mmol) in dimethylformamide (1.5 ml). The solution was stood for 5 minutes then added to N′-((2S)-2-amino-4-methylpentanoyl)-N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl) hydrazine carboxylic acid tert-butyl ester (117) (56 mg, 0.13 mmol). The mixture was stirred for 1.5 hour then the solvents were removed in vacuo (water bath temperature<33° C.). The residue was dissolved in dichloromethane (15 ml) then washed with pH 3 hydrochloric acid (5 ml), saturated aqueous sodium hydrogen carbonate solution (5 ml) and brine (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The yellow residue (102 mg) was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 1:1 to give N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)-N′-[(2S-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]hydrazinecarboxylic acid tert-butyl ester (118) as a white solid (52 mg, 68%). TLC (Rf=0.46, EtOAc:heptane 1:1), analytical HPLC Rt=22.310 min; HPLC-MS 491.2 [M+2H−Boc]+, 591.2 [M+H]+.
Preparation of N-((2S)-3-benzoyl-6-oxa-3-aza-bicyclo[3.1.0]hex-2-ylmethyl)-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]hydrazine carboxylic acid tert-butyl ester (119)
A solution of meta-chloroperoxybenzoic acid (57-86%, 210 mg, ˜0.86 mmol) in dichloromethane (1.25 ml) was added to N-((2S)-1-benzoyl-2,5-dihydro-1H-pyrrol-2-ylmethyl)-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]hydrazine carboxylic acid tert-butyl ester (118) (51 mg, 0.086 mmol) under an atmosphere of nitrogen. The solution was stirred for 20 hours then dichloromethane (15 ml) was added and the mixture washed with 10% aqueous sodium hydroxide solution (10 ml). The aqueous layer was extracted with dichloromethane (5 ml) then the combined organic layers washed with 10% aqueous sodium hydroxide solution (10 ml), dried (Na2SO4), and the solvents removed in vacuo. The yellow oily residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 1:1 to give N-((2S)-3-benzoyl-6-oxa-3-aza-bicyclo[3.1.0]hex-2-ylmethyl)-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]hydrazinecarboxylic acid tert-butyl ester (119) as a white solid (27.5 mg, 52%). TLC (Rf=0.25, EtOAc:heptane 1:1), analytical HPLC Rt=21.769 min; HPLC-MS 507.2 [M+2H−Boc]+, 607.2 [M+H]+.
Preparation of (3aR,6S,6aS)-4-benzoyl-1-[(2S-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (106)
A solution of N-((2S)-3-benzoyl-6-oxa-3-aza-bicyclo[3.1.0]hex-2-ylmethyl)-N′-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]hydrazinecarboxylic acid tert-butyl ester (119) (26 mg, 0.043 mmol) in acetonitrile (2.5 ml) was added to potassium carbonate (150 mg, 1.09 mmol). The suspension was placed under an atmosphere of nitrogen then heated at 60° C. whilst stirring for 3.25 hours before being allowed to cool to ambient temperature. The suspension was filtered and the collected solid washed with acetonitrile (20 ml), then the filtrate was concentrated in vacuo. The residue was dissolved in dichloromethane (15 ml), washed with water (10 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate heptane mixtures 1:4 to 1:1 to give (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (106) as a white solid (16.2 mg, 62%). TLC (Rf=0.30, EtOAc:heptane 3:2), analytical HPLC Rt=22.013 min; HPLC-MS 278.1, 507.2 [M+2H−Boc]+, 607.2 [M+H]+.
EXAMPLES 249b and 249c were prepared from the intermediate (2S)-2-[N′-((2S)-2-amino-4-methylpentanoyl)-N-tert-butoxycarbonylhydrazinomethyl]-2,5-dihydro pyrrole-1-carboxylic acid benzyl ester (101) following Scheme 25;
Preparation of (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-hydrazinoyl methyl}-2,5-dihydro pyrrole-1-carboxylic acid benzyl ester (120)
4-Methylmorpholine (44.7 μl, 0.407 mmol) was added to a solution of HBTU (77 mg, 0.204 mmol), 1-hydroxybenzotriazole monohydrate (31 mg, 0.204 mmol) and 4-(tert-butoxycarbonylamino)benzoic acid (48 mg, 0.204 mmol) in dimethylformamide (2.0 ml). The solution was stood for 5 minutes then added to (2S)-2-[N′-((2S)-2-amino-4-methylpentanoyl)-N-tert-butoxycarbonylhydrazino methyl]-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (101) (94 mg, 0.204 mmol). The mixture was stirred for 1 hour 35 minutes then the solvents were removed in vacuo (water bath temperature<37° C.). The residue was dissolved in dichloromethane (15 ml) then washed with pH 3 hydrochloric acid (5 ml), saturated aqueous sodium hydrogen carbonate solution (5 ml) and brine (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue (166 mg) was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 4:6 to give (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-hydrazinoylmethyl}-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (120) as a white solid (116 mg, 84%). TLC (Rf=0.48, EtOAc:heptane 1:1), analytical HPLC Rt=22.296 min; HPLC-MS 580.4 [M+2H−Boc]+, 680.4 [M+H]+.
Preparation of (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butoxy carbonylaminobenzoylamino)-4-methylpentanoyl]-hydrazinomethyl}-6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid benzyl ester (121)
A solution of meta-chloroperoxybenzoic acid (57-86%, 411 mg, ˜1.7 mmol) in dichloromethane (2.5 ml) was added to (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-hydrazinoyl methyl}-2,5-dihydropyrrole-1-carboxylic acid benzyl ester (120) (115 mg, 0.169 mmol) under an atmosphere of nitrogen. The solution was stirred for 20 hours then dichloromethane (15 ml) was added and the solution twice washed with a mixture of water (5 ml) and aqueous saturated sodium hydrogen carbonate solution (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue (127 mg) was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:9 to 1:1 to give (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-hydrazinomethyl}-6-oxa-3-aza-bicyclo[3.1.0] hexane-3-carboxylic acid benzyl ester (121) as a white solid (63.7 mg, 54%). TLC (Rf=0.25, EtOAc:heptane 1:1), analytical HPLC Rt=21.723 min; HPLC-MS 596.4 [M+2H−Boc]+, 696.4 [M+H]+, 718.4 [M+Na]+.
Preparation of (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylamino benzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2c pyrazole-2,4-dicarboxylic acid 4-benzyl ester 2-tert-butyl ester (122)
A solution of (2S)-2-{N-tert-butoxycarbonyl-N′-[(2S)-2-(4-tert-butoxycarbonyl aminobenzoylamino)-4-methylpentanoyl]-hydrazinomethyl}-6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid benzyl ester (121) (62.2 mg, 0.090 mmol) in acetonitrile (3.0 ml) was added to potassium carbonate (300 mg, 2.17 mmol). The suspension was placed under an atmosphere of nitrogen then heated at 60° C. whilst stirring for 3 hours before being allowed to cool to ambient temperature. The suspension was filtered then the filtrate concentrated in vacuo. The product was extracted into dichloromethane (15 ml) then washed with water (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:4 to 3:2 to give (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2,4-dicarboxylic acid 4-benzyl ester 2-tert-butyl ester (122) as a white solid (36.7 mg, 59%). TLC (Rf=0.28, EtOAc:heptane 1:1), analytical HPLC Rt=22.528 min; HPLC-MS 333.3, 596.4 [M+2H−Boc]+, 640.4 [M+2H−Bu]+, 696.4 [M+H]+.
Preparation of (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylamino benzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c] pyrazole-2-carboxylic acid tert-butyl ester (123)
Under an atmosphere of nitrogen ethanol (2.6 ml) was added to a mixture of (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methyl pentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2,4-dicarboxylic acid 4 benzyl ester 2-tert-butyl ester (122) (35.2 mg, 0.051 mmol) and 10% palladium on charcoal (20 mg) whilst stirring. The nitrogen was replaced by hydrogen then stirring continued for 1 hour. The hydrogen was replaced by nitrogen then the mixture filtered through celite. The filter cake was washed with ethanol (20 ml) then the filtrate concentrated in vacuo. The residue (28.3 mg, 100%) was used without further purification. Analytical HPLC Rt=17.437 min; HPLC-MS 462.3 [M+2H−Boc]+, 562.4 [M+H]+ for (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydro pyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (123).
Preparation of (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butoxycarbonyl aminobenzoylamino)-4-methylpentanoyl]hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (124)
Benzoic anhydride (5.3 mg, 0.024 mmol), dimethylformamide (0.275 ml) then 4-methylmorpholine (5.2 μd, 0.047 mmol) were added consecutively to (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-hydroxy hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (123) (12.6 mg, 0.0225 mmol, prepared as above). The solution was stirred for 90 minutes then the majority of solvents were removed in vacuo. The residue was dissolved in ethyl acetate (10 ml), then washed with saturated aqueous sodium hydrogen carbonate solution (5 ml), pH 3 hydrochloric acid (5 ml) and brine (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The solid white residue (15.4 mg, 100%) was used without further purification. Data for (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methyl pentanoyl]-6-hydroxyhexahydro pyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (124): TLC (Rf=0.25, EtOAc:heptane 2:1), analytical HPLC Rt=20.787 min; HPLC-MS 333.3, 566.4 [M+2H−Boc]+, 666.4 [M+H]+.
Preparation of (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butoxycarbonylamino benzoylamino)-4-methylpentanoyl]6-oxo-hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (126)
A solution of Dess-Martin periodinane (48 mg, 0.113 mmol) in dichloromethane (1.1 ml) was added to (3aR,6S,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butoxycarbonyl aminobenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (124) (15.4 mg, 0.0225 mmol, prepared as above) under an atmosphere of nitrogen. The mixture was stirred for 3 hours then purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 1:4 to 1:1 to give (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-oxo-hexahydro pyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (126) as an off-white solid (9.7 mg, 65%). TLC (Rf=0.28, EtOAc:heptane 2:1), analytical HPLC broad peak Rt=20.05-22.80 min; HPLC-MS single broad main UV peak 333.2, 664.4 [M+H]+, 682.4 [M+H2O+H]+.
Preparation of (3aR,6aS)-4-amino-N-[(1S)-1-(4-benzoyl-oxo-hexahydro pyrrolo[3,2-c]pyrazole-1-carbonyl)-3-methylbutyl]benzamide
EXAMPLE 249b
Trifluoroacetic acid (0.05 ml) was added to (3aR,6aS)-4-benzoyl-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-oxo-hexahydro pyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (126) (6.4 mg, 9.7 μmol) under an atmosphere of nitrogen. The solution was stirred for 2.5 hours then diluted with dichloromethane (1 ml) and cautiously added to saturated aqueous sodium hydrogen carbonate solution (1 ml). The dichloromethane was separated then washed with water (1 ml). The saturated aqueous sodium hydrogen carbonate solution was extracted with dichloromethane (0.5 ml) which was then washed with the water layer. The combined organic layers were dried (Na2SO4), and the solvents removed in vacuo to obtain (3aR,6aS)-4-amino-N-[1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-1-carbonyl)-3-methylbutyl)benzamide (EXAMPLE 249b) as a red solid (0.72 mg, 16%). Analytical HPLC broad peak Rt=11.0-12.1 min; HPLC-MS broad UV peak 464.2 [M+H]+, 482.4 [M+H2O+H]+, 949.3 [2M+Na]+, 967.4 [2M+H2O+Na]+, 985.3 [2M+2H2O+Na]+.
Preparation of (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonyl aminobenzoylamino)-4-methylpentanoyl]-6-hydroxy-4-(3-methanesulfonyl benzoyl)hexahydropyrrolo[3,2-]pyrazole-2-carboxylic acid tert-butyl ester (125)
4-Methylmorpholine (5.7 μl, 0.052 mmol) was added to a solution of HBTU (9.9 mg, 0.026 mmol), 1-hydroxybenzotriazole monohydrate (4.0 mg, 0.026 mmol) and 3-(methylsulfonyl)benzoic acid (5.2 mg, 0.026 mmol) in dimethylformamide (0.3 ml). The solution was stood for 5 minutes then added to (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-hydroxyhexahydro pyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (123) (14.7 mg, 0.026 mmol, prepared as above). The mixture was stirred for 2.5 hour then the solvents were removed in vacuo (water bath temperature<37° C.). The residue was dissolved in dichloromethane (10 ml) then washed with pH 3 hydrochloric acid (5 ml), saturated aqueous sodium hydrogen carbonate solution (5 ml) and brine (5 ml), dried (Na2SO4), and the solvents removed in vacuo. The pale yellow solid residue (19.7 mg, 100%) was used without further purification. Data for (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-6-hydroxy-4-(3-methanesulfonylbenzoyl)hexahydropyrrolo [3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (125): TLC (Rf=0.05, EtOAc:heptane 2:1), analytical HPLC Rt=19.945 min; HPLC-MS 333.3, 644.3 [M+2H−Boc]+, 688.3 [M+2H−Bu]+, 744.3 [M+H]+, 766.3 [M+Na]+.
Preparation of (3aR,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoyl amino)-4-methylpentanoyl]-4-(3-methanesulfonylbenzoyl)-6-oxohexahydro pyrrolo[3,2-c] pyrazole-2-carboxylic acid tert-butyl ester (127)
A solution of Dess-Martin periodinane (56 mg, 0.132 mmol) in dichloromethane (1.25 ml) was added to (3aR,6S,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylamino benzoylamino)-4-methylpentanoyl]-6-hydroxy-4-(3-methanesulfonylbenzoyl) hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (125) (19.7 mg, 0.0262 mmol, prepared as above) under an atmosphere of nitrogen. The mixture was stirred for 4 hours then purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 3:7 to 4:1 to give (3aR,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-4-(3-methanesulfonylbenzoyl)-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (127) as an off-white solid (11.1 mg, 57%). TLC (Rf=0.10, EtOAc:heptane 2:1), analytical HPLC broad peak Rt=19.20-21.70 min; HPLC-MS single broad main UV peak 333.2, 642.3 [M+2H−Boc]+, 660.3 [M+2H+H2O— Boc]+, 686.3 [M+2H−Bu]+, 704.2 [M+2H+H2O— Bu]+, 742.3 [M+H]+, 760.3 [M+H2O+H]+.
Preparation of (3aR,6aS)-4-amino-N-{(1S)-1-[4-(3-methanesulfonylbenzoyl)-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-1-carbonyl]-3-methylbutyl} benzamide
EXAMPLE 249c
Trifluoroacetic acid (0.05 ml) was added to (3aR,6aS)-1-[(2S)-2-(4-tert-butoxycarbonylaminobenzoylamino)-4-methylpentanoyl]-4-(3-methanesulfonyl benzoyl)-6-oxo-hexahydropyrrolo[3,2-c]pyrazole-2-carboxylic acid tert-butyl ester (127) (4.93 mg, 6.7 μmol) under an atmosphere of nitrogen. The solution was stirred for 2.5 hours then diluted with dichloromethane (1 ml) and cautiously added to saturated aqueous sodium hydrogen carbonate solution (1 ml). The dichloromethane was separated then washed with water (1 ml). The saturated aqueous sodium hydrogen carbonate solution was extracted with dichloromethane (0.5 ml) which was then washed with the water layer. The combined organic layers were dried (Na2SO4), and the solvents removed in vacuo to obtain (3aR,6aS)-4-amino-N-{(1S)-1-[4-(3-methanesulfonylbenzoyl)-6-oxo-hexahydropyrrolo [3,2-c]pyrazole-1-carbonyl]-3-methylbutyl}benzamide (EXAMPLE 249c) as a red solid (0.66 mg, 18%). Analytical HPLC broad peak Rt=10.2-11.4 min; HPLC-MS broad UV peak 233.1, 542.2 [M+H]+, 560.2 [M+H2O+H]+.
EXAMPLES 250 to 295 were prepared as detailed for EXAMPLES 1 and 119, substituting the appropriate carboxylic acids as required and are inhibitors of cathepsin S with Ki ranging from 10-5000 nM;
EXAMPLE 250
(3aR,6aS)-Thiophene-3-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=16.4-17.2 mins (>90%), HPLC-MS 494.2 [M+H]+, 1009.4 [2M+Na]+.
EXAMPLE 251
(3aR,6aS)-Thiophene-3-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=14.78 mins (>90%), HPLC-MS 534.1 [M+H]+.
EXAMPLE 252
(3aR,6aS)-Benzo[b]thiophene-2-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=18.5-19.8 mins (>85%), HPLC-MS 584.1 [M+H]+.
EXAMPLE 253
(3aR,6aS)-Benzo[b]thiophene-3-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=17.8-19.0 mins (>80%), HPLC-MS 584.2 [M+H]+.
EXAMPLE 254
(3aR,6aS)-Benzo[b]thiophene-3-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=19.5-20.5 mins (>75%), HPLC-MS 544.1 [M+H]+.
EXAMPLE 255
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-[4-(naphthalene-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=18.3-19.5 mins (>80%), HPLC-MS 544.1 [M+H]+.
EXAMPLE 256
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-[4-(naphthalene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=18.9-19.7 mins (>85%), HPLC-MS 544.1 [M+H]+.
EXAMPLE 257
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(4-[1,2,4]triazol-1-yl-benzoyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide
HPLC Rt=15.5-16.5 mins (>85%), HPLC-MS 561.2 [M+H]+.
EXAMPLE 258
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-oxo-2-[6-oxo-4-(5-phenyl-thiophene-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-amide
HPLC Rt=19.5-20.2 mins (>85%), HPLC-MS 576.1 [M+H]+.
EXAMPLE 259
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-3-phenoxy-benzamide
HPLC Rt=19.4-20.3 mins (>85%), —HPLC-MS 580.2 [M+H]+.
EXAMPLE 260
(3aR,6aS)-N-[(1R)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-3-phenoxy-benzamide
HPLC Rt=18.3-19.6 mins (>90%), HPLC-MS 620.2 [M+H]+.
EXAMPLE 261
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=14.5-15.2 mins (>80%), HPLC-MS 612.0 [M+H]+.
EXAMPLE 262
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-(4-(3-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-2-oxo-ethyl}-amide
HPLC Rt=14.09 mins (>90%), HPLC-MS 612.1 [M+H]+.
EXAMPLE 263
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(2-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=14.93 mins (>90%), HPLC-MS 579.0 [M+H]+.
EXAMPLE 264
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(3-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=15.53 mins (>85%), HPLC-MS 579.0 [M+H]+.
EXAMPLE 265
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(4-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=15.41 mins (>90%), HPLC-MS 579.1 [M+H]+.
EXAMPLE 266
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(hexahydro-2,5-methano-pentalene-3a-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=17.0-18.2 mins (>80%), HPLC-MS 578.1 [M+H]+.
EXAMPLE 267
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(4-hydroxy-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=13.43 mins (>80%), HPLC-MS 550.0 [M+H]+.
EXAMPLE 268
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-2-(4-(4-amino-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-benzylsulfanylmethyl-2-oxo-ethyl}-amide
HPLC Rt=11.8-12.4 mins (>75%), HPLC-MS 549.1 [M+H]+.
EXAMPLE 269
(3aR,6aS)-N-[(1R)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=19.1-20.3 mins (>90%), HPLC-MS 618.2 [M+H]+.
EXAMPLE 270
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=19.9-21.0 mins (>90%), HPLC-MS 578.3 [M+H]+.
EXAMPLE 271
(3aR,6aS)-N-{(1S)-1-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl]-3-methyl-butyl}-2,2-diphenyl-acetamide
HPLC Rt=19.4-20.7 mins (>90%), HPLC-MS 594.2 [M+H]+.
EXAMPLE 272
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-oxo-2-[6-oxo-4-(thiophene-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-amide
HPLC Rt=14.56 mins (>90%), HPLC-MS 540.0 [M+H]+.
EXAMPLE 273
(3aR,6aS)-Thiophene-3-carboxylic acid [(1R)-1-benzylsulfanyl methyl-2-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-2-oxo-ethyl]-amide
HPLC Rt=15.5-16.4 mins (>75%), HPLC-MS 540.1 [M+H]+.
EXAMPLE 274
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(2-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=16.0-17.9 mins (>90%), HPLC-MS 548.1 [M+H]+.
EXAMPLE 275
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(3-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=16.3-17.8 mins (>90%), HPLC-MS 548.1 [M+H]+.
EXAMPLE 276
(3aR,6aS)-Thiophene-3-carboxylic acid {(1R)-1-benzylsulfanyl methyl-2-[4-(4-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=15.5-16.8 mins (>90%), HPLC-MS 548.1 [M+H]+.
EXAMPLE 277
(3aR,6aS)-Morpholine-4-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=12.5-13.8 mins (>80%), HPLC-MS 537.1 [M+H]+.
EXAMPLE 278
(3aR,6aS)-3-Aminomethyl-N-[(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-benzamide
HPLC Rt=12.0-13.4 mins (>80%), HPLC-MS 557.2 [M+H]+.
EXAMPLE 279
(3aR,6aS)-N-{(1S)-1-Cyclohexylmethyl-2-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-2,2-diphenyl-acetamide
HPLC Rt=20.1-21.4 mins (>90%), HPLC-MS 656.2 [M # H)+.
EXAMPLE 280
(3aR,6aS)-Morpholine-4-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=14.96 mins (>95%), HPLC-MS 497.2 [M+H]+, 515.2 [M+H+H2O]+.
EXAMPLE 281
(3aR,6aS)-Benzothiazole-6-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=15.15 mins (>85%), HPLC-MS 585.1 [M+H]+, 603.1 [M+H+H2O]+.
EXAMPLE 282
(3aR,6aS)-Thiophene-2-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=15.06 mins (>85%), HPLC-MS 534.0 [M+H]+.
EXAMPLE 283
(3aR,6aS)-Furan-2-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl)-amide
HPLC Rt=14.1-15.4 mins (>80%), HPLC-MS 518.1 [M+H]+, 536.1 [M+H+H2O]+.
EXAMPLE 284
(3aR,6aS)-Furan-3-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-amide
HPLC Rt=15.7-17.3 mins (>85%), HPLC-MS 518.1 [M+H]+.
EXAMPLE 285
(3aR,6aS)-N-[(1R)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b] pyrrol-1-yl)-1-benzylsulfanylmethyl-2-oxo-ethyl]-benzamide
HPLC Rt=15.34 mins (>90%), HPLC-MS 528.1 [M+H]+.
EXAMPLE 286
(3aR,6aS)-Benzothiazole-6-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=18.25 mins (>90%), HPLC-MS 5452 [M+H]+.
EXAMPLE 287
(3aR,6aS)-Thiophene-2-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=18.28 mins (>90%), HPLC-MS 494.1 [M+H]+.
EXAMPLE 288
(3aR,6aS)-Furan-2-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=16.66 mins (>90%), HPLC-MS 478.1 [M+H]+, 977.3 [2M+Na]+.
EXAMPLE 289
(3aR,6aS)-Furan-3-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-amide
HPLC Rt=16.37 mins (>90%), HPLC-MS 478.1 [M+H]+, 977.3 [2M+Na]+.
EXAMPLE 290
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-cyclohexylmethyl-2-oxo-ethyl]-benzamide
HPLC Rt=16.71 mins (>95%), HPLC-MS 488.2 [M+H]+, 997.3 [2M+Na]+.
EXAMPLE 291
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-[4-(2-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=15.65 mins (>95%), HPLC-MS 508.2 [M+H]+, 526.2 [M+H+H2O]+.
EXAMPLE 292
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-[4-(3-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=16.10 mins (>90%), HPLC-MS 508.1 [M+H]+.
EXAMPLE 293
(3aR,6aS)-Thiophene-3-carboxylic acid {(1S)-1-cyclohexylmethyl-2-[4-(4-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=15.88 mins (>90%), HPLC-MS 508.1 [M+H]+.
EXAMPLE 294
(3aR,6aS)-Thiophene-3-carboxylic acid [(1R)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-methanesulfonylmethyl-2-oxo-ethyl]-amide
HPLC Rt=8.61 mins (>90%), HPLC-MS 504.1 [M+H]+.
EXAMPLE 295
(3aR,6aS)-Furan-2-carboxylic acid {(1S)-2-[4-((2S)-2-acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-cyclohexylmethyl-2-oxo-ethyl}-amide
HPLC Rt=14.35 mins (>95%), HPLC-MS 529.2 [M+H]+.
In addition, EXAMPLES 7, 8, 9, 10, 12, 13, 14, 16, 17, 19, 20, 37, 39, 59, 61, 65, 85, 86, 87, 88, 89, 90, 91, 92, 93, 98, 103, 123, 145, 151, 154, 158, 159, 161, 164, 170, 171, 172, 173, 174, 185, 187, 193, 194, 245, 247, 249a, 249b, 249c, 298, 303, 310, 314, 315, 316, 317, 323, 329, 330, 334, 335 and 340 have utility as inhibitors of cathepsin S with Ki less than 5000 nM.
EXAMPLES 296 to 345 were prepared as detailed for EXAMPLES 1 and 119, substituting the appropriate carboxylic acids as required and are inhibitors of cathepsin L with Ki ranging from 10-5000 nM;
EXAMPLE 296
(3aR,6aS)-Naphthalene-1-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxybenzyl)-2-oxo-ethyl]-amide
HPLC Rt=13.5-14.4 mins (>90%), HPLC-MS 548.2 [M+H]+, 1117.4 [2M+Na]+.
EXAMPLE 297
(3aR,6aS)-Quinoline-8-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-amide
HPLC Rt=11.79 mins (>85%), HPLC-MS 549.2 [M+H]+, 567.3 [M+H+H2O]+.
EXAMPLE 298
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=13.21 mins (>95%), HPLC-MS 576.1/578.1 [M+H]+.
EXAMPLE 299
(3aR,6aS)-Isoquinoline-1-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-amide
HPLC Rt=14.1-15.1 mins (>85%), HPLC-MS 549.2 [M+H]+, 567.2 [M+H+H2O]+.
EXAMPLE 300
(3aR,6aS)-Benzo[b]thiophene-2-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-amide
HPLC Rt=14.8-15.6 mins (>85%), HPLC-MS 554.2 [M+H]+.
EXAMPLE 301
(3aR,6aS)-Naphthalene-1-carboxylic acid {(1S)-1-(4-hydroxy-benzyl)-2-[4-(naphthalene-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=15.5-16.8 mins (>85%), HPLC-MS 598.2 [M+H]+, 616.2 [M+H+H2O]+.
EXAMPLE 302
(3aR,6aS)-Naphthalene-1-carboxylic acid {(1S)-1-(4-hydroxy-benzyl)-2-[4-(naphthalene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=16.0-16.9 mins (>90%), HPLC-MS 598.2 [M+H]+.
EXAMPLE 303
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(2-methane sulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=12.66 mins (>90%), HPLC-MS 654.0/656.0 [M+H]+.
EXAMPLE 304
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(3-methane sulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=12.95 mins (>75%), HPLC-MS 654.0/656.0 [M+H]+.
EXAMPLE 305
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(3-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=13.52 mins (>90%), HPLC-MS 621.0/623.0 [M+H]+.
EXAMPLE 306
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4 (4-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl)-benzamide
HPLC Rt=13.50 mins (>95%), HPLC-MS 621.0/623.0 [M+H]+.
EXAMPLE 307
(3aR,6aS)-N-[(1S)-2-[4-(Adamantane-1-carbonyl)-6-oxo-hexa hydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=15.9-17.3 mins (>50%), HPLC-MS 634.0/636.0 [M+H]+.
EXAMPLE 308
(3aR,6aS)-3-Bromo-N-[(1S)-2-[4-(hexahydro-2,5-methano-pentalene-3a-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=14.7-16.2 mins (>80%), HPLC-MS 620.0/622.0 [M+H]+, 638.1/640.1 [M+H+H2O]+.
EXAMPLE 309
(3aR,6aS)-3-Bromo-N-[(1S)-2-[4-(4-hydroxy-benzoyl)-6-oxo-hexa hydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=11.92 mins (>80%), HPLC-MS 592.0/594.0 [M+H]+.
EXAMPLE 310
(3aR,6aS)-N-[(1S)-2-[4-(4-Amino-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=9.9-10.6 mins (>75%), HPLC-MS 591.0/593.0 [M+H]+, 609.0/611.0 [M+H+H2O]+.
EXAMPLE 311
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(quinoline-6-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-benzamide
HPLC Rt=11.13 mins (>75%), HPLC-MS 627.0/629.0 [M+H]+, 645.0/647.0 [M+H+H2O]+.
EXAMPLE 312
(3aR,6aS)-4,5-Dimethyl-furan-2-carboxylic acid {(1S)-1-(4-hydroxy-benzyl)-2-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=11.43 mins (>90%), HPLC-MS 594.1 [M+H]+.
EXAMPLE 313
(3aR,6aS)-2-Ethyl-5-methyl-2H-pyrazole-3-carboxylic acid {(1S)-1-(4-hydroxy-benzyl)-2-[4-(2-methanesulfonylbenzoyl)-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-amide
HPLC Rt=10.03 mins (>90%), HPLC-MS 608.1 [M+H]+, 626.1 [M+H+H2O]+.
EXAMPLE 314
(3aR,6aS)-N-[(1S)-2-[Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(3-methyl-benzyl)-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=20.2-21.4 mins (>95%), HPLC-MS 642.2 [M+H]+.
EXAMPLE 315
(3aR,6aS)-N-[(1S)-2-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(3-fluoro-benzyl)-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=19.7-21.0 mins (>90%), HPLC-MS 646.2 [M+H]+.
EXAMPLE 316
(3aR,6aS)-N-[(1S)-2-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(3,5-difluoro-benzyl)-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=20.1-21.3 mins (>90%), HPLC-MS 664.2 [M+H]+.
EXAMPLE 317
(3aR,6aS)-Benzothiazole-6-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-amide
HPLC Rt=12.02 mins (>95%), HPLC-MS 555.1 [M+H]+.
EXAMPLE 318
(3aR,6aS)-4-Aminomethyl-N-[(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=8.92 mins (>95%), HPLC-MS 527.2 [M+H]+, 545.2 [M+H+H2O]+.
EXAMPLE 319
(3aR,6aS)-3-Aminomethyl-N-[(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=9.14 mins (>°/0), HPLC-MS 527.2 [M+H]+, 545.3 [M+H+H2O]+.
EXAMPLE 320
(3aR,6aS)-N-[(1S)-2-(4-Benzenesulfonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=16.1-17.9 mins (>90%), HPLC-MS 612.0/614.0 [M+H]+.
EXAMPLE 321
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(3-nitro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=10.75 mins (>80%), HPLC-MS 586.2 [M+H]+, 604.2 [M+H+H2O]+.
EXAMPLE 322
(3aR,6aS)-4-Dimethylamino-N-[(1S)-2-[((3-fluoro-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=10.59 mins (>90%), HPLC-MS 559.2 [M+H]+, 577.2 [M+H+H2O]+.
EXAMPLE 323
(3aR,6aS)-N-[(1S)-2-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=14.61 mins (>90%), HPLC-MS 632.0/634.0 (M+H]+.
EXAMPLE 324
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(thiophene-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-benzamide
HPLC Rt=12.93 mins (>90%), HPLC-MS 582.0/584.0 [M+H]+.
EXAMPLE 325
(3aR,6aS)-3-Bromo-N-[(1S)-2-(4-cyclohexanecarbonyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=15.0-17.0 mins (>90%), HPLC-MS 582.1/584.1 [M+H]+.
EXAMPLE 326
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(2-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=14.4-16.1 mins (>90%), HPLC-MS 590.0/592.0 [M+H]+.
EXAMPLE 327
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(3-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=14.4-15.8 mins (>90%), HPLC-MS 590.0/592.0 [M+H]+.
EXAMPLE 328
(3aR,6aS)-3-Bromo-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(4-methyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=13.8-14.9 mins (>90%), HPLC-MS 590.0/592.0 [M+H]+.
EXAMPLE 329
(3aR,6aS)-N-[(1S)-2-[4-(Benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=17.0-18.5 mins (>80%), HPLC-MS 644.1 [M+H]+.
EXAMPLE 330
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-2,2-diphenyl-acetamide
HPLC Rt=16.4-17.5 mins (>85%), HPLC-MS 588.2 [M+H]+.
EXAMPLE 331
(3aR,6aS)-3-Aminomethyl-N-[(1S)-2-[4-(benzo[b]thiophene-3-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=10.82 mins (>90%), HPLC-MS 583.1 [M+H]+.
EXAMPLE 332
(3aR,6aS)-3-Aminomethyl-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=8.16 mins (>85%), HPLC-MS 605.1 [M+H]+, 623.2 [M+H+H2O]+.
EXAMPLE 333
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-benzamide
HPLC Rt=11.79 mins (>95%), HPLC-MS 498.1 [M+H]+.
EXAMPLE 334
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-chloro-benzamide
HPLC Rt=13.64 mins (>95%), HPLC-MS 532.1/534.1 [M+H]+.
EXAMPLE 335
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-fluoro-benzamide
HPLC Rt=12.10 mins (>90%), HPLC-MS 516.1 [M+H]+.
EXAMPLE 336
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-nicotinamide
HPLC Rt=8.16 mins (>95%), HPLC-MS 499.1 [M+H]+, 997.2 [2M+H]+.
EXAMPLE 337
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl)-3-bromo-4-methyl-benzamide
HPLC Rt=14.0-15.1 mins (>85%), HPLC-MS 590.0/592.0 [M+H]+.
EXAMPLE 338
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-methoxy-benzamide
HPLC Rt=11.81 mins (>95%), HPLC-MS 528.1 [M+H]+.
EXAMPLE 339
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-trifluoromethoxy-benzamide
HPLC Rt=14.21 mins (>90%), HPLC-MS 582.1 [M+H]+, 600.2 [M+H+H2O]+.
EXAMPLE 340
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl-butyl]-3-bromo-benzamide
HPLC Rt=15.0-16.1 mins (>85%), HPLC-MS 526.1/528.1 [M+H]+.
EXAMPLE 341
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(3-methyl-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=17.0-18.3 mins (>85%), HPLC-MS 574.0/576.0[M+H]+.
EXAMPLE 342
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(3-fluoro-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=15.8-17.1 mins (>90%), HPLC-MS 578.0/580.0 [M+H]+.
EXAMPLE 343
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(3,5-difluoro-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=15.9-17.3 mins (>90%), HPLC-MS 596.0/598.0 (M+H]+.
EXAMPLE 344
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b] pyrrol-1-yl)-1-(4-fluoro-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=17.1-18.2 mins (>90%), HPLC-MS 578.0/580.0 [M+H]+.
EXAMPLE 345
(3aR,6aS)-N-[(1S)-2-[4-((2S)-2-Acetylamino-4-methyl-pentanoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-3-bromo-benzamide
HPLC Rt=12.73 mins (>90%), HPLC-MS 627.0/629.0 [M+H]+.
In addition, EXAMPLES 7, 8, 9, 10, 12, 14, 15, 16, 17, 18, 28, 31, 37, 59, 63, 65, 68, 73, 85, 86, 87, 88, 89, 90, 91, 92, 93, 98, 103, 104, 111, 113, 117, 118, 145, 151, 154, 158, 159, 161, 164, 170, 171, 172, 173, 174, 175, 178, 179, 180, 181, 182, 185, 193, 194, 204, 216, 244, 245, 246, 247, 249a, 249b, 249c, 250, 251, 254, 255, 256, 258, 259, 261, 262, 268, 269, 270, 271, 272, 273, 275, 278, 280, 281, 282, 285, 286, 287, 288, 289, 290, 291, 292, 293, 295, 346, 356, 357, 358 and 359 have utility as inhibitors of cathepsin L with Ki less than 5000 nM.
EXAMPLES 346 to 359 were prepared as detailed for EXAMPLES 1 and 119, substituting the appropriate carboxylic acids as required and are inhibitors of cruzain and cruzipains with Ki ranging from 10-5000 nM;
EXAMPLE 346
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxybenzyl)-2-oxo-ethyl]-4-tert-butyl-benzamide
HPLC Rt=16.0-17.1 mins (>90%), HPLC-MS 554.3 [M+H]+, 1129.5 [2M+Na]+.
EXAMPLE 347
(3aR,6aS)-4-tert-Butyl-N-{(1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridin-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide
HPLC Rt=16.82 mins (>90%), HPLC-MS 557.2 [M+H]+.
EXAMPLE 348
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-fluoro-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide
HPLC Rt=16.44 mins (>85%), HPLC-MS 557.2 [M+H]+, 575.3 [M+H+H2O]+.
EXAMPLE 349
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-fluoro-benzyl)-2-[4-(naphthalene-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=19.6-20.8 mins (>80%), HPLC-MS 606.1 [M+H]+.
EXAMPLE 350
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-fluoro-benzyl)-2-[4-(naphthalene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=21.0-22.0 mins (>85%), HPLC-MS 606.1 [M+H]+.
EXAMPLE 351
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-3-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide
HPLC Rt=14.27 mins (>85%), HPLC-MS 555.3 [M+H]+, 573.3 [M+H+H2O]+.
EXAMPLE 352
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(pyridine-4-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-ethyl}-benzamide
HPLC Rt=14.35 mins (>90%), HPLC-MS 555.2 [M+H]+, 573.3 [M+H+H2O]+.
EXAMPLE 353
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(naphthalene-1-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=17.8-18.7 mins (>85%), HPLC-MS 604.2 [M+H]+.
EXAMPLE 354
(3aR,6aS)-4-tert-Butyl-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(naphthalene-2-carbonyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=17.3-18.2 mins (>85%), HPLC-MS 604.1 [M+H]+.
EXAMPLE 355
(3aR,6aS)-Quinoline-4-carboxylic acid [(1S)-2-(4-benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl]-amide
HPLC Rt=10.10 mins (>90%), HPLC-MS 549.2 [M+H]+, 567.2 [M+H+H2O]+.
EXAMPLE 356
(3aR,6aS)-N-[(1S)-2-(4-Benzoyl-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl)-1-(4-hydroxy-benzyl)-2-oxo-ethyl)-4-dimethylamino-benzamide
HPLC Rt=10.34 mins (>90%), HPLC-MS 541.2 [M+H]+.
EXAMPLE 357
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(2-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=9.78 mins (>90%), HPLC-MS 619.2 [M+H]+, 637.2 [M+H+H2O]+.
EXAMPLE 358
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-(4-hydroxy-benzyl)-2-[4-(3-methanesulfonyl-benzoyl)-6-oxo-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-2-oxo-ethyl}-benzamide
HPLC Rt=9.95 mins (>80%), HPLC-MS 619.2 [M+H]+, 637.2 [M+H+H2O]+.
EXAMPLE 359
(3aR,6aS)-4-Dimethylamino-N-{(1S)-1-(4-hydroxy-benzyl)-2-oxo-2-[6-oxo-4-(thiophene-2-carbonyl)-hexahydro-pyrrolo[3,2-b]pyrrol-1-yl]-ethyl}-benzamide
HPLC Rt=10.69 mins (>85%), HPLC-MS 547.2 [M+H]+, 565.2 (M+H+ H2O]+.
In addition, EXAMPLES 1, 2, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 39, 42, 43, 44, 46, 47, 48, 49, 50, 51, 53, 54, 55, 56, 58, 59, 60, 61, 62, 63, 64, 65, 66, 68, 69, 70, 71, 72, 73, 74, 77, 79, 80, 81, 82, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 111, 113, 114, 115, 116, 117, 118, 128, 130, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 145, 147, 150, 151, 154, 156, 157, 158, 159, 160, 161, 162, 164, 165, 166, 167, 168, 170, 171, 172, 173, 174, 175, 180, 183, 184, 185, 190, 191, 192, 193, 194, 196, 197, 199, 200, 203, 204, 205, 206, 207, 208, 209, 210, 212, 214, 216, 217, 218, 220, 221, 223, 224, 226, 227, 228, 233, 235, 238, 240, 241, 242, 244, 245, 246, 247, 248, 249a, 249b, 249c, 254, 255, 256, 260, 261, 271, 286, 287, 288, 290, 292, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 313, 314, 315, 316, 317, 318, 319, 321, 322, 323, 324, 325, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 342, 343, 344 and 345 have utility as inhibitors of cruzain and cruzipains with Ki less than 5000 nM.
EXAMPLE 360 was prepared as detailed for EXAMPLE 1 substituting the appropriate carboxylic acids as required and is an inhibitor of Leismania mexicana CPB protease with Ki less than 5000 nM;
EXAMPLE 360
(3aR,6aS)-4-tert-Butyl-N-[(1S)-1-(4-methyl-benzyl)-2-oxo-2-(6-oxo-4-phenylacetyl-hexahydro-pyrrolo[3,2-b]pyrrole-1-yl)-ethyl]-benzamide
HPLC Rt=19.5-20.6 mins (>80%), HPLC-MS 566.3 [M+H]+.
In addition, EXAMPLES 1, 2, 3, 5, 6, 13, 14, 16, 17, 20, 21, 24, 25, 26, 27, 28, 29, 31, 32, 34, 35, 37, 39, 42, 43, 44, 46, 47, 48, 50, 56, 57, 59, 60, 62, 63, 64, 65, 66, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 82, 85, 86, 87, 88, 89, 90, 91, 92, 93, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 128, 130, 132, 134, 135, 136, 137, 138, 139, 141, 142, 145, 147, 148, 150, 151, 154, 158, 159, 160, 161, 164, 165, 166, 167, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 185, 190, 191, 192, 193, 194, 201, 204, 207, 208, 209, 212, 213, 214, 215, 216, 220, 230, 233, 234, 235, 245, 246, 247, 248, 249a, 249b, 249c, 271, 278, 286, 295, 314, 315, 316, 318, 319, 329, 330, 331, 332 and 345 have utility as inhibitors of Leismania mexicana CPB protease with Ki less than 5000 nM.
In addition, EXAMPLES 2, 7, 14, 15, 27, 28, 31, 34, 35, 39, 40, 41, 43, 46, 48, 54, 57, 58, 59, 60, 61, 73, 74, 77, 87, 90, 91, 99, 102, 103, 104, 113, 135, 141, 151, 158, 166, 173, 194, 247, 249a, 249b, 249c, 251, 252, 253, 254, 255, 258, 259, 261, 262, 264, 266, 267, 269, 271, 273, 275, 279, 281, 286, 290, 292, 296, 298, 299, 300, 301, 304, 305, 307, 308, 309, 310, 314, 315, 316, 323, 325, 327, 329 and 330 have utility as inhibitors of cathepsin B with Ki less than 5000 nM.
Solution Phase Syntheses
Alternative strategies to the solid phase techniques described for EXAMPLES 1→360 above are broadly outlined in Schemes 15, 17 and 18. Here, building blocks may be prepared for solution phase syntheses for example 3-Oxo-hexahydro-pyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (analogue of compound 53, Scheme 15), prepared in 7 steps as follows:
(1) Preparation of (2S,3S) 3-Hydroxypyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester
- Boc anhydride (2.95 g, 13.5 mmol) was added to a stirred solution of the (2S,3S)-3-hydroxypyrrolidine-2-carboxylic acid (1.61 g, 12.3 mmol) and sodium carbonate (1.3 g, 12.3 mmol) in a mixture of dioxane (25 ml) and water (12.3 ml). The mixture was stirred for 1.5 h at ambient temperature then evaporated under reduced pressure to afford a residue (−10 ml). The residue was diluted with water (30 ml) then extracted with ethyl acetate (40 ml). The aqueous phase was acidified (pH˜2.5) with dilute aqueous hydrochloric acid (0.1 M) then extracted with chloroform (4×50 ml). The combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to afford (2S,3S)-3-hydroxypyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester as a white crystalline solid (2.39 g, ˜85%), HPLC-MS (single main peak, 254.1 [M+Na]+ and 485.2 [M+H]+).
(2) Preparation of (2S,3S) 3-Hydroxypyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-tert-butyl ester
- A solution of allyl bromide (26 ml, 301 mmol) and tricaprylmethylammonium chloride (38.4 ml, 86.1 mmol) in dichloromethane (307 ml) was added to a stirred solution of (2S,3S) 3-hydroxypyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (19.89 g, 86.1 mmol) and sodium hydrogen carbonate (7.23 g, 86.1 mmol) in water (307 ml). The biphasic mixture was vigorously stirred overnight then diluted with water (100 ml) and the product extracted into dichloromethane (3×200 ml). The combined organic layers were dried (Na2SO4) and evaporated under reduced pressure to afford a residue. Flash chromatography of the residue over silica gel (400 g) using ethyl acetate:heptane (1:4) as the eluent afforded (2S,3S) 3-hydroxypyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-tert-butyl ester (9.4 g, 40%), TLC (single spot, Rf=0.28, 50% ethyl acetate in heptane), HPLC-MS (single main peak, 294.1 [M+Na]+, 565.3 [2M+Na]+); δH (400 MHz, CDCl3) 1.41 and 1.46 (combined integration 9H, 2×s, C(CH3)3 of geometric isomers), 1.87-1.97 (1H, m, 4-H), 2.06-2.18 (1H, m, 4-H), 2.28-2.36 (1H, m, OH), 3.55-3.71 (2H, m, 5-H2), 4.20 and 4.32 (combined integration of 1H, 2×s, 2-H geometric isomers), 4.46 (1H, br. s, 3-H), 4.57-4.73 (1H, m, OCH2), 5.25-5.37 (2H, m, OCH2CHCH2) and 5.86-5.98 (1H, m, OCH2CHCH2); δC (100 MHz, CDCl3) 28.6 and 28.7 (C(CH3)3), 32.5 and 32.95 (C-4), 44.5 and 44.9 (C-5), 66.2 (OCH2), 68.3 (C-2), 74.6 and 75.7 (C-3), 80.6 (OC(CH3)3), 118.95 and 119.4 (OCH2CHCH2), 131.9 (OCH2CHCH2), 154.25 and 154.9 (NCO2), 170.8 and 171.1 (CO2Allyl).
(3) Preparation of (2S,3R) 3-Azido-pyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-tert-buytl ester
- Diethyl azodicarboxylate (0.62 ml, 4.0 mmol) was added dropwise over 25 minutes to a stirred solution of (2S,3S) 3-hydroxypyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-tert-butyl ester (895 mg, 3.3 mmol) and triphenylphosphine (1.08 g, 4.1 mmol) in tetrahydrofuran (30 ml) at 0° C. under an atmosphere of argon. The solution was stirred for 5 minutes then diphenylphosphoryl azide (0.89 ml, 4.1 mmol) was added dropwise over 10 minutes. The mixture was stirred for 10 minutes at 0° C. then for 24 hours at ambient temperature before removing solvents in vacuo to obtain a residue which was purified by flash chromatography over silica gel eluting with a gradient of heptane:ethyl acetate 3:1→1:1. Appropriate fractions were combined and the solvents removed in vacuo to obtain (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-tert-butyl ester as a colourless oil (850 mg, 88%) which was contaminated with 5% of 4,5-dihydropyrrole-1,2-dicarboxylic acid 2-allyl ester 1-tert-butyl ester. TLC (main spot, Rf=0.70, heptane:ethyl acetate 1:1), HPLC-MS 197.1 [M−Boc+H]+, 241.1 [M−Bu+2H]+, 319.2 [M+Na]+, 615.3 [2M+Na]+; δH (CDCl3 at 298 K); (Doubling up of peaks in spectrum due to restricted rotation around Fmoc amide bond) 1.45 and 1.49 (1.8 and 1.2H respectively, Me3C, each s), 2.10-2.24 (2H, H-4, m), 3.44-3.52 and 3.60-3.73 (each 1H, H-5, m), 4.31-4.40 (1H, H-3, m), 4.45 and 4.54 (0.6 and 0.4H respectively, H-2, each d, J=7.6 Hz), 4.66-4.78 (2H, CH2CH═CH2, m), 5.28-5.33 (1H, CH2CH═CH2, m), 5.42 (1H, CH2CH═CH2, dd, J=17.2 and 3.7 Hz), 5.91-6.04 (1H, CH2CH═CH2); δC (CDCl3 at 298 K); 28.40 (u, Me3C), 29.40/30.18 (d, C-4), 44.22/44.62 (d, C-5), 61.21/61.86/61.98/62.23 (u, C-2 and C-3), 65.81/66.10 (d, CH2CH═CH2), 80.76/81.24 (q, Me3C), 118.79/119.21 (d, CH2CH═CH2), 131.82/131.87 (u, CH2CH═CH2), 153.53/154.11 (q, OCON), 169.19/169.38 (q, CO2CH2).
(4) Preparation of (2S,3R) 3-Benzyloxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-propyl ester
- Palladium (10 wt. % on carbon powder, 300 mg) was added portion wise to a solution of (2S,3R) 3-azidopyrrolidine-1,2-dicarboxylic acid 2-allyl ester 1-tert-butyl ester (790 mg, 2.66 mmol) in ethanol (20 ml) at 0° C. The mixture was stirred for 2 h under an atmosphere of hydrogen at ambient temperature, then filtered over celite and concentrated in vacuo to afford a residue (540 mg). The residue was suspended in dioxane (6 ml) then a solution of sodium carbonate (529 mg, 5 mmol) in water (12 ml) added. The mixture was cooled to 0° C. then a solution of benzyloxy chloroformate (0.314 ml) in dioxane (6 ml) added portion wise over 40 min at 0° C. The mixture was stirred for 30 min at 0° C. then at ambient temperature for 40 min. Water (150 ml) was added and the products extracted with chloroform (3×100 ml), dried (Na2SO4) and evaporated under reduced pressure to afford a residue. Flash chromatography of the residue over silica (100 g) using ethyl acetate:heptane (1:4) as the eluent afforded (2S,3R) 3-benzyl oxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-propyl ester (240 mg, 22%), TLC (single spot, Rf=0.47, 50% ethyl acetate in heptane); analytical HPLC Rt=18.06 min, HPLC-MS (single main peak, 429.2 [M+Na]+, 835.4 [2M+Na]+); δH (400 MHz, CDCl3) 0.90 (3H, t, J=7.3 Hz, CH3), 1.41 and 1.45 (combined integration 9H, 2×s, C(CH3)3 of geometric isomers), 1.46-1.66 (OCH2CH2CH3), 1.89-2.00 (1H, m, 4-H2), 2.12-2.25 (1H, m, 4-H2), 3.32-3.46 (1H, m, 5-H), 3.55-3.72 (1H, m, 5-H), 3.99-4.07 (1H, m, 3-H), 4.46-4.55 (OCH2CH2CH3), 4.88-5.17 (combined integration of 3H, m, 2-H and OCH2Ph), and 7.29-7.42 (6H, m, C6H5 and NB); δC (100 MHz, CDCl3) 10.5 (CH3), 22.10 (OCH2CH2), 28.41 and 28.50 (C(CH3)3), 29.4 and 30.5 (C-4), 43.9 and 44.3 (C-5), 52.8 (C-3), 60.5 and 61.3 (C-2), 66.9, 67.0 and 67.2 (OCH2Ph and OCH2), 80.5 (OC(CH3)3), 128.3, 128.4 and 128.7 (o-, m- and p-C6H5), 136.2 (NHCOOCH2C), 153.8 and 155.7 (NCO2 and NHCO2) and 171.1 (CO2Propyl).
(5) Preparation of (2S,3R) 3-Benzyloxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester
- A solution of sodium hydroxide (185 mg, 4.6 mmol) in water (1.6 ml) was added to a solution of (2S,3R) 3-benzyloxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-propyl ester (229 mg, 0.56 mmol) in ethanol (6 ml). The mixture was stirred for 8 h at ambient temperature. Water (50 ml) was added and the ethanol removed under reduced pressure. The aqueous residue was acidified to pH=2 by the addition of dilute aqueous hydrochloric acid (0.1 M). The mixture was then extracted with ethyl acetate (3×50 ml), dried Na2SO4) and evaporated under reduced pressure to afford (2S,3R) 3-benzyloxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (200 mg, 98%), analytical HPLC Rt=14.03 min, HPLC-MS (single main peak, 387.2 [M+Na]+, 751.4 [2M+Na]+); δH (400 MHz, CDCl3) 1.35 and 1.37 (combined integration 9H, 2×s, C(CH3)3 of geometric isomers), 1.86-2.15 (2H, m, 4-H2), 3.14-3.71 (2H, m, 5-H2), 4.20-4.49 (2H, m, 2-H and 3-H), 5.02-5.22 (2H, m, OCH2Ph), and 7.18-7.37 (6H, m, C6H5 and NH); δC (100 MHz, CDCl3) 28.3, 28.4, 28.5 and 29.2 (C(CH3)3 and C-4), 43.8 and 44.3 (C-5), 52.3 and 53.1 (C-3), 61.0 and 61.4 (C-2), 67.2 and 68.4 (OCH2Ph), 80.6 and 80.8 (OC(CH3)3), 128.2, 128.5 and 128.6 and 128.7 (o-, m- and p-C6H5), 135.5 (NHCOOCH2C), 153.8 and 154.3 (NCO2), 158.6 (NHCO2), 175.6 and 175.9 (CO2H).
(6) Preparation of (2S,3R) 3-Benzyloxycarbonylamino-2-(2-diazoacetyl) pyrrolidine-1-carboxylic acid tert-butyl ester
- (2S,3R) 3-benzyloxycarbonylaminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (161 mg, 0.443 mmol) was dissolved with stirring in anhydrous dichloromethane (18 ml). The reaction was flushed with nitrogen and cooled to −15° C. iso-Butylchloroformate (0.063 ml, 0.487 mmol) in anhydrous dichloromethane (1.5 ml) and N-methylmorpholine (0.097 ml, 0.886 mmol) in anhydrous dichloromethane (1.5 ml) were added simultaneously in 0.5 ml aliquots over 15 min. The mixture was stirred for 45 min at −15° C. then ethereal diazomethane (generated from addition of diazald (4.7 g, ˜15 mmol) in diethyl ether (75 ml) onto sodium hydroxide (5.25 g) in water (7.5 ml)/ethanol (15 ml) at 60° C.] was added to the activated amino acid solution. The mixture was allowed to warm to ambient temperature and stirred for 24 h. A few drops of acetic acid were added to the mixture, followed by diethyl ether (200 ml). The ethereal layer was washed with saturated aqueous sodium hydrogen carbonate (80 ml), dried (Na2SO4) and the solvents removed under reduced pressure to give a yellow residue (300 mg). Flash chromatography of the residue over silica (35 g) using ethyl acetate:heptane (1:3) afforded (2S,3R) 3-benzyloxycarbonylamino-2-(2-diazoacetyl)pyrrolidine-1-carboxylic acid tert-butyl ester (150 mg, 87%), TLC (single spot, Rf=0.29, 50% ethyl acetate in heptane); analytical HPLC Rt=15.15 min, HPLC-MS (single main peak, 411.2 [M+Na]+, 799.4 [2M+Na]+).
(7) Preparation of (2S,3R) 3-Oxohexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester
- A solution of (2S,3R) 3-benzyloxycarbonylamino-2-(2-diazoacetyl) pyrrolidine-1-carboxylic acid tert-butyl ester (90 mg, 0.23 mmol) was added over 1 h to a refluxing solution of rhodium(II) acetate dimer (2 mg, 0.0046 mmol) in dichloromethane (3 ml). The mixture was heated under reflux for 2 h and the solvent then removed in vacuo. The residue was diluted with tetrahydrofuran (40 ml) then filtered through a pad of celite. The filtrate was then concentrated in vacuo to afford a residue (106 mg). Flash chromatography of the residue over silica (35 g) using ethyl acetate:heptane (1:3) afforded (2S,3R) 3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (14 mg, 17%), TLC (two possible rotameric spots, Rf=0.30 and 0.23, 50% ethyl acetate in heptane), analytical HPLC Rt=15.479 min (−60%), 16.393 (−10%), 17.197 (˜10%), 18.085 (˜10%) and 21.665 (−10%); HPLC-MS (4 main peaks, 361.0=[M+H]+, 379=[M+H3O]+, 401.0 [M+H2O+Na]+, [2M+H]+=721.0, [2M+Na]+=743.0, [2[M+H2O]+Na]+=779.0); δH (500 MHz, CDCl3) 1.40-1.50 (9H, m, C(CH3)3), 1.78-1.86 (1H, m, NCH2CH2), 2.30-2.47 (1H, m, NCH2CH2), 3.90-4.06 (2H, m, NCH2), 5.05-5.20 (4H, m, OCH2, BocNCHCO and CbzNCH), 5.44 (1H, d, J=2.2 Hz, CbzNCH2), 5.56 (1H, br. s, CbzNCH2) and 7.30-7.37 (5H, m, C6H5); δC (126 MHz, CDCl3) 27.5 (C(CH3)3), 29.6 and 32.2 (NCH2CH2), 57.7 (CbzNCH), 59.1 (NCH2), 67.0 (OCH2), 77.2 (BocNCH), 83.5 (OC(CH3)3), 110.7 (CbzNCH2), 128.0, 128.2 and 128.5 (o-, m- and p-C6H5), 136.1 (OCH2C of Cbz), 147.6, 151.4 155.7 and 167.1 (2×NCO2 and CbzNCH2CO).
(8) Preparation of (2S,3R) 3-Oxohexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester hydrochloride salt (analogue of compound 54)
- (2S,3R) 3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester (9 mg, 0.025 mmol) was dissolved in 4M HCl in dioxane (1.25 ml) then stirred for 1 h at room temperature. The mixture was concentrated in vacuo then toluene (10 ml) added. The mixture was concentrated once again in vacuo and the procedure repeated to afford a residue (10 mg, ˜100%), HPLC-MS (single main peak, 261.1 [M+H]+ and 279.1 [M+H3O]+).
Alternatively, a useful building block for solution phase synthesis is (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 4-benzyl ester 1-tert-butyl ester (80) described earlier in Scheme 20. The utility of building block (80) is detailed in alternative syntheses of EXAMPLES 1 and 14, through Scheme 26, which is an example of the general synthetic strategy detailed in Scheme 18.
Preparation of (3aR,6S,6aS)-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (128)
A solution of HCl in 1,4-dioxane (4.0M, 11 ml, 44 mmol) was added to (3S,3aS,6aR)-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1,4-dicarboxylic acid 4-benzyl ester 1-tert-butyl ester (80) (450 mg, 1.24 mmol). The solution was stirred for 65 minutes whereupon a white suspension formed. The solvents were removed in vacuo and the residue azeotroped with diethyl ether (3×15 ml) and then dimethylformamide (10 ml) and benzoic anhydride (295 mg, 1.31 mmol) added. The solution was placed under an atmosphere of argon then 4-methylmorpholine (0.29 ml, 2.6 mmol) was added to the solution dropwise whilst stirring over 0.5 minutes. The mixture was stirred for 1.75 hours then the solvents were removed in vacuo. The residue was dissolved in ethyl acetate (100 ml) then washed with saturated aqueous sodium hydrogen carbonate solution (100 ml), pH 3 hydrochloric acid (100 ml) then brine (100 ml). The organic layer was dried (Na2SO4) and evaporated in vacuo to afford (3aR,6S,6aS)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (128) as a pale yellow gum (465 mg), which was used without further purification. Analytical HPLC Rt=14.967 min; HPLC-MS 367.1 [M+H]+, 733.1 [2M+H]+; Elemental analysis C21H22N2O4.0.4EtOAc req. (fnd.) % C 67.62 (67.73), % H 6.33 (6.17), % N 6.98 (7.08); HRMS C21H22N2O4Na req. 389.1477, fnd. 389.1476 (−0.40 ppm); dH (500 MHz, CDCl3) approximately 3:1 mixture of rotamers, 2.10-2.21 (1H, m, BzNCHCH2), 2.24-2.36 (1H, m, BzNCHCH2), 3.20-3.35 (1H, m, CbzNCH2), 3.35-3.66 (2H, m, BzNCH2), 3.74-3.80 (1H, m, CbzNCH2), 4.16-4.20 (1H, m, CbzNCR), 4.38-4.42 (1H, br. s; CHOH), 4.94-5.04 (1H, m, BzNCB), 5.08-5.22 (2H, m, OCH2Ph), 7.30-7.52 (10H, aromatic CB); dC (125 MHz, CDCl3) 31.02, 30.40 (BzNCHCH2), 45.73, 45.86 (CbzNCH2), 56.43, 56.74 (BzNCH2), 60.58, 61.49 (BzNCH), 66.68, 67.33 (OCH2Ph), 66.92, 67.76 (CbzNCH), 73.01, 73.86 (CHOH), 126.77, 127.48, 127.99, 128.23, 128.28, 128.45, 128.56, 128.87, 130.02, 130.38 and 134.53 (CH aromatics), 136.16, 136.23, 136.33 (aromatic quaternary), 154.26, 154.97 (CbzC═O), 170.06, 171.19 (BzC═O).
Preparation of (3aR,6aS)-4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (129)
(3aR,6S,6aS)-4-Benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (128) (0.78 g, 2.13 mmol) was dissolved in dichloromethane (20 ml) with stirring under argon. Dess-Martin periodinane (1.804 g, 4.26 mmol) was added and the mixture stirred for 16 hours. The mixture was concentrated in vacuo and the residue purified by flash chromatography over silica, eluting with ethyl acetate:heptane mixtures to give (3aR,6aS)-4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (129) (0.61 g, 78%) as an off-white gum. TLC (Rf=0.27, EtOAc:heptane 3:1), analytical HPLC single main peak, Rt=14.65-16.30 min., HPLC-MS 365.1 [M+H]+, 383.1 [M+H+H2O]+; Elemental analysis C21H20N2O4.1.2H2O req. (fnd.) % C 65.38 (65.12), % H 5.85 (5.65), % N 7.26 (6.95>; HRMS C21H20N2O4Na req. 387.1321, fnd. 387.1324 (0.76 ppm); Sc (125 MHz, CDCl3) 30.41, 30.89, 31.23 (BzNCHCH2), 45.75 (CbzNCH2), 54.55, 63.04 (BzNCH+CbzNCH), 57.91, 58.45, 58.99, 59.73 (BzNCH2), 67.60, 68.07 (OCH2Ph), 127.00, 127.38, 127.48, 127.98, 128.11, 128.48, 128.62, 128.74, 130.48, 130.83 (CH aromatics), 135.07, 136.14 (quaternary aromatics), 154.54, 155.03 (CbzCO2), 170.58 (BzCO), 204-207 (broad, C═O).
Preparation of (3aR,6aS)-4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (130)
(3aR,6aS)-4-Benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (129) (0.60 g, 1.65 mmol) was dissolved in methanol (10 ml) with stirring. Trimethylorthoformate (1.8 ml, 16.5 mmol) was added followed by para-toluenesulfonic acid (40 mg) and the mixture heated under argon at 65° C. for 16 hours. The mixture was reduced in vacuo to leave a dark oil (0.8 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (3aR,6aS)-4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (130) (0.52 g, 77%) as a fine white crystalline solid. TLC (Rf=0.40, EtOAc:heptane 3:1), analytical HPLC single main peak, Rt=18.22 min., HPLC-MS 411.1 [M+H]+, 433.1 [M+Na]+, 843.1 [2M+Na]+; HRMS C23H26N2O5Na req. 433.1739, fnd. 433.1727 (−2.94 ppm); δH (500 MHz, CDCl3) 1.96-2.07, 2.15-2.22 (2H, m, BzNCHCH2), 3.04-3.42 (6H, m, 2×OCH3), 3.25 (1H, m, CbzNCH2), 3.4 (1H, m, BzNCH2), 3.58-3.67 (1H, m, BzNCH2), 3.96-4.07 (1H, m, CbzNCH2), 4.35-4.58 (1H, m, CbzNC), 4.98-5.26 (3H, BzNCH+OCH2Ph), 7.28-7.49 (10H aromatics); δC (125 MHz, CDCl3) 32.27, 32.59 (BzNCHCH2), 46.74 (CbzNCH2), 49.36, 51.10, 51.59 (2×OCH3), 54.59, 56.08 (BzNCH2), 60.77, 61.08 (BzNCH), 62.47 (CbzNCH), 67.28 (OCH2Ph), 106.76, 107.02 (C(OCH3)2), 126.84, 127.35, 127.90, 128.06, 128.39, 130.05, 130.38 (CH aromatics), 135.91, 136.48 (quaternary aromatics), 155.44 (CbzCO2), 169.54 (BzCO).
Preparation of (3aS,6aR)-(3,3-dimethoxyhexahydropyrrolo[3,2-b]pyrrol-1-yl)phenylmethanone (131)
Methanol (15 ml) was added cautiously dropwise to a stirred mixture of (3aR,6aS)-4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (130) (0.48 g, 1.17 mmol) and 10% palladium on charcoal (100 mg) at 0° C. under an atmosphere of argon over 10 minutes. The argon was then replaced by an atmosphere of hydrogen and stirring continued at ambient temperature for 85 minutes before replacing the hydrogen with argon and adding ethanol (30 ml). The mixture was filtered under reduced pressure through celite and the filter cake washed with methanol (25 ml) then ethanol (70 ml). Solvents were removed from the filtrate in vacuo to obtain (3aS,6aR)-(3,3-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-yl) phenylmethanone (131) as a colourless oil (340 mg), which was used without further purification. HPLC-MS 277.1 [M+H]+, 553.2 [2M+H]+.
Preparation of (3aR,6aS)-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrol [3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (132)
(i) Preparation of Cbz-L-Leucine Fluoride
Cbz-L-Leucine (1.115 g, 4.2 mmol) was dissolved in dichloromethane (50 ml) with stirring under argon. (Diethylamino)sulfur trifluoride (DAST, 792 μl, 6.0 mmol) was added and the mixture stirred for 40 minutes. Ice-cooled water (200 ml) was added to the mixture and the organic layer separated, dried (Na2SO4) and reduced in vacuo to a mobile tan oil (1.14 g). An analytical sample, pre-treated with 10% pyridine in methanol for 15 minutes gave HPLC-MS 266.1 [M+H]+ (acid, <5%), 280.1 [M+H]+, 302.1 [M+Na]+, 581.1 [2M+Na]+ (methyl ester, ˜95%).
(ii) Crude (3aS,6aR)-(3,3-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-yl)phenyl methanone (131) (˜1.17 mmol) was dissolved in anhydrous dimethylformamide (5 ml) with stirring. Cbz-L-Leucine fluoride (0.33 g, 1.23 mmol) was added and the mixture stirred under argon for 1 hour. The mixture was reduced in vacuo to a semi-mobile dark oil (˜1.0 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (3aR,6aS)-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydro pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (132) (0.55 g, 90%) as an off-white crystalline solid. TLC (Rf=0.35, EtOAc:heptane 3:1), analytical HPLC single main peak, Rt=19.396 min., HPLC-MS 524.1 [M+H]+, 546.1 [M+Na]+, 1069.2 [2M+Na]+; Elemental analysis C29H37N3O6 req. (fnd.) % C 66.52 (66.26), % H 7.12 (7.30), % N 8.02 (7.86); HRMS C29H37N3O6Na req. 546.2580, fnd. 546.2584 (0.67 ppm); δH (500 MHz, CDCl3) 0.92-1.04 (6H, m, 2× Leu δCH3), 1.45-1.55 (2H, m, Leu βCH2), 1.73-1.84 (1H, m, Leu γCH), 1.92-1.99, 2.10-2.16, 2.22-2.30 (2H, 4:6:10, m, BzNCHCH2), 2.94, 3.19, 3.23 and 3.40 (6H total, each s, C(OCH3)2), 3.14-3.38 (2H, m, 1×BzNCH2 and 1×CbzLeuNCH2), 3.60-3.68 (1H, 4:6, each d, J=12 Hz, 1×BzNCH2), 4.03-4.10, 4.11-4.18 (1H, 4:6, m, 1×CbzLeuNCH2), 4.33 (0.4H, d, J=6.3 Hz, 0.4×CbzLeuNCE), 4.5-4.65 (0.6H, m, 0.6× Leu aCH), 4.82 (0.6H, d, J=6.45 Hz, 0.6×CbzLeuNCH), 4.87-4.93 (0.4H, m, 0.4× Leu aCH), 5.0-5.14 (3H, m, BzNCH+OCH2Ph), 5.42 (0.6H, d, J=8.3 Hz, LeuNH), 5.57 (0.4H, d, J=8.9 Hz, LeuNH), 7.3-7.5 (10H, aromatics); δC (125 MHz, CDCl3) 21.99, 22.20, 22.67, 23.06, 23.67 (2× Leu δCH3), 24.37, 24.57 (Leu γCH), 31.58, 31.86, 33.26 (BzNCHCH2), 42.78 (Leu βCH2), 44.12, 45.79, 47.05 (CbzLeuNCH2), 49.31, 49.99 (1×OCH3), 51.18, 51.27, 51.30, 51.47 (1×OCH3+Leu αCH), 55.55, 57.03 (BzNCH2), 59.69, 61.32 (BzNCH), 60.30, 61.04 (CbzLeuNCH), 66.39, 66.88(OCH2Ph), 106.27, 107.11 (C(OCH3)2), 126.84, 127.32, 127.42, 127.87, 127.94, 128.09, 128.43, 128.48, 130.18, 130.43, 130.50 (CH aromatics), 135.68, 135.81, 136.28, 136.73 (quaternary aromatics), 155.58, 156.21 (CbzCO2), 169.56, 169.62 (BzCO), 172.35, 173.36 (Leu C═O).
Preparation of (2S,3aR,6aS)-2-amino-1-(4-benzoyl-6,6-dimethoxyhexahydro pyrrolo[3,2-b]pyrrole-1-yl)-4-methylpentan-1-one (133)
Methanol (15 ml) was added cautiously dropwise to 10% palladium on charcoal (75 mg) at 0° C. under an atmosphere of argon over 10 minutes whilst stirring followed by a solution of (3aR,6aS)-[(1S)-1-(4-benzoyl-6,6-dimethoxy hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (132) (0.52 g, 0.99 mmol) in methanol (15 ml). The argon was then replaced by an atmosphere of hydrogen and stirring continued at ambient temperature for 5.5 hours. A suspension of 10% palladium on charcoal (15 mg) in methanol (1 ml) was added and stirring continued for 2.25 hours. The hydrogen was replaced by argon then ethanol (100 ml) was added before filtering the mixture through celite. The filter cake was washed with ethanol (100 ml) then the filtrate separated into two equal portions before concentrating separately in vacuo to obtain two identical batches of (2S,3aR,6aS)-2-amino-1-(4-benzoyl-6,6-dimethoxy hexahydropyrrolo[3,2-b]pyrrole-1-yl)-4-methyl pentan-1-one (133). TLC (Single spot, Rf=0.05, EtOAc:heptane 9:1), HPLC-MS 390.2 [M+H]+, 801.2 [2M+Na]+ as white solids which were contaminated with approximately 5% of (3aR,6aS)-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (132) starting material. Each batch was used without further purification (see preparations of (134) and (135) below).
Preparation of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6,6-dimethoxy hexa hydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butyl benzamide (134)
4-Methylmorpholine (0.109 ml, 0.994 mmol) was added to a solution of HBTU (189 mg, 0.497 mmol), 1-hydroxybenzotriazole monohydrate (76 mg, 0.497 mmol) and 4-(tert-butyl)benzoic acid (88 mg, 0.497 mmol) in dimethylformamide (12.5 ml). The solution was stood for 5 minutes then added to (2S,3aR,6aS)-2-amino-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-yl)-4-methylpentan-1-one (133) (prepared as above, 0.497 mmol). The mixture was stirred at ambient temperature for 1 hour 50 minutes then the solvents were removed in vacuo. The residue was dissolved in dichloromethane (60 ml) then washed with pH 3 hydrochloric acid (40 ml), saturated aqueous sodium hydrogen carbonate solution (40 ml) and brine (40 ml), then dried (Na2SO4) and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 50:50 to give (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydro pyrrolo [3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butyl benzamide (134) as a white solid (230 mg) which contained approximately 5% of (3aR,6aS)-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl] carbamic acid benzyl ester (132) The latter compound was removed prior to the hydrolysis step (i.e. preparation of EXAMPLE 1 below) by dissolving (220 mg) in methanol (11 ml) then adding to a stirred suspension of 10% palladium on charcoal (70 mg) in ethanol (11 ml) under an atmosphere of argon at 0° C. The argon was then replaced by hydrogen and the mixture stirred at ambient temperature for 80 minutes, then water (11 ml) was added and the mixture filtered through celite. The filter cake was washed with ethanol (200 ml) then the filtrate concentrated in vacuo to give an oily solid (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butylbenzamide (134) (203 mg) which was used without her purification. TLC (Single spot, Rf=0.65, EtOAc in heptane 9:1), analytical HPLC Rt=21.412 min; HPLC-MS 550.2 [M+H]+; Elemental analysis C32H43N3O5 req. (fnd.) % C 69.92 (69.52), % H 7.88 (8.12), % N 7.64 (7.40); HRMS C32H44N3O5 req. 550.3281, fnd. 550.3284 (0.55 ppm).
Preparation of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydro pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4 dimethylaminobenzamide (135)
4-Methylmorpholine (0.109 ml, 0.994 mmol) was added to a solution of HBTU (189 mg, 0.497 mmol), 1-hydroxybenzotriazole monohydrate (76 mg, 0.497 mmol) and 4-(dimethylamino)benzoic acid (82 mg, 0.497 mmol) in dimethylformamide (12.5 ml). The solution was stood for 5 minutes then added to (2S,3aR,6aS)-2-amino-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrol-1-yl)-4-methylpentan-1-one (133) (prepared as above, 0.497 mmol). The mixture was stirred at ambient temperature for 7 hours then the solvents removed in vacuo (water bath temperature<26° C.) to obtain a volume of approximately 3 ml. Stirring was continued for 1.25 hours then the remaining solvent was removed in vacuo. The residue was dissolved in dichloromethane (60 ml) then washed with pH 3 hydrochloric acid (40 ml), saturated aqueous sodium hydrogen carbonate solution (40 ml) and brine (40 ml), then dried (Na2SO4) and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 65:35 to give (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-dimethylamino benzamide (135) as a white solid (180 mg, 68%). TLC (Single spot, Rf=0.30, EtOAc:heptane 9:1), analytical HPLC Rt=15.789 min; HPLC-MS 537.2 [M+H]+; Elemental analysis C30H30N4O5.0.4EtOAc req. (fnd.) % C 66.41 (66.60), % H 7.62 (7.92), % N 9.80 (9.51); HRMS C30H40N4O5Na req. 559.2896, fnd. 559.2902 (0.95 ppm).
Preparation of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-oxo-hexahydropyrrolo[3,2-b]pyrrole-carbonyl)-3-methylbutyl]-4-tert-butylbenzamide (EXAMPLE 1)
(3aR,6aS)-N-[(1S)-1-(4-Benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl butyl]-4-tert-butylbenzamide (134) (0.19 g, 0.345 mmol) was dissolved in ice-cooled trifluoroacetic acid/water (95:5 v/v, 10 ml) with stirring. The ice-bath was removed and the mixture stirred at ambient temperature for 3.5 hours. The mixture was then reduced in vacuo and evaporated from diethyl ether (2×10 ml) to give a semi-mobile tan gum (0.3 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butyl benzamide (EXAMPLE 1) (0.042 g, 24%) as a white solid. TLC (Rf=0.45, EtOAc:heptane 9:1), analytical HPLC single broad main peak, Rt=19.43-21.37 min., HPLC-MS 504.1 [M+H]+; Elemental analysis C30H37N3O4.0.5TFA req. (fnd.) % C 66.45 (66.04), % H 6.75 (7.19), % N 7.50 (7.24); HRMS C30H37N3O4Na req. 526.2682, fnd. 526.2677 (−0.96 ppm); dH (500 MHz, CDCl3) Tentative assignment of peaks due to presence of rotamers 0.95 (3H, d, J=6.5 Hz, Leu δCH3), 1.01 (3H, d, J=6.2 Hz, Leu δCH3), 1.31 (9H, s, C(CH3)3), 1.58-1.81 (3H, m, Leu βCH2 and Leu γCH), 1.85-2.73 (2H, m, BzNCHCH2), 3.55-3.69 (1H, m, BzNCHCH2CH2), 3.85-5.20 (6H, m, BzNCHCH2CH2, BzNCH2C(═O)CH and Leu αCH), 6.70-6.89 (1H, m, NH), 7.40-7.52 (7H, m, COC6H5 and CHCHCC(CH3)3), 7.65-7.76 (2H, m, CHCHCC(CH3)3); δC (500 MHz, CDCl3) 22.06, 23.28 (2× Leu δCH3), 24.82 (Leu γCH), 31.11, 31.14 (C(CH3)3), 31.67, 31.86 (BzNCHCH2), 34.89, 34.92 (C(CH3)3), 42.43 (Leu βCH2), 46.10 (BzNCHCH2CH2), 48.93 (Leu αCH), 60.2 (BzNCH2), 61.0 (BzNCH or BzNCH2C(═O)CH), 68.2 (BzNCH or BzNCH2C(═O)CH), 125.41, 125.49, 125.54, 126.91, 126.97, 127.11, 127.46, 128.33, 128.79, 130.84 (CH aromatics), 130.70, 131.16, 135.0 (quaternary aromatics), 155.35 (CC(CH3)3), 167.07, 170.67, 172.61 (3×NC═O).
Preparation of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrol-1-carbonyl)-3-methylbutyl]-4-dimethylamiobenzamide (EXAMPLE 14)
Water (1.75 ml) was added dropwise to a stirred solution of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6,6-dimethoxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-dimethylaminobenzamide (135) (175 mg, 0.327 mmol) in trifluoroacetic acid (17.5 ml) at 0° C. over 3 minutes. The solution was then stirred at ambient temperature for 17 hours then the solvents removed in vacuo (water bath<25° C.). The residue was azeotroped with diethyl ether (25 ml) then the residue purified by flash chromatography over silica eluting with ethyl acetate: heptane mixtures 0:100 to 70:30 to give (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-dimethylaminobenzamide (EXAMPLE 14) as a white solid (113.6 mg, 71%). TLC (Single spot, Rf=0.25, EtOAc:heptane 9:1), analytical HPLC Rt=14.241 min; HPLC-MS 491.2 [M+H]+; C28H34N4O4.0.5TFA req. (fnd.) % C 63.64 (63.07), % H 6.35 (6.76), % N 10.23 (9.91); HRMS C28H34N4O4Na req. 513.2478, fnd. 513.2492 (2.72 ppm); dH (500 MHz, CDCl3) Tentative assignment of peaks due to presence of rotamers 0.94 (3H, d, J=6.5 Hz, Leu δCH3), 0.99 (3H, d, J=6.2 Hz, Leu δCH3), 1.46-1.83 (3H, m, Leu βCH2 and Leu γCH), 1.90-2.70 (2H, m, BzNCHCH2), 2.99 (6H, s, N(CH3)2), 3.45-3.69 (1H, m, BzNCHCH2CH2), 3.90-5.25 (6H, m, BzNCHCH2CH2, BzNCH2C(═O)CH and Leu aCH), 6.58-6.75 (1H, m, NH), 6.60-6.68 (2H, m, CHCN(CH3)2), 7.35-7.55 (5H, m, COC6H5), 7.60-7.73 (2H, m, CHCHCN(CH3)2); δC (500 MHz, CDCl3) 22.13, 23.25 (2× Leu δCH3), 24.78 (Leu γCH), 31.65, 31.85 (BzNCHCH2), 40.04, 40.09, 40.13 (N(CH3)2), 42.35 (Leu γCH2), 46.12 (BzNCHCH2CH2), 48.79 (Leu αCH), 59.99 (BzNCH2), 60.80 (BZNCH or BzNCH2C(═O)CH), 67.7 (BzNCH or BzNCH2C(═O)CH), 110.89, 111.00, 111.04, 111.35 (CHCN(CH3)2), 120.17 (CCHCHCN(CH3)2), 126.92, 127.12, 127.48, 128.31, 128.63, 128.67, 128.77, 129.00, 130.81, 130.96 (CH aromatics), 135.0 (quaternary aromatics), 152.61 (CN(CH3)2), 167.21, 170.69, 173.01 (3×NC═O).
Alternatively, a useful building block for solution phase synthesis is (3aR,6S,6aS)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (128) described earlier in Scheme 26. The utility of building block (128) is detailed in an alternative synthesis of EXAMPLE 1, through Scheme 27, which is an example of the general synthetic strategy detailed in Scheme 17.
Preparation of (3S,3aS,6aR)-(3-hydroxyhexahydropyrrolo[3,2-b]pyrrol-1-yl)phenylmethanone (136)
Ethanol (5 ml) was added cautiously dropwise to 10% palladium on charcoal (50 mg) at 0° C. under an atmosphere of argon over 10 minutes whilst stirring followed by a solution of (3aR,6S,6aS)-4-benzoyl-6-hydroxy hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid benzyl ester (128) (465 mg, 1.27 mmol prepared as above) in ethanol (10 ml). The argon was then replaced by an atmosphere of hydrogen and stirring continued at ambient temperature for 4.5 hours. The hydrogen was then replaced by argon and 10% palladium on charcoal (20 mg) was added at 0° C. The argon was then replaced with hydrogen and stirring was continued for 4 hours. The hydrogen was replaced by argon then the mixture was filtered through celite. The filter cake was washed with ethanol (75 ml) then the filtrate concentrated in vacuo to obtain (3S,3aS,6aR)-(3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-yl)phenylmethanone (136) as a colourless oil (309 mg) which was used without further purification. HPLC-MS 233.1 [M+H]+, 465.1 [2M+H]+.
Preparation of (3aR,6aS)[(1S)-1-((6S)-4-benzoyl-hydroxyhexa hydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (137)
Cbz-Leu-F (350 mg, 1.31 mmol) was dissolved in dimethylformamide (5 ml) then added to (3S,3aS,6aR)-(3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-yl)phenyl methanone (136) (304 mg, 1.24 mmol, prepared as above) under an atmosphere of argon. The solution was stirred for 1.25 hours then the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 80:20 to give (3aR,6aS)-[(1S)-1-((6S)-4 benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl] carbamic acid benzyl ester (137) as a white solid (402 mg, 68%). TLC (Single spot, Rf=0.10, EtOAc:heptane 65:35), analytical HPLC Rt=16.803 min; HPLC-MS 480.2 [M+H]+, 981.3 [2M+Na]+; HRMS C27H33N3O5Na req. 502.2318, fnd. 502.2311 (−1.44 ppm).
Alternative preparation of (3aR,6aS)-[(1S)-1-(6S)-4-(benzoyl-6-hydroxyhexa hydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (137)
Dimethylformamide (1 ml) was added to a mixture of (3S,3aS,6aR)-(3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-yl)phenylmethanone (136) (24 mg, 0.087 mmol, prepared as above) and Cbz-Leu-OSuc (32 mg, 0.088 mmol) under an atmosphere of argon. The solution was stirred for 20 hours then the solvents removed in vacuo to obtain a residue which was dissolved in dichloromethane (20 nm) then washed with water (10 ml), dried (Na2SO4) and the solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 30:70 to 80:20 to give (3aR,6aS)-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methyl butyl]carbamic acid benzyl ester (137) as a white solid (25 mg, 60%). TLC (Single spot, Rf=0.10, EtOAc:heptane 65:35), analytical HPLC Rt=17.301 min; HPLC-MS 480.2 [M+H]+, 981.3 [2M+Na]+; C27H33N3O5.0.2EtOAc req. (fnd.) % C 67.20 (67.03), % H 7.02 (7.16), % N 8.45 (8.27); dH (500 MHz, CDCl3) mixture of rotamers, tentative assignment of proton 1.2-2.4 (11H, m, 2×Leu δCH3, Leu βCH2, Leu γCH, BzNCHCH2), 3.3-4.0 (4H, m, BzNCH2, CbzLeuNCH2), 4.2-5.0 (4H, BzNCH, CbzLeuNCH, CHOH, Leu αCH), 5.0-5.1 (2H, OCH2Ph), 5.4 (1H, d, J=8.3 Hz, NH), 7.4-7.6 (10H, aromatic); dC (125 MHz, CDCl3) 21.73, 21.89 and 23.22, 23.36 (2× Leu δCH3), 24.59, 24.67 (Leu γCH), 31.86 (BzNCHCH2), 42.02, 42.22 (Leu PCH2), 46.52 (CbzLeuNCH2), 50.94, 51.02 (Leu αCH), 56.58 (BzNCH2), 59.72 (BzNCH), 67.00 (OCH2Ph), 67.98 (CbzLeuNCH), 75.25 (CHOH), 127.34, 128.02, 128.18, 128.28, 128.36, 128.52, 130.34 (aromatic CH), 136.09, 136.18 (aromatic quaternary), 156.18 (NHC═O), 170.08 (PhC═O), 172.32 (CH2NC═O).
Preparation of (2S,3aR,6aS)-2-amino-1-((6S)-4-benzoyl-6-hydroxyhexahydro pyrrolo[3,2-b]pyrrole-1-yl)-4-methylpentan-1-one (138)
Ethanol (15 ml) was added cautiously to a stirred mixture of (3aR,6aS)-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl] carbamic acid benzyl ester (137) (370 mg, 0.77 mmol) and 10% palladium on charcoal (50 mg) at 0° C. under an atmosphere of argon. The argon was replaced by an atmosphere of hydrogen then stirring continued at ambient temperature for 1.75 hours. The hydrogen was replaced by argon then the mixture was cooled to 0° C. before adding a further portion of 10% palladium on charcoal (20 mg). The argon was replaced by hydrogen then stirring continued at ambient temperature for 5.25 hours. The hydrogen was replaced by argon then the mixture was cooled to 0° C. before adding a further portion of 10% palladium on charcoal (20 mg). The argon was replaced by hydrogen then stirring continued at ambient temperature for 14 hours. The hydrogen was replaced by argon then the mixture was cooled to 0° C. before adding a further portion of 10% palladium on charcoal (10 mg). The argon was replaced by hydrogen then stirring continued at ambient temperature for 2 hours. The hydrogen was replaced by argon then the mixture was diluted with ethanol (60 ml) and filtered through celite. The filter cake was washed with ethanol (40 ml) then the filtrate concentrated in vacuo. The residue was azeotroped with ethyl acetate (35 ml) to obtain (2S,3aR,6aS)-2-amino-1-((6S)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-yl)-methylpentan-1-one (138) as an oily white solid (270 mg), which was used without further purification. HPLC-MS 346.2 [M+H]+, 713.3 [2M+Na]+.
Preparation of (3aR,6aS)-N-[(1-(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl-4-tert-butyl-benzamide (139)
4-Methylmorpholine (0.17 ml, 1.55 mmol) was added to a solution of HBTU (293 mg, 0.77 mmol), 1-hydroxybenzotriazole monohydrate (118 mg, 0.77 mmol) and 4-(tert-butyl)benzoic acid (138 mg, 0.77 mmol) in dimethylformamide (7.5 ml). The solution was stood for 5 minutes then added to (2S,3aR,6aS)-2-amino-1-((6S)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-yl]-4-methylpentan-1-one (138) (prepared as above, 0.77 mmol). The mixture was stirred at ambient temperature for 1 hour 5 minutes then the solvents removed in vacuo (water bath temperature<28° C.). The residue was dissolved in dichloromethane (75 ml) then washed with pH 3 hydrochloric acid (60 ml), saturated aqueous sodium hydrogen carbonate solution (60 ml) and brine (60 ml), dried (Na2SO4) and the solvents removed in vacuo. The residue (512 mg) was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 85:15 to give (3aR,6aS)-N-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butyl-benzamide (139) as a white solid (263 mg, 68%). TLC (Single spot, Rf=0.15, EtOAc:heptane 9:1), analytical HPLC Rt=19.340 min; HPLC-MS 506.2[M+H]+; C30H39N3O4.0.5EtOAc req. (fnd.) % C 69.97 (69.86), % H 7.89 (7.87), % N 7.65 (7.88); HRMS C30H39N3O4Na req. 528.2838, fnd. 528.2818 (−3.89 ppm).
Preparation of (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butylbenzamide (EXAMPLE 1)
A solution of (3aR,6aS)-N-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydro-pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butyl-benzamide (139) (174 mg, 0.345 mmol) in dichloromethane (10 ml) was added to Dess-Martin periodinane (292 mg, 0.689 mmol) under an atmosphere of argon whilst stirring over 2.5 minutes. The mixture was stirred for 3 minutes then trifluoroacetic acid (53 μl, 0.689 mmol) was added. The mixture was stirred for 14 hours then solvents removed in vacuo. The residue was purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 55:45 to give (3aR,6aS)-N-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]-4-tert-butylbenzamide (EXAMPLE 1) as a white solid (128 mg, 74%). TLC (Single spot, Rf=0.20, EtOAc:heptane 9:1), analytical HPLC broad peak Rt=19.2-20.6 min; HPLC-MS single broad UV peak, 504.1 [M+H]+.
Preparation of (3aR,6aS)-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (EXAMPLE 361)
A solution of (3aR,6aS)-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexa hydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (137) (15.0 mg, 0.031 mmol) in dichloromethane (0.75 ml) was added dropwise to Dess-Martin periodinane (26.6 mg, 0.063 mmol) under an atmosphere of argon whilst stirring over 1 minute. The solution was stirred for 4.5 hours then purified by flash chromatography over silica eluting with ethyl acetate:heptane mixtures 0:100 to 80:20 to give (3aR,6aS)-[(1S)-1-(4-benzoyl-6-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]carbamic acid benzyl ester (EXAMPLE 361) as a white solid (8.8 mg, 58%). TLC (Single spot, Rf=0.35, EtOAc:heptane 9:1), analytical HPLC broad peak Rt=17.7-19.5 min; HPLC-MS single broad UV peak, 478.1 [M+H]+, 977.2 [2M+Na]+; HRMS C27H31N3O5Na req. 500.2161, fnd. 500.2168 (1.26 ppm).
Alternatively, the general synthetic strategy detailed in Scheme 28 involves construction of an extended compound prior to intramolecular ring closure to the 5,5-cis bicycle as the penultimate step. As detailed in Scheme 20, the building block (R)-2-(2-azidoethyl)-2,5 dihydropyrrole-1-carboxylic acid tert-butyl ester (76) may be reduced to the primary amine, which in Scheme 28 is directly acylated with a protected aminoacid. Following epoxidation, then conversion of the aminoacid protecting group to a suitable capping group, with all of the potency and specificity components now in place, ring-closure and oxidation provides the final inhibitor compound. The utility of such synthetic flexibility is detailed in an alternativesynthesis of EXAMPLE 1, through Scheme 28.
Preparation of (2R)-2-[2-((2S)-2-benzyloxycarbonylamino-4-methylpentanoyl amino)ethyl]-2,5-dihydro pyrrole-1-carboxylic acid tert-butyl ester (140)
(R)-2-(2-Aminoethyl)-2,5-dihydropyrrole-1-carboxylic acid tert-butyl ester (see preparation of (77) above, ˜0.63 mmol) was dissolved in 1,4-dioxane (10 ml) with stirring, ice-cooled and a solution of sodium carbonate (0.14 g, 1.32 mmol) in water (10 ml) was added. Cbz-L-Leu-OSu (0.251 g, 0.693 mmol) in 1,4-dioxane (10 ml) was added dropwise over 30 minutes, then the ice bath removed and the mixture stirred for a further 30 minutes. Water (100 ml) was then added and the aqueous phase extracted with dichloromethane (2×100 ml). The combined organic layers were dried (Na2SO4), filtered and reduced in vacuo to leave a clear gum (0.54 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (2R)-2-[2-((2S)-2-benzyloxycarbonylamino-4-methylpentanoylamino)ethyl]-2,5-dihydro pyrrole-1-carboxylic acid tert-butyl ester (140) (0.21 g, 72%) as a clear oil. TLC (Rf=0.30, EtOAc:heptane 1:1), analytical HPLC single main peak, Rt=20.326 min., HPLC-MS 360.1 [M+2H−Boc]+, 404.1 [M+2H−Bu]+, 460.2 [M+H]+, 482.1 [M+Na]+, 941.2 [2M+Na]+; Elemental analysis C25H37N3O5 req. (fnd.) % C 65.34 (65:14), % H 8.11 (8.19), % N 9.14 (9.07); HRMS C25H37N3O5Na req. 482.2631, fnd. 482.2620 (−2.33 ppm).
Preparation of (2R)-2-[2-((2S)-2-benzyloxycarbonylamino-4-methylpentanoyl amino)ethyl]-6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (141)
(2R)-2-[2-((2S)-2-Benzyloxycarbonylamino-4-methylpentanoylamino)ethyl]-2,5-di hydropyrrole-1-carboxylic acid tert-butyl ester (140) (0.20 g, 0.435 mmol) was dissolved in dichloromethane (5 ml) with stirring then meta-chloroperoxybenzoic acid (65% reagent, 1.15 g, 4.35 mmol) added. The mixture was stirred at ambient temperature under argon for 16 hours. Dichloromethane (100 ml) was added and the organic phase washed with 10% w/v aqueous sodium hydroxide solution (2×100 ml), then dried (Na2SO4), filtered and reduced in vacuo to leave an oily solid (0.19 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (2R)-2-[2-((2S)-2-benzyloxycarbonylamino-4-methylpentanoyl amino)ethyl]-6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxlic acid tert-butyl ester (141) (0.19 g, 92%) as an opaque gum. TLC (Rf=0.35 (major) and 0.42 (minor) (mixture of anti and syn epoxides), EtOAc:heptane 3:1), analytical HPLC single main peak, Rt=19.21 min., HPLC-MS 376.1 [M+2H−Boc]+, 420.1 [M+2H−Bu]+, 476.1 [M+H]+, 498.1 [M+Na]+, 973.2 [2M+Na]+; Elemental analysis C25H37N3O6 req. (fnd.) % C 63.14 (63.11), % H 7.84 (7.96), % N 8.84 (8.80); HRMS C25H37N3O6Na req. 498.2580, fnd. 498.2602 (4.34 ppm).
Preparation of (2R)-2-{2-[(2S)-2-(4-tert-butylbenzoylamino)-4-methyl pentanoylamino]ethyl}-6-oxa-3-aza-bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester (142)
(i) (2R)-2-[2-((2S)-2-Benzyloxycarbonylamino-4-methylpentanoylamino)ethyl]-6-oxa-3-azabicyclo [3.1.0]hexane-3-carboxlic acid tert-butyl ester (141) (0.17 g, 0.357 mmol) was dissolved in ethanol (5 ml), cooled to 0° C. and 10% palladium on charcoal (0.034 g) added. The mixture was stirred, then evacuated and flushed with hydrogen. The mixture was allowed to warm to ambient temperature, stirred for 45 minutes then filtered through celite. The filter cake was washed with ethanol (3×10 ml) and the combined organic layers reduced in vacuo to provide the crude free amine, which was used without further purification. HPLC-MS 342.2 [M+H]+, 683.3 [2M+H]+, 705.3 [2M+Na]+.
(ii) The crude free amine was dissolved in anhydrous dimethylformamide (3 ml) with stirring and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluroniumhexafluoro phosphate (HBTU, 0.136 g, 0.357 mmol) and 1-hydroxybenzotriazole monohydrate (HOBT, 0.0548 g, 0.357 mmol) added. 4-Methylmorpholine (78.6 μl, 0.715 mmol) was added and the mixture stirred for 1.5 hours, then reduced in vacuo. The residue was dissolved in dichloromethane (50 ml) and washed with pH 3 hydrochloric acid (50 ml), saturated sodium hydrogen carbonate solution (50 ml) and brine (50 ml). The organic phase was dried ((Na2SO4), filtered and reduced in vacuo to leave a pale yellow gum (0.19 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (2R)-2-{2-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoylamino]ethyl}-6-oxa-3-aza-bicyclo[3.1.0] hexane-3-carboxylic acid tert-butyl ester (142) (0.08 g, 45%) as a white crystalline solid. TLC (Rf=0.26, EtOAc:heptane 3:1), analytical HPLC single main peak, Rt=21.195 min. HPLC-MS 446.2 [M+2H−Bu]+, 502.3 [M+H]+, 524.2 [M+Na]+; Elemental analysis C28H43N3O5 req. (fnd.) % C 67.04 (67.07), % H 8.64 (8.96), % N 8.38 (7.87); HRMS C28H43N3O5Na req. 524.3100, fnd. 524.3086 (−2.81 ppm).
Preparation of (3S,3aS,6aR)-4-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-3-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (143)
(2R)-2-{2-[(2S)-2-(4-tert-Butylbenzoylamino)-4-methylpentanoylamino]ethyl}-6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid tert-butyl ester (142) (0.06 g, 0.12 mmol) was dissolved in tetrahydrofuran (3 ml) with stirring under nitrogen and ice-cooled. Sodium hydride (60% dispersion in oil, 0.010 g, 0.25 mmol) was added over 1 minute and the mixture stirred at ambient temperature for 16 hours. Water (10 ml) was added, then saturated aqueous ammonium chloride solution (5 ml) and the product extracted into ethyl acetate (2×25 ml). The combined organic layers were dried (Na2SO4), filtered and reduced in vacuo to leave a clear film (0.06 g). Flash chromatography over silica, eluting with ethyl acetate:heptane mixtures gave (3S,3aS,6aR)-4-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-3-hydroxyhexa hydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (143) (0.021 g, 35%) as a white solid. TLC (Rf=0.40, EtOAc:heptane 2:1), HPLC-MS 502.3 [M+H]+, 524.2 [M+Na]+.
A second product fraction contaminated by starting epoxide (˜25% by WV analysis) was obtained as a white solid (0.0239 g).
Preparation of (3aS,6aR)-4-[(2S)-2-(4-tert-butylbenzoylamino)-4-methyl pentanoyl]-3-oxo-hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (EXAMPLE 362)
(3S,3aS,6aR)-4-[(2S)-2-(4-tert-Butylbenzoylamino)-4-methylpentanoyl]-3-hydroxy hexahydropyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (143) (0.021 g, 0.042 mmol) was dissolved in dichloromethane (2 ml) with stirring under argon. Dess-Martin periodinane (0.0373 g, 0.088 mmol) was added and the mixture stirred for 16 hours. The mixture was reduced in vacuo and the residue purified by flash chromatography over silica, eluting with ethyl acetate:heptane mixtures to give (3aS,6aR)-4-[(2S)-2-(4-tert-butylbenzoylamino)-4-methylpentanoyl]-3-oxo-hexahydro pyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (EXAMPLE 362) (0.015 g, 71%) as an off-white gum. TLC (Rf=0.53, EtOAc:heptane 2:1), analytical HPLC single broad main peak, Rt=20.6-22.5 min., HPLC-MS 500.1 [M+H]+. HRMS C28H41N3O5Na req. 522.2944, fnd. 522.2952 (1.49 ppm); δH (500 z, CDCl3) 0.85-1.03 (7H, m, 2× Leu δCH3+Leu γCH), 1.32 (9H, s, (CH3)3CPh), 1.47 (9H, s, (CH3)3COCO), 1.6-1.8 (2H, m, Leu βCH2), 2.03-2.15/2.33-2.45 (2H, b, BocNCHCH2), 3.50-3.60 (1H, m, LeuNCH2), 3.75-3.82 (1H, m, BocNCH2), 3.93-4.02 (1H, m, BocNCH2), 4.02-4.08 (1H, m, LeuNCH2), 4.58-4.80 (1H, b, BocNCH or LeuNCH), 4.96-4.98 (1H, b, BocNCH or LeuNCR), 5.0-5.06/5.25-5.30 (1H, bm, Leu αCH), 6.83-6.93 (1H, b, LeuNH), 7.42-7.45 (2H, d, J=8.5 Hz, (CH3)3C—C—CH═CH), 7.72-7.75 (2H, d, J=8.5 Hz, (CH3)3C—C—CH═CH); δC (125 MHz, CDCl3) 22.27, 23.48 (2×Leu δCH3), 24.78 (Leu γCH), 28.32 ((CH3)3COCO), 29.64, 31.82 (BocNCHCH2), 31.09 ((CH3)3CPh), 34.88 ((CH3)3CPh), 42.50 (Leu βCH2), 45.95 (LeuNCH2), 49.09, 49.67 (Leu αCH), 52.37 (BocNCH2), 56.82 (BocNCH), 62.92 (LeuNCH), 81.16 ((CH3)3COCO), 125.34, 125.44 ((CH3)3C—C—CH═CH), 126.89, 126.95 ((CH3)3C—C—CH═CH), 130.83 (quatemnary aromatics), 155.26 ((CH3)3COCO), 167.01 (CH3)3CPhCO), 172.28 ((Leu C═O).
Preparation of (3aR,6aS)-N-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydro pyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbuty]-4-tert-butylbenzamide (139)
(i) (3S,3aS,6aR)-4-[(2S)-2-(4-tert-Butylbenzoylamino)-4-methylpentanoyl]-3-hydroxyhexahydro pyrrolo[3,2-b]pyrrole-1-carboxylic acid tert-butyl ester (143) (0.023 g, 0.046 mmol) was dissolved in 4.0M HCl in 1,4-dioxane (2 ml, 8 mmol) with stirring. After 45 minutes the solvents were removed in vacuo and the residue triturated then evaporated from diethyl ether (3×3 ml) to leave (3aR,6aS)-4-tert-butyl-N-[(1S)-1-((6S)-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]benzamide hydrochloride as a white solid which was used without further purification; HPLC-MS 402.2 [M+H]+, 424.2 [M+Na]+, 803.4 [2M+H]+, 825.4 [2M+Na]+.
(ii) (3aR,6aS)-4-tert-Butyl-N-[(1S)-1-((6S)-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbutyl]benzamide hydrochloride (prepared as above, ˜0.048 mmol) was dissolved in dimethylformamide (2 ml) with stirring, then benzoic anhydride (0.0114 g, 0.05 mmol) added followed by 4-methylmorpholine (11.1 μl, 0.0102 g, 0.101 mmol). After 1 hour, ethyl acetate (25 ml) was added and the organics washed with saturated aqueous sodium hydrogen carbonate solution (25 ml) solution, pH 3 hydrochloric acid (25 ml), and brine (25 ml). The organics were dried (Na2SO4), filtered and reduced in vacuo to a colourless film (3aR,6aS)-N-[(1S)-1-((6S)-4-benzoyl-6-hydroxyhexahydropyrrolo[3,2-b]pyrrole-1-carbonyl)-3-methylbuty]-4-tert-butylbenzamide (139) (0.028 g). TLC (Rf=0.16, EtOAc:heptane 4:1), analytical HPLC single broad main peak, Rt=19.15 min., HPLC-MS 506.2 [M+H]+, 528.2 [M+Na]+.
Oxidation to EXAMPLE 1 is as detailed in Scheme 27.
EXAMPLE A
Assays for Cysteine Protease Activity
The compounds of this invention may be tested in one of a number of literature based biochemical assays that are designed to elucidate the characteristics of compound inhibition. The data from these types of assays enables compound potency and the rates of reaction to be measured and quantified. This information, either alone or in combination with other information, would allow the amount of compound required to produce a given pharmacological effect to be determined.
General Materials and Methods
Unless otherwise stated, all general chemicals and biochemicals were purchased from either the Sigma Chemical Company, Poole, Dorset, U.K or from Fisher Scientific UK, Loughborough, Leicestershire, U.K. Absorbance assays were carried out in flat-bottomed 96-well plates (Spectra; Greiner Bio-One Ltd., Stonehouse, Gloucestershire, U.K.) using a SpectraMax PLUS384 plate reader (Molecular Devices, Crawley, U.K.). Fluorescence high throughput assays were carried out in either 384-well microtitre plates (Corning Costar 3705 plates, Fisher Scientific) or 96-well ‘U’ bottomed Microfluor W1 microtitre plates (Thermo Labsystems, Ashford, Middlesex, U.K.). Fluorescence assays were monitored using a SpectraMax Gemini fluorescence plate reader (Molecular Devices). For substrates employing either a 7-amino-4-methylcoumarin (AMC) or a 7-amino-4-trifluoromethylcoumarin (AFC) fluorophore, assays were monitored at an excitation wavelength of 365 nm and an emission wavelength of 450 nm and the fluorescence plate reader calibrated with AMC. For substrates employing a 3-amino-benzoyl (Abz) fluorophore, assays were monitored at an excitation wavelength of 310 nm and an emission wavelength of 445 nm; the fluorescence plate reader calibrated with 3-amino-benzamide (Fluka). Unless otherwise indicated, all the peptidase substrates were purchased from Bachem UK, St Helens, Merseyside, UK. Substrates utilizing fluorescence resonance energy transfer methodology (i.e. FRET-based substrates) were synthesized at Incenta Limited using published methods (Atherton & Sheppard, Solid Phase Peptide Synthesis, IRL Press, Oxford, U.K, 1989) and employed Abz (2-aminobenzoyl) as the fluorescence donor and 3-nitro-tyrosine [Tyr(NO2)] as the fluorescence quencher (Meldal, M. and Breddam, K., Anal. Biochem, 195, 141-147, 1991). Hydroxyethylpiperazine ethanesulfonate (HEPES), tris-hydroxylmethyl aminomethane (tris) base, bis-tris-propane and all the biological detergents (e.g. CHAPS, zwittergents, etc.) were purchased from CN Biosciences UK, Beeston, Nottinghamshire, U.K. Glycerol was purchased from Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, U.K. Stock solutions of substrate or inhibitor were made up to 10 mM in 100% dimethylsulfoxide (DMSO) (Rathburns, Glasgow, U.K.) and diluted as appropriately required. In all cases the DMSO concentration in the assays was maintained at less than 1% (vol./vol.).
Assay protocols were based on literature precedent (Table 4; Barrett, A. J., Rawlings, N. D. and Woessner, J. F., 1998, Handbook of Proteolytic Enzymes, Academic Press, London and references therein) and modified as required to suit local assay protocols. Enzyme was added as required to initiate the reaction and the activity, as judged by the change in fluorescence upon conversion of substrate to product, was monitored over time. All assays were carried out at 25±1° C.
TABLE 4
|
|
The enzyme assays described herein were carried out according to
literature precedents.
EnzymeBufferSubstrateReference
|
Cathepsin BIZ-Phe-Arg-AMCa, b
Cathepsin HIIBz-Phe-Val-Arg-AMCa, b
Cathepsin LIAc-Phe-Arg-AMCb, c
Cathepsin SIBoc-Val-Leu-Lys-AMCc, d
Caspase 1IIIAc-Leu-Glu-His-Asp-AMCe
Caspase 2IIIZ-Val-Asp-Val-Ala-Asp-AFCf
Caspase 3IIIAc-Asp-Glu-Val-Asp-AMCg, h
Caspase 4IIISuc-Tyr-Val-Ala-Asp-AMCf
Caspase 5IIIAc-Leu-Glu-His-Asp-AMC
Caspase 6IIIAc-Val-Glu-Ile-Asp-AMCi, j, k
Caspase 7IIIAc-Asp-Glu-Val-Asp-AMC
Caspase 8IIIAc-Ile-Glu-Thr-Asp-AMCl
Caspase 9IIIAc-Leu-Glu-His-Asp-AMC
Caspase 10IIIAc-Ile-Glu-Thr-Asp-AMC
CruzipainIVD-Val-Leu-Lys-AMCm, n
CPB2.8ΔCTEXIPro-Phe-Arg-AMCq
S. AureusIAbz-Ile-Ala-Ala-Pro-o
ExtracellularTyr(NO2)-Glu-NH2
cysteine
peptidase
ClostripainZ-Gly-Gly-Arg-AMCp
FMDV LPVAbz-Arg-Lys-Leu-Lys-Gly-r
Ala-Gly-Ser-Tyr(NO2)-Glu-
NH2
TrypsinVIZ-Gly-Gly-Arg-AMCs
Calpain μVIIAbz-Ala-Asn-Leu-Gly-Arg-Pro-t
Ala-Leu-Tyr(NO2)-Asp-NH2
Calpain mVIIIAbz-Lys-Leu-Cys(Bzl)-Phe-Ser-t
Lys-Gln-Tyr(NO2)-Asp-NH2
Cathepsin KIXZ-Phe-Arg-AMCu
Cathepsin XXv, w
|
I: 10 mM BTP, pH 6.5 containing 1 mM EDTA, 5 mM 2-mercaptoethanol and 1 mM CaCl2
|
II: 10 mM BTP, pH 6.5 containing 1 mM EDTA, 142 mM NaCl, 1 mM DTT, 1 mM CaCl2, 0.035 mM Zwittergent 3-16
|
III: 50 mM HEPES pH 7.2, 10% Glycerol, 0.1% CHAPS, 142 mM NaCl, 1 mM EDTA, 5 mM DTT
|
IV: 100 mM sodium phosphate, pH 6.75 containing 1 mM EDTA and 10 mM L-cysteine
|
V: 50 mM tris.acetate, pH 8.4 containing 1 mM EDTA, 10 mM L-cysteine and 0.25% (w/v) CHAPS
|
VI: 10 mM HEPES, pH 8.0 containing 5 mM CaCl2
|
VII: 10 mM HEPES, pH 7.5 containing 2 mM 2-mercaptoethanol and 100 μM CaCl2
|
VIII: 10 mM HEPES, pH 7.5 containing 2 mM 2-mercaptoethanol and 200 μM CaCl2
|
IX: 100 mM sodium acetate; pH 5.5 containing 10 mM L-cysteine and 1 mM EDTA
|
X: 100 mM sodium acetate; pH 5.5 containing 10 mM L-cysteine; 0.05% (w/v) Brij 35 and 1 mM EDTA
|
XI: 100 mM sodium acetate; pH 5.5 containing 10 mM L-cysteine; 142 mM sodium chloride and 1 mM EDTA
|
a Barrett, A. J., Biochem. J., 187, 909-912, 1980
|
b Barret, A. J. and Kirschke, H., Methods Enzymol., 80, 535-561, 1981
|
c Quibell, M. and Taylor, S., WO0069855, 2000
|
d Bromme, D., Steinert, ., Freibe, S., Fittkau, S., Wiederanders, B., and Kirschke, H., Biochem. J., 264, 475-481, 1989
|
e Rano T. A., et. al., Chem. Biol., 4, 149, 1997
|
f Talanian, R. V., et. al., J. Biol. Chem., 272, 9677, 1997
|
g Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirer, G. G. and Earnshaw, W. C., Nature., 371, 768-774, 1994
|
h Han, Z., et. al., J. Biol. Chem., 272, 13432, 1997
|
i Takahashi, A., et. al., PNAS, 93, 8395, 1996
|
j Martins, L. M., et. al., J. Biol. Chem., 272, 7421, 1997
|
k Nagata, S., Cell., 88, 355, 1997
|
l Harris, J. L., et. al., J. Biol. Chem., 273, 27364, 1998
|
m Cazzulo, J. J., Cazzulo Franke, M. C., Martinez, J. and Franke de Cazzulo, B. M., Biochim. Biophys. Acta., 1037, 186-191, 1990
|
n Cazzulo, J. J., Bravo, M., Raimondi, A., Engstrom, U., Lindeberg, G. and Hellman, U., Cell Mol. Biol., 42, 691-696, 1996
|
o Potempa, J., Dubin, A., Korzus, G. and Travis, J., Biochem. J., 263, 2664-2667, 1988
|
p Kembhavi, A. A., Buttle, D. J., Rauber, P. and Barrett, A. J., FEBS Lett., 283, 277-280, 1991
|
q Alves, L. C., et. al., Mol. Biochem. Parasitol, 116, 1-9, 2001.
|
r Guarné, et.al., J. Mol. Biol., 302, 1227-1240, 2000.
|
s Halfon and Craik, (Barret, Rawlings and Woessner, eds.), in Handbook of Proteolytic Enzymes, Academic Press, London, 12-21, 1998.
|
t Sasaki, et. al., (1984), J. Biol. Chem., 259, 12489-12494, 1984.
|
u Bossard, M. J., et. al., , J. Biol. Chem., 21, 12517-12524, 1996
|
v Santamaria, I., et. al., J. Biol. Chem., 273, 16816-16823, 1998
|
w Klemencic, J, et al., Eur.J.Biochem., 267, 5404-5412, 2000
|
Trypanosoma cruzi Cruzipain Peptidase Activity Assays
Wild-type cruzipain, derived from Trypanosoma cruzi Dm28 epimastigotes, was obtained from Dr. Julio Scharfstein (Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil). Activity assays were carried out in 100 mM sodium phosphate, pH 6.75 containing 1 mM EDTA and 10 mM L-cysteine using 2.5 nM enzyme. Ac-Phe-Arg-AMC (KMapp˜ 12 μM) and D-Val-leu-Lys-AMC (KMapp˜ 4 μM) were used as the substrates. Routinely, Ac-FR-AMC was used at a concentration equivalent to KMapp and D-Val-Leu-Lys-AMC was used at a concentration of 25 μM. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Leishmania mexicana Cysteine Protease B (CPB) Peptidase Activity Assays
Wild-type recombinant CPB without the C-terminal extention (i.e. CPB2.8ΔCTE; Sanderson, S. J., et. al., Biochem. J., 347, 383-388, 2000) was obtained from Dr. Jeremy Mottram (Wellcome Centre for Molecular Parasitology, The Anderson College, University of Glasgow, Glasgow, U.K.). Activity assays were carried out in 100 mM sodium acetate; pH 5.5 containing 1 mM EDTA; 200 mM NaCl and 10 mM DTT (Alves, L. C., et. al., Mol. Biochem. Parasitol, 116, 1-9, 2001) using 0.25 nM enzyme. Pro-Phe-Arg-AMC (KMapp˜ 38 μM) was used as the substrate at a concentration equivalent to KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Cathepsin Peptidase Activity Assays
Bovine cathepsin S, human cathepsin L, human cathepsin H and human cathepsin B were obtained from CN Biosciences. Recombinant human cathepsin S, human cathepsin K and human cathepsin X were obtained from Dr. Boris Turk (Josef Stefan Institute, Ljubljana, Slovenia). Unless otherwise stated, all peptidase activity assays were carried out in 10 mM bis-tris-propane (BTP), pH 6.5 containing 1 mM EDTA, 5 mM 2-mercaptoethanol and 1 mM CaCl2. Human cathepsin H activity assays were carried out in 10 mM BTP pH 6.5, 142 mM NaCl2, 1 mM CaCl2, 1 mM EDTA, 1 mM DTT, 0.035 mM Zwittergent 3-16. Human cathepsin K assays were carried out in 100 mM sodium acetate; pH 5.5 containing 20 mM L-cysteine and 1 mM EDTA (Bossard, M. J., et. al., J. Biol. Chem., 21, 12517-12524, 1996). Human cathepsin X assays were carried out in 100 mM sodium acetate; pH 5.5 containing 20 mM L-cysteine; 0.05% (w/v) Brij 35 and 1 mM EDTA (Santamaria, I., et. al., J. Biol. Chem., 273, 16816-16823, 1998; Klemencic, J, et al., Eur. J. Biochem., 267, 5404-5412, 2000). The final enzyme concentrations used in the assays were 0.5 nM bovine cathepsin S, 1 nM cathepsin L, 0.1 nM cathepsin B, 0.25 nM Cathepsin K; 1 nM cathepsin X and 10 nM cathepsin H. For the inhibition assays, the substrates used for cathepsin S, cathepsin L, cathepsin B, cathepsin K and cathepsin H were boc-Val-Leu-Lys-AMC (KMapp˜ 30 μM), Ac-Phe-Arg-AMC (KMapp˜ 20 μM, Z-Phe-Arg-AMC (KMapp˜ 40 μM), Z-Leu-Arg-AMC (KMapp˜ 2 μM); Bz-Phe-Val-Arg-AMC (KMapp˜ 150 μM) respectively. In each case the substrate concentration used in each assay was equivalent to the KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Trypsin Peptidase Activity Assays
Human pancreatic trypsin (iodination grade; CN Biosciences) activity assays were carried out in 10 mM HEPES, pH 8.0 containing 5 mM CaCl2 using 0.1 nM trypsin. For the inhibition assays, Z-Gly-Gly-Arg-AMC (KMapp· 84 μM) was used as the substrate at a concentration equivalent to KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Clostripain Peptidase Activity Assays
Clostripain (Sigma) activity assays were carried out in 10 mM BTP, pH 6.5 containing 1 mM EDTA, 5 mM 2-mercaptoethanol and 1 mM CaCl2 using 0.3 nM enzyme. For the inhibition assays, Z-Gly-Gly-Arg-AMC (KMapp˜ 100 μM) was used as the substrate at a concentration equivalent to KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Calpain Peptidase Activity Assays
Calpain (human erythrocyte μ-calpain and porcine kidney m-calpain; CN Biosciences) activity assays were carried out in 10 mM HEPES, pH 7.5 containing 2 mM 2-mercaptoethanol and CaCl2 using 25 nM of either enzyme (Sasaki, et. al., J. Biol. Chem., 259, 12489-12494, 1984). For μ-calpain inhibition assays, the buffer contained 100 μM CaCl2 and Abz-Ala-Asn-Leu-Gly-Arg-Pro-Ala-Leu-Tyr(NO2)-Asp-NH2 (KMapp˜ 20 μM; Incenta Limited) was used as the substrate. For m-calpain inhibition assays, the assay buffer contained 200 μM CaCl2 and Abz-Lys-Leu-Cys(Bzl)-Phe-Ser-Lys-Gln-Tyr(NO2)-Asp-NH2 (KMapp˜ 22 μM; Incenta Limited) was used as the substrate. In both cases the substrate concentration employed in the assays was equivalent to the KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Extracellular S. aureus V8 Cysteine Peptidase (Staphylopain) Peptidase Activity Assays
S. aureus V8 was obtained from Prof S. Aridson, Karolinska Institute, Stockholm, Sweden. Extracellular S. aureus V8 cysteine peptidase (staphylopain) activity assays were carried out using partially purified S. aureus V8 culture supernatant (obtained from Dr. Peter Lambert, Aston University, Birmingham, U.K.). Activity assays were carried out in 10 mM BTP, pH 6.5 containing 1 mM EDTA, 5 mM 2-mercaptoethanol and 1 mM CaCl2 using two-times diluted partially purified extract. For the inhibition assays, Abz-Ile-Ala-Ala-Pro-Tyr(NO2)-Glu-NH2 (KMapp˜ 117 μM; Incenta Limited) was used as the substrate at a concentration equivalent to KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Foot-and-Mouth Disease Leader Peptidase (FMDV-LP) Activity Assays
Recombinant wild-type FMDV-LP was obtained from Dr. Tim Skern (Institut für Medizinische Biochemie, Abteilung für Biochemie, Universtät Wien, Wien, Austria). Activity assays were carried out in 50 mM tris.acetate, pH 8.4 containing 1 mM EDTA, 10 mM L-cysteine and 0.25% (w/v) CHAPS using 10 nM enzyme. For the inhibition assays, Abz-Arg-Lys-Leu-Lys-Gly-Ala-Gly-Ser-Tyr(NO2)-Glu-NH2 (KMapp˜ 51 μM, Incenta Limited) was used as the substrate at a concentration equivalent to KMapp. The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Caspase Peptidase Activity Assays
Caspases 1-10 were obtained from CN Biosciences or BioVision Inc. (Mountain View, Calif., USA) and all assays were carried out in 50 mM HEPES; pH 7.2, 10% (v/v) glycerol, 0.1% (w/v) CHAPS, 142 mM NaCl, 1 mM EDTA, 5 mM dithiothreitol (DTT) using 0.1-1 Upper assay. For caspase 1, Ac-Leu-Glu-His-Asp-AMC was used as the substrate; for caspase 2, Z-Val-Asp-Val-Ala-Asp-AFC was used as the substrate; for caspase 3, Ac-Asp-Glu-Val-Asp-AMC was used as the substrate; for caspase 4, Suc-Tyr-Val-Ala-Asp-AMC was used as the substrate; for caspase 5, Ac-Leu-Glu-His-Asp-AMC was used as the substrate; for caspase 6, Ac-Val-Glu-Ile-Asp-AMC was used as the substrate; for caspase 7, Ac-Asp-Glu-Val-Asp-AMC was used as the substrate; for caspase 8, Ac-Ile-Glu-Thr-Asp-AMC was used as the substrate; for caspase 9, Ac-Leu-Glu-His-Asp-AMC was used as the substrate; for caspase 10, Ac-Ile-Glu-Tbr-Asp-AMC was used as the substrate (Nicholson, D. W. and Thornberry, N. A., TIBS, 22, 299-306, 1997; Stennicke, H. R. and Salvesen, G. S., J. Biol. Chem., 272(41), 25719-25723, 1997; Talanian, R. V., et. al., J. Biol. Chem., 272(15), 9677-9682, 1997; Wolf, B. B. and Green, D. R., J. Biol. Chem., 274(29), 20049-20052, 1999). The rate of conversion of substrate to product was derived from the slope of the increase in fluorescence monitored continuously over time.
Measurement of the Apparent Macroscopic Binding (Michaelis) Constants (KMapp) for Substrates
The apparent macroscopic binding constant (KMapp) for each substrate was calculated, from the dependence of enzyme activity as a function of substrate concentration. The observed rates were plotted on the ordinate against the related substrate concentration on the abscissa and the data fitted by direct regression analysis (Prism v 3.02; GraphPad, San Diego, USA) using Equation 1 (Cornish-Bowden, A. Fundamentals of enzyme kinetics Portland Press; 1995, 93-128.).
In Equation 1 ‘vi’ is the observed initial rate, ‘Vmaxapp’ is the observed maximum activity at saturating substrate concentration, ‘KMapp’ is the apparent macroscopic binding (Michaelis) constant for the substrate, ‘[S0]’ is the initial substrate concentration.
Measurement of the Inhibition Constants
The apparent inhibition constant (Ki) for each compound was determined on the basis that inhibition was reversible and occurred by a pure-competitive mechanism. The Ki values were calculated, from the dependence of enzyme activity as a function of inhibitor concentration, by direct regression analysis (Prism v 3.02) using Equation 2 (Cornish-Bowden, A., 1995.).
In Equation 2 ‘vi’ is the observed residual activity, ‘Vmaxapp’ is the observed maximum activity (i.e. in the absence of inhibitor), ‘KMapp’ is the apparent macroscopic binding (Michaelis) constant for the substrate, ‘[S]’ is the initial substrate concentration, ‘K1’ is the apparent dissociation constant and ‘[I]’ is the inhibitor concentration.
In situations where the apparent dissociation constant (Kiapp) approached the enzyme concentrations, the Kiapp values were calculated using a quadratic solution in the form described by Equation 3 (Morrison, J. F. Trends Biochem. Sci., 7, 102-105, 1982; Morrison, J. F. Biochim. Biophys. Acta, 185, 269-286, 1969; Stone, S. R. and Hofsteenge, J. Biochemistry, 25, 4622-4628, 1986).
Kiapp=Ki(1+[So]/KMapp) (4)
In Equation 3 ‘v1’ is the observed residual activity, ‘F’ is the difference between the maximum activity (i.e. in the absence of inhibitor) and minimum enzyme activity, ‘Eo’ is the total enzyme concentration, ‘Kiapp’ is the apparent dissociation constant and ‘Io’ is the inhibitor concentration. Curves were fitted by non-linear regression analysis (Prism) using a fixed value for the enzyme concentration. Equation 4 was used to account for the substrate kinetics, where ‘K1’ is the inhibition constant, ‘[So]’ is the initial substrate concentration and ‘KMapp’ is the apparent macroscopic binding (Michaelis) constant for the substrate (Morrison, 1982).
The Second-Order Rate of Reaction of Inhibitor with Enzyme
Where applicable, the concentration dependence of the observed rate of reaction (kobs) of each compound with enzyme was analysed by determining the rate of enzyme inactivation under pseudo-first order conditions in the presence of substrate (Morrison, J. F., TIBS, 102-105, 1982; Tian, W. X. and Tsou, C. L., Biochemistry, 21, 1028-1032, 1982; Morrison, J. F. and Walsh, C. T., from Meister (Ed.), Advances in Enzymol., 61, 201-301, 1988; Tsou, C. L., from Meister (Ed.), Advances in Enzymol., 61, 381-436, 1988;). Assays were carried out by addition of various concentrations of inhibitor to assay buffer containing substrate. Assays were initiated by the addition of enzyme to the reaction mixture and the change in fluorescence monitored over time. During the course of the assay less than 10% of the substrate was consumed.
The activity fluorescence progress curves were fitted by non-linear regression analysis (Prism) using Eq. 5 (Morrison, 1969; Morrison, 1982); where ‘F’ is the fluorescence response, ‘t’ is time, ‘vo’ is the initial velocity, ‘vs’ is the equilibrium steady-state velocity, ‘kobs’ is the observed pseudo first-order rate constant and ‘D’ is the intercept at time zero (i.e. the ordinate displacement of the curve). The second order rate constant was obtained from the slope of the line of a plot of kobs versus the inhibitor concentration (i.e. kobs/[I]). To correct for substrate kinetics, Eq. 6 was used, where ‘[So]’ is the iniitial substrate concentration and ‘KMapp’ is the apparent macroscopic binding (Michaelis) constant for the substrate.
Compounds of the invention were tested by the above described assays and observed to exhibit cathepsin K inhibitory activity or inhibitory activity against an alternative CA C1 cysteine protease with an in vitro Ki inhibitory constant of less than or equal to 100 μM. Exemplary inhibition data for examples of the invention are given in Table 5.
TABLE 5
|
|
Exemplary inhibition data (Ki expressed as μM).
ExampleHumanBovineHuman
N°Cathepsin KCruzipainCathepsin SCathepsin LCPB
|
2<0.01>0.3>1>3>0.2
296>50>1>5<0.2>5
250>5>5<0.1>1>5
346>8<0.2>10>3>5
|
Human Osteoclast Resorption Assay
Bone resorption was studied using a model where human osteoclast precursor cells were cultured on bovine bone slices for 9 days and allowed to differentiate into bone-resorbing osteoclasts. The formed mature osteoclasts were then allowed to resorb bone. The assay was performed by Pharmatest Services Ltd, Itainen Pitkakatu 4C, Turku, Finland. After the culture period, bone collagen degradation products were quantified from the culture medium as an index of bone resorption. Inhibitor compounds were added into the cell cultures after the differentiation period and their effects on the resorbing activity of mature osteoclasts were determined. The studies included a baseline group without added compounds and a positive control group where a potent cathepsin K inhibitor E-64 was added.
Human peripheral blood monocytes were suspended to culture medium and allowed to attach to bovine bone slices. The bone slices were transferred into 96-well tissue culture plates containing culture medium with appropriate amounts of important growth factors favouring osteoclast differentiation, including M-CSF, RANK-ligand and TGF-β. The cells were incubated in a CO2 incubator in humidified atmosphere of 95% air and 5% carbon dioxide at 37° C. At day 7 when osteoclast differentiation was complete, the culture medium was replaced with culture medium containing conditions favouring osteoclast activity. The cell culture was continued for an additional 2 days, during which the formed mature osteoclasts were allowed to resorb bone in the presence of vehicle, control inhibitor (E64) or test compounds. At the end of the culture, bone collagen degradation products released into the culture medium were determined using a commercially available ELISA method (CrossLaps® for culture, Nordic Bioscience, Herlev, Denmark) as an index of bone resorption (see Bagger, Y. Z. et al, J. Bone. Miner. Res. 14 (suppl. 1), S370).
In this assay, selected EXAMPLES of the invention exhibited more than 70% inhibition of bone resorption at a concentration of 100 nM.